PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Knoch, D; Pascual-Leone, A; Meyer, K; Treyer, V; Fehr, E				Knoch, Daria; Pascual-Leone, Alvaro; Meyer, Kaspar; Treyer, Valerie; Fehr, Ernst			Diminishing reciprocal fairness by disrupting the right prefrontal cortex	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DECISION-MAKING; ULTIMATUM GAME; INHIBITION; COGNITION	Humans restrain self-interest with moral and social values. They are the only species known to exhibit reciprocal fairness, which implies the punishment of other individuals' unfair behaviors, even if it hurts the punisher's economic self-interest. Reciprocal fairness has been demonstrated in the Ultimatum Game, where players often reject their bargaining partner's unfair offers. Despite progress in recent years, however, little is known about how the human brain limits the impact of selfish motives and implements fair behavior. Here we show that disruption of the right, but not the left, dorsolateral prefrontal cortex (DLPFC) by low-frequency repetitive transcranial magnetic stimulation substantially reduces subjects' willingness to reject their partners' intentionally unfair offers, which suggests that subjects are less able to resist the economic temptation to accept these offers. Importantly, however, subjects still judge such offers as very unfair, which indicates that the right DLPFC plays a key role in the implementation of fairness-related behaviors.	Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Coll Helveticum, CH-8092 Zurich, Switzerland; Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; Harvard Univ, Sch Med, Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Univ Zurich Hosp, Dept Radiol, PET Ctr, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Zurich; University Zurich Hospital	Knoch, D (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.	dknoch@iew.unizh.ch; efehr@iew.unizh.ch	Pascual-Leone, Alvaro/AAC-5101-2019; Knoch, Daria/H-7324-2012; Pascual-Leone, Alvaro/G-6566-2011; Treyer, Valerie/G-6986-2018	Pascual-Leone, Alvaro/0000-0001-8975-0382; Treyer, Valerie/0000-0002-4584-3031	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NCRR NIH HHS [K24 RR018875] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abler B, 2005, BRAIN TOPOGR, V17, P193, DOI 10.1007/s10548-005-6028-y; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Boyd R, 2005, ORIGIN EVOLUTION CUL; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Camerer ColinF., 2003, BEHAV GAME THEORY EX; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Damasio A, 1995, DESCARTES ERROR EMOT; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Freud S., 1962, EGO ID; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; OEWENSTEIN GF, 2004, ANIMAL SPIRITS AFFEC; Perugini M, 2003, EUR J PERSONALITY, V17, P251, DOI 10.1002/per.474; RABIN M, 1993, AM ECON REV, V83, P1281; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; [No title captured]	28	650	679	7	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					829	832		10.1126/science.1129156	http://dx.doi.org/10.1126/science.1129156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17023614	Green Published			2022-12-01	WOS:000241729800050
J	Molofsky, AV; Slutsky, SG; Joseph, NM; He, SH; Pardal, R; Krishnamurthy, J; Sharpless, NE; Morrison, SJ				Molofsky, Anna V.; Slutsky, Shalom G.; Joseph, Nancy M.; He, Shenghui; Pardal, Ricardo; Krishnamurthy, Janakiraman; Sharpless, Norman E.; Morrison, Sean J.			Increasing p16(INK4a) expression decreases forebrain progenitors and neurogenesis during ageing	NATURE			English	Article							NEURAL STEM-CELL; SELF-RENEWAL; SUBVENTRICULAR ZONE; TUMOR SUPPRESSION; ADULT; PROLIFERATION; SENESCENCE; GROWTH; MICE; TUMORIGENESIS	Mammalian ageing is associated with reduced regenerative capacity in tissues that contain stem cells(1,2). It has been proposed that this is at least partially caused by the senescence of progenitors with age(3,4); however, it has not yet been tested whether genes associated with senescence functionally contribute to physiological declines in progenitor activity. Here we show that progenitor proliferation in the subventricular zone and neurogenesis in the olfactory bulb, as well as multipotent progenitor frequency and self-renewal potential, all decline with age in the mouse forebrain. These declines in progenitor frequency and function correlate with increased expression of p16(INK4a), which encodes a cyclin-dependent kinase inhibitor linked to senescence(5). Ageing p16(INK4a)-deficient mice showed a significantly smaller decline in subventricular zone proliferation, olfactory bulb neurogenesis, and the frequency and self-renewal potential of multipotent progenitors. p16(INK4a) deficiency did not detectably affect progenitor function in the dentate gyrus or enteric nervous system, indicating regional differences in the response of neural progenitors to increased p16(INK4a) expression during ageing. Declining subventricular zone progenitor function and olfactory bulb neurogenesis during ageing are thus caused partly by increasing p16(INK4a) expression.	Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Morrison, SJ (corresponding author), Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	IBIS, FISIOPATOLOGIA/O-9510-2015; Molofsky, Anna Victoria/P-2506-2018; Morrison, Sean/ABD-5326-2021; Pardal, Ricardo/C-4370-2015; He, Shenghui/L-4833-2018	Molofsky, Anna Victoria/0000-0002-4709-2411; Pardal, Ricardo/0000-0003-1085-0714; He, Shenghui/0000-0001-8842-7137; Sharpless, Norman/0000-0001-7078-9455; Slutsky, Guy/0000-0001-5135-5694; Morrison, Sean/0000-0003-1587-8329	NATIONAL INSTITUTE ON AGING [R01AG024945] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG024945-02, R01 AG024945-05, R01 AG024945-03, R01 AG024945-03S1, R01 AG024945-04, R01 AG024945, R01 AG024945-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nielsen GP, 1999, LAB INVEST, V79, P1137; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	30	732	778	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					448	452		10.1038/nature05091	http://dx.doi.org/10.1038/nature05091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	16957738	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000240798800044
J	Alkuraya, FS; Saadi, I; Lund, JJ; Turbe-Doan, A; Morton, CC; Maas, RL				Alkuraya, Fowzan S.; Saadi, Irfan; Lund, Jennifer J.; Turbe-Doan, Annick; Morton, Cynthia C.; Maas, Richard L.			SUMO1 haploinsufficiency leads to cleft lip and palate	SCIENCE			English	Article							SATB2; GENE		Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol & Reprod Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Maas, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, NRB-458,77 Louis Pasteur, Boston, MA 02115 USA.	maas@genetics.med.harvard.edu	Saadi, Irfan/I-5989-2019; Alkuraya, Fowzan S./A-1542-2009	Saadi, Irfan/0000-0002-6250-6651; Alkuraya, Fowzan S./0000-0003-4158-341X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD043430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE011697, R01DE015246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NICHD NIH HHS [HD043430] Funding Source: Medline; NIDCR NIH HHS [DE11697, DE015246] Funding Source: Medline; NIGMS NIH HHS [GM061365, P01 GM061354] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722	7	145	159	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1751	1751		10.1126/science.1128406	http://dx.doi.org/10.1126/science.1128406			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990542				2022-12-01	WOS:000240655700037
J	Fukata, Y; Adesnik, H; Iwanaga, T; Bredt, DS; Nicoll, RA; Fukata, M				Fukata, Yuko; Adesnik, Hillel; Iwanaga, Tsuyoshi; Bredt, David S.; Nicoll, Roger A.; Fukata, Masaki			Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission	SCIENCE			English	Article							PROTEINS; GENE; MUTATIONS; RECEPTORS; MICE; MECHANISMS; SYNAPSES; PSD-95; 10Q24; BRAIN	Abnormally synchronized synaptic transmission in the brain causes epilepsy. Most inherited forms of epilepsy result from mutations in ion channels. However, one form of epilepsy, autosomal dominant partial epilepsy with auditory features (ADPEAF), is characterized by mutations in a secreted neuronal protein, LGI1. We show that ADAM22, a transmembrane protein that when mutated itself causes seizure, serves as a receptor for LGI1. LGI1 enhances AMPA receptor-mediated synaptic transmission in hippocampal slices. The mutated form of LGI1 fails to bind to ADAM22. ADAM22 is anchored to the postsynaptic density by cytoskeletal scaffolds containing stargazin. These studies in rat brain indicate possible avenues for understanding human epilepsy.	Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Genom & Proteom, Aichi 4748522, Japan; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Eli Lilly & Co, Dept Integrat Biol, Indianapolis, IN 46285 USA; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	National Center for Geriatrics & Gerontology; University of California System; University of California San Francisco; Eli Lilly; Japan Science & Technology Agency (JST)	Fukata, M (corresponding author), Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Genom & Proteom, Aichi 4748522, Japan.	fmasaki@nils.go.jp	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Fukata, Yuko/0000-0001-7724-8643				Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; El-Hussein AE, 2000, SCIENCE, V290, P1364; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Novak U, 2004, J CLIN NEUROSCI, V11, P227, DOI 10.1016/j.jocn.2003.10.006; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Yagi H, 2005, J NEUROCHEM, V92, P191, DOI 10.1111/j.1471-4159.2004.02875.x	25	265	278	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1792	1795		10.1126/science.1129947	http://dx.doi.org/10.1126/science.1129947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990550				2022-12-01	WOS:000240655700050
J	Shaked, Y; Ciarrocchi, A; Franco, M; Lee, CR; Man, S; Cheung, AM; Hicklin, DJ; Chaplin, D; Foster, FS; Benezra, R; Kerbel, RS				Shaked, Yuval; Ciarrocchi, Alessia; Franco, Marcela; Lee, Christina R.; Man, Shan; Cheung, Alison M.; Hicklin, Daniel J.; Chaplin, David; Foster, F. Stuart; Benezra, Robert; Kerbel, Robert S.			Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors	SCIENCE			English	Article							STEM-CELLS; ANGIOGENESIS; GROWTH; CHEMOTHERAPY; TERM	The contribution of bone marrow-derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads to an acute mobilization of CEPs, which home to the viable tumor rim that characteristically remains after such therapy. Disruption of this CEP spike by antiangiogenic drugs or by genetic manipulation resulted in marked reductions in tumor rim size and blood flow as well as enhanced VDA antitumor activity. These findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.	Sunnybrook Hlth Sci Ctr, Dept Mol & Cellular Biol Res, Toronto, ON M4N 3M5, Canada; Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; Sunnybrook Hlth Sci Ctr, Dept Imaging Res, Toronto, ON M4N 3M5, Canada; ImClone Syst, New York, NY 10014 USA; OXiGENE Inc, Waltham, MA 02451 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Memorial Sloan Kettering Cancer Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Eli Lilly	Kerbel, RS (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Mol & Cellular Biol Res, Toronto, ON M4N 3M5, Canada.	robert.kerbel@sri.utoronto.ca	Ciarrocchi, Alessia/AAA-1130-2019	Ciarrocchi, Alessia/0000-0002-5541-2075; Foster, F. Stuart/0000-0003-3972-8296	NCI NIH HHS [R01 CA-107429, CA-41233] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041233, R01CA107429] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bertolini F, 2003, CANCER RES, V63, P4342; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Heil M, 2004, CIRC RES, V94, P573, DOI 10.1161/01.RES.0000124603.46777.EB; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Prewett M, 1999, CANCER RES, V59, P5209; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shaked Y, 2005, CANCER RES, V65, P7045, DOI 10.1158/0008-5472.CAN-05-0765; Siemann DW, 2004, CANCER-AM CANCER SOC, V100, P2491, DOI 10.1002/cncr.20299; Siemann DW, 2005, INT J RADIAT ONCOL, V62, P846, DOI 10.1016/j.ijrobp.2005.02.048; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78	19	470	493	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1785	1787		10.1126/science.1127592	http://dx.doi.org/10.1126/science.1127592			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990548				2022-12-01	WOS:000240655700048
J	Hulko, M; Berndt, F; Gruber, M; Linder, JU; Truffault, V; Schultz, A; Martin, J; Schultz, JE; Lupas, AN; Coles, M				Hulko, Michael; Berndt, Franziska; Gruber, Markus; Linder, Juergen U.; Truffault, Vincent; Schultz, Anita; Martin, Joerg; Schultz, Joachim E.; Lupas, Andrei N.; Coles, Murray			The HAMP domain structure implies helix rotation in transmembrane signaling	CELL			English	Article							LINKER REGION; COILED-COIL; ESCHERICHIA-COLI; HISTIDINE KINASE; MUTATIONAL ANALYSIS; ASPARTATE RECEPTOR; ADENYLYL CYCLASES; SENSORY-RHODOPSIN; EXCHANGE-RATES; LAC REPRESSOR	HAMP domains connect extracellular sensory with intracellular signaling domains in over 7500 proteins, including histidine kinases, adenylyl cyclases, chemotaxis receptors, and phosphatases. The solution structure of an archaeal HAMP domain shows a homodimeric, four-helical, parallel coiled coil with unusual interhelical packing, related to the canonical packing by rotation of the helices. This suggests a model for the mechanism of signal transduction, in which HAMP alternates between the observed conformation and a canonical coiled coil. We explored this mechanism in vitro and in vivo using HAMP domain fusions with a mycobacterial adenylyl cyclase and an E coli chemotaxis receptor. Structural and functional studies show that the equilibrium between the two forms is dependent on the sidechain size of residue 291, which is alanine in the wild-type protein.	Univ Tubingen, Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; Univ Tubingen, Sch Pharm, Dept Pharmaceut Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen	Lupas, AN (corresponding author), Univ Tubingen, Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany.	andrei.lupas@tuebingen.mpg.de						ALBERTI S, 1993, EMBO J, V12, P3227, DOI 10.1002/j.1460-2075.1993.tb05992.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1111/j.1574-6968.1999.tb13650.x; Berg, 2018, RANDOM WALKS BIOL; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Cochran AG, 1996, SCIENCE, V271, P1113, DOI 10.1126/science.271.5252.1113; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Deng YQ, 2006, STRUCTURE, V14, P247, DOI 10.1016/j.str.2005.10.010; Diercks T, 1999, J BIOMOL NMR, V15, P177, DOI 10.1023/A:1008367912535; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GEMMECKER G, 1993, J AM CHEM SOC, V115, P11620, DOI 10.1021/ja00077a080; GERNERT KM, 1995, PROTEIN SCI, V4, P2252, DOI 10.1002/pro.5560041102; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; KOIDE S, 1995, J BIOMOL NMR, V6, P306; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; KORETKE KK, 2003, HISTIDINE KINASES SI, P483; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Miller AS, 2004, BIOCHEMISTRY-US, V43, P1763, DOI 10.1021/bi0360206; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SCOTT WG, 1994, STRUCTURE, V2, P877, DOI 10.1016/S0969-2126(94)00088-3; Singh M, 1998, P NATL ACAD SCI USA, V95, P2738, DOI 10.1073/pnas.95.6.2738; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Solan A, 2002, J MOL BIOL, V317, P601, DOI 10.1006/jmbi.2002.5427; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOKISHITA S, 1992, J BIOCHEM-TOKYO, V111, P707, DOI 10.1093/oxfordjournals.jbchem.a123823; Truffault V, 2001, J MOL BIOL, V309, P949, DOI 10.1006/jmbi.2001.4683; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; WANG AC, 1995, J AM CHEM SOC, V117, P1810, DOI 10.1021/ja00111a021; Williams SB, 1999, MOL MICROBIOL, V33, P1093, DOI 10.1046/j.1365-2958.1999.01562.x; Yadav MK, 2005, BIOCHEMISTRY-US, V44, P9723, DOI 10.1021/bi050742a; Yadav MK, 2006, BIOCHEMISTRY-US, V45, P4463, DOI 10.1021/bi060092q; Zhu Y, 2003, J BIOL CHEM, V278, P22812, DOI 10.1074/jbc.M300916200	46	318	322	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					929	940		10.1016/j.cell.2006.06.058	http://dx.doi.org/10.1016/j.cell.2006.06.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959572	Bronze			2022-12-01	WOS:000240675000020
J	McCauley, DJ				McCauley, Douglas J.			Selling out on nature	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	McCauley, DJ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							[Anonymous], 1997, NATURES SERVICES; DEPALMA A, 2006, NY TIMES        0720; Gibbard S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024550; HAYWARD B, 2005, MOUNTAIN TAP LAND US; Mea, 2003, ECOSYSTEMS HUMAN WEL; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Terborgh J., 1999, REQUIEM NATURE; Willott E, 2004, RESTOR ECOL, V12, P147, DOI 10.1111/j.1061-2971.2004.00392.x; WILSON E O, 1992; Woodroffe R., 2005, PEOPLE WILDLIFE CONF	10	444	459	10	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					27	28		10.1038/443027a	http://dx.doi.org/10.1038/443027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957711				2022-12-01	WOS:000240313900020
J	Spratt, A; Ogunbowale, L; Wormald, R; Franks, W				Spratt, A.; Ogunbowale, L.; Wormald, R.; Franks, W.			What's in a name? New glaucoma drugs	LANCET			English	Editorial Material							TIMOLOL		Moorfields Eye Hosp, London EC1V 2PD, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Spratt, A (corresponding author), Moorfields Eye Hosp, City Rd, London EC1V 2PD, England.	alex.spratt@moorfields.nhs.uk						GLYNN RJ, 1991, ARCH OPHTHALMOL-CHIC, V109, P205, DOI 10.1001/archopht.1991.01080020051041; Kirwan JF, 2002, BRIT MED J, V325, P1396, DOI 10.1136/bmj.325.7377.1396; Lee AJ, 2006, OPHTHALMOLOGY, V113, P1069, DOI 10.1016/j.ophtha.2006.02.062; Miller JA, 2000, RESPIRATION, V67, P216, DOI 10.1159/000029491; NELSON WL, 1986, AM J OPHTHALMOL, V102, P606, DOI 10.1016/0002-9394(86)90532-5; Nieminen T, 2005, EUR J CLIN PHARMACOL, V61, P369, DOI 10.1007/s00228-005-0945-2; PATEL SC, 1995, OPHTHALMIC SURG LAS, V26, P233; UUSALITO H, 2005, ACTA OPHTHALMOL SCAN, V83, P723; VUORI M, 1995, GRAEFES ARCH CLIN EX, V223, P131	9	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					826	827		10.1016/S0140-6736(06)69304-5	http://dx.doi.org/10.1016/S0140-6736(06)69304-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950343				2022-12-01	WOS:000240371200009
J	Behrenfeld, MJ; Worthington, K; Sherrell, RM; Chavez, FP; Strutton, P; McPhaden, M; Shea, DM				Behrenfeld, Michael J.; Worthington, Kirby; Sherrell, Robert M.; Chavez, Francisco P.; Strutton, Peter; McPhaden, Michael; Shea, Donald M.			Controls on tropical Pacific Ocean productivity revealed through nutrient stress diagnostics	NATURE			English	Article							IRON-DEFICIENCY; ELECTRON-TRANSPORT; SYNECHOCOCCUS SP; PHOTOSYSTEM-II; PHYTOPLANKTON BLOOM; SOUTHERN-OCEAN; CHLOROPHYLL; LIGHT; CYANOBACTERIA; FLUORESCENCE	In situ enrichment experiments have shown that the growth of bloom-forming diatoms in the major high-nitrate low-chlorophyll (HNLC) regions of the world's oceans is limited by the availability of iron(1-3). Yet even the largest of these manipulative experiments represents only a small fraction of an ocean basin, and the responses observed are strongly influenced by the proliferation of rare species rather than the growth of naturally dominant populations(4,5). Here we link unique fluorescence attributes of phytoplankton to specific physiological responses to nutrient stress, and use these relationships to evaluate the factors that constrain phytoplankton growth in the tropical Pacific Ocean on an unprecedented spatial scale. On the basis of fluorescence measurements taken over 12 years, we delineate three major ecophysiological regimes in this region. We find that iron has a key function in regulating phytoplankton growth in both HNLC and oligotrophic waters near the Equator and further south, whereas nitrogen and zooplankton grazing are the primary factors that regulate biomass production in the north. Application of our findings to the interpretation of satellite chlorophyll fields shows that productivity in the tropical Pacific basin may be 1.2 - 2.5 Pg C yr(-1) lower than previous estimates have suggested, a difference that is comparable to the global change in ocean production that accompanied the largest El Nino to La Nina transition on record(6).	Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; NASA, Sci Applicat Int Corp, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	Oregon State University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Applications International Corporation (SAIC); Rutgers State University New Brunswick; Rutgers State University New Brunswick; Monterey Bay Aquarium Research Institute; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Behrenfeld, MJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Cordley Hall 2082, Corvallis, OR 97331 USA.	mjb@science.oregonstate.edu	McPhaden, Michael J/D-9799-2016; Strutton, Peter G/C-4466-2011	McPhaden, Michael J/0000-0002-8423-5805; Strutton, Peter G/0000-0002-2395-9471				Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Belkhodja R, 1998, PHOTOSYNTH RES, V56, P265, DOI 10.1023/A:1006039917599; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DITULLIO GR, 1993, LIMNOL OCEANOGR, V38, P495, DOI 10.4319/lo.1993.38.3.0495; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Larbi A, 2004, PHOTOSYNTH RES, V79, P59, DOI 10.1023/B:PRES.0000011919.35309.5e; LaRoche J, 1996, NATURE, V382, P802; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Morales F, 2001, PHOTOSYNTH RES, V70, P207, DOI 10.1023/A:1017965229788; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Olson RJ, 2000, DEEP-SEA RES PT II, V47, P3181, DOI 10.1016/S0967-0645(00)00064-3; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; RIETHMAN HC, 1988, BIOCHIM BIOPHYS ACTA, V935, P141, DOI 10.1016/0005-2728(88)90211-3; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; Sandstrom S, 2002, PHYSIOL PLANTARUM, V116, P255, DOI 10.1034/j.1399-3054.2002.1160216.x; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Troyan T., 1989, TECHNIQUES NEW DEV P, P601; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Varsano T, 2003, J PLANT NUTR, V26, P2197, DOI 10.1081/PLN-120024275; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963	29	203	217	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1025	1028		10.1038/nature05083	http://dx.doi.org/10.1038/nature05083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943835				2022-12-01	WOS:000240142000046
J	Huang, AL; Chen, XK; Hoon, MA; Chandrashekar, J; Guo, W; Trankner, D; Ryba, NJP; Zuker, CS				Huang, Angela L.; Chen, Xiaoke; Hoon, Mark A.; Chandrashekar, Jayaram; Guo, Wei; Trankner, Dimitri; Ryba, Nicholas J. P.; Zuker, Charles S.			The cells and logic for mammalian sour taste detection	NATURE			English	Article							DIPHTHERIA-TOXIN; RECEPTORS; SWEET; FAMILY; BITTER; CHANNELS; NEURONS; SYSTEM	Mammals taste many compounds yet use a sensory palette consisting of only five basic taste modalities: sweet, bitter, sour, salty and umami ( the taste of monosodium glutamate)(1,2). Although this repertoire may seem modest, it provides animals with critical information about the nature and quality of food. Sour taste detection functions as an important sensory input to warn against the ingestion of acidic ( for example, spoiled or unripe) food sources(1-3). We have used a combination of bioinformatics, genetic and functional studies to identify PKD2L1, a polycystic-kidney-disease-like ion channel(4), as a candidate mammalian sour taste sensor. In the tongue, PKD2L1 is expressed in a subset of taste receptor cells distinct from those responsible for sweet, bitter and umami taste. To examine the role of PKD2L1-expressing taste cells in vivo, we engineered mice with targeted genetic ablations of selected populations of taste receptor cells. Animals lacking PKD2L1-expressing cells are completely devoid of taste responses to sour stimuli. Notably, responses to all other tastants remained unaffected, proving that the segregation of taste qualities even extends to ionic stimuli. Our results now establish independent cellular substrates for four of the five basic taste modalities, and support a comprehensive labelled-line mode of taste coding at the periphery(5-10). Notably, PKD2L1 is also expressed in specific neurons surrounding the central canal of the spinal cord. Here we demonstrate that these PKD2L1-expressing neurons send projections to the central canal, and selectively trigger action potentials in response to decreases in extracellular pH. We propose that these cells correspond to the long-sought components of the cerebrospinal fluid chemosensory system(11). Taken together, our results suggest a common basis for acid sensing in disparate physiological settings.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurobiol & Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu	chen, xiaoke/E-5385-2011	Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NIDCD NIH HHS [R01 DC004861] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004861] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Delmas P, 2005, PFLUG ARCH EUR J PHY, V451, P264, DOI 10.1007/s00424-005-1431-5; DeSimone JA, 2001, RESP PHYSIOL, V129, P231, DOI 10.1016/S0034-5687(01)00293-6; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; Lahiri S, 2003, INT J BIOCHEM CELL B, V35, P1413, DOI 10.1016/S1357-2725(03)00050-5; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Richerson GB, 2005, EXP PHYSIOL, V90, P259, DOI 10.1113/expphysiol.2005.029843; Richerson GB, 2005, EXP PHYSIOL, V90, P269, DOI 10.1111/j.1469-445X.2005.t01-2-00135.x; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Vinnikova AK, 2004, J NEUROPHYSIOL, V91, P1297, DOI 10.1152/jn.00809.2003; Wu GQ, 1998, GENOMICS, V54, P564, DOI 10.1006/geno.1998.5618; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	31	522	544	11	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2006	442	7105					934	938		10.1038/nature05084	http://dx.doi.org/10.1038/nature05084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16929298	Green Accepted			2022-12-01	WOS:000239960500041
J	Drenth, JPH; van der Meer, JWM				Drenth, Joost P. H.; van der Meer, Jos W. M.			The inflammasome - A linebacker of innate defense	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MUTATIONS; ACTIVATE; CIAS1		Radboud Univ Med Ctr, Dept Gastroenterol, Nijmegen, Netherlands; Radboud Univ Med Ctr, Dept Hepatol, Nijmegen, Netherlands; Radboud Univ Med Ctr, Dept Gen Internal Med, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Drenth, JPH (corresponding author), Radboud Univ Med Ctr, Dept Gastroenterol, Nijmegen, Netherlands.		van der Meer, Jos W.M./C-8521-2013; Drenth, J.P.H./H-8025-2014; Drenth, Joost/V-7436-2019	van der Meer, Jos W.M./0000-0001-5120-3690; 				Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516	6	89	100	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2006	355	7					730	732		10.1056/NEJMcibr063500	http://dx.doi.org/10.1056/NEJMcibr063500			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074AN	16914711	Green Published			2022-12-01	WOS:000239784500015
J	Segal, E; Fondufe-Mittendorf, Y; Chen, LY; Thastrom, A; Field, Y; Moore, IK; Wang, JPZ; Widom, J				Segal, Eran; Fondufe-Mittendorf, Yvonne; Chen, Lingyi; Thastroem, AnnChristine; Field, Yair; Moore, Irene K.; Wang, Ji-Ping Z.; Widom, Jonathan			A genomic code for nucleosome positioning	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-SEQUENCE; EXPRESSION PROFILES; GENE-EXPRESSION; YEAST; CHROMATIN; PROMOTER; HISTONE; IDENTIFICATION; BINDING	Eukaryotic genomes are packaged into nucleosome particles that occlude the DNA from interacting with most DNA binding proteins. Nucleosomes have higher affinity for particular DNA sequences, reflecting the ability of the sequence to bend sharply, as required by the nucleosome structure. However, it is not known whether these sequence preferences have a significant influence on nucleosome position in vivo, and thus regulate the access of other proteins to DNA. Here we isolated nucleosome-bound sequences at high resolution from yeast and used these sequences in a new computational approach to construct and validate experimentally a nucleosome - DNA interaction model, and to predict the genome-wide organization of nucleosomes. Our results demonstrate that genomes encode an intrinsic nucleosome organization and that this intrinsic organization can explain similar to 50% of the in vivo nucleosome positions. This nucleosome positioning code may facilitate specific chromosome functions including transcription factor binding, transcription initiation, and even remodelling of the nucleosomes themselves.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Stat, Evanston, IL 60208 USA	Weizmann Institute of Science; Northwestern University; Northwestern University	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il; j-widom@northwestern.edu	Segal, Eran/AAF-4855-2019; Chen, Lingyi/G-6309-2013	Segal, Eran/0000-0002-6859-1164	NCI NIH HHS [R01 CA119176-01, R01 CA119176] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KENT NA, 1994, MOL CELL BIOL, V14, P5229, DOI 10.1128/MCB.14.8.5229; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li H, 2002, P NATL ACAD SCI USA, V99, P11772, DOI 10.1073/pnas.112341999; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SHIMIZU M, 1991, EMBO J, V10, P3033, DOI 10.1002/j.1460-2075.1991.tb07854.x; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; TRIFONOV EN, 1980, NUCLEIC ACIDS RES, V8, P4041, DOI 10.1093/nar/8.17.4041; van Holde K.E., 1989, CHROMATIN; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Wang JPZ, 2005, NUCLEIC ACIDS RES, V33, P6743, DOI 10.1093/nar/gki977; Weiss K, 1997, EMBO J, V16, P4352, DOI 10.1093/emboj/16.14.4352; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	44	1143	1174	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					772	778		10.1038/nature04979	http://dx.doi.org/10.1038/nature04979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862119	Green Accepted			2022-12-01	WOS:000239792700037
J	Alerstam, T				Alerstam, Thomas			Conflicting evidence about long-distance animal navigation	SCIENCE			English	Editorial Material							SEA-TURTLES; BIRD NAVIGATION; MIGRATION; ORIENTATION; MAGNETORECEPTION; MIGRANTS; CUES; INFORMATION; ALBATROSSES; MECHANISM	Because of conflicting evidence about several fundamental issues, long-distance animal navigation has yet to be satisfactorily explained. Among the unsolved problems are the nature of genetic spatial control of migration and the relationships between celestial and magnetic compass mechanisms and between different map-related cues in orientation and homing, respectively. In addition, navigation is expected to differ between animal groups depending on sensory capabilities and ecological conditions. Evaluations based on modern long-term tracking techniques of the geometry of migration routes and individual migration history, combined with behavioral experiments and exploration of the sensory and genetic mechanisms, will be crucial for understanding the spatial principles that guide animals on their global journeys.	Lund Univ, Dept Anim Ecol, SE-22362 Lund, Sweden	Lund University	Alerstam, T (corresponding author), Lund Univ, Dept Anim Ecol, Ecol Bldg, SE-22362 Lund, Sweden.	thomas.alerstam@ekol.lu.se						Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 2001, SCIENCE, V291, P300, DOI 10.1126/science.291.5502.300; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Benhamou S, 2003, ANIM BEHAV, V65, P729, DOI 10.1006/anbe.2003.2092; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bohning-Gaese K, 1998, EVOL ECOL, V12, P767, DOI 10.1023/A:1006538414645; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Bonadonna F, 2005, P ROY SOC B-BIOL SCI, V272, P489, DOI 10.1098/rspb.2004.2984; Chernetsov N, 2004, J EXP BIOL, V207, P937, DOI 10.1242/jeb.00853; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Emlen S.T., 1975, AVIAN BIOL, P129; Fischer JH, 2001, ANIM BEHAV, V62, P1, DOI 10.1006/anbe.2000.1722; Fransson T, 2005, J AVIAN BIOL, V36, P6, DOI 10.1111/j.0908-8857.2005.03471.x; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; GRINNELL JOSEPH, 1931, AUK, V48, P22; Hays GC, 2003, P ROY SOC B-BIOL SCI, V270, pS5, DOI 10.1098/rsbl.2003.0022; Hunter E, 2003, P ROY SOC B-BIOL SCI, V270, P2097, DOI 10.1098/rspb.2003.2473; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; Luschi P, 2003, MAR BIOL, V143, P793, DOI 10.1007/s00227-003-1117-5; Luschi P, 2001, BEHAV ECOL SOCIOBIOL, V50, P528, DOI 10.1007/s002650100396; Mettke-Hofmann C, 2003, P NATL ACAD SCI USA, V100, P5863, DOI 10.1073/pnas.1037505100; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2003, J EXP BIOL, V206, P4155, DOI 10.1242/jeb.00650; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Papi F, 2000, J EXP BIOL, V203, P3435; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sutherland WJ, 1998, J AVIAN BIOL, V29, P441, DOI 10.2307/3677163; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x; THORUP K, IN PRESS ANIM BEHAV; Wallraff H.G., 2005, AVIAN NAVIGATION PIG; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7	38	130	133	5	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2006	313	5788					791	794		10.1126/science.1129048	http://dx.doi.org/10.1126/science.1129048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902128				2022-12-01	WOS:000239671300046
J	Pokholok, DK; Zeitlinger, J; Hannett, NM; Reynolds, DB; Young, RA				Pokholok, Dmitry K.; Zeitlinger, Julia; Hannett, Nancy M.; Reynolds, David B.; Young, Richard A.			Activated signal transduction kinases frequently occupy target genes	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; YEAST; MAP; PROTEIN; EXPRESSION; HOG1; GENOME; LOCALIZATION; ORGANIZATION; RECRUITMENT	Cellular signal transduction pathways modify gene expression programs in response to changes in the environment, but the mechanisms by which these pathways regulate populations of genes under their control are not entirely understood. We present evidence that most mitogen-activated protein kinases and protein kinase A subunits become physically associated with the genes that they regulate in the yeast ( Saccharomyces cerevisiae) genome. The ability to detect this interaction of signaling kinases with target genes can be used to more precisely and comprehensively map the regulatory circuitry that eukaryotic cells use to respond to their environment.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069676] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG002668] Funding Source: Medline; NIGMS NIH HHS [GM069676] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Tomas-Cobos L, 2004, J BIOL CHEM, V279, P22010, DOI 10.1074/jbc.M400609200; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3	27	202	210	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					533	536		10.1126/science.1127677	http://dx.doi.org/10.1126/science.1127677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873666				2022-12-01	WOS:000239308600066
J	Marcus, DM; Grollman, AP				Marcus, Donald M.; Grollman, Arthur P.			Review for NCCAM is overdue	SCIENCE			English	Editorial Material							ALTERNATIVE MEDICINE; CHELATION-THERAPY; HERBAL REMEDIES; HEART-DISEASE; HEALTH		Baylor Coll Med, Dept Med, Houston, TX 77030 USA; SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Marcus, DM (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	dmarcus@bcm.tmc.edu						*AM HEART ASS, QUEST ANSW CHEL THER; Bent S, 2006, NEW ENGL J MED, V354, P557, DOI 10.1056/NEJMoa053085; Berman JD, 2004, ANNU REV MED, V55, P239, DOI 10.1146/annurev.med.55.091902.103657; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; BUDIANSKY S, 1995, US NEWS WORLD R 0717, P48; *COMM US COMPL ALT, 2005, COMPL ALT MED US, pCH9; Couzin J, 1998, SCIENCE, V282, P2175, DOI 10.1126/science.282.5397.2175; De Smet PAGM, 2004, CLIN PHARMACOL THER, V76, P1, DOI 10.1016/j.clpt.2004.03.005; Elvin-Lewis Memory, 2005, Adv Food Nutr Res, V50, P219, DOI 10.1016/S1043-4526(05)50007-X; Ernst E, 2000, AM HEART J, V140, P139, DOI 10.1067/mhj.2000.107548; Knudtson ML, 2002, JAMA-J AM MED ASSOC, V287, P481, DOI 10.1001/jama.287.4.481; KOLATA G, 2005, NY TIMES        0728; Markowitz JS, 2003, JAMA-J AM MED ASSOC, V290, P1500, DOI 10.1001/jama.290.11.1500; MARSHALL E, 1994, SCIENCE, V265, P2000, DOI 10.1126/science.8091220; Mervis J, 2006, SCIENCE, V311, P28, DOI 10.1126/science.311.5757.28; *NCCAM US DEP HHS, 2005, EXP HOR HLTH CAR STR; Sampson W, 2005, NEW ENGL J MED, V353, P337, DOI 10.1056/NEJMp058130; Seely Dugald M R, 2005, BMC Cardiovasc Disord, V5, P32, DOI 10.1186/1471-2261-5-32; Stokstad E, 2000, SCIENCE, V288, P1568, DOI 10.1126/science.288.5471.1568; Turner RB, 2005, NEW ENGL J MED, V353, P341, DOI 10.1056/NEJMoa044441; Villarruz MV, 2002, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD002785, DOI 10.1002/14651858.CD002785, DOI 10.1002/14651858]; Vogel G, 1997, SCIENCE, V278, P378, DOI 10.1126/science.278.5337.378; Young JH, 1998, B HIST MED, V72, P279, DOI 10.1353/bhm.1998.0110; 1992, WORKSH ALT MED CHANT	24	10	10	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					301	302		10.1126/science.1126978	http://dx.doi.org/10.1126/science.1126978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857923				2022-12-01	WOS:000239154300025
J	Machado, RF; Anthi, A; Steinberg, MH; Bonds, D; Sachdev, V; Kato, GJ; Taveira-DaSilva, AM; Ballas, SK; Blackwelder, W; Xu, XL; Hunter, L; Barton, B; Waclawiw, M; Castro, O; Gladwin, MT				Machado, Roberto F.; Anthi, Anastasia; Steinberg, Martin H.; Bonds, Duane; Sachdev, Vandana; Kato, Gregory J.; Taveira-DaSilva, Angelo M.; Ballas, Samir K.; Blackwelder, William; Xu, Xiuli; Hunter, Lori; Barton, Bruce; Waclawiw, Myron; Castro, Oswaldo; Gladwin, Mark T.		MSH Investigators	N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; PRIMARY PULMONARY-HYPERTENSION; NITRIC-OXIDE BIOAVAILABILITY; VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; VASCULAR ENDOTHELIUM; ARGININE METABOLISM; PRACTICE GUIDELINES; PLATELET-ADHESION; PROGNOSTIC VALUE	Context Thirty percent of patients with sickle cell disease (SCD) develop pulmonary hypertension, a major risk factor for death in this population. A validated blood biomarker of pulmonary hypertension in SCD could provide important prognostic and diagnostic information and allow the exploration of the prevalence of pulmonary hypertension in participants in the 1996 Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) Patients' Follow-up Study. Levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) provide such information in patients with idiopathic pulmonary arterial hypertension. Objective To determine the relationship between NT-proBNP levels and severity of pulmonary hypertension and prospective mortality in patients with SCD. Design, Setting, and Participants NT-proBNP levels were measured in 230 participants in the National Institutes of Health (NIH) Sickle Cell Disease-Pulmonary Hypertension Screening Study (enrollment between February 2001 and March 2005) and in 121 samples from patients enrolled starting in 1996 in the MSH Patients' Follow-up Study. A threshold level predictive of high pulmonary artery pressure and mortality was identified in the NIH Sickle Cell Disease-Pulmonary Hypertension Screening Study and used to define an a priori analytical plan to determine the prevalence and associated mortality of pulmonary hypertension in the MSH follow-up study. Main Outcome Measures Severity of pulmonary hypertension and risk of all-cause mortality. Results NT-proBNP levels were higher in patients with sickle cell pulmonary hypertension and correlated directly with tricuspid regurgitant jet velocity in the NIH cohort (R = 0.50, P<.001). An NT-proBNP level of 160 pg/mL or greater had a 78% positive predictive value for the diagnosis of pulmonary hypertension and was an independent predictor of mortality (21 deaths at 31 months' median follow-up; risk ratio, 5.1; 95% confidence interval, 2.1-12.5; P<.001; 19.5% absolute increase in risk of death). In the MSH cohort, 30% of patients had an NT-proBNP level of 160 pg/mL or greater. An NT-proBNP level of 160 pg/mL or greater in the MSH cohort was independently associated with mortality by Cox proportional hazards regression analysis (24 deaths at 47 months' median follow-up; risk ratio, 2.87; 95% confidence interval, 1.2-6.6; P=.02; 11.9% absolute increase in risk of death). Conclusions Pulmonary hypertension, as indicated by an NT-proBNP level of 160 pg/mL or greater, was very common in patients in the NIH study and in the MSH cohort. The MSH analysis suggests that rates of vaso-occlusive pain episodes in these patients were unrelated to risk of death; this risk was largely determined by occult hemolytic anemia-associated pulmonary hypertension.	NHLBI, Vasc Med Branch, Ctr Clin, NIH, Bethesda, MD 20892 USA; NHLBI, Div Blood Dis & Resources, Bethesda, MD 20892 USA; NHLBI, Cardiovasc Branch, Bethesda, MD 20892 USA; NHLBI, Pulm & Crit Care Med Branch, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Cardeza Fdn, Philadelphia, PA 19107 USA; Maryland Med Res Inst, Baltimore, MD USA; Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Boston University; Jefferson University; Howard University	Machado, RF (corresponding author), NHLBI, Vasc Med Branch, Ctr Clin, NIH, 10 Ctr Dr,Bldg 10-CRC,Room 5-5130, Bethesda, MD 20892 USA.	robertom@nhlbi.nih.gov	Kato, Gregory J/I-7615-2014	Kato, Gregory J/0000-0003-4465-3217; Steinberg, Martin/0000-0001-8800-8020; Barton, Bruce/0000-0001-7878-8895; Machado, Roberto/0000-0002-3722-5954	CLINICAL CENTER [Z01CL001174, Z01CL008070] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HL006012-01, Z99 HL999999] Funding Source: Medline	CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aessopos A, 2001, BLOOD, V97, P3411, DOI 10.1182/blood.V97.11.3411; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; Aslan M, 2003, J BIOL CHEM, V278, P4194, DOI 10.1074/jbc.M208916200; Ataga KI, 2004, AM J MED, V117, P665, DOI 10.1016/j.amjmed.2004.03.034; Ballas SK, 1999, BRIT J HAEMATOL, V105, P491, DOI 10.1046/j.1365-2141.1999.01339.x; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Cox D.R., 1989, MONOGRAPHS STAT APPL, V2nd ed.; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; De Castro LM, 2004, BLOOD, V104, p462A, DOI 10.1182/blood.V104.11.1663.1663; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; HAGGER D, 1995, BLOOD COAGUL FIBRIN, V6, P93, DOI 10.1097/00001721-199504000-00001; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kaul DK, 2004, J CLIN INVEST, V114, P1136, DOI 10.1172/JCI200421633; Keh D, 1996, INT J ARTIF ORGANS, V19, P291, DOI 10.1177/039139889601900506; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; KURANTSINMILLS J, 1992, BRIT J HAEMATOL, V81, P539, DOI 10.1111/j.1365-2141.1992.tb02989.x; Leuchte HH, 2004, AM J RESP CRIT CARE, V170, P360, DOI 10.1164/rccm.200308-1142OC; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin ER, 1998, NEW ENGL J MED, V339, P321; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Michelson AD, 1996, AM J PHYSIOL-HEART C, V270, pH1640, DOI 10.1152/ajpheart.1996.270.5.H1640; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; Nagaya N, 1998, AM HEART J, V136, P297, DOI 10.1053/hj.1998.v136.89729; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nath KA, 2004, MICROCIRCULATION, V11, P179, DOI 10.1080/10739680490278592; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 2005, AM J CARDIOL, V95, P24, DOI 10.1016/j.amjcard.2004.08.058; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 2002, AM J CARDIOL, V89, P463, DOI 10.1016/S0002-9149(01)02271-8; PETERS M, 1994, THROMB HAEMOSTASIS, V71, P169; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; RADOMSKI MW, 1993, CARDIOVASC RES, V27, P1380, DOI 10.1093/cvr/27.7.1380; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schnog JJB, 2004, ANN HEMATOL, V83, P371, DOI 10.1007/s00277-004-0856-9; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Studt JD, 2005, BLOOD, V105, P542, DOI 10.1182/blood-2004-06-2096; Taveira-DaSilva AM, 2003, AM J RESP CRIT CARE, V168, P1427, DOI 10.1164/rccm.200206-593OC; Tsutamoto T, 1997, CIRCULATION, V96, P509; von Lukowicz T, 2005, EUR J HEART FAIL, V7, P525, DOI 10.1016/j.ejheart.2004.12.010; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704	60	139	143	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					310	318		10.1001/jama.296.3.310	http://dx.doi.org/10.1001/jama.296.3.310			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849664	Bronze			2022-12-01	WOS:000239089900023
J	Erickson, GM; Currie, PJ; Inouye, BD; Winn, AA				Erickson, Gregory M.; Currie, Philip J.; Inouye, Brian D.; Winn, Alice A.			Tyrannosaur life tables: An example of nonavian dinosaur population biology	SCIENCE			English	Article							NATURAL-POPULATIONS; GROWTH-PATTERNS; MORTALITY	The size and age structures for four assemblages of North American tyrannosaurs-Albertosaurus, Tyrannosaurus, Gorgosaurus, and Daspletosaurus - reveal a pronounced, bootstrap-supported pattern of age-specific mortality characterized by relatively high juvenile survivorship and increased mortality at midlife and near the maximum life span. Such patterns are common today in wild populations of long-lived birds and mammals. Factors such as predation and entrance into the breeding population may have influenced tyrannosaur survivorship. This survivorship pattern can explain the rarity of juvenile specimens in museum collections.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Univ Alberta, Dept Biol Sci, Calgary, AB T6G 2E, Canada	State University System of Florida; Florida State University; University of Alberta	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161				Abercrombie CL, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P409; ANDREWS RM, 1982, BIOL REPTILIA PHYS D, V13; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Ebert TA, 1999, PLANT ANIMAL POPULAT; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Estes, 1991, BEHAV GUIDE AFRICAN; FLOWERDUE JR, 1987, MAMMALS THEIR REPROD; IVERSON JB, 1991, CAN J ZOOL, V69, P385, DOI 10.1139/z91-060; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Kurten B., 1988, EVOLUTION FOSSIL MAM; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Newton I., 1989, LIFETIME REPROD BIRD; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; Postupalsky S., 1989, P297; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; Ricklefs RE, 2001, EXP GERONTOL, V36, P845, DOI 10.1016/S0531-5565(00)00245-X; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; SANDER PM, 1990, ANN SCI NAT ZOOL, V11, P213; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SPINAGE CA, 1972, ECOLOGY, V53, P645, DOI 10.2307/1934778; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; Webb G., 1989, CROCODILES AUSTR; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; [No title captured]	30	85	87	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					213	217		10.1126/science.1125721	http://dx.doi.org/10.1126/science.1125721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840697				2022-12-01	WOS:000239008000041
J	Ahel, I; Rass, U; El-Khamisy, SF; Katyal, S; Clements, PM; McKinnon, PJ; Caldecott, KW; West, SC				Ahel, Ivan; Rass, Ulrich; El-Khamisy, Sherif F.; Katyal, Sachin; Clements, Paula M.; McKinnon, Peter J.; Caldecott, Keith W.; West, Stephen C.			The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates	NATURE			English	Article							STRAND BREAK REPAIR; HISTIDINE TRIAD SUPERFAMILY; AMP-LYSINE HYDROLASE; ATAXIA; HINT; FHIT; MUTATIONS; MECHANISM; BINDING; DAMAGE	Ataxia oculomotor apraxia-1 (AOA1) is a neurological disorder caused by mutations in the gene (APTX) encoding aprataxin(1,2). Aprataxin is a member of the histidine triad (HIT) family of nucleotide hydrolases and transferases(3), and inactivating mutations are largely confined to this HIT domain. Aprataxin associates with the DNA repair proteins XRCC1 and XRCC4, which are partners of DNA ligase III and ligase IV, respectively(4-7), suggestive of a role in DNA repair. Consistent with this, APTX-defective cell lines are sensitive to agents that cause single-strand breaks and exhibit an increased incidence of induced chromosomal aberrations(4,5,8). It is not, however, known whether aprataxin has a direct or indirect role in DNA repair, or what the physiological substrate of aprataxin might be. Here we show, using purified aprataxin protein and extracts derived from either APTX-defective chicken DT40 cells or Aptx(-/-) mouse primary neural cells, that aprataxin resolves abortive DNA ligation intermediates. Specifically, aprataxin catalyses the nucleophilic release of adenylate groups covalently linked to 5'-phosphate termini at single-strand nicks and gaps, resulting in the production of 5'-phosphate termini that can be efficiently rejoined. These data indicate that neurological disorders associated with APTX mutations may be caused by the gradual accumulation of unrepaired DNA strand breaks resulting from abortive DNA ligation events.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Fac Pharm, Dept Biochem, Cairo, Egypt; St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Cancer Research UK; University of Sussex; St Jude Children's Research Hospital	West, SC (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Caldecott, Keith/S-4245-2019	, Sherif/0000-0003-2721-7763; Ahel, Ivan/0000-0002-9446-3756; Caldecott, Keith/0000-0003-4255-9016; Katyal, Sachin/0000-0002-7790-4054; West, Stephen/0000-0001-8848-9418; Rass, Ulrich/0000-0001-9275-9062	Medical Research Council [G0300662B] Funding Source: researchfish; Medical Research Council [G0001259] Funding Source: Medline; MRC [G0001259] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abner CW, 2004, DNA REPAIR, V3, P1141, DOI 10.1016/j.dnarep.2004.03.009; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Barnes DE, 2002, CURR BIOL, V12, pR262, DOI 10.1016/S0960-9822(02)00788-1; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Draganescu A, 2000, J BIOL CHEM, V275, P4555, DOI 10.1074/jbc.275.7.4555; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Krakowiak A, 2004, J BIOL CHEM, V279, P18711, DOI 10.1074/jbc.M314271200; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0; PLATEAU P, 1989, J BACTERIOL, V171, P6437, DOI 10.1128/jb.171.12.6437-6445.1989; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808; Seidle HF, 2005, J BIOL CHEM, V280, P20927, DOI 10.1074/jbc.M502889200; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Ward JF, 1998, CONT CANC RES, P65; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7	30	282	297	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					713	716		10.1038/nature05164	http://dx.doi.org/10.1038/nature05164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	16964241				2022-12-01	WOS:000241160500051
J	Pagel, M; Venditti, C; Meade, A				Pagel, Mark; Venditti, Chris; Meade, Andrew			Large punctuational contribution of speciation to evolutionary divergence at the molecular level	SCIENCE			English	Article							RAPID EVOLUTION; SUBSTITUTIONS; EQUILIBRIUM; POPULATIONS; PHYLOGENIES; GRADUALISM; SEQUENCE; DYNAMICS; TEMPO; MODEL	A long-standing debate in evolutionary biology concerns whether species diverge gradually through time or by punctuational episodes at the time of speciation. We found that approximately 22% of substitutional changes at the DNA level can be attributed to punctuational evolution, and the remainder accumulates from background gradual divergence. Punctuational effects occur at more than twice the rate in plants and fungi than in animals, but the proportion of total divergence attributable to punctuational change does not vary among these groups. Punctuational changes cause departures from a clock-like tempo of evolution, suggesting that they should be accounted for in deriving dates from phylogenies. Punctuational episodes of evolution may play a larger role in promoting evolutionary divergence than has previously been appreciated.	Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	University of Reading	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England.	m.pagel@rdg.ac.uk			Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Coyne J.A., 2004, SPECIATION; Culotta E, 2005, SCIENCE, V310, P1878, DOI 10.1126/science.310.5756.1878; Draper N. R., 2014, APPL REGRESSION ANAL; ELDREDGE N, 1971, EVOLUTION, V25, P156, DOI 10.1111/j.1558-5646.1971.tb01868.x; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Eldredge N., 1972, P82; FITCH WM, 1990, MOL BIOL EVOL, V7, P438; FITCH WM, 1987, MOL BIOL EVOL, V4, P381; Gibson G, 2005, SCIENCE, V307, P1890, DOI 10.1126/science.1109835; GOULD S J, 1977, Paleobiology, V3, P115; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; HECHT M K, 1986, Oxford Surveys in Evolutionary Biology, P1; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; Kay KM, 2005, AM J BOT, V92, P1899, DOI 10.3732/ajb.92.11.1899; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MALMGREN BA, 1984, SCIENCE, V225, P317, DOI 10.1126/science.225.4659.317; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RHODES FHT, 1983, NATURE, V305, P269, DOI 10.1038/305269a0; Ricklefs RE, 2006, SYST BIOL, V55, P151, DOI 10.1080/10635150500431205; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Telschow A, 2005, EVOLUTION, V59, P1607, DOI 10.1111/j.0014-3820.2005.tb01812.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Webster AJ, 2003, SCIENCE, V301, P478, DOI 10.1126/science.1083202	34	161	166	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					119	121		10.1126/science.1129647	http://dx.doi.org/10.1126/science.1129647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023657				2022-12-01	WOS:000241031200049
J	Sardi, SP; Murtie, J; Koirala, S; Patten, BA; Corfas, G				Sardi, S. Pablo; Murtie, Joshua; Koirala, Samir; Patten, Brooke A.; Corfas, Gabriel			Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; GABAERGIC INTERNEURONS; TRANSGENIC MICE; KNOCKOUT MICE; RECEPTORS; ACTIVATION; EXPRESSION; CLEAVAGE; ADULT	Embryonic multipotent neural precursors are exposed to extracellular signals instructing them to adopt different fates, neuronal or glial. However, the mechanisms by which precursors integrate these signals to make timely fate choices remained undefined. Here we show that direct nuclear signaling by a receptor tyrosine kinase inhibits the responses of precursors to astrocyte differentiation factors while maintaining their neurogenic potential. Upon neuregulin-induced activation and presenilin-dependent cleavage of ErbB4, the receptor's intracellular domain forms a complex with TAB2 and the corepressor N-CoR. This complex undergoes nuclear translocation and binds promoters of astrocytic genes, repressing their expression. Consistent with this observation, astrogenesis occurs precociously in ErbB4 knockout mice. Our studies define how presenilin-dependent nuclear signaling by a receptor tyrosine kinase directly regulates gene transcription and cell fate. This pathway could be of importance for neural stem cell biology and for understanding the pathogenesis of Alzheimer's disease.	Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Sardi, SP (corresponding author), Childrens Hosp, Neurobiol Program, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884, T32NS007484] Funding Source: NIH RePORTER; NICHD NIH HHS [P30-HD 18655] Funding Source: Medline; NINDS NIH HHS [T32 NS007484-06, R01 NS35884, R01 NS035884] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Craft JM, 2005, GLIA, V51, P209, DOI 10.1002/glia.20194; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; FINLEY RL, 1996, DNA CLONING EXPRESSI, P169; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fox IJ, 2005, J NEUROSCI RES, V79, P584, DOI 10.1002/jnr.20381; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Liu Y, 2001, J NEUROSCI, V21, P5660, DOI 10.1523/JNEUROSCI.21-15-05660.2001; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922	42	273	282	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					185	197		10.1016/j.cell.2006.07.037	http://dx.doi.org/10.1016/j.cell.2006.07.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018285	Bronze			2022-12-01	WOS:000241445800023
J	Gregersen, JW; Kranc, KR; Ke, XY; Svendsen, P; Madsen, LS; Thomsen, AR; Cardon, LR; Bell, JI; Fugger, L				Gregersen, Jon W.; Kranc, Kamil R.; Ke, Xiayi; Svendsen, Pia; Madsen, Lars S.; Thomsen, Allan Randrup; Cardon, Lon R.; Bell, John I.; Fugger, Lars			Functional epistasis on a common MHC haplotype associated with multiple sclerosis	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN BASIC-PROTEIN; OLIGONUCLEOTIDE HYBRIDIZATION; AFRICAN-AMERICANS; HUMAN GENOME; HLA-DR; ALLELES; HLA-DR2; MAP; SUSCEPTIBILITY	Genes in the major histocompatibility complex (MHC) encode proteins important in activating antigen-specific immune responses. Alleles at adjacent MHC loci are often in strong linkage disequilibrium; however, little is known about the mechanisms responsible for this linkage disequilibrium. Here we report that the human MHC HLA-DR2 haplotype, which predisposes to multiple sclerosis(1-3), shows more extensive linkage disequilibrium than other common caucasian HLA haplotypes in the DR region and thus seems likely to have been maintained through positive selection. Characterization of two multiple-sclerosis-associated HLA-DR alleles at separate loci by a functional assay in humanized mice indicates that the linkage disequilibrium between the two alleles may be due to a functional epistatic interaction, whereby one allele modifies the T-cell response activated by the second allele through activation-induced cell death. This functional epistasis is associated with a milder form of multiple-sclerosis-like disease. Such epistatic interaction might prove to be an important general mechanism for modifying exuberant immune responses that are deleterious to the host and could also help to explain the strong linkage disequilibrium in this and perhaps other HLA haplotypes.	Aarhus Univ Hosp, Dept Clin Immunol, DK-8200 Aarhus N, Denmark; Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Copenhagen Hosp, Dept Clin Immunol, Rigshosp, DK-2100 Copenhagen O, Denmark; Univ Copenhagen, Inst Med Microbiol & Immunol, DK-2200 Copenhagen N, Denmark; Univ Oxford, Off Regius Prof Med, Oxford OX3 7BN, England	Aarhus University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Oxford	Fugger, L (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Skejby Sygehus, DK-8200 Aarhus N, Denmark.	lars.fugger@imm.ox.ac.uk	Kranc, Kamil/B-3449-2009; Ke, Xiayi/C-7674-2009	Thomsen, Allan Randrup/0000-0002-2392-9803	MRC [MC_U137881016] Funding Source: UKRI; Medical Research Council [MC_U137881016] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bateson W., 1909, MENDELS PRINCIPLES H, P79; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GAO XJ, 1991, IMMUNOGENETICS, V34, P401, DOI 10.1007/BF01787491; GAO XJ, 1991, TISSUE ANTIGENS, V38, P24, DOI 10.1111/j.1399-0039.1991.tb02031.x; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lee A, 1999, EUR J IMMUNOGENET, V26, P275, DOI 10.1046/j.1365-2370.1999.00144.x; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; MEHRA NK, 1991, HUM IMMUNOL, V32, P246, DOI 10.1016/0198-8859(91)90087-P; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; MORAES ME, 1991, HUM IMMUNOL, V31, P139, DOI 10.1016/0198-8859(91)90017-4; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Phillips PC, 1998, GENETICS, V149, P1167; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Song EY, 2000, HUM IMMUNOL, V61, P937, DOI 10.1016/S0198-8859(00)00155-5; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Suvannavejh GC, 2000, J CLIN INVEST, V105, P223, DOI 10.1172/JCI8561; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2003, AM J HUM GENET, V73, P580, DOI 10.1086/378101; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZINKERNAGEL RM, 1985, NATURE, V316, P814, DOI 10.1038/316814a0	27	150	153	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					574	577		10.1038/nature05133	http://dx.doi.org/10.1038/nature05133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006452				2022-12-01	WOS:000240988200043
J	Saliba, KJ; Martin, RE; Broer, A; Henry, RI; McCarthy, CS; Downie, MJ; Allen, RJW; Mullin, KA; McFadden, GI; Broer, S; Kirk, K				Saliba, Kevin J.; Martin, Rowena E.; Broeer, Angelika; Henry, Roselani I.; McCarthy, C. Siobhan; Downie, Megan J.; Allen, Richard J. W.; Mullin, Kylie A.; McFadden, Geoffrey I.; Broeer, Stefan; Kirk, Kiaran			Sodium-dependent uptake of inorganic phosphate by the intracellular malaria parasite	NATURE			English	Article							PLASMODIUM-FALCIPARUM; MEMBRANE-TRANSPORT; ACID; CHLOROQUINE; EXPRESSION; RETROVIRUS; PROTEINS; CLONING; CELLS	As the malaria parasite, Plasmodium falciparum, grows within its host erythrocyte it induces an increase in the permeability of the erythrocyte membrane to a range of low-molecular-mass solutes, including Na+ and K+ ( ref. 1). This results in a progressive increase in the concentration of Na+ in the erythrocyte cytosol(2,3). The parasite cytosol has a relatively low Na+ concentration(2,4) and there is therefore a large inward Na+ gradient across the parasite plasma membrane. Here we show that the parasite exploits the Na+ electrochemical gradient to energize the uptake of inorganic phosphate (P-i), an essential nutrient. P-i was taken up into the intracellular parasite by a Na+-dependent transporter, with a stoichiometry of 2Na(+): 1P(i) and with an apparent preference for the monovalent over the divalent form of P-i. A P-i transporter (PfPiT) belonging to the PiT family was cloned from the parasite and localized to the parasite surface. Expression of PfPiT in Xenopus oocytes resulted in Na+-dependent P-i uptake with characteristics similar to those observed for P-i uptake in the parasite. This study provides new insight into the significance of the malaria-parasite-induced alteration of the ionic composition of its host cell.	Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; Australian Natl Univ, Sch Med, Canberra, ACT 0200, Australia; Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia	Australian National University; Australian National University; University of Melbourne	Kirk, K (corresponding author), Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia.	kiaran.kirk@anu.edu.au	McFadden, Geoffrey McFadden I/F-7667-2014; Kirk, Kiaran/C-8299-2009; Saliba, Kevin J/C-9166-2009; Broer, Stefan/A-1286-2008; Martin, Rowena E/C-9992-2009; Allen, Richard/B-4752-2008	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Kirk, Kiaran/0000-0002-5613-2622; Saliba, Kevin J/0000-0003-3345-8440; Broer, Stefan/0000-0002-8040-1634; Martin, Rowena E/0000-0001-7408-5295; Henry, Roselani/0000-0001-7448-7358				Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Bai L, 2000, AM J PHYSIOL-CELL PH, V279, pC1135, DOI 10.1152/ajpcell.2000.279.4.C1135; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Dubyak GR, 2004, ADV PHYSIOL EDUC, V28, P143, DOI 10.1152/advan.00046.2004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Kumler WD, 1943, J AM CHEM SOC, V65, P2355, DOI 10.1021/ja01252a028; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; TURNER RJ, 1985, ANN NY ACAD SCI, V456, P10, DOI 10.1111/j.1749-6632.1985.tb14839.x; Wunsch S, 1998, J CELL BIOL, V140, P335, DOI 10.1083/jcb.140.2.335	22	77	77	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					582	585		10.1038/nature05149	http://dx.doi.org/10.1038/nature05149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006451				2022-12-01	WOS:000240988200045
J	Tang, J; Maximov, A; Shin, OH; Dai, H; Rizo, J; Sudhof, TC				Tang, Jiong; Maximov, Anton; Shin, Ok-Ho; Dai, Han; Rizo, Josep; Sudhof, Thomas C.			A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis	CELL			English	Article							SNARE COMPLEX; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; PHOSPHOLIPID-BINDING; FUSION; COMPONENTS; TERMINALS; PROTEINS	Ca2+ binding to synaptotagmin 1 triggers fast exocytosis of synaptic vesicles that have been primed for release by SNARE-complex assembly. Besides synaptotagmin 1, fast Ca2+-triggered exocytosis requires complexins. Synaptotagmin 1 and complexins both bind to assembled SNARE complexes, but it is unclear how their functions are coupled. Here we propose that complexin binding activates SNARE complexes into a metastable state and that Ca2+ binding to synaptotagmin 1 triggers fast exocytosis by displacing complexin from metastable SNARE complexes. Specifically, we demonstrate that, biochemically, synaptotagmin 1 competes with complexin for SNARE-complex binding, thereby dislodging complexin from SNARE complexes in a Ca2+-dependent manner. Physiologically, increasing the local concentration of complexin selectively impairs fast Ca2+-triggered exocytosis but retains other forms of SNARE-dependent fusion. The hypothesis that Ca2+-induced displacement of complexins from SNARE complexes triggers fast exocytosis accounts for the loss-of-function and gain-of-function phenotypes of complexins and provides a molecular explanation for the high speed and synchronicity of fast Ca2+-triggered neurotransmitter release.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Karakhanov, Edward/P-1660-2015					Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dykes IM, 2004, GENE EXPR PATTERNS, V4, P93, DOI 10.1016/S1567-133X(03)00143-1; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hill JJ, 2006, BIOCHEM BIOPH RES CO, V342, P791, DOI 10.1016/j.bbrc.2006.02.029; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Katz B., 1969, RELEASE NEURAL TRANS; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	44	331	343	1	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1175	1187		10.1016/j.cell.2006.08.030	http://dx.doi.org/10.1016/j.cell.2006.08.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990140	Bronze			2022-12-01	WOS:000240897600022
J	Pellegrini, M; Celeste, A; Difilippantonio, S; Guo, R; Wang, WD; Feigenbaum, L; Nussenzweig, A				Pellegrini, Manuela; Celeste, Arkady; Difilippantonio, Simone; Guo, Rong; Wang, Weidong; Feigenbaum, Lionel; Nussenzweig, Andre			Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo	NATURE			English	Article							TELANGIECTASIA MUTATED ATM; DOUBLE-STRAND BREAKS; DNA-DAMAGE; MRE11-RAD50-NBS1 COMPLEX; CHECKPOINT; KINASE; SITES; CELLS; NBS1; PHOSPHORYLATION	The ATM ( ataxia telangiectasia mutated) protein kinase is activated under physiological and pathological conditions that induce DNA double-strand breaks (DSBs). Loss of ATM or failure of its activation in humans and mice lead to defective cellular responses to DSBs, such as cell cycle checkpoints, radiation sensitivity, immune dysfunction, infertility and cancer predisposition. A widely used biological marker to identify the active form of ATM is the autophosphorylation of ATM at a single, conserved serine residue (Ser 1981 in humans; Ser 1987 in mouse)(1). Here we show that Atm-dependent responses are functional at the organismal and cellular level in mice that express a mutant form of Atm ( mutation of Ser to Ala at position 1987) as their sole Atm species. Moreover, the mutant protein does not exhibit dominant-negative interfering activity when expressed physiologically or overexpressed in the context of Atm heterozygous mice. These results suggest an alternative mode for stimulation of Atm by DSBs in which Atm autophosphorylation at Ser 1987, like transphosphorylation of downstream substrates, is a consequence rather than a cause of Atm activation.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; NCI, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Pellegrini, manuela/AAC-1423-2022; Wang, Weidong/AAV-2446-2021	pellegrini, manuela/0000-0001-6387-5187; Wang, Weidong/0000-0002-0658-7928	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010283, ZICBC009255, Z01BC009255, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000688, ZIAAG000657, Z01AG000657, Z01AG000688] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Goldstine JV, 2006, DNA REPAIR, V5, P432, DOI 10.1016/j.dnarep.2005.12.002; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kozlov S, 2003, J BIOL CHEM, V278, P9309, DOI 10.1074/jbc.M300003200; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu QH, 2000, GENE DEV, V14, P1448; Mochan TA, 2003, CANCER RES, V63, P8586; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takai H, 2000, GENE DEV, V14, P1439; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Yang YP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng080; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060	30	152	153	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					222	225		10.1038/nature05112	http://dx.doi.org/10.1038/nature05112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16906133				2022-12-01	WOS:000240467000049
J	Walter, KM; Zimov, SA; Chanton, JP; Verbyla, D; Chapin, FS				Walter, K. M.; Zimov, S. A.; Chanton, J. P.; Verbyla, D.; Chapin, F. S., III			Methane bubbling from Siberian thaw lakes as a positive feedback to climate warming	NATURE			English	Article							ATMOSPHERIC METHANE; CARBON-DIOXIDE; CH4; EMISSIONS; ALASKA; TUNDRA; FLUX; CO2	Large uncertainties in the budget of atmospheric methane, an important greenhouse gas, limit the accuracy of climate change projections(1,2). Thaw lakes in North Siberia are known to emit methane(3), but the magnitude of these emissions remains uncertain because most methane is released through ebullition (bubbling), which is spatially and temporally variable. Here we report a new method of measuring ebullition and use it to quantify methane emissions from two thaw lakes in North Siberia. We show that ebullition accounts for 95 per cent of methane emissions from these lakes, and that methane flux from thaw lakes in our study region may be five times higher than previously estimated(3). Extrapolation of these fluxes indicates that thaw lakes in North Siberia emit 3.8 teragrams of methane per year, which increases present estimates of methane emissions from northern wetlands (<6-40 teragrams per year; refs 1, 2, 4-6) by between 10 and 63 per cent. We find that thawing permafrost along lake margins accounts for most of the methane released from the lakes, and estimate that an expansion of thaw lakes between 1974 and 2000, which was concurrent with regional warming, increased methane emissions in our study region by 58 per cent. Furthermore, the Pleistocene age (35,260-42,900 years) of methane emitted from hotspots along thawing lake margins indicates that this positive feedback to climate warming has led to the release of old carbon stocks previously stored in permafrost.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; NE Sci Stn, Cherskii 678830, Russia; Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; Univ Alaska, Dept Forest Sci, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; State University System of Florida; Florida State University; University of Alaska System; University of Alaska Fairbanks	Walter, KM (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	ftkmw1@uaf.edu	Zimov, Sergey/K-3009-2018; Chapin, F Stuart/AAZ-3931-2020	Chapin, F Stuart/0000-0002-2558-9910; Zimov, Sergey/0000-0002-0053-6599				ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; BARTLETT KB, 1992, J GEOPHYS RES-ATMOS, V97, P16645, DOI 10.1029/91JD00610; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Casper P, 2000, BIOGEOCHEMISTRY, V49, P1, DOI 10.1023/A:1006269900174; Conrad R, 2002, CHEMOSPHERE, V47, P797, DOI 10.1016/S0045-6535(02)00120-0; Corradi C, 2005, GLOBAL CHANGE BIOL, V11, P1910, DOI 10.1111/j.1365-2486.2005.01023.x; Czudek T., 1970, QUATERNARY RES, V1, P103, DOI [10.1016/0033-5894(70)90013-X, DOI 10.1016/0033-5894(70)90013-X]; Dlugokencky EJ, 1998, NATURE, V393, P447, DOI 10.1038/30934; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; IPCC, 2001, CLIMATE CHANGE 2001; KELLER M, 1994, J GEOPHYS RES-ATMOS, V99, P8307, DOI 10.1029/92JD02170; KLING GW, 1992, HYDROBIOLOGIA, V240, P23, DOI 10.1007/BF00013449; MOSTAKHOV SE, 1973, MEZHD C MERZL PODZ V; Nakagawa F, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001384; NAKAYAMA T, 1995, THESIS HOKKAIDO U, P1; Phelps AR, 1998, J GEOPHYS RES-ATMOS, V103, P29029, DOI 10.1029/98JD00044; Reeburgh WS, 1998, J GEOPHYS RES-ATMOS, V103, P29005, DOI 10.1029/98JD00993; Romanovskii NN, 2000, PERMAFROST PERIGLAC, V11, P137, DOI 10.1002/1099-1530(200004/06)11:2<137::AID-PPP345>3.0.CO;2-L; Romanovsky N.N., 1993, OSNOVY KRIOGENEZA LI; ROULET NT, 1994, J GEOPHYS RES-ATMOS, V99, P1439, DOI 10.1029/93JD00261; Roulet NT, 1997, J GEOPHYS RES-ATMOS, V102, P29313, DOI 10.1029/97JD01237; Sazonova TS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003680; Smith LC, 2005, SCIENCE, V308, P1429, DOI 10.1126/science.1108142; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; WILLMOTT CJ, 1930, ARCTIC TERRESTRIAL A; Worthy DEJ, 2000, J GEOPHYS RES-ATMOS, V105, P4031, DOI 10.1029/1999JD901100; Zhuang Q, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002239; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; [No title captured]	31	680	717	16	442	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					71	75		10.1038/nature05040	http://dx.doi.org/10.1038/nature05040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957728				2022-12-01	WOS:000240313900041
J	Zhang, CS; Griffith, BR; Fu, Q; Albermann, C; Fu, X; Lee, IK; Li, LJ; Thorson, JS				Zhang, Changsheng; Griffith, Byron R.; Fu, Qiang; Albermann, Christoph; Fu, Xun; Lee, In-Kyoung; Li, Lingjun; Thorson, Jon S.			Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions	SCIENCE			English	Article							GLYCOSYLATION; CALICHEAMICIN; GLYCORANDOMIZATION; OLIGOSACCHARIDES; BIOSYNTHESIS; PURIFICATION; TOOLS	Glycosyltransferases (GTs), an essential class of ubiquitous enzymes, are generally perceived as unidirectional catalysts. In contrast, we report that four glycosyltransferases from two distinct natural product biosynthetic pathways-calicheamicin and vancomycin-readily catalyze reversible reactions, allowing sugars and aglycons to be exchanged with ease. As proof of the broader applicability of these new reactions, more than 70 differentially glycosylated calicheamicin and vancomycin variants are reported. This study suggests the reversibility of GT-catalyzed reactions may be general and useful for generating exotic nucleotide sugars, establishing in vitro GT activity in complex systems, and enhancing natural product diversity.	Univ Wisconsin, Natl Cooperat Drug Discovery Grp Program, Sch Pharm, Pharmaceut Sci Div,Lab Biosynthet Chem, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Thorson, JS (corresponding author), Univ Wisconsin, Natl Cooperat Drug Discovery Grp Program, Sch Pharm, Pharmaceut Sci Div,Lab Biosynthet Chem, 777 Highland Ave, Madison, WI 53705 USA.	jsthorson@pharmacy.wisc.edu	Thorson, Jon S/L-3696-2013; Zhang, Changsheng/B-5965-2012	Thorson, Jon S/0000-0002-7148-0721; Zhang, Changsheng/0000-0003-2349-3138	NCI NIH HHS [CA84374, U19 CA113297] Funding Source: Medline; NIAID NIH HHS [AI52218] Funding Source: Medline; NIGMS NIH HHS [GM70637] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084374, U19CA113297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070637] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Bililign T, 2002, CHEMBIOCHEM, V3, P1143, DOI 10.1002/1439-7633(20021104)3:11<1143::AID-CBIC1143>3.0.CO;2-W; Blanchard S, 2006, CURR OPIN CHEM BIOL, V10, P263, DOI 10.1016/j.cbpa.2006.04.001; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; CARDINI C. E., 1955, JOUR BIOL CHEM, V214, P149; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909; GLASER L, 1957, J BIOL CHEM, V228, P729; Griffith BR, 2005, CURR OPIN BIOTECH, V16, P622, DOI 10.1016/j.copbio.2005.10.002; HITCHCOCK SA, 1995, J AM CHEM SOC, V117, P5750, DOI 10.1021/ja00126a014; KIM SH, 1994, J AM CHEM SOC, V116, P1766, DOI 10.1021/ja00084a018; Koeller KM, 2000, CHEM REV, V100, P4465, DOI 10.1021/cr990297n; Losey HC, 2001, BIOCHEMISTRY-US, V40, P4745, DOI 10.1021/bi010050w; MARUMO K, 1992, EUR J BIOCHEM, V204, P539, DOI 10.1111/j.1432-1033.1992.tb16665.x; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Minami A, 2005, TETRAHEDRON LETT, V46, P6187, DOI 10.1016/j.tetlet.2005.07.083; NEUFELD EF, 1963, ADV CARBOHYD CHEM, V18, P309; NICOLAOU KC, 1993, J AM CHEM SOC, V115, P7625, DOI 10.1021/ja00070a006; Oberthur M, 2004, ORG LETT, V6, P2873, DOI 10.1021/ol049187f; Quiros LM, 2000, J BIOL CHEM, V275, P11713, DOI 10.1074/jbc.275.16.11713; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WALKER S, 1992, P NATL ACAD SCI USA, V89, P4608, DOI 10.1073/pnas.89.10.4608; Walsh CT, 2003, BIOCHEM SOC T, V31, P487, DOI 10.1042/BST0310487	25	235	244	10	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1291	1294		10.1126/science.1130028	http://dx.doi.org/10.1126/science.1130028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	081JI	16946071				2022-12-01	WOS:000240313500042
J	Takahashi, K; Yamanaka, S				Takahashi, Kazutoshi; Yamanaka, Shinya			Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors	CELL			English	Article							TRANSCRIPTION FACTOR KLF4; SELF-RENEWAL; C-MYC; SOMATIC-CELLS; ES CELLS; TUMOR-SUPPRESSOR; BETA-CATENIN; DIFFERENTIATION; EXPRESSION; NANOG	Differentiated cells can be reprogrammed to an embryonic-like state by transfer of nuclear contents into oocytes or by fusion with embryonic stem (ES) cells. Little is known about factors that induce this reprogramming. Here, we demonstrate induction of pluripotent stem cells from mouse embryonic or adult fibroblasts by introducing four factors, Oct3/4, Sox2, c-Myc, and Klf4, under ES cell culture conditions. Unexpectedly, Nanog was dispensable. These cells, which we designated iPS (induced pluripotent stem) cells, exhibit the morphology and growth properties of ES cells and express ES cell marker genes. Subcutaneous transplantation of iPS cells into nude mice resulted in tumors containing a variety of tissues from all three germ layers. Following injection into blastocysts, iPS cells contributed to mouse embryonic development. These data demonstrate that pluripotent stem cells can be directly generated from fibroblast cultures by the addition of only a few defined factors.	Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Yamanaka, S (corresponding author), Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Jeong, Wonjun/AAM-5937-2020; Wilson, Matthew H/K-3193-2013; Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Domashenko AD, 1997, MOL REPROD DEV, V47, P57, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;57::AID-MRD8&gt;3.0.CO;2-P; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyamoto Y, 2004, J BIOL CHEM, V279, P34336, DOI 10.1074/jbc.M402767200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sadot E, 2002, J CELL SCI, V115, P2771; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	50	16918	18768	313	8583	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 25	2006	126	4					663	676		10.1016/j.cell.2006.07.024	http://dx.doi.org/10.1016/j.cell.2006.07.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16904174	Green Published, Bronze			2022-12-01	WOS:000240276700016
J	Yang, XY; Downes, M; Yu, RT; Bookout, AL; He, WM; Straume, M; Mangelsdorf, DJ; Evans, RM				Yang, Xiaoyong; Downes, Michael; Yu, Ruth T.; Bookout, Angie L.; He, Weimin; Straume, Marty; Mangelsdorf, David J.; Evans, Ronald M.			Nuclear receptor expression links the circadian clock to metabolism	CELL			English	Article							REV-ERB-ALPHA; GENE-EXPRESSION; ROR-ALPHA; MICE LACKING; RESPONSE ELEMENT; LIPID-METABOLISM; PPAR-ALPHA; FAT MASS; TRANSCRIPTION; MOUSE	As sensors for fat-soluble hormones and dietary lipids, oscillations in nuclear receptor (NR) expression in key metabolic tissues may contribute to circadian entrainment of nutrient and energy metabolism. Surveying the diurnal expression profiles of all 49 mouse nuclear receptors in white and brown adipose tissue, liver, and skeletal muscle revealed that of the 45 NRs expressed, 25 are in a rhythmic cycle and 3 exhibit a single transient pulse of expression 4 hr into the light cycle. While thyroid hormones are generally constant, we find that TR alpha and beta dramatically cycle, suggesting that fundamental concepts such as "basal metabolism" may require reexamination. The dynamic but coordinated changes in nuclear receptor expression, along with their key target genes, offers a logical explanation for known cyclic behavior of lipid and glucose metabolism and suggests novel roles for endocrine and orphan receptors in coupling the peripheral circadian clock to divergent metabolic outputs.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA; Texas A&M Univ, System Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; Univ Virginia, Ctr Biomath Technol, Charlottesville, VA 22904 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; University of Virginia	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Yu, Ruth/0000-0002-9527-9627; Mangelsdorf, David/0000-0002-4355-0796	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19DK62434-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Boethel CD, 2002, CURR OPIN PULM MED, V8, P502, DOI 10.1097/00063198-200211000-00003; Bois-Joyeux B, 2000, DNA CELL BIOL, V19, P589, DOI 10.1089/104454900750019344; CALNAN BJ, 1995, IMMUNITY, V3, P273; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; DeYoung RA, 2003, J BIOL CHEM, V278, P47104, DOI 10.1074/jbc.M307496200; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dussault I, 1997, MOL CELL BIOL, V17, P1860, DOI 10.1128/MCB.17.4.1860; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Horard B, 2004, J MOL ENDOCRINOL, V33, P87, DOI 10.1677/jme.0.0330087; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Inoue I, 2005, J ATHEROSCLER THROMB, V12, P169, DOI 10.5551/jat.12.169; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raspe E, 2002, J BIOL CHEM, V277, P49275, DOI 10.1074/jbc.M206215200; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Seo JB, 2004, J BIOL CHEM, V279, P22108, DOI 10.1074/jbc.M400238200; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	49	727	750	7	84	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 25	2006	126	4					801	810		10.1016/j.cell.2006.06.050	http://dx.doi.org/10.1016/j.cell.2006.06.050			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923398	Bronze			2022-12-01	WOS:000240276700027
J	Margolis, TP; Whitcher, JP				Margolis, Todd P.; Whitcher, John P.			Fusarium - A new culprit in the contact lens case	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORNEAL ULCERATION; ETIOLOGIC DIAGNOSIS; SOUTH FLORIDA; KERATITIS; WEAR; SPECTRUM; OUTBREAK; NEPAL		Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Margolis, TP (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, Med Sci Bldg,S-310,513 Parnassus Ave,Box 0412, San Francisco, CA 94143 USA.	todd.margolis@ucsf.edu			NATIONAL EYE INSTITUTE [R01EY010008, P30EY002162] Funding Source: NIH RePORTER; NEI NIH HHS [EY10008, EY02162] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALFONSO E, 1986, AM J OPHTHALMOL, V101, P429, DOI 10.1016/0002-9394(86)90641-0; Alfonso EC, 2006, ARCH OPHTHALMOL-CHIC, V124, P941, DOI 10.1001/archopht.124.7.ecs60039; Bernal MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P1051, DOI 10.1001/archopht.124.7.ecr60006; Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; ERIE JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P1665, DOI 10.1001/archopht.1993.01090120087027; Gonzales C A, 1996, Ophthalmic Epidemiol, V3, P159, DOI 10.3109/09286589609080122; HAGAN M, 1995, BRIT J OPHTHALMOL, V79, P1024, DOI 10.1136/bjo.79.11.1024; Khor WB, 2006, JAMA-J AM MED ASSOC, V295, P2867, DOI 10.1001/jama.295.24.2867; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; RAPUANAO CJ, 2005, BACTERIAL KERATITIS, P11; *REG OFF SE AS, 2004, GUID MAN CORN ULC PR, P1; ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005; *SING HLTH MIN HLT, 2006, INCR INC CONT LENS R; Srinivasan M, 1997, BRIT J OPHTHALMOL, V81, P965, DOI 10.1136/bjo.81.11.965; Upadhyay MP, 2001, BRIT J OPHTHALMOL, V85, P388, DOI 10.1136/bjo.85.4.388; UPADHYAY MP, 1991, AM J OPHTHALMOL, V111, P92, DOI 10.1016/S0002-9394(14)76903-X; Whitcher JP, 1997, BRIT J OPHTHALMOL, V81, P622, DOI 10.1136/bjo.81.8.622; 2006, MMWR MORB MORTAL WKL, V55, P400; 2006, FUSARIUM KERATITIS U	19	16	16	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2006	296	8					985	987		10.1001/jama.296.8.985	http://dx.doi.org/10.1001/jama.296.8.985			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076AL	16929565				2022-12-01	WOS:000239929300028
J	Barcelo, A				Barcelo, Alberto			Cardiovascular diseases in Latin America and the Caribbean	LANCET			English	Editorial Material									Pan Amer Hlth Org, Unit Non Communicable Dis, Washington, DC 20037 USA	Pan American Health Organization	Barcelo, A (corresponding author), Pan Amer Hlth Org, Unit Non Communicable Dis, Washington, DC 20037 USA.	barceloa@paho.org		BARCELO, ALBERTO/0000-0002-5258-6299				Arredondo A, 2005, PUBLIC HEALTH, V119, P711, DOI 10.1016/j.puhe.2005.01.009; Hennis A, 2002, J HYPERTENS, V20, P2363, DOI 10.1097/00004872-200212000-00014; Menendez J, 2005, REV PANAM SALUD PUBL, V17, P353; Murray CJL., 1996, GLOBAL BURDEN DIS CO; PERALTA MR, 2005, ARCH CARDIOL MEX, V75, P96; *SECR SAL MEX, 1996, ENC NAC ENF CRON; VELAZQUEZMONROY O, 2003, ARCH CARDIOL MEX, V73, P62; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	9	29	30	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2006	368	9536					625	626		10.1016/S0140-6736(06)69223-4	http://dx.doi.org/10.1016/S0140-6736(06)69223-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074YT	16920450				2022-12-01	WOS:000239849200007
J	Krantz, MJ; Mehler, PS				Krantz, Mori J.; Mehler, Philip S.			QTc prolongation: methadone's efficacy-safety paradox	LANCET			English	Editorial Material							TORSADE-DE-POINTES; CARDIAC REPOLARIZATION; OPIOID DEPENDENCE; USERS; BUPRENORPHINE		Denver Hlth Med Ctr, Denver, CO 80204 USA	Denver Health Medical Center	Mehler, PS (corresponding author), Denver Hlth Med Ctr, Denver, CO 80204 USA.	PMehler@dhha.org						Ehret GB, 2006, ARCH INTERN MED, V166, P1280, DOI 10.1001/archinte.166.12.1280; HAYS H, 1999, PAIN RES MANAG, V4, P23; Huber A, 2001, DRUG ALCOHOL DEPEN, V63, pS70; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Krantz MJ, 2005, PHARMACOTHERAPY, V25, P611, DOI 10.1592/phco.25.4.611.61020; Krantz MJ, 2003, PHARMACOTHERAPY, V23, P802, DOI 10.1592/phco.23.6.802.32186; Krantz MJ, 2002, ANN INTERN MED, V137, P501, DOI 10.7326/0003-4819-137-6-200209170-00010; Krantz MJ, 2004, ARCH INTERN MED, V164, P277, DOI 10.1001/archinte.164.3.277; LIPSKI J, 1973, AM HEART J, V86, P663, DOI 10.1016/0002-8703(73)90344-X; Martell BA, 2005, AM J CARDIOL, V95, P915, DOI 10.1016/j.amjcard.2004.11.055; Pearson EC, 2005, PHARMACOEPIDEM DR S, V14, P747, DOI 10.1002/pds.1112	11	25	25	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2006	368	9535					556	557		10.1016/S0140-6736(06)69173-3	http://dx.doi.org/10.1016/S0140-6736(06)69173-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074OF	16905001				2022-12-01	WOS:000239821000005
J	Freeman, AS; Byers, JE				Freeman, Aaren S.; Byers, James E.			Divergent induced responses to an invasive predator in marine mussel populations	SCIENCE			English	Article							BLUE MUSSEL; TRADE-OFFS; RECOGNITION; DEFENSES; HISTORY	Invasive species may precipitate evolutionary change in invaded communities. In southern New England ( USA) the invasive Asian shore crab, Hemigrapsus sanguineus, preys on mussels (Mytlius edulis), but the crab has not yet invaded northern New England. We show that southern New England mussels express inducible shell thickening when exposed to waterborne cues from Hemigrapsus, whereas naive northern mussel populations do not respond. Yet, both populations thicken their shells in response to a long-established crab, Carcinus maenas. Our findings are consistent with the rapid evolution of an inducible morphological response to Hemigrapsus within 15 years of its introduction.	Univ New Hampshire, Dept Zool, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Freeman, AS (corresponding author), Univ New Hampshire, Dept Zool, Rudman Hall, Durham, NH 03824 USA.	afreeman@cisunix.unh.edu	Byers, James/AFJ-8413-2022	Byers, James/0000-0001-9240-0287				Barbosa GE., 2005, ECOLOGY PREDATOR PRE; BERTNESS MD, 1981, EVOLUTION, V35, P995, DOI 10.1111/j.1558-5646.1981.tb04965.x; Byers JE, 2006, MAR ECOL PROG SER, V313, P27, DOI 10.3354/meps313027; Carlton JT, 2003, J BIOGEOGR, V30, P1809, DOI 10.1111/j.1365-2699.2003.00962.x; Cox G.W., 2004, ALIEN SPECIES EVOLUT; DETHIER MN, 1988, MAR ECOL PROG SER, V50, P97, DOI 10.3354/meps050097; Kiesecker JM, 1997, ECOLOGY, V78, P1752; Leonard GH, 1999, ECOLOGY, V80, P1; Lohrer AM, 2002, MAR ECOL PROG SER, V227, P135, DOI 10.3354/meps227135; MALONEY RF, 1995, ANIM BEHAV, V50, P1193, DOI 10.1016/0003-3472(95)80036-0; McDermott JJ, 1998, ICES J MAR SCI, V55, P289, DOI 10.1006/jmsc.1997.0273; Padilla DK, 1996, EVOL ECOL, V10, P105, DOI 10.1007/BF01239351; Payne CM, 2004, ANN ZOOL FENN, V41, P843; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Raimondi PT, 2000, OIKOS, V91, P353, DOI 10.1034/j.1600-0706.2000.910215.x; Reimer O, 2001, MAR BIOL, V139, P959; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Riginos C, 2004, EVOLUTION, V58, P2438; Sanford E, 2003, SCIENCE, V300, P1135, DOI 10.1126/science.1083437; Schlichting C.D., 1998, AM J PHYS ANTHR; SEELEY R, COMMUNICATION; SIH A, 2004, PHENOTYPIC PLASTICIT, V1, P112; Smith LD, 2000, MAR BIOL, V136, P461, DOI 10.1007/s002270050705; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Tollrian R., 1998, ECOLOGY EVOLUTION IN; Trussell GC, 2000, EVOLUTION, V54, P151, DOI 10.1111/j.0014-3820.2000.tb00016.x; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 2002, ECOL LETT, V5, P241, DOI 10.1046/j.1461-0248.2002.00304.x	29	199	203	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					831	833		10.1126/science.1125485	http://dx.doi.org/10.1126/science.1125485			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902136				2022-12-01	WOS:000239671300058
J	Pobbati, AV; Stein, A; Fasshauer, D				Pobbati, Ajaybabu V.; Stein, Alexander; Fasshauer, Dirk			N- to C-terminal SNARE complex assembly promotes rapid membrane fusion	SCIENCE			English	Article							T-SNARE; SYNAPTIC EXOCYTOSIS; PROTEINS; VESICLES; DOMAIN; CORE	Assembly of the soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) syntaxin 1, SNAP-25, and synaptobrevin 2 is thought to be the driving force for the exocytosis of synaptic vesicles. However, whereas exocytosis is triggered at a millisecond time scale, the SNARE-mediated fusion of liposomes requires hours for completion, which challenges the idea of a key role for SNAREs in the final steps of exocytosis. We found that liposome fusion was dramatically accelerated when a stabilized syntaxin/SNAP-25 acceptor complex was used. Thus, SNARES do have the capacity to execute fusion at a speed required for neuronal secretion, demonstrating that the maintenance of acceptor complexes is a critical step in biological fusion reactions.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Max Planck Society	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Stein, Alexander/I-4950-2012; Fasshauer, Dirk/B-1563-2013	Stein, Alexander/0000-0002-2696-0611; Fasshauer, Dirk/0000-0002-1040-4282	NIGMS NIH HHS [P01 GM072694] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dieter B, 2002, PFLUG ARCH EUR J PHY, V443, P333, DOI 10.1007/s00424-001-0742-4; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Pelham HRB, 1995, COLD SPRING HARB SYM, V60, P105, DOI 10.1101/SQB.1995.060.01.013; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174	24	265	271	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					673	676		10.1126/science.1129486	http://dx.doi.org/10.1126/science.1129486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16888141	Green Published			2022-12-01	WOS:000239667500045
J	Dong, L; Agarwal, AK; Beebe, DJ; Jiang, HR				Dong, Liang; Agarwal, Abhishek K.; Beebe, David J.; Jiang, Hongrui			Adaptive liquid microlenses activated by stimuli-responsive hydrogels	NATURE			English	Article							MICROFLUIDIC CHANNELS; POLYMER GELS; LENS; ARRAYS; FABRICATION; LIGHT	Despite its compactness, the human eye can easily focus on different distances by adjusting the shape of its lens with the help of ciliary muscles(1). In contrast, traditional man-made optical systems achieve focusing by physical displacement of the lenses used. But in recent years, advances in miniaturization technology have led to optical systems that no longer require complicated mechanical systems to tune and adjust optical performance. These systems have found wide use in photonics, displays and biomedical systems. They are either based on arrays of microlenses with fixed focal lengths(2-5), or use external control to adjust the microlens focal length(6-12). An intriguing example is the tunable liquid lens, where electrowetting or external pressure manipulates the shape of a liquid droplet and thereby adjusts its optical properties. Here we demonstrate a liquid lens system that allows for autonomous focusing. The central component is a stimuli-responsive hydrogel(13) integrated into a microfluidic system and serving as the container for a liquid droplet, with the hydrogel simultaneously sensing the presence of stimuli and actuating adjustments to the shape - and hence focal length - of the droplet. By working at the micrometre scale where ionic diffusion and surface tension scale favourably(14), we can use pinned liquid - liquid interfaces to obtain stable devices and realize response times of ten to a few tens of seconds. The microlenses, which can have a focal length ranging from -infinity to +infinity ( divergent and convergent), are also readily integrated into arrays that may find use in applications such as sensing, medical diagnostics and lab-on-a-chip technologies(15-19).	Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jiang, HR (corresponding author), Univ Wisconsin, Dept Elect & Comp Engn, 1415 Johnson Dr, Madison, WI 53706 USA.	hongrui@engr.wisc.edu						Agarwal AK, 2005, J MICROELECTROMECH S, V14, P1409, DOI 10.1109/JMEMS.2005.859101; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Bassetti MJ, 2005, J MICROELECTROMECH S, V14, P1198, DOI 10.1109/JMEMS.2005.845407; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Camou S, 2003, LAB CHIP, V3, P40, DOI 10.1039/b211280a; Carlson K, 2005, APPL OPTICS, V44, P1792, DOI 10.1364/AO.44.001792; Cayre OJ, 2004, J MATER CHEM, V14, P3300, DOI 10.1039/b413361g; Choi HW, 2004, APPL PHYS LETT, V84, P2253, DOI 10.1063/1.1690876; Chronis N, 2003, OPT EXPRESS, V11, P2370, DOI 10.1364/OE.11.002370; Hayes RA, 2003, NATURE, V425, P383, DOI 10.1038/nature01988; Jacobs HO, 2002, SCIENCE, V296, P323, DOI 10.1126/science.1069153; Kuiper S, 2004, APPL PHYS LETT, V85, P1128, DOI 10.1063/1.1779954; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Lele AK, 1997, MACROMOLECULES, V30, P157, DOI 10.1021/ma950894l; Lopez CA, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2058209; Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619; Osada Y, 2004, J MACROMOL SCI-POL R, VC44, P87, DOI 10.1081/MC-120027935; PARK TG, 1992, J APPL POLYM SCI, V46, P659, DOI 10.1002/app.1992.070460413; POPOVIC ZD, 1988, APPL OPTICS, V27, P1281, DOI 10.1364/AO.27.001281; Ren H, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1935749; Ren HW, 2004, OPT LETT, V29, P1608, DOI 10.1364/OL.29.001608; Saitoh A, 2003, APPL PHYS LETT, V83, P1725, DOI 10.1063/1.1598650; Sershen SR, 2005, ADV MATER, V17, P1366, DOI 10.1002/adma.200401239; SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0; TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467; TOATES FM, 1972, PHYSIOL REV, V52, P828, DOI 10.1152/physrev.1972.52.4.828; Yang R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1901829; Yang S, 2005, ADV MATER, V17, P435, DOI 10.1002/adma.200401002; Zhang DY, 2003, APPL PHYS LETT, V82, P3171, DOI 10.1063/1.1573337	30	815	836	25	741	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					551	554		10.1038/nature05024	http://dx.doi.org/10.1038/nature05024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16885981				2022-12-01	WOS:000239455900040
J	Jin, HC; Sperka, T; Herrlich, P; Morrison, H				Jin, Hongchuan; Sperka, Tobias; Herrlich, Peter; Morrison, Helen			Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase	NATURE			English	Article							NF2 TUMOR-SUPPRESSOR; MYOSIN-BINDING SUBUNIT; RHO-ASSOCIATED KINASE; NEUROFIBROMATOSIS TYPE-2; PROTEIN PHOSPHATASE; SMOOTH-MUSCLE; GENE-PRODUCT; PHOSPHORYLATION; ASSOCIATION; CANCER	The tumour suppressor protein merlin ( encoded by the neurofibromatosis type 2 gene NF2) is an important regulator of proliferation in many cell and tissue types(1-4). Merlin is activated by dephosphorylation at serine 518 (S518), which occurs on serum withdrawal or on cell - cell or cell - matrix contact(5,6). However, the relevant phosphatase that activates merlin's tumour suppressor function is unknown. Here we identify this enzyme as the myosin phosphatase (MYPT-1-PP1 delta). The cellular MYPT-1-PP1 delta - specific inhibitor CPI-17 causes a loss of merlin function characterized by merlin phosphorylation, Ras activation and transformation. Constitutively active merlin (S518A) reverses CPI-17-induced transformation, showing that merlin is the decisive substrate of MYPT-1-PP1 delta in tumour suppression. In addition we show that CPI-17 levels are raised in several human tumour cell lines and that the downregulation of CPI-17 induces merlin dephosphorylation, inhibits Ras activation and abolishes the transformed phenotype. MYPT-1-PP1 delta and its substrate merlin are part of a previously undescribed tumour suppressor cascade that can be hindered in two ways, by mutation of the NF2 gene and by upregulation of the oncoprotein CPI-17.	Fritz Lipmann Inst, Liebniz Inst Age Res, D-07745 Jena, Germany; Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Helmholtz Association; Karlsruhe Institute of Technology	Morrison, H (corresponding author), Fritz Lipmann Inst, Liebniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	helen@fli-leibniz.de	Morrison, Helen/F-9748-2014; Jin, Hongchuan/C-3686-2009; Morrison, Helen/B-3984-2017; Sperka, Tobias/E-2659-2017	Morrison, Helen/0000-0003-4938-1409; Morrison, Helen/0000-0003-4938-1409; Jin, Hongchuan/0000-0002-6697-3097				Baser ME, 2004, AM J HUM GENET, V75, P231, DOI 10.1086/422700; Baser ME, 1996, NEUROLOGY, V47, P1269, DOI 10.1212/WNL.47.5.1269; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Colbran RJ, 1997, J NEUROCHEM, V69, P920; DeVitis LR, 1996, HUM GENET, V97, P632; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Eto M, 1999, BIOCHEMISTRY-US, V38, P16952, DOI 10.1021/bi992030o; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Evans DGR, 2000, J MED GENET, V37, P897, DOI 10.1136/jmg.37.12.897; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; GUTMANN DH, 1994, CURR OPIN NEUROL, V7, P166, DOI 10.1097/00019052-199404000-00014; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Liu QR, 2002, J BIOL CHEM, V277, P13312, DOI 10.1074/jbc.M107558200; McClatchey AI, 1997, GENE DEV, V11, P1253, DOI 10.1101/gad.11.10.1253; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Uppal S, 2003, INT J CLIN PRACT, V57, P698; Xiao GH, 2003, GENE CHROMOSOME CANC, V38, P389, DOI 10.1002/gcc.10282	28	143	152	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					576	579		10.1038/nature04856	http://dx.doi.org/10.1038/nature04856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16885985	Bronze			2022-12-01	WOS:000239455900046
J	Fox, M; Young, A; Anggiansah, R; Anggiansah, A; Sanderson, J				Fox, Mark; Young, Alasdair; Anggiansah, Roy; Anggiansah, Angela; Sanderson, Jeremy			Interactive case report - A 22 year old man with persistent regurgitation and vomiting: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material							RUMINATION SYNDROME; DISORDERS; DIAGNOSIS		St Thomas Hosp, Oesophageal Lab, London SE1 7EH, England; St Thomas Hosp, Dept Gastroenterol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Fox, M (corresponding author), St Thomas Hosp, Oesophageal Lab, London SE1 7EH, England.	markfox@doctors.org.uk						AMARNATH RP, 1986, ANN INTERN MED, V105, P513, DOI 10.7326/0003-4819-105-4-513; Chial HJ, 2003, PEDIATRICS, V111, P158, DOI 10.1542/peds.111.1.158; Clouse RE, 1999, GUT, V45, P31; OBRIEN MD, 1995, GASTROENTEROLOGY, V108, P1024, DOI 10.1016/0016-5085(95)90199-X; Rasquin-Weber A, 1999, GUT, V45, P60, DOI 10.1136/gut.45.2008.ii60; Thumshirn M, 1998, AM J PHYSIOL-GASTR L, V275, pG314, DOI 10.1152/ajpgi.1998.275.2.G314	6	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 15	2006	333	7559					133	133		10.1136/bmj.333.7559.133	http://dx.doi.org/10.1136/bmj.333.7559.133			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16840471	Green Published			2022-12-01	WOS:000239155900019
J	Chen, ZY; Jing, DQ; Bath, KG; Ieraci, A; Khan, T; Siao, CJ; Herrera, DG; Toth, M; Yang, C; McEwen, BS; Hempstead, BL; Lee, FS				Chen, Zhe-Yu; Jing, Deqiang; Bath, Kevin G.; Ieraci, Alessandro; Khan, Tanvir; Siao, Chia-Jen; Herrera, Daniel G.; Toth, Miklos; Yang, Chingwen; McEwen, Bruce S.; Hempstead, Barbara L.; Lee, Francis S.			Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior	SCIENCE			English	Article							ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; HIPPOCAMPAL FUNCTION; ANIMAL-MODELS; HUMAN-MEMORY; BRAIN; DEPRESSION; MICE; NEURONS; TRAITS	A common single-nucleotide polymorphism in the brain-derived neurotrophic factor ( BDNF) gene, a methionine ( Met) substitution for valine (Val) at codon 66 (Val66Met), is associated with alterations in brain anatomy and memory, but its relevance to clinical disorders is unclear. We generated a variant BDNF mouse (BDNF(Met/Met)) that reproduces the phenotypic hallmarks in humans with the variant allele. BDNF(Met) was expressed in brain at normal levels, but its secretion from neurons was defective. When placed in stressful settings, BDNF(Met/Met) mice exhibited increased anxiety-related behaviors that were not normalized by the antidepressant, fluoxetine. A variant BDNF may thus play a key role in genetic predispositions to anxiety and depressive disorders.	Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Shandong Univ, Sch Med, Jinan 250012, Shandong, Peoples R China; Rockefeller Univ, Gene Targeting Facil, New York, NY 10021 USA; Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Shandong University; Rockefeller University; Rockefeller University	Chen, ZY (corresponding author), Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA.	zheyuchen@sdu.edu.cn; fslee@med.cornell.edu	Toth, Miklos/O-3343-2017; Ieraci, Alessandro/AAA-8738-2020; McEwen, Bruce/Z-1630-2019	Ieraci, Alessandro/0000-0001-6737-7695; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060478, K08MH068850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687, R01NS052819] Funding Source: NIH RePORTER; NIMH NIH HHS [MH068850, MH060478] Funding Source: Medline; NINDS NIH HHS [R01 NS052819, NS052819, NS30687] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; CASERTA F, 1995, J NEUROSCI METH, V56, P133, DOI 10.1016/0165-0270(94)00115-W; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chan JP, 2006, NEUROSCIENCE, V142, P49, DOI 10.1016/j.neuroscience.2006.06.002; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hensler JG, 2003, J NEUROCHEM, V85, P1139, DOI 10.1046/j.1471-4159.2003.01748.x; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; Lang UE, 2005, PSYCHOPHARMACOLOGY, V180, P95, DOI 10.1007/s00213-004-2137-7; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Rios M, 2006, J NEUROBIOL, V66, P408, DOI 10.1002/neu.20233; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; SURTEES PG, 2006, IN PRESS J PSYCHIAT, DOI DOI 10.1016/J.JPSYCHIRES.2006.05.015; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656	28	982	1011	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					140	143		10.1126/science.1129663	http://dx.doi.org/10.1126/science.1129663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023662	Green Accepted			2022-12-01	WOS:000241031200055
J	Scannell, K				Scannell, Kate			An aging un-American	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Kaiser Permanente No Calif, Dept Med Eth, Oakland, CA USA	University of California System; University of California San Francisco; Kaiser Permanente	Scannell, K (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.								0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1415	1417		10.1056/NEJMp068068	http://dx.doi.org/10.1056/NEJMp068068			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	090UA	17021317				2022-12-01	WOS:000240976200003
J	Zahradka, K; Slade, D; Bailone, A; Sommer, S; Averbeck, D; Petranovic, M; Lindner, AB; Radman, M				Zahradka, Ksenija; Slade, Dea; Bailone, Adriana; Sommer, Suzanne; Averbeck, Dietrich; Petranovic, Mirjana; Lindner, Ariel B.; Radman, Miroslav			Reassembly of shattered chromosomes in Deinococcus radiodurans	NATURE			English	Article							RADIATION-RESISTANT BACTERIA; IONIZING-RADIATION; DEOXYRIBONUCLEIC ACID; ESCHERICHIA-COLI; STRAND BREAKS; DNA-REPAIR; GENOME; RADIORESISTANCE; RECOMBINATION; RECA	Dehydration or desiccation is one of the most frequent and severe challenges to living cells(1). The bacterium Deinococcus radiodurans is the best known extremophile among the few organisms that can survive extremely high exposures to desiccation and ionizing radiation, which shatter its genome into hundreds of short DNA fragments(2-5). Remarkably, these fragments are readily reassembled into a functional 3.28-megabase genome. Here we describe the relevant two-stage DNA repair process, which involves a previously unknown molecular mechanism for fragment reassembly called 'extended synthesis-dependent strand annealing' (ESDSA), followed and completed by crossovers. At least two genome copies and random DNA breakage are requirements for effective ESDSA. In ESDSA, chromosomal fragments with overlapping homologies are used both as primers and as templates for massive synthesis of complementary single strands, as occurs in a single-round multiplex polymerase chain reaction. This synthesis depends on DNA polymerase I and incorporates more nucleotides than does normal replication in intact cells. Newly synthesized complementary single-stranded extensions become 'sticky ends' that anneal with high precision, joining together contiguous DNA fragments into long, linear, double-stranded intermediates. These intermediates require RecA-dependent crossovers to mature into circular chromosomes that comprise double-stranded patchworks of numerous DNA blocks synthesized before radiation, connected by DNA blocks synthesized after radiation.	Univ Paris 05, Fac Med, INSERM, F-75015 Paris, France; Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10002, Croatia; Univ Paris 11, Inst Genet & Microbiol, CNRS, CEA,UMR8621, F-91405 Orsay, France; Ctr Univ Paris Sud, Inst Curie, Sect Rech, CNRS,UMR 2027, F-91405 Orsay, France; Mediterranean Inst Life Sci, Split 21000, Croatia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Rudjer Boskovic Institute; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Radman, M (corresponding author), Univ Paris 05, Fac Med, INSERM, Site Necker,U571,156 Rue Vaugirard, F-75015 Paris, France.	radman@necker.fr	Lindner, Ariel B/I-8503-2016; Lindner, Ariel/K-9247-2019; Radman, Miroslav/HDM-5955-2022	Lindner, Ariel B/0000-0001-5015-6511; Lindner, Ariel/0000-0001-5015-6511; Radman, Miroslav/0000-0003-0216-3148; Slade, Dea/0000-0002-0052-5910; Radman, Miroslav/0000-0002-7034-4365				ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; DEAN CJ, 1966, NATURE, V209, P49, DOI 10.1038/209049a0; Ferreira AC, 1999, EXTREMOPHILES, V3, P235, DOI 10.1007/s007920050121; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HARSOJO, 1981, J BIOCHEM-TOKYO, V90, P877, DOI 10.1093/oxfordjournals.jbchem.a133544; KRASIN F, 1977, J MOL BIOL, V116, P81, DOI 10.1016/0022-2836(77)90120-6; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; LION MB, 1970, BIOCHIM BIOPHYS ACTA, V209, P24, DOI 10.1016/0005-2787(70)90657-X; LOHMAN PHM, 1972, RADIAT RES, V52, P627, DOI 10.2307/3573520; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; MESELSON M, 1958, COLD SPRING HARB SYM, V23, P9, DOI 10.1101/SQB.1958.023.01.004; Milligan JR, 2000, INT J RADIAT BIOL, V76, P1475; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Narumi I, 2003, TRENDS MICROBIOL, V11, P422, DOI 10.1016/S0966-842X(03)00204-X; Potts M, 2001, TRENDS MICROBIOL, V9, P553, DOI 10.1016/S0966-842X(01)02231-4; Rainey FA, 2005, APPL ENVIRON MICROB, V71, P5225, DOI 10.1128/AEM.71.9.5225-5235.2005; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; SANDERS SW, 1979, APPL ENVIRON MICROB, V38, P436, DOI 10.1128/AEM.38.3.436-439.1979; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	29	306	332	5	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2006	443	7111					569	573		10.1038/nature05160	http://dx.doi.org/10.1038/nature05160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006450				2022-12-01	WOS:000240988200042
J	Arzy, S; Seeck, M; Ortigue, S; Spinelli, L; Blanke, O				Arzy, Shahar; Seeck, Margitta; Ortigue, Stephanie; Spinelli, Laurent; Blanke, Olaf			Induction of an illusory shadow person	NATURE			English	Article									Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland; Univ Hosp, Presurg Epilepsy Evaluat Unit, CH-1211 Geneva, Switzerland; Univ Hosp, Dept Neurol, CH-1211 Geneva, Switzerland; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; Dartmouth College	Arzy, S (corresponding author), Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland.	olaf.blanke@epfl.ch		Arzy, Shahar/0000-0001-6500-8095				Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blanke O, 2000, J NEUROL NEUROSUR PS, V69, P553, DOI 10.1136/jnnp.69.4.553; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2003, NEUROCASE, V9, P329, DOI 10.1076/neur.9.4.329.15552; Brugger P, 1996, NEUROPSY NEUROPSY BE, V9, P114; Critchley M, 1955, ACTA PSYCH NEUROL, V30, P155, DOI 10.1111/j.1600-0447.1955.tb06055.x; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Jaspers K., 1972, GEN PSYCHOPATHOLOGY; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; THOMPSON C, 1982, BRIT J PSYCHIAT, V141, P628, DOI 10.1192/bjp.141.6.628	10	138	138	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					287	287		10.1038/443287a	http://dx.doi.org/10.1038/443287a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988702	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000240622000032
J	Murray, F; Spar, D				Murray, Fiona; Spar, Debora			Bit players or powerhouse? China and stemm-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Cody Edward, 2006, WASH POST, pA16; DEP'T OF DEF. TECH. AND PRIVACY ADVISORY COMM, 2004, STAND US CHALL HOM S, P4; Fishman T.C., 2005, RISE NEXT SUPERPOWER	3	17	18	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1191	1194		10.1056/NEJMp068151	http://dx.doi.org/10.1056/NEJMp068151			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	085IT	16990381				2022-12-01	WOS:000240598500002
J	Melotto, M; Underwood, W; Koczan, J; Nomura, K; He, SY				Melotto, Maeli; Underwood, William; Koczan, Jessica; Nomura, Kinya; He, Sheng Yang			Plant stomata function in innate immunity against bacterial invasion	CELL			English	Article							SALICYLIC-ACID; GUARD-CELLS; PHYTOTOXIN CORONATINE; ARABIDOPSIS-THALIANA; SECRETION SYSTEM; ABSCISIC-ACID; III EFFECTORS; SIGNALING PATHWAYS; DISEASE RESISTANCE; DEFENSE	Microbial entry into host tissue is a critical first step in causing infection in animals and plants. In plants, it has been assumed that microscopic surface openings, such as stomata, serve as passive ports of bacterial entry during infection. Surprisingly, we found that stomatal closure is part of a plant innate immune response to restrict bacterial invasion. Stomatal guard cells of Arabidopsis perceive bacterial surface molecules, which requires the FLS2 receptor, production of nitric oxide, and the guard-cell-specific OST1 kinase. To circumvent this innate immune response, plant pathogenic bacteria have evolved specific virulence factors to effectively cause stomatal reopening as an important pathogenesis strategy. We provide evidence that supports a model in which stomata, as part of an integral innate immune system, act as a barrier against bacterial infection.	Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	He, SY (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	hes@msu.edu	poinssot, benoit/B-2569-2009	poinssot, benoit/0000-0001-5890-4318; He, Sheng Yang/0000-0003-1308-498X; Melotto, Maeli/0000-0001-6021-9803; Underwood, William/0000-0002-9920-8228				Abramovitch RB, 2004, CURR OPIN PLANT BIOL, V7, P356, DOI 10.1016/j.pbi.2004.05.002; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1; Blatt MR, 1999, PLANT J, V19, P453, DOI 10.1046/j.1365-313x.1999.00534.x; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI 10.1111/J.1364-3703.2005.00311.X; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Katagiri F., 2002, ARABIDOPSIS BOOK; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kinkel LL, 2000, MICROBIAL ECOL, V39, P1, DOI 10.1007/s002489900182; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; MA SW, 1991, MOL PLANT MICROBE IN, V4, P69, DOI 10.1094/MPMI-4-069; MITTAL S, 1995, MOL PLANT MICROBE IN, V8, P165, DOI 10.1094/MPMI-8-0165; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Naimi TS, 2003, J FOOD PROTECT, V66, P535, DOI 10.4315/0362-028X-66.4.535; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nomura K, 2005, P NATL ACAD SCI USA, V102, P3527, DOI 10.1073/pnas.0500724102; Park SS, 2001, CRIT REV BIOTECHNOL, V21, P27, DOI 10.1080/20013891081674; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Penaloza-Vazquez A, 2000, MICROBIOL-SGM, V146, P2447, DOI 10.1099/00221287-146-10-2447; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	54	1189	1269	9	357	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					969	980		10.1016/j.cell.2006.06.054	http://dx.doi.org/10.1016/j.cell.2006.06.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959575	Bronze			2022-12-01	WOS:000240675000023
J	Rudebeck, PH; Buckley, MJ; Walton, ME; Rushworth, MFS				Rudebeck, P. H.; Buckley, M. J.; Walton, M. E.; Rushworth, M. F. S.			A role for the macaque anterior cingulate gyrus in social valuation	SCIENCE			English	Article							ORBITAL PREFRONTAL CORTEX; RHESUS-MONKEYS; ORBITOFRONTAL CORTEX; DECISION-MAKING; LESIONS; AMYGDALA; BEHAVIOR; EMOTION; HUMANS; AUTISM	Complex human social interaction is disrupted when the frontal lobe is damaged in disease, and in extreme cases patients are described as having acquired sociopathy. We compared, in macaques, the effects of lesions in subdivisions of the anterior cingulate and the orbitofrontal cortices believed to be anatomically homologous to those damaged in such patients. We show that the anterior cingulate gyrus in male macaques is critical for normal patterns of social interest in other individual male or female macaques. Conversely, the orbitofrontal cortex lesion had a marked effect only on responses to mildly fear-inducing stimuli. These results suggest that damage to the anterior cingulate gyrus may be the cause of changes in social interaction seen after frontal lobe damage.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Rudebeck, PH (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	peter.rudebeck@psy.ox.ac.uk	Rudebeck, Peter/G-7931-2012; Tudusciuc, Oana/C-1339-2011	Rudebeck, Peter/0000-0002-1411-7555; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0300665] Funding Source: UKRI; Medical Research Council [G0300665] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mineka S., 1987, THEORETICAL FDN BEHA; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paxinos G, 2000, RHESUS MONKEY BRAIN; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rolls E. T., 1999, BRAIN EMOTION, P367; Saunders RC, 1998, NATURE, V393, P169, DOI 10.1038/30245; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sprague DS, 1998, AM J PHYS ANTHROPOL, V105, P511, DOI 10.1002/(SICI)1096-8644(199804)105:4<511::AID-AJPA8>3.3.CO;2-Z; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9	29	227	228	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1310	1312		10.1126/science.1128197	http://dx.doi.org/10.1126/science.1128197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946075				2022-12-01	WOS:000240313500048
J	King, MC; Lusk, CP; Blobel, G				King, Megan C.; Lusk, C. Patrick; Blobel, Guenter			Karyopherin-mediated import of integral inner nuclear membrane proteins	NATURE			English	Article							PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; YEAST NUCLEOPORIN; NUCLEOCYTOPLASMIC TRANSPORT; CELL-CYCLE; ENVELOPE; EXPORT; NUP2P; SIGNALS	Targeting of newly synthesized integral membrane proteins to the appropriate cellular compartment is specified by discrete sequence elements, many of which have been well characterized. An understanding of the signals required to direct integral membrane proteins to the inner nuclear membrane (INM) remains a notable exception. Here we show that integral INM proteins possess basic sequence motifs that resemble 'classical' nuclear localization signals. These sequences can mediate direct binding to karyopherin-alpha and are essential for the passage of integral membrane proteins to the INM. Furthermore, karyopherin-alpha, karyopherin-beta 1 and the Ran GTPase cycle are required for INM targeting, underscoring parallels between mechanisms governing the targeting of integral INM proteins and soluble nuclear transport. We also provide evidence that specific nuclear pore complex proteins contribute to this process, suggesting a role for signal-mediated alterations in the nuclear pore complex to allow for passage of INM proteins along the pore membrane.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	King, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	mking@rockefeller.edu; plusk@rockefeller.edu		Lusk, C. Patrick/0000-0003-4703-0533				AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360; Chial HJ, 1998, J CELL BIOL, V143, P1789, DOI 10.1083/jcb.143.7.1789; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hood JK, 2000, J CELL SCI, V113, P1471; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Iovine MK, 1997, J CELL BIOL, V137, P797, DOI 10.1083/jcb.137.4.797; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Leslie DM, 2002, MOL CELL BIOL, V22, P2544, DOI 10.1128/MCB.22.8.2544-2555.2002; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Mans BJ, 2004, CELL CYCLE, V3, P1612; Miao M, 2006, GENETICS, V172, P1441, DOI 10.1534/genetics.105.052068; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Vaughan OA, 2001, J CELL SCI, V114, P2577; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wu W, 2002, J CELL SCI, V115, P1361; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880	32	210	215	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1003	1007		10.1038/nature05075	http://dx.doi.org/10.1038/nature05075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16929305				2022-12-01	WOS:000240142000040
J	Murphy, GE; Leadbetter, JR; Jensen, GJ				Murphy, Gavin E.; Leadbetter, Jared R.; Jensen, Grant J.			In situ structure of the complete Treponema primitia flagellar motor	NATURE			English	Article							FREEZE ELECTRON-MICROSCOPY; SALMONELLA-TYPHIMURIUM; BASAL BODY; MEMBRANE; ROTOR; FLIG; ULTRASTRUCTURE; ARRANGEMENT	The bacterial flagellar motor is an amazing nanomachine: built from approximately 25 different proteins, it uses an electrochemical ion gradient to drive rotation at speeds of up to 300 Hz (refs 1, 2). The flagellar motor consists of a fixed, membrane-embedded, torque-generating stator and a typically bidirectional, spinning rotor that changes direction in response to chemotactic signals. Most structural analyses so far have targeted the purified rotor(3,4), and hence little is known about the stator and its interactions. Here we show, using electron cryotomography of whole cells, the in situ structure of the complete flagellar motor from the spirochaete Treponema primitia at 7 nm resolution. Twenty individual motor particles were computationally extracted from the reconstructions, aligned and then averaged. The stator assembly, revealed for the first time, possessed 16-fold symmetry and was connected directly to the rotor, C ring and a novel P-ring-like structure. The unusually large size of the motor suggested mechanisms for increasing torque and supported models wherein critical interactions occur atop the C ring, where our data suggest that both the carboxy-terminal and middle domains of FliG are found.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Environm Sci & Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Jensen, GJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jensen@caltech.edu		Leadbetter, Jared/0000-0002-7033-0844				Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; COULTON JW, 1978, J BACTERIOL, V136, P1037, DOI 10.1128/JB.136.3.1037-1049.1978; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; JACKSON S, 1971, ARCH MIKROBIOL, V76, P325, DOI 10.1007/BF00408529; Katayama E, 1996, J MOL BIOL, V255, P458, DOI 10.1006/jmbi.1996.0038; KHAN S, 1988, J MOL BIOL, V202, P575, DOI 10.1016/0022-2836(88)90287-2; KHAN S, 1992, J BACTERIOL, V174, P5123, DOI 10.1128/JB.174.15.5123-5126.1992; KHAN S, 1991, J BACTERIOL, V173, P2888, DOI 10.1128/JB.173.9.2888-2896.1991; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Limberger RJ, 2004, J MOL MICROB BIOTECH, V7, P30, DOI 10.1159/000077867; Lowder BJ, 2005, J BACTERIOL, V187, P5640, DOI 10.1128/JB.187.16.5640-5647.2005; SOSINSKY GE, 1992, J MOL BIOL, V223, P171, DOI 10.1016/0022-2836(92)90724-X; STALLMEYER MJB, 1989, J MOL BIOL, V205, P511, DOI 10.1016/0022-2836(89)90222-2; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Yonekura K, 2006, J MOL BIOL, V357, P73, DOI 10.1016/j.jmb.2005.12.041; Young HS, 2003, BIOPHYS J, V84, P571, DOI [10.1016/s0006-3495(03)74877-2, 10.1016/S0006-3495(03)74877-2]	21	143	143	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1062	1064		10.1038/nature05015	http://dx.doi.org/10.1038/nature05015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16885937				2022-12-01	WOS:000240142000055
J	Wilf, P; Labandeira, CC; Johnson, KR; Ellis, B				Wilf, Peter; Labandeira, Conrad C.; Johnson, Kirk R.; Ellis, Beth			Decoupled plant and insect diversity after the end-Cretaceous extinction	SCIENCE			English	Article							TERTIARY BOUNDARY; TROPICAL FORESTS; MASS EXTINCTION; ASSOCIATIONS; RECOVERY; HERBIVORY; RICHNESS; CLIMATE; EVENT	Food web recovery from mass extinction is poorly understood. We analyzed insect-feeding damage on 14,999 angiosperm leaves from 14 latest Cretaceous, Paleocene, and early Eocene sites in the western interior United States. Most Paleocene floras have low richness of plants and of insect damage. However, a low-diversity 64.4-million-year-old flora from southeastern Montana shows extremely high insect damage richness, especially of leaf mining, whereas an anomalously diverse 63.8-million-year-old flora from the Denver Basin shows little damage and virtually no specialized feeding. These findings reveal severely unbalanced food webs 1 to 2 million years after the end-Cretaceous extinction 65.5 million years ago.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Penn State Univ, Inst Environm, University Pk, PA 16802 USA; Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park	Wilf, P (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	pwilf@psu.edu		Wilf, Peter/0000-0001-6813-1937				Burnham RJ, 2004, PHILOS T R SOC B, V359, P1595, DOI 10.1098/rstb.2004.1531; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Coxall HK, 2006, GEOLOGY, V34, P297, DOI 10.1130/G21702.1; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; ELLIS B, 2004, 20042 DENV MUS NAT S, P1; ELLIS B, 2003, ROCKY MT GEOL, V38, P73, DOI DOI 10.2113/GSR0CKY.38.1.173; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson KR, 2002, SCIENCE, V296, P2379, DOI 10.1126/science.1072102; JOHNSON KR, 2002, GEOL S AM S, V361, P329, DOI DOI 10.1130/0-8137-2361-2.329; Johnson KR., 2003, ROCKY MT GEOL, V38, P101; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Labandeira Conrad C., 2002, Geological Society of America Special Paper, V361, P297; Labandeira Conrad C., 2002, Rocky Mountain Geology, V37, P31, DOI 10.2113/gsrocky.37.1.31; LANG PJ, 1996, THESIS U LONDON; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; POWELL J, 1998, HDB ZOOLOGY, P403; Raman Anantanarayanan, 2005, P1; Sewall JO, 2006, GEOLOGY, V34, P81, DOI 10.1130/G22177.1; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sole RV, 2002, PHILOS T R SOC B, V357, P697, DOI 10.1098/rstb.2001.0987; Spencer KA, 1990, HOST SPECIALIZATION, DOI 10.1007/978-94-009-1874-0; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; Wilf P, 2005, P NATL ACAD SCI USA, V102, P8944, DOI 10.1073/pnas.0500516102; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright MG, 1998, OECOLOGIA, V115, P427, DOI 10.1007/s004420050537; ZACHOS JC, 1989, NATURE, V337, P61, DOI 10.1038/337061a0	28	118	120	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1112	1115		10.1126/science.1129569	http://dx.doi.org/10.1126/science.1129569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931760				2022-12-01	WOS:000239998200044
J	Tsou, MFB; Stearns, T				Tsou, Meng-Fu Bryan; Stearns, Tim			Mechanism limiting centrosome duplication to once per cell cycle	NATURE			English	Article							SISTER-CHROMATID SEPARATION; CENTRIOLE; MITOSIS; KINASE; ONCOPROTEIN; INSTABILITY; PROGRESSION; CDK2-CYCLIN; CHROMOSOME; INTERPHASE	The centrosome organizes the microtubule cytoskeleton and consists of a pair of centrioles surrounded by pericentriolar material. Cells begin the cell cycle with a single centrosome, which duplicates once before mitosis. During duplication, new centrioles grow orthogonally to existing ones and remain engaged ( tightly opposed) with those centrioles until late mitosis or early G1 phase, when they become disengaged(1). The relationship between centriole engagement/disengagement and centriole duplication potential is not understood, and the mechanisms that control these processes are not known. Here we show that centriole disengagement requires the protease separase(2) at anaphase, and that this disengagement licences centriole duplication in the next cell cycle. We describe an in vitro system using Xenopus egg extract and purified centrioles in which both centriole disengagement and centriole growth occur. Centriole disengagement at anaphase is independent of mitotic exit and Cdk2/cyclin E activity, but requires the anaphase-promoting complex and separase. In contrast to disengagement, new centriole growth occurs in interphase, is dependent on Cdk2/cyclin E, and requires previously disengaged centrioles. This suggests that re-duplication of centrioles within a cell cycle is prevented by centriole engagement itself. We propose that the 'once-only' control of centrosome duplication is achieved by temporally separating licensing in anaphase from growth of new centrioles during S phase. The involvement of separase in both centriole disengagement and sister chromatid separation would prevent premature centriole disengagement before anaphase onset, which can lead to multipolar spindles and genomic instability(3,4).	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	stearns@stanford.edu		Stearns, Tim/0000-0002-0671-6582				Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; CALLAINI G, 1990, J CELL SCI, V97, P539; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1576, DOI 10.4161/cc.4.11.2147; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Liu BY, 2003, MOL CELL BIOL, V23, P5269, DOI 10.1128/MCB.23.15.5269-5281.2003; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Paoletti A, 1996, J CELL SCI, V109, P3089; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Vidwans SJ, 1999, J CELL BIOL, V147, P1371, DOI 10.1083/jcb.147.7.1371; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	28	320	323	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					947	951		10.1038/nature04985	http://dx.doi.org/10.1038/nature04985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16862117				2022-12-01	WOS:000239960500044
J	Kim, Y; Sung, JY; Ceglia, I; Lee, KW; Ahn, JH; Halford, JM; Kim, AM; Kwak, SP; Park, JB; Ryu, SH; Schenck, A; Bardoni, B; Scott, JD; Nairn, AC; Greengard, P				Kim, Yong; Sung, Jee Young; Ceglia, Ilaria; Lee, Ko-Woon; Ahn, Jung-Hyuck; Halford, Jonathan M.; Kim, Amie M.; Kwak, Seung P.; Park, Jong Bae; Ryu, Sung Ho; Schenck, Annette; Bardoni, Barbara; Scott, John D.; Nairn, Angus C.; Greengard, Paul			Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology	NATURE			English	Article							CYCLIN-DEPENDENT KINASE-5; NUCLEUS-ACCUMBENS; FAMILY PROTEINS; ARP2/3 COMPLEX; SMALL GTPASES; CDK5; WASP; DOPAMINE; NEURONS; COCAINE	WAVE1 - the Wiskott - Aldrich syndrome protein ( WASP)- family verprolin homologous protein 1 - is a key regulator of actin-dependent morphological processes(1) in mammals, through its ability to activate the actin-related protein (Arp2/3) complex. Here we show that WAVE1 is phosphorylated at multiple sites by cyclin-dependent kinase 5 (Cdk5) both in vitro and in intact mouse neurons. Phosphorylation of WAVE1 by Cdk5 inhibits its ability to regulate Arp2/3 complex-dependent actin polymerization. Loss of WAVE1 function in vivo or in cultured neurons results in a decrease in mature dendritic spines. Expression of a dephosphorylation-mimic mutant of WAVE1 reverses this loss of WAVE1 function in spine morphology, but expression of a phosphorylation-mimic mutant does not. Cyclic AMP ( cAMP) signalling reduces phosphorylation of the Cdk5 sites in WAVE1, and increases spine density in a WAVE1-dependent manner. Our data suggest that phosphorylation/dephosphorylation of WAVE1 in neurons has an important role in the formation of the filamentous actin cytoskeleton, and thus in the regulation of dendritic spine morphology.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Wyeth Res, Discovery Neurosci, Princeton, NJ 08543 USA; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Vollum Inst, Howard Hughes Med Inst, Portland, OR 97239 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; Pfizer; Pohang University of Science & Technology (POSTECH); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Howard Hughes Medical Institute; Yale University	Kim, Y (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.	kimyo@rockefeller.edu; angus.nairn@yale.edu; greengard@rockefeller.edu	Bardoni, Barbara/F-9918-2013; Schenck, Annette/E-4514-2012	Schenck, Annette/0000-0002-6918-3314; Ryu, Sung Ho/0000-0003-0913-3048; Ceglia, Ilaria/0000-0003-0692-9518; Kim, Yong/0000-0002-1387-2962; Nairn, Angus/0000-0002-7075-0195; Bardoni, Barbara/0000-0001-6411-1517; Ahn, Jung-Hyuck/0000-0001-9589-3881	NIDA NIH HHS [P01 DA010044] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Dahl JP, 2003, J NEUROSCI, V23, P3343; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nishi A, 1997, J NEUROSCI, V17, P8147; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takenawa T, 2001, J CELL SCI, V114, P1801	25	228	234	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					814	817		10.1038/nature04976	http://dx.doi.org/10.1038/nature04976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862120				2022-12-01	WOS:000239792700046
J	Farooqi, N; Kouyialis, AT; Brodbelt, A				Farooqi, Naeem; Kouyialis, Andreas T.; Brodbelt, Andrew			First things first	LANCET			English	Editorial Material									Walton Ctr Neurol & Neurosurg, Dept Neurosurg, Liverpool, Merseyside, England	Walton Centre	Farooqi, N (corresponding author), Walton Ctr Neurol & Neurosurg, Dept Neurosurg, Liverpool, Merseyside, England.	drnaf@yahoo.com							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2006	368	9535					617	617		10.1016/S0140-6736(06)69206-4	http://dx.doi.org/10.1016/S0140-6736(06)69206-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074OF	16905027				2022-12-01	WOS:000239821000036
J	Holland, RA; Wikelski, M; Wilcove, DS				Holland, Richard A.; Wikelski, Martin; Wilcove, David S.			How and why do insects migrate?	SCIENCE			English	Editorial Material							WIND DRIFT COMPENSATION; REVEALS; COMPASS; CRICKET	Countless numbers of insects migrate within and between continents every year, and yet we know very little about the ultimate reasons and proximate mechanisms that would explain these mass movements. Here we suggest that perhaps the most important reason for insects to migrate is to hedge their reproductive bets. By spreading their breeding efforts in space and time, insects distribute their offspring over a range of environmental conditions. We show how the study of individual long-distance movements of insects may contribute to a better understanding of migration. In the future, advances in tracking methods may enable the global surveillance of large insects such as desert locusts.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England	Princeton University; Princeton University; University of Leeds	Wikelski, M (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	wikelski@princeton.edu	Holland, Richard A/A-6107-2010	Holland, Richard A/0000-0003-4495-8061; Wilcove, David S./0000-0002-1354-0503				ARIDJIS H, 1996, NY TIMES        0126, pA27; Berthold P, 2001, BIRD MIGRATION GEN S; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; Brower L.P., 1988, Animal Kingdom, V91, P42; Brower LP, 1996, J EXP BIOL, V199, P93; Busvine JR, 1993, DIS TRANSMISSION INS; Calvert William H., 2001, Journal of the Lepidopterists' Society, V55, P162; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Collett M, 2006, CURR BIOL, V16, pR48, DOI 10.1016/j.cub.2006.01.007; Dingle H., 1996, MIGRATION BIOL LIFE; DRAKE VA, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P427, DOI 10.1017/CBO9780511470875.022; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Farrow R.A., 1990, P227; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; GATEHOUSE AG, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P193; Gatehouse AG, 1997, ANNU REV ENTOMOL, V42, P475, DOI 10.1146/annurev.ento.42.1.475; GREGG PC, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P151; HARVEY MJ, 1999, BATS US; Johnsgard PA, 1991, CRANE MUSIC NATURAL; Kennedy J.S., 1985, Contributions in Marine Science, V27, P5; Kremen C, 2005, FRONT ECOL ENVIRON, V3, P540, DOI 10.1890/1540-9295(2005)003[0540:ACTEMA]2.0.CO;2; Lorch PD, 2005, ECOL ENTOMOL, V30, P548, DOI 10.1111/j.0307-6946.2005.00725.x; Magor J.I., 2003, DESERT LOCUST POPULA; MAGOR JI, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P399; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Naef-Daenzer B, 2005, J EXP BIOL, V208, P4063, DOI 10.1242/jeb.01870; Oliveira EG, 1998, J EXP BIOL, V201, P3317; PERDECK A. C., 1958, ARDEA, V46, P1; Russell RW, 1998, AM MIDL NAT, V140, P325, DOI 10.1674/0003-0031(1998)140[0325:MSMODO]2.0.CO;2; SHAW MJP, 1970, ANN APPL BIOL, V65, P197, DOI 10.1111/j.1744-7348.1970.tb04579.x; SINCLAIR ARE, 1995, SERENGETI, V2; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; Srygley RB, 2006, ANIM BEHAV, V71, P183, DOI 10.1016/j.anbehav.2005.04.013; Srygley RB, 2001, J NAVIGATION, V54, P405, DOI 10.1017/S0373463301001448; Srygley RB, 1996, P ROY SOC B-BIOL SCI, V263, P1351, DOI 10.1098/rspb.1996.0198; Swenson G.W., 2004, P IEEE INT GEOSC REM; TAYLOR LR, 1974, J ANIM ECOL, V43, P225, DOI 10.2307/3169; URQUHART FA, 1964, P ENTOMOL SOC ONT, V95, P23; WIKELSKI M, IN PRESS BIOL LETT; WILLIAMS CB, 1957, ANNU REV ENTOMOL, V2, P163, DOI 10.1146/annurev.en.02.010157.001115; WILSON K, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P243; Woiwod I.P., 2001, INSECT MOVEMENT MECH, V1st; Zera AJ, 2005, INTEGR COMP BIOL, V45, P511, DOI 10.1093/icb/45.3.511	43	158	174	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					794	796		10.1126/science.1127272	http://dx.doi.org/10.1126/science.1127272			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902129				2022-12-01	WOS:000239671300047
J	Kondo, T; Sawa, S; Kinoshita, A; Mizuno, S; Kakimoto, T; Fukuda, H; Sakagami, Y				Kondo, Tatsuhiko; Sawa, Shinichiro; Kinoshita, Atsuko; Mizuno, Satoko; Kakimoto, Tatsuo; Fukuda, Hiroo; Sakagami, Youji			A plant peptide encoded by CLV3 identified by in situ MALDI-TOF MS analysis	SCIENCE			English	Article							GENE ENCODES; ARABIDOPSIS; MERISTEM; SHOOT; CLAVATA3; KINASES; FAMILY; CLE40	The Arabidopsis CLAVATA3 (CLV3) gene encodes a stem cell - specific protein presumed to be a precursor of a secreted peptide hormone. Matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) applied to in situ Arabidopsis tissues determined the structure of a modified 12 - amino acid peptide (MCLV3), which was derived from a conserved motif in the CLV3 sequence. Synthetic MCLV3 induced shoot and root meristem consumption as cells differentiated into other organs, displaying the typical phenotype of transgenic plants overexpressing CLV3. These results suggest that the functional peptide of CLV3 is MCLV3.	Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Univ Tokyo, Grad Sch Sci, Tokyo 1130033, Japan; Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Nagoya University; University of Tokyo; Osaka University	Sawa, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	sawa@biol.s.u-tokyo.ac.jp; ysaka@agr.nagoya-u.ac.jp		Kinoshita, Atsuko/0000-0001-9095-389X; Sawa, Shinichiro/0000-0002-9309-9104				Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Cock JM, 2001, PLANT PHYSIOL, V126, P939, DOI 10.1104/pp.126.3.939; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Hobe M, 2003, DEV GENES EVOL, V213, P371, DOI 10.1007/s00427-003-0329-5; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Ni J, 2006, PLANT PHYSIOL, V140, P726, DOI 10.1104/pp.105.072678; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Yasuda A, 2004, GEN COMP ENDOCR, V135, P391, DOI 10.1016/j.ygcen.2003.10.001	18	347	380	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					845	848		10.1126/science.1128439	http://dx.doi.org/10.1126/science.1128439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	072KC	16902141				2022-12-01	WOS:000239671300063
J	Feeley, F				Feeley, Frank			Fight AIDS as well as the brain drain	LANCET			English	Editorial Material									Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA	Boston University	Feeley, F (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA.	ffeeley@bu.edu		Feeley, Frank/0000-0002-7176-5698				[Anonymous], 2004, HUM RES HLTH OV CRIS; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; FEELEY R, 2004, COSTS HIV AIDS PROFE; GAUMER G, 2006, FEASIBILITY INSURANC; *MIN HLTH REP ZAMB, 2001, NAT 10 YEAR HUM RES; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Nullis-Kapp C, 2005, B WORLD HEALTH ORGAN, V83, P84; Thirumurthy H., 2005, EC IMPACT AIDS TREAT; *WHO, 2006, 2006 WORLD HLTH REP	9	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2006	368	9534					435	436		10.1016/S0140-6736(06)69133-2	http://dx.doi.org/10.1016/S0140-6736(06)69133-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890815				2022-12-01	WOS:000239569000010
J	Liu, W; Jawerth, LM; Sparks, EA; Falvo, MR; Hantgan, RR; Superfine, R; Lord, ST; Guthold, M				Liu, W.; Jawerth, L. M.; Sparks, E. A.; Falvo, M. R.; Hantgan, R. R.; Superfine, R.; Lord, S. T.; Guthold, M.			Fibrin fibers have extraordinary extensibility and elasticity	SCIENCE			English	Article							CLOT		Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Univ N Carolina, Curriculum Appl & Mat Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center	Lord, ST (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	stl@med.unc.edu; gutholdm@wfu.edu	Superfine, Richard/A-1968-2012; Liu, Wenhua/B-8044-2010; , Guthold/AAU-9371-2021	Superfine, Richard/0000-0002-2569-071X; Liu, Wenhua/0000-0002-1199-435X; Guthold, Martin/0000-0003-4177-6115	NATIONAL CANCER INSTITUTE [R41CA103120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NCI NIH HHS [R41 CA103120, R41 CA10312, R41 CA103120-01] Funding Source: Medline; NHLBI NIH HHS [R01 HL31048] Funding Source: Medline; NIBIB NIH HHS [P41 EB002025] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102; FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066; Guthold M, 2004, BIOPHYS J, V87, P4226, DOI 10.1529/biophysj.104.042333; MCKEE PA, 1970, P NATL ACAD SCI USA, V66, P738, DOI 10.1073/pnas.66.3.738; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029	6	210	212	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					634	634		10.1126/science.1127317	http://dx.doi.org/10.1126/science.1127317			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16888133	Green Submitted, Green Accepted			2022-12-01	WOS:000239667500033
J	Pearson, ER; Flechtner, I; Njolstad, PR; Malecki, MT; Flanagan, SE; Larkin, B; Ashcroft, FM; Klimes, I; Codner, E; Iotova, V; Slingerland, AS; Shield, J; Robert, J; Holst, JJ; Clark, PM; Ellard, S; Sovik, O; Polak, M; Hattersley, AT				Pearson, Ewan R.; Flechtner, Isabelle; Njolstad, Pal R.; Malecki, Maciej T.; Flanagan, Sarah E.; Larkin, Brian; Ashcroft, Frances M.; Klimes, Iwar; Codner, Ethel; Iotova, Violeta; Slingerland, Annabelle S.; Shield, Julian; Robert, Jean-Jacques; Holst, Jens J.; Clark, Penny M.; Ellard, Sian; Sovik, Oddmund; Polak, Michel; Hattersley, Andrew T.		Neonatal Diabet Int Collaborative	Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVATING MUTATIONS; ENCODES KIR6.2; COMMON-CAUSE; KCNJ11; THERAPY; ATP; MELLITUS; SUBUNIT; CHANNEL; GLUCOSE	BACKGROUND: Heterozygous activating mutations in KCNJ11, encoding the Kir6.2 subunit of the ATP-sensitive potassium (K(sub ATP)) channel, cause 30 to 58 percent of cases of diabetes diagnosed in patients under six months of age. Patients present with ketoacidosis or severe hyperglycemia and are treated with insulin. Diabetes results from impaired insulin secretion caused by a failure of the beta-cell K(sub ATP) channel to close in response to increased intracellular ATP. Sulfonylureas close the K(sub ATP) channel by an ATP-independent route. METHODS: We assessed glycemic control in 49 consecutive patients with Kir6.2 mutations who received appropriate doses of sulfonylureas and, in smaller subgroups, investigated the insulin secretory responses to intravenous and oral glucose, a mixed meal, and glucagon. The response of mutant K(sub ATP) channels to the sulfonylurea tolbutamide was assayed in xenopus oocytes. RESULTS: A total of 44 patients (90 percent) successfully discontinued insulin after receiving sulfonylureas. The extent of the tolbutamide blockade of K(sub ATP) channels in vitro reflected the response seen in patients. Glycated hemoglobin levels improved in all patients who switched to sulfonylurea therapy (from 8.1 percent before treatment to 6.4 percent after 12 weeks of treatment, P<0.001). Improved glycemic control was sustained at one year. Sulfonylurea treatment increased insulin secretion, which was more highly stimulated by oral glucose or a mixed meal than by intravenous glucose. Exogenous glucagon increased insulin secretion only in the presence of sulfonylureas. CONCLUSIONS: Sulfonylurea therapy is safe in the short term for patients with diabetes caused by KCNJ11 mutations and is probably more effective than insulin therapy. This pharmacogenetic response to sulfonylureas may result from the closing of mutant K(sub ATP) channels, thereby increasing insulin secretion in response to incretins and glucose metabolism.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; Univ Dundee, Div Med & Therapeut, Dundee, Scotland; Univ Lab Physiol, Oxford, England; Univ Bristol, Dept Child Hlth, Bristol, Avon, England; Univ Hosp Birmingham, Birmingham, W Midlands, England; Univ Paris 05, Fac Med, Hop Necker Enfants Malad, Paris, France; Univ Bergen, Dept Clin Med, Bergen, Norway; Haukeland Univ Hosp, Dept Pediat, N-5021 Bergen, Norway; Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland; Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia; Univ Chile, Sch Med, Inst Maternal & Child Res, Santiago, Chile; Med Univ, Varna, Bulgaria; Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark	University of Exeter; University of Dundee; University of Oxford; University of Bristol; University of Birmingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; University of Bergen; University of Bergen; Haukeland University Hospital; Jagiellonian University; Collegium Medicum Jagiellonian University; Slovak Academy of Sciences; Universidad de Chile; Medical University Varna; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen	Hattersley, AT (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Barrack Rd, Exeter EX2 5DW, Devon, England.	andrew.hattersley@pms.ac.uk	Shield, Julian PH/D-6297-2014; Holst, Jens/AAA-8022-2022; Iotova, Violeta/AAO-2387-2021	Shield, Julian PH/0000-0003-2601-7575; Jaap, Alan/0000-0001-8289-704X; Ellard, Sian/0000-0002-7620-5526; Holst, Jens Juul/0000-0001-6853-3805; Pearson, Ewan/0000-0001-9237-8585; Flanagan, Sarah/0000-0002-8670-6340; Iotova, Violeta/0000-0003-4160-1200	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashcroft F, 2004, HUM MOL GENET, V13, pR21, DOI 10.1093/hmg/ddh066; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Codner E, 2005, DIABETES CARE, V28, P758, DOI 10.2337/diacare.28.3.758; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Gloyn AL, 2004, NEW ENGL J MED, V351, P1470; Gloyn AL, 2004, J CLIN ENDOCR METAB, V89, P3932, DOI 10.1210/jc.2004-0568; Gloyn AL, 2005, HUM MOL GENET, V14, P925, DOI 10.1093/hmg/ddi086; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; HOLST JJ, 1982, BIOCHEM J, V207, P381, DOI 10.1042/bj2070381; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Klupa T, 2005, DIABETOLOGIA, V48, P1029, DOI 10.1007/s00125-005-1731-5; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; KRARUP T, 1983, J CLIN ENDOCR METAB, V56, P1306, DOI 10.1210/jcem-56-6-1306; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Massa O, 2005, HUM MUTAT, V25, P22, DOI 10.1002/humu.20124; MUSCELLI E, IN PRESS AM J PHYSL; Nauck MA, 2004, REGUL PEPTIDES, V122, P209, DOI 10.1016/j.regpep.2004.06.020; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; Proks P, 2005, EMBO REP, V6, P470, DOI 10.1038/sj.embor.7400393; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Sagen JV, 2005, DIABETIC MED, V22, P406, DOI 10.1111/j.1464-5491.2005.01439.x; Sagen JV, 2004, DIABETES, V53, P2713, DOI 10.2337/diabetes.53.10.2713; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Slingerland AS, 2005, ANN MED, V37, P186, DOI 10.1080/07853890510007287; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Vaxillaire M, 2004, DIABETES, V53, P2719, DOI 10.2337/diabetes.53.10.2719; Zung A, 2004, J CLIN ENDOCR METAB, V89, P5504, DOI 10.1210/jc.2004-1241	31	674	719	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2006	355	5					467	477		10.1056/NEJMoa061759	http://dx.doi.org/10.1056/NEJMoa061759			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FT	16885550	Bronze			2022-12-01	WOS:000239432500006
J	Pilot, F; Philippe, JM; Lemmers, C; Lecuit, T				Pilot, Fanny; Philippe, Jean-Marc; Lemmers, Celine; Lecuit, Thomas			Spatial control of actin organization at adherens junctions by the synaptotagmin-like protein Btsz	NATURE			English	Article							DROSOPHILA E-CADHERIN; EPITHELIAL-CELLS; POLARITY; MORPHOGENESIS; ARMADILLO; ADHESION; REARRANGEMENT; NEUROBLASTS; MECHANISMS; OOGENESIS	Epithelial tissues maintain a robust architecture during development. This fundamental property relies on intercellular adhesion through the formation of adherens junctions containing E-cadherin molecules(1,2). Localization of E-cadherin is stabilized through a pathway involving the recruitment of actin filaments by E-cadherin(3-6). Here we identify an additional pathway that organizes actin filaments in the apical junctional region (AJR) where adherens junctions form in embryonic epithelia. This pathway is controlled by Bitesize (Btsz), a synaptotagmin-like protein(7,8) that is recruited in the AJR independently of E-cadherin and is required for epithelial stability in Drosophila embryos. On loss of btsz, E-cadherin is recruited normally to the AJR, but is not stabilized properly and actin filaments fail to form a stable continuous network. In the absence of E-cadherin, actin filaments are stable for a longer time than they are in btsz mutants. We identify two polarized cues that localize Btsz: phosphatidylinositol (4,5)-bisphosphate, to which Btsz binds; and Par-3. We show that Btsz binds to the Ezrin - Radixin - Moesin protein Moesin, an F-actin-binding protein that is localized apically(9) and is recruited in the AJR in a btsz-dependent manner. Expression of a dominant-negative form of Ezrin that does not bind F-actin phenocopies the loss of btsz. Thus, our data indicate that, through their interaction, Btsz and Moesin may mediate the proper organization of actin in a local domain, which in turn stabilizes E-cadherin. These results provide a mechanism for the spatial order of actin organization underlying junction stabilization in primary embryonic epithelia.	Univ Mediterrannee, CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Mediterrannee, CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, Campus Luminy,Case 907, F-13288 Marseille 09, France.	lecuit@ibdm.univ-mrs.fr		Pilot-Storck, Fanny/0000-0001-8139-9911				Bershadsky A, 2004, TRENDS CELL BIOL, V14, P589, DOI 10.1016/j.tcb.2004.09.009; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Serano J, 2003, P NATL ACAD SCI USA, V100, P13368, DOI 10.1073/pnas.1835727100; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2002, J CELL SCI, V115, P2569; Zelhof AC, 2004, J CELL BIOL, V164, P417, DOI 10.1083/jcb.200307048	30	94	95	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					580	584		10.1038/nature04935	http://dx.doi.org/10.1038/nature04935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16862128				2022-12-01	WOS:000239455900047
J	Selmecki, A; Forche, A; Berman, J				Selmecki, Anna; Forche, Anja; Berman, Judith			Aneuploidy and isochromosome formation in drug-resistant Candida albicans	SCIENCE			English	Article							MESSENGER-RNA LEVELS; FLUCONAZOLE RESISTANCE; EXPERIMENTAL POPULATIONS; WIDESPREAD ANEUPLOIDY; LABORATORY STRAINS; CHROMOSOME LOSS; EVOLUTION; CDR; TRANSPORTERS; SEQUENCE	Resistance to the limited number of available antifungal drugs is a serious problem in the treatment of Candida albicans. We found that aneuploidy in general and a specific segmental aneuploidy, consisting of an isochromosome composed of the two left arms of chromosome 5, were associated with azole resistance. The isochromosome forms around a single centromere flanked by an inverted repeat and was found as an independent chromosome or fused at the telomere to a full-length homolog of chromosome 5. Increases and decreases in drug resistance were strongly associated with gain and loss of this isochromosome, which bears genes expressing the enzyme in the ergosterol pathway targeted by azole drugs, efflux pumps, and a transcription factor that positively regulates a subset of efflux pump genes.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Berman, J (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-160 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	jberman@umn.edu	Berman, Judith/AAS-5115-2021; Berman, Judith/ABA-8528-2021	Berman, Judith/0000-0002-8577-0084; Selmecki, Anna/0000-0003-3298-2400	NIAID NIH HHS [R01 AI062427] Funding Source: Medline; NIDCR NIH HHS [DE10641-S] Funding Source: Medline; PHS HHS [R01 AIO62427] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE010641] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Anderson JB, 2003, GENETICS, V163, P1287; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Calvet HM, 1997, ANTIMICROB AGENTS CH, V41, P535, DOI 10.1128/AAC.41.3.535; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2001, J BACTERIOL, V183, P2971, DOI 10.1128/JB.183.10.2971-2978.2001; Cowen LE, 2000, J BACTERIOL, V182, P1515, DOI 10.1128/JB.182.6.1515-1522.2000; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; Lephart PR, 2005, EUKARYOT CELL, V4, P733, DOI 10.1128/EC.4.4.733-741.2005; Marr KA, 1998, ANTIMICROB AGENTS CH, V42, P2584, DOI 10.1128/AAC.42.10.2584; Marr KA, 1997, CLIN INFECT DIS, V25, P908, DOI 10.1086/515553; Sanyal K, 2004, P NATL ACAD SCI USA, V101, P11374, DOI 10.1073/pnas.0404318101; SCHONIAN G, 1993, MYCOSES, V36, P171, DOI 10.1111/j.1439-0507.1993.tb00746.x; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482	26	475	486	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					367	370		10.1126/science.1128242	http://dx.doi.org/10.1126/science.1128242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857942	Green Accepted			2022-12-01	WOS:000239154300049
J	Yeung, T; Terebiznik, M; Yu, LM; Silvius, J; Abidi, WM; Philips, M; Levine, T; Kapus, A; Grinstein, S				Yeung, Tony; Terebiznik, Mauricio; Yu, Liming; Silvius, John; Abidi, Wasif M.; Philips, Mark; Levine, Tim; Kapus, Andras; Grinstein, Sergio			Receptor activation alters inner surface potential during phagocytosis	SCIENCE			English	Article							PLASMA-MEMBRANE; LOCALIZATION; K-RAS4B; BINDING	The surface potential of biological membranes varies according to their lipid composition. We devised genetically encoded probes to assess surface potential in intact cells. These probes revealed marked, localized alterations in the charge of the inner surface of the plasma membrane of macrophages during the course of phagocytosis. Hydrolysis of phosphoinositides and displacement of phosphatidylserine accounted for the change in surface potential at the phagosomal cup. Signaling molecules such as K-Ras, Rac1, and c-Src that are targeted to the membrane by electrostatic interactions were rapidly released from membrane subdomains where the surface charge was altered by lipid remodeling during phagocytosis.	Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Gastroenterol Hepatol & Nutr Dept, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; NYU, Sch Med, Dept Med, New York, NY 10016 USA; UCL, Div Cell Biol, London EC1V 9EL, England; St Michaels Hosp, Res Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; New York University; University of London; University College London; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca		Mark, Philips/0000-0002-1179-8156; Yeung, Tony/0000-0002-1970-5751				Botelho RJ, 2004, CURR TOP MICROBIOL, V282, P1; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Olivotto M, 1996, BIOESSAYS, V18, P495, DOI 10.1002/bies.950180612; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q	9	248	253	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					347	351		10.1126/science.1129551	http://dx.doi.org/10.1126/science.1129551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857939				2022-12-01	WOS:000239154300043
J	Rooney, N; McCann, K; Gellner, G; Moore, JC				Rooney, Neil; McCann, Kevin; Gellner, Gabriel; Moore, John C.			Structural asymmetry and the stability of diverse food webs	NATURE			English	Article							TROPHIC INTERACTIONS; REAL; DYNAMICS; PREDATOR; COMPARTMENTATION	Untangling the influence of human activities on food-web stability and persistence is complex given the large numbers of species and overwhelming number of interactions within ecosystems. Although biodiversity has been associated with stability, the actual structures and processes that confer stability to diverse food webs remain largely unknown. Here we show that real food webs are structured such that top predators act as couplers of distinct energy channels that differ in both productivity and turnover rate. Our theoretical analysis shows that coupled fast and slow channels convey both local and non-local stability to food webs. Alarmingly, the same human actions that have been implicated in the loss of biodiversity also directly erode the very structures and processes that we show to confer stability on food webs.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA	University of Guelph; University of Northern Colorado	Rooney, N (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	nrooney@uoguelph.ca	Moore, John/E-9802-2011	Rooney, Neil/0000-0003-4360-4034; Gellner, Gabriel/0000-0001-8170-1463				BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; BERG MP, 1987, THESIS VRIJE U AMSTE; Cohen J., 1978, FOOD WEBS NICHE SPAC; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; DOLES J, 2000, SURVEY SOIL BIOTA AR; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HOLT RD, 1983, AM NAT, V122, P521, DOI 10.1086/284153; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Ives AR, 2002, AM NAT, V159, P388, DOI 10.1086/338994; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MAY R M, 1971, Mathematical Biosciences, V12, P59, DOI 10.1016/0025-5564(71)90074-5; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MOORE JC, 1993, SCIENCE, V261, P906, DOI 10.1126/science.261.5123.906; MOORE JC, 1989, SCIENCE, V243, P238, DOI 10.1126/science.2911739; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Neira S, 2004, J EXP MAR BIOL ECOL, V312, P349, DOI 10.1016/j.jembe.2004.07.011; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2000, ECOLOGY, V81, P8, DOI 10.2307/177129; RAFELI DG, 1996, FOOD WEBS INTEGRATIO, P185; Sanchez F, 2004, ECOL MODEL, V172, P151, DOI 10.1016/j.ecolmodel.2003.09.005; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Teng J, 2004, AM NAT, V164, P85, DOI 10.1086/421723; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; TRITES AW, 1999, FISHERIES CTR RES RE, V7; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0	41	598	615	10	309	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					265	269		10.1038/nature04887	http://dx.doi.org/10.1038/nature04887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855582				2022-12-01	WOS:000239122100030
J	Zelhof, AC; Hardy, RW; Becker, A; Zuker, CS				Zelhof, Andrew C.; Hardy, Robert W.; Becker, Ann; Zuker, Charles S.			Transforming the architecture of compound eyes	NATURE			English	Article							DROSOPHILA-MELANOGASTER; GENE-FUNCTION; MORPHOGENESIS; CHAOPTIN; PHOTORECEPTORS; DEGENERATION; GLYCOPROTEIN; PROMININ; MUTANTS	Eyes differ markedly in the animal kingdom, and are an extreme example of the evolution of multiple anatomical solutions to light detection and image formation. A salient feature of all photoreceptor cells is the presence of a specialized compartment ( disc outer segments in vertebrates, and microvillar rhabdomeres in insects), whose primary role is to accommodate the millions of light receptor molecules required for efficient photon collection. In insects, compound eyes can have very different inner architectures(1-3). Fruitflies and houseflies have an open rhabdom system, in which the seven rhabdomeres of each ommatidium are separated from each other and function as independent light guides. In contrast, bees and various mosquitoes and beetle species have a closed system, in which rhabdomeres within each ommatidium are fused to each other, thus sharing the same visual axis. To understand the transition between open and closed rhabdom systems, we isolated and characterized the role of Drosophila genes involved in rhabdomere assembly. Here we show that Spacemaker, a secreted protein expressed only in the eyes of insects with open rhabdom systems, acts together with Prominin and the cell adhesion molecule Chaoptin to choreograph the partitioning of rhabdomeres into an open system. Furthermore, the complete loss of spacemaker (spam) converts an open rhabdom system to a closed one, whereas its targeted expression to photoreceptors of a closed system markedly reorganizes the architecture of the compound eyes to resemble an open system. Our results provide a molecular atlas for the construction of microvillar assemblies and illustrate the critical effect of differences in a single structural protein in morphogenesis.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	azelhof@flyeye.ucsd.edu; charles@flyeye.ucsd.edu		Zelhof, Andrew/0000-0001-7085-822X	NEI NIH HHS [R01 EY006979-17, R01 EY006979] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006979] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Franceschini N., 1972, INFORMATION PROCESSI, P75; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Land M.F., 1989, P90; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Nilsson D.-E., 1989, P30; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Shaw S.R., 1989, P186; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; Yoon CS, 1996, CELL TISSUE RES, V284, P77, DOI 10.1007/s004410050568; Zelhof AC, 2004, J CELL BIOL, V164, P417, DOI 10.1083/jcb.200307048; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	21	123	126	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					696	699		10.1038/nature05128	http://dx.doi.org/10.1038/nature05128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036004				2022-12-01	WOS:000241160500047
J	Kim, H; Lim, SW; Kim, S; Kim, JW; Chang, YH; Carroll, BJ; Kim, DK				Kim, Hyeran; Lim, Shinn-Won; Kim, Seonwoo; Kim, Jong-Won; Chang, Yun Hee; Carroll, Bernard J.; Kim, Doh Kwan			Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN REUPTAKE INHIBITORS; HUMAN NOREPINEPHRINE TRANSPORTER; RECURRENT MAJOR DEPRESSION; TRICYCLIC ANTIDEPRESSANTS; ALLELIC VARIATION; ASSOCIATION; PROMOTER; EFFICACY; DISORDER; VARIANTS	Context Polymorphisms in the serotonin transporter gene (5-HTT) may influence antidepressant response to selective serotonin reuptake inhibitors (SSRIs). The norepinephrine transporter ( NET) is the analogous target for norepinephrine reuptake inhibitors (NRIs). Objective To determine whether antidepressant responses to SSRIs or NRIs are associated with genetic polymorphisms of the corresponding monoamine transporters. Design, Setting, and Patients A 6-week naturalistic treatment study with blinded outcome evaluation of 241 Korean inpatients and outpatients with major depression at an academic psychiatry service. Patients were recruited to the study from March 1998 through February 2003. Interventions Treatment with an SSRI (fluoxetine or sertraline; n=136) or an NRI ( nortriptyline; n=105) antidepressant. Adherence was assessed by measuring plasma concentration at 4 weeks. Patients were genotyped for s/l polymorphisms in 5-HTT promoter region (5-HTTLPR), 5-HTT intron 2 s/l variation, and NET G1287A variation of exon 9. Main Outcome Measures An SSRI and NRI response ( defined as >= 50% decrease in Hamilton Rating Scale for Depression score at 6 weeks). Results NRI response was associated with the NET G1287A polymorphism ( odds ratio [ OR], 7.54; 95% confidence interval [CI], 2.53-22.49; P <. 001). An SSRI response was associated with the 5-HTT intron 2 s/l variation ( OR, 20.11; 95% CI, 4.27-94.74; P <. 001). The 5-HTTLPR was also associated with an SSRI response ( OR, 3.34; 95% CI, 1.41-7.91; P=. 006). In contrast to studies in white patients, the favorable allele for SSRI response was S 5-HTTLPR. The S 5-HTTLPR was associated also with NRI response ( OR, 3.73; 95% CI, 1.32-10.53; P=. 01). The NET polymorphism was not associated with an SSRI response. The NET G1287A GG genotype (56% of the population) was associated with better response to the NRI (83.3% [35/42]) than to SSRI ( 58.7% [44/75]) ( OR, 3.52; 95% CI, 1.39-8.95; P=. 006). Some genotype combinations were associated with high rates of antidepressant response and others with low rates of response. Conclusions Monoamine transporter gene polymorphisms were associated with response to antidepressants with homologous monoamine transporter targets. Combinations of polymorphisms were informative for response and nonresponse. Confirmation of these preliminary findings would permit refined pharmacogenetic selection of antidepressant treatment.	Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Genet, Seoul 135710, South Korea; Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; Samsung Biomed Res Inst, Biostat Unit, Seoul, South Korea; Myongji Univ, Dept Food & Nutr, Yongin, South Korea; Pacific Behav Res Fdn, Carmel, CA USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Myongji University	Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 50 Irwon Dong, Seoul 135710, South Korea.	paulkim@smc.samsung.co.kr	Kim, Doh Kwan/F-4616-2014; Kim, Jong Won/C-9615-2011	Kim, Doh Kwan/0000-0002-2302-6153; 				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Arias B, 2003, J CLIN PSYCHOPHARM, V23, P563, DOI 10.1097/01.jcp.0000095350.32154.73; Bellivier F, 1998, NEUROSCI LETT, V255, P143, DOI 10.1016/S0304-3940(98)00677-6; Benedetti F, 2003, BIOL PSYCHIAT, V54, P687, DOI 10.1016/S0006-3223(02)01894-2; DELGADO PL, 1993, PSYCHOPHARMACOL BULL, V29, P389; DELGADO PL, 1991, PSYCHOPHARMACOL BULL, V27, P321; Driscoll HC, 2005, INT J GERIATR PSYCH, V20, P661, DOI 10.1002/gps.1334; Durham LK, 2004, PSYCHOPHARMACOLOGY, V174, P525, DOI 10.1007/s00213-003-1562-3; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; First M. B., 1997, STRUCTURED CLIN INTE; Fredman SJ, 2000, J CLIN PSYCHIAT, V61, P403, DOI 10.4088/JCP.v61n0602; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Golimbet V. E., 2002, Genetika, V38, P671; Hachisu Mitsugu, 2000, Folia Pharmacologica Japonica, V115, P271, DOI 10.1254/fpj.115.271; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; Jonsson EG, 1998, PSYCHIAT RES, V79, P1, DOI 10.1016/S0165-1781(98)00027-4; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Koch S, 2002, NEUROPSYCHOPHARMACOL, V27, P949, DOI 10.1016/S0893-133X(02)00377-9; Kollroser M, 2002, THER DRUG MONIT, V24, P537, DOI 10.1097/00007691-200208000-00013; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Leszczynska-Rodziewicz A, 2002, NEUROPSYCHOBIOLOGY, V45, P182, DOI 10.1159/000063668; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; McGue M, 1997, J ABNORM PSYCHOL, V106, P439, DOI 10.1037/0021-843X.106.3.439; Minov C, 2001, NEUROSCI LETT, V303, P119, DOI 10.1016/S0304-3940(01)01704-9; Murphy GM, 2004, ARCH GEN PSYCHIAT, V61, P1163, DOI 10.1001/archpsyc.61.11.1163; Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698; Ng CH, 2006, INT CLIN PSYCHOPHARM, V21, P87, DOI 10.1097/01.yic.0000188214.46667.3f; NYSTROM C, 1985, ACTA PSYCHIAT SCAND, V72, P6, DOI 10.1111/j.1600-0447.1985.tb02563.x; ORSULAK PJ, 2001, CLIN TOXICOLOGY LAB; Owen D, 1999, PSYCHIAT RES, V87, P1, DOI 10.1016/S0165-1781(99)00050-5; Perlis RH, 2003, BIOL PSYCHIAT, V54, P879, DOI 10.1016/S0006-3223(03)00424-4; Pollock BG, 2000, NEUROPSYCHOPHARMACOL, V23, P587, DOI 10.1016/S0893-133X(00)00132-9; Rausch JL, 2002, BIOL PSYCHIAT, V51, P723, DOI 10.1016/S0006-3223(01)01283-5; Reynolds CF, 1996, AM J PSYCHIAT, V153, P1288; Reynolds CF, 1998, AM J PSYCHIAT, V155, P795; Runkel F, 2000, PHARMACOGENETICS, V10, P397, DOI 10.1097/00008571-200007000-00003; Samochowiec J, 2002, PSYCHIAT RES, V111, P229, DOI 10.1016/S0165-1781(02)00145-2; Sand PG, 2002, NEUROSCI LETT, V333, P41, DOI 10.1016/S0304-3940(02)00984-9; Serretti A, 2005, PHARMACOGENET GENOM, V15, P61, DOI 10.1097/01213011-200502000-00001; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Srisurapanont Manit, 1998, Journal of the Medical Association of Thailand, V81, P387; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P185, DOI 10.1176/appi.ajgp.10.2.185; Stober G, 1999, AM J MED GENET, V88, P158, DOI 10.1002/(SICI)1096-8628(19990416)88:2<158::AID-AJMG12>3.0.CO;2-W; Stober G, 1996, AM J MED GENET, V67, P523, DOI 10.1002/(SICI)1096-8628(19961122)67:6<523::AID-AJMG3>3.0.CO;2-I; Tournel G, 2001, J CHROMATOGR B, V761, P147, DOI 10.1016/S0378-4347(01)00305-X; Tsapakis E, 2005, EUR NEUROPSYCHOPHARM, V15, pS26, DOI 10.1016/S0924-977X(05)80137-3; Yang L, 2004, J AM ACAD CHILD PSY, V43, P1154, DOI 10.1097/01.chi.0000131134.63368.46; Yoshida K, 2004, AM J PSYCHIAT, V161, P1575, DOI 10.1176/appi.ajp.161.9.1575; YOSHIDA K, 1908, PROG NEUROPSYCHOPHAR, V26, P383; Zanardi R, 2001, BIOL PSYCHIAT, V50, P323, DOI 10.1016/S0006-3223(01)01118-0	54	164	183	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1609	1618		10.1001/jama.296.13.1609	http://dx.doi.org/10.1001/jama.296.13.1609			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	090JS	17018806	Bronze			2022-12-01	WOS:000240948200021
J	Hladik, W; Dollard, SC; Mermin, J; Fowlkes, AL; Downing, R; Amin, MM; Banage, F; Nzaro, E; Kataaha, P; Dondero, TJ; Pellett, PE; Lackritz, EM				Hladik, Wolfgang; Dollard, Sheila C.; Mermin, Jonathan; Fowlkes, Ashley L.; Downing, Robert; Amin, Minal M.; Banage, Flora; Nzaro, Esau; Kataaha, Peter; Dondero, Timothy J.; Pellett, Philip E.; Lackritz, Eve M.			Transmission of human herpesvirus 8 by blood transfusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; SEROLOGIC ASSAYS; DNA-SEQUENCES; INFECTION; RISK; DONORS; AIDS; SEROPREVALENCE; PREVALENCE	Background: Whether human herpesvirus 8 (HHV-8) is transmissible by blood transfusion remains undetermined. We evaluated the risk of HHV-8 transmission by blood transfusion in Uganda, where HHV-8 is endemic. Methods: We enrolled patients in Kampala, Uganda, who had received blood transfusions between December 2000 and October 2001. Pretransfusion and multiple post-transfusion blood specimens from up to nine visits over a 6-month period were tested for HHV-8 antibody. We calculated the excess risk of seroconversion over time among recipients of HHV-8-seropositive blood as compared with recipients of seronegative blood. Results: Of the 1811 transfusion recipients enrolled, 991 were HHV-8-seronegative before transfusion and completed the requisite follow-up, 43% of whom received HHV-8-seropositive blood and 57% of whom received seronegative blood. HHV-8 seroconversion occurred in 41 of the 991 recipients. The risk of seroconversion was significantly higher among recipients of HHV-8-seropositive blood than among recipients of seronegative blood (excess risk, 2.8%; P < 0.05), and the increase in risk was seen mainly among patients in whom seroconversion occurred 3 to 10 weeks after transfusion (excess risk, 2.7%; P=0.005), a result consistent with the transmission of the virus by transfusion. Blood units stored for up to 4 days were more often associated with seroconversion than those stored for more than 4 days (excess risk, 4.2%; P < 0.05). Conclusions: This study provides strong evidence that HHV-8 is transmitted by blood transfusion. The risk may be diminished as the period of blood storage increases.	Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Global Acquired Immunodeficiency Syndrome Program, Natl Ctr Human Immunodeficiency Virus Sexually Tr, Entebbe, Uganda; Ctr Dis Control & Prevent, Global Acquired Immunodeficiency Syndrome Program, Natl Ctr Human Immunodeficiency Virus Sexually Tr, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; Mulago Hosp, Kampala, Uganda; Nakasero Blood Bank, Kampala, Uganda; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Centers for Disease Control & Prevention - USA; Uganda Virus Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Mulago National Referral Hospital; Cleveland Clinic Foundation	Dollard, SC (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Infect Dis, Mailstop G-18,1600 Clifton Rd, Atlanta, GA 30333 USA.	sgd5@cdc.gov	Parisi, Saverio G/C-6088-2009; cruciani, mario/A-3181-2012; Chang, Yuan/F-4146-2011; Moore, Patrick/GVR-8294-2022; Moore, Patrick S./F-3960-2011	Chang, Yuan/0000-0003-1125-4041; Moore, Patrick S./0000-0002-8132-858X; Pellett, Philip/0000-0002-8536-8343; Lackritz, Eve/0000-0002-5397-7291				ADLER SP, 1989, TRANSFUSION, V29, P667, DOI 10.1046/j.1537-2995.1989.29890020436.x; Atkinson J, 2003, J INFECT DIS, V187, P974, DOI 10.1086/368332; Belec L, 1998, TRANSFUSION, V38, P771, DOI 10.1046/j.1537-2995.1998.38898375517.x; Bigoni B, 1996, J INFECT DIS, V173, P542, DOI 10.1093/infdis/173.3.542; Blackbourn DJ, 1997, LANCET, V349, P609, DOI 10.1016/S0140-6736(96)10004-0; Cannon MJ, 2001, NEW ENGL J MED, V344, P637, DOI 10.1056/NEJM200103013440904; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; COCKERILL FR, 1986, AM J MED, V80, P1237, DOI 10.1016/0002-9343(86)90695-9; DAVIS KC, 1983, ANN INTERN MED, V98, P284, DOI 10.7326/0003-4819-98-3-284; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.6600745; Dodd RY, 2005, TRANSFUSION, V45, P463, DOI 10.1111/j.0041-1132.2005.05008.x; Dollard SC, 2005, TRANSFUSION, V45, P500, DOI 10.1111/j.0041-1132.2005.04334.x; Engels EA, 1999, J NATL CANCER I, V91, P1773, DOI 10.1093/jnci/91.20.1773; Henke-Gendo C, 2004, CURR OPIN INFECT DIS, V17, P53, DOI 10.1097/00001432-200402000-00011; Hladik W, 2003, JAIDS-J ACQ IMM DEF, V33, P206, DOI 10.1097/00126334-200306010-00015; Lefrere JJ, 1997, LANCET, V350, P217, DOI 10.1016/S0140-6736(05)62382-3; Lennette ET, 1996, LANCET, V348, P858, DOI 10.1016/S0140-6736(96)03240-0; Marcelin AG, 1998, AIDS, V12, P2351; Marchioli CC, 1996, J CLIN MICROBIOL, V34, P2635, DOI 10.1128/JCM.34.10.2635-2638.1996; Mbulaiteye SM, 2003, J NATL CANCER I, V95, P1330, DOI 10.1093/jnci/djg039; Offner PJ, 2004, CRIT CARE, V8, pS24, DOI 10.1186/cc2405; Operskalski EA, 1997, LANCET, V349, P1327, DOI 10.1016/S0140-6736(05)62544-5; Parravicini C, 1997, BLOOD, V90, P2826; Pau CP, 1998, J CLIN MICROBIOL, V36, P1574, DOI 10.1128/JCM.36.6.1574-1577.1998; Pellett PE, 2003, TRANSFUSION, V43, P1260, DOI 10.1046/j.1537-2995.2003.00490.x; Pfeiffer RM, 2004, BIOMETRICS, V60, P249, DOI 10.1111/j.0006-341X.2004.00168.x; Pierrotti LC, 2000, J CLIN VIROL, V16, P247, DOI 10.1016/S1386-6532(99)00078-5; Regamey N, 1998, NEW ENGL J MED, V339, P1358, DOI 10.1056/NEJM199811053391903; Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174; Velez-Garcia E, 1984, AIDS Res, V1, P401; VELEZGARCIA E, 1985, NEW ENGL J MED, V312, P648; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9	32	125	140	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1331	1338		10.1056/NEJMoa055009	http://dx.doi.org/10.1056/NEJMoa055009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005950				2022-12-01	WOS:000240793600006
J	Smellie, WSA; Ryder, SD				Smellie, W. Stuart A.; Ryder, Stephen			Cases in primary care laboratory medicine - Biochemical "liver function tests"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHEMISTRY TESTS		Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England; Queens Med Ctr, Dept Gastroenterol, Nottingham NG7 2UH, England	University of Nottingham	Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England.	info@smellie.com		Ryder, Stephen David/0000-0001-9649-4444				Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dubois-Laforgue D, 2000, DIABETES METAB, V26, P318; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Hoagland R J, 1975, Prim Care, V2, P295; HULTCRANTZ R, 1986, SCAND J GASTROENTERO, V21, P109, DOI 10.3109/00365528609034632; Lichtenstein GR, 2002, GASTROENTEROLOGY, V123, P1364, DOI 10.1053/gast.2002.36060; Skelly MM, 2001, J HEPATOL, V35, P195, DOI 10.1016/S0168-8278(01)00094-0; SMELLIE WSA, 2006, J CLIN PATHOL   0705; TOMSEN HF, 1981, SCAND J GASTROENTERO, V16, P699	9	2	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2006	333	7566					481	483		10.1136/bmj.333.7566.481	http://dx.doi.org/10.1136/bmj.333.7566.481			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085QP	16946336	Green Published			2022-12-01	WOS:000240618900021
J	Fenwick, A				Fenwick, Alan			Waterborne infectious diseases - Could they be consigned to history?	SCIENCE			English	Editorial Material							DRACUNCULIASIS ERADICATION; PUBLIC-HEALTH; SCHISTOSOMIASIS; MALARIA; ELIMINATION; FILARIASIS; PROGRAMS; SENEGAL; DAMS	The development of water resources, particularly in Africa, has changed the face of the continent, opening up land for agriculture, providing electric power, encouraging settlements adjacent to water bodies, and bringing prosperity to poor people. Unfortunately, the created or altered water bodies provide ideal conditions for the transmission of waterborne diseases and a favorable habitat for intermediate hosts of tropical parasitic infections that cause disease and suffering. The recent progress in control of these waterborne and vector-borne diseases, such as guinea worm, schistosomiasis, lymphatic filariasis, and onchocerciasis, suggests that many of them could be controlled effectively by 2015, which is the target for reaching the Millennium Development Goals. Donations of safe and effective drugs by several pharmaceutical companies, funds for delivering these donated drugs from foundations and bilateral donors, and effective global health partnerships should make these diseases history.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London WC2 1PG, England	Imperial College London	Fenwick, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London WC2 1PG, England.	a.fenwick@imperial.ac.uk						Barry M, 2006, AM J TROP MED HYG, V75, P1; Crichton-Harris Ann, 2006, J Med Biogr, V14, P8; Dadzie K Y, 1997, Afr Health, V19, P13; Dadzie Yankum, 2003, Filaria J, V2, P2, DOI 10.1186/1475-2883-2-2; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Edwards G, 2006, BRIT J CLIN PHARMACO, V61, P690, DOI 10.1111/j.1365-2125.2006.02674.x; ELGADDAL AA, 1989, MEM I OSWALDO CRUZ, V84, P117, DOI 10.1590/S0074-02761989000500012; ELGADDAL AA, 1985, J TROP MED HYG, V88, P47; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fenwick A, 2006, T ROY SOC TROP MED H, V100, P200, DOI 10.1016/j.trstmh.2005.03.014; Garba A, 2006, TRENDS PARASITOL, V22, P322, DOI 10.1016/j.pt.2006.04.007; GREANY WH, 1952, ANN TROP MED PARASIT, V46, P298, DOI 10.1080/00034983.1952.11685535; GREANY WH, 1952, ANN TROP MED PARASIT, V46, P250, DOI 10.1080/00034983.1952.11685530; Gyapong JO, 2005, EXPERT OPIN PHARMACO, V6, P179, DOI 10.1517/14656566.6.2.179; HOMEIDA M, 1988, AM J TROP MED HYG, V39, P196, DOI 10.4269/ajtmh.1988.39.196; HOMEIDA MA, 1988, LANCET, V2, P437; Hopkins DR, 2005, AM J TROP MED HYG, V73, P669, DOI 10.4269/ajtmh.2005.73.669; Hotez P, 2005, LANCET, V365, P2089, DOI 10.1016/S0140-6736(05)66730-X; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 1997, EMERG INFECT DIS, V3, P303, DOI 10.3201/eid0303.970306; KABATEREINE BS, IN PRESS B WHO; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; Kjetland EF, 2005, AM J TROP MED HYG, V72, P311, DOI 10.4269/ajtmh.2005.72.311; Lakwo TL, 2006, MED VET ENTOMOL, V20, P93, DOI 10.1111/j.1365-2915.2006.00603.x; LEIPER R. T., 1915, Journal of the Royal Army Medical Corps, V25, P1; Molyneux David, 2003, Filaria J, V2, P13, DOI 10.1186/1475-2883-2-13; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Paperna I, 1970, Z Tropenmed Parasitol, V21, P411; Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2; Savioli L, 2005, LANCET, V365, P1520, DOI 10.1016/S0140-6736(05)66433-1; Southgate VR, 1997, J HELMINTHOL, V71, P125, DOI 10.1017/S0022149X00015790; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; TALLA I, 1990, ANN SOC BELG MED TR, V70, P173; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; von Schirnding Y, 2002, B WORLD HEALTH ORGAN, V80, P970; Zagaria N, 2002, ANN TROP MED PARASIT, V96, pS3, DOI [10.1179/0034980215002347, 10.1179/00034980215002347]; 1973, WHO TECH REP SER, V515; 2002, WHO TECH REP SER, V912	39	135	139	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1077	1081		10.1126/science.1127184	http://dx.doi.org/10.1126/science.1127184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931751				2022-12-01	WOS:000239998200033
J	Whitlock, JR; Heynen, AJ; Shuler, MG; Bear, MF				Whitlock, Jonathan R.; Heynen, Arnold J.; Shuler, Marshall G.; Bear, Mark F.			Learning induces long-term potentiation in the hippocampus	SCIENCE			English	Article							SYNAPTIC TRANSMISSION; FIELD POTENTIALS; MEMORY CONSOLIDATION; BRAIN TEMPERATURE; PASSIVE-AVOIDANCE; PERFORANT PATH; FASCIA-DENTATA; GLUR1 SUBUNIT; ENHANCEMENT; RATS	Years of intensive investigation have yielded a sophisticated understanding of long-term potentiation (LTP) induced in hippocampal area CA1 by high-frequency stimulation (HFS). These efforts have been motivated by the belief that similar synaptic modifications occur during memory formation, but it has never been shown that learning actually induces LTP in CA1. We found that one-trial inhibitory avoidance learning in rats produced the same changes in hippocampal glutamate receptors as induction of LTP with HFS and caused a spatially restricted increase in the amplitude of evoked synaptic transmission in CA1 in vivo. Because the learning-induced synaptic potentiation occluded HFS-induced LTP, we conclude that inhibitory avoidance training induces LTP in CA1.	MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Brown University	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	mbear@mit.edu		Bear, Mark/0000-0002-9903-2541				Abraham WC, 2003, NEUROSCIENTIST, V9, P463, DOI 10.1177/1073858403259119; Andersen P, 1995, HIPPOCAMPUS, V5, P491, DOI 10.1002/hipo.450050602; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bevilaqua LR, 2005, NEUROSCIENCE, V136, P397, DOI 10.1016/j.neuroscience.2005.08.007; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bliss TVP, 2003, PHILOS T ROY SOC B, V358, P607, DOI 10.1098/rstb.2003.1282; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.t01-1-00254.x; CAMMAROTA M, 1995, NEUROBIOL LEARN MEM, V64, P257, DOI 10.1006/nlme.1995.0008; Cammarota M, 1996, NEUROBIOL LEARN MEM, V66, P85, DOI 10.1006/nlme.1996.0046; ERICKSON CA, 1993, BRAIN RES, V615, P275, DOI 10.1016/0006-8993(93)90038-O; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; GREEN EJ, 1990, J NEUROSCI, V10, P1455; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; ISAACSON RL, 1962, SCIENCE, V138, P1104, DOI 10.1126/science.138.3545.1104; IZQUIERDO I, 1992, BEHAV NEURAL BIOL, V58, P16, DOI 10.1016/0163-1047(92)90847-W; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lomo T, 2003, PHILOS T R SOC B, V358, P617, DOI 10.1098/rstb.2002.1226; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Moser EI, 1995, BEHAV BRAIN RES, V71, P11, DOI 10.1016/0166-4328(95)00051-8; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; SHARP PE, 1985, BRAIN RES, V339, P361, DOI 10.1016/0006-8993(85)90105-2; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; WEISZ DJ, 1984, BEHAV BRAIN RES, V12, P145, DOI 10.1016/0166-4328(84)90037-8	36	1309	1372	1	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1093	1097		10.1126/science.1128134	http://dx.doi.org/10.1126/science.1128134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931756				2022-12-01	WOS:000239998200038
J	Vastenhouw, NL; Brunschwig, K; Okihara, KL; Muller, F; Tijsterman, M; Plasterk, RHA				Vastenhouw, Nadine L.; Brunschwig, Karin; Okihara, Kristy L.; Mueller, Fritz; Tijsterman, Marcel; Plasterk, Ronald H. A.			Long-term gene silencing by RNAi	NATURE			English	Article							C-ELEGANS; INTERFERENCE; INHERITANCE		Hubrecht Lab KNAW, NL-3584 CT Utrecht, Netherlands; Univ Utrecht, NL-3584 CT Utrecht, Netherlands; Univ Fribourg, Inst Zool, CH-1700 Fribourg, Switzerland	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; University of Fribourg	Vastenhouw, NL (corresponding author), Hubrecht Lab KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Tijsterman, Marcel/H-5663-2018	Tijsterman, Marcel/0000-0001-8465-9002; Platt, Thomas/0000-0003-0082-1127; Shaulsky, Gad/0000-0002-0532-0551; Kalla, Sara/0000-0003-2437-5352				Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X	6	197	216	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					882	882		10.1038/442882a	http://dx.doi.org/10.1038/442882a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16929289	Green Submitted, Bronze			2022-12-01	WOS:000239960500026
J	Lorenz, IC; Marcotrigiano, J; Dentzer, TG; Rice, CM				Lorenz, Ivo C.; Marcotrigiano, Joseph; Dentzer, Thomas G.; Rice, Charles M.			Structure of the catalytic domain of the hepatitis C virus NS2-3 protease	NATURE			English	Article							CRYSTAL-STRUCTURE; NS3 PROTEASE	Hepatitis C virus is a major global health problem affecting an estimated 170 million people worldwide(1). Chronic infection is common and can lead to cirrhosis and liver cancer. There is no vaccine available and current therapies have met with limited success(2). The viral RNA genome encodes a polyprotein that includes two proteases essential for virus replication(3,4). The NS2-3 protease mediates a single cleavage at the NS2/NS3 junction, whereas the NS3-4A protease cleaves at four downstream sites in the polyprotein. NS3-4A is characterized as a serine protease with a chymotrypsin-like fold(5,6), but the enzymatic mechanism of the NS2-3 protease remains unresolved(7-9). Here we report the crystal structure of the catalytic domain of the NS2-3 protease at 2.3 angstrom resolution. The structure reveals a dimeric cysteine protease with two composite active sites. For each active site, the catalytic histidine and glutamate residues are contributed by one monomer, and the nucleophilic cysteine by the other. The carboxy-terminal residues remain coordinated in the two active sites, predicting an inactive post-cleavage form. Proteolysis through formation of a composite active site occurs in the context of the viral polyprotein expressed in mammalian cells. These features offer unexpected insights into polyprotein processing by hepatitis C virus and new opportunities for antiviral drug design.	Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA	Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	marcotj@rockefeller.edu; ricec@rockefeller.edu	Marcotrigiano, Joseph/K-6697-2016	Marcotrigiano, Joseph/0000-0003-0346-3353				Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; MALCOLM BA, 1995, PROTEIN SCI, V4, P1439, DOI 10.1002/pro.5560040801; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallaoro M, 2001, J VIROL, V75, P9939, DOI 10.1128/JVI.75.20.9939-9946.2001; PICKERSGILL RW, 1992, ACTA CRYSTALLOGR B, V48, P49; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; SANTOLINI E, 1995, J VIROL, V69, P7461, DOI 10.1128/JVI.69.12.7461-7471.1995; Thibeault D, 2001, J BIOL CHEM, V276, P46678, DOI 10.1074/jbc.M108266200; TONG L, 1993, J MOL BIOL, V230, P228, DOI 10.1006/jmbi.1993.1139; Urbani A, 1998, J BIOL CHEM, V273, P18760, DOI 10.1074/jbc.273.30.18760; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wlodawer A, 2000, BBA-PROTEIN STRUCT M, V1477, P16, DOI 10.1016/S0167-4838(99)00267-8; Wu Z, 1998, TRENDS BIOCHEM SCI, V23, P92, DOI 10.1016/S0968-0004(98)01180-3; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200	29	144	152	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2006	442	7104					831	835		10.1038/nature04975	http://dx.doi.org/10.1038/nature04975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862121				2022-12-01	WOS:000239792700050
J	Sack, DA; Sack, RB; Chaignat, C				Sack, David A.; Sack, R. Bradley; Chaignat, Claire-Lise			Getting serious about cholera	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; WHO, Global Task Force Cholera Control, Geneva, Switzerland	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Sack, DA (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.				NIAID NIH HHS [R01 AI039129] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039129] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; COLOMBO MM, 1993, EUR J EPIDEMIOL, V9, P563, DOI 10.1007/BF00209537; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; *WHO, 2006, CHOL ANG UPD 5	5	75	79	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2006	355	7					649	651		10.1056/NEJMp068144	http://dx.doi.org/10.1056/NEJMp068144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074AN	16914700				2022-12-01	WOS:000239784500003
J	Esposito, JJ; Sammons, SA; Frace, AM; Osborne, JD; Olsen-Rasmussen, M; Zhang, M; Govil, D; Damon, IK; Kline, R; Laker, M; Li, Y; Smith, GL; Meyer, H; LeDuc, JW; Wohlhueter, RM				Esposito, Joseph J.; Sammons, Scott A.; Frace, A. Michael; Osborne, John D.; Olsen-Rasmussen, Melissa; Zhang, Ming; Govil, Dhwani; Damon, Inger K.; Kline, Richard; Laker, Miriam; Li, Yu; Smith, Geoffrey L.; Meyer, Hermann; LeDuc, James W.; Wohlhueter, Robert M.			Genome sequence diversity and clues to the evolution of variola (smallpox) virus	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; DNA; VIRULENCE; TRANSPOSITION	Comparative genomics of 45 epidemiologically varied variola virus isolates from the past 30 years of the smallpox era indicate low sequence diversity, suggesting that there is probably little difference in the isolates' functional gene content. Phylogenetic clustering inferred three clades coincident with their geographical origin and case-fatality rate; the latter implicated putative proteins that mediate viral virulence differences. Analysis of the viral linear DNA genome suggests that its evolution involved direct descent and DNA end-region recombination events. Knowing the sequences will help understand the viral proteome and improve diagnostic test precision, therapeutics, and systems for their assessment.	Ctr Dis Control & Prevent, Biotech Core Facil Branch, Div Sci Resources, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA 30329 USA; Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA 30329 USA; Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, Atlanta, GA 30329 USA; Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England; Bundeswehr Inst Microbiol, D-80937 Munich, Germany	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Imperial College London; Bundeswehr Institute of Microbiology (IMB)	Esposito, JJ (corresponding author), Ctr Dis Control & Prevent, Biotech Core Facil Branch, Div Sci Resources, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA 30329 USA.	jesposito@cdc.gov	Smith, Geoffrey L/G-2894-2012; Osborne, John/F-3445-2016	Smith, Geoffrey L/0000-0002-3730-9955; Osborne, John/0000-0002-0851-1150	Medical Research Council [G0501257] Funding Source: Medline; MRC [G0501257] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alcami A, 1996, P NATL ACAD SCI USA, V93, P11029, DOI 10.1073/pnas.93.20.11029; Balbas P, 2001, MOL BIOTECHNOL, V19, P1, DOI 10.1385/MB:19:1:001; BANHAM AH, 1993, J GEN VIROL, V74, P2807, DOI 10.1099/0022-1317-74-12-2807; BEDSON HS, 1964, J HYG-CAMBRIDGE, V62, P147, DOI 10.1017/S0022172400039887; Camus-Bouclainville C, 2004, J VIROL, V78, P2510, DOI 10.1128/JVI.78.5.2510-2516.2004; de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Dumbell KR, 1999, EPIDEMIOL INFECT, V122, P287, DOI 10.1017/S0950268899002150; DUMBELL KR, 1986, AM J EPIDEMIOL, V123, P403, DOI 10.1093/oxfordjournals.aje.a114255; DUMBELL KR, 1975, T ROY SOC TROP MED H, V69, P303, DOI 10.1016/0035-9203(75)90123-6; ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4; ESPOSITO JJ, 1981, VIROLOGY, V109, P231, DOI 10.1016/0042-6822(81)90495-5; Fenner F., 1988, SMALLPOX ITS ERADICA; Hamilton MD, 2005, NUCLEIC ACIDS RES, V33, P2259, DOI 10.1093/nar/gki525; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Huq F, 2003, T ROY SOC TROP MED H, V97, P97, DOI 10.1016/S0035-9203(03)90036-8; Institute of Medicine, 1999, ASS FUT SCI NEEDS LI; MASSUNG RF, 1995, VIROLOGY, V211, P350, DOI 10.1006/viro.1995.1416; Massung RF, 1996, VIROLOGY, V221, P291, DOI 10.1006/viro.1996.0378; MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0; MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288; Meyer H, 2002, J VET MED B, V49, P17, DOI 10.1046/j.1439-0450.2002.00532.x; MOSS B, 2001, POXVIRIDAE VIRUSES T, V2, P2849; MOYER RW, 1980, CELL, V22, P545, DOI 10.1016/0092-8674(80)90364-5; National Research Council, 2004, BIOT RES AG TERR; NIZAMUDDIN M, 1961, LANCET, V1, P68; PICKUP DJ, 1984, P NATL ACAD SCI-BIOL, V81, P6817, DOI 10.1073/pnas.81.21.6817; Salemi M, 2003, PHYLOGENETIC HDB PRA; SHAFA E, 1972, WHOSE7235; SHCHELKUNOV SN, 1993, VIRUS RES, V30, P239, DOI 10.1016/0168-1702(93)90093-3; Shchelkunov SN, 2000, VIROLOGY, V266, P361, DOI 10.1006/viro.1999.0086; SHCHELKUNOV SN, 1994, VIRUS RES, V32, P37, DOI 10.1016/0168-1702(94)90060-4; SHCHELKUNOV SN, 1993, DOKL AKAD NAUK+, V328, P629; SHCHELKUNOV SN, 1995, VIRUS RES, V36, P107, DOI 10.1016/0168-1702(94)00113-Q; SHCHELKUNOV SN, 1993, VIRUS RES, V27, P25, DOI 10.1016/0168-1702(93)90110-9; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; *WHO, 1999, WEEKLY EPIDEMIOL REC, V74, P188; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P34; *WORLD HLTH ASS, 2002, 5515 WHA	40	139	143	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					807	812		10.1126/science.1125134	http://dx.doi.org/10.1126/science.1125134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16873609	Green Published			2022-12-01	WOS:000239671300051
J	Kokko, H; Lopez-Sepulcre, A				Kokko, Hanna; Lopez-Sepulcre, Andres			From individual dispersal to species ranges: Perspectives for a changing world	SCIENCE			English	Editorial Material							DEPENDENT DISPERSAL; ECOLOGICAL TRAPS; EVOLUTION; CONSEQUENCES; DYNAMICS; SPEED		Univ Helsinki, Dept Biol & Environm Sci, Lab Ecol & Evolutionary Dynam, FIN-00014 Helsinki, Finland; Univ Jyvaskyla, Dept Biol & Environm Sci, Evolutionary Ecol Unit, FI-40014 Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla	Kokko, H (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Lab Ecol & Evolutionary Dynam, POB 65,Viikinkaari 1, FIN-00014 Helsinki, Finland.	hanna.kokko@helsinki.fi	Sepulcre, Andres Lopez/G-2404-2010; Kokko, Hanna/C-7861-2009	Sepulcre, Andres Lopez/0000-0001-9708-0788; Kokko, Hanna/0000-0002-5772-4881				Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Baglione V, 2006, P ROY SOC B-BIOL SCI, V273, P1529, DOI 10.1098/rspb.2006.3481; Baguette M, 2006, ECOLOGY, V87, P648, DOI 10.1890/04-1631; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bohning-Gaese K, 2006, AM NAT, V167, P555, DOI 10.1086/501078; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Clobert J, 2001, DISPERSAL; Dwyer G, 2006, AM NAT, V167, P165, DOI 10.1086/498944; Ekman J, 2002, P ROY SOC B-BIOL SCI, V269, P1709, DOI 10.1098/rspb.2002.2082; Ekman J, 2002, ANIM BEHAV, V64, P453, DOI 10.1006/anbe.2002.3075; French DR, 2001, OIKOS, V95, P125, DOI 10.1034/j.1600-0706.2001.950114.x; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Gyllenberg M, 2002, J MATH BIOL, V45, P79, DOI 10.1007/s002850200151; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; Heino M, 2001, AM NAT, V157, P495, DOI 10.1086/319927; Holt RD, 2003, EVOL ECOL RES, V5, P159; Horvath G, 1998, NATURWISSENSCHAFTEN, V85, P292, DOI 10.1007/s001140050503; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kokko H, 2001, EVOL ECOL RES, V3, P537; Matthiopoulos J, 2005, J ANIM ECOL, V74, P716, DOI 10.1111/j.1365-2656.2005.00970.x; Nocera JJ, 2006, P ROY SOC B-BIOL SCI, V273, P349, DOI 10.1098/rspb.2005.3318; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Vuilleumier S, 2006, OIKOS, V113, P139, DOI 10.1111/j.0030-1299.2006.14405.x	29	273	277	1	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					789	791		10.1126/science.1128566	http://dx.doi.org/10.1126/science.1128566			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902127				2022-12-01	WOS:000239671300045
J	Eshaghi, S; Niegowski, D; Kohl, A; Molina, DM; Lesley, SA; Nordlund, P				Eshaghi, Said; Niegowski, Damian; Kohl, Andreas; Molina, Daniel Martinez; Lesley, Scott A.; Nordlund, Par			Crystal structure of a divalent metal ion transporter CorA at 2.9 angstrom resolution	SCIENCE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MAGNESIUM TRANSPORT; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; CONSERVED RESIDUES; MG2+ TRANSPORTER; MEMBRANE DOMAIN; PROTEIN; TOPOLOGY; MUTAGENESIS	CorA family members are ubiquitously distributed transporters of divalent metal cations and are considered to be the primary Mg2+ transporter of Bacteria and Archaea. We have determined a 2.9 angstrom resolution structure of CorA from Thermotoga maritima that reveals a pentameric cone shaped protein. Two potential regulatory metal binding sites are found in the N-terminal domain that bind both Mg2+ and Co2+. The structure of CorA supports an efflux system involving dehydration and rehydration of divalent metal ions potentially mediated by a ring of conserved aspartate residues at the cytoplasmic entrance and a carbonyl funnel at the periplasmic side of the pore.	Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, SE-17177 Stockholm, Sweden; Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; Novartis Res Fdn, Joint Ctr Struct Genom, San Diego, CA 92121 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Karolinska Institutet; Stockholm University; Novartis; Novartis	Eshaghi, S (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, SE-17177 Stockholm, Sweden.	Said.Eshaghi@ki.se; Par.Nordlund@ki.se						Andersen C, 2002, MOL MICROBIOL, V44, P1131, DOI 10.1046/j.1365-2958.2002.02898.x; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Caldwell AM, 2003, J BACTERIOL, V185, P374, DOI 10.1128/JB.185.1.374-376.2003; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DIEBLER H, 1969, Pure and Applied Chemistry, V20, P93, DOI 10.1351/pac196920010093; Doyle DA, 2004, EUR BIOPHYS J BIOPHY, V33, P175, DOI 10.1007/s00249-003-0382-z; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Higgins MK, 2004, J MOL BIOL, V342, P697, DOI 10.1016/j.jmb.2004.07.088; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Schock I, 2000, PLANT J, V24, P489, DOI 10.1046/j.1365-313x.2000.00895.x; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; SMITH RL, 1993, J BIOL CHEM, V268, P14071; Smith RL, 1998, J BIOL CHEM, V273, P28663, DOI 10.1074/jbc.273.44.28663; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Szegedy MA, 1999, J BIOL CHEM, V274, P36973, DOI 10.1074/jbc.274.52.36973; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Warren MA, 2004, J BACTERIOL, V186, P4605, DOI 10.1128/JB.186.14.4605-4612.2004; Worlock AJ, 2002, J BACTERIOL, V184, P4369, DOI 10.1128/JB.184.16.4369-4373.2002; [No title captured]	27	149	154	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					354	357		10.1126/science.1127121	http://dx.doi.org/10.1126/science.1127121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857941				2022-12-01	WOS:000239154300045
J	Loreau, M; Oteng-Yeboah, A; Arroyo, MTK; Babin, D; Barbault, R; Donoghue, M; Gadgil, M; Hauser, C; Heip, C; Larigauderie, A; Ma, K; Mace, G; Mooney, HA; Perrings, C; Raven, P; Sarukhan, J; Schei, P; Scholes, RJ; Watson, RT				Loreau, Michel; Oteng-Yeboah, Alfred; Arroyo, M. T. K.; Babin, D.; Barbault, R.; Donoghue, M.; Gadgil, M.; Hauser, C.; Heip, C.; Larigauderie, A.; Ma, K.; Mace, G.; Mooney, H. A.; Perrings, C.; Raven, P.; Sarukhan, J.; Schei, P.; Scholes, R. J.; Watson, R. T.			Diversity without representation	NATURE			English	Editorial Material									McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; CSIR, Accra, Ghana	McGill University	Loreau, M (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	executive-secretariat@imoseb.net	Heip, Carlo/C-2446-2009; Mace, Georgina M/I-3072-2016	Mace, Georgina M/0000-0001-8965-5211; Scholes, Robert/0000-0001-5537-6935				[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Dirzo R, 2005, SCIENCE, V310, P943, DOI 10.1126/science.1119958; Hendriks IE, 2006, SCIENCE, V312, P1715, DOI 10.1126/science.1128548; Mooney H, 2005, NATURE, V434, P561, DOI 10.1038/434561a; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121	6	92	100	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					245	246		10.1038/442245a	http://dx.doi.org/10.1038/442245a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855567				2022-12-01	WOS:000239122100016
J	Sjoblom, T; Jones, S; Wood, LD; Parsons, DW; Lin, J; Barber, TD; Mandelker, D; Leary, RJ; Ptak, J; Silliman, N; Szabo, S; Buckhaults, P; Farrell, C; Meeh, P; Markowitz, SD; Willis, J; Dawson, D; Willson, JKV; Gazdar, AF; Hartigan, J; Wu, L; Liu, CS; Parmigiani, G; Park, BH; Bachman, KE; Papadopoulos, N; Vogelstein, B; Kinzler, KW; Velculescu, VE				Sjoeblom, Tobias; Jones, Sian; Wood, Laura D.; Parsons, D. Williams; Lin, Jimmy; Barber, Thomas D.; Mandelker, Diana; Leary, Rebecca J.; Ptak, Janine; Silliman, Natalie; Szabo, Steve; Buckhaults, Phillip; Farrell, Christopher; Meeh, Paul; Markowitz, Sanford D.; Willis, Joseph; Dawson, Dawn; Willson, James K. V.; Gazdar, Adi F.; Hartigan, James; Wu, Leo; Liu, Changsheng; Parmigiani, Giovanni; Park, Ben Ho; Bachman, Kurtis E.; Papadopoulos, Nickolas; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.			The consensus coding sequences of human breast and colorectal cancers	SCIENCE			English	Article							MUTATIONAL ANALYSIS; SOMATIC MUTATIONS; GENE FAMILY; PROTEIN; RECEPTOR; IDENTIFICATION; TRANSLOCATION; INACTIVATION; TRANSCRIPTS; PREVALENCE	The elucidation of the human genome sequence has made it possible to identify genetic alterations in cancers in unprecedented detail. To begin a systematic analysis of such alterations, we determined the sequence of well-annotated human protein-coding genes in two common tumor types. Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of similar to 90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes ( average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention, and open fertile avenues for basic research in tumor biology.	Johns Hopkins, Ludwig Ctr, Baltimore, MD 21231 USA; Johns Hopkins, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Univ S Carolina, Sch Med, S Carolina Canc Ctr, Div Basic Res, Columbia, SC 29229 USA; Univ S Carolina, Sch Med, Ctr Colon Canc Res, Dept Pathol & Microbiol, Columbia, SC 29229 USA; Case Western Reserve Univ, Ireland Canc Ctr, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Univ Texas, SW Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol & Res, Dallas, TX 75390 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; SoftGenet LLC, State Coll, PA 16803 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; University Hospitals of Cleveland; Case Western Reserve University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Vogelstein, B (corresponding author), Johns Hopkins, Ludwig Ctr, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu; kinzlke@jhmi.edu; velculescu@jhmi.edu	Wood, Laura/ABF-1531-2020; Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012	Velculescu, Victor/0000-0003-1195-438X; Edsall, Lee Elizabeth/0000-0002-0326-2829; Parsons, Donald/0000-0002-8775-3501	NATIONAL CANCER INSTITUTE [R01CA043460, R37CA057345, P30CA043703, R55CA109274, R37CA043460, P50CA062924, R01CA109274, R01CA121113, R01CA057345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER; NCI NIH HHS [CA 121113, CA 57345, CA 62924, CA 43460, P30-CA43703, CA109274] Funding Source: Medline; NCRR NIH HHS [RR 017698] Funding Source: Medline; NIGMS NIH HHS [GM 07309] Funding Source: Medline; PHS HHS [HHSN261200433002C] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], CANC GENOME ATLAS; Arai Y, 1997, BLOOD, V89, P3936, DOI 10.1182/blood.V89.11.3936; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bardelli A, 2005, CURR OPIN GENET DEV, V15, P5, DOI 10.1016/j.gde.2004.12.009; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; *CCDS, CCDS DAT; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Duval A, 1999, CANCER RES, V59, P4213; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Kern SE, 2006, CANCER BIOL THER, V5, P349, DOI 10.4161/cbt.5.4.2551; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Ku JL, 2007, CANCER LETT, V247, P283, DOI 10.1016/j.canlet.2006.05.008; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loeb LA, 2001, CANCER RES, V61, P3230; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Olivier Magali, 2004, IARC Sci Publ, P247; Onishi Y, 2003, CLIN EXP METASTAS, V20, P51, DOI 10.1023/A:1022594503657; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; OWENS AH, 1982, TUMOR CELL HETEROGEN, P441; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Salassidis K, 2000, CANCER RES, V60, P2786; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; SHEN DW, UNPUB; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; TANAKA M, 1995, CANCER RES, V55, P3228; Tang XX, 1999, CLIN CANCER RES, V5, P455; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vogelstein B., 2002, GENETIC BASIS HUMAN; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587	47	2640	3712	3	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					268	274		10.1126/science.1133427	http://dx.doi.org/10.1126/science.1133427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	16959974				2022-12-01	WOS:000241194100033
J	Balmana, J; Stockwell, DH; Steyerberg, EW; Stoffel, EM; Deffenbaugh, AM; Reid, JE; Ward, B; Scholl, T; Hendrickson, B; Tazelaar, J; Burbidge, LA; Syngal, S				Balmana, Judith; Stockwell, David H.; Steyerberg, Ewout W.; Stoffel, Elena M.; Deffenbaugh, Amie M.; Reid, Julia E.; Ward, Brian; Scholl, Thomas; Hendrickson, Brant; Tazelaar, John; Burbidge, Lynn Anne; Syngal, Sapna			Prediction of MLH1 and MSH2 mutations in Lynch syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; DNA MISMATCH-REPAIR; REVISED BETHESDA GUIDELINES; FAMILY-HISTORY; MICROSATELLITE INSTABILITY; CARRIER PROBABILITIES; AMSTERDAM CRITERIA; GENE-MUTATIONS; BREAST-CANCER; IMMUNOHISTOCHEMISTRY	Context Lynch syndrome is caused primarily by mutations in the mismatch repair genes MLH1 and MSH2. Objectives To analyze MLH1/MSH2 mutation prevalence in a large cohort of patients undergoing genetic testing and to develop a clinical model to predict the likelihood of finding a mutation in at-risk patients. Design, Setting, and Participants Personal and family history were obtained for 1914 unrelated probands who submitted blood samples starting in the year 2000 for full gene sequencing of MLH1/MSH2. Genetic analysis was performed using a combination of sequence analysis and Southern blotting. A multivariable model was developed using logistic regression in an initial cohort of 898 individuals and subsequently prospectively validated in 1016 patients. The complex model that we have named PREMM1,2 (Prediction of Mutations in MLH1 and MSH2) was developed into a Web-based tool that incorporates personal and family history of cancer and adenomas. Main Outcome Measure Deleterious mutations in MLH1/MSH2 genes. Results Overall, 14.5% of the probands (130/898) carried a pathogenic mutation (MLH1, 6.5%; MSH2, 8.0%) in the development cohort and 15.3% (155/1016) in the validation cohort, with 42 (27%) of the latter being large rearrangements. Strong predictors of mutations included proband characteristics (presence of colorectal cancer, especially >= 2 separate diagnoses, or endometrial cancer) and family history (especially the number of first-degree relatives with colorectal or endometrial cancer). Age at diagnosis was particularly important for colorectal cancer. The multivariable model discriminated well at external validation, with an area under the receiver operating characteristic curve of 0.80 (95% confidence interval, 0.76-0.84). Conclusions Personal and family history characteristics can accurately predict the outcome of genetic testing in a large population at risk of Lynch syndrome. The PREMM1,2 model provides clinicians with an objective, easy-to-use tool to estimate the likelihood of finding mutations in the MLH1/MSH2 genes and may guide the strategy for molecular evaluation.	Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; Myriad Genet Labs Inc, Salt Lake City, UT USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Myriad Genetics, Inc	Syngal, S (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 44 Binney St, Boston, MA 02115 USA.	ssyngal@partners.org	Califano, Andrea/F-7239-2012; Steyerberg, Ewout/C-1509-2018	Balmana, Judith/0000-0002-0762-6415; Steyerberg, Ewout/0000-0002-7787-0122	NATIONAL CANCER INSTITUTE [K24CA113433] Funding Source: NIH RePORTER; NCI NIH HHS [K24 CA 113433] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; AITKEN J, 1995, AM J EPIDEMIOL, V141, P863, DOI 10.1093/oxfordjournals.aje.a117522; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Bellacosa A, 1996, AM J MED GENET, V62, P353, DOI 10.1002/(SICI)1096-8628(19960424)62:4<353::AID-AJMG7>3.0.CO;2-S; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lipton LR, 2004, J CLIN ONCOL, V22, P4934, DOI 10.1200/JCO.2004.11.084; Lynch HT, 1999, J MED GENET, V36, P801; Marroni F, 2006, CLIN GENET, V69, P254, DOI 10.1111/j.1399-0004.2006.00577.x; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Southey MC, 2005, J CLIN ONCOL, V23, P6524, DOI 10.1200/JCO.2005.04.671; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Stormorken AT, 2005, J CLIN ONCOL, V23, P4705, DOI 10.1200/JCO.2005.05.180; Terdiman JP, 2005, GASTROENTEROLOGY, V129, P741, DOI 10.1053/j.gastro.2005.06.033; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; WLJNEN JT, 1998, NEW ENGL J MED, V339, P511	32	130	132	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1469	1478		10.1001/jama.296.12.1469	http://dx.doi.org/10.1001/jama.296.12.1469			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003395				2022-12-01	WOS:000240770000023
J	Albright, RA; Ibar, JLV; Kim, CU; Gruner, SM; Morais-Cabral, JH				Albright, Ronald A.; Ibar, Jose-Luis Vaquez; Kim, Chae Un; Gruner, Soi M.; Morais-Cabral, Joao Henrique			The RCK domain of the KtrAB K+ transporter: Multiple conformations of an octameric ring	CELL			English	Article							ESCHERICHIA-COLI; VIBRIO-ALGINOLYTICUS; POTASSIUM CHANNEL; UPTAKE SYSTEM; SELECTIVITY; SEQUENCE; BINDING; NA+	The KtrAB ion transporter is a complex of the KtrB membrane protein and KtrA, an RCK domain. RCK domains regulate eukaryotic and prokaryotic membrane proteins involved in K+ transport. Conflicting functional models have proposed two different oligomeric arrangements for RCK domains, tetramer versus octamer. Our results for the KtrAB RCK domain clearly show an octamer in solution and in the crystal. We determined the structure of this protein in three different octameric ring conformations that resemble the RCK-domain octamer observed in the MthK potassium channel but show striking differences in size and symmetry. We present experimental evidence for the association between one RCK octameric ring and two KtrB membrane proteins. These results provide insights into the quaternary organization of the KtrAB transporter and its mechanism of activation and show that the RCK-domain octameric ring model is generally applicable to other ion-transport systems.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Yale University; Cornell University; Cornell University	Morais-Cabral, JH (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	joao.cabral@yale.edu	Morais-Cabral, Joao H/J-4914-2013; Gruner, Sol/G-2924-2010; Kim, Chae Un/D-2956-2014; Vazquez-Ibar, Jose-Luis/AAD-8827-2021	Morais-Cabral, Joao H/0000-0002-4461-9716; Gruner, Sol/0000-0002-1171-4426; Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378	NIGMS NIH HHS [GM 068585] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068585] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAKAWA T, 1992, ANAL BIOCHEM, V203, P53, DOI 10.1016/0003-2697(92)90042-6; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canonaco F, 2003, BIOTECHNOL LETT, V25, P1013, DOI 10.1023/A:1024172518062; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Folta-Stogniew Ewa, 2006, V328, P97; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; Jensen PR, 1999, EUR J BIOCHEM, V266, P865; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim CU, 2005, ACTA CRYSTALLOGR D, V61, P881, DOI 10.1107/S090744490500836X; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MUNRO AW, 1991, MOL MICROBIOL, V5, P607, DOI 10.1111/j.1365-2958.1991.tb00731.x; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q	30	70	72	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1147	1159		10.1016/j.cell.2006.08.028	http://dx.doi.org/10.1016/j.cell.2006.08.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990138	Bronze			2022-12-01	WOS:000240897600020
J	Balanya, J; Oller, JM; Huey, RB; Gilchrist, GW; Serra, L				Balanya, Joan; Oller, Josep M.; Huey, Raymond B.; Gilchrist, George W.; Serra, Luis			Global genetic change tracks global climate warming in Drosophila subobscura	SCIENCE			English	Article							CHROMOSOMAL-INVERSION POLYMORPHISM; LONG-TERM CHANGES; RAPID EVOLUTION; POPULATIONS; COLONIZATION; CLINES; PSEUDOOBSCURA; FREQUENCIES; AMERICA; PATTERN	Comparisons of recent with historical samples of chromosome inversion frequencies provide opportunities to determine whether genetic change is tracking climate change in natural populations. We determined the magnitude and direction of shifts over time (24 years between samples on average) in chromosome inversion frequencies and in ambient temperature for populations of the fly Drosophila subobscura on three continents. In 22 of 26 populations, climates warmed over the intervals, and genotypes characteristic of low latitudes (warm climates) increased in frequency in 21 of those 22 populations. Thus, genetic change in this fly is tracking climate warming and is doing so globally.	Univ Barcelona, Fac Biol, Dept Genet, E-08071 Barcelona, Spain; Univ Barcelona, Fac Biol, Dept Stat, E-08071 Barcelona, Spain; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	University of Barcelona; University of Barcelona; University of Washington; University of Washington Seattle; William & Mary	Balanya, J (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Diagonal 645, E-08071 Barcelona, Spain.	jbalanya@ub.edu	/A-8683-2008; Huey, Raymond/F-1597-2010; Oller, JM/G-4284-2015	/0000-0002-8236-4101; Oller, JM/0000-0002-9643-4406; Huey, Raymond/0000-0002-4962-8670				ANDERSON WW, 1991, P NATL ACAD SCI USA, V88, P10367, DOI 10.1073/pnas.88.22.10367; AYALA FJ, 1989, GENOME, V31, P246, DOI 10.1139/g89-042; Balanya J, 2004, J ZOOL SYST EVOL RES, V42, P191, DOI 10.1111/j.1439-0469.2004.00274.x; Balanya J, 2003, EVOLUTION, V57, P1837; BECKENBACH AT, 1986, AM MIDL NAT, V115, P10, DOI 10.2307/2425832; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; BRNCIC D, 1981, GENETICA, V56, P3; Brncic D, 1980, DROSOPHILA INF SERV, V55, P20; COYNE JA, 1992, EVOLUTION, V46, P1558, DOI 10.1111/j.1558-5646.1992.tb01146.x; de Jong PW, 1998, P ROY SOC B-BIOL SCI, V265, P39, DOI 10.1098/rspb.1998.0261; DOBZHANSKY T, 1944, CARNEGIE I WASH PUBL, V554; Gilchrist GW, 2001, GENETICA, V112, P273, DOI 10.1023/A:1013358931816; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Krimbas CB., 1993, DROSOPHILA SUBOBSCUR; Levitan M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-4; Lovejoy T.E, 2006, CLIMATE CHANGE BIODI; MENOZZI P, 1992, J EVOLUTION BIOL, V5, P625, DOI 10.1046/j.1420-9101.1992.5040625.x; Orengo DJ, 1996, EVOLUTION, V50, P1346, DOI 10.1111/j.1558-5646.1996.tb02376.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pascual M, 2001, MOL BIOL EVOL, V18, P731, DOI 10.1093/oxfordjournals.molbev.a003855; PREVOSTI A, 1985, EVOLUTION, V39, P838, DOI 10.1111/j.1558-5646.1985.tb00425.x; PREVOSTI A, 1964, GENET RES, V5, P27, DOI 10.1017/S0016672300001002; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; RODRIGUEZTRELLES F, 1998, CONSERV ECOL, V2; Santos M, 2005, AM NAT, V165, P258, DOI 10.1086/427093; Sole E, 2002, EVOLUTION, V56, P830, DOI 10.1111/j.0014-3820.2002.tb01393.x; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523	29	252	263	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1773	1775		10.1126/science.1131002	http://dx.doi.org/10.1126/science.1131002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16946033				2022-12-01	WOS:000240655700045
J	Greenwood, RC; Franchi, IA; Jambon, A; Barrat, JA; Burbine, TH				Greenwood, R. C.; Franchi, I. A.; Jambon, A.; Barrat, J. A.; Burbine, T. H.			Oxygen isotope variation in stony-iron meteorites	SCIENCE			English	Article							PARENT BODY; PLANETESIMALS; ORIGIN; MESOSIDERITES; CONSTRAINTS; COLLISIONS; ACCRETION; HISTORY; SYSTEM	Asteroidal material, delivered to Earth as meteorites, preserves a record of the earliest stages of planetary formation. High-precision oxygen isotope analyses for the two major groups of stony-iron meteorites (main-group pallasites and mesosiderites) demonstrate that each group is from a distinct asteroidal source. Mesosiderites are isotopically identical to the howardite-eucrite-diogenite clan and, like them, are probably derived from the asteroid 4 Vesta. Main-group pallasites represent intermixed core-mantle material from a single disrupted asteroid and have no known equivalents among the basaltic meteorites. The stony-iron meteorites demonstrate that intense asteroidal deformation accompanied planetary accretion in the early Solar System.	Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Paris 06, Lab Magmatol & Geochim Inorgan & Expt, CNRS, UMR 7047, F-75252 Paris 05, France; Univ Bretagne Occidentale, Univ Europeen Mer, CNRS, UMR 6538, F-29280 Plouzane, France; Mt Holyoke Coll, Dept Astron, S Hadley, MA 01075 USA	Open University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Mount Holyoke College	Greenwood, RC (corresponding author), Open Univ, Planetary & Space Sci Res Inst, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	r.c.greenwood@open.ac.uk	Jean-Alix, BARRAT/F-8035-2012; Barrat, Jean-Alix/C-8416-2017	Barrat, Jean-Alix/0000-0003-3158-3109; Greenwood, Richard/0000-0002-5544-8027				Asphaug E, 2006, NATURE, V439, P155, DOI 10.1038/nature04311; Bizzarro M, 2005, ASTROPHYS J, V632, pL41, DOI 10.1086/497638; Burbine T.H., 2002, ASTEROIDS, P653, DOI DOI 10.2307/J.CTV1V7ZDN4.50; Burbine TH, 2001, METEORIT PLANET SCI, V36, P761, DOI 10.1111/j.1945-5100.2001.tb01915.x; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; HEWINS RH, 1983, J GEOPHYS RES, V88, pB257, DOI 10.1029/JB088iS01p0B257; Markowski A, 2006, EARTH PLANET SC LETT, V242, P1, DOI 10.1016/j.epsl.2005.11.048; Miller MF, 1999, RAPID COMMUN MASS SP, V13, P1211, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1211::AID-RCM576>3.3.CO;2-D; Miller MF, 2002, GEOCHIM COSMOCHIM AC, V66, P1881, DOI 10.1016/S0016-7037(02)00832-3; MITTLEFEHLDT DW, 1998, MIN SOC AM REV MINER, V36; ROSING MT, 2004, LUNAR PLANET SCI C, V35, P1487; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; RUBIN AE, 1993, ICARUS, V101, P201, DOI 10.1006/icar.1993.1018; Russell CT, 2004, PLANET SPACE SCI, V52, P465, DOI 10.1016/j.pss.2003.06.013; Scott E.R.D., 1990, 21 LUN PLAN SCI C, P1119; Scott ERD, 2001, METEORIT PLANET SCI, V36, P869, DOI 10.1111/j.1945-5100.2001.tb01927.x; Song IS, 2005, NATURE, V436, P363, DOI 10.1038/nature03853; TOMIYAMA T, 2005, LUNAR PLANET SCI C, V36, P2071; Wadhwa M, 2003, GEOCHIM COSMOCHIM AC, V67, P5047, DOI 10.1016/j.gca.2003.08.005; WASSON JT, 1985, NATURE, V318, P168, DOI 10.1038/318168a0; Wasson JT, 2003, GEOCHIM COSMOCHIM AC, V67, P3079, DOI 10.1016/S0016-7037(03)00306-5; Weidenschilling SJ, 2000, SPACE SCI REV, V92, P295, DOI 10.1023/A:1005259615299; Wiechert UH, 2004, EARTH PLANET SC LETT, V221, P373, DOI 10.1016/S0012-821X(04)00090-1; YAMAGUCHI A, 2006, LUNAR PLANET SCI C, V37, P1678	25	94	94	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1763	1765		10.1126/science.1128865	http://dx.doi.org/10.1126/science.1128865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16931721				2022-12-01	WOS:000240655700041
J	Gurcel, L; Abrami, L; Girardin, S; Tschopp, J; van der Goot, FG				Gurcel, Laure; Abrami, Laurence; Girardin, Stephen; Tschopp, Jurg; van der Goot, F. Gisou			Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival	CELL			English	Article							ELEMENT-BINDING PROTEINS; AEROMONAS-HYDROPHILA; CYTOTOXIC ENTEROTOXIN; ALPHA-TOXIN; GENE-EXPRESSION; INTERLEUKIN-1-BETA; RECEPTOR; CHOLESTEROL; SECRETION; AEROLYSIN	Many pathogenic organisms produce pore-forming toxins as virulence factors. Target cells however mount a response to such membrane damage. Here we show that toxin-induced membrane permeabilization leads to a decrease in cytoplasmic potassium, which promotes the formation of a multiprotein oligomeric innate immune complex, called the inflammasome, and the activation of caspase-1. Further, we find that when rendered proteolytic in this context caspase-1 induces the activation of the central regulators of membrane biogenesis, the Sterol Regulatory Element Binding Proteins (SREBPs), which in turn promote cell survival upon toxin challenge possibly by facilitating membrane repair. This study highlights that, in addition to its well-established role in triggering inflammation via the processing of the precursor forms of interleukins, caspase-1 has a broader role, in particular linking the intracellular ion composition to lipid metabolic pathways, membrane biogenesis, and survival.	Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland; Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; Inst Pasteur, F-75724 Paris, France; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Ecole Polytech Fed Lausanne, Inst Global Hlth, CH-1015 Lausanne, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, 1 Rue Servet, CH-1211 Geneva 4, Switzerland.	gisou.vandergoot@epfl.ch	van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X; ABRAMI, laurence/0000-0002-1774-0481				Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; CHAKRABORTY T, 1987, INFECT IMMUN, V55, P2274, DOI 10.1128/IAI.55.9.2274-2280.1987; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Fickl H, 2005, CLIN EXP IMMUNOL, V140, P274, DOI 10.1111/j.1365-2249.2005.02757.x; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; Galindo CL, 2004, INFECT IMMUN, V72, P5439, DOI 10.1128/IAI.72.9.5439-5445.2004; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Krause KH, 1998, J BIOL CHEM, V273, P18122, DOI 10.1074/jbc.273.29.18122; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Logette E, 2005, BBA-MOL CELL BIOL L, V1738, P1, DOI 10.1016/j.bbalip.2005.11.006; Logette E, 2005, MOL CELL BIOL, V25, P9621, DOI 10.1128/MCB.25.21.9621-9631.2005; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Nadeau KJ, 2004, J BIOL CHEM, V279, P34380, DOI 10.1074/jbc.M403596200; Nelson KL, 1999, CELL MICROBIOL, V1, P69, DOI 10.1046/j.1462-5822.1999.00009.x; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Ribardo DA, 2002, MICROB PATHOGENESIS, V32, P149, DOI 10.1006/mpat.2001.0490; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tsitrin Y, 2002, NAT STRUCT BIOL, V9, P729, DOI 10.1038/nsb839; VecseySemjen B, 1996, J BIOL CHEM, V271, P8655, DOI 10.1074/jbc.271.15.8655; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; WALEV I, 1994, MICROB PATHOGENESIS, V17, P187, DOI 10.1006/mpat.1994.1065; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; Wang H, 2001, J NEUROCHEM, V77, P53; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; [No title captured]; [No title captured]; [No title captured]	56	409	420	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1135	1145		10.1016/j.cell.2006.07.033	http://dx.doi.org/10.1016/j.cell.2006.07.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990137	Bronze			2022-12-01	WOS:000240897600019
J	Salehi-Ashtiani, K; Luptak, A; Litovchick, A; Szostak, JW				Salehi-Ashtiani, Kourosh; Luptak, Andrej; Litovchick, Alexander; Szostak, Jack W.			A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene	SCIENCE			English	Article							HEPATITIS-DELTA-VIRUS; IN-VITRO SELECTION; SELF-CLEAVAGE; MESSENGER-RNA; NEURONAL ISOFORM; TRANSCRIPTION; CATALYSIS; SITE; HAMMERHEAD; EXPRESSION	Ribozymes are thought to have played a pivotal role in the early evolution of life, but relatively few have been identified in modern organisms. We performed an in vitro selection aimed at isolating self-cleaving RNAs from the human genome. The selection yielded several ribozymes, one of which is a conserved mammalian sequence that resides in an intron of the CPEB3 gene, which belongs to a family of genes regulating messenger RNA polyadenylation. The CPEB3 ribozyme is structurally and biochemically related to the human hepatitis delta virus (HDV) ribozymes. The occurrence of this ribozyme exclusively in mammals suggests that it may have evolved as recently as 200 million years ago. We postulate that HDV arose from the human transcriptome.	Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, CCIB, Simches Res Ctr 7215, Boston, MA 02114 USA; Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, 185 Cambridge St, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu		Salehi-Ashtiani, Kourosh/0000-0002-6521-5243	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053936] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66678] Funding Source: Medline; NIGMS NIH HHS [GM53936] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; CHRISTIAN EL, 1992, J MOL BIOL, V228, P743, DOI 10.1016/0022-2836(92)90861-D; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; Daubendiek SL, 1997, NAT BIOTECHNOL, V15, P273, DOI 10.1038/nbt0397-273; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; KUO MYP, 1988, J VIROL, V62, P4439, DOI 10.1128/JVI.62.12.4439-4444.1988; Legiewicz M, 2006, NUCLEIC ACIDS RES, V34, P1270, DOI 10.1093/nar/gkl018; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nehdi A, 2006, NUCLEIC ACIDS RES, V34, P584, DOI 10.1093/nar/gkj463; Nielsen H, 2005, SCIENCE, V309, P1584, DOI 10.1126/science.1113645; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Prabhu NS, 1997, NUCLEIC ACIDS RES, V25, P5119, DOI 10.1093/nar/25.24.5119; Rosenstein SP, 1996, BIOCHEMISTRY-US, V35, P11403, DOI 10.1021/bi9609984; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; UCKER DS, 1984, J BIOL CHEM, V259, P7416; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362	34	198	210	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1788	1792		10.1126/science.1129308	http://dx.doi.org/10.1126/science.1129308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990549				2022-12-01	WOS:000240655700049
J	Kuriyama, S; Shimazu, T; Ohmori, K; Kikuchi, N; Nakaya, N; Nishino, Y; Tsubono, Y; Tsuji, I				Kuriyama, Shinichi; Shimazu, Taichi; Ohmori, Kaori; Kikuchi, Nobutaka; Nakaya, Naoki; Nishino, Yoshikazu; Tsubono, Yoshitaka; Tsuji, Ichiro			Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan - The Ohsaki Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH INSURANCE BENEFICIARIES; MEDICINAL BENEFITS; PREVENTION; CATECHINS	Context Green tea polyphenols have been extensively studied as cardiovascular disease and cancer chemopreventive agents in vitro and in animal studies. However, the effects of green tea consumption in humans remain unclear. Objective To investigate the associations between green tea consumption and all-cause and cause-specific mortality. Design, Setting, and Participants The Ohsaki National Health Insurance Cohort Study, a population-based, prospective cohort study initiated in 1994 among 40 530 Japanese adults aged 40 to 79 years without history of stroke, coronary heart disease, or cancer at baseline. Participants were followed up for up to 11 years (1995-2005) for all-cause mortality and for up to 7 years (1995-2001) for cause-specific mortality. Main Outcome Measures Mortality due to cardiovascular disease, cancer, and all causes. Results Over 11 years of follow-up (follow-up rate, 86.1%), 4209 participants died, and over 7 years of follow-up (follow-up rate, 89.6%), 892 participants died of cardiovascular disease and 1134 participants died of cancer. Green tea consumption was inversely associated with mortality due to all causes and due to cardiovascular disease. The inverse association with all-cause mortality was stronger in women (P = .03 for interaction with sex). In men, the multivariate hazard ratios of mortality due to all causes associated with different green tea consumption frequencies were 1.00 (reference) for less than 1 cup/d, 0.93 (95% confidence interval [CI], 0.83-1.05) for 1 to 2 cups/d, 0.95 (95% CI, 0.85-1.06) for 3 to 4 cups/d, and 0.88 (95% CI, 0.79-0.98) for 5 or more cups/d, respectively (P = .03 for trend). The corresponding data for women were 1.00, 0.98 (95% CI, 0.84-1.15), 0.82 (95% CI, 0.70-0.95), and 0.77 (95% CI, 0.67-0.89), respectively (P < .001 for trend). The inverse association with cardiovascular disease mortality was stronger than that with all-cause mortality. This inverse association was also stronger in women (P = .08 for interaction with sex). In women, the multivariate hazard ratios of cardiovascular disease mortality across increasing green tea consumption categories were 1.00, 0.84 (95% CI, 0.63-1.12), 0.69 (95% CI, 0.52-0.93), and 0.69 ( 95% CI, 0.53-0.90), respectively (P = .004 for trend). Among the types of cardiovascular disease mortality, the strongest inverse association was observed for stroke mortality. In contrast, the hazard ratios of cancer mortality were not significantly different from 1.00 in all green tea categories compared with the lowest-consumption category. Conclusion Green tea consumption is associated with reduced mortality due to all causes and due to cardiovascular disease but not with reduced mortality due to cancer.	Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Publ Policy, Div Hlth Policy, Sendai, Miyagi 980, Japan; Miyagi Canc Ctr Res Inst, Div Epidemiol, Natori, Miyagi, Japan	Tohoku University; Tohoku University; Miyagi Cancer Center	Kuriyama, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kuriyama-thk@umin.ac.jp	Shimazu, Taichi/A-4470-2015	Shimazu, Taichi/0000-0001-6000-9830				Arts ICW, 2001, AM J CLIN NUTR, V74, P227; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Cooper R, 2005, J ALTERN COMPLEM MED, V11, P639, DOI 10.1089/acm.2005.11.639; Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; Iwai Nobuo, 2002, J Epidemiol, V12, P191; Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007; Kuriyama S, 2004, PREV MED, V39, P1194, DOI 10.1016/j.ypmed.2004.04.033; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Nakachi K, 2003, AGEING RES REV, V2, P1, DOI 10.1016/S1568-1637(02)00047-8; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411; Rahman RMA, 2005, NEUROSCI LETT, V382, P227, DOI 10.1016/j.neulet.2005.03.018; Rimm EB, 2004, JAMA-J AM MED ASSOC, V292, P1490, DOI 10.1001/jama.292.12.1490; SATO Y, 1989, TOHOKU J EXP MED, V157, P337, DOI 10.1620/tjem.157.337; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; Tsubono Yoshitaka, 2002, J Epidemiol, V12, P305; Tsuji I, 1999, J AM GERIATR SOC, V47, P470, DOI 10.1111/j.1532-5415.1999.tb07241.x; Tsuji I, 1998, J Epidemiol, V8, P258; WHO, 2004, LANCET, V363, P902; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; 1995, WHO TECH REP SER, V854, P312	25	566	590	4	144	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1255	1265		10.1001/jama.296.10.1255	http://dx.doi.org/10.1001/jama.296.10.1255			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968850	Bronze			2022-12-01	WOS:000240437500028
J	Araujo, MB; Rahbek, C				Araujo, Miguel B.; Rahbek, Carsten			How does climate change affect biodiversity?	SCIENCE			English	Editorial Material							EXTINCTION RISK; MODELS; PROJECTIONS; UNCERTAINTY; PREDICTION; EUROPE		Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid 28006, Spain; Inst Biol, Ctr Macroecol, DK-2100 Copenhagen, Denmark		Araujo, MB (corresponding author), Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid 28006, Spain.	maraujo@mncn.csic.es; crahbek@bi.ku.dk	Araújo, Miguel B/B-6117-2008; Rahbek, Carsten/L-1129-2013; Rahbek, Carsten/D-9372-2013	Araújo, Miguel B/0000-0002-5107-7265; Rahbek, Carsten/0000-0003-4585-0300; 				Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102	16	376	392	13	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1396	1397		10.1126/science.1131758	http://dx.doi.org/10.1126/science.1131758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081WQ	16959994				2022-12-01	WOS:000240348700028
J	Sturm, A; Amino, R; van de Sand, C; Regen, T; Retzlaff, S; Rennenberg, A; Krueger, A; Pollok, JM; Menard, R; Heussler, VT				Sturm, Angelika; Amino, Rogerio; van de Sand, Claudia; Regen, Tommy; Retzlaff, Silke; Rennenberg, Annika; Krueger, Andreas; Pollok, Joerg-Matthias; Menard, Robert; Heussler, Volker T.			Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids	SCIENCE			English	Article							PLASMODIUM-BERGHEI; PHOSPHATIDYLSERINE; EXPOSURE; MOSQUITO; CELLS	The merozoite stage of the malaria parasite that infects erythrocytes and causes the symptoms of the disease is initially formed inside host hepatocytes. However, the mechanism by which hepatic merozoites reach blood vessels (sinusoids) in the liver and escape the host immune system before invading erythrocytes remains unknown. Here, we show that parasites induce the death and the detachment of their host hepatocytes, followed by the budding of parasite-filled vesicles (merosomes) into the sinusoid lumen. Parasites simultaneously inhibit the exposure of phosphatidylserine on the outer leaflet of host plasma membranes, which act as "eat me'' signals to phagocytes. Thus, the hepatocyte-derived merosomes appear to ensure both the migration of parasites into the bloodstream and their protection from host immunity.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Inst Pasteur, Dept Parasitol, F-75724 Paris 15, France; Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil; Univ Hamburg, Hosp Eppendorf, Dept Hepatobiliary Surg, D-20246 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade Federal de Sao Paulo (UNIFESP); University of Hamburg	Heussler, VT (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	heussler@bni-hamburg.de	Heussler, Volker/H-9322-2019; Regen, Tommy/GQH-6929-2022	Heussler, Volker/0000-0001-8028-9825; Regen, Tommy/0000-0002-7275-3330				Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Biagini GA, 2003, J BIOL CHEM, V278, P27910, DOI 10.1074/jbc.M304193200; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Leiriao P, 2005, CELL MICROBIOL, V7, P603, DOI 10.1111/j.1462-5822.2004.00490.x; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; TERZAKIS JA, 1979, J PROTOZOOL, V26, P385, DOI 10.1111/j.1550-7408.1979.tb04641.x; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; WASSERMAN M, 1990, PARASITOL RES, V76, P681, DOI 10.1007/BF00931087	12	338	347	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1287	1290		10.1126/science.1129720	http://dx.doi.org/10.1126/science.1129720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16888102				2022-12-01	WOS:000240313500041
J	Gore, J; Bryant, Z; Nollmann, M; Le, MU; Cozzarelli, NR; Bustamante, C				Gore, Jeff; Bryant, Zev; Noellmann, Marcelo; Le, Mai U.; Cozzarelli, Nicholas R.; Bustamante, Carlos			DNA overwinds when stretched	NATURE			English	Article							SUPERCOILED DNA; SINGLE-MOLECULE; ELASTICITY; SIMULATIONS; MECHANICS; TWEEZERS	DNA is often modelled as an isotropic rod(1-4), but its chiral structure suggests the possible importance of anisotropic mechanical properties, including coupling between twisting and stretching degrees of freedom. Simple physical intuition predicts that DNA should unwind under tension, as it is pulled towards a denatured structure(4-8). We used rotor bead tracking to directly measure twist - stretch coupling in single DNA molecules. Here we show that for small distortions, contrary to intuition, DNA overwinds under tension, reaching a maximum twist at a tension of similar to 30 pN. As tension is increased above this critical value, the DNA begins to unwind. The observed twist - stretch coupling predicts that DNA should also lengthen when overwound under constant tension, an effect that we quantitatively confirm. We present a simple model that explains these unusual mechanical properties, and also suggests a possible origin for the anomalously large torsional rigidity of DNA. Our results have implications for the action of DNA-binding proteins that must stretch and twist DNA to compensate for variability in the lengths of their binding sites(9-11). The requisite coupled DNA distortions are favoured by the intrinsic mechanical properties of the double helix reported here.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Nollmann, Marcelo/0000-0003-3339-2349				Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Feynman R. P., 1970, FEYNMAN LECT PHYS; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Gore J, 2005, THESIS U CALIFORNIA; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; HOGAN ME, 1987, NATURE, V329, P263, DOI 10.1038/329263a0; Howard J., 2001, MECH MOTOR PROTEINS; Kamien RD, 1997, EUROPHYS LETT, V38, P237, DOI 10.1209/epl/i1997-00231-y; Kosikov KM, 1999, J MOL BIOL, V289, P1301, DOI 10.1006/jmbi.1999.2798; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Lionnet T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.178102; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marko JF, 1997, EUROPHYS LETT, V38, P183, DOI 10.1209/epl/i1997-00223-5; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; Nelson P, 2003, BIOL PHYS; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Travers AA, 2004, PHILOS T R SOC A, V362, P1265, DOI 10.1098/rsta.2004.1392; Wahl MC, 1997, BIOPOLYMERS, V44, P45, DOI 10.1002/(SICI)1097-0282(1997)44:1<45::AID-BIP4>3.0.CO;2-#; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0	30	303	308	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					836	839		10.1038/nature04974	http://dx.doi.org/10.1038/nature04974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862122				2022-12-01	WOS:000239792700051
J	Kim, JY; Farmer, P				Kim, Jim Yong; Farmer, Paul			AIDS in 2006 - Moving toward one world, one hope?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SURVIVAL; HEALTH		Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Partners Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System	Kim, JY (corresponding author), Brigham & Womens Hosp, Div Social Med & Hlth Inequal, 75 Francis St, Boston, MA 02115 USA.							Behforouz HL, 2004, CLIN INFECT DIS, V38, pS429, DOI 10.1086/421408; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013	5	35	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2006	355	7					645	647		10.1056/NEJMp068166	http://dx.doi.org/10.1056/NEJMp068166			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074AN	16914698				2022-12-01	WOS:000239784500001
J	Krivtsov, AV; Twomey, D; Feng, ZH; Stubbs, MC; Wang, YZ; Faber, J; Levine, JE; Wang, J; Hahn, WC; Gilliland, DG; Golub, TR; Armstrong, SA				Krivtsov, Andrei V.; Twomey, David; Feng, Zhaohui; Stubbs, Matthew C.; Wang, Yingzi; Faber, Joerg; Levine, Jason E.; Wang, Jing; Hahn, William C.; Gilliland, D. Gary; Golub, Todd R.; Armstrong, Scott A.			Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC PROGENITORS; FUSION GENE; HOXA9; MICE; IMMORTALIZATION; TRANSLOCATIONS; IDENTIFICATION; MLL-GAS7; TARGETS	Leukaemias and other cancers possess a rare population of cells capable of the limitless self-renewal necessary for cancer initiation and maintenance(1-7). Eradication of these cancer stem cells is probably a critical part of any successful anti-cancer therapy, and may explain why conventional cancer therapies are often effective in reducing tumour burden, but are only rarely curative. Given that both normal and cancer stem cells are capable of self-renewal, the extent to which cancer stem cells resemble normal tissue stem cells is a critical issue if targeted therapies are to be developed. However, it remains unclear whether cancer stem cells must be phenotypically similar to normal tissue stem cells or whether they can retain the identity of committed progenitors. Here we show that leukaemia stem cells (LSC) can maintain the global identity of the progenitor from which they arose while activating a limited stem-cell- or self-renewal-associated programme. We isolated LSC from leukaemias initiated in committed granulocyte macrophage progenitors through introduction of the MLL - AF9 fusion protein encoded by the t(9; 11)(p22; q23). The LSC were capable of transferring leukaemia to secondary recipient mice when only four cells were transferred, and possessed an immunophenotype and global gene expression profile very similar to that of normal granulocyte macrophage progenitors. However, a subset of genes highly expressed in normal haematopoietic stem cells was re-activated in LSC. LSC can thus be generated from committed progenitors without widespread reprogramming of gene expression, and a leukaemia self-renewal-associated signature is activated in the process. Our findings define progression from normal progenitor to cancer stem cell, and suggest that targeting a self-renewal programme expressed in an abnormal context may be possible.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Armstrong, SA (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	Scott.Armstrong@childrens.harvard.edu	Faber, Joerg/G-4549-2010; Krivtsov, Andrei/AAJ-9966-2021; Wang, Jenny Y./ABD-2091-2020	, Matthew/0000-0003-3771-7083; Krivtsov, Andrei/0000-0002-5511-1686; Wang, Jenny Y./0000-0002-1325-7943				Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	30	1086	1140	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					818	822		10.1038/nature04980	http://dx.doi.org/10.1038/nature04980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862118				2022-12-01	WOS:000239792700047
J	Shlipak, MG; Katz, R; Sarnak, MJ; Fried, LF; Newman, AB; Stehman-Breen, C; Seliger, SL; Kestenbaum, B; Psaty, B; Tracy, RP; Siscovick, DS				Shlipak, Michael G.; Katz, Ronit; Sarnak, Mark J.; Fried, Linda F.; Newman, Anne B.; Stehman-Breen, Catherine; Seliger, Stephen L.; Kestenbaum, Brian; Psaty, Bruce; Tracy, Russell P.; Siscovick, David S.			Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; THYROID-DYSFUNCTION; RENAL DYSFUNCTION; HEART-FAILURE; RISK-FACTOR; CREATININE; EVENTS; DEFINITION; MORTALITY; GLUCOSE	Background: Cystatin C is an alternative measure of kidney function that may have prognostic importance among elderly persons who do not meet standard criteria for chronic kidney disease (estimated glomerular filtration rate [GFR] >= 60 mL/min per 1.73 m(2)). Objective: To evaluate cystatin C as a prognostic biomarker for death, cardiovascular disease, and incident chronic kidney disease among elderly persons without chronic kidney disease. Design: Cohort study. Setting: The Cardiovascular Health Study, a population-based cohort recruited from 4 communities in the United States. Participants: 4663 elderly persons Measurements: Measures of kidney function were creatinine-based estimated GFR by using the Modification of Diet in Renal Disease equation and cystatin C concentration. Outcomes were death, cardiovascular death, noncardiovascular death, heart failure, stroke, myocardial infarction, and incident chronic kidney disease during follow-up (median, 9.3 years). Results: At baseline, 78% of participants did not have chronic kidney disease (estimated GFR 60 mL/min per 1.73 m(2)) and mean cystatin C concentration, creatinine concentration, and estimated GFR were 1.0 mg/L, 79.6 mu mol/L (0.9 mg/dL, and 83 mL/min per 1.73 m(2), respectively. Cystatin C concentrations (per SD, 0.18 mg/L) had strong associations with death (hazard ratio, 1.33 [95% CI, 1.25 to 1.40]), cardiovascular death (hazard ratio, 1.42 [CI, 1.30 to 1.54]), noncardiovascular death (hazard ratio, 1.26 [CI, 1.17 to 1.36]), incident heart failure (hazard ratio, 1.28 [CI, 1.17 to 1.401), stroke (hazard ratio, 1.22 [CI, 1.08 to 1.381), and myocardial infarction (hazard ratio, 1.20 [CI, 1.06 to 1.36]) among these participants. Serum creatinine concentrations had much weaker associations with each outcome and only predicted cardiovascular death. Participants without chronic kidney disease who had elevated cystatin C concentrations (>= 1.0 mg/L) had a 4-fold risk for progressing to chronic kidney disease after 4 years of follow-up compared with those with cystatin C concentrations less than 1.0 mg/L. Limitations: Because this study did not directly measure GFR or albuminuria, the extent to which cystatin C may be influenced by nonrenal factors was not determined and participants with albuminuria might have been misclassified as having no kidney disease. Conclusions: Among elderly persons without chronic kidney disease, cystatin C is a prognostic biomarker of risk for death, cardiovascular disease, and chronic kidney disease. In this setting, cystatin C seems to identify a "preclinical" state of kidney dysfunction that is not detected with serum creatinine or estimated GFR.	Vet Adm Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Seattle, WA 98195 USA; Tufts Univ, New England Med Ctr, Boston, MA 02111 USA; Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; Univ Pittsburgh, Pittsburgh, PA USA; Amgen Inc, Thousand Oaks, CA 91320 USA; Univ Vermont, Coll Med, Burlington, VT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Tufts Medical Center; Tufts University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Amgen; University of Vermont	Shlipak, MG (corresponding author), Vet Adm Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	michael.shlipak@ucsf.edu	Katz, Ronit/ABA-1880-2021; Newman, Anne B./C-6408-2013	Newman, Anne B./0000-0002-0106-1150	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085086, N01HC085080, N01HC085081, N01HC085085, N01HC035129, N01HC085084, N01HC085083, N01HC085082, N01HC085079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027002] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BJARNADOTTIR M, 1995, SCAND J CLIN LAB INV, V55, P617, DOI 10.3109/00365519509110261; Burkhardt H, 2002, GERONTOLOGY, V48, P140, DOI 10.1159/000052832; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CUSHMAN M, 1995, CLIN CHEM, V41, P264; den Hollander JG, 2005, CLIN ENDOCRINOL, V62, P423, DOI 10.1111/j.1365-2265.2005.02236.x; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Erlandsen EJ, 1999, SCAND J CLIN LAB INV, V59, P1, DOI 10.1080/00365519950185940; Finney H, 2000, ANN CLIN BIOCHEM, V37, P49, DOI 10.1258/0004563001901524; Fliser D, 2001, AM J KIDNEY DIS, V37, P79, DOI 10.1053/ajkd.2001.20591; Fricker M, 2003, KIDNEY INT, V63, P1944, DOI 10.1046/j.1523-1755.2003.00925.x; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kanaya AM, 2005, ANN INTERN MED, V142, P813, DOI 10.7326/0003-4819-142-10-200505170-00006; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; O'Hare AM, 2005, ARCH INTERN MED, V165, P2666, DOI 10.1001/archinte.165.22.2666; O'Riordan SE, 2003, ANN CLIN BIOCHEM, V40, P648, DOI 10.1258/000456303770367243; Perkins BA, 2005, J AM SOC NEPHROL, V16, P1404, DOI 10.1681/ASN.2004100854; Price T R, 1993, Ann Epidemiol, V3, P504; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Risch L, 2001, CLIN CHEM, V47, P2055; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008; Shlipak MG, 2005, J AM COLL CARDIOL, V45, P268, DOI 10.1016/j.jacc.2004.09.061; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Stevens LA, 2004, ANN INTERN MED, V141, P959, DOI 10.7326/0003-4819-141-12-200412210-00013; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Van Den Noortgate NJ, 2002, J AM GERIATR SOC, V50, P1278, DOI 10.1046/j.1532-5415.2002.50317.x; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; 2005, NEPHROLOGY CARLTON, V10, pS157	41	409	438	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2006	145	4					237	246		10.7326/0003-4819-145-4-200608150-00003	http://dx.doi.org/10.7326/0003-4819-145-4-200608150-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075CC	16908914				2022-12-01	WOS:000239858800001
J	Nathan, R				Nathan, Ran			Long-distance dispersal of plants	SCIENCE			English	Review							SEED DISPERSAL; COMPETITION; CONSEQUENCES; EVOLUTION; PATTERNS; MODELS; LIFE		Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Evolut Systemat & Ecol, Movement Ecol Lab, IL-91904 Jerusalem, Israel; Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Hebrew University of Jerusalem; Smithsonian Institution; Smithsonian Tropical Research Institute	Nathan, R (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Evolut Systemat & Ecol, Movement Ecol Lab, IL-91904 Jerusalem, Israel.	rnathan@cc.huji.ac.il	Nathan, Ran/A-9380-2008	Nathan, Ran/0000-0002-5733-6715				Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; Boedeltje G, 2003, J ECOL, V91, P855, DOI 10.1046/j.1365-2745.2003.00820.x; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; CARLQUIST S, 1981, AM SCI, V69, P509; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Clobert J, 2001, DISPERSAL; Couvreur M, 2005, ECOGRAPHY, V28, P37, DOI 10.1111/j.0906-7590.2005.04159.x; Darwin C., 1859, ORIGINS SPECIES MEAN; GIVNISH TJ, 2004, INT J PLANT SCI, V165, P51; Godoy JA, 2001, MOL ECOL, V10, P2275, DOI 10.1046/j.0962-1083.2001.01342.x; Greene DF, 2005, ECOLOGY, V86, P3105, DOI 10.1890/04-1430; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Higgins SI, 2002, J ECOL, V90, P616, DOI 10.1046/j.1365-2745.2002.00694.x; Hubbell Stephen P., 2001, V32, pi; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Muller-Landau HC, 2003, ECOLOGY, V84, P1957, DOI 10.1890/01-0617; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2005, DIVERS DISTRIB, V11, P125, DOI 10.1111/j.1366-9516.2005.00159.x; NATHAN R, IN PRESS SEED DISPER; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Visher SS, 1925, AM NAT, V59, P70, DOI 10.1086/280016; WILLSON MF, 1993, VEGETATIO, V108, P261	33	785	861	4	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					786	788		10.1126/science.1124975	http://dx.doi.org/10.1126/science.1124975			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902126				2022-12-01	WOS:000239671300044
J	Parsons, AB; Lopez, A; Givoni, IE; Williams, DE; Gray, CA; Porter, J; Chua, G; Sopko, R; Brost, RL; Ho, CH; Wang, JY; Ketela, T; Brenner, C; Brill, JA; Fernandez, GE; Lorenz, TC; Payne, GS; Ishihara, S; Ohya, Y; Andrews, B; Hughes, TR; Frey, BJ; Graham, TR; Andersen, RJ; Boone, C				Parsons, Ainslie B.; Lopez, Andres; Givoni, Inmar E.; Williams, David E.; Gray, Christopher A.; Porter, Justin; Chua, Gordon; Sopko, Richelle; Brost, Renee L.; Ho, Cheuk-Hei; Wang, Jiyi; Ketela, Troy; Brenner, Charles; Brill, Julie A.; Fernandez, G. Esteban; Lorenz, Todd C.; Payne, Grego S.; Ishihara, Satoru; Ohya, Yoshikazu; Andrews, Brenda; Hughes, Timothy R.; Frey, Brendan J.; Graham, Todd R.; Andersen, Raymond J.; Boone, Charles			Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast	CELL			English	Article							GENOME-WIDE ANALYSIS; BREAST-CANCER CELLS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; 1,3-BETA-D-GLUCAN SYNTHASE; INDUCED HAPLOINSUFFICIENCY; THEONELLA-SWINHOEI; DELETION MUTANTS; DRUG; EXPRESSION	Discovering target and off-target effects of specific compounds is critical to drug discovery and development. We generated a compendium of "chemical-genetic interaction" profiles by testing the collection of viable yeast haploid deletion mutants for hypersensitivity to 82 compounds and natural product extracts. To cluster compounds with a similar mode-of-action and to reveal insights into the cellular pathways and proteins affected, we applied both a hierarchical clustering and a factorgram method, which allows a gene or compound to be associated with more than one group. In particular, tamoxifen, a breast cancer therapeutic, was found to disrupt calcium homeostasis and phosphatidylserine (PS) was recognized as a target for papuamide B, a cytotoxic lipopeptide with anti-HIV activity. Further, the profile of crude extracts resembled that of its constituent purified natural product, enabling detailed classification of extract activity prior to purification. This compendium should serve as a valuable key for interpreting cellular effects of novel compounds with similar activities.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Probabilist & Stat Inference Grp, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; Univ Toronto, Probabilist & Stat Inference Grp, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; Univ British Columbia, Dept Chem Earth & Ocean Sci, Vancouver, BC V6T 1Z1, Canada; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Infin Pharmaceut Inc, Cambridge, MA 02130 USA; Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of British Columbia; Vanderbilt University; Dartmouth College; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo	Boone, C (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	charlie.boone@utoronto.ca	Fernandez, G. Esteban/AAE-4589-2022; Brenner, Charles/D-6339-2014; Brill, Julie A/A-1044-2008; Ohya, Yoshikazu/AAW-2200-2021	Brenner, Charles/0000-0002-4955-3226; Brill, Julie A/0000-0002-5925-9901; Ohya, Yoshikazu/0000-0003-0837-1239; Fernandez, G. Esteban/0000-0002-8393-9229	NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM072119, R01GM067911] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA075954, R01 CA075954-10] Funding Source: Medline; NIGMS NIH HHS [GM72119, GM67911] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoun M, 2000, INT J ANTIMICROB AG, V16, P143, DOI 10.1016/S0924-8579(00)00220-X; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Callahan MK, 2003, J IMMUNOL, V170, P4840, DOI 10.4049/jimmunol.170.9.4840; Chang HT, 2002, BREAST CANCER RES TR, V71, P125, DOI 10.1023/A:1013807731642; Chang HT, 2001, ARCH TOXICOL, V75, P184, DOI 10.1007/s002040100212; Cheng Y., 2000, P 8 INT C INT SYST M, P93; CHEUNG V, 2006, PSI200644 U TOR; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Courchesne WE, 2002, J PHARMACOL EXP THER, V300, P195, DOI 10.1124/jpet.300.1.195; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; DOUGLAS CM, 1994, J BACTERIOL, V176, P5686, DOI 10.1128/JB.176.18.5686-5696.1994; DOUGLAS CM, 1994, P NATL ACAD SCI USA, V91, P12907, DOI 10.1073/pnas.91.26.12907; Dueck D, 2005, BIOINFORMATICS, V21, pI144, DOI 10.1093/bioinformatics/bti1041; Flaherty P, 2005, BIOINFORMATICS, V21, P3286, DOI 10.1093/bioinformatics/bti515; Ford PW, 1999, J AM CHEM SOC, V121, P5899, DOI 10.1021/ja990582o; FRIED HM, 1982, NUCLEIC ACIDS RES, V10, P3133, DOI 10.1093/nar/10.10.3133; FROMTILING R A, 1988, Clinical Microbiology Reviews, V1, P187; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HEMANDEZ F, 1982, J ANTIBIOT, V35, P875; Hosono K, 2000, ARCH MICROBIOL, V173, P284, DOI 10.1007/s002030000147; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jain PT, 1997, ANTICANCER RES, V17, P1167; Jan CR, 2003, ARCH TOXICOL, V77, P160, DOI 10.1007/s00204-002-0420-0; Jan CR, 2000, TOXICOL APPL PHARM, V168, P58, DOI 10.1006/taap.2000.9011; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kartsonis NA, 2003, DRUG RESIST UPDATE, V6, P197, DOI 10.1016/S1368-7646(03)00064-5; KITAGAWA I, 1981, CHEM PHARM BULL, V29, P2387; KIYONO K, 1987, J BIOCHEM-TOKYO, V102, P1089, DOI 10.1093/oxfordjournals.jbchem.a122147; KUNKEL W, 1980, Z ALLG MIKROBIOL, V20, P315, DOI 10.1002/jobm.3630200503; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Moebius FF, 1996, BIOCHEMISTRY-US, V35, P16871, DOI 10.1021/bi961996m; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; ROSE M, 1983, J MOL BIOL, V170, P883, DOI 10.1016/S0022-2836(83)80193-4; Schmidt EW, 1998, J ORG CHEM, V63, P1254, DOI 10.1021/jo9718455; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; THOMAS JH, 1985, GENETICS, V111, P715; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45; TRUAN G, 1994, GENE, V142, P123, DOI 10.1016/0378-1119(94)90366-2; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Williams DE, 2005, J NAT PROD, V68, P327, DOI 10.1021/np049711r; YOSHIDA S, 1992, MOL GEN GENET, V231, P337, DOI 10.1007/BF00292700; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	68	368	381	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2006	126	3					611	625		10.1016/j.cell.2006.06.040	http://dx.doi.org/10.1016/j.cell.2006.06.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901791	Bronze			2022-12-01	WOS:000239883400019
J	Liberles, SD; Buck, LB				Liberles, Stephen D.; Buck, Linda B.			A second class of chemosensory receptors in the olfactory epithelium	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; PUBERTY-ACCELERATING PHEROMONES; TRACE AMINES; ODORANT RECEPTORS; GENE; MOUSE; IDENTIFICATION; FAMILY; EXPRESSION; STRESS	The mammalian olfactory system detects chemicals sensed as odours as well as social cues that stimulate innate responses. Odorants are detected in the nasal olfactory epithelium by the odorant receptor family, whose,1,000 members allow the discrimination of a myriad of odorants. Here we report the discovery of a second family of receptors in the mouse olfactory epithelium. Genes encoding these receptors, called ' trace amine- associated receptors' ( TAARs), are present in human, mouse and fish. Like odorant receptors, individual mouse TAARs are expressed in unique subsets of neurons dispersed in the epithelium. Notably, at least three mouse TAARs recognize volatile amines found in urine: one detects a compound linked to stress, whereas the other two detect compounds enriched in male versus female urine - one of which is reportedly a pheromone. The evolutionary conservation of the TAAR family suggests a chemosensory function distinct from odorant receptors. Ligands identified for TAARs thus far suggest a function associated with the detection of social cues.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Buck, LB (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	lbuck@fhcrc.org		Liberles, Stephen/0000-0002-2177-9741				Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; Gloriam DEI, 2005, MOL PHYLOGENET EVOL, V35, P470, DOI 10.1016/j.ympev.2004.12.003; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kandel ER., 2000, PRINCIPLES NEURAL SC, P67; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lee MB, 2006, CLIN CHIM ACTA, V365, P264, DOI 10.1016/j.cca.2005.09.004; Lewin AH, 2006, AAPS J, V8, pE138, DOI 10.1208/aapsj080116; Lindemann L, 2005, TRENDS PHARMACOL SCI, V26, P274, DOI 10.1016/j.tips.2005.03.007; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McKee CLG, 2006, J PROTEOME RES, V5, P378, DOI 10.1021/pr050255h; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; NISHIMURA K, 1989, J EXP ZOOL, V251, P300, DOI 10.1002/jez.1402510306; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; PAULOS MA, 1982, SCIENCE, V215, P1127, DOI 10.1126/science.7063846; PRICE MA, 1992, J EXP ZOOL, V264, P42, DOI 10.1002/jez.1402640107; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Restrepo D, 2004, HORM BEHAV, V46, P247, DOI 10.1016/j.yhbeh.2004.02.009; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; SNODDY AM, 1985, PHARMACOL BIOCHEM BE, V22, P497, DOI 10.1016/0091-3057(85)90054-1; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Vanti WB, 2003, GENOMICS, V82, P531, DOI 10.1016/S0888-7543(03)00173-3; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	40	508	534	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					645	650		10.1038/nature05066	http://dx.doi.org/10.1038/nature05066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16878137				2022-12-01	WOS:000239630200036
J	Zhao, M; Song, B; Pu, J; Wada, T; Reid, B; Tai, GP; Wang, F; Guo, AH; Walczysko, P; Gu, Y; Sasaki, T; Suzuki, A; Forrester, JV; Bourne, HR; Devreotes, PN; McCaig, CD; Penninger, JM				Zhao, Min; Song, Bing; Pu, Jin; Wada, Teiji; Reid, Brian; Tai, Guangping; Wang, Fei; Guo, Aihua; Walczysko, Petr; Gu, Yu; Sasaki, Takehiko; Suzuki, Akira; Forrester, John V.; Bourne, Henry R.; Devreotes, Peter N.; McCaig, Colin D.; Penninger, Josef M.			Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN	NATURE			English	Article							CHEMOATTRACTANT GRADIENTS; IN-VIVO; CHEMOTAXIS; FIELDS; ORIENTATION; MIGRATION; CURRENTS; CELLS; POLARIZATION; REGENERATION	Wound healing is essential for maintaining the integrity of multicellular organisms. In every species studied, disruption of an epithelial layer instantaneously generates endogenous electric fields, which have been proposed to be important in wound healing(1-3). The identity of signalling pathways that guide both cell migration to electric cues and electric-field-induced wound healing have not been elucidated at a genetic level. Here we show that electric fields, of a strength equal to those detected endogenously, direct cell migration during wound healing as a prime directional cue. Manipulation of endogenous wound electric fields affects wound healing in vivo. Electric stimulation triggers activation of Src and inositol - phospholipid signalling, which polarizes in the direction of cell migration. Notably, genetic disruption of phosphatidylinositol-3-OH kinase-gamma (PI( 3) K gamma) decreases electric-field-induced signalling and abolishes directed movements of healing epithelium in response to electric signals. Deletion of the tumour suppressor phosphatase and tensin homolog (PTEN) enhances signalling and electrotactic responses. These data identify genes essential for electrical-signal-induced wound healing and show that PI(3) K gamma and PTEN control electrotaxis.	Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Ophthalmol, Aberdeen AB25 2ZD, Scotland; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Akita Univ, Sch Med, Dept Pathol & Immunol, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Mol Biol, Akita 0108543, Japan; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	University of Aberdeen; University of Aberdeen; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of California System; University of California San Francisco; Akita University; Akita University; Johns Hopkins University	Zhao, M (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland.	m.zhao@abdn.ac.uk; josef.penninger@imba.oeaw.ac.at	Penninger, Josef M/I-6860-2013; gu, yu/GSD-4507-2022; Wang, Fei/A-7968-2013; Reid, Brian John/AFT-8587-2022; Suzuki, Akira/GYD-6697-2022; McCaig, Colin/B-1774-2010; Song, Bing/AAB-4755-2021	Penninger, Josef M/0000-0002-8194-3777; Reid, Brian John/0000-0002-9613-979X; Suzuki, Akira/0000-0002-5950-8808; Song, Bing/0000-0001-9356-2333; Sasaki, Takehiko/0000-0003-1837-3748	NIGMS NIH HHS [R01 GM028007] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028007] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARKER AT, 1982, AM J PHYSIOL, V242, P358; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Du Bois-Reymond EH, 1843, FISCHE; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; JAFFE LF, 1974, J CELL BIOL, V63, P614, DOI 10.1083/jcb.63.2.614; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kimmel AR, 2003, SCIENCE, V300, P1525, DOI 10.1126/science.1085439; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Suzuki A, 2004, BIOCHEM SOC T, V32, P362, DOI 10.1042/BST0320362; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhao M, 2003, FASEB J, V17, P397, DOI 10.1096/fj.02-0610com; Zhao M, 1996, J CELL SCI, V109, P1405	30	668	708	23	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					457	460		10.1038/nature04925	http://dx.doi.org/10.1038/nature04925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871217				2022-12-01	WOS:000239278900044
J	Pan, XJ; Eathiraj, S; Munson, M; Lambright, DG				Pan, Xiaojing; Eathiraj, Sudharshan; Munson, Mary; Lambright, David G.			TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanism	NATURE			English	Article							TRANSITION-STATE ANALOG; ACTIVATING PROTEIN; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; YEAST; FAMILY; GYP1P; IDENTIFICATION; G(I-ALPHA-1)	Rab GTPases regulate membrane trafficking by cycling between inactive (GDP-bound) and active (GTP-bound) conformations(1). The duration of the active state is limited by GTPase-activating proteins ( GAPs), which accelerate the slow intrinsic rate of GTP hydrolysis. Proteins containing TBC (Tre-2, Bub2 and Cdc16) domains are broadly conserved in eukaryotic organisms and function as GAPs for Rab GTPases as well as GTPases that control cytokinesis(2). An exposed arginine residue is a critical determinant of GAP activity in vitro and in vivo(3-5). It has been expected that the catalytic mechanism of TBC domains would parallel that of Ras and Rho family GAPs. Here we report crystallographic, mutational and functional analyses of complexes between Rab GTPases and the TBC domain of Gyp1p. In the crystal structure of a TBC-domain-Rab-GTPase-aluminium fluoride complex, which approximates the transition-state intermediate for GTP hydrolysis, the TBC domain supplies two catalytic residues in trans, an arginine finger analogous to Ras/Rho family GAPs and a glutamine finger that substitutes for the glutamine in the DxxGQ motif of the GTPase. The glutamine from the Rab GTPase does not stabilize the transition state as expected but instead interacts with the TBC domain. Strong conservation of both catalytic fingers indicates that most TBC-domain GAPs may accelerate GTP hydrolysis by a similar dual-finger mechanism.	UMASS Med Sch, Program Mol Med, Worcester, MA 01605 USA; UMASS Med Sch, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lambright, DG (corresponding author), UMASS Med Sch, Program Mol Med, 2 Biotech,373 Plantat St, Worcester, MA 01605 USA.	david.lambright@umassmed.edu	Munson, Mary/A-9777-2009	Munson, Mary/0000-0003-2297-8053				Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; SARASTE J, 1995, J CELL SCI, V108, P1541; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; Segev N, 2001, SCI STKE, pre11, DOI DOI 10.1126/STKE.2001.100.RE11; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vollmer P, 1999, EUR J BIOCHEM, V260, P284, DOI 10.1046/j.1432-1327.1999.00192.x; Will E, 2001, J BIOL CHEM, V276, P12135, DOI 10.1074/jbc.M011451200; Zheng JY, 1998, J CELL SCI, V111, P1061	30	233	244	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					303	306		10.1038/nature04847	http://dx.doi.org/10.1038/nature04847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855591				2022-12-01	WOS:000239122100039
J	Hockemeyer, D; Daniels, JP; Takai, H; de Lange, T				Hockemeyer, Dirk; Daniels, Jan-Peter; Takai, Hiroyuki; de Lange, Titia			Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres	CELL			English	Article							END-BINDING-PROTEIN; SINGLE-STRANDED-DNA; MAMMALIAN TELOMERES; LENGTH REGULATOR; DAMAGE RESPONSE; TRF2; ATM; DYSFUNCTION; CELLS; RECOMBINATION	Human telomeres are protected by shelterin, a complex that includes the POT1 single-stranded DNA binding protein. We found that mouse telomeres contain two POT1 paralogs, POT1a and POT1b, and we used conditional deletion to determine their function. Double-knockout cells showed that POT1a/b are required to prevent a DNA damage signal at chromosome ends, endoreduplication, and senescence. In contrast, POT1a/b were largely dispensable for repression of telomere fusions. Single knockouts and complementation experiments revealed that POT1a and POT1b have distinct functions. POT1a, but not POT1b, was required to repress a DNA damage signal at telomeres. Conversely, POT1b, but not POT1a, had the ability to regulate the amount of single-stranded DNA at the telomere terminus. We conclude that mouse telomeres require two distinct POT1 proteins whereas human telomeres have one. Such divergence is unprecedented in mammalian chromosome biology and has implications for modeling human telomere biology in mice.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011; Takai, Hiroyuki/B-8352-2011	de Lange, Titia/0000-0002-9267-367X; Hockemeyer, Dirk/0000-0002-5598-5092	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046, R01GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER; NIA NIH HHS [AG16642] Funding Source: Medline; NIGMS NIH HHS [GM49046] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; FANNING TG, 1983, NUCLEIC ACIDS RES, V11, P5073, DOI 10.1093/nar/11.15.5073; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Qi L, 2003, CANCER RES, V63, P8188; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stansel RM, 2001, EMBO J, V20, P5532; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	39	300	309	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					63	77		10.1016/j.cell.2006.04.044	http://dx.doi.org/10.1016/j.cell.2006.04.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839877	Bronze			2022-12-01	WOS:000239224800017
J	Kudo, NR; Wassmann, K; Anger, M; Schuh, M; Wirth, KG; Xu, HL; Helmhart, W; Kudo, H; Mckay, M; Maro, B; Ellenberg, J; de Boer, P; Nasmyth, K				Kudo, Nobuaki R.; Wassmann, Katja; Anger, Martin; Schuh, Melina; Wirth, Karin G.; Xu, Huiling; Helmhart, Wolfgang; Kudo, Hiromi; Mckay, Michael; Maro, Bernard; Ellenberg, Jan; de Boer, Peter; Nasmyth, Kim			Resolution of chiasmata in oocytes requires separase-mediated proteolysis	CELL			English	Article							SISTER-CHROMATID COHESION; ANAPHASE-PROMOTING COMPLEX; MEIOSIS-I DEPENDS; MOUSE OOCYTES; CHROMOSOME SEGREGATION; CAENORHABDITIS-ELEGANS; SYNAPTONEMAL COMPLEXES; MAMMALIAN OOCYTES; XENOPUS-OOCYTES; FISSION YEAST	In yeast, resolution of chiasmata in meiosis I requires proteolytic cleavage along chromosome arms of cohesin's Rec8 subunit by separase. Since activation of separase by the anaphase-promoting complex (APC/C) is supposedly not required for meiosis I in Xenopus oocytes, it has been suggested that animal cells might resolve chiasmata by a separase-independent mechanism related to the so-called "prophase pathway" that removes cohesin from chromosome arms during mitosis. By expressing Cre recombinase from a zona pellucida promoter, we have deleted a floxed allele of separase specifically in mouse oocytes. This prevents removal of Rec8 from chromosome arms and resolution of chiasmata. It also hinders extrusion of the first polar body (PBE) and causes female sterility. mRNA encoding wild-type but not catalytically inactive separase restores chiasma resolution. Both types of mRNA restore PBE. Proteolytic activity of separase is therefore essential for Rec8's removal from chromosome arms and for chiasma resolution but not for PBE.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Paris 06, IFR83, CNRS, UMR7622, F-75005 Paris, France; European Mol Biol Lab, Gene Express & Cell Biol Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Biophys Unit, D-69117 Heidelberg, Germany; Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Ramat Aviv, Israel; Radboud Univ Nijmegen Med Ctr, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Peter Maccallum Cancer Center; Tel Aviv University; Sackler Faculty of Medicine; Radboud University Nijmegen	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Pks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Anger, Martin/R-9917-2019; Kudo, Nobuaki/AAU-7196-2021; Maro, Bernard/AAL-2220-2020; Ellenberg, Jan/I-4688-2014; Holt, Janet E/B-2415-2013; Anger, Martin/A-3152-2015	Anger, Martin/0000-0003-0128-1054; Ellenberg, Jan/0000-0001-5909-701X; Anger, Martin/0000-0003-0128-1054; Kudo, Nobuaki/0000-0001-8134-1242; Kudo, Hiromi/0000-0003-4313-7165; Wassmann, Katja/0000-0001-5442-5192; Nasmyth, Kim/0000-0001-7030-4403	Medical Research Council [G0901046] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; EPIFANO O, 1995, DEVELOPMENT, V121, P1947; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; KUBIAK JZ, 1992, J CELL SCI, V102, P457; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Prieto I, 2004, CHROMOSOME RES, V12, P197, DOI 10.1023/B:CHRO.0000021945.83198.0e; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	46	178	188	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					135	146		10.1016/j.cell.2006.05.033	http://dx.doi.org/10.1016/j.cell.2006.05.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839882	Bronze, Green Submitted			2022-12-01	WOS:000239224800022
J	Reith, F; Rogers, SL; McPhail, DC; Webb, D				Reith, Frank; Rogers, Stephen L.; McPhail, D. C.; Webb, Daryl			Biomineralization of gold: Biofilms on bacterioform gold	SCIENCE			English	Article							THIOSULFATE COMPLEX; PRECIPITATION; METALLIDURANS	Bacterial biofilms are associated with secondary gold grains from two sites in Australia. 16S ribosomal DNA clones of the genus Ralstonia that bear 99% similarity to the bacterium Ralstonia metallidurans - shown to precipitate gold from aqueous gold(III) tetrachloride - were present on all DNA-positive gold grains but were not detected in the surrounding soils. These results provide evidence for the bacterial contribution to the authigenic formation of secondary bacterioform gold grains and nuggets.	Cooperat Res Ctr Landscape Environm & Mineral Exp, Bentley, WA 6102, Australia; Australian Natl Univ, Dept Earth & Marine Sci, Acton, ACT 0200, Australia; Australian Natl Univ, Res Sch Biol Sci, Electron Microscopy Unit, Acton, ACT 0200, Australia; CSIRO Land & Water, Glen Osmond, SA 5064, Australia	Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reith, F (corresponding author), Cooperat Res Ctr Landscape Environm & Mineral Exp, POB 1130, Bentley, WA 6102, Australia.	frank.reith@csiro.au	Reith, Frank/E-5542-2011					Bischoff G.C., 1997, NEUES JB GEOL PALAON, V6, P329, DOI [10.1127/njgpm/1997/1997/329, DOI 10.1127/NJGPM/1997/1997/329]; BISCHOFF GCO, 1994, N JB GEOL PALAONT AB, V194, P187; BOWMAN HN, 1979, 1979256 GS DEP MIN R; Boyle R.W., 1979, GEOL SURV CAN B, V280; BULTITUDE RJ, 1992, 19925 DEP RES IND QU; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; KARAMUSHKA V I, 1987, Prikladnaya Biokhimiya i Mikrobiologiya, V23, P697; KARAMUSHKA VI, 1990, UKR BIOKHIM ZH+, V62, P103; KARAMUSHKA VI, 1990, UKR BIOKHIM ZH+, V62, P76; Karthikeyan S, 2002, ENVIRON MICROBIOL, V4, P667, DOI 10.1046/j.1462-2920.2002.00353.x; Kashefi K, 2001, APPL ENVIRON MICROB, V67, P3275, DOI 10.1128/AEM.67.7.3275-3279.2001; KEELING JR, 1993, S AUST GEOL SURV Q G, V126, P12; Korobushkina E.D., 1983, ECOL B, V35, P325; Ledrich ML, 2005, BIOMETALS, V18, P643, DOI 10.1007/s10534-005-3858-8; Lengke MF, 2005, GEOCHIM COSMOCHIM AC, V69, P3759, DOI 10.1016/j.gca.2005.03.012; LYALIKOVA NN, 1969, MICROBIOLOGY, V38, P682; MANN S, 1992, NATURE, V357, P358, DOI 10.1038/357358b0; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; Mossman DJ, 1999, GEOSCI CAN, V26, P131; NAKJIMA A, 2003, WORLD J MICROB BIOT, V19, P369; Reith F, 2006, GEOCHIM COSMOCHIM AC, V70, P1421, DOI 10.1016/j.gca.2005.11.013; SOUTHAM G, 1994, GEOCHIM COSMOCHIM AC, V58, P4227; WATTERSON JR, 1994, GEOLOGY, V22, P1144, DOI 10.1130/0091-7613(1994)022<1144:ARBBPI>2.3.CO;2; WATTERSON JR, 1992, GEOLOGY, V20, P1147; WITKIEWICZ PL, 1981, J CHEM SOC CHEM COMM, P1111, DOI 10.1039/c39810001111	25	165	171	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					233	236		10.1126/science.1125878	http://dx.doi.org/10.1126/science.1125878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840703	Green Published			2022-12-01	WOS:000239008000047
J	Wohrle, J				Woehrle, Jochen			Closure of patent foramen ovale after cryptogenic stroke	LANCET			English	Editorial Material							ATRIAL SEPTAL ANEURYSM; RECURRENT CEREBROVASCULAR EVENTS; PARADOXICAL EMBOLISM; TRANSCATHETER CLOSURE; PERCUTANEOUS CLOSURE; THROMBUS FORMATION; MEDICAL-TREATMENT; DEVICE CLOSURE; DEFECT; PREVENTION		Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany	Ulm University	Wohrle, J (corresponding author), Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany.	jochen.woehrle@uniklinik-ulm.de						Anzai H, 2004, AM J CARDIOL, V93, P426, DOI 10.1016/j.amjcard.2003.10.036; Beitzke A, 2002, Z KARDIOL, V91, P693, DOI 10.1007/s00392-002-0835-x; Bogousslavsky J, 1996, NEUROLOGY, V46, P1301, DOI 10.1212/WNL.46.5.1301; Braun M, 2004, EUR HEART J, V25, P424, DOI 10.1016/j.ehj.2003.10.021; Cujec B, 1999, CAN J CARDIOL, V15, P57; De Castro S, 2000, STROKE, V31, P2407, DOI 10.1161/01.STR.31.10.2407; El Said HG, 2005, PEDIATR CARDIOL, V26, P62, DOI 10.1007/s00246-004-0686-5; Herrmann HC, 2005, CATHETER CARDIO INTE, V64, P197, DOI 10.1002/ccd.20260; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Hung J, 2000, J AM COLL CARDIOL, V35, P1311, DOI 10.1016/S0735-1097(00)00514-3; Khositseth A, 2004, MAYO CLIN PROC, V79, P35, DOI 10.4065/79.1.35; Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030; Martin F, 2002, CIRCULATION, V106, P1121, DOI 10.1161/01.CIR.0000027819.19722.EE; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; MAS JL, 1995, AM HEART J, V130, P1083, DOI 10.1016/0002-8703(95)90212-0; Onorato Eustaquio, 2003, J Interv Cardiol, V16, P43; SCHLUCHLENZ HW, 2005, INT J CARDIOL, V101, P77; Wahl A, 2005, J AM COLL CARDIOL, V45, P377, DOI 10.1016/j.jacc.2004.10.043; Wahl A, 2001, NEUROLOGY, V57, P1330, DOI 10.1212/WNL.57.7.1330; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044	20	46	48	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					350	352		10.1016/S0140-6736(06)69087-9	http://dx.doi.org/10.1016/S0140-6736(06)69087-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876648				2022-12-01	WOS:000239441900009
J	Kim, SV; Mehal, WZ; Dong, XM; Heinrich, V; Pypaert, M; Mellman, I; Dembo, M; Mooseker, MS; Wu, DQ; Flavell, RA				Kim, Sangwon V.; Mehal, Wajahat Z.; Dong, Xuemei; Heinrich, Volkmar; Pypaert, Marc; Mellman, Ira; Dembo, Micah; Mooseker, Mark S.; Wu, Dianqing; Flavell, Richard A.			Modulation of cell adhesion and motility in the immune system by Myo1f	SCIENCE			English	Article							MYOSIN-I; ENDOCYTOSIS; MIGRATION; MOVEMENT; STRATEGY; MUTANTS; GENE	Although class I myosins are known to play a wide range of roles, the physiological function of long-tailed class I myosins in vertebrates remains elusive. We demonstrated that one of these proteins, Myo1f, is expressed predominantly in the mammalian immune system. Cells from Myo1f-deficient mice exhibited abnormally increased adhesion and reduced motility, resulting from augmented exocytosis of beta 2 integrin - containing granules. Also, the cortical actin that co-localizes with Myo1f was reduced in Myo1f-deficient cells. In vivo, Myo1f-deficient mice showed increased susceptibility to infection by Listeria monocytogenes and an impaired neutrophil response. Thus, Myo1f directs immune cell motility and innate host defense against infection.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, New Haven, CT 06520 USA; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Yale Univ, Dept Pathol, New Haven, CT 06511 USA; Yale Univ, Dept Mol Biol, New Haven, CT 06511 USA; Yale Univ, Dept Cellular Biol, New Haven, CT 06511 USA; Yale Univ, Dept Dev Biol, New Haven, CT 06511 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Ludwig Institute for Cancer Research; Yale University; University of Connecticut; Boston University; Yale University; Yale University; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Heinrich, Volkmar/D-1169-2009; Dembo, Micah/C-2755-2013; Mellman, Ira/ABG-5896-2020; Kim, Sangwon V./S-1166-2016	Kim, Sangwon V./0000-0001-8453-7080; Heinrich, Volkmar/0000-0002-4932-5012	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025387, K08DK002965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073823, R01GM054597, R01GM072002] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080706-11, R01 HL080706-10, R01 HL080706] Funding Source: Medline; NIDDK NIH HHS [R01 DK25387, K08 DK02965] Funding Source: Medline; NIGMS NIH HHS [R01 GM073823, R01 GM72002, R01 GM054597] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chen AH, 2001, ARCH OTOLARYNGOL, V127, P921, DOI 10.1001/archotol.127.8.921; CONLAN JW, 1991, J EXP MED, V174, P741, DOI 10.1084/jem.174.3.741; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Crozet F, 1997, GENOMICS, V40, P332, DOI 10.1006/geno.1996.4526; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Redowicz MJ, 2002, ACTA BIOCHIM POL, V49, P789; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Rogers HW, 1996, J IMMUNOL, V156, P679; SMITH CW, 2001, CLIN IMMUNOLOGY  PRI; STOFFLER HE, 1995, J CELL BIOL, V129, P819, DOI 10.1083/jcb.129.3.819; Swanson JA, 1999, J CELL SCI, V112, P307; Taki T, 2005, ONCOGENE, V24, P5191, DOI 10.1038/sj.onc.1208711; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Titus MA, 2000, J EUKARYOT MICROBIOL, V47, P191, DOI 10.1111/j.1550-7408.2000.tb00038.x; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406	27	82	83	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					136	139		10.1126/science.1131920	http://dx.doi.org/10.1126/science.1131920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023661				2022-12-01	WOS:000241031200054
J	Betzig, E; Patterson, GH; Sougrat, R; Lindwasser, OW; Olenych, S; Bonifacino, JS; Davidson, MW; Lippincott-Schwartz, J; Hess, HF				Betzig, Eric; Patterson, George H.; Sougrat, Rachid; Lindwasser, O. Wolf; Olenych, Scott; Bonifacino, Juan S.; Davidson, Michael W.; Lippincott-Schwartz, Jennifer; Hess, Harald F.			Imaging intracellular fluorescent proteins at nanometer resolution	SCIENCE			English	Article							STRUCTURED-ILLUMINATION MICROSCOPY; DIFFRACTION LIMIT; LIVING CELLS; LOCALIZATION; SPECTROSCOPY; MOLECULES	We introduce a method for optically imaging intracellular proteins at nanometer spatial resolution. Numerous sparse subsets of photoactivatable fluorescent protein molecules were activated, localized ( to similar to 2 to 25 nanometers), and then bleached. The aggregate position information from all subsets was then assembled into a superresolution image. We used this method - termed photoactivated localization microscopy - to image specific target proteins in thin sections of lysosomes and mitochondria; in fixed whole cells, we imaged vinculin at focal adhesions, actin within a lamellipodium, and the distribution of the retroviral protein Gag at the plasma membrane.	Howard Hughes Med Inst, Ashburn, VA USA; New Millennium Res LLC, Okemos, MI 48864 USA; NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA; Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; NuQuest Res LLC, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University System of Florida; Florida State University	Betzig, E (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	betzige@janelia.hhmi.org	Patterson, George/ABI-4751-2020	Sougrat, Rachid/0000-0001-6476-1886; Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008850, ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008834, ZIAHD008834, Z01HD008850, Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2005, OPT EXPRESS, V13, P3021, DOI 10.1364/OPEX.13.003021; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; HESS HF, 1994, SCIENCE, V264, P1740, DOI 10.1126/science.264.5166.1740; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Moerner WE, 2002, J PHYS CHEM B, V106, P910, DOI 10.1021/jp012992g; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Politz JC, 1999, TRENDS CELL BIOL, V9, P284, DOI 10.1016/S0962-8924(99)01585-8; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; van Oijen AM, 1999, J OPT SOC AM A, V16, P909, DOI 10.1364/JOSAA.16.000909; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	29	5731	6005	103	2003	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1642	1645		10.1126/science.1127344	http://dx.doi.org/10.1126/science.1127344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16902090	Green Submitted			2022-12-01	WOS:000240498900047
J	Inoki, K; Ouyang, H; Zhu, TQ; Lindvall, C; Wang, Y; Zhang, XJ; Yang, Q; Bennett, C; Harada, Y; Stankunas, K; Wang, CY; He, X; MacDougald, OA; You, M; Williams, BO; Guan, KL				Inoki, Ken; Ouyang, Hongjiao; Zhu, Tianqing; Lindvall, Charlotta; Wang, Yian; Zhang, Xiaojie; Yang, Qian; Bennett, Christina; Harada, Yuko; Stankunas, Kryn; Wang, Cun-yu; He, Xi; MacDougald, Ormond A.; You, Ming; Williams, Bart O.; Guan, Kun-Liang			TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth	CELL			English	Article							ACTIVATED PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; TUBEROUS-SCLEROSIS; TUMOR-SUPPRESSOR; CYCLIN D1; COMPLEX; EXPRESSION; TOR; INHIBITION	Mutation in the TSC2 tumor suppressor causes tuberous sclerosis complex, a disease characterized by hamartoma formation in multiple tissues. TSC2 inhibits cell growth by acting as a GTPase-activating protein toward Rheb, thereby inhibiting mTOR, a central controller of cell growth. Here, we show that Wnt activates mTOR via inhibiting GSK3 without involving beta-catenin-dependent transcription. GSK3 inhibits the mTOR pathway by phosphorylating TSC2 in a manner dependent on AMPK-priming phosphorylation. Inhibition of mTOR by rapamycin blocks Wnt-induced cell growth and tumor development, suggesting a potential therapeutic value of rapamycin for cancers with activated Wnt signaling. Our results show that, in addition to transcriptional activation, Wnt stimulates translation and cell growth by activating the TSC-mTOR pathway. Furthermore, the sequential phosphorylation of TSC2 by AMPK and GSK3 reveals a molecular mechanism of signal integration in cell growth regulation.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cariol Restorat Sci & Endodontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integerat Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI 49503 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Van Andel Institute; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; Stanford University; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Williams, Bart/A-3539-2013; INOKI, KEN/A-1202-2007; Guan, Kun-Liang/ADK-7088-2022	Williams, Bart/0000-0002-5261-5301; MacDougald, Ormond/0000-0001-6907-7960	NATIONAL CANCER INSTITUTE [R21CA161150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017439] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA161150] Funding Source: Medline; NIDCR NIH HHS [R01 DE017439-02, R01 DE017439] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Astrinidis A, 2003, J BIOL CHEM, V278, P51372, DOI 10.1074/jbc.M303956200; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2000, BIOESSAYS, V22, P961; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.tb20498.x; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Easwaran V, 2003, CANCER RES, V63, P3145; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kolligs FT, 2000, GENE DEV, V14, P1319; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mak BC, 2005, AM J PATHOL, V167, P107, DOI 10.1016/S0002-9440(10)62958-6; Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Ouyang HJ, 2000, ENDOCRINOLOGY, V141, P4671, DOI 10.1210/en.141.12.4671; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang XB, 2001, CANCER RES, V61, P6050; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	53	988	1029	1	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					955	968		10.1016/j.cell.2006.06.055	http://dx.doi.org/10.1016/j.cell.2006.06.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959574	Bronze			2022-12-01	WOS:000240675000022
J	Masly, JP; Jones, CD; Noor, MAF; Locke, J; Orr, HA				Masly, John P.; Jones, Corbin D.; Noor, Mohamed A. F.; Locke, John; Orr, H. Allen			Gene transposition as a cause of hybrid sterility in Drosophila	SCIENCE			English	Article							EVOLUTION; MELANOGASTER; ORIGIN; DIVERGENCE; ISOFORM; COMPLEX; RESCUE	We describe reproductive isolation caused by a gene transposition. In certain Drosophila melanogaster - D. simulans hybrids, hybrid male sterility is caused by the lack of a single-copy gene essential for male fertility, JYAlpha. This gene is located on the fourth chromosome of D. melanogaster but on the third chromosome of D. simulans. Genomic and molecular analyses show that JYAlpha transposed to the third chromosome during the evolutionary history of the D. simulans lineage. Because of this transposition, a fraction of hybrids completely lack JYAlpha and are sterile, representing reproductive isolation without sequence evolution.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Rochester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Alberta	Masly, JP (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	msly@mail.rochester.edu	Locke, John/A-2661-2014	Locke, John/0000-0003-4998-3127; Noor, Mohamed/0000-0002-5400-4408				Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BRIDGES C. B., 1935, Biol. Z., V4, P401; Coyne J.A., 2004, SPECIATION; Davis AW, 1996, NATURE, V380, P157, DOI 10.1038/380157a0; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Jones CD, 2005, GENETICS, V170, P207, DOI 10.1534/genetics.104.037283; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kliman RM, 2000, GENETICS, V156, P1913; Lingrel J, 2003, ANN NY ACAD SCI, V986, P354, DOI 10.1111/j.1749-6632.2003.tb07214.x; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; MULLER H. J., 1942, GENETICS, V27, P157; Muller HJ, 1940, NATURE, V146, P199, DOI 10.1038/146199b0; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; ORR HA, 1992, GENET RES, V59, P73, DOI 10.1017/S0016672300030275; Podemski L, 2004, CHROMOSOMA, V112, P381, DOI 10.1007/s00412-002-0286-4; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Przeworski M, 2002, GENETICS, V160, P1179; SAWAMURA K, 1993, GENETICS, V133, P307; Stempfl T, 2002, GENETICS, V160, P571; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Woo AL, 1999, J MEMBRANE BIOL, V169, P39, DOI 10.1007/PL00005899	27	141	143	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1448	1450		10.1126/science.1128721	http://dx.doi.org/10.1126/science.1128721			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960009				2022-12-01	WOS:000240348700046
J	Oury, F; Murakami, Y; Renaud, JS; Pasqualetti, M; Charnay, P; Ren, SY; Rijli, FM				Oury, Franck; Murakami, Yasunori; Renaud, Jean-Sebastien; Pasqualetti, Massimo; Charnay, Patrick; Ren, Shu-Yue; Rijli, Filippo M.			Hoxa2- and rhombomere-dependent development of the mouse facial somatosensory map	SCIENCE			English	Article							CRE-MEDIATED RECOMBINATION; PRINCIPAL SENSORY NUCLEUS; STEM TRIGEMINAL COMPLEX; VIBRISSAL INFORMATION; TRANSCRIPTION FACTOR; NEURONAL DEVELOPMENT; NEURAL DEVELOPMENT; ROSTRAL HINDBRAIN; NEONATAL RAT; SYSTEM	In the mouse trigeminal pathway, sensory inputs from distinct facial structures, such as whiskers or lower jaw and lip, are topographically mapped onto the somatosensory cortex through relay stations in the thalamus and hindbrain. In the developing hindbrain, the mechanisms generating such maps remain elusive. We found that in the principal sensory nucleus, the whisker-related map is contributed by rhombomere 3 - derived neurons, whereas the rhombomere 2 - derived progeny supply the lower jaw and lip representation. Moreover, early Hoxa2 expression in neuroepithelium prevents the trigeminal nerve from ectopically projecting to the cerebellum, whereas late expression in the principal sensory nucleus promotes selective arborization of whisker-related afferents and topographic connectivity to the thalamus. Hoxa2 inactivation further results in the absence of whisker-related maps in the postnatal brain. Thus, Hoxa2- and rhombomere 3 - dependent cues determine the whisker area map and are required for the assembly of the whisker-to-barrel somatosensory circuit.	Univ Strasbourg 1, INSERM, CNRS, UMR 7104,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Oslo, Inst Basic Med Sci, Dept Physiol, N-0317 Oslo, Norway; Ecole Normale Super, INSERM, U784, F-75230 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Rijli, FM (corresponding author), Univ Strasbourg 1, INSERM, CNRS, UMR 7104,Inst Genet & Biol Mol & Cellulaire, BP 10142, F-67404 Illkirch Graffenstaden, France.	rijli@igbmc.u-strasbg.fr	RIJLI, Filippo/AAP-2516-2020; Pasqualetti, Massimo/F-8682-2012	RIJLI, Filippo/0000-0003-0515-0182; Charnay, Patrick/0000-0002-3847-6042; Pasqualetti, Massimo/0000-0002-0844-8139; OURY, FRANCK/0000-0003-0562-9900				ALGHOUL WM, 1993, J COMP NEUROL, V330, P464, DOI 10.1002/cne.903300403; BELFORD GR, 1980, J COMP NEUROL, V193, P335, DOI 10.1002/cne.901930203; BELFORD GR, 1979, J COMP NEUROL, V183, P305, DOI 10.1002/cne.901830207; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Davenne M, 1999, NEURON, V22, P677, DOI 10.1016/S0896-6273(00)80728-X; Davies AM, 1997, J ANAT, V191, P483, DOI 10.1046/j.1469-7580.1997.19140483.x; Ding YQ, 2003, J NEUROSCI, V23, P7246; ERZURUMLU RS, 1993, P NATL ACAD SCI USA, V90, P7235, DOI 10.1073/pnas.90.15.7235; ERZURUMLU RS, 1980, NEUROSCIENCE, V5, P1891, DOI 10.1016/0306-4522(80)90037-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gaufo GO, 2004, DEVELOPMENT, V131, P1259, DOI 10.1242/dev.01029; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Genc B, 2005, J NEUROBIOL, V64, P145, DOI 10.1002/neu.20134; Jacquin MF, 1996, EUR J NEUROSCI, V8, P1641, DOI 10.1111/j.1460-9568.1996.tb01308.x; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; KILLACKEY HP, 1994, J NEUROSCI, V14, P1496, DOI 10.1523/JNEUROSCI.14-03-01496.1994; KILLACKEY HP, 1985, DEV BRAIN RES, V22, P141, DOI 10.1016/0165-3806(85)90077-X; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MA PM, 1993, J COMP NEUROL, V327, P376, DOI 10.1002/cne.903270306; Maklad A, 2003, BRAIN RES BULL, V60, P497, DOI 10.1016/S0361-9230(03)00054-6; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; Ozdinler PH, 2002, J NEUROSCI, V22, P4540, DOI 10.1523/JNEUROSCI.22-11-04540.2002; Pasqualetti M, 2002, GENESIS, V32, P109, DOI 10.1002/gene.10053; Pierret T, 2000, J NEUROSCI, V20, P7455; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Ren SY, 2002, GENESIS, V32, P105, DOI 10.1002/gene.10052; Santagati F, 2005, DEVELOPMENT, V132, P4927, DOI 10.1242/dev.02078; Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; WONGRILEY M, 1979, BRAIN RES, V162, P201, DOI 10.1016/0006-8993(79)90284-1; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	39	103	104	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1408	1413		10.1126/science.1130042	http://dx.doi.org/10.1126/science.1130042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16902088				2022-12-01	WOS:000240348700034
J	Ledford, H				Ledford, Heidi			The farmyard drug store	NATURE			English	News Item								Pharmaceuticals made in genetically modified animals was hailed as a way to drive down production costs while maintaining production. Despite a disappointing beginning, hopes have been renewed by a transgenic goat named Sweetheart. In August 2006, the anti-clotting agent in Sweetheart's milk, ATryn, was approved by the European Medicines Agency. Other companies have also created pharmaceuticals in a similar way.											0	8	8	7	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					16	17		10.1038/443016a	http://dx.doi.org/10.1038/443016a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957702				2022-12-01	WOS:000240313900013
J	Nalley, K; Johnston, SA; Kodadek, T				Nalley, Kip; Johnston, Stephen Albert; Kodadek, Thomas			Proteolytic turnover of the Gal4 transcription factor is not required for function in vivo	NATURE			English	Article							RECEPTOR-REGULATED TRANSCRIPTION; MOLECULAR CHAPERONES; SACCHAROMYCES-CEREVISIAE; GLUCOCORTICOID-RECEPTOR; BINDING DOMAIN; ACTIVATOR; ALPHA; RECRUITMENT; PROMOTER; YEAST	Transactivator - promoter complexes are essential intermediates in the activation of eukaryotic gene expression. Recent studies of these complexes have shown that some are quite dynamic in living cells(1) owing to rapid and reversible disruption of activator promoter complexes by molecular chaperones(2-6), or a slower, ubiquitin - proteasome-pathway-mediated turnover of DNA-bound activator(7-9). These mechanisms may act to ensure continued responsiveness of activators to signalling cascades by limiting the lifetime of the active protein - DNA complex. Furthermore, the potency of some activators is compromised by proteasome inhibition, leading to the suggestion that periodic clearance of activators from a promoter is essential for high-level expression(8,10-12). Here we describe a variant of the chromatin immunoprecipitation assay that has allowed direct observation of the kinetic stability of native Gal4-promoter complexes in yeast. Under non-inducing conditions, the complex is dynamic, but on induction the Gal4 - promoter complexes 'lock in' and exhibit long half-lives. Inhibition of proteasome-mediated proteolysis had little or no effect on Gal4-mediated gene expression. These studies, combined with earlier data, show that the lifetimes of different transactivator - promoter complexes in vivo can vary widely and that proteasome-mediated turnover is not a general requirement for transactivator function.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.Kodadek@utsouthwestern.edu		Kodadek, Thomas/0000-0003-1930-4795				Arndt K, 2005, CELL, V120, P733, DOI 10.1016/j.cell.2005.03.004; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; FANKHAUSER CP, 1994, BIOCHEM BIOPH RES CO, V200, P195, DOI 10.1006/bbrc.1994.1433; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Freeman BC, 2000, GENE DEV, V14, P422; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SIDDIQUI AH, 1989, MOL CELL BIOL, V9, P4706, DOI 10.1128/MCB.9.11.4706; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; YAO J, NATURE	24	69	70	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1054	1057		10.1038/nature05067	http://dx.doi.org/10.1038/nature05067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16929306				2022-12-01	WOS:000240142000053
J	Rodrigues, ASL				Rodrigues, Ana S. L.			Are global conservation efforts successful?	SCIENCE			English	Editorial Material							EXTINCTIONS		Univ Cambridge, Dept Zool, Cambridge CB4 1AD, England	University of Cambridge	Rodrigues, ASL (corresponding author), Univ Cambridge, Dept Zool, Cambridge CB4 1AD, England.	aslr2@cam.ac.uk	Rodrigues, Ana S.L./A-5914-2009; Rodrigues, Ana/GYQ-6273-2022	Rodrigues, Ana S.L./0000-0003-4775-0127; 				[Anonymous], 2001, RED LIST CAT CRIT VE; [Anonymous], 2005, ECOL MANAG RESTOR, V6, P226; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; *BIRDL INT, 2006, DAT ZON SPEC; Butchart S. H. M., 2006, Bulletin of the British Ornithologists' Club, V126, P7; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Collar NJ, 1998, ORYX, V32, P239, DOI 10.1046/j.1365-3008.1998.d01-51.x; Gaston K.J, 1996, BIODIVERSITY BIOL NU; *IUCN, 2006, 2006 IUCN RED LIST T; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102	12	52	55	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1051	1052		10.1126/science.1131302	http://dx.doi.org/10.1126/science.1131302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	076ZT	16931741				2022-12-01	WOS:000239998200023
J	Kannel, WB; Vasan, RS				Kannel, William B.; Vasan, Ramachandran S.			Aggressive lowering of blood pressure	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; HYPERTENSION; DISEASE		Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA 01702 USA	Boston University; Framingham Heart Study	Kannel, WB (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA 01702 USA.	billkannel@yahoo.com	Ramachandran, Vasan/Y-2527-2019	Ramachandran, Vasan/0000-0001-7357-5970				[Anonymous], 1991, JAMA, V265, P3255; Chalmers J, 1999, J HYPERTENS, V17, P151; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CRUICKSHANK JM, 1987, LANCET, V1, P581; DAGOSTINO RB, 1991, BRIT MED J, V303, P385, DOI 10.1136/bmj.303.6799.385; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; KANNEL WB, 1980, AM J CARDIOL, V45, P326, DOI 10.1016/0002-9149(80)90654-2; Kannel WB, 2004, AM J CARDIOL, V94, P380, DOI 10.1016/j.amjcard.2004.04.043; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; MESSERLI FH, 2004, INCREASED PULSE PRES; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; PERRY HM, 1986, J HYPERTENS, V4, pS21; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Wang JG, 2005, HYPERTENSION, V45, P907, DOI 10.1161/01.HYP.0000165020.14745.79; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211	15	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2006	368	9536					627	628		10.1016/S0140-6736(06)69224-6	http://dx.doi.org/10.1016/S0140-6736(06)69224-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074YT	16920451				2022-12-01	WOS:000239849200008
J	Minkler, M; Fuller-Thomson, E; Guralnik, JM				Minkler, Meredith; Fuller-Thomson, Esme; Guralnik, Jack M.			Gradient of disability across the socioeconomic spectrum in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SELF-REPORT; HEALTH; INEQUALITIES; PERFORMANCE; DISPARITIES; DETERMINANTS; AGE	BACKGROUND: Although the relationship between extreme poverty and poor health among older adults has long been recognized, less attention has been devoted to investigating whether a gradient in disability exists in the United States among persons with middle-class and upper-class incomes. We attempted to determine whether a gradient in functional limitation exists across the full spectrum of income among persons 55 years of age or older. METHODS: We obtained data from the Census 2000 Supplementary Survey, which used the methods and questionnaire of the American Community Survey, a nationally representative survey of 890,698 households with a response rate of 95 percent. Our sample included 149,000 men and 186,675 women who were at least 55 years of age, of whom 32,680 men and 48,111 women reported having a functional limitation (a long-lasting condition that substantially limited one or more basic physical activities, such as climbing stairs or lifting). RESULTS: A social-class gradient was observed for both men and women between the ages of 55 and 84, a gradient that held true even at the upper rungs of the socioeconomic ladder. For example, in comparison to persons between the ages of 55 and 64 who lived at 700 percent of the poverty line or above, persons of the same age but below the poverty line had six times the odds of reporting a functional limitation. With increasing income, the odds ratio declined. A significant gradient was present up to, but not beyond, the age of 85 years. CONCLUSIONS: Our findings suggest that functional limitation in Americans between the ages of 55 and 84 years is inversely related to social class across the full spectrum of the socioeconomic gradient.	Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; NIA, Dept Demog & Biometry, Lab Epidmeiol, Bethesda, MD 20892 USA	University of California System; University of California Berkeley; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Minkler, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 316 Warren Hall, Berkeley, CA 94720 USA.	mink@berkeley.edu			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Breeze E, 2001, AM J PUBLIC HEALTH, V91, P277, DOI 10.2105/AJPH.91.2.277; BULATAO RA, 2004, UNDERSTANDING RACE E; *BUR CENS, 2000, AM COMM SURV US DAT; *BUR CENS, 2002, 63RV BUR CENS; *BUR CENS, 2004, MIDDL INT MIGR SER 1; *BUR CENS, 2002, 2 BUR CENS; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; CRESS ME, 1995, J AM GERIATR SOC, V43, P93, DOI 10.1111/j.1532-5415.1995.tb06372.x; DALAKER J, 2001, CURRENT POPULATION S; Department of Health Human Services Washington DC. Healthy People 2010 (Group) and United States Government Printing Office., 2000, HLTH PEOPL 2010; Eichner J, 2005, HEALTH AFFAIR, V24, P365, DOI 10.1377/hlthaff.24.2.365; FRANK JW, 1994, DAEDALUS, V123, P1; HARRINGTON C, 2004, NURSING FACILITIES S; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; House JS, 2002, J HEALTH SOC BEHAV, V43, P125, DOI 10.2307/3090192; Institute of Medicine, 1991, DIS AM NAT AG PREV; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Kempen GIJM, 1996, J GERONTOL B-PSYCHOL, V51, pP254, DOI 10.1093/geronb/51B.5.P254; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; Kitagawa EM, 1973, DIFFERENTIAL MORTALI, V80, P532; Lantz PM, 2001, SOC SCI MED, V53, P29, DOI 10.1016/S0277-9536(00)00319-1; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056; McDonough P, 1999, J HEALTH SOC BEHAV, V40, P17, DOI 10.2307/2676376; *NAT CTR HLTH STAT, 1999, 1999 NAT NURS HOM SU; PAPPAS G, 1993, NEW ENGL J MED, V329, P1139; SAGER MA, 1992, J AM GERIATR SOC, V40, P457, DOI 10.1111/j.1532-5415.1992.tb02011.x; SATARIANO WA, 2005, SOCIAL EPIDEMIOLOGY; Schoeni RF, 2005, AM J PUBLIC HEALTH, V95, P2065, DOI 10.2105/AJPH.2004.048744; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6	31	191	193	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2006	355	7					695	703		10.1056/NEJMsa044316	http://dx.doi.org/10.1056/NEJMsa044316			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074AN	16914705				2022-12-01	WOS:000239784500008
J	Lee, BJ; Cansizoglu, AE; Suel, KE; Louis, TH; Zhang, ZC; Chook, YM				Lee, Brittany J.; Cansizoglu, Ahmet E.; Suel, Katherine E.; Louis, Thomas H.; Zhang, Zichao; Chook, Yuh Min			Rules for nuclear localization sequence recognition by karyopherin beta 2	CELL			English	Article							NUCLEOCYTOPLASMIC SHUTTLING SEQUENCE; HNRNP A1; STRUCTURAL BASIS; IMPORT; TRANSPORT; RECEPTOR; IDENTIFICATION; DISSOCIATION; DOMAIN; SIGNAL	Karyopherin beta (Kap beta) proteins bind nuclear localization and export signals (NLSs and NESs) to mediate nucleocytoplasmic trafficking, a process regulated by Ran GTPase through its nucleotide cycle. Diversity and complexity of signals recognized by Kapos have prevented prediction of new Kap beta substrates. The structure of Kap beta 2 (also known as Transportin) bound to one of its substrates, the NILS of hnRNP A1, that we report here explains the mechanism of substrate displacement by Ran GTPase. Further analyses reveal three rules for NILS recognition by Kap beta 2: NLSs are structurally disordered in free substrates, have overall basic character, and possess a central hydrophobic or basic motif followed by a C-terminal R/H/KX(2-5)PY consensus sequence. We demonstrate the predictive nature of these rules by identifying NLSs in seven previously known Kap beta 2 substrates and uncovering 81 new candidate substrates, confirming five experimentally. These studies define and validate a new NLS that could not be predicted by primary sequence analysis alone.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75235 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019; ZHANG, ZICHAO/C-1764-2014	ZHANG, ZICHAO/0000-0003-3402-7757; Zhang, Zi Chao/0000-0001-5769-948X	NIGMS NIH HHS [R01- GM069909, R01 GM069909] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069909] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Bogerd HP, 1999, J BIOL CHEM, V274, P9771, DOI 10.1074/jbc.274.14.9771; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2002, BIOCHEMISTRY-US, V41, P6955, DOI 10.1021/bi012122p; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; DeLano WL., 2002, PYMOL USERS MANUAL D; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Floer M, 1996, J BIOL CHEM, V271, P5313, DOI 10.1074/jbc.271.10.5313; Fridell RA, 1997, J CELL SCI, V110, P1325; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Iijima M, 2006, FEBS LETT, V580, P1365, DOI 10.1016/j.febslet.2006.01.058; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawamura H, 2002, J BIOL CHEM, V277, P2732, DOI 10.1074/jbc.M108477200; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nakielny S, 1996, EXP CELL RES, V229, P261, DOI 10.1006/excr.1996.0369; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Suzuki M, 2005, FEBS J, V272, P3975, DOI 10.1111/j.1742-4658.2005.04820.x; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	45	411	425	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2006	126	3					543	558		10.1016/j.cell.2006.05.049	http://dx.doi.org/10.1016/j.cell.2006.05.049			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901787	Green Accepted, Bronze			2022-12-01	WOS:000239883400014
J	Afraz, SR; Kiani, R; Esteky, H				Afraz, Seyed-Reza; Kiani, Roozbeh; Esteky, Hossein			Microstimulation of inferotemporal cortex influences face categorization	NATURE			English	Article							PYRAMIDAL TRACT CELLS; ELECTRICAL MICROSTIMULATION; SINGLE NEURONS; AREA; RESPONSES; MONKEY; ORGANIZATION; EXCITATION; DIRECTION; PRIMATE	The inferior temporal cortex ( IT) of primates is thought to be the final visual area in the ventral stream of cortical areas responsible for object recognition(1,2). Consistent with this hypothesis, single IT neurons respond selectively to highly complex visual stimuli such as faces(3-6). However, a direct causal link between the activity of face- selective neurons and face perception has not been demonstrated. In the present study of macaque monkeys, we artificially activated small clusters of IT neurons by means of electrical microstimulation while the monkeys performed a categorization task, judging whether noisy visual images belonged to ' face ' or ' non- face' categories. Here we show that microstimulation of face-selective sites, but not other sites, strongly biased the monkeys' decisions towards the face category. The magnitude of the effect depended upon the degree of face selectivity of the stimulation site, the size of the stimulated cluster of face- selective neurons, and the exact timing of microstimulation. Our results establish a causal relationship between the activity of face- selective neurons and face perception.	Inst Studies Theoret Phys & Math, Sch Cognit Sci, Tehran 19395, Iran; Shahid Beheshti Univ Med Sci, Res Ctr Brain & Cognit Sci, Tehran 19385, Iran; Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran 19385, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Esteky, H (corresponding author), Inst Studies Theoret Phys & Math, Sch Cognit Sci, Tehran 19395, Iran.	esteky@ipm.ir						ASANUMA H, 1976, EXP BRAIN RES, V26, P443; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; DeAngelis GC, 2004, PLOS BIOL, V2, P394, DOI 10.1371/journal.pbio.0020077; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Foldiak P, 2003, PROG BRAIN RES, V144, P107, DOI 10.1016/S0079-6123(03)14400-7; Green DM, 1988, SIGNAL DETECTION THE; Gross CG, 2005, AM PSYCHOL, V60, P755, DOI 10.1037/0003-066X.60.8.755; HOREL JA, 1987, BEHAV BRAIN RES, V23, P29, DOI 10.1016/0166-4328(87)90240-3; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MEEKER WQ, 1995, AM STAT, V49, P48, DOI 10.2307/2684811; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nichols MJ, 2002, J NEUROSCI, V22, P9530; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 1999, CURR OPIN NEUROBIOL, V9, P487, DOI 10.1016/S0959-4388(99)80073-7; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SALZMAN CD, 1990, NATURE, V346, P589, DOI 10.1038/346589b0; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Zangenehpour S, 2005, CURR BIOL, V15, P993, DOI 10.1016/j.cub.2005.04.031	30	211	214	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2006	442	7103					692	695		10.1038/nature04982	http://dx.doi.org/10.1038/nature04982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16878143				2022-12-01	WOS:000239630200047
J	Braude, P				Braude, Peter			Preimplantation diagnosis for genetic susceptibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kings Coll London, Sch Med, Dept Womens Hlth, London WC2R 2LS, England	University of London; King's College London	Braude, P (corresponding author), Kings Coll London, Sch Med, Dept Womens Hlth, London WC2R 2LS, England.							MEIKLE J, 2005, GUARDIAN        0317; Rechitsky Svetlana, 2002, Reprod Biomed Online, V5, P148; Renwick P, 2006, REPROD BIOMED ONLINE, V13, P110, DOI 10.1016/S1472-6483(10)62024-X	3	24	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2006	355	6					541	543		10.1056/NEJMp068139	http://dx.doi.org/10.1056/NEJMp068139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	071QM	16899771				2022-12-01	WOS:000239616700001
J	MacDonald, R				MacDonald, Rhona			Where next for arms control?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), The Lancet, London NW1 7BY, England.							*CONTR ARMS, 2006, UN WORLD C SMALL ARM; *CONTR ARMS, 2006, ALM ON 3 AFF GUN CRI; *CONTR ARMS AMN IN, 2006, SHATT LIV CAS TOUGH; *UN, 2006, UN SMALL ARMS REV C	4	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG-SEP	2006	368	9537					713	714		10.1016/S0140-6736(06)69264-7	http://dx.doi.org/10.1016/S0140-6736(06)69264-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080ID	16935670				2022-12-01	WOS:000240240200008
J	Scaglioni, PP; Yung, TM; Cai, LF; Erdjument-Bromage, H; Kaufman, AJ; Singh, B; Teruya-Feldstein, J; Tempst, P; Pandolfi, PP				Scaglioni, Pier Paolo; Yung, Thomas M.; Cai, Lu Fan; Erdjument-Bromage, Hediye; Kaufman, Andrew J.; Singh, Bhuvanesh; Teruya-Feldstein, Julie; Tempst, Paul; Pandolfi, Pier Paolo			A CK2-dependent mechanism for degradation of the PML tumor suppressor	CELL			English	Article							PROTEIN-KINASE CK2; NUCLEAR-BODY FORMATION; DNA-DAMAGE; P53; APOPTOSIS; EXPRESSION; GROWTH; ACTIVATION; SENESCENCE; CARCINOMA	The PML tumor suppressor controls key pathways for growth suppression, induction of apoptosis, and cellular senescence. PML loss occurs frequently in human tumors through unknown posttranslational mechanisms. Casein kinase 2 (CK2) is oncogenic and frequently upregulated in human tumors. Here we show that CK2 regulates PML protein levels by promoting its ubiquitin-mediated degradation dependent on direct phosphorylation at Ser517. Consequently, PML mutants that are resistant to CK2 phosphorylation display increased tumor-suppressive functions. In a faithful mouse model of lung cancer, we demonstrate that Pml inactivation leads to increased tumorigenesis. Furthermore, CK2 pharmacological inhibition enhances the PML tumor-suppressive property in vivo. Importantly, we found an inverse correlation between CK2 kinase activity and PML protein levels in human lung cancer-derived cell lines and primary specimens. These data identify a key posttranslational mechanism that controls PML protein levels and provide therapeutic means toward PML restoration through CK2 inhibition.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Sloan Kettering Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, Sloan Kettering Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Cai, Lu/AAG-9920-2019	Tempst, Paul/0000-0002-6680-3987; Scaglioni, Pier Paolo/0000-0002-6036-5138	NCI NIH HHS [R01 CA71692, K08 CA112325-01, P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071692, K08CA112325, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Elenitoba-Johnson KSJ, 2003, P NATL ACAD SCI USA, V100, P7259, DOI 10.1073/pnas.1137463100; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; KOKEN MHM, 1995, ONCOGENE, V10, P1315; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; LAVAU C, 1995, ONCOGENE, V11, P871; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1984, J BIOL CHEM, V259, P4576; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Piazza F, 2001, ONCOGENE, V20, P7216, DOI 10.1038/sj.onc.1204855; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Salomoni P, 2005, BLOOD, V105, P3686, DOI 10.1182/blood-2004-09-3782; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Schuster N, 2001, J CELL BIOCHEM, V81, P172, DOI 10.1002/1097-4644(20010401)81:1<172::AID-JCB1033>3.0.CO;2-O; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wang ZG, 1998, SCIENCE, V279, P1547; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Yamada M, 2005, P NATL ACAD SCI USA, V102, P7736, DOI 10.1073/pnas.0409818102; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	43	233	250	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					269	283		10.1016/j.cell.2006.05.041	http://dx.doi.org/10.1016/j.cell.2006.05.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873060	Bronze			2022-12-01	WOS:000239552600014
J	Pontes, O; Li, CF; Nunes, PC; Haag, J; Ream, T; Vitins, A; Jacobsen, SE; Pikaard, CS				Pontes, Olga; Li, Carey Fei; Nunes, Pedro Costa; Haag, Jeremy; Ream, Thomas; Vitins, Alexa; Jacobsen, Steven E.; Pikaard, Craig S.			The Arabidopsis chromatin-modifying nuclear siRNA pathway involves a nucleolar RNA processing center	CELL			English	Article							DIRECTED DNA METHYLATION; HETEROCHROMATIN FORMATION; HISTONE METHYLATION; POLYMERASE-IV; CAJAL BODIES; ARGONAUTE; TRANSCRIPTION; INTERFERENCE; LOCALIZATION; INITIATION	In Arabidopsis thaliana, small interfering RNAs (siRNAs) direct cytosine methylation at endogenous DNA repeats in a pathway involving two forms of nuclear RNA polymerase IV (Pol IVa and Pol IVb), RNA-DEPENDENT RNA POLYMERASE 2 (RDR2), DICER-LIKE 3 (DCL3), ARGONAUTE4 (AGO4), the chromatin remodeler DRD1, and the de novo cytosine methyltransferase DRM2. We show that RDR2, DCL3, AG04, and NRPD1b (the largest subunit of Pol IVb) colocalize, with siRNAs within the nucleolus. By contrast, Pol IVa and DRD1 are external to the nucleolus and colocalize with endogenous repeat loci. Mutation-induced loss of pathway proteins causes downstream proteins to mislocalize, revealing their order of action. Pol IVa acts first, and its localization is RNA dependent, suggesting an RNA template. We hypothesize that maintenance of the heterochromatic state involves locus-specific Pol IVa transcription followed by siRNA production and assembly of AGO4- and NRPD1b-containing silencing complexes within nucleolar processing centers.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Inst Super Agron, Seccao Genet, Ctr Bot Aplicada Agr, P-1349017 Lisbon, Portugal	Washington University (WUSTL); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Universidade de Lisboa	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012; Pontes, Olga MF/F-9768-2011	Pikaard, Craig S/0000-0001-8204-7459; Pontes, Olga MF/0000-0003-3316-1145	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590, R01GM060398, R01GM060380, R37GM060398] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM077590, GM60398, R01GM60380, R01 GM077590, GM07185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HIGHETT MI, 1993, J CELL SCI, V105, P1151; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sontheimer EJ, 2004, SCIENCE, V305, P1409, DOI 10.1126/science.1103076; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vaucheret H, 2005, NAT GENET, V37, P659, DOI 10.1038/ng0705-659; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	42	334	364	1	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					79	92		10.1016/j.cell.2006.05.031	http://dx.doi.org/10.1016/j.cell.2006.05.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839878	Bronze			2022-12-01	WOS:000239224800018
J	Slessareva, JE; Routt, SM; Temple, B; Bankaitis, VA; Dohlman, HG				Slessareva, Janna E.; Routt, Sheri M.; Temple, Brenda; Bankaitis, Vytas A.; Dohlman, Henrik G.			Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome	CELL			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HETEROTRIMERIC G-PROTEIN; LYSOSOME-LIKE VACUOLE; BETA-GAMMA; C-ELEGANS; PHOSPHOINOSITIDE 3-KINASES; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; PTDINS 3-KINASE	In the yeast Saccharomyces cerevisiae, the G protein beta gamma subunits are essential for pheromone signaling. The G alpha subunit Gpa1 can also promote signaling, but the effectors in this pathway are not well characterized. To identify candidate Gpa1 effectors, we expressed the constitutively active Gpa1(Q323L) mutant in each of nearly 5000 gene-deletion strains and measured mating-specific responses. Our analysis reveals a requirement for both the catalytic (Vps34) and regulatory (Vps15) subunits of the sole phosphaticlylinositol 3-kinase in yeast. We demonstrate that Gpa1 is present at endosomes, where it interacts directly with both Vps34 and Vps15 and stimulates increased production of phosphatidlylinositol 3-phosphate. Notably, Vps15 binds to GDP-bound Gpa1 and is predicted to have a seven-WID repeat structure similar to that of known G protein beta subunits. These findings reveal two new components of the pheromone signaling pathway. More remarkably, these proteins appear to comprise a preformed effector-G beta subunit assembly and function at the endosome rather than at the plasma membrane.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729	NIGMS NIH HHS [R01 GM44530, P01 GM065533, P01 GM65533] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533, R01GM044530] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; AUGER KR, 1989, J BIOL CHEM, V264, P20181; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; Chasse SA, 2004, METHOD ENZYMOL, V389, P399; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; FINEGOLD AA, 1990, SCIENCE, V249, P165, DOI 10.1126/science.1695391; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schug S A, 1993, Pharmacoeconomics, V3, P260, DOI 10.2165/00019053-199303040-00002; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STACK JH, 1994, J BIOL CHEM, V269, P31552; Stack JH, 1995, COLD SPRING HARB SYM, V60, P157, DOI 10.1101/SQB.1995.060.01.019; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; STERNWEIS PC, 1986, J BIOL CHEM, V261, P631; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Takahashi T, 2001, MOL GENET GENOMICS, V265, P1112, DOI 10.1007/s004380100510; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vollert CS, 2004, MOL CELL PROTEOMICS, V3, P1053, DOI 10.1074/mcp.M400081-MCP200; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Windmiller DA, 2003, J BIOL CHEM, V278, P11874, DOI 10.1074/jbc.M211787200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200	60	173	181	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					191	203		10.1016/j.cell.2006.04.045	http://dx.doi.org/10.1016/j.cell.2006.04.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839886	Bronze			2022-12-01	WOS:000239224800026
J	Barres, BA				Barres, Ben A.			Does gender matter?	NATURE			English	Editorial Material									Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Fairchild Bldg Room D235,299 Campus Dr, Stanford, CA 94305 USA.	barres@stanford.edu						[Anonymous], 1997, SPEAKING SEX DENIAL; Baron-Cohen Simon, 2004, ESSENTIAL DIFFERENCE; Carnes M, 2005, J WOMENS HEALTH, V14, P684, DOI 10.1089/jwh.2005.14.684; Fels A., 2004, NECESSARY DREAMS; Gneezy U, 2003, Q J ECON, V118, P1049, DOI 10.1162/00335530360698496; Gould S.J., 1996, MISMEASURE MAN; Lawrence PA, 2006, PLOS BIOL, V4, P13, DOI 10.1371/journal.pbio.0040019; Leahey E, 2001, SOC FORCES, V80, P713, DOI 10.1353/sof.2001.0102; Mansfield H. C., 2006, MANLINESS; Moody A, 2004, FACULTY DIVERSITY PR, DOI DOI 10.4324/9780203463741; PETSKO GA, 2005, GENOME BIOL, V6, P1; Pinker S, 2005, NEW REPUBLIC, V232, P15; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; SUMMERS L, COMMUNICATION; Valian, 1998, WHY SO SLOW; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; Xie Y., 2003, WOMEN SCI CAREER PRO; 2005, SCI GENDER SCI PINKE	19	108	109	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					133	136		10.1038/442133a	http://dx.doi.org/10.1038/442133a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	062XJ	16848004				2022-12-01	WOS:000238979700022
J	Tuomilehto, J; Wareham, N				Tuomilehto, Jaakko; Wareham, Nicholas			Glucose lowering and diabetes prevention: are they the same?	LANCET			English	Editorial Material							LIFE-STYLE; TYPE-2; MELLITUS		Elsie Widdowson Lab, MRC, Epidemiol Unit, Cambridge, England; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Helsinki	Tuomilehto, J (corresponding author), Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.	jaakko.tuomilehto@ktl.fi						Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *DREAM TRIAL INV, 2006, LANCET          0915, DOI DOI 10.1016/S0140-6736(06)69420-8; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; FOROUHI NG, IN PRESS DIABET MED; HERMAN WH, 2005, ANN INTERN MED, V346, P393; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Muhlhauser I, 2006, DIABETOLOGIA, V49, P1742, DOI 10.1007/s00125-006-0290-8; Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	13	23	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1218	1219		10.1016/S0140-6736(06)69421-X	http://dx.doi.org/10.1016/S0140-6736(06)69421-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027710				2022-12-01	WOS:000241058300007
J	Angers, S; Li, T; Yi, XH; MacCoss, MJ; Moon, RT; Zheng, N				Angers, Stephane; Li, Ti; Yi, Xianhua; MacCoss, Michael J.; Moon, Randall T.; Zheng, Ning			Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery	NATURE			English	Article							PIGMENTOSUM GROUP-E; DNA-DAMAGE; SCHIZOSACCHAROMYCES-POMBE; V-PROTEIN; DEGRADATION; COMPLEX; UBIQUITYLATION; PROTEOLYSIS; MECHANISMS; CHECKPOINT	Protein ubiquitination is a common form of post-translational modification that regulates a broad spectrum of protein substrates in diverse cellular pathways(1). Through a three-enzyme (E1 - E2 - E3) cascade, the attachment of ubiquitin to proteins is catalysed by the E3 ubiquitin ligase, which is best represented by the superfamily of the cullin-RING complexes(2,3). Conserved from yeast to human, the DDB1 - CUL4 - ROC1 complex is a recently identified cullin-RING ubiquitin ligase, which regulates DNA repair(4-10), DNA replication(11-14) and transcription(15), and can also be subverted by pathogenic viruses to benefit viral infection(16). Lacking a canonical SKP1-like cullin adaptor and a defined substrate recruitment module, how the DDB1 - CUL4 - ROC1 E3 apparatus is assembled for ubiquitinating various substrates remains unclear. Here we present crystallographic analyses of the virally hijacked form of the human DDB1 - CUL4A - ROC1 machinery, which show that DDB1 uses one beta-propeller domain for cullin scaffold binding and a variably attached separate double-beta-propeller fold for substrate presentation. Through tandem-affinity purification of human DDB1 and CUL4A complexes followed by mass spectrometry analysis, we then identify a novel family of WD40-repeat proteins, which directly bind to the double-propeller fold of DDB1 and serve as the substrate-recruiting module of the E3. Together, our structural and proteomic results reveal the structural mechanisms and molecular logic underlying the assembly and versatility of a new family of cullin-RING E3 complexes.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	rtmoon@u.washington.edu; nzheng@u.washington.edu	Moon, Randall/M-5605-2019; Angers, Stephane/E-1432-2014; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Angers, Stephane/0000-0001-7241-9044; Moon, Randall T/0000-0002-9352-1408				Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leupin O, 2003, J VIROL, V77, P6274, DOI 10.1128/JVI.77.11.6274-6283.2003; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Shiyanov P, 1999, MOL CELL BIOL, V19, P4935; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	26	496	542	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					590	593		10.1038/nature05175	http://dx.doi.org/10.1038/nature05175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	16964240				2022-12-01	WOS:000240988200047
J	Kunze, E; Dower, JF; Beveridge, I; Dewey, R; Bartlett, KP				Kunze, Eric; Dower, John F.; Beveridge, Ian; Dewey, Richard; Bartlett, Kevin P.			Observations of biologically generated turbulence in a coastal inlet	SCIENCE			English	Article							VISUAL PREDATION RISK; EUPHAUSIA-PACIFICA; VERTICAL MIGRATION; ZOOPLANKTON; KRILL; WAKE	Measurements in a coastal inlet revealed turbulence that was three to four orders of magnitude larger during the dusk ascent of a dense acoustic-scattering layer of krill than during the day, elevating daily-averaged mixing in the inlet by a factor of 100. Because vertically migrating layers of swimming organisms are found in much of the ocean, biologically generated turbulence may affect (i) the transport of inorganic nutrients to the often nutrient-depleted surface layer from underlying nutrient-rich stratified waters to affect biological productivity and (ii) the exchange of atmospheric gases such as CO2 with the stratified ocean interior, which has no direct communication with the atmosphere.	Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	University of Victoria; University of Victoria	Kunze, E (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 3055,STN CSC, Victoria, BC V8W 3P6, Canada.	kunze@uvic.ca; dower@uvic.ca						Brierley AS, 2006, LIMNOL OCEANOGR-METH, V4, P18, DOI 10.4319/lom.2006.4.18; Cheng JY, 2001, COMP BIOCHEM PHYS A, V131, P51, DOI 10.1016/S1095-6433(01)00464-0; De Robertis A, 2003, ICES J MAR SCI, V60, P885, DOI 10.1016/S1054-3139(03)00070-5; De Robertis A, 2002, LIMNOL OCEANOGR, V47, P925, DOI 10.4319/lo.2002.47.4.0925; De Robertis A, 2000, LIMNOL OCEANOGR, V45, P1838, DOI 10.4319/lo.2000.45.8.1838; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; DEWEY RK, 1988, J PHYS OCEANOGR, V18, P1167, DOI 10.1175/1520-0485(1988)018<1167:BSEFVD>2.0.CO;2; Gargett AE, 2003, ESTUAR COAST SHELF S, V56, P1141, DOI 10.1016/S0272-7714(02)00319-0; Gargett AE, 1999, J ATMOS OCEAN TECH, V16, P1973, DOI 10.1175/1520-0426(1999)016<1973:VMOTKE>2.0.CO;2; GREENLAW CF, 1979, LIMNOL OCEANOGR, V24, P226, DOI 10.4319/lo.1979.24.2.0226; GREGG MC, 1987, J GEOPHYS RES-OCEANS, V92, P5249, DOI 10.1029/JC092iC05p05249; Hamme RC, 2006, J MAR RES, V64, P73, DOI 10.1357/002224006776412322; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Jaffe JS, 1999, CAN J FISH AQUAT SCI, V56, P2000, DOI 10.1139/cjfas-56-11-2000; Jenkins WJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002085; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; MACKIE GO, 1983, CAN J FISH AQUAT SCI, V40, P763, DOI 10.1139/f83-099; Mangel M, 2000, CAN J FISH AQUAT SCI, V57, P1, DOI 10.1139/cjfas-57-S3-1; Muller UK, 1997, J EXP BIOL, V200, P2893; Munk W.H., 1966, DEEP SEA RES, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Videler JJ, 2002, INTEGR COMP BIOL, V42, P988, DOI 10.1093/icb/42.5.988; Vogel S., 1981, LIFE MOVING FLUIDS P, V2nd; Yamamura O, 1998, MAR BIOL, V132, P195, DOI 10.1007/s002270050386; Yen J, 2003, MAR FRESHW BEHAV PHY, V36, P307, DOI 10.1080/10236240310001614439	24	96	96	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1768	1770		10.1126/science.1129378	http://dx.doi.org/10.1126/science.1129378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990545				2022-12-01	WOS:000240655700043
J	Kiel, S; Little, CTS				Kiel, Steffen; Little, Crispin T. S.			Cold-seep mollusks are older than the general marine mollusk fauna	SCIENCE			English	Article							HYDROTHERMAL VENT; SEA; EVOLUTION; PATTERNS; ECOLOGY; ORIGINS	The origin and possible antiquity of faunas at deep- sea hydrothermal vents and seeps have been debated since their discovery. We used the fossil record of seep mollusks to show that the living seep genera have significantly longer geologic ranges than the marine mollusks in general, but have ranges similar to those of deep- sea taxa, suggesting that seep faunas may be shaped by the factors that drive the evolution of life in the deep sea in general. Our data indicate that deep- sea anoxic/dysoxic events did not affect seep faunas, casting doubt on the suggested anoxic nature and/or global extent of these events.	Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; Smithsonian Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	University of Leeds; Smithsonian Institution; Smithsonian National Museum of Natural History	Kiel, S (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	steffen.kiel@gmx.de	Kiel, Steffen/C-3150-2009	Kiel, Steffen/0000-0001-6281-100X; Little, Crispin/0000-0002-1917-4460				Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Foote M, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P245; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Geiger Daniel L., 2005, Molluscan Research, V25, P47; Halanych KM, 1998, CAH BIOL MAR, V39, P355; HICKMAN CS, 1984, ZOOL SCR, V13, P19, DOI 10.1111/j.1463-6409.1984.tb00018.x; JABLONSKI D, 1983, SCIENCE, V222, P1123, DOI 10.1126/science.222.4628.1123; JABLONSKI D, 1991, SCIENCE, V252, P1831, DOI 10.1126/science.252.5014.1831; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; Newman W. A., 1985, B BIOL SOC WASH, V6, P231; Nunes F, 2006, NATURE, V439, P60, DOI 10.1038/nature04386; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Powell EN, 1998, PALAEOGEOGR PALAEOCL, V144, P85, DOI 10.1016/S0031-0182(98)00087-X; Sepkoski, 2002, B AM PALEONTOL, V363, P1; Smith AB, 2005, P ROY SOC B-BIOL SCI, V272, P865, DOI 10.1098/rspb.2004.2996; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SQUIRES RL, 1991, NATURE, V349, P574, DOI 10.1038/349574a0; TUNNICLIFFE V, 1992, Palaios, V7, P338, DOI 10.2307/3514820; UHEN MD, 2001, ENCY MARINE MAMMALS, P78; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361	27	102	108	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1429	1431		10.1126/science.1126286	http://dx.doi.org/10.1126/science.1126286			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960004				2022-12-01	WOS:000240348700040
J	Tyler, BM; Tripathy, S; Zhang, XM; Dehal, P; Jiang, RHY; Aerts, A; Arredondo, FD; Baxter, L; Bensasson, D; Beynon, JL; Chapman, J; Damasceno, CMB; Dorrance, AE; Dou, DL; Dickerman, AW; Dubchak, IL; Garbelotto, M; Gijzen, M; Gordon, SG; Govers, F; Grunwald, NJ; Huang, W; Ivors, KL; Jones, RW; Kamoun, S; Krampis, K; Lamour, KH; Lee, MK; McDonald, WH; Medina, M; Meijer, HJG; Nordberg, EK; Maclean, DJ; Ospina-Giraldo, MD; Morris, PF; Phuntumart, V; Putnam, NH; Rash, S; Rose, JKC; Sakihama, Y; Salamov, AA; Savidor, A; Scheuring, CF; Smith, BM; Sobral, BWS; Terry, A; Torto-Alalibo, TA; Win, J; Xu, ZY; Zhang, HB; Grigoriev, IV; Rokhsar, DS; Boore, JL				Tyler, Brett M.; Tripathy, Sucheta; Zhang, Xuemin; Dehal, Paramvir; Jiang, Rays H. Y.; Aerts, Andrea; Arredondo, Felipe D.; Baxter, Laura; Bensasson, Douda; Beynon, Jim L.; Chapman, Jarrod; Damasceno, Cynthia M. B.; Dorrance, Anne E.; Dou, Daolong; Dickerman, Allan W.; Dubchak, Inna L.; Garbelotto, Matteo; Gijzen, Mark; Gordon, Stuart G.; Govers, Francine; Grunwald, Niklaus J.; Huang, Wayne; Ivors, Kelly L.; Jones, Richard W.; Kamoun, Sophien; Krampis, Konstantinos; Lamour, Kurt H.; Lee, Mi-Kyung; McDonald, W. Hayes; Medina, Monica; Meijer, Harold J. G.; Nordberg, Eric K.; Maclean, Donald J.; Ospina-Giraldo, Manuel D.; Morris, Paul F.; Phuntumart, Vipaporn; Putnam, Nicholas H.; Rash, Sam; Rose, Jocelyn K. C.; Sakihama, Yasuko; Salamov, Asaf A.; Savidor, Alon; Scheuring, Chantel F.; Smith, Brian M.; Sobral, Bruno W. S.; Terry, Astrid; Torto-Alalibo, Trudy A.; Win, Joe; Xu, Zhanyou; Zhang, Hongbin; Grigoriev, Igor V.; Rokhsar, Daniel S.; Boore, Jeffrey L.			Phytophthora genome sequences uncover evolutionary origins and mechanisms of pathogenesis	SCIENCE			English	Article							EFFECTOR PROTEINS; AVIRULENCE; RESISTANCE; GENES; LOCUS; SOJAE; ARABIDOPSIS; EXPRESSION; VIRULENCE; SECRETOME	Draft genome sequences have been determined for the soybean pathogen Phytophthora sojae and the sudden oak death pathogen Phytophthora ramorum. Oomycetes such as these Phytophthora species share the kingdom Stramenopila with photosynthetic algae such as diatoms, and the presence of many Phytophthora genes of probable phototroph origin supports a photosynthetic ancestry for the stramenopiles. Comparison of the two species' genomes reveals a rapid expansion and diversification of many protein families associated with plant infection such as hydrolases, ABC transporters, protein toxins, proteinase inhibitors, and, in particular, a superfamily of 700 proteins with similarity to known oomycete avirulence genes.	Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; Dept Energy, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Wageningen & Res Ctr, Phytopathol Lab, NL-6709 PD Wageningen, Netherlands; Hort Res Int, Warwick CV35 9EF, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SL5 7PY, England; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA; Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Agr & Agri Food Canada, London, ON N5V 4T3, Canada; ARS, Hort Crops Res Lab, USDA, Corvallis, OR 97330 USA; Lawrence Livermore Natl Lab, Biosci Directorate, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Computat Directorate, Livermore, CA 94550 USA; N Carolina State Univ, Mt Hort Crops Res & Extens Ctr, Fletcher, NC 28732 USA; ARS, Vegetable Lab, Henry Wallace Beltsville Agr Res Ctr, USDA, Beltsville, MD 20705 USA; Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA; Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; Univ Calif, Sch Nat Sci, Merced, CA 95344 USA; Univ Queensland, Dept Biochem & Mol Biol, St Lucia, Qld 4072, Australia; Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA; Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43402 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Hokkaido Univ, Lab Ecol Chem, Sapporo, Hokkaido 0608589, Japan; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Genome Project Solut, Hercules, CA 94547 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Wageningen University & Research; Imperial College London; University of California System; University of California Berkeley; Cornell University; University System of Ohio; Ohio State University; University of California System; University of California Berkeley; Agriculture & Agri Food Canada; United States Department of Agriculture (USDA); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Texas A&M University System; Texas A&M University College Station; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Merced; University of Queensland; Wilkes University; University System of Ohio; Bowling Green State University; Cornell University; Hokkaido University; University of California System; University of California Berkeley	Tyler, BM (corresponding author), Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	bmtyler@vt.edu	Win, Joe/H-2557-2014; Govers, Francine/A-5616-2009; Terry, Astrid Y/A-2538-2011; Damasceno, Cynthia/C-3074-2008; Putnam, Nicholas/B-9968-2008; Meijer, Harold/S-3891-2019; Grunwald, Niklaus J/B-9535-2008; Kamoun, Sophien/B-3529-2009; Gijzen, Mark/C-6284-2011; McDonald, W. Hayes/B-4109-2016; Tripathy, Sucheta/N-3097-2019; Meijer, Harold/G-5703-2012; Grunwald, Niklaus` J/K-6041-2013; Baxter, laura/GWD-1304-2022; Meijer, HJG/AFN-5216-2022; Sakihama, Yasuko/B-1047-2012; Sobral, Bruno/GVU-7637-2022	Win, Joe/0000-0002-9851-2404; Govers, Francine/0000-0001-5311-929X; Terry, Astrid Y/0000-0002-5234-1224; Putnam, Nicholas/0000-0002-1315-782X; Meijer, Harold/0000-0002-0883-219X; Grunwald, Niklaus J/0000-0003-1656-7602; Kamoun, Sophien/0000-0002-0290-0315; Gijzen, Mark/0000-0002-3715-6389; McDonald, W. Hayes/0000-0002-3510-426X; Tripathy, Sucheta/0000-0003-0611-8088; Grunwald, Niklaus` J/0000-0003-1656-7602; Meijer, HJG/0000-0002-0883-219X; Sobral, Bruno/0000-0003-3908-577X; Bensasson, Douda/0000-0002-9015-2707; Grigoriev, Igor/0000-0002-3136-8903; Dou, Daolong/0000-0001-5226-6642; Morris, Paul/0000-0002-2989-041X; Rokhsar, Daniel/0000-0002-8704-2224	Biotechnology and Biological Sciences Research Council [BB/C509123/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; CATERINA MJ, 1991, FASEB J, V5, P3078, DOI 10.1096/fasebj.5.15.1743439; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Dvornyk V, 2006, MICROBIOL-SGM, V152, P75, DOI 10.1099/mic.0.28400-0; ERWIN DC, 1996, PHYTOPHTHORAC DIS WO; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Gao HY, 2005, MOL PLANT MICROBE IN, V18, P1035, DOI 10.1094/MPMI-18-1035; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kelly SL, 2001, BIOCHEM SOC T, V29, P122, DOI 10.1042/0300-5127:0290122; Li SL, 2006, MOL BIOL EVOL, V23, P663, DOI 10.1093/molbev/msj075; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MORRIS PF, 1992, PHYSIOL MOL PLANT P, V40, P17, DOI 10.1016/0885-5765(92)90067-6; Orsomando G, 2001, J BIOL CHEM, V276, P21578, DOI 10.1074/jbc.M101377200; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Swofford DL, 2002, PAUP VERSION 4 0 B10, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2001, TRENDS GENET, V17, P611, DOI 10.1016/S0168-9525(01)02517-3; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899	30	791	864	4	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1261	1266		10.1126/science.1128796	http://dx.doi.org/10.1126/science.1128796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946064	Green Submitted			2022-12-01	WOS:000240313500033
J	Park, KS; Mohapatra, DP; Misonou, H; Trimmer, JS				Park, Kang-Sik; Mohapatra, Durga P.; Misonou, Hiroaki; Trimmer, James S.			Graded regulation of the Kv2.1 potassium channel by variable phosphorylation	SCIENCE			English	Article							K+ CHANNEL; PROTEIN-PHOSPHORYLATION; NEURONAL EXCITABILITY; LOCALIZATION; MODULATION; PROTEOMICS; MECHANISM	Dynamic modulation of ion channels by phosphorylation underlies neuronal plasticity. The Kv2.1 potassium channel is highly phosphorylated in resting mammalian neurons. Activity-dependent Kv2.1 dephosphorylation by calcineurin induces graded hyperpolarizing shifts in voltage-dependent activation, causing suppression of neuronal excitability. Mass spectrometry-SILAC ( stable isotope labeling with amino acids in cell culture) identified 16 Kv2.1 phosphorylation sites, of which 7 were dephosphorylated by calcineurin. Mutation of individual calcineurin-regulated sites to alanine produced incremental shifts mimicking dephosphorylation, whereas mutation to aspartate yielded equivalent resistance to calcineurin. Mutations at multiple sites were additive, showing that variable phosphorylation of Kv2.1 at a large number of sites allows graded activity-dependent regulation of channel gating and neuronal firing properties.	Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Sch Med GBSF 3502, Dept Pharmacol, 451 E Hlth Sci Dr, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu	Durga, Mohapatra/B-3620-2008; Park, Kang-Sik/AAK-2486-2020; Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Misono, Hiroaki/0000-0001-5892-1804	NINDS NIH HHS [NS42225, R01 NS042225-06, R01 NS042225] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Malin SA, 2002, J NEUROSCI, V22, P10094; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Surmeier DJ, 2004, NAT NEUROSCI, V7, P691, DOI 10.1038/nn0704-691; WALAAS SI, 1991, PHARMACOL REV, V43, P299	17	224	228	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2006	313	5789					976	979		10.1126/science.1124254	http://dx.doi.org/10.1126/science.1124254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917065				2022-12-01	WOS:000239817000046
J	Check, E				Check, Erika			Silent running: the race to the clinic	NATURE			English	News Item							RNAI											Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	3	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					614	615		10.1038/442614a	http://dx.doi.org/10.1038/442614a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16900171				2022-12-01	WOS:000239630200014
J	Jewkes, R				Jewkes, Rachel			Beyond stigma: social responses to HIV in South Africa	LANCET			English	Editorial Material									MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267				Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; CAMERON E, 2000, 13 INT AIDS C DURB S; Campbell C, 2005, AM J PUBLIC HEALTH, V95, P808, DOI 10.2105/AJPH.2003.037499; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; *S AFR DEP HLTH, 2005, NAT HIV SYPH ANT SER; Shisana O., 2005, S AFRICAN NATL HIV P; WOOD K, 2003, THESIS LONDON SCH HY	7	27	29	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2006	368	9534					430	431		10.1016/S0140-6736(06)69130-7	http://dx.doi.org/10.1016/S0140-6736(06)69130-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890812				2022-12-01	WOS:000239569000007
J	Willem, M; Garratt, AN; Novak, B; Citron, M; Kaufmann, S; Rittger, A; DeStrooper, B; Saftig, P; Birchmeier, C; Haass, C				Willem, Michael; Garratt, Alistair N.; Novak, Bozidar; Citron, Martin; Kaufmann, Steve; Rittger, Andrea; DeStrooper, Bart; Saftig, Paul; Birchmeier, Carmen; Haass, Christian			Control of peripheral nerve myelination by the beta-secretase BACE1	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; NEUREGULIN ISOFORMS; ASPARTYL PROTEASE; CLEAVING ENZYME; SCHWANN-CELL; CLEAVAGE; SITE; GENERATION	Although BACE1 (beta-site amyloid precursor protein - cleaving enzyme 1) is essential for the generation of amyloid-beta peptide in Alzheimer's disease, its physiological function is unclear. We found that very high levels of BACE1 were expressed at time points when peripheral nerves become myelinated. Deficiency of BACE1 resulted in the accumulation of unprocessed neuregulin 1 (NRG1), an axonally expressed factor required for glial cell development and myelination. BACE1(-/-) mice displayed hypomyelination of peripheral nerves and aberrant axonal segregation of small-diameter afferent fibers, very similar to that seen in mice with mutations in type III NRG1 or Schwann cell specific ErbB2 knockouts. Thus, BACE1 is required for myelination and correct bundling of axons by Schwann cells, probably through processing of type III NRG1.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Univ Munich, Adolf Butenandt Inst, Lab Alzheimers & Parkinsons Dis Res, Dept Biochem, D-80336 Munich, Germany; Amgen Inc, Dept Neurosci, Thousand Oaks, CA 93120 USA; Amgen Inc, Dept Pathol, Thousand Oaks, CA 93120 USA; Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; VIB, Dept Human Genet, B-3000 Louvain, Belgium	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich; Amgen; Amgen; University of Kiel; KU Leuven; Flanders Institute for Biotechnology (VIB)	Garratt, AN (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	agarratt@mdc-berlin.de; chaass@med.uni-muenchen.de	Saftig, Paul/A-7966-2010; de+Strooper, Bart/Z-1638-2019; Messier, Claude/A-2322-2008; De Strooper, Bart/F-6507-2012; Garratt, Alistair N/D-9893-2013; Garratt, Alistair/AAG-2715-2021	Messier, Claude/0000-0002-4791-1763; De Strooper, Bart/0000-0001-5455-5819; Garratt, Alistair N/0000-0001-9631-3041; 				Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; CITRON M, 2004, 4413 SOC NEUR; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.3.CO;2-X; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; LEMKE G, 2006, SCI STKE, pPE11; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Montero JC, 2002, BIOCHEM J, V363, P211, DOI 10.1042/0264-6021:3630211; Oberto M, 2001, EUR J NEUROSCI, V14, P513, DOI 10.1046/j.0953-816x.2001.01667.x; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shi XP, 2003, J BIOL CHEM, V278, P21286, DOI 10.1074/jbc.M209859200; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vandermeeren M, 2001, NEUROSCI LETT, V315, P145, DOI 10.1016/S0304-3940(01)02369-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	43	561	580	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					664	666		10.1126/science.1132341	http://dx.doi.org/10.1126/science.1132341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	16990514				2022-12-01	WOS:000241557800053
J	Neumann, M; Sampathu, DM; Kwong, LK; Truax, AC; Micsenyi, MC; Chou, TT; Bruce, J; Schuck, T; Grossman, M; Clark, CM; McCluskey, LF; Miller, BL; Masliah, E; Mackenzie, IR; Feldman, H; Feiden, W; Kretzschmar, HA; Trojanowski, JQ; Lee, VMY				Neumann, Manuela; Sampathu, Deepak M.; Kwong, Linda K.; Truax, Adam C.; Micsenyi, Matthew C.; Chou, Thomas T.; Bruce, Jennifer; Schuck, Theresa; Grossman, Murray; Clark, Christopher M.; McCluskey, Leo F.; Miller, Bruce L.; Masliah, Eliezer; Mackenzie, Ian R.; Feldman, Howard; Feiden, Wolfgang; Kretzschmar, Hans A.; Trojanowski, John Q.; Lee, Virginia M. -Y.			Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis	SCIENCE			English	Article							NUCLEAR FACTOR TDP-43; MOTOR-NEURON DISEASE; DEMENTIA; TAU; CHROMOSOME-17; MUTATIONS; GENE; EXON-9; FAMILY; 17Q21	Ubiquitin-positive, tau- and alpha-synuclein - negative inclusions are hallmarks of frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. Although the identity of the ubiquitinated protein specific to either disorder was unknown, we showed that TDP-43 is the major disease protein in both disorders. Pathologic TDP-43 was hyperphosphorylated, ubiquitinated, and cleaved to generate C-terminal fragments and was recovered only from affected central nervous system regions, including hippocampus, neocortex, and spinal cord. TDP-43 represents the common pathologic substrate linking these neurodegenerative disorders.	Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Alzheimers Dis Core Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; Univ San Francisco, Dept Neurol, San Francisco, CA 94117 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Div Neurol, Vancouver, BC V6T 2B5, Canada; Univ Saarland, Inst Neuropathol, D-66421 Homburg, Germany; Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of San Francisco; University of California System; University of California San Diego; University of British Columbia; University of British Columbia; Saarland University; University of Munich	Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Neumann, Manuela/F-6558-2011	Neumann, Manuela/0000-0002-6232-4057; Feldman, Howard/0000-0002-9258-4538	NATIONAL INSTITUTE ON AGING [P01AG017586, P01AG019724, T32AG000255, P30AG010124] Funding Source: NIH RePORTER; NIA NIH HHS [AG17586, T32 AG00255, P01 AG019724, AG10124] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Grossman M, 2002, J INT NEUROPSYCH SOC, V8, P566, DOI 10.1017/S1355617702814357; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20203; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson JK, 2005, ARCH NEUROL-CHICAGO, V62, P925, DOI 10.1001/archneur.62.6.925; Lendon CL, 1998, NEUROLOGY, V50, P1546, DOI 10.1212/WNL.50.6.1546; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mackenzie IR, 2006, BRAIN, V129, P853, DOI 10.1093/brain/awh724; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; SAMPATHU DM, IN PRESS AM J PATHOL; Shi J, 2005, ACTA NEUROPATHOL, V110, P501, DOI 10.1007/s00401-005-1079-4; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099	27	4219	4343	11	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					130	133		10.1126/science.1134108	http://dx.doi.org/10.1126/science.1134108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023659				2022-12-01	WOS:000241031200052
J	Tsao, D				Tsao, Doris			A dedicated system for processing faces	SCIENCE			English	Editorial Material							NEURONS; MACAQUE; CORTEX; PERCEPTION; AREA		Univ Bremen, Inst Brain Res, D-28359 Bremen, Germany; Univ Bremen, Ctr Adv Imaging, D-28359 Bremen, Germany	University of Bremen; University of Bremen	Tsao, D (corresponding author), Univ Bremen, Inst Brain Res, D-28359 Bremen, Germany.	doris@nmr.mgh.harvard.edu						BAYLIS GC, 1987, J NEUROSCI, V7, P330; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Kanwisher N, 1997, J NEUROSCI, V17, P4302; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111	9	9	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					72	73		10.1126/science.1135163	http://dx.doi.org/10.1126/science.1135163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023644				2022-12-01	WOS:000241031200035
J	Storchova, Z; Breneman, A; Cande, J; Dunn, J; Burbank, K; O'Toole, E; Pellman, D				Storchova, Zuzana; Breneman, Amanda; Cande, Jessica; Dunn, Joshua; Burbank, Kendra; O'Toole, Eileen; Pellman, David			Genome-wide genetic analysis of polyploidy in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BI-ORIENTATION; SISTER CHROMATIDS; MITOTIC SPINDLE; BUDDING YEAST; RECOMBINATION; PROTEIN; EVOLUTION; TENSION; KINASE	Polyploidy, increased sets of chromosomes, occurs during development, cellular stress, disease and evolution. Despite its prevalence, little is known about the physiological alterations that accompany polyploidy. We previously described 'ploidy-specific lethality', where a gene deletion that is not lethal in haploid or diploid budding yeast causes lethality in triploids or tetraploids. Here we report a genome-wide screen to identify ploidy-specific lethal functions. Only 39 out of 3,740 mutations screened exhibited ploidy-specific lethality. Almost all of these mutations affect genomic stability by impairing homologous recombination, sister chromatid cohesion, or mitotic spindle function. We uncovered defects in wild-type tetraploids predicted by the screen, and identified mechanisms by which tetraploidization affects genomic stability. We show that tetraploids have a high incidence of syntelic/monopolar kinetochore attachments to the spindle pole. We suggest that this defect can be explained by mismatches in the ability to scale the size of the spindle pole body, spindle and kinetochores. Thus, geometric constraints may have profound effects on genome stability; the phenomenon described here may be relevant in a variety of biological contexts, including disease states such as cancer.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Dept Phys, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Hematol Oncol, Childrens Hosp, Boston, MA 02115 USA; Univ Colorado, Boulder Lab 3D Elect Microscopy Cells, Boulder, CO 80309 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Boulder	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu		Dunn, Joshua/0000-0003-4476-7257; Storchova, Zuzana/0000-0003-2376-7047				AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Akhmanova A, 2005, GENE DEV, V19, P2501, DOI 10.1101/gad.344505; Andalis AA, 2004, GENETICS, V167, P1109, DOI 10.1534/genetics.104.029256; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; BYERS B, 1973, COLD SPRING HARB SYM, V38, P123, DOI 10.1101/SQB.1974.038.01.016; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Dong Z, 2003, NUCLEIC ACIDS RES, V31, P2576, DOI 10.1093/nar/gkg352; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Flygare J, 2001, EXP CELL RES, V268, P61, DOI 10.1006/excr.2001.5265; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; KADYK LC, 1992, GENETICS, V132, P387; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Klein HL, 1997, GENETICS, V147, P1533; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mable BK, 2001, GENET RES, V77, P9, DOI 10.1017/S0016672300004821; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; MAYER VW, 1992, MUTAT RES, V279, P41, DOI 10.1016/0165-1218(92)90264-Z; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; Melo JA, 2001, GENE DEV, V15, P2809; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORTIMER RK, 1958, RADIAT RES, V9, P312, DOI 10.2307/3570795; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Raderschall E, 2002, CANCER RES, V62, P219; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WHELAN WL, 1979, GENETICS, V91, P35; Yoder TJ, 2003, MOL BIOL CELL, V14, P3494, DOI 10.1091/mbc.E02-10-0655	47	258	266	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					541	547		10.1038/nature05178	http://dx.doi.org/10.1038/nature05178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024086				2022-12-01	WOS:000240988200036
J	Hoekstra, EJ; McFarland, JW; Shaw, C; Salama, P				Hoekstra, Edward J.; McFarland, Jeffrey W.; Shaw, Catherine; Salama, Peter			Reducing measles mortality, reducing child mortality	LANCET			English	Editorial Material									UNICEF, Hlth Programme Div, Child Survival & Immunizat Unit, New York, NY 10017 USA	UNICEF	Hoekstra, EJ (corresponding author), UNICEF, Hlth Programme Div, Child Survival & Immunizat Unit, New York, NY 10017 USA.	ehoekstra@unicef.org						[Anonymous], 2006, Wkly Epidemiol Rec, V81, P90; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P994; de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; DEQUADROS CA, 1996, JAMA-J AM MED ASSOC, V275, P1311; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; Roll Back Malaria/WHO, 2000, AB DEC 192 TION PLAN; *WHO UNICEF, 2006, WHOIVB0511 UNICEF; *WHO UNICEF, 2001, GLOB MEASL MORT RED; WHO UNICEF, 2005, WORLD MAL REP 2005	9	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1050	1052		10.1016/S0140-6736(06)69335-5	http://dx.doi.org/10.1016/S0140-6736(06)69335-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997650				2022-12-01	WOS:000240873000008
J	Ballon, DR; Flanary, PL; Gladue, DP; Konopka, JB; Dohlman, HG; Thorner, J				Ballon, Daniel R.; Flanary, Paul L.; Gladue, Douglas P.; Konopka, James B.; Dohlman, Henrik G.; Thorner, Jeremy			DEP-domain-mediated regulation of GPCR signaling responses	CELL			English	Article							PROTEIN ALPHA-SUBUNIT; GTPASE-ACTIVATING PROTEIN; YEAST SACCHAROMYCES-CEREVISIAE; HETEROTRIMERIC G-PROTEINS; SINGLE-POINT MUTATION; PLASMA-MEMBRANE; FACTOR RECEPTOR; PHEROMONE RECEPTOR; COUPLED RECEPTOR; BINDING DOMAINS	G protein-coupled receptors (GPCRs) mediate cellular responses to a variety of stimuli, but how specific responses are regulated has been elusive, as the types of GPCRs vastly outnumber the classes of G protein heterotrimers available to initiate downstream signaling. In our analysis of signaling proteins containing DEP domains (similar to 90 residue sequence motifs first recognized in fly Dishevelled, worm EGL-10, and mammalian Pleckstrin), we find that DEP domains are responsible for specific recognition of GPCRs. We examined the yeast regulator of G protein signaling (RGS) protein Sst2 and demonstrate that the DEP domains in Sst2 mediate binding to its cognate GPCR (Ste2). DEP-domain-mediated tethering promotes downregulation by placing the RGS protein in proximity to its substrate (receptor-activated G alpha subunit). Sst2 docks to the Ste2 cytosolic tail, but only its unphosphorylated state, allowing for release and recycling of this regulator upon receptor desensitization and internalization. DEP-domain-mediated targeting of effectors and regulators to specific GPCRs provides a means to dictate the nature, duration, and specificity of the response.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA.	jthorner@berkeley.edu	Gladue, Douglas/P-6280-2018; THORNER, Jeremy/O-6132-2019	Gladue, Douglas/0000-0002-7894-0233; THORNER, Jeremy/0000-0002-2583-500X; Konopka, James/0000-0001-5989-4086; Dohlman, Henrik/0000-0003-2443-0729	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055107, P01GM065533, T32GM007232, R01GM021841, R37GM021841] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM65533, GM07232, P01 GM065533, GM55107, GM21841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Chen QJ, 1996, MOL CELL BIOL, V16, P247; Civera C, 2005, PROTEINS, V58, P354, DOI 10.1002/prot.20320; David NE, 1997, J BIOL CHEM, V272, P15553, DOI 10.1074/jbc.272.24.15553; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Horecka J, 2000, METHOD ENZYMOL, V326, P107; Huang HC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-234; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kharrat A, 1998, BBA-PROTEIN STRUCT M, V1385, P157, DOI 10.1016/S0167-4838(98)00041-7; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; KONOPKA JB, 2004, ENCY BIOL CHEM, P256; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Penton A, 2002, GENETICS, V161, P747; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wu YL, 2004, J BIOL CHEM, V279, P35287, DOI 10.1074/jbc.M404896200	48	139	142	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1079	1093		10.1016/j.cell.2006.07.030	http://dx.doi.org/10.1016/j.cell.2006.07.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990133	Green Submitted, Bronze			2022-12-01	WOS:000240897600015
J	Zhang, XY; Yazaki, J; Sundaresan, A; Cokus, S; Chan, SWL; Chen, HM; Henderson, IR; Shinn, P; Pellegrini, M; Jacobsen, SE; Ecker, JR				Zhang, Xiaoyu; Yazaki, Junshi; Sundaresan, Ambika; Cokus, Shawn; Chan, Simon W. -L.; Chen, Huaming; Henderson, Ian R.; Shinn, Paul; Pellegrini, Matteo; Jacobsen, Steve E.; Ecker, Joseph R.			Genome-wide high-resolution mapping and functional analysis of DNA methylation in Arabidopsis	CELL			English	Article							HISTONE H3 METHYLTRANSFERASE; TRANS-ACTING SIRNAS; TRANSPOSABLE ELEMENTS; PROMOTER METHYLATION; NEUROSPORA-CRASSA; GENE-EXPRESSION; CPG METHYLATION; MESSENGER-RNAS; THALIANA; PATTERNS	Cytosine methylation is important for transposon silencing and epigenetic regulation of endogenous genes, although the extent to which this DNA modification functions to regulate the genome is still unknown. Here we report the first comprehensive DNA methylation map of an entire genome, at 35 base pair resolution, using the flowering plant Arabidopsis thaliana as a model. We find that pericentromeric heterochromatin, repetitive sequences, and regions producing small interfering RNAs are heavily methylated. Unexpectedly, over one-third of expressed genes contain methylation within transcribed regions, whereas only similar to 5% of genes show methylation within promoter regions. Interestingly, genes methylated in transcribed regions are highly expressed and constitutively active, whereas promoter-methylated genes show a greater degree of tissue-specific expression. Whole-genome tiling-array transcriptional profiling of DNA methyltransferase null mutants identified hundreds of genes and intergenic noncoding RNAs with altered expression levels, many of which may be epigenetically controlled by DNA methylation.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Salk Institute; Salk Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Yazaki, Junshi/B-1557-2012; Jacobsen, Sten Eirik W/D-3974-2018; jia, xu/A-8386-2016; Henderson, Ian/A-2174-2012; Zhang, xiaoyu/GXA-3206-2022	Ecker, Joseph R/0000-0001-5799-5895; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Pellegrini, Matteo/0000-0001-9355-9564; Henderson, Ian/0000-0001-5066-1489; Yazaki, Junshi/0000-0002-0697-8320; Chen, Huaming/0000-0001-5289-7882	NHGRI NIH HHS [HG003523] Funding Source: Medline; NIGMS NIH HHS [T32 GM08666, GM60398] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Faghihi MA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r38; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hollander M, 1999, NONPARAMETRIC STAT M; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; NGERNPRASIRTSIRI J, 1988, P NATL ACAD SCI USA, V85, P4750, DOI 10.1073/pnas.85.13.4750; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	46	1252	1354	3	219	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1189	1201		10.1016/j.cell.2006.08.003	http://dx.doi.org/10.1016/j.cell.2006.08.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16949657	Bronze			2022-12-01	WOS:000240897600023
J	Squyres, SW; Knoll, AH; Arvidson, RE; Clark, BC; Grotzinger, JP; Jolliff, BL; McLennan, SM; Tosca, N; Bell, JF; Calvin, WM; Farrand, WH; Glotch, TD; Golombek, MP; Herkenhoff, KE; Johnson, JR; Klingelhofer, G; McSween, HY; Yen, AS				Squyres, S. W.; Knoll, A. H.; Arvidson, R. E.; Clark, B. C.; Grotzinger, J. P.; Jolliff, B. L.; McLennan, S. M.; Tosca, N.; Bell, J. F., III; Calvin, W. M.; Farrand, W. H.; Glotch, T. D.; Golombek, M. P.; Herkenhoff, K. E.; Johnson, J. R.; Klingelhoefer, G.; McSween, H. Y.; Yen, A. S.			Two years at Meridiani Planum: Results from the Opportunity Rover	SCIENCE			English	Article							BURNS FORMATION; ENVIRONMENT; DIAGENESIS; ORIGIN	The Mars Exploration Rover Opportunity has spent more than 2 years exploring Meridiani Planum, traveling similar to 8 kilometers and detecting features that reveal ancient environmental conditions. These include well-developed festoon ( trough) cross-lamination formed in flowing liquid water, strata with smaller and more abundant hematite-rich concretions than those seen previously, possible relict "hopper crystals'' that might reflect the formation of halite, thick weathering rinds on rock surfaces, resistant fracture fills, and networks of polygonal fractures likely caused by dehydration of sulfate salts. Chemical variations with depth show that the siliciclastic fraction of outcrop rock has undergone substantial chemical alteration from a precursor basaltic composition. Observations from microscopic to orbital scales indicate that ancient Meridiani once had abundant acidic groundwater, arid and oxidizing surface conditions, and occasional liquid flow on the surface.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Nevada, Reno, NV 89557 USA; Space Sci Inst, Boulder, CO 80301 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55099 Mainz, Germany; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA	Cornell University; Harvard University; Washington University (WUSTL); Lockheed Martin; California Institute of Technology; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Nevada System of Higher Education (NSHE); University of Nevada Reno; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; University of Tennessee System; University of Tennessee Knoxville	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.		Johnson, Jeffrey R/F-3972-2015; Glotch, Timothy/B-6829-2008	Johnson, Jeffrey R/0000-0002-5586-4901; McLennan, Scott/0000-0003-4259-7178; Tosca, Nicholas/0000-0003-4415-4231				Ahlbrandt T.S., 1979, 1052 US GEOL SURV, P21; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; ARVIDSON RE, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2002JE0011982; BANFIELD JF, 2001, NANOPARTICLES ENV, V44; BELL JF, 2003, J GEOPHYS RES-PLANET, V108, DOI DOI 10.1029/2003JE002070; Branney M.J., 2002, MEMOIRS, DOI DOI 10.1144/GSL.MEM.2003.027; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; GORNITZ VM, 1981, J SEDIMENT PETROL, V51, P787; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; HUNTER RE, 1977, SEDIMENTOLOGY, V24, P361, DOI 10.1111/j.1365-3091.1977.tb00128.x; HYNEK BM, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2002E001891; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Knauth LP, 2005, NATURE, V438, P1123, DOI 10.1038/nature04383; Knoll AH, 2005, EARTH PLANET SC LETT, V240, P179, DOI 10.1016/j.epsl.2005.09.045; Lasaga AC, 1998, PR S GEOCH; McCollom TM, 2005, NATURE, V438, P1129, DOI 10.1038/nature04390; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Rubin D. M., 1987, CROSS BEDDING BEDFOR, DOI [10.2110/csp.87.01, DOI 10.2110/CSP.87.01]; RUBIN DM, 1987, J SEDIMENT PETROL, V57, P39; Schreiber BC, 2000, SEDIMENTOLOGY, V47, P215, DOI 10.1046/j.1365-3091.2000.00002.x; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; Shearman DJ., 1978, MARINE EVAPORITES, V4, P6; SOUTHARD JB, 1990, J SEDIMENT PETROL, V60, P658, DOI 10.1306/212F9241-2B24-11D7-8648000102C1865D; SOUTHARD JB, 1971, J SEDIMENT PETROL, V41, P903; SPARKS RSJ, 1976, SEDIMENTOLOGY, V23, P147, DOI 10.1111/j.1365-3091.1976.tb00045.x; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; WALKER GPL, 1971, J GEOL, V79, P696, DOI 10.1086/627699	34	150	150	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1403	1407		10.1126/science.1130890	http://dx.doi.org/10.1126/science.1130890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959999				2022-12-01	WOS:000240348700033
J	Varki, A				Varki, Ajit			Nothing in glycobiology makes sense, except in the light of evolution	CELL			English	Editorial Material							DIVERSITY; SIGLECS	The remarkable structural diversity of glycans in nature, and their roles in cellular processes, host-pathogen interactions, biological diversity and speciation can be explained by evolutionary processes.	Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu						Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Diekman AB, 2003, CELL MOL LIFE SCI, V60, P298, DOI 10.1007/s000180300025; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; Lapid K, 2006, GLYCOBIOLOGY, V16, p39R, DOI 10.1093/glycob/cwj059; Lederberg J, 1999, GENETICS, V153, P1; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sharon N, 1996, ADV EXP MED BIOL, V408, P1; Takeuchi Y, 1996, NATURE, V379, P85, DOI 10.1038/379085a0; VANVALEN L, 1974, NATURE, V252, P298; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008	23	179	189	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					841	845		10.1016/j.cell.2006.08.022	http://dx.doi.org/10.1016/j.cell.2006.08.022			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959563	Bronze			2022-12-01	WOS:000240675000011
J	Freedman, DJ; Assad, JA				Freedman, David J.; Assad, John A.			Experience-dependent representation of visual categories in parietal cortex	NATURE			English	Article							LATERAL INTRAPARIETAL AREA; PERCEPTUAL DECISION; PREFRONTAL CORTEX; SINGLE NEURONS; MONKEY; ATTENTION; STIMULI; SIGNALS; MOTION	Categorization is a process by which the brain assigns meaning to sensory stimuli. Through experience, we learn to group stimuli into categories, such as 'chair', 'table' and 'vehicle', which are critical for rapidly and appropriately selecting behavioural responses(1,2). Although much is known about the neural representation of simple visual stimulus features (for example, orientation, direction and colour), relatively little is known about how the brain learns and encodes the meaning of stimuli. We trained monkeys to classify 360 degrees of visual motion directions into two discrete categories, and compared neuronal activity in the lateral intraparietal (LIP) and middle temporal (MT) areas, two interconnected brain regions(3) known to be involved in visual motion processing(4-6). Here we show that neurons in LIP-an area known to be centrally involved in visuo-spatial attention(7-9), motor planning(10-13) and decision-making(14-16)-robustly reflect the category of motion direction as a result of learning. The activity of LIP neurons encoded directions of motion according to their category membership, and that encoding shifted after the monkeys were retrained to group the same stimuli into two new categories. In contrast, neurons in area MT were strongly direction selective but carried little, if any, explicit category information. This indicates that LIP might be an important nexus for the transformation of visual direction selectivity to more abstract representations that encode the behavioural relevance, or meaning, of stimuli.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Freedman, DJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	davidfreedman@alum.mit.edu						Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Barsalou L. W., 1992, COGNITIVE PSYCHOL OV; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FREEDMAN DJ, IN PRESS CEREB CORTE; Ghose GM, 2004, CURR OPIN NEUROBIOL, V14, P513, DOI 10.1016/j.conb.2004.07.003; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055	28	351	354	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					85	88		10.1038/nature05078	http://dx.doi.org/10.1038/nature05078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16936716				2022-12-01	WOS:000240313900044
J	Wang, XL; Chory, J				Wang, Xuelu; Chory, Joanne			Brassinosteroids regulate dissociation of BKI1, a negative regulator of BRI1 signaling, from the plasma membrane	SCIENCE			English	Article							RECEPTOR KINASE; GENE-EXPRESSION; ARABIDOPSIS; PROTEIN; GROWTH; BIOSYNTHESIS; HOMEOSTASIS; ACTIVATION; STEROIDS; BZR1	Brassinosteroids, the steroid hormones of plants, are perceived at the plasma membrane by a leucine-rich repeat receptor serine/threonine kinase called BRI1. We report a BRI1-interacting protein, BKI1, which is a negative regulator of brassinosteroid signaling. Brassinosteroids cause the rapid dissociation of BKI1 - yellow fluorescent protein from the plasma membrane in a process that is dependent on BRI1-kinase. BKI1 is a substrate of BRI1 kinase and limits the interaction of BRI1 with its proposed coreceptor, BAK1, suggesting that BKI1 prevents the activation of BRI1.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu						Altmann T, 1998, CURR OPIN PLANT BIOL, V1, P378, DOI 10.1016/S1369-5266(98)80259-8; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Guy GR, 2002, CELL SIGNAL, V14, P11, DOI 10.1016/S0898-6568(01)00227-3; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Hirabayashi S., 2004, PLANT BIOTECHNOL, V21, P35, DOI 10.5511/plantbiotechnology.21.35; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Nam KH, 2004, PLANT CELL, V16, P2406, DOI 10.1105/tpc.104.023903; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Sekimata K, 2002, TETRAHEDRON-ASYMMETR, V13, P1875, DOI 10.1016/S0957-4166(02)00475-5; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	27	338	375	14	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1118	1122		10.1126/science.1127593	http://dx.doi.org/10.1126/science.1127593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16857903				2022-12-01	WOS:000239998200046
J	Ito, Y; Nakanomyo, I; Motose, H; Iwamoto, K; Sawa, S; Dohmae, N; Fukuda, H				Ito, Yasuko; Nakanomyo, Ikuko; Motose, Hiroyasu; Iwamoto, Kuninori; Sawa, Shinichiro; Dohmae, Naoshi; Fukuda, Hiroo			Dodeca-CLE peptides as suppressors of plant stem cell differentiation	SCIENCE			English	Article							TRACHEARY ELEMENT DIFFERENTIATION; ROOT-MERISTEM; ARABIDOPSIS; CLAVATA3; SHOOT; CLV3; PATHWAY; FAMILY; DOMAIN; GENES	In plants and animals, small peptide ligands that signal in cell-cell communication have been suggested to be a crucial component of development. A bioassay of single-cell transdifferentation demonstrates that a dodecapeptide with two hydroxyproline residues is the functional product of genes from the CLE family, which includes CLAVATA3 in Arabidopsis. The dodecapeptide suppresses xylem cell development at a concentration of 10(-11) M and promotes cell division. An application, corresponding to all 26 Arabidopsis CLE protein family members, of synthetic dodecapeptides reveals two counteracting signaling pathways involved in stem cell fate.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Fukuda, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	fukuda@biol.s.u-tokyo.ac.jp	MOTOSE, Hiroyasu/B-1474-2011; Dohmae, Naoshi/C-2040-2011	Dohmae, Naoshi/0000-0002-5242-9410; Sawa, Shinichiro/0000-0002-9309-9104				Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Cock JM, 2001, PLANT PHYSIOL, V126, P939, DOI 10.1104/pp.126.3.939; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; Hobe M, 2003, DEV GENES EVOL, V213, P371, DOI 10.1007/s00427-003-0329-5; Kepinski S, 2006, CURR OPIN PLANT BIOL, V9, P28, DOI 10.1016/j.pbi.2005.11.001; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Lenhard M, 2003, DEVELOPMENT, V130, P3163, DOI 10.1242/dev.00525; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Ni J, 2006, PLANT PHYSIOL, V140, P726, DOI 10.1104/pp.105.072678; Olsen AN, 2003, TRENDS PLANT SCI, V8, P55, DOI 10.1016/S1360-1385(03)00003-7; Shimizu M, 2005, PLANT J, V42, P877, DOI 10.1111/j.1365-313X.2005.02419.x; Strabala TJ, 2006, PLANT PHYSIOL, V140, P1331, DOI 10.1104/pp.105.075515; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Williams L, 2005, CURR OPIN PLANT BIOL, V8, P582, DOI 10.1016/j.pbi.2005.09.010; Yamamoto R, 1997, PLANT CELL PHYSIOL, V38, P980, DOI 10.1093/oxfordjournals.pcp.a029262	22	460	512	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					842	845		10.1126/science.1128436	http://dx.doi.org/10.1126/science.1128436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902140				2022-12-01	WOS:000239671300062
J	Rosmarin, D; Tan, CS				Rosmarin, David; Tan, Chen S.			Inguinal hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY 10016 USA	New York University	Rosmarin, D (corresponding author), NYU, Sch Med, New York, NY 10016 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2006	355	6					601	601		10.1056/NEJMicm050827	http://dx.doi.org/10.1056/NEJMicm050827			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071QM	16899780				2022-12-01	WOS:000239616700010
J	Kaneko, Y; Nimmerjahn, F; Ravetch, EV				Kaneko, Yoshikatsu; Nimmerjahn, Falk; Ravetch, Jeffrey V.			Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation	SCIENCE			English	Article							RHEUMATOID-ARTHRITIS; IMMUNE-SYSTEM; SERUM IGG; RECEPTOR; GLYCOSYLATION; PROTECTION; GLOBULIN; BINDING	Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fc gamma receptors (Fc gamma Rs). One class of Fc-Fc gamma R interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, EV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Nimmerjahn, Falk/J-4986-2013	Ravetch, Jeffrey/0000-0003-2024-9041; Nimmerjahn, Falk/0000-0002-5418-316X				Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; DWYER JM, 1992, NEW ENGL J MED, V326, P107; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; HOLLAND M, 2005, BIOCHIM BIOPHYS ACTA, V1760, P669; IMBACH P, 1981, LANCET, V1, P1228; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Lastra GC, 1998, AUTOIMMUNITY, V28, P25, DOI 10.3109/08916939808993842; Matsumoto A, 2000, J BIOCHEM-TOKYO, V128, P621, DOI 10.1093/oxfordjournals.jbchem.a022794; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; Routier FH, 1998, J IMMUNOL METHODS, V213, P113, DOI 10.1016/S0022-1759(98)00032-5; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shikata K, 1998, GLYCOCONJUGATE J, V15, P683, DOI 10.1023/A:1006936431276; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7	21	1287	1429	2	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2006	313	5787					670	673		10.1126/science.1129594	http://dx.doi.org/10.1126/science.1129594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16888140				2022-12-01	WOS:000239667500044
J	Austin, AT; Vivanco, L				Austin, Amy T.; Vivanco, Lucia			Plant litter decomposition in a semi-arid ecosystem controlled by photodegradation	NATURE			English	Article							ULTRAVIOLET-B RADIATION; RAINFALL GRADIENT; INORGANIC CARBON; ORGANIC-MATTER; DYNAMICS; DESERT; INCREASES; NITROGEN; STORAGE; IMPACT	The carbon balance in terrestrial ecosystems is determined by the difference between inputs from primary production and the return of carbon to the atmosphere through decomposition of organic matter(1). Our understanding of the factors that control carbon turnover in water-limited ecosystems is limited, however, as studies of litter decomposition have shown contradictory results and only a modest correlation with precipitation(2-5). Here we evaluate the influence of solar radiation, soil biotic activity and soil resource availability on litter decomposition in the semi-arid Patagonian steppe using the results of manipulative experiments carried out under ambient conditions of rainfall and temperature. We show that intercepted solar radiation was the only factor that had a significant effect on the decomposition of organic matter, with attenuation of ultraviolet-B and total radiation causing a 33 and 60 per cent reduction in decomposition, respectively. We conclude that photodegradation is a dominant control on above-ground litter decomposition in this semi-arid ecosystem. Losses through photochemical mineralization may represent a short-circuit in the carbon cycle, with a substantial fraction of carbon fixed in plant biomass being lost directly to the atmosphere without cycling through soil organic matter pools. Furthermore, future changes in radiation interception due to decreased cloudiness, increased stratospheric ozone depletion, or reduced vegetative cover may have a more significant effect on the carbon balance in these water-limited ecosystems than changes in temperature or precipitation.	Univ Buenos Aires, Inst Invest Fisiol & Ecol Vinculadas Agr, RA-1417 Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Agron, CONICET, RA-1417 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Austin, AT (corresponding author), Univ Buenos Aires, Inst Invest Fisiol & Ecol Vinculadas Agr, Av San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.	austin@ifeva.edu.ar	Austin, Amy/E-7988-2011; Vivanco, Lucia/AAQ-6127-2020	Austin, Amy/0000-0002-7468-5861; Vivanco, Lucia/0000-0001-7615-8865				ABER JD, 1982, CAN J BOT, V60, P2263, DOI 10.1139/b82-277; Anesio AM, 1999, ECOLOGY, V80, P1852, DOI 10.1890/0012-9658(1999)080[1852:POICFA]2.0.CO;2; Austin AT, 2002, ECOLOGY, V83, P328, DOI 10.1890/0012-9658(2002)083[0328:DEOPOP]2.0.CO;2; GEHRKE C, 1995, OIKOS, V72, P213, DOI 10.2307/3546223; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Johnson D, 2002, NATURE, V416, P82, DOI 10.1038/416082a; KIEBER DJ, 1989, NATURE, V341, P637, DOI 10.1038/341637a0; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; MILLER WL, 1995, GEOPHYS RES LETT, V22, P417, DOI 10.1029/94GL03344; MONTANA C, 1988, J ARID ENVIRON, V14, P55, DOI 10.1016/S0140-1963(18)31096-6; Moody SA, 2001, PLANT ECOL, V154, P27, DOI 10.1023/A:1012965610170; MOORHEAD DL, 1994, BIOL FERT SOILS, V18, P19, DOI 10.1007/BF00336439; MOORHEAD DL, 1989, J ARID ENVIRON, V16, P157, DOI 10.1016/S0140-1963(18)31022-X; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Pancotto VA, 2005, GLOBAL CHANGE BIOL, V11, P1982, DOI 10.1111/j.1365-2486.2005.01027.x; Pancotto VA, 2003, GLOBAL CHANGE BIOL, V9, P1465, DOI 10.1046/j.1365-2486.2003.00667.x; SALA OE, 1989, OECOLOGIA, V81, P501, DOI 10.1007/BF00378959; Schade GW, 1999, TELLUS B, V51, P889, DOI 10.1034/j.1600-0889.1999.t01-4-00003.x; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; STEINBERGER Y, 1990, OECOLOGIA, V82, P322, DOI 10.1007/BF00317478; Swift M.J., 1979, DECOMPOSITION TERRES; TARR MA, 1995, J GEOPHYS RES-ATMOS, V100, P11403, DOI 10.1029/94JD03324; Thomas DSG, 2005, NATURE, V435, P1218, DOI 10.1038/nature03717; VOSSBRINCK CR, 1979, ECOLOGY, V60, P265, DOI 10.2307/1937654; WHITFORD WG, 1986, OECOLOGIA, V68, P512, DOI 10.1007/BF00378764; Yahdjian L, 2006, ECOSYSTEMS, V9, P128, DOI 10.1007/s10021-004-0118-7	30	543	611	23	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					555	558		10.1038/nature05038	http://dx.doi.org/10.1038/nature05038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16885982				2022-12-01	WOS:000239455900041
J	Singh, S; Houston, J; van Swol, F; Brinker, CJ				Singh, Seema; Houston, Jack; van Swol, Frank; Brinker, C. Jeffrey			Superhydrophobicity - Drying transition of confined water	NATURE			English	Article							HYDROPHOBIC SURFACES; LONG-RANGE; FORCE		Sandia Natl Labs, Albuquerque, NM 87185 USA; Univ New Mexico, Albuquerque, NM 87131 USA	United States Department of Energy (DOE); Sandia National Laboratories; University of New Mexico	Singh, S (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	cjbrink@sandia.gov						BLAKE TD, 1972, J CHEM SOC FARAD T 1, V68, P1435, DOI 10.1039/f19726801435; Christenson HK, 2001, ADV COLLOID INTERFAC, V91, P391, DOI 10.1016/S0001-8686(00)00036-1; CHRISTENSON HK, 1988, SCIENCE, V239, P390, DOI 10.1126/science.239.4838.390; Doshi DA, 2005, LANGMUIR, V21, P7805, DOI 10.1021/la050750s; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; JOYCE SA, 1991, REV SCI INSTRUM, V62, P710, DOI 10.1063/1.1142072; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Luzar A, 2004, J PHYS CHEM B, V108, P19859, DOI 10.1021/jp0470703; PARKER JL, 1994, J PHYS CHEM-US, V98, P8468, DOI 10.1021/j100085a029; PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349; Stevens H, 2005, LANGMUIR, V21, P6399, DOI 10.1021/la0507535	12	110	114	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					526	526		10.1038/442526a	http://dx.doi.org/10.1038/442526a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16885976	Bronze			2022-12-01	WOS:000239455900033
J	Sarbib, JL; Nankani, G; Patel, P				Sarbib, Jean-Louis; Nankani, Gobind; Patel, Praful			The Booster Program for Malaria Control: putting knowledge and money to work	LANCET			English	Editorial Material									World Bank Grp, Human Dev Network, Washington, DC 20433 USA; World Bank Grp, Africa Reg, Washington, DC 20433 USA; World Bank Grp, S Asia Reg, Washington, DC 20433 USA	The World Bank; The World Bank; The World Bank	Sarbib, JL (corresponding author), World Bank Grp, Human Dev Network, 1818 H St NW, Washington, DC 20433 USA.	jsarbib@worldbank.org						Arrow KJ, 2004, SAVING LIVES BUYING; ATTARAN A, 2006, LANCET          0425; *B M GAT FFDN, 2005, GLOB HLTH PARTN ASS; *BANQ MOND, 2005, DOC FORM PROJ CRED P; *GLOB FUND FIGHT A, TUB MAL FUND WORKS; High Level Forum on the Health MDGs, 2005, BEST PRACT PRINC GLO; *PROGR APPR TECHN, 2005, NEW PARTN LAUNCH ACC; RAMANA GNV, COMMUNICATION; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Shakow A., 2006, GLOBAL FUND WORLD BA; *UNICEF WHO, WORLD MAL REP 2005; *US PRES MAL IN, OV; *WHO, 2005, GUID TREATM MAL, pCH9; World Bank, 2005, PROJ APPR DOC PROP G; *WORLD BANK, 2005, PROJ APPR DOC PROP C; *WORLD BANK, 2006, MAL WORLD BANK GLOB; *WORLD BANK, 2005, IND VECT BORN DIS CO; World Bank, 1997, PROJ APPR DOC PROP C	18	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					253	257		10.1016/S0140-6736(06)68437-7	http://dx.doi.org/10.1016/S0140-6736(06)68437-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844496				2022-12-01	WOS:000239095000038
J	Wu, L; Multani, AS; He, H; Cosme-Blanco, W; Deng, Y; Deng, JM; Bachilo, O; Pathak, S; Tahara, H; Bailey, SM; Deng, YB; Behringer, RR; Chang, S				Wu, Ling; Multani, Asha S.; He, Hua; Cosme-Blanco, Wilfredo; Deng, Yu; Deng, Jian Min; Bachilo, Olga; Pathak, Sen; Tahara, Hedioshi; Bailey, Susan M.; Deng, Yibin; Behringer, Richard R.; Chang, Sandy			Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres	CELL			English	Article							SINGLE-STRANDED-DNA; LENGTH HOMEOSTASIS; PROTEIN; CELLS; END; COMPLEX; TRF1; REGULATOR; WRN; PHOSPHORYLATION	The terminal t-loop structure adopted by mammalian telomeres is thought to prevent telomeres from being recognized as double-stranded DNA breaks by sequestering the 3' single-stranded G-rich overhang from exposure to the DNA damage machinery. The POT1 (protection of telomeres) protein binds the single-stranded overhang and is required for both chromosomal end protection and telomere length regulation. The mouse genome contains two POT1 orthologs, Pot1a and Pot1b. Here we show that conditional deletion of Pot1a elicits a DNA damage response at telomeres, resulting in p53-dependent replicative senescence. Pot1a-deficient cells exhibit overall telomere length and 3' overhang elongation as well as aberrant homologous recombination (HR) at telomeres, manifested as increased telomere sister chromatid exchanges and formation of telomere circles. Telomeric HR following Pot1a loss requires NBS1. Pot1a deletion also results in chromosomal instability. Our results suggest that POT1a is crucial for the maintenance of both telomere integrity and overall genomic stability.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; Rice Univ, Dept Bioengn, Houston, TX 77251 USA; Hiroshima Univ, Grad Sch Biomed Sci, Program Biomed Res, Dept Cellular & Mol Bio,Minami Ku, Hiroshima 734, Japan; Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University; Hiroshima University; Colorado State University	Chang, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd,Box 1006, Houston, TX 77030 USA.	schang@mdanderson.org		Deng, Yibin/0000-0001-5711-3565	NCI NIH HHS [CA016672, R01 CA129037] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA129037, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kim WJ, 2004, INT J CONTROL AUTOM, V2, P279; Kondo T, 2004, CANCER RES, V64, P523, DOI 10.1158/0008-5472.CAN-03-1196; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; Maser RS, 2004, DNA REPAIR, V3, P979, DOI 10.1016/j.dnarep.2004.05.009; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shakirov EV, 2005, MOL CELL BIOL, V25, P7725, DOI 10.1128/MCB.25.17.7725-7733.2005; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wei C, 2004, MOL CELL BIOL, V24, P2091, DOI 10.1128/MCB.24.5.2091-2102.2004; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhu SY, 2000, IUBMB LIFE, V50, P57, DOI 10.1080/15216540050176601; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	63	318	330	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					49	62		10.1016/j.cell.2006.05.037	http://dx.doi.org/10.1016/j.cell.2006.05.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839876	Bronze			2022-12-01	WOS:000239224800016
J	Quam, L; Smith, R; Yach, D				Quam, Lois; Smith, Richard; Yach, Derek			Rising to the global challenge of the chronic disease epidemic	LANCET			English	Editorial Material							HEALTH		Ovations, Minneapolis, MN 55440 USA; UnitedHlth Europe, London, England		Quam, L (corresponding author), Ovations, Minneapolis, MN 55440 USA.	Lois_E_Quam@uhc.com						Boyle P, 2006, LANCET, V368, P629, DOI 10.1016/S0140-6736(06)69225-8; *CLINT GLOB IN, 2006, CLINT GLOB IN NYC; Fuster V, 2006, NAT CLIN PRACT CARD, V3, P401, DOI 10.1038/ncpcardio0630; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Okie S, 2006, NEW ENGL J MED, V355, P1084, DOI 10.1056/NEJMp068186; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2	7	33	33	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1221	1223		10.1016/s0140-6736(06)69422-1	http://dx.doi.org/10.1016/s0140-6736(06)69422-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091WF	17027712				2022-12-01	WOS:000241058300009
J	Hanna, J; Hathaway, NA; Tone, Y; Crosas, B; Elsasser, S; Kirkpatrick, DS; Leggett, DS; Gygi, SP; King, RW; Finley, D				Hanna, John; Hathaway, Nathaniel A.; Tone, Yoshiko; Crosas, Bernat; Elsasser, Suzanne; Kirkpatrick, Donald S.; Leggett, David S.; Gygi, Steven P.; King, Randall W.; Finley, Daniel			Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation	CELL			English	Article							UBIQUITIN-SPECIFIC PROTEASE; YEAST; INHIBITORS; PROTEINS; DEPLETION; FIDELITY; RPN11; USP14	Ubiquitin chains serve as a recognition motif for the proteasome, a multisubunit protease, which degrades its substrates into polypeptides while releasing ubiquitin for reuse. Yeast proteasomes contain two deubiquitinating enzymes, Ubp6 and Rpn11. Rpn11 promotes protein breakdown through its degradation-coupled activity. In contrast, we show here that Ubp6 has the capacity to delay the degradation of ubiquitinated proteins by the proteasome. However, delay of degradation by Ubp6 does not require its catalytic activity, indicating that Ubp6 has both deubiquitinating activity and proteasome-inhibitory activity. Delay of degradation by Ubp6 appears to provide a time window allowing gradual deubiquitination of the substrate by Ubp6. Rpn11 catalyzes en bloc chain removal, and Ubp6 interferes with degradation at or upstream of this step, so that degradation delay by Ubp6 is accompanied by a switch in the mode of ubiquitin chain processing. We propose that Ubp6 regulates both the nature and magnitude of proteasome activity.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; CSIC, Inst Mol Biol, ES-08034 Barcelona, Spain	Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Hanna, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu		King, Randall/0000-0001-7882-8180; Kirkpatrick, Donald/0000-0003-3091-2804	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R56GM066492, R01GM066492, R01GM065592] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM65592, GM66492, GM67945] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Cochella L, 2005, CURR BIOL, V15, pR536, DOI 10.1016/j.cub.2005.07.018; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Miura T, 2004, FEMS MICROBIOL LETT, V239, P171, DOI 10.1016/j.femsle.2004.08.035; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	28	267	274	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					99	111		10.1016/j.cell.2006.07.038	http://dx.doi.org/10.1016/j.cell.2006.07.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018280	Bronze			2022-12-01	WOS:000241445800017
J	Krishnamurthy, PC; Du, GQ; Fukuda, Y; Sun, DX; Sampath, J; Mercer, KE; Wang, JF; Sosa-Pineda, B; Murti, KG; Schuetz, JD				Krishnamurthy, Partha C.; Du, Guoqing; Fukuda, Yu; Sun, Daxi; Sampath, Janardhan; Mercer, Kelly E.; Wang, Junfeng; Sosa-Pineda, Beatriz; Murti, K. Gopal; Schuetz, John D.			Identification of a mammalian mitochondrial porphyrin transporter	NATURE			English	Article							RAT-LIVER MITOCHONDRIA; PROTOPORPHYRIN-IX; HEME; BINDING; MEMBRANES; ATP; BIOSYNTHESIS; OXIDASE; CELLS	The movement of anionic porphyrins ( for example, haem) across intracellular membranes is crucial to many biological processes, but their mitochondrial translocation and coordination with haem biosynthesis is not understood. Transport of porphyrins into isolated mitochondria is energy-dependent(1-3), as expected for the movement of anions into a negatively charged environment. ATP-binding cassette transporters actively facilitate the transmembrane movement of substances. We found that the mitochondrial ATP-binding cassette transporter ABCB6 is upregulated ( messenger RNA and protein in human and mouse cells) by elevation of cellular porphyrins and postulated that ABCB6 has a function in porphyrin transport. We also predicted that ABCB6 is functionally linked to haem biosynthesis, because its mRNA is found in both human bone marrow and CD71(+) early erythroid cells ( by database searching), and because our results show that ABCB6 is highly expressed in human fetal liver, and Abcb6 in mouse embryonic liver. Here we demonstrate that ABCB6 is uniquely located in the outer mitochondrial membrane and is required for mitochondrial porphyrin uptake. After ABCB6 is upregulated in response to increased intracellular porphyrin, mitochondrial porphyrin uptake activates de novo porphyrin biosynthesis. This process is blocked when the Abcb6 gene is silenced. Our results challenge previous assumptions about the intracellular movement of porphyrins and the factors controlling haem biosynthesis.	St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Sci Imaging Resource Ctr, Memphis, TN 38105 USA; Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38103 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Schuetz, JD (corresponding author), St Jude Childrens Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	john.schuetz@stjude.org	Schuetz, John D/N-2692-2018	Fukuda, Yu/0000-0001-6182-540X				AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Furuya KN, 1997, CANCER RES, V57, P3708; GARDNER LC, 1988, J BIOL CHEM, V263, P6676; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Hirsch-Ernst KI, 1998, BIOCHEM BIOPH RES CO, V249, P151, DOI 10.1006/bbrc.1998.9110; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kepczynski M, 2002, PHOTOCHEM PHOTOBIOL, V76, P127, DOI 10.1562/0031-8655(2002)076<0127:DLBCOP>2.0.CO;2; KOLLER ME, 1979, FEBS LETT, V100, P47, DOI 10.1016/0014-5793(79)81128-X; KOLLER ME, 1980, BIOCHEM J, V188, P329, DOI 10.1042/bj1880329; Krieg RC, 2003, PHOTOCHEM PHOTOBIOL, V78, P393, DOI 10.1562/0031-8655(2003)078<0393:ILIACF>2.0.CO;2; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; KUROSS SA, 1988, BLOOD, V71, P876; KUZELOVA K, 1994, BIOCHEMISTRY-US, V33, P9447, DOI 10.1021/bi00198a010; Lavi A, 2002, BIOPHYS J, V82, P2101, DOI 10.1016/S0006-3495(02)75557-4; LIGHT WR, 1990, J BIOL CHEM, V265, P15632; LIGHT WR, 1990, J BIOL CHEM, V265, P15623; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; PIOMELLI S, 1976, PEDIATRICS, V57, P136; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rebeiz N, 1996, ARCH BIOCHEM BIOPHYS, V333, P475, DOI 10.1006/abbi.1996.0417; RICCHELLI F, 1995, EUR J BIOCHEM, V233, P165, DOI 10.1111/j.1432-1033.1995.165_1.x; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Sassa S, 2000, J INTERN MED, V247, P169, DOI 10.1046/j.1365-2796.2000.00618.x; Susa S, 2002, BLOOD, V100, P4678, DOI 10.1182/blood-2002-08-2621; TSIFTSOGLOU AS, 1983, P NATL ACAD SCI-BIOL, V80, P7528, DOI 10.1073/pnas.80.24.7528; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707	29	285	299	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2006	443	7111					586	589		10.1038/nature05125	http://dx.doi.org/10.1038/nature05125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006453				2022-12-01	WOS:000240988200046
J	Syken, J; GrandPre, T; Kanold, PO; Shatz, CJ				Syken, Josh; GrandPre, Tadzia; Kanold, Patrick O.; Shatz, Carla J.			PirB restricts ocular-dominance plasticity in visual cortex	SCIENCE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; CLASS-I MHC; NEGATIVELY REGULATES NEUTROPHIL; LONG-TERM POTENTIATION; INHIBITORY RECEPTORS; GENE-EXPRESSION; CRITICAL PERIOD; CELLS; MICE; REQUIREMENT	Experience can alter synaptic connectivity throughout life, but the degree of plasticity present at each age is regulated by mechanisms that remain largely unknown. Here, we demonstrate that Paired-immunoglobulin-like receptor B (PirB), a major histocompatibility complex class I (MHCI) receptor, is expressed in subsets of neurons throughout the brain. Neuronal PirB protein is associated with synapses and forms complexes with the phosphatases Shp-1 and Shp-2. Soluble PirB fusion protein binds to cortical neurons in an MHCI-dependent manner. In mutant mice lacking functional PirB, cortical ocular-dominance plasticity is more robust at all ages. Thus, an MHCI receptor is expressed in central nervous system neurons and functions to limit the extent of experience-dependent plasticity in the visual cortex throughout life. PirB is also expressed in many other regions of the central nervous system, suggesting that it may function broadly to stabilize neural circuits.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu		Kanold, Patrick/0000-0002-7529-5435	NEI NIH HHS [F32EY1352, F32 EY013526, EY02858, F32 EY013526-01] Funding Source: Medline; NICHD NIH HHS [HD18655] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R37EY002858, R01EY002858, F32EY013526] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Chun D, 2001, NEUROSCIENCE, V105, P815, DOI 10.1016/S0306-4522(01)00173-7; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Dorfman JR, 1997, J IMMUNOL, V159, P5219; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Hensch TK, 2003, NEUROSCI RES, V47, P17, DOI 10.1016/S0168-0102(03)00164-0; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kramar EA, 2002, NEUROSCIENCE, V110, P29, DOI 10.1016/S0306-4522(01)00540-1; Kramar EA, 2003, J BIOL CHEM, V278, P10722, DOI 10.1074/jbc.M210225200; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Pereira S, 2004, J IMMUNOL, V173, P5757, DOI 10.4049/jimmunol.173.9.5757; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Taha SA, 2005, PROG BRAIN RES, V147, P103, DOI 10.1016/S0079-6123(04)47008-3; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Zhang H, 2005, IMMUNITY, V22, P235, DOI 10.1016/j.immuni.2005.01.004	40	262	282	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1795	1800		10.1126/science.1128232	http://dx.doi.org/10.1126/science.1128232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16917027				2022-12-01	WOS:000240655700051
J	D'Orazio, JA; Nobuhisa, T; Cui, RT; Arya, M; Spry, M; Wakamatsu, K; Igras, V; Kunisada, T; Granter, SR; Nishimura, EK; Ito, S; Fisher, DE				D'Orazio, John A.; Nobuhisa, Tetsuji; Cui, Rutao; Arya, Michelle; Spry, Malinda; Wakamatsu, Kazumasa; Igras, Vivien; Kunisada, Takahiro; Granter, Scott R.; Nishimura, Emi K.; Ito, Shosuke; Fisher, David E.			Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning	NATURE			English	Article							STEM-CELL FACTOR; HUMAN MELANOCYTES; DNA-DAMAGE; TRANSCRIPTION FACTOR; ULTRAVIOLET-LIGHT; CYCLIC-AMP; EXPRESSION; GENE; KERATINOCYTES; MELANOGENESIS	Ultraviolet-light (UV)-induced tanning is defective in numerous 'fair-skinned' individuals, many of whom contain functional disruption of the melanocortin 1 receptor (MC1R)(1-3). Although this suggested a critical role for the MC1R ligand melanocyte stimulating hormone (MSH) in this response, a genetically controlled system has been lacking in which to determine the precise role of MSH - MC1R. Here we show that ultraviolet light potently induces expression of MSH in keratinocytes, but fails to stimulate pigmentation in the absence of functional MC1R in red/blonde-haired Mc1r(e/e) mice. However, pigmentation could be rescued by topical application of the cyclic AMP agonist forskolin, without the need for ultraviolet light, demonstrating that the pigmentation machinery is available despite the absence of functional MC1R. This chemically induced pigmentation was protective against ultraviolet-light-induced cutaneous DNA damage and tumorigenesis when tested in the cancer-prone, xerodermapigmentosum-complementation-group- C-deficient genetic background. These data emphasize the essential role of intercellular MSH signalling in the tanning response, and suggest a clinical strategy for topical small-molecule manipulation of pigmentation.	Dana Farber Canc Inst, Melanoma Program, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; Univ Kentucky, Coll Med, Dept Pediat, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Aichi 4701192, Japan; Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu 501, Japan; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Kanazawa Univ, Dept Stem Cell Med, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; University of Kentucky; University of Kentucky; Fujita Health University; Gifu University; Harvard University; Brigham & Women's Hospital; Kanazawa University	Fisher, DE (corresponding author), Dana Farber Canc Inst, Melanoma Program, 44 Binney St, Boston, MA 02115 USA.	david_fisher@dfci.harvard.edu	Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Cui, Rutao/0000-0002-4377-9988; Ito, Shosuke/0000-0001-9182-5144				Bayerl C, 1995, PHOTODERMATOL PHOTO, V11, P149, DOI 10.1111/j.1600-0781.1995.tb00157.x; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; ELLER MS, 1994, NATURE, V372, P413, DOI 10.1038/372413a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; HIROBE T, 1992, DEVELOPMENT, V114, P435; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lassalle MW, 2003, PIGM CELL RES, V16, P81, DOI 10.1034/j.1600-0749.2003.00004.x; Lin CB, 2002, J INVEST DERMATOL, V119, P1330, DOI 10.1046/j.1523-1747.2002.19615.x; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Park SB, 1999, CLIN EXP DERMATOL, V24, P315; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Sturm RA, 2003, ANN NY ACAD SCI, V994, P348, DOI 10.1111/j.1749-6632.2003.tb03199.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496	30	242	258	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					340	344		10.1038/nature05098	http://dx.doi.org/10.1038/nature05098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988713				2022-12-01	WOS:000240622000047
J	Halpern, SD; Hansen-Flaschen, J				Halpern, Scott D.; Hansen-Flaschen, John			Terminal withdrawal of life-sustaining supplemental oxygen	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSISTED SUICIDE; ASSOCIATION; SEDATION; THERAPY; SUPPORT; DISEASE; CARE		Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 711 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	scott.halpern@uphs.upenn.edu		Hansen-Flaschen, John/0000-0003-1989-7244				Abernethy AP, 2005, PALLIATIVE MED, V19, P168, DOI 10.1177/026921630501900219; Abrahm JL, 2002, CHEST, V121, P220, DOI 10.1378/chest.121.1.220; Alpers A, 1997, JAMA-J AM MED ASSOC, V277, P1705, DOI 10.1001/jama.277.21.1705; Ashby M, 2005, PALLIATIVE MED, V19, P389, DOI 10.1191/0269216305pm1043oa; BAILEY PL, 1990, ANESTHESIOLOGY, V73, P826, DOI 10.1097/00000542-199011000-00005; Booth S, 2004, RESP MED, V98, P66, DOI 10.1016/j.rmed.2003.08.008; Bruera E, 2003, PALLIATIVE MED, V17, P659, DOI 10.1191/0269216303pm826oa; Capellier G, 1999, Minerva Anestesiol, V65, P388; Chan JD, 2004, CHEST, V126, P286, DOI 10.1378/chest.126.1.286; Cohen LM, 1996, GEN HOSP PSYCHIAT, V18, P431, DOI 10.1016/S0163-8343(96)00091-6; DAVIS WB, 1983, NEW ENGL J MED, V309, P878, DOI 10.1056/NEJM198310133091502; *ESRD NETW NEW ENG, 2002, 2001 ANN REP CTR MED, P60; Gallagher Romayne, 2004, J Pain Palliat Care Pharmacother, V18, P3; Hjalmarsen A, 1999, EUR NEUROL, V42, P27, DOI 10.1159/000008065; Kampelmacher MJ, 1997, EUR RESPIR J, V10, P828; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Luce JM, 2000, AM J RESP CRIT CARE, V162, P2029, DOI 10.1164/ajrccm.162.6.1-00; Miller FG, 2000, ANN INTERN MED, V132, P470, DOI 10.7326/0003-4819-132-6-200003210-00008; Pearlman RA, 2005, J GEN INTERN MED, V20, P234, DOI 10.1111/j.1525-1497.2005.40225.x; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, DEC FOR LIF SUST TRE, P3; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Rubenfeld GD, 2004, CRIT CARE CLIN, V20, P435, DOI 10.1016/j.ccc.2004.03.005; Waugh Jonathan B, 2004, Respir Care, V49, P902	23	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1397	1400		10.1001/jama.296.11.1397	http://dx.doi.org/10.1001/jama.296.11.1397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985234				2022-12-01	WOS:000240595800029
J	Sulmasy, DP				Sulmasy, Daniel P.			Spiritual issues in the care of dying patients "... it's okay between me and God"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; TERMINALLY-ILL PATIENTS; INAPPROPRIATE TREATMENT; TREATMENT PREFERENCES; ASSISTED SUICIDE; END; PHYSICIANS; ATTITUDES; CANCER; RELIGION	Spiritual issues arise frequently in the care of dying patients, yet health care professionals may not recognize them, may not believe they have a duty to address these issues, and may not understand how best to respond to their patients' spiritual needs. The case of a patient with a strong religious belief in a miraculous cure of metastatic pancreatic cancer is used to explore how better understanding of this belief and more explicitly spiritual conversation with the patient by his treating team might have provided opportunities for an improved plan of care. This article distinguishes spirituality from religion; describes the salient spiritual needs of patients at the end of life as encompassing questions of meaning, value, and relationship; delineates the role physicians ought to play in ascertaining and responding to those needs; and discusses the particular issue of miracles, arguing that expectations of miraculous cure ought not preclude referral to hospice care.	St Vincents Hosp Manhattan, John J Conley Dept Eth, New York, NY 10011 USA; New York Med Coll, Valhalla, NY 10595 USA	Saint Vincents Hospital Manhattan; New York Medical College	Sulmasy, DP (corresponding author), St Vincents Hosp Manhattan, John J Conley Dept Eth, 153 W 11th St, New York, NY 10011 USA.	daniel_sulmasy@nymc.edu						Astrow AB, 2005, J CLIN ONCOL, V23, P2569, DOI 10.1200/JCO.2005.07.151; Astrow AB, 2001, AM J MED, V110, P283; BLACK BC, DENIAL CONTEXT ILLNE; Brett AS, 2003, ARCH INTERN MED, V163, P1645, DOI 10.1001/archinte.163.14.1645; Buckley Jenny, 2004, Nurs Stand, V19, P33; Burker EJ, 2005, J BEHAV MED, V28, P513, DOI 10.1007/s10865-005-9025-4; Buryska JF, 2001, J MED ETHICS, V27, P118, DOI 10.1136/jme.27.2.118; Byock I, 2003, ANN INTERN MED, V138, P335, DOI 10.7326/0003-4819-138-4-200302180-00013; Clarfield AM, 2006, J GERONTOL A-BIOL, V61, P621, DOI 10.1093/gerona/61.6.621; Clark D, 2001, J Palliat Med, V4, P353, DOI 10.1089/109662101753123977; Cohen CB, 2001, HASTINGS CENT REP, V31, P29, DOI 10.2307/3527702; Cohen SR, 1996, CANCER-AM CANCER SOC, V77, P576, DOI 10.1002/(SICI)1097-0142(19960201)77:3<576::AID-CNCR22>3.0.CO;2-0; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Connors RB, 1996, HASTINGS CENT REP, V26, P23, DOI 10.2307/3527604; Coyle Nessa, 2003, J Support Oncol, V1, P206; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Curlin FA, 2005, J GEN INTERN MED, V20, P629, DOI 10.1111/j.1525-1497.2005.0119.x; Daaleman TP, 2000, JAMA-J AM MED ASSOC, V284, P2514, DOI 10.1001/jama.284.19.2514; Du Val G, 2001, J MED ETHICS, V27, pI24, DOI 10.1136/jme.27.suppl_1.i24; Dugan D O, 1995, HEC Forum, V7, P228, DOI 10.1007/BF01463335; Dula A, 2005, CLIN GERIATR MED, V21, P239, DOI 10.1016/j.cger.2004.10.003; DuVal G, 2004, J GEN INTERN MED, V19, P251, DOI 10.1111/j.1525-1497.2004.21238.x; Ehman JW, 1999, ARCH INTERN MED, V159, P1803, DOI 10.1001/archinte.159.15.1803; El-Rayes Basil F, 2003, Clin Adv Hematol Oncol, V1, P430; Ellis MR, 1999, J FAM PRACTICE, V48, P105; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Fisch MJ, 2003, J CLIN ONCOL, V21, P2754, DOI 10.1200/JCO.2003.06.093; Goldstein D, 2004, INTERN MED J, V34, P475, DOI 10.1111/j.1444-0903.2004.00658.x; Graves Darci L, 2002, Acad Med, V77, P1167, DOI 10.1097/00001888-200211000-00035; Heeren O, 2001, INT J GERIATR PSYCH, V16, P203, DOI 10.1002/1099-1166(200102)16:2<203::AID-GPS306>3.0.CO;2-M; Hills Judith, 2005, J Palliat Med, V8, P782, DOI 10.1089/jpm.2005.8.782; Johnson KS, 2005, J AM GERIATR SOC, V53, P711, DOI 10.1111/j.1532-5415.2005.53224.x; *JOINT COMM ACCR H, 2004, SPIR ASS; Kaldjian LC, 1998, AIDS, V12, P103, DOI 10.1097/00002030-199801000-00012; King DE, 2004, TEACH LEARN MED, V16, P64, DOI 10.1207/s15328015tlm1601_13; KING DE, 1994, J FAM PRACTICE, V39, P349; Kristeller JL, 1999, PSYCHO-ONCOLOGY, V8, P451, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<451::AID-PON422>3.3.CO;2-V; LAPUMA J, 1992, AM J MED, V92, P346, DOI 10.1016/0002-9343(92)90262-A; LeFavi Robert G, 2003, J Pastoral Care Counsel, V57, P281; Lo B, 2002, JAMA-J AM MED ASSOC, V287, P749, DOI 10.1001/jama.287.6.749; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; MacLean CD, 2003, J GEN INTERN MED, V18, P38, DOI 10.1046/j.1525-1497.2003.20403.x; Maugans TA, 1996, ARCH FAM MED, V5, P11, DOI 10.1001/archfami.5.1.11; MAUGANS TA, 1991, J FAM PRACTICE, V32, P210; Moadel A, 1999, PSYCHO-ONCOL, V8, P378, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<378::AID-PON406>3.0.CO;2-A; Monroe MH, 2003, ARCH INTERN MED, V163, P2751, DOI 10.1001/archinte.163.22.2751; O'Connell KA, 2006, SOC SCI MED, V62, P1486, DOI 10.1016/j.socscimed.2005.08.001; OCONNELL LJ, 2006, TIME LISTENING CARIN; Orr RD, 1997, J MED ETHICS, V23, P142, DOI 10.1136/jme.23.3.142; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; Perron V, 2001, PRIMARY CARE, V28, P427, DOI 10.1016/S0095-4543(05)70032-4; Post SG, 2000, ANN INTERN MED, V132, P578, DOI 10.7326/0003-4819-132-7-200004040-00010; Puchalski Christina M, 2002, J Palliat Med, V5, P289, DOI 10.1089/109662102753641287; Puchalski CM, 1998, ACAD MED, V73, P970, DOI 10.1097/00001888-199809000-00015; RINPOCHE S, 2002, TIBETAN BOOK LIVING, P199; Steinhauser KE, 2006, ARCH INTERN MED, V166, P101, DOI 10.1001/archinte.166.1.101; Suarez-Almazor ME, 2002, J CLIN ONCOL, V20, P2134, DOI 10.1200/JCO.2002.08.025; Sulmasy D, 2006, REBIRTH CLIN INTRO S; Sulmasy Daniel P, 2002, Ethical Perspect, V9, P103, DOI 10.2143/EP.9.2.503850; Sulmasy Daniel P, 2002, Gerontologist, V42 Spec No 3, P24; Sulmasy DP, 1999, ACAD MED, V74, P1002, DOI 10.1097/00001888-199909000-00012; Sulmasy DP, 1997, THEOR MED, V18, P63, DOI 10.1023/A:1005749217702; Sulmasy DP, 1997, JAMA-J AM MED ASSOC, V277, P1854; SULMASY DP, 2001, J GEN INTERN MED S1, V16, P223; SULMASY DP, IN PRESS BALM GILEAD; SULMASY DP, 1997, HEALERS CALLING SPIR, P66; Torke Alexia M, 2005, J Palliat Med, V8, P593, DOI 10.1089/jpm.2005.8.593; Wagner JT, 1996, CRIT CARE CLIN, V12, P15, DOI 10.1016/S0749-0704(05)70212-8; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454; [No title captured]; 2006, CBS NEWS        0413	72	124	125	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1385	1392		10.1001/jama.296.11.1385	http://dx.doi.org/10.1001/jama.296.11.1385			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	085HS	16985231				2022-12-01	WOS:000240595800026
J	Poon, EG; Cina, JL; Churchill, W; Patel, N; Featherstone, E; Rothschild, JM; Keohane, CA; Whittemore, AD; Bates, DW; Gandhi, TK				Poon, Eric G.; Cina, Jennifer L.; Churchill, William; Patel, Nirali; Featherstone, Erica; Rothschild, Jeffrey M.; Keohane, Carol A.; Whittemore, Anthony D.; Bates, David W.; Gandhi, Tejal K.			Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; HOSPITALIZED-PATIENTS; SYSTEMS; SAFETY; PREVENTION; CARE	Background: Many dispensing errors made in hospital pharmacies can harm patients. Some hospitals are investing in bar code technology to reduce these errors, but data about its efficacy are limited. Objective: To evaluate whether implementation of bar code technology reduced dispensing errors and potential adverse drug events (ADEs). Design: Before-and-after study using direct observations. Setting: Hospital pharmacy at a 735-bed tertiary care academic medical center. Intervention: A bar code-assisted dispensing system was implemented in 3 configurations. In 2 configurations, all doses were scanned once during the dispensing process. In the third configuration, only 1 dose was scanned if several doses of the same medication were being dispensed. Measurements: Target dispensing errors, defined as dispensing errors that bar code technology was designed to address, and target potential ADEs, defined as target dispensing errors that can harm patients. Results: In the pre- and post-bar code implementation periods, the authors observed 115 164 and 253 984 dispensed medication doses, respectively. Overall, the rates of target potential ADEs and all potential ADEs decreased by 74% and 63%, respectively. Of the 3 configurations of bar code technology studied, the 2 configurations that required staff to scan all doses had a 93% to 96% relative reduction in the incidence of target dispensing errors (P < 0.001) and 86% to 97% relative reduction in the incidence of potential ADEs (P < 0.001). However, the configuration that did not require scanning of every dose had only a 60% relative reduction in the incidence of target dispensing errors (P < 0.001) and an increased (by 2.4-fold) incidence of target potential ADEs (P = 0.014). There were several potentially life-threatening ADEs involving intravenous dopamine and intravenous heparin in that configuration. Limitations: The authors used surrogate outcomes; did not mask assessors to the purpose of study; and excluded the controlled substance fill process (a process with low error rates at baseline) from the study, which may bias the combined decrease in error rates toward a larger magnitude. Conclusions: The overall rates of dispensing errors and potential ADEs substantially decreased after implementing bar code technology. However, the technology should be configured to scan every dose during the dispensing process.	Harvard Univ, Div Gen Med & Primary Care, Sch Med, Brigham & Womens Hosp, Boston, MA 02120 USA; Partners Informat Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Poon, EG (corresponding author), Harvard Univ, Div Gen Med & Primary Care, Sch Med, Brigham & Womens Hosp, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	epoon@partners.org	Bates, David/AAE-7283-2019	Poon, Eric/0000-0002-7251-5842	AHRQ HHS [HS14053-02] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS014053] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2000, BRIT MED J, V320, P788, DOI 10.1136/bmj.320.7237.788; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berger RG, 2004, J AM MED INFORM ASSN, V11, P100, DOI 10.1197/jamia.M1411; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BUSH GW, 2004, STATE UNION ADDRESS; Cina JL, 2006, JT COMM J QUAL PATIE, V32, P73, DOI 10.1016/S1553-7250(06)32010-7; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; *IS SIGM, YIELD SIGM CONV TABL; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; *MARKL FDN RW JOHN, 2004, CONN AM HEALTHC FIN; *MARKL FDN RW JOHN, 2004, ACH EL CONN HEALTHC; Murray M, 2001, AHRQ PUBLICATION, P111; *NAT COMM VIT HLTH, 2001, INF HLTH STRAT BUILD; Neuenschwander M, 2003, AM J HEALTH-SYST PH, V60, P1219; Oren E, 2003, AM J HEALTH-SYST PH, V60, P1447, DOI 10.1093/ajhp/60.14.1447; Patterson ES, 2004, J AM MED INFORM ASSN, V11, P50, DOI 10.1197/jamia.M1364; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; Pedersen CA, 2003, AM J HEALTH-SYST PH, V60, P52, DOI 10.1093/ajhp/60.1.52; Rothschild JM, 2005, CRIT CARE MED, V33, P533, DOI 10.1097/01.ccm.0000155912.73313.cd; Thompson T, 2004, DECADE HLTH INFORM T; 2004, FED REG, V69, P9119	28	174	178	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					426	434		10.7326/0003-4819-145-6-200609190-00006	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087OU	16983130				2022-12-01	WOS:000240752500004
J	Hickie, I; Davenport, T; Wakefield, D; Vollmer-Conna, U; Cameron, B; Vernon, SD; Reeves, WC; Lloyd, A				Hickie, Ian; Davenport, Trace; Wakefield, Denis; Vollmer-Conna, Ute; Cameron, Barbara; Vernon, Suzanne D.; Reeves, William C.; Lloyd, Andrew		Dubbo Infection Outcomes Study	Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ACUTE SICKNESS BEHAVIOR; PRIMARY-CARE; Q-FEVER; PROLONGED FATIGUE; GLANDULAR FEVER; MONONUCLEOSIS; DISEASE; DISORDERS; ILLNESS; SCALE	Objective To delineate the risk factors, symptom patterns, and longitudinal course of prolonged illnesses after a variety of acute infections. Design Prospective cohort stud), following patients from the time of acute infection with Epstein-Barr virus (glandular fever), Coxiella burnetti (Q fever), or Ross River virus (epidemic polyarthritis). Setting The region surrounding the township of Dubbo in rural Australia, encompassing a 200 km geographical radius and 104 400 residents. Participants 253 patients enrolled and followed at regular intervals over 12 months by self report, structured interview, and clinical assessment. Outcome measures Detailed medical, psychiatric, and laboratory evaluations at six months to apply diagnostic criteria for chronic fatigue syndrome. Premorbid and intercurrent illness characteristics recorded to define risk factors for chronic fatigue syndrome. Self reported illness phenotypes compared between infective groups. Results Prolonged. illness characterised by disabling fatigue, musculoskeletal pain, neurocognitive difficulties, and mood disturbance Was evident in 29 (12%) of 253 participants at six months, of whom 28 (11%) met die diagnostic criteria for chronic fatigue syndrome. This post-infective fatigue syndrome phenotype was stereotyped and occurred at a similar 1 incidence after each infection. The syndrome was predicted largely by the severity of the acute illness rather dian by demographic, psychological, or microbiological factors. Conclusions A relatively uniform post-infective fatigue syndrome persists in a significant minority of patients for six months or more after clinical infection With several different viral and non-viral micro-organisms. Post-infective fatigue syndrome is a valid illness model for investigating one pathophysiological pathway to chronic fatigue syndrome.	Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia; Univ New S Wales, Sch Psychiat, Kensington, NSW 2033, Australia; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Atlanta, GA 31033 USA	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; Centers for Disease Control & Prevention - USA	Lloyd, A (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.	alloyd@unsw.edu.au	Lloyd, Andrew/AAF-6071-2022; Hickie, Ian B/K-8975-2015; Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/E-7334-2017	Lloyd, Andrew/0000-0001-6277-8887; Hickie, Ian B/0000-0001-8832-9895; Lloyd, Andrew/0000-0001-6277-8887; 	PHS HHS [U50/CCU019851-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; Buchwald DS, 2000, AM J MED, V109, P531, DOI 10.1016/S0002-9343(00)00560-X; Cameron B, 2006, J INFECT DIS, V193, P664, DOI 10.1086/500248; Candy B, 2003, PSYCHOL MED, V33, P847, DOI 10.1017/S0033291703007554; CRAIG AR, 1984, BRIT J MED PSYCHOL, V57, P173, DOI 10.1111/j.2044-8341.1984.tb01597.x; Evans AC, 1934, J AMER MED ASSOC, V103, P0665, DOI 10.1001/jama.1934.02750350029008; Eysenck HJ., 1975, MANUAL EYSENCK PERSO; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GOLD D, 1990, JAMA-J AM MED ASSOC, V264, P48, DOI 10.1001/jama.264.1.48; Hadzi-Pavlovic D, 2000, SOC PSYCH PSYCH EPID, V35, P471, DOI 10.1007/s001270050266; Harley D, 2002, MED J AUSTRALIA, V177, P352, DOI 10.5694/j.1326-5377.2002.tb04836.x; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; HENEINE W, 1994, CLIN INFECT DIS, V18, pS121, DOI 10.1093/clinids/18.Supplement_1.S121; Hickie I, 1999, PSYCHOL MED, V29, P855, DOI 10.1017/S0033291799008582; Hickie IB, 2001, MED J AUSTRALIA, V175, pS10; HOTOPF M, 1996, J NEUROL NEUROSUR PS, V60, P495; ISAACS R, 1948, BLOOD, V3, P858, DOI 10.1182/blood.V3.8.858.858; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mawle AC, 1995, CLIN INFECT DIS, V21, P1386, DOI 10.1093/clinids/21.6.1386; Robertson P, 2003, J MED VIROL, V70, P617, DOI 10.1002/jmv.10439; SHADICK NA, 1994, ANN INTERN MED, V121, P560, DOI 10.7326/0003-4819-121-8-199410150-00002; SHARLICK NA, 1994, ANN INTERN MED, V121, P560; Vollmer-Conna U, 2004, PSYCHOL MED, V34, P1289, DOI 10.1017/S0033291704001953; Vollmer-Conna U, 2001, PSYCHOL MED, V31, P761, DOI 10.1017/S0033291701003841; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; White PD, 2004, PSYCHOL MED, V34, P499, DOI 10.1017/S0033291703001302; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; WHITE PD, 1995, PSYCHOL MED, V25, P907, DOI 10.1017/S0033291700037399; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6; Wilson A, 2001, AUST NZ J PSYCHIAT, V35, P520, DOI 10.1046/j.1440-1614.2001.00888.x; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Working Group of the Royal Australasian College of Physicians, 2002, Med J Aust, V176, pS17; WORSWICK D, 1985, J MED MICROBIOL, V19, P281, DOI 10.1099/00222615-19-3-281	36	415	418	0	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 16	2006	333	7568					575	578		10.1136/bmj.38933.585764.AE	http://dx.doi.org/10.1136/bmj.38933.585764.AE			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089KB	16950834	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000240878200014
J	Griffith, CA; Penteado, P; Rannou, P; Brown, R; Boudon, V; Baines, KH; Clark, R; Drossart, P; Buratti, B; Nicholson, P; McKay, CP; Coustenis, A; Negrao, A; Jaumann, R				Griffith, C. A.; Penteado, P.; Rannou, P.; Brown, R.; Boudon, V.; Baines, K. H.; Clark, R.; Drossart, P.; Buratti, B.; Nicholson, P.; McKay, C. P.; Coustenis, A.; Negrao, A.; Jaumann, R.			Evidence for a polar ethane cloud on Titan	SCIENCE			English	Article							SURFACE; ATMOSPHERE; METHANE; TEMPERATURES; TRITON; WINDS; RAIN; N-2; ICE	Spectra from Cassini's Visual and Infrared Mapping Spectrometer reveal the presence of a vast tropospheric cloud on Titan at latitudes 51 degrees to 68 degrees north and all longitudes observed (10 degrees to 190 degrees west). The derived characteristics indicate that this cloud is composed of ethane and forms as a result of stratospheric subsidence and the particularly cool conditions near the moon's north pole. Preferential condensation of ethane, perhaps as ice, at Titan's poles during the winters may partially explain the lack of liquid ethane oceans on Titan's surface at middle and lower latitudes.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Versailles, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Bourgogne, Phys Lab, CNRS, UMR 5027, F-21078 Dijon, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Denver, CO 80225 USA; Observ Paris, Meudon, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; NASA, Ames Res Ctr, Mountain View, CA USA; Observ Astron Lisboa, P-1349018 Lisbon, Portugal; Deutsch Zentrum Luft & Raumfahrt, Inst Planetary Explorat, Oberpfaffenhofen, Germany	University of Arizona; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Cornell University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universidade de Lisboa; Helmholtz Association; German Aerospace Centre (DLR)	Griffith, CA (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		BOUDON, Vincent/A-4504-2010; Jaumann, Ralf/N-1001-2018; Penteado, Paulo/F-9081-2012; Drossart, Pierre/H-8670-2013; RANNOU, Pascal/I-9059-2012	Jaumann, Ralf/0000-0002-9759-6597; Penteado, Paulo/0000-0001-6759-2037; Negrao, Alberto/0000-0001-6042-1294; RANNOU, pascal/0000-0003-0836-723X				Barth EL, 2003, ICARUS, V162, P94, DOI 10.1016/S0019-1035(02)00067-2; Boudon V, 2006, J QUANT SPECTROSC RA, V98, P394, DOI 10.1016/j.jqsrt.2005.06.003; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Brown RH, 2003, ICARUS, V164, P461, DOI 10.1016/S0019-1035(03)00134-9; COUSTENIS A, 1995, ICARUS, V115, P126, DOI 10.1006/icar.1995.1084; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Fulchignoni M, 2005, NATURE, V438, P785, DOI 10.1038/nature04314; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Lorenz RD, 2001, GEOPHYS RES LETT, V28, P4453, DOI 10.1029/2001GL013728; LUNINE J, 2005, 36 ANN LUN PLAN SCI; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; Mayo LA, 2005, ICARUS, V176, P316, DOI 10.1016/j.icarus.2005.01.020; MCDONALD JE, 1964, J ATMOS SCI, V21, P76, DOI 10.1175/1520-0469(1964)021<0076:OACGTM>2.0.CO;2; MCKELLAR ARW, 1989, ICARUS, V80, P361, DOI 10.1016/0019-1035(89)90146-2; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Osegovic JP, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002435; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Quirico E, 1997, ICARUS, V127, P354, DOI 10.1006/icar.1996.5663; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; Roe HG, 2002, ASTROPHYS J, V581, P1399, DOI 10.1086/344403; Rothman LS, 2003, J QUANT SPECTROSC RA, V82, P5, DOI 10.1016/S0022-4073(03)00146-8; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; THOMPSON WR, 1990, NASA C PUBL, V3077, P303; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tokano T, 2005, ICARUS, V173, P222, DOI 10.1016/j.icarus.2004.08.019; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X; West RA, 2005, NATURE, V436, P670, DOI 10.1038/nature03824; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	34	140	140	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1620	1622		10.1126/science.1128245	http://dx.doi.org/10.1126/science.1128245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973876				2022-12-01	WOS:000240498900040
J	Tu, HP; Nelson, O; Bezprozvanny, A; Wang, ZN; Lee, SF; Hao, YH; Serneels, L; De Strooper, B; Yu, G; Bezprozvanny, I				Tu, Huiping; Nelson, Omar; Bezprozvanny, Arseny; Wang, Zhengnan; Lee, Sheu-Fen; Hao, Yi-Heng; Serneels, Lutgarde; De Strooper, Bart; Yu, Gang; Bezprozvanny, Ilya			Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; 1,4,5-TRISPHOSPHATE RECEPTOR ISOFORMS; CAPACITATIVE CALCIUM-ENTRY; LONG-TERM POTENTIATION; ENDOPLASMIC-RETICULUM; STORES; CELLS; MICE; COMPARTMENTS	Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disorder. Mutations in presenilins 1 and 2 (PS1 and PS2) account for similar to 40% of familial AD (FAD) cases. FAD mutations and genetic deletions of presenilins have been associated with calcium (Ca2+) signaling abnormalities. We demonstrate that wild-type presenilins, but not PS1-M146V and PS2-N141I FAD mutants, can form low-conductance divalent-cation-permeable ion channels in planar lipid bilayers. In experiments with PS1/2 double knockout (DKO) mouse embryonic fibroblasts (MEFs), we find that presenilins account for similar to 80% of passive Ca2+ leak from the endoplasmic reticulum. Deficient Ca2+ signaling in DKO MEFs can be rescued by expression of wild-type PS1 or PS2 but not by expression of PS1-M146V or PS2-N141I mutants. The ER Ca2+ leak function of presenilins is independent of their gamma-secretase activity. Our data suggest a Ca2+ signaling function for presenilins and provide support for the "Ca2+ hypothesis of AD".	Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; Katholieke Univ Leuven, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol VIB4, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Texas, SW Med Ctr Dallas, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; KU Leuven; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bezprozvanny, I (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	ilya.bezprozvanny@utsouthwestern.edu	De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019	De Strooper, Bart/0000-0001-5455-5819; Serneels, Lutgarde/0000-0002-5463-4231	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG012300, R01AG023104] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG12300, P30 AG012300, R01 AG023104] Funding Source: Medline; NINDS NIH HHS [R01 NS038082-05A2, R01 NS38082, R01 NS038082] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Begley JG, 1999, J NEUROCHEM, V72, P1030, DOI 10.1046/j.1471-4159.1999.0721030.x; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Cedazo-Minguez A, 2002, J BIOL CHEM, V277, P36646, DOI 10.1074/jbc.M112117200; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Herms J, 2003, J BIOL CHEM, V278, P2484, DOI 10.1074/jbc.M206769200; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hofer AM, 1999, METH MOL B, V114, P249; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; KHACHATURIAN ZS, 1989, ANN NY ACAD SCI, V568, P1, DOI 10.1111/j.1749-6632.1989.tb12485.x; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Ris L, 2003, J BIOL CHEM, V278, P44393, DOI 10.1074/jbc.M300971200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tandon A, 2002, GENOME BIOL, V3; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tu HP, 2005, BIOPHYS J, V88, P1056, DOI 10.1529/biophysj.104.049601; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WOODBURY DJ, 1990, BIOPHYS J, V58, P833, DOI 10.1016/S0006-3495(90)82429-2; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	41	517	535	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					981	993		10.1016/j.cell.2006.06.059	http://dx.doi.org/10.1016/j.cell.2006.06.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959576	Green Accepted, Bronze			2022-12-01	WOS:000240675000024
J	Ayas, NT; Barger, LK; Cade, BE; Hashimoto, DM; Rosner, B; Cronin, JW; Speizer, FE; Czeisler, CA				Ayas, Najib T.; Barger, Laura K.; Cade, Brian E.; Hashimoto, Dean M.; Rosner, Bernard; Cronin, John W.; Speizer, Frank E.; Czeisler, Charles A.			Extended work duration and the risk of self-reported percutaneous injuries in interns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP-DEPRIVATION; PERFORMANCE; RESIDENTS; NIGHT; WAKEFULNESS; ALCOHOL; FATIGUE; CALL; EEG	Context In their first year of postgraduate training, interns commonly work shifts that are longer than 24 hours. Extended-duration work shifts are associated with increased risks of automobile crash, particularly during a commute from work. Interns may be at risk for other occupation-related injuries. Objective To assess the relationship between extended work duration and rates of percutaneous injuries in a diverse population of interns in the United States. Design, Setting, and Participants National prospective cohort study of 2737 of the estimated 18 447 interns in US postgraduate residency programs from July 2002 through May 2003. Each month, comprehensive Web-based surveys that asked about work schedules and the occurrence of percutaneous injuries in the previous month were sent to all participants. Case-crossover within-subjects analyses were performed. Main Outcome Measures Comparisons of rates of percutaneous injuries during day work (6:30 AM to 5:30 PM) after working overnight (extended work) vs day work that was not preceded by working overnight (nonextended work). We also compared injuries during the nighttime (11:30 PM to 7:30 AM) vs the daytime (7:30 AM to 3:30 PM). Results From a total of 17 003 monthly surveys, 498 percutaneous injuries were reported (0.029/intern-month). In 448 injuries, at least 1 contributing factor was reported. Lapse in concentration and fatigue were the 2 most commonly reported contributing factors (64% and 31% of injuries, respectively). Percutaneous injuries were more frequent during extended work compared with nonextended work (1.31/1000 opportunities vs 0.76/1000 opportunities, respectively; odds ratio [OR], 1.61; 95% confidence interval [CI], 1.46-1.78). Extended work injuries occurred after a mean of 29.1 consecutive work hours; nonextended work injuries occurred after a mean of 6.1 consecutive work hours. Injuries were more frequent during the nighttime than during the daytime (1.48/1000 opportunities vs 0.70/1000 opportunities, respectively; OR, 2.04; 95% CI, 1.98-2.11). Conclusion Extended work duration and night work were associated with an increased risk of percutaneous injuries in this study population of physicians during their first year of clinical training.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Work Hours Hlth & Safety Grp, Div Sleep Med, Boston, MA USA; Univ British Columbia, Sleep Disorders Program, Vancouver, BC V5Z 1M9, Canada; Vancouver Gen Hosp, Dept Med, Vancouver, BC, Canada; Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Czeisler, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, 221 Longwood Ave, Boston, MA 02115 USA.	caczeisler@hms.harvard.edu	Cade, Brian/J-6770-2019	Cade, Brian/0000-0003-1424-0673	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS012032, F32HS014130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH007567] Funding Source: NIH RePORTER; AHRQ HHS [F32 HS14130, R01 HS12032] Funding Source: Medline; NHLBI NIH HHS [T32 HL079010] Funding Source: Medline; NIOSH CDC HHS [1 R01 OH07567] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIOSH CDC HHS		Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Baldwin DC, 2004, SLEEP, V27, P217, DOI 10.1093/sleep/27.2.217; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Cajochen C, 1999, AM J PHYSIOL-REG I, V277, pR640, DOI 10.1152/ajpregu.1999.277.3.R640; CARSKADON MA, 1992, SLEEP, V15, P396, DOI 10.1093/sleep/15.5.396; COOPERSTOCK M, 1987, OBSTET GYNECOL, V70, P852; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Gerberding JL, 2003, NEW ENGL J MED, V348, P826, DOI 10.1056/NEJMcp020892; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; *NAT RES MATCH PRO, POS OFF PERC FILL US; Parks DK, 2000, CHRONOBIOL INT, V17, P61, DOI 10.1081/CBI-100101032; Rosner B., 1999, FUNDAMENTALS BIOSTAT; TORSVALL L, 1987, ELECTROEN CLIN NEURO, V66, P502, DOI 10.1016/0013-4694(87)90096-4; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Wertz AT, 2006, JAMA-J AM MED ASSOC, V295, P163, DOI 10.1001/jama.295.2.163; PHYS HLTH STUDY, V1; PHYS HLTH STUDY, V2	21	269	274	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1055	1062		10.1001/jama.296.9.1055	http://dx.doi.org/10.1001/jama.296.9.1055			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954484	Bronze			2022-12-01	WOS:000240298400006
J	Pinkston, JM; Garigan, D; Hansen, M; Kenyon, C				Pinkston, Julie M.; Garigan, Delia; Hansen, Malene; Kenyon, Cynthia			Mutations that increase the life span of C-elegans inhibit tumor growth	SCIENCE			English	Article							DAMAGE-INDUCED APOPTOSIS; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; CELL-DEATH; GERMLINE; MUTANTS; PATHWAY; LONG; P53; LONGEVITY	Mutations in gld-1 cause lethal germline tumors in the nematode Caenorhabditis elegans. We find that a wide variety of mutations that extend C. elegans' life span confer resistance to these tumors. The long life spans of daf-2/insulin-receptor mutants were not shortened at all by gld-1 mutations; we attribute this finding to decreased cell division and increased DAF-16/p53 dependent apoptosis within the tumors. Mutations that increase life span by restricting food intake or inhibiting respiration did not affect apoptosis but reduced tumor cell division. Unexpectedly, none of these longevity mutations affected mitosis in normal germlines; this finding suggests that cellular changes that lead to longevity preferentially antagonize tumor cell growth.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	ckenyon@biochem.ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [AG000278] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Braeckman BP, 2002, MECH AGEING DEV, V123, P1447, DOI 10.1016/S0047-6374(02)00085-4; Deng XZ, 2004, NAT GENET, V36, P906, DOI 10.1038/ng1396; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; FRANCIS R, 1995, GENETICS, V139, P607; Garigan D, 2002, GENETICS, V161, P1101; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gems D, 1998, GENETICS, V150, P129; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pepper ASR, 2003, GENETICS, V163, P115; Ramsey MM, 2002, ENDOCRINOLOGY, V143, P4139, DOI 10.1210/en.2002-220717; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	28	174	196	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2006	313	5789					971	975		10.1126/science.1121908	http://dx.doi.org/10.1126/science.1121908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917064				2022-12-01	WOS:000239817000045
J	Nemhauser, JL; Hong, FX; Chory, J				Nemhauser, Jennifer L.; Hong, Fangxin; Chory, Joanne			Different plant hormones regulate similar processes through largely nonoverlapping transcriptional responses	CELL			English	Article							GROWTH-RESPONSES; AUXIN; ETHYLENE; GENES; GIBBERELLIN; POWERFUL; ROLES	Small-molecule hormones govern every aspect of the biology of plants. Many processes, such as growth, are regulated in similar ways by multiple hormones, and recent studies have revealed extensive crosstalk among different hormonal signaling pathways. These results have led to the proposal that a common set of signaling components may integrate inputs from multiple hormones to regulate growth. In this study, we tested this proposal by asking whether different hormones converge on a common set of transcriptional targets in Arabidopsis seedlings. Using publicly available microarray data, we analyzed the transcriptional effects of seven hormones, including abscisic acid, gibberellin, auxin, ethylene, cytokinin, brassinosteroid, and jasmonate. A high-sensitivity analysis revealed a surprisingly low number of common target genes. Instead, different hormones appear to regulate distinct members of protein families. We conclude that there is not a core transcriptional growth-regulatory module in young Arabidopsis seedlings.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu						Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; ALONSO JM, 2001, SCI STKE, pRE1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Force A, 1999, GENETICS, V151, P1531; Friedrichsen DM, 2002, GENETICS, V162, P1445; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Halliday KJ, 2004, CURR BIOL, V14, pR1008, DOI 10.1016/j.cub.2004.11.025; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; Nakamura A, 2006, PLANT J, V45, P193, DOI 10.1111/j.1365-313X.2005.02582.x; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Sampedro J, 2006, J PLANT RES, V119, P11, DOI 10.1007/s10265-005-0253-z; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Steber CM, 1998, GENETICS, V149, P509; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; WU Z, 2004, MODEL BASED BACKGROU; Yang T, 1996, PLANT PHYSIOL, V110, P1029, DOI 10.1104/pp.110.3.1029; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P1025, DOI 10.1093/pcp/pce154; ZUREK DM, 1994, PLANT PHYSIOL, V104, P505, DOI 10.1104/pp.104.2.505	33	669	722	10	157	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2006	126	3					467	475		10.1016/j.cell.2006.05.050	http://dx.doi.org/10.1016/j.cell.2006.05.050			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901781	Bronze			2022-12-01	WOS:000239883400008
J	Hyun, I				Hyun, Insoo			Fair payment or undue inducement?	NATURE			English	Editorial Material									Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44109 USA	Case Western Reserve University	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44109 USA.							[Anonymous], 1993, IRB GUID; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Emanuel EJ, 2004, J LAW MED ETHICS, V32, P100, DOI 10.1111/j.1748-720X.2004.tb00453.x; *FOOD DRUG ADM, 2001, IRB INF SHEETS; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; McGee Glenn, 2006, AM J BIOETHICS, V6, pW33; *NIH, 2006, CLIN RES VOL PROGR H; *NIH, 2000, REM RES SUBJ INTR RE; Steinbrook R, 2006, NEW ENGL J MED, V354, P324, DOI 10.1056/NEJMp058313	9	51	51	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					629	630		10.1038/442629a	http://dx.doi.org/10.1038/442629a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16900181				2022-12-01	WOS:000239630200023
J	Xu, K; Xu, X; Fukao, T; Canlas, P; Maghirang-Rodriguez, R; Heuer, S; Ismail, AM; Bailey-Serres, J; Ronald, PC; Mackill, DJ				Xu, Kenong; Xu, Xia; Fukao, Takeshi; Canlas, Patrick; Maghirang-Rodriguez, Reycel; Heuer, Sigrid; Ismail, Abdelbagi M.; Bailey-Serres, Julia; Ronald, Pamela C.; Mackill, David J.			Sub1A is an ethylene-response-factor-like gene that confers submergence tolerance to rice	NATURE			English	Article							ORYZA-SATIVA L.; TRANSCRIPTION FACTORS; LINKAGE MAP; DEEP-WATER; GENOME; EXPRESSION; SEQUENCE; MARKER; PLANTS; ACTIVATION	Most Oryza sativa cultivars die within a week of complete submergence - a major constraint to rice production in south and southeast Asia that causes annual losses of over US$ 1 billion and affects disproportionately the poorest farmers in the world(1,2). A few cultivars, such as the O. sativa ssp. indica cultivar FR13A, are highly tolerant and survive up to two weeks of complete submergence owing to a major quantitative trait locus designated Submergence 1 ( Sub1) near the centromere of chromosome 9 ( refs 3 - 6). Here we describe the identification of a cluster of three genes at the Sub1 locus, encoding putative ethylene response factors. Two of these genes, Sub1B and Sub1C, are invariably present in the Sub1 region of all rice accessions analysed. In contrast, the presence of Sub1A is variable. A survey identified two alleles within those indica varieties that possess this gene: a tolerance- specific allele named Sub1A- 1 and an intolerance- specific allele named Sub1A- 2. Overexpression of Sub1A- 1 in a submergence- intolerant O. sativa ssp. japonica conferred enhanced tolerance to the plants, downregulation of Sub1C and upregulation of Alcohol dehydrogenase 1 ( Adh1), indicating that Sub1A- 1 is a primary determinant of submergence tolerance. The FR13A Sub1 locus was introgressed into a widely grown Asian rice cultivar using marker- assisted selection. The new variety maintains the high yield and other agronomic properties of the recurrent parent and is tolerant to submergence. Cultivation of this variety is expected to provide protection against damaging floods and increase crop security for farmers.	Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA; Int Rice Res Inst, Manila, Philippines	University of California System; University of California Davis; University of California System; University of California Riverside; CGIAR; International Rice Research Institute (IRRI)	Ronald, PC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu; d.mackill@cgiar.org	Ronald, Pamela/AAK-7664-2020; Mackill, David/AAB-7176-2022; Fukao, Takeshi/H-6548-2016; Bailey-Serres, Julia/A-2470-2010; Mackill, David/C-6368-2014	Fukao, Takeshi/0000-0002-9930-1318; Bailey-Serres, Julia/0000-0002-8568-7125; Mackill, David/0000-0003-4224-6781				[Anonymous], [No title captured]; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; CATLING D, 1992, RICE DEEP WATER, P5; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; FUKAO T, IN PRESS PLANT CELL; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Harushima Y, 1998, GENETICS, V148, P479; Herdt R. W., 1991, Rice biotechnology., P19; Jackson MB, 2003, ANN BOT-LONDON, V91, P227, DOI 10.1093/aob/mcf242; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Parnell SC, 2005, BIOCHEMISTRY-US, V44, P8159, DOI 10.1021/bi0503091; Ram PC, 2002, FIELD CROP RES, V76, P131, DOI 10.1016/S0378-4290(02)00035-7; Sauter M, 2000, NATURWISSENSCHAFTEN, V87, P289, DOI 10.1007/s001140050725; Setter TL, 1997, ANN BOT-LONDON, V79, P67, DOI 10.1006/anbo.1996.0304; Siangliw M, 2003, ANN BOT-LONDON, V91, P255, DOI 10.1093/aob/mcf123; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Xu K, 2000, MOL GEN GENET, V263, P681, DOI 10.1007/s004380051217; Xu KN, 1996, MOL BREEDING, V2, P219, DOI 10.1007/BF00564199; Xu KN, 2004, CROP SCI, V44, P248, DOI 10.2135/cropsci2004.0248	30	951	1052	17	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					705	708		10.1038/nature04920	http://dx.doi.org/10.1038/nature04920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16900200	Green Published			2022-12-01	WOS:000239630200050
J	Abzhanov, A; Kuo, WP; Hartmann, C; Grant, BR; Grant, PR; Tabin, CJ				Abzhanov, Arhat; Kuo, Winston P.; Hartmann, Christine; Grant, B. Rosemary; Grant, Peter R.; Tabin, Clifford J.			The calmodulin pathway and evolution of elongated beak morphology in Darwin's finches	NATURE			English	Article							THREESPINE STICKLEBACKS; HOX GENES	A classic textbook example of adaptive radiation under natural selection is the evolution of 14 closely related species of Darwin's finches (Fringillidae, Passeriformes), whose primary diversity lies in the size and shape of their beaks(1-6). Thus, ground finches have deep and wide beaks, cactus finches have long and pointed beaks ( low depth and narrower width), and warbler finches have slender and pointed beaks, reflecting differences in their respective diets(6). Previous work has shown that even small differences in any of the three major dimensions ( depth, width and length) of the beak have major consequences for the overall fitness of the birds(3-7). Recently we used a candidate gene approach to explain one pathway involved in Darwin's finch beak morphogenesis(8). However, this type of analysis is limited to molecules with a known association with craniofacial and/or skeletogenic development. Here we use a less constrained, complementary DNA microarray analysis of the transcripts expressed in the beak primordia to find previously unknown genes and pathways whose expression correlates with specific beak morphologies. We show that calmodulin (CaM), a molecule involved in mediating Ca2+ signalling, is expressed at higher levels in the long and pointed beaks of cactus finches than in more robust beak types of other species. We validated this observation with in situ hybridizations. When this upregulation of the CaM-dependent pathway is artificially replicated in the chick frontonasal prominence, it causes an elongation of the upper beak, recapitulating the beak morphology of the cactus finches. Our results indicate that local upregulation of the CaM-dependent pathway is likely to have been a component of the evolution of Darwin's finch species with elongated beak morphology and provide a mechanistic explanation for the independence of beak evolution along different axes. More generally, our results implicate the CaM-dependent pathway in the developmental regulation of craniofacial skeletal structures.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USA; Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; Inst Mol Pathol, A-1030 Vienna, Austria; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Princeton University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Hartmann, Christine/0000-0002-6854-8633				Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 1999, DEVELOPMENT, V126, P1121; Abzhanov A, 2000, DEVELOPMENT, V127, P2239; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; BOWMAN ROBERT I., 1961, UNIV CALIFORNIA PUBL ZOOL, V58, P1; BURKE AC, 1995, DEVELOPMENT, V121, P333; Darwin C., 1845, J RES GEOLOGY NATURA, V2; Dudoit S, 2002, STAT SINICA, V12, P111; Freeman S., 2003, EVOLUTIONARY ANAL; Futuyma D.J., 1998, EVOL BIOL; Grant B. R., 1989, EVOLUTIONARY DYNAMIC; Grant P.R., 1999, ECOLOGY EVOLUTION DA; GRANT PR, 1994, EVOLUTION, V48, P297, DOI 10.1111/j.1558-5646.1994.tb01313.x; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, 1981, PROC R SOC SER B-BIO, V212, P403, DOI 10.1098/rspb.1981.0046; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Kimmel CB, 2005, P NATL ACAD SCI USA, V102, P5791, DOI 10.1073/pnas.0408533102; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Lack D., 1947, DARWINS FINCHES; O'Day DH, 2003, CELL SIGNAL, V15, P347, DOI 10.1016/S0898-6568(02)00116-X; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; PRICE TD, 1985, AM NAT, V125, P169, DOI 10.1086/284336; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415	23	395	402	2	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					563	567		10.1038/nature04843	http://dx.doi.org/10.1038/nature04843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16885984				2022-12-01	WOS:000239455900043
J	Enemark, EJ; Joshua-Tor, L				Enemark, Eric J.; Joshua-Tor, Leemor			Mechanism of DNA translocation in a replicative hexameric helicase	NATURE			English	Article							SINGLE-STRANDED-DNA; LARGE TUMOR-ANTIGEN; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; BINDING DOMAIN; T-ANTIGEN; PROTEIN; E1; PAPILLOMAVIRUS; COMPLEX	The E1 protein of papillomavirus is a hexameric ring helicase belonging to the AAA+ family. The mechanism that couples the ATP cycle to DNA translocation has been unclear. Here we present the crystal structure of the E1 hexamer with single-stranded DNA discretely bound within the hexamer channel and nucleotides at the subunit interfaces. This structure demonstrates that only one strand of DNA passes through the hexamer channel and that the DNA-binding hairpins of each subunit form a spiral 'staircase' that sequentially tracks the oligonucleotide backbone. Consecutively grouped ATP, ADP and apo configurations correlate with the height of the hairpin, suggesting a straightforward DNA translocation mechanism. Each subunit sequentially progresses through ATP, ADP and apo states while the associated DNA-binding hairpin travels from the top staircase position to the bottom, escorting one nucleotide of single-stranded DNA through the channel. These events permute sequentially around the ring from one subunit to the next.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu	Enemark, Eric/N-8086-2018	Joshua-Tor, Leemor/0000-0001-8185-8049	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046724] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI046724] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Chen G, 2002, MOL CELL BIOL, V22, P7712, DOI 10.1128/MCB.22.21.7712-7720.2002; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2000, MOL CELL, V6, P149, DOI 10.1016/S1097-2765(00)00016-2; Enemark EJ, 2002, EMBO J, V21, P1487, DOI 10.1093/emboj/21.6.1487; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fouts ET, 1999, J BIOL CHEM, V274, P4447, DOI 10.1074/jbc.274.7.4447; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GILLETTE TG, 1994, P NATL ACAD SCI USA, V91, P8846, DOI 10.1073/pnas.91.19.8846; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lin BY, 2002, MOL CELL BIOL, V22, P6592, DOI 10.1128/MCB.22.18.6592-6604.2002; Luo XL, 1996, NAT STRUCT BIOL, V3, P1034, DOI 10.1038/nsb1296-1034; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Neuwald AF, 1999, GENOME RES, V9, P27; Sanders CM, 1998, EMBO J, V17, P7044, DOI 10.1093/emboj/17.23.7044; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Sedman J, 1998, J VIROL, V72, P6893, DOI 10.1128/JVI.72.8.6893-6897.1998; SEO YS, 1993, J BIOL CHEM, V268, P10282; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086	36	404	408	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					270	275		10.1038/nature04943	http://dx.doi.org/10.1038/nature04943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855583				2022-12-01	WOS:000239122100031
J	Thirumurugan, K; Sakamoto, T; Hammer, JA; Sellers, JR; Knight, PJ				Thirumurugan, Kavitha; Sakamoto, Takeshi; Hammer, John A., III; Sellers, James R.; Knight, Peter J.			The cargo-binding domain regulates structure and activity of myosin 5	NATURE			English	Article							ATPASE ACTIVITY; TAIL DOMAIN; CONFORMATION; CALMODULIN; ACTIVATION; MUSCLE; VA	Myosin 5 is a two-headed motor protein that moves cargoes along actin filaments(1,2). Its tail ends in paired globular tail domains (GTDs) thought to bind cargo(3). At nanomolar calcium levels, actin-activated ATPase is low and the molecule is folded. Micromolar calcium concentrations activate ATPase and the molecule unfolds(3-6). Here we describe the structure of folded myosin and the GTD's role in regulating activity. Electron microscopy shows that the two heads lie either side of the tail, contacting the GTDs at a lobe of the motor domain (similar to Pro 117 - Pro 137) that contains conserved acidic side chains, suggesting ionic interactions between motor domain and GTD. Myosin 5 heavy meromyosin, a constitutively active fragment lacking the GTDs, is inhibited and folded by a dimeric GST - GTD fusion protein. Motility assays reveal that at nanomolar calcium levels heavy meromyosin moves robustly on actin filaments whereas few myosins bind or move. These results combine to show that with no cargo, the GTDs bind in an intramolecular manner to the motor domains, producing an inhibited and compact structure that binds weakly to actin and allows the molecule to recycle towards new cargoes.	Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	University of Leeds; University of Leeds; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Knight, PJ (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	p.j.knight@leeds.ac.uk	Thirumurugan, Kavitha/B-3282-2010	Thirumurugan, Kavitha/0000-0002-4673-4099	Wellcome Trust [076057] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229, Z01HL004229, Z01HL000514, ZIAHL000514] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANKRETT RJ, 1991, J MOL BIOL, V217, P323, DOI 10.1016/0022-2836(91)90546-I; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Nguyen H, 2005, NAT STRUCT MOL BIOL, V12, P127, DOI 10.1038/nsmb894; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schilstra MJ, 2006, J R SOC INTERFACE, V3, P153, DOI 10.1098/rsif.2005.0098; Sellers J. R., 1999, MYOSINS; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	24	134	137	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					212	215		10.1038/nature04865	http://dx.doi.org/10.1038/nature04865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838021	Green Accepted			2022-12-01	WOS:000238979700050
J	Marmot, M				Marmot, Michael			Smoking and inequalities	LANCET			English	Editorial Material							CIVIL-SERVANTS; DEATH RATES; MORTALITY		UCL, Int Inst Soc & Hlth, London WC1E 6BT, England	University of London; University College London	Marmot, M (corresponding author), UCL, Int Inst Soc & Hlth, Mortimer St, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Medical Research Council [G0100222, G8802774, G19/35] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acheson D., 1998, INEQUALITIES HLTH RE; [Anonymous], 2002, WORLD HLTH REP 2002; Barker D.J.P., 1998, MOTHERS BABIES HLTH; Emberson JR, 2004, INT J EPIDEMIOL, V33, P289, DOI 10.1093/ije/dyh006; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Mackenbach JP, 2004, EUR J CANCER, V40, P126, DOI 10.1016/j.ejca.2003.10.018; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2004, STATUS SYNDROME; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; van Rossum CTM, 2000, J EPIDEMIOL COMMUN H, V54, P178, DOI 10.1136/jech.54.3.178	11	44	45	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2006	368	9533					341	342		10.1016/S0140-6736(06)68976-9	http://dx.doi.org/10.1016/S0140-6736(06)68976-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069JJ	16876643				2022-12-01	WOS:000239441900004
J	Davison, SN; Simpson, C				Davison, Sara N.; Simpson, Christy			Hope and advance care planning in patients with end stage renal disease: qualitative interview study	BRITISH MEDICAL JOURNAL			English	Article							DIALYSIS PATIENTS; CARDIOPULMONARY-RESUSCITATION; PATIENTS PREFERENCES; DIRECTIVES; DISCONTINUATION; ATTITUDES; ONCOLOGY	Objective To understand hope in the context of advance care planning from the perspective of patients with end stage renal disease. Design Qualitative in-depth interview study. Setting Outpatient department of a university affiliated nephrology programme. Participants 19 patients with end stage renal disease purposively selected from the renal insufficiency, haemodialysis, and peritoneal dialysis clinics. Results Patients' hopes were highly individualised and were shaped by personal values. They reflected a preoccupation with their daily lives. Participants identified hope as central to the process of advance care planning in that hope helped them to determine future goals of care and provided insight into the perceived benefits of advance care planning and their willingness to engage in end of life discussions. More information earlier in the course of the illness focusing on the impact on daily life, along with empowerment of the patient and enhancing professional and personal relationships, were key factors in sustaining patients' ability to hope. is helped them to imagine possibilities for a future that were consistent with their values and hopes. The reliance on health professionals to initiate end of life discussions and the daily focus of clinical care were seen as potential barriers to hope. Conclusions Facilitated advance care planning through the provision of timely appropriate information can positively enhance rather than diminish patients' hope. Current practices concerning disclosure of prognosis are ethically and psychologically inadequate in that they do not meet the needs of patients.	Univ Alberta, Div Nephrol & Immunol, Edmonton, AB, Canada; Dalhousie Univ, Dept Bioeth, Halifax, NS, Canada	University of Alberta; Dalhousie University	Davison, SN (corresponding author), Univ Alberta, Div Nephrol & Immunol, Edmonton, AB, Canada.	sara.davison@ualberta.ca		Simpson, Christy/0000-0001-7201-5867				Carson V, 1990, Perspect Psychiatr Care, V26, P28; Chambers EJ, 2004, SUPPORTIVE CARE RENA, P1; CHAMBERS FJ, 2004, SUPPORTIVE CARE RENA, P1; CHRISTAKIS NA, 1999, DEATH FARETOLD PROPH; Christakis Nicholas A., 1999, DEATH FORETOLD PROPH; Cohen LM, 1997, PSYCHOSOMATICS, V38, P27, DOI 10.1016/S0033-3182(97)71500-7; COHEN LM, 1993, PSYCHOSOMATICS, V34, P395, DOI 10.1016/S0033-3182(93)71842-3; DAVISON S, 2002, SEMIN DIALYSIS, V15, P1; DESOUSA R, 1987, RATIONALITY EMOTION, P195; ELLIOTT TR, 1991, J PERS SOC PSYCHOL, V61, P608, DOI 10.1037/0022-3514.61.4.608; Forbes MA, 1999, ADV NURS SCI, V22, P74, DOI 10.1097/00012272-199912000-00008; GOOD MJD, 1994, SOC SCI MED, V38, P855, DOI 10.1016/0277-9536(94)90157-0; Hines S C, 2001, J Palliat Med, V4, P481, DOI 10.1089/109662101753381629; Hines SC, 1999, ANN INTERN MED, V130, P825, DOI 10.7326/0003-4819-130-10-199905180-00016; Holley JL, 1999, AM J KIDNEY DIS, V33, P688, DOI 10.1016/S0272-6386(99)70220-9; HOLLEY JL, 1993, AM J KIDNEY DIS, V22, P413, DOI 10.1016/S0272-6386(12)70144-0; JOHNSTON SC, 1995, ARCH INTERN MED, V155, P1025, DOI 10.1001/archinte.155.10.1025; KODISH E, 1995, J CLIN ONCOL, V13, P1817, DOI 10.1200/JCO.1995.13.7.1817; MIYAJI NT, 1993, SOC SCI MED, V36, P264; MORRISON RS, 1994, ARCH INTERN MED, V154, P2311, DOI 10.1001/archinte.154.20.2311; MOSS AH, 1992, J AM SOC NEPHROL, V3, P1238; Moss AH, 2001, AM J KIDNEY DIS, V38, P847, DOI 10.1053/ajkd.2001.27705; Perry E, 1996, J AM SOC NEPHROL, V7, P2160; SARDELL AN, 1993, CANCER, V72, P3355, DOI 10.1002/1097-0142(19931201)72:11<3355::AID-CNCR2820721135>3.0.CO;2-D; Simpson C, 2004, BIOETHICS, V18, P428, DOI 10.1111/j.1467-8519.2004.00408.x; Thorne S, 1997, RES NURS HEALTH, V20, P169; Thorne S., 2004, INT J QUAL METH, V3, P1, DOI [DOI 10.1177/160940690400300101, 10.1177/160940690400300101]; *US REN DAT SYST N, 2004, US REN DAT SYST USRD; WONGWYLIE G, 1997, QUAL HEALTH RES, V7, P56	29	189	193	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 28	2006	333	7574					886	889		10.1136/bmj.38965.626250.55	http://dx.doi.org/10.1136/bmj.38965.626250.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	101WT	16990294	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000241772600015
J	Ginsburg, GS; Angrist, M; Cook-Deegan, R				Ginsburg, Geoffrey S.; Angrist, Misha; Cook-Deegan, Robert			Genomics and medicine at a crossroads in Chernobyl	SCIENCE			English	Editorial Material							CLEANUP WORKERS; IONIZING-RADIATION; IRRADIATION; ACCIDENT; CELLS		Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Ginsburg, GS (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237				BELLABY MD, 2006, ASS PRESS       0422; Braselmann H, 2005, MUTAT RES-FUND MOL M, V578, P124, DOI 10.1016/j.mrfmmm.2005.04.006; *CHERN FOR, 2005, CHERN LEG HLTH ENV S; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; Eged K, 2001, HEALTH PHYS, V80, P137, DOI 10.1097/00004032-200102000-00004; Gluzman D, 2005, HEMATOL J, V5, P565, DOI 10.1038/sj.thj.6200568; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605, DOI 10.1176/ajp.154.11.1605; Herodin F, 2005, FOLIA HISTOCHEM CYTO, V43, P223; *ICRP, 2005, OPT RAD PROT; Jacquet P, 2004, J BIOL REG HOMEOS AG, V18, P106; Kellerer AM, 2002, RADIAT ENVIRON BIOPH, V41, P1, DOI 10.1007/s00411-002-0150-y; KRUSHELNYCKY A, 2006, SUNDAY TIMES    0423; Mazurik V K, 2004, Radiats Biol Radioecol, V44, P296; Neronova E, 2003, RADIAT RES, V160, P46, DOI 10.1667/0033-7587(2003)160[0046:CAICWS]2.0.CO;2; Rahu M, 2006, INT J CANCER, V119, P162, DOI 10.1002/ijc.21733; Rahu M, 2003, EUR J CANCER, V39, P295, DOI 10.1016/S0959-8049(02)00764-5; SCHMIEMAN EA, 2006, NUCL ENG INT    0406; Silasi G, 2004, BIOCHEM BIOPH RES CO, V325, P1223, DOI 10.1016/j.bbrc.2004.10.166; Smith MT, 2005, CHEM-BIOL INTERACT, V153, P123, DOI 10.1016/j.cbi.2005.03.017; Stone R, 2006, SCIENCE, V312, P180, DOI 10.1126/science.312.5771.180; Touil N, 2002, MUTAGENESIS, V17, P223, DOI 10.1093/mutage/17.3.223	21	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					62	63		10.1126/science.1130274	http://dx.doi.org/10.1126/science.1130274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023637				2022-12-01	WOS:000241031200028
J	Yang, LQ; Lin, CR; Liu, ZR				Yang, Liuqing; Lin, Chunru; Liu, Zhi-Ren			P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from beta-catenin	CELL			English	Article							SRC FAMILY KINASES; GROWTH-FACTOR-BETA; C-ABL; TYROSINE PHOSPHORYLATION; TUMOR-METASTASIS; DNA-DAMAGE; PROTEIN; EXPRESSION; WNT; DIFFERENTIATION	The nuclear p68 RNA helicase (referred to as p68) is a prototypical member of the DEAD box family of RNA helicases. The protein plays a very important role in early organ development. In the present study, we characterized the tyrosine phosphorylation of p68 under platelet-derived growth factor (PDGF) stimulation. We demonstrated that tyrosine phosphorylation of p68 at Y593 mediated PDGF-stimulated epithelial-mesenchymal transition (EMT). We showed that PDGF treatment led to phosphorylation of p68 at Y593 in the cell nucleus. The Y593-phosphorylated p68 (referred to as phosphor-p68) promotes beta-catenin nuclear translocation via a Wnt-independent pathway. The phosphor-p68 facilitates beta-catenin nuclear translocation by blocking phosphorylation of beta-catenin by GSK-3 beta and displacing Axin from beta-catenin. The beta-catenin nuclear translocation and subsequent interaction with the LEF/TCF was required for the EMT process. These data demonstrated a novel mechanism of phosphor-p68 in mediating the growth factor-induced EMT and uncovered a new pathway to promote beta-catenin nuclear translocation.	Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Yang, LQ (corresponding author), Georgia State Univ, Dept Biol, Univ Plaza, Atlanta, GA 30303 USA.	biozrl@langate.gsu.edu	Yang, Liuqing/B-7935-2011		NIGMS NIH HHS [GM063874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boyer B, 1997, EMBO J, V16, P5904, DOI 10.1093/emboj/16.19.5904; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; CALUSEVIC M, 2001, ONCOGENE, V20, P7734; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Hirabayashi S, 2004, J NEUROCHEM, V90, P332, DOI 10.1111/j.1471-4159.2004.02497.x; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Kahlina K, 2004, J BIOL CHEM, V279, P44872, DOI 10.1074/jbc.M402467200; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu ZR, 1998, MOL CELL BIOL, V18, P6910, DOI 10.1128/MCB.18.12.6910; Lu J, 2001, DEV BIOL, V240, P404, DOI 10.1006/dbio.2001.0403; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; NESON WJ, 2004, SCIENCE, V303, P1483; Nicol SM, 2000, EXP CELL RES, V257, P272, DOI 10.1006/excr.2000.4886; Pagan R, 1999, J HEPATOL, V31, P895, DOI 10.1016/S0168-8278(99)80292-X; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Seufert DW, 2000, J EXP ZOOL, V288, P193, DOI 10.1002/1097-010X(20001015)288:3<193::AID-JEZ1>3.0.CO;2-V; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Wei Y, 2001, Yi Chuan Xue Bao, V28, P991; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yang LQ, 2004, PROTEIN EXPRES PURIF, V35, P327, DOI 10.1016/j.pep.2004.02.004; Yang LQ, 2004, BIOCHEM BIOPH RES CO, V314, P622, DOI 10.1016/j.bbrc.2003.12.129; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	50	228	236	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					139	155		10.1016/j.cell.2006.08.036	http://dx.doi.org/10.1016/j.cell.2006.08.036			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018282	Bronze			2022-12-01	WOS:000241445800020
J	Bibring, JP; Squyres, SW; Arvidson, RE				Bibring, Jean-Pierre; Squyres, Steven W.; Arvidson, Raymond E.			Merging views on Mars	SCIENCE			English	Editorial Material							MERIDIANI-PLANUM		Inst Astrophys Spatiale, Orsay, France; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Cornell University; Washington University (WUSTL)	Arvidson, RE (corresponding author), Inst Astrophys Spatiale, Orsay, France.	arvidson@wunder.wustl.edu						Bibring J.-P., 2004, EUR SPACE AGENCY SPE, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; 2006, 1 MER OMEGA WORKSH V	8	20	22	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1899	1901		10.1126/science.1132311	http://dx.doi.org/10.1126/science.1132311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008516				2022-12-01	WOS:000240832200034
J	Veneman, AM				Veneman, Ann M.			Achieving Millennium Development Goal 4	LANCET			English	Editorial Material							CHILDREN		UNICEF, New York, NY 10017 USA	UNICEF	Veneman, AM (corresponding author), UNICEF, New York, NY 10017 USA.	psalama@unicef.org						*BEST PRACT PRINC, 2005, BACKGR PAP HIGH LEV; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BOERMA T, 2006, B WORLD HEALTH ORGAN, V84, P145; BRYCE J, 2006, LANCET          0918, DOI [10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)69339-2]; Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4; HOEKSTRA E, 2006, LANCET          0918; LAWN JE, 2005, LANCET, V364, P9; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; STOLTENBERG J, 2006, LANCET          0918; UNAIDS, 2006, REP GLOB AIDS EP; *UNICEF, 2006, ACC CHILD SURV DEV P; *UNICEF, 2006, UNICEF JOINT HLTH NU; WARDLAW T, 2006, LANCET          0918, DOI DOI 10.1016/S0140-6736(06)69334-3	13	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1044	1047		10.1016/S0140-6736(06)69333-1	http://dx.doi.org/10.1016/S0140-6736(06)69333-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997648				2022-12-01	WOS:000240873000006
J	Yeromin, AV; Zhang, SYL; Jiang, WH; Yu, Y; Safrina, O; Cahalan, MD				Yeromin, Andriy V.; Zhang, Shenyuan L.; Jiang, Weihua; Yu, Ying; Safrina, Olga; Cahalan, Michael D.			Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai	NATURE			English	Article							OPERATED CALCIUM-CHANNEL; ACTIVATED CA2+ CHANNELS; PLASMA-MEMBRANE; T-LYMPHOCYTES; MIC CHANNELS; I-CRAC; STORE; CELLS; STIM1; POTENTIATION	Recent RNA interference screens have identified several proteins that are essential for store-operated Ca2+ influx and Ca2+ release-activated Ca2+ ( CRAC) channel activity in Drosophila and in mammals, including the transmembrane proteins Stim ( stromal interaction molecule)(1,2) and Orai(3-5). Stim probably functions as a sensor of luminal Ca2+ content and triggers activation of CRAC channels in the surface membrane after Ca2+ store depletion(1,6). Among three human homologues of Orai ( also known as olf186-F), ORAI1 on chromosome 12 was found to be mutated in patients with severe combined immunodeficiency disease, and expression of wild-type Orai1 restored Ca2+ influx and CRAC channel activity in patient T cells(3). The overexpression of Stim and Orai together markedly increases CRAC current(5,7-9). However, it is not yet clear whether Stim or Orai actually forms the CRAC channel, or whether their expression simply limits CRAC channel activity mediated by a different channel-forming subunit. Here we show that interaction between wild-type Stim and Orai, assessed by coimmunoprecipitation, is greatly enhanced after treatment with thapsigargin to induce Ca2+ store depletion. By site-directed mutagenesis, we show that a point mutation from glutamate to aspartate at position 180 in the conserved S1 - S2 loop of Orai transforms the ion selectivity properties of CRAC current from being Ca2+-selective with inward rectification to being selective for monovalent cations and outwardly rectifying. A charge-neutralizing mutation at the same position ( glutamate to alanine) acts as a dominant-negative non-conducting subunit. Other charge-neutralizing mutants in the same loop express large inwardly rectifying CRAC current, and two of these exhibit reduced sensitivity to the channel blocker Gd3+. These results indicate that Orai itself forms the Ca2+-selectivity filter of the CRAC channel.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu			NINDS NIH HHS [R37 NS014609-28, R37 NS014609] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; MERCER JC, 2006, J BIOL CHEM     0628; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zweifach A, 1996, J GEN PHYSIOL, V107, P597, DOI 10.1085/jgp.107.5.597; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	23	646	673	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					226	229		10.1038/nature05108	http://dx.doi.org/10.1038/nature05108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16921385	Green Accepted			2022-12-01	WOS:000240467000050
J	Coker, R; Mounier-Jack, S				Coker, Richard; Mounier-Jack, Sandra			Pandemic influenza preparedness in the Asia-Pacific region	LANCET			English	Article								Concerns are mounting that the threat of another influenza pandemic will become a reality and that the epicentre of the outbreak could be the Asia-Pacific region. We assessed the documents that some Asia-Pacific countries have published as part of preparedness planning for an outbreak of influenza in people. Regional approaches were polarised. Thailand, China, and Vietnam had set out a strategic vision to strengthen future capacity in preparedness planning. By contrast, Hong Kong, Australia, and New Zealand took a strategic approach aimed mainly at harnessing available resources or preparing for the deployment of resources such as stockpiled antiviral agents and vaccines. The plans of Hong Kong, Australia, and New Zealand compared favourably with the best European plans. The plans of resource-poor countries addressed some issues that were largely neglected by most European plans. Other countries (including those that do not yet have plans) could benefit from analysis of the strengths and weaknesses of the plans drawn up by countries in the region and in Europe.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	richard.coker@lshtm.ac.uk						Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5	2	80	80	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					886	889		10.1016/S0140-6736(06)69209-X	http://dx.doi.org/10.1016/S0140-6736(06)69209-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950366	Green Published, Bronze			2022-12-01	WOS:000240371200036
J	Gould, IM				Gould, Ian M.			Community-acquired MRSA: can we control it?	LANCET			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; INFECTIONS; EMERGENCE; COLONIZATION; PNEUMONIA; BARS; SKIN		Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Gould, IM (corresponding author), Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen AB25 2ZN, Scotland.	i.m.gould@abdn.ac.uk						Barrett SP, 1998, J HOSP INFECT, V39, P85, DOI 10.1016/S0195-6701(98)90322-X; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Chickering HT, 1919, J AMER MED ASSOC, V72, P617, DOI 10.1001/jama.1919.02610090001001; Coia JE, 2006, J HOSP INFECT, V63, P354, DOI 10.1016/j.jhin.2006.03.004; COIA JE, 2006, J HOSP INFECT S1, V63, P44; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Dancer SJ, 2006, J HOSP INFECT, V62, P261, DOI 10.1016/j.jhin.2005.09.018; Diederen BMW, 2006, J INFECTION, V52, P157, DOI 10.1016/j.jinf.2005.09.001; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Jensen JUS, 2006, J HOSP INFECT, V63, P84, DOI 10.1016/j.jhin.2005.10.016; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Moellering RC, 2006, ANN INTERN MED, V144, P368, DOI 10.7326/0003-4819-144-5-200603070-00014; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Que TL, 2003, EUR J CLIN MICROBIOL, V22, P268, DOI 10.1007/s10096-002-0880-4; ROUNDTREE P. M., 1958, MED JOUR AUSTRALIA II, V45, P789; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978	19	25	25	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					824	826		10.1016/S0140-6736(06)69303-3	http://dx.doi.org/10.1016/S0140-6736(06)69303-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950342				2022-12-01	WOS:000240371200008
J	Seeger, MA; Schiefner, A; Eicher, T; Verrey, F; Diederichs, K; Pos, KM				Seeger, Markus A.; Schiefner, Andre; Eicher, Thomas; Verrey, Francois; Diederichs, Kay; Pos, Klaas M.			Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism	SCIENCE			English	Article							MULTIDRUG EFFLUX SYSTEM; ATOMIC-RESOLUTION STRUCTURES; ORGANIC-SOLVENT TOLERANCE; MEDIATED DRUG-RESISTANCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; TRANSPORTER ACRB; REENTRANT LOOP; BACTERIORHODOPSIN	The AcrA/AcrB/TolC complex spans the inner and outer membranes of Escherichia coli and serves as its major drug-resistance pump. Driven by the proton motive force, it mediates the efflux of bile salts, detergents, organic solvents, and many structurally unrelated antibiotics. Here, we report a crystallographic structure of trimeric AcrB determined at 2.9 and 3.0 angstrom resolution in space groups that allow asymmetry of the monomers. This structure reveals three different monomer conformations representing consecutive states in a transport cycle. The structural data imply an alternating access mechanism and a novel peristaltic mode of drug transport by this type of transporter.	Univ Zurich, Inst Physiol, Zurich, Switzerland; Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Konstanz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pos, KM (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, Zurich, Switzerland.	kmpos@access.unizh.ch		Seeger, Markus/0000-0003-1761-8571; Verrey, Francois/0000-0003-3250-9824; Schiefner, Andre/0000-0001-5215-4122				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Edmonds BW, 2004, FRONT BIOSCI-LANDMRK, V9, P1556, DOI 10.2741/1264; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lanyi JK, 2004, MOL MEMBR BIOL, V21, P143, DOI 10.1080/09687680410001666345; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Luecke H, 2000, BBA-BIOENERGETICS, V1460, P133, DOI 10.1016/S0005-2728(00)00135-3; Markham PN, 2001, CURR OPIN MICROBIOL, V4, P509, DOI 10.1016/S1369-5274(00)00243-5; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nehme D, 2005, ANTIMICROB AGENTS CH, V49, P4375, DOI 10.1128/AAC.49.10.4375-4378.2005; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Pos KM, 2004, FEBS LETT, V564, P333, DOI 10.1016/S0014-5793(04)00272-8; Pos KM, 2002, ACTA CRYSTALLOGR D, V58, P1865, DOI 10.1107/S0907444902013963; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	34	413	431	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1295	1298		10.1126/science.1131542	http://dx.doi.org/10.1126/science.1131542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946072	Green Submitted			2022-12-01	WOS:000240313500043
J	Irvine, DV; Zaratiegui, M; Tolia, NH; Goto, DB; Chitwood, DH; Vaughn, MW; Joshua-Tor, L; Martienssen, RA				Irvine, Danielle V.; Zaratiegui, Mikel; Tolia, Niraj H.; Goto, Derek B.; Chitwood, Daniel H.; Vaughn, Matthew W.; Joshua-Tor, Leemor; Martienssen, Robert A.			Argonaute slicing is required for heterochromatic silencing and spreading	SCIENCE			English	Article							FISSION YEAST; RNA INTERFERENCE; HISTONE H3; METHYLATION; DROSOPHILA; RISC; TRANSCRIPTION; COMPLEX; RITS; DNA	Small interfering RNA ( siRNA) guides dimethylation of histone H3 lysine-9 (H3K9me2) via the Argonaute and RNA-dependent RNA polymerase complexes, as well as base-pairing with either RNA or DNA. We show that Argonaute requires the conserved aspartate-aspartate-histidine motif for heterochromatic silencing and for ribonuclease H - like cleavage ( slicing) of target messages complementary to siRNA. In the fission yeast Schizosaccharomyces pombe, heterochromatic repeats are transcribed by polymerase II. We show that H3K9me2 spreads into silent reporter genes when they are embedded within these transcripts and that spreading requires read-through transcription, as well as slicing by Argonaute. Thus, siRNA guides histone modification by base-pairing interactions with RNA.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Chitwood, Daniel/M-2841-2013; Tolia, Niraj H/D-2332-2014; Goto, Derek B/B-7053-2009	Chitwood, Daniel/0000-0003-4875-1447; Tolia, Niraj H/0000-0002-2689-1337; Joshua-Tor, Leemor/0000-0001-8185-8049; Zaratiegui, Mikel/0000-0002-0342-0268; Vaughn, Matthew/0000-0002-1384-4283	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396, R01GM067014, R01GM072659] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM072659, R01 GM076396-01A1, R01 GM076396, R01-GM067014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARKAN A, 1991, P NATL ACAD SCI USA, V88, P3502, DOI 10.1073/pnas.88.8.3502; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; LI F, 2002, CURR BIOL; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MARTIENSSEN R, 2003, RNAI GUIDE GENE SILE; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Talbert PB, 2000, GENETICS, V154, P259; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	27	156	172	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1134	1137		10.1126/science.1128813	http://dx.doi.org/10.1126/science.1128813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931764				2022-12-01	WOS:000239998200050
J	Cruts, M; Gijselinck, I; van der Zee, J; Engelborghs, S; Wils, H; Pirici, D; Rademakers, R; Vandenberghe, R; Dermaut, B; Martin, JJ; van Duijn, C; Peeters, K; Sciot, R; Santens, P; De Pooter, T; Mattheijssens, M; Van den Broeck, M; Cuijt, I; Vennekens, K; De Deyn, PP; Kumar-Singh, S; Van Broeckhoven, C				Cruts, Marc; Gijselinck, Ilse; van der Zee, Julie; Engelborghs, Sebastiaan; Wils, Hans; Pirici, Daniel; Rademakers, Rosa; Vandenberghe, Rik; Dermaut, Bart; Martin, Jean-Jacques; van Duijn, Cornelia; Peeters, Karin; Sciot, Raf; Santens, Patrick; De Pooter, Tim; Mattheijssens, Maria; Van den Broeck, Marleen; Cuijt, Ivy; Vennekens, Krist'l; De Deyn, Peter P.; Kumar-Singh, Samir; Van Broeckhoven, Christine			Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21	NATURE			English	Article							VALOSIN-CONTAINING PROTEIN; GROWTH-FACTOR; LOBAR DEGENERATION; PICKS-DISEASE; TAU; INCLUSIONS; EXPRESSION; GRANULIN; FAMILY; GENE	Frontotemporal dementia (FTD) with ubiquitin-immunoreactive neuronal inclusions ( both cytoplasmic and nuclear) of unknown nature has been linked to a chromosome 17q21 region (FTDU-17) containing MAPT (microtubule-associated protein tau)(1-3). FTDU-17 patients have consistently been shown to lack a tau-immunoreactive pathology(1-3), a feature characteristic of FTD with parkinsonism linked to mutations in MAPT (FTDP-17)(4). Furthermore, in FTDU-17 patients, mutations in MAPT and genomic rearrangements in the MAPT region have been excluded by both genomic sequencing(5) and fluorescence in situ hybridization on mechanically stretched chromosomes(6). Here we demonstrate that FTDU-17 is caused by mutations in the gene coding for progranulin (PGRN), a growth factor involved in multiple physiological and pathological processes including tumorigenesis(7). Besides the production of truncated PGRN proteins due to premature stop codons(8), we identified a mutation within the splice donor site of intron 0 (IVS0+5G> C), indicating loss of the mutant transcript by nuclear degradation. The finding was made within an extensively documented Belgian FTDU-17 founder family(3). Transcript and protein analyses confirmed the absence of the mutant allele and a reduction in the expression of PGRN. We also identified a mutation ( c. 3G>A) in the Met1 translation initiation codon, indicating loss of PGRN due to lack of translation of the mutant allele. Our data provide evidence that PGRN haploinsufficiency leads to neurodegeneration because of reduced PGRN-mediated neuronal survival. Furthermore, in a Belgian series of familial FTD patients, PGRN mutations were 3.5 times more frequent than mutations in MAPT, underscoring a principal involvement of PGRN in FTD pathogenesis.	Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, BE-2610 Antwerp, Belgium; Inst Born Bunge, Neurogenet Lab, BE-2610 Antwerp, Belgium; Inst Born Bunge, Lab Neurochem & Behav, BE-2610 Antwerp, Belgium; Inst Born Bunge, Neuropathol Lab, BE-2610 Antwerp, Belgium; Univ Antwerp, BE-2610 Antwerp, Belgium; Middleheim Gen Hosp, Dept Neurol, Memory Clin, BE-2610 Antwerp, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Pathol, BE-3000 Louvain, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurol, BE-3000 Louvain, Belgium; Univ Ghent, State Univ Ghent Hosp, Dept Neurol, BE-9000 Ghent, Belgium; Erasmus MC, Dept Epidemiol & Biostat, Genet Epidemiol Grp, NL-3000 DR Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Van Broeckhoven, C (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, Univ Pl 1, BE-2610 Antwerp, Belgium.	christine.vanbroeckhoven@ua.ac.be	Pirici, Daniel/C-5760-2012; Dermaut, Bart/AAM-2483-2020; Vandenberghe, Rik/K-2145-2014; Kumar-Singh, Samir/G-6280-2012; Van Broeckhoven, Christine/G-8362-2017; santens, patrick/O-2505-2013; Vandenberghe, Rik/AAR-7485-2020; Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/M-7853-2019	Pirici, Daniel/0000-0001-9192-7319; Vandenberghe, Rik/0000-0001-6237-2502; Kumar-Singh, Samir/0000-0001-9466-6732; Van Broeckhoven, Christine/0000-0003-0183-7665; Vandenberghe, Rik/0000-0001-6237-2502; Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Duijn, Cornelia/0000-0002-2374-9204; Santens, Patrick/0000-0002-8886-9776; Pirici, Daniel/0000-0002-0196-0949; sciot, raf/0000-0003-2244-5839				Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; BAKER M, 2006, NATURE          0716; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; CRUTS M, IN PRESS CURR ALZHEI; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Engelborghs S, 2003, J NEUROL NEUROSUR PS, V74, P1148, DOI 10.1136/jnnp.74.8.1148; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; GIJSELINCK I, IN PRESS HUM MUTAT; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Liau LM, 2000, CANCER RES, V60, P1353; Mackenzie IR, 2006, BRAIN, V129, P853, DOI 10.1093/brain/awh724; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pirici D, 2006, J NEUROPATH EXP NEUR, V65, P289, DOI 10.1097/01.jnen.0000205147.39210.c7; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; Rosso SM, 2001, BRAIN, V124, P1948, DOI 10.1093/brain/124.10.1948; Rozen S, 2000, Methods Mol Biol, V132, P365; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Suzuki M, 2002, MOL GENET METAB, V75, P31, DOI 10.1006/mgme.2001.3274; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; van der Zee J, 2006, BRAIN, V129, P841, DOI 10.1093/brain/awl029; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	28	1121	1147	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					920	924		10.1038/nature05017	http://dx.doi.org/10.1038/nature05017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16862115				2022-12-01	WOS:000239960500038
J	Ohmoto, H; Watanabe, Y; Ikemi, H; Poulson, SR; Taylor, BE				Ohmoto, Hiroshi; Watanabe, Yumiko; Ikemi, Hiroaki; Poulson, Simon R.; Taylor, Bruce E.			Sulphur isotope evidence for an oxic Archaean atmosphere	NATURE			English	Article							FRACTIONATION; MICROPROBE; RISE	The presence of mass-independently fractionated sulphur isotopes (MIF-S) in many sedimentary rocks older than similar to 2.4 billion years (Gyr), and the absence of MIF-S in younger rocks, has been considered the best evidence for a dramatic change from an anoxic to oxic atmosphere around 2.4 Gyr ago(1-9). This is because the only mechanism known to produce MIF-S has been ultraviolet photolysis of volcanic sulphur dioxide gas in an oxygen-poor atmosphere. Here we report the absence of MIF-S throughout similar to 100-m sections of 2.76-Gyr-old lake sediments and 2.92-Gyr-old marine shales in the Pilbara Craton, Western Australia. We propose three possible interpretations of the MIF-S geologic record: ( 1) the level of atmospheric oxygen fluctuated greatly during the Archaean era; ( 2) the atmosphere has remained oxic since similar to 3.8 Gyr ago, and MIF-S in sedimentary rocks represents times and regions of violent volcanic eruptions that ejected large volumes of sulphur dioxide into the stratosphere; or ( 3) MIF-S in rocks was mostly created by non-photochemical reactions during sediment diagenesis, and thus is not linked to atmospheric chemistry.	Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Kyushu Univ, Inst Technol, Fukuoka 8128581, Japan; Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA; Geol Survey Canada, Ottawa, ON K1A 0E8, Canada	National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kyushu University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Ohmoto, H (corresponding author), Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA.	ohmoto@geosc.psu.edu	Ikemi, Hiroaki/AAX-5903-2021	Ikemi, Hiro/0000-0002-6557-051X				Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BUICK R, 2005, 16 JOINT M EARTH PLA; Deines P, 2003, CHEM GEOL, V199, P179, DOI 10.1016/S0009-2541(03)00076-7; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HICKMAN AH, 1983, GSWA B, V127, P83; Hu GX, 2003, GEOCHIM COSMOCHIM AC, V67, P3101, DOI 10.1016/S0016-7037(02)00929-8; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Kasting James F., 1998, P35; Kasting JF, 2001, SCIENCE, V293, P819, DOI 10.1126/science.1063811; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Nisbet E.G., 1987, YOUNG EARTH INTRO AR, V1; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Ohmoto H, 1990, PUBLICATION U W AUST, V23, P70; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Pickard AL, 2004, SEDIMENT GEOL, V170, P37, DOI 10.1016/j.sedgeo.2004.06.007; Savarino J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018134; THORNE AM, 2001, GSWA B, V144, P21; Tomlinson KY, 2001, GEOL S AM S, P341; Tyson R.V., 1995, SEDIMENTARY ORGANIC, P81; VANKRANENDONK MJ, 2004, GEOLOGICAL SURVEY W, P49; WATANABE Y, 2006, EOS S, V87; WING BA, 2004, ABSTR PROGR GEOL SOC, V36	28	174	177	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2006	442	7105					908	911		10.1038/nature05044	http://dx.doi.org/10.1038/nature05044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16929296				2022-12-01	WOS:000239960500035
J	Foger, N; Rangell, L; Danilenko, DM; Chan, AC				Foeger, Niko; Rangell, Linda; Danilenko, Dimitry M.; Chan, Andrew C.			Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis	SCIENCE			English	Article							ARP2/3 COMPLEX; ACTIN NUCLEATION; PROTEIN CORONIN; ACTIVATION; MOTILITY; POLYMERIZATION; CYTOSKELETON; CYTOKINESIS; APOPTOSIS; FILAMENTS	The evolutionarily conserved actin-related protein (Arp2/3) complex is a key component of actin filament networks that is dynamically regulated by nucleation-promoting and inhibitory factors. Although much is known about actin assembly, the physiologic functions of inhibitory proteins are unclear. We generated coronin 1(-/-) mice and found that coronin 1 exerted an inhibitory effect on cellular steady-state F-actin formation via an Arp2/3-dependent mechanism. Whereas coronin 1 was required for chemokine-mediated migration, it was dispensable for T cell antigen receptor functions in T cells. Moreover, actin dynamics, through a mitochondrial pathway, was linked to lymphocyte homeostasis.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Chan, AC (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	acc@gene.com		Danilenko, Dimitry/0000-0002-8326-1921				Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BROCK MA, 1993, J CELL PHYSIOL, V157, P367, DOI 10.1002/jcp.1041570221; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Fukui Y, 1999, CELL MOTIL CYTOSKEL, V42, P204, DOI 10.1002/(SICI)1097-0169(1999)42:3<204::AID-CM4>3.0.CO;2-L; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Grogan A, 1997, J CELL SCI, V110, P3071; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; RAO KMK, 1992, J GERONTOL, V47, P37; Rengan R, 2000, BLOOD, V95, P1283, DOI 10.1182/blood.V95.4.1283.004k44_1283_1292; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200	25	188	202	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					839	842		10.1126/science.1130563	http://dx.doi.org/10.1126/science.1130563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902139				2022-12-01	WOS:000239671300061
J	Savard, J; Marques-Souza, H; Aranda, M; Tautz, D				Savard, Joel; Marques-Souza, Henrique; Aranda, Manuel; Tautz, Diethard			A segmentation gene in Tribolium produces a polycistronic mRNA that codes for multiple conserved peptides	CELL			English	Article							CELL-PENETRATING PEPTIDES; DROSOPHILA-MELANOGASTER; BEETLE TRIBOLIUM; HYBRIDIZATION; EXPRESSION; HUNCHBACK; DATABASE; EMBRYO	Segmentation genes in insects are required for generating the subdivisions of the early embryo. We describe here a new member of the gap family of segmentation genes in the flour beetle Tribolium, mille-pattes (mlpt). mlpt knockdown leads to transformation of the abdominal segments into thoracic segments, providing embryos with up to ten pairs of legs. We show that there are crossregulatory interactions between mlpt and the known gap genes in Tribolium, suggesting that mlpt is itself a gap gene. The mlpt gene reveals an unusual structure, as it encodes a polycistronic mRNA that codes for four peptides. mlpt appears to be the prototype of this previously unknown gene structure in eukaryotes, as we find homologous genes with the same polycistronic arrangement in other insect genomes; as well.	Univ Cologne, Dept Genet, D-50674 Cologne, Germany	University of Cologne	Tautz, D (corresponding author), Univ Cologne, Dept Genet, Zulpicerstr 47, D-50674 Cologne, Germany.	tautz@uni-koeln.de	Tautz, Diethard/D-4304-2011; Aranda Lastra, Manuel/D-9530-2011; Marques-Souza, Henrique/X-5865-2019; Tautz, Diethard/H-8436-2014	Aranda Lastra, Manuel/0000-0001-6673-016X; Tautz, Diethard/0000-0002-0460-5344; Marques-Souza, Henrique/0000-0002-5008-8413				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews J, 1996, GENETICS, V143, P1699; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Bosch TCG, 2001, BIOESSAYS, V23, P420, DOI 10.1002/bies.1060; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Brown SJ, 2003, GENET RES, V82, P155, DOI 10.1017/S0016672303006451; Bucher G, 2004, DEVELOPMENT, V131, P1729, DOI 10.1242/dev.01073; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Cerny AC, 2005, DEVELOPMENT, V132, P5353, DOI 10.1242/dev.02154; Eckert C, 2004, EMBO REP, V5, P638, DOI 10.1038/sj.embor.7400148; El-Andaloussi S, 2005, CURR PHARM DESIGN, V11, P3597, DOI 10.2174/138161205774580796; Erdmann VA, 1999, NUCLEIC ACIDS RES, V27, P192, DOI 10.1093/nar/27.1.192; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; HULSKAMP M, 1991, BIOESSAYS, V13, P261, DOI 10.1002/bies.950130602; Klingler M, 2004, CURR BIOL, V14, pR639, DOI 10.1016/j.cub.2004.08.004; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; PANKRATZ MJ, 1990, TRENDS GENET, V6, P287, DOI 10.1016/0168-9525(90)90234-W; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; SAVARD J, 2004, THESIS U COLOGNE COL; Schroder R, 2000, P NATL ACAD SCI USA, V97, P6591, DOI 10.1073/pnas.100005497; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Wolff C, 1995, DEVELOPMENT, V121, P4227	31	106	109	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 11	2006	126	3					559	569		10.1016/j.cell.2006.05.053	http://dx.doi.org/10.1016/j.cell.2006.05.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901788	Bronze			2022-12-01	WOS:000239883400015
J	Denic, V; Quan, EM; Weissman, JS				Denic, Vladimir; Quan, Erin M.; Weissman, Jonathan S.			A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; UNFOLDED PROTEIN RESPONSE; MANNOSIDASE-LIKE PROTEIN; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; RETRO-TRANSLOCATION; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; IDENTIFIES YOS9P	How the ER-associated degradation (ERAD) machinery accurately identifies terminally misfolded proteins is poorly understood. For luminal ERAD substrates, this recognition depends on their folding and glycosylation status as well as on the conserved ER lectin Yos9p. Here we show that Yos9p is part of a stable complex that organizes key components of ERAD machinery on both sides of the ER membrane, including the transmembrane ubiquitin ligase Hrd1p. We further demonstrate that Yos9p, together with Kar2p and Hrd3p, forms a luminal surveillance complex that both recruits nonnative proteins to the core ERAD machinery and assists a distinct sugar-dependent step necessary to commit substrates for degradation. When Hrd1p is uncoupled from the Yos9p surveillance complex, degradation can occur independently of the requirement for glycosylation. Thus, Yos9p/Kar2p/Hrd3p acts as a gatekeeper, ensuring correct identification of terminally misfolded proteins by recruiting misfolded forms to the ERAD machinery, contributing to the interrogation of substrate sugar status, and preventing glycosylation-independent degradation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Adams J, 2002, CURR OPIN CHEM BIOL, V6, P493, DOI 10.1016/S1367-5931(02)00343-5; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Jakob CA, 2001, EMBO REP, V2, P423; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jimenez C., 1998, CURRENT PROTOCOLS PR; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Plemper RK, 1999, J CELL SCI, V112, P4123; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	54	326	333	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					349	359		10.1016/j.cell.2006.05.045	http://dx.doi.org/10.1016/j.cell.2006.05.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873065	Bronze			2022-12-01	WOS:000239552600020
J	Reysenbach, AL; Liu, YT; Banta, AB; Beveridge, TJ; Kirshtein, JD; Schouten, S; Tivey, MK; Von Damm, KL; Voytek, MA				Reysenbach, Anna-Louise; Liu, Yitai; Banta, Amy B.; Beveridge, Terry J.; Kirshtein, Julie D.; Schouten, Stefan; Tivey, Margaret K.; Von Damm, Karen L.; Voytek, Mary A.			A ubiquitous thermoacidophilic archaeon from deep-sea hydrothermal vents	NATURE			English	Article							DIVERSITY; MICROORGANISMS; ENVIRONMENTS; SEDIMENTS; BACTERIAL; CHIMNEY; GROWTH; ARC; NOV	Deep-sea hydrothermal vents are important in global biogeochemical cycles, providing biological oases at the sea floor that are supported by the thermal and chemical flux from the Earth's interior. As hot, acidic and reduced hydrothermal fluids mix with cold, alkaline and oxygenated sea water, minerals precipitate to formporous sulphide - sulphate deposits. These structures provide microhabitats for a diversity of prokaryotes that exploit the geochemical and physical gradients in this dynamic ecosystem(1). It has been proposed that fluid pH in the actively venting sulphide structures is generally low( pH < 4.5)(2), yet no extreme thermoacidophile has been isolated from vent deposits. Culture-independent surveys based on ribosomal RNA genes from deep-sea hydrothermal deposits have identified a widespread euryarchaeotal lineage, DHVE2 (deep-sea hydrothermal vent euryarchaeotic 2)(3-6). Despite the ubiquity and apparent deep-sea endemism of DHVE2, cultivation of this group has been unsuccessful and thus its metabolism remains a mystery. Here we report the isolation and cultivation of a member of the DHVE2 group, which is an obligate thermoacidophilic sulphur- or iron-reducing heterotroph capable of growing from pH 3.3 to 5.8 and between 55 and 75 degrees C. In addition, we demonstrate that this isolate constitutes up to 15% of the archaeal population, providing evidence that thermoacidophiles may be key players in the sulphur and iron cycling at deep-sea vents.	Portland State Univ, Dept Biol, Portland, OR 97201 USA; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; US Geol Survey, Reston, VA USA; Royal Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ New Hampshire, EOS, Complex Syst Res Ctr, Durham, NH 03824 USA	Portland State University; University of Guelph; United States Department of the Interior; United States Geological Survey; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Woods Hole Oceanographic Institution; University System Of New Hampshire; University of New Hampshire	Reysenbach, AL (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97201 USA.	reysenbacha@pdx.edu		Tivey, Margaret/0000-0003-3218-5882; Banta, Amy/0000-0002-1843-5059				BEVERIDGE TJ, 1999, J BACTERIOL, V7, P253; Hoek J, 2003, GEOBIOLOGY, V1, P119, DOI 10.1046/j.1472-4669.2003.00015.x; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.0.CO;2-N; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Ishibashi J.-I., 2006, EOS T AGU, V87, P13, DOI DOI 10.1029/2006EO020001; KOBAYASHI T, 2001, BERGEYS MANUAL SYSTE, P342; LANGMUIR CH, 2004, EOS, V85; Le Bris N, 2005, DEEP-SEA RES PT I, V52, P1071, DOI 10.1016/j.dsr.2005.01.003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macalady JL, 2004, EXTREMOPHILES, V8, P411, DOI 10.1007/s00792-004-0404-5; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; Moussard H, 2006, APPL ENVIRON MICROB, V72, P2268, DOI 10.1128/AEM.72.3.2268-2271.2006; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa T, 2006, ENVIRON MICROBIOL, V8, P37, DOI 10.1111/j.1462-2920.2005.00884.x; Nercessian O, 2003, ENVIRON MICROBIOL, V5, P492, DOI 10.1046/j.1462-2920.2003.00437.x; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Prokofeva MI, 2005, EXTREMOPHILES, V9, P437, DOI 10.1007/s00792-005-0461-4; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; SCHLEPER C, 1995, J BACTERIOL, V177, P7050, DOI 10.1128/jb.177.24.7050-7059.1995; Schrenk MO, 2003, APPL ENVIRON MICROB, V69, P3580, DOI 10.1128/AEM.69.6.3580-3592.2003; SEGERER A, 1988, SYST APPL MICROBIOL, V10, P161, DOI 10.1016/S0723-2020(88)80031-6; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; Takai K, 2005, INT J SYST EVOL MICR, V55, P183, DOI 10.1099/ijs.0.63330-0; Takai K, 1999, GENETICS, V152, P1285; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; Tivey MK, 2004, GEOPH MONOG SERIES, V144, P137, DOI 10.1029/144GM09; VONDAMM KL, 1995, PHYS CHEM BIOL GEOLO, P222	28	166	180	5	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					444	447		10.1038/nature04921	http://dx.doi.org/10.1038/nature04921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871216	Green Submitted			2022-12-01	WOS:000239278900041
J	Olusanya, BO; Ruben, RJ; Parving, A				Olusanya, Bolajoko O.; Ruben, Robert J.; Parving, Agnete			Reducing the burden of communication disorders in the developing world - An opportunity for the millennium development project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SENSORINEURAL HEARING-LOSS; CHRONIC DISEASES; LANGUAGE; PREVALENCE; IMPACT		Inst Child Hlth, London WC1N 1EH, England; Univ Lagos, Coll Med, Inst Child Hlth & Primary Care, Lagos, Nigeria; UCL, Great Ormond St Hosp Children NHS Trust, London, England; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bronx, NY 10467 USA; Bispebjerg Hosp, Dept Audiol, WHO, Collaborating Ctr Prevent Deafness, DK-2400 Copenhagen, Denmark	University of London; University College London; University of Lagos; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Copenhagen; Bispebjerg Hospital; World Health Organization	Olusanya, BO (corresponding author), Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	b.olusanya@ich.ucl.ac.uk	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583				Allen T., 1986, DEAF CHILDREN AM, P161, DOI DOI 10.1177/15257401050270010201; [Anonymous], 2005, STAT WORLDS CHILDR 2; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; BOYLE CA, 1994, PEDIATRICS, V93, P399; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; Elwan A., 1999, 9932 WORLD BANK; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; Munoz-Baell IM, 2000, J EPIDEMIOL COMMUN H, V54, P40, DOI 10.1136/jech.54.1.40; Olusanya B, 2005, BRIT MED J, V330, P480, DOI 10.1136/bmj.330.7489.480-c; Olusanya BO, 2006, INT J PEDIATR OTORHI, V70, P1495, DOI 10.1016/j.ijporl.2006.04.002; Parving A, 2004, ACTA OTO-LARYNGOL, V124, P416, DOI 10.1080/00016480310000638a; PARVING A, 1993, SCAND AUDIOL, V22, P133, DOI 10.3109/01050399309046029; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Schuele CM, 2004, MENT RETARD DEV D R, V10, P176, DOI 10.1002/mrdd.20014; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; *UN DEP PUBL INF, 2005, MILL DEV GOALS REP 2; *WHO, 2005, 58 WORLD HLTH ASS DI; *WHO, 1995, 48 WORLD HLTH ASS PR; *WHO, FACT SHEET DEAFN HEA; *WHO, 2001, GUID HEAR AIDS SERV; *WORLD BANK HUM DE, 2003, ED ALL INCL CHILDR D; World Health Organization, 2005, PREVENTING CHRONIC D; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	25	91	94	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					441	444		10.1001/jama.296.4.441	http://dx.doi.org/10.1001/jama.296.4.441			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066PN	16868302				2022-12-01	WOS:000239242500030
J	Baca, HK; Ashley, C; Carnes, E; Lopez, D; Flemming, J; Dunphy, D; Singh, S; Chen, Z; Liu, NG; Fan, HY; Lopez, GP; Brozik, SM; Werner-Washburne, M; Brinker, CJ				Baca, Helen K.; Ashley, Carlee; Carnes, Eric; Lopez, Deanna; Flemming, Jeb; Dunphy, Darren; Singh, Seema; Chen, Zhu; Liu, Nanguo; Fan, Hongyou; Lopez, Gabriel P.; Brozik, Susan M.; Werner-Washburne, Margaret; Brinker, C. Jeffrey			Cell-directed assembly of lipid-silica nanostructures providing extended cell viability	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; LIVING BACTERIA; MICROORGANISMS; ENCAPSULATION; FILMS; DYNAMICS; ARRAYS; ROUTE; STATE; GELS	Amphiphilic phospholipids were used to direct the formation of biocompatible, uniform silica nanostructures in the presence of Saccharomyces cerevisiae and bacterial cell lines. The cell surfaces organize multilayered phospholipid vesicles that interface coherently with the silica host and help relieve drying stresses that develop with conventional templates. These host structures maintain cell accessibility, addressability, and viability in the absence of buffer or an external fluidic architecture. The cell surfaces are accessible and can be used to localize added proteins, plasmids, and nanocrystals. Prolonged cell viability combined with reporter protein expression enabled stand-alone cell-based sensing.	Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87185 USA; Sandia Natl Labs, Albuquerque, NM 87185 USA; Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Los Alamos National Laboratory; University of New Mexico; University of New Mexico	Brinker, CJ (corresponding author), Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87185 USA.	cjbrink@sandia.gov	Chen, Zhu/M-3834-2015		PHS HHS [206-00139-06] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bottcher H, 2004, J MATER CHEM, V14, P2176, DOI 10.1039/b401724b; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; Chia SY, 2000, J AM CHEM SOC, V122, P6488, DOI 10.1021/ja0011515; Coiffier A, 2001, J MATER CHEM, V11, P2039, DOI 10.1039/b101308o; Conroy JFT, 2000, J SOL-GEL SCI TECHN, V18, P269, DOI 10.1023/A:1008704208324; deMaranon IM, 1996, BIOCHEM BIOPH RES CO, V227, P519, DOI 10.1006/bbrc.1996.1539; Doshi DA, 2003, J PHYS CHEM B, V107, P7683, DOI 10.1021/jp027214i; Doshi DA, 2003, J AM CHEM SOC, V125, P11646, DOI 10.1021/ja0295523; Fan HY, 2004, SCIENCE, V304, P567, DOI 10.1126/science.1095140; Ferrer ML, 2003, CHEM MATER, V15, P3614, DOI 10.1021/cm034372t; Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568; Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3; INAMA L, 1993, J BIOTECHNOL, V30, P197, DOI 10.1016/0168-1656(93)90113-2; Israelachvili J., 1992, INTERMOLECULAR SURFA; Kleinschmidt JH, 2002, BIOPHYS J, V83, P994, DOI 10.1016/S0006-3495(02)75225-9; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Malanoski AP, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041602; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709; POPE EJA, 1995, J SOL-GEL SCI TECHN, V4, P225, DOI 10.1007/BF00488377; Premkumar JR, 2002, CHEM MATER, V14, P2676, DOI 10.1021/cm020020v; Sahai N, 2002, J COLLOID INTERF SCI, V252, P309, DOI 10.1006/jcis.2002.8448; Service RF, 2002, SCIENCE, V297, P962, DOI 10.1126/science.297.5583.962; Sinclair MB, 2004, APPL OPTICS, V43, P2079, DOI 10.1364/AO.43.002079; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	32	133	142	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					337	341		10.1126/science.1126590	http://dx.doi.org/10.1126/science.1126590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857936				2022-12-01	WOS:000239154300040
J	Lagage, PO; Doucet, C; Pantin, E; Habart, E; Duchene, G; Menard, F; Pinte, C; Charnoz, S; Pel, JW				Lagage, Pierre-Olivier; Doucet, Coralie; Pantin, Eric; Habart, Emilie; Duchene, Gaspard; Menard, Francois; Pinte, Christophe; Charnoz, Sebastien; Pel, Jan-Willem			Anatomy of a flaring proto-planetary disk around a young intermediate-mass star	SCIENCE			English	Article							HERBIG AE/BE STARS; ISO SPECTROSCOPY; PLANET FORMATION; BETA-PICTORIS; DUST; SYSTEMS; DISTRIBUTIONS; EMISSION; NEBULA; GAS	Although planets are being discovered around stars more massive than the Sun, information about the proto-planetary disks where such planets have built up is sparse. We have imaged mid-infrared emission from polycyclic aromatic hydrocarbons at the surface of the disk surrounding the young intermediate-mass star HD 97048 and characterized the disk. The disk is in an early stage of evolution, as indicated by its large content of dust and its hydrostatic flared geometry, indicative of the presence of a large amount of gas that is well mixed with dust and gravitationally stable. The disk is a precursor of debris disks found around more-evolved A stars such as beta-Pictoris and provides the rare opportunity to witness the conditions prevailing before ( or during) planet formation.	Univ Paris 07, CEA Saclay,CNRS,Unite Mixte Rech 7158, Lab Astrophys Interact Multiechelles,Direct Sci M, Lab Rech Lois Fondamentales,Univers DAPNIA,Serv A, F-91191 Gif Sur Yvette, France; Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Grenoble 1, CNRS, Unite Mixte Rech 5571, F-38041 Grenoble, France; Univ Groningen, Groningen, Netherlands; Netherlands Fdn Res Astron, NL-7990 AA Dwingeloo, Netherlands	UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Groningen	Lagage, PO (corresponding author), Univ Paris 07, CEA Saclay,CNRS,Unite Mixte Rech 7158, Lab Astrophys Interact Multiechelles,Direct Sci M, Lab Rech Lois Fondamentales,Univers DAPNIA,Serv A, F-91191 Gif Sur Yvette, France.	Pierre-Olivier.Lagage@cea.fr		Duchene, Gaspard/0000-0002-5092-6464				Acke B, 2004, ASTRON ASTROPHYS, V426, P151, DOI 10.1051/0004-6361:20040400; Artymowicz P, 1997, ANNU REV EARTH PL SC, V25, P175, DOI 10.1146/annurev.earth.25.1.175; Authier, 2004, MESSENGER, V117, P12; Chiang EI, 2001, ASTROPHYS J, V547, P1077, DOI 10.1086/318427; DURISEN RH, 2006, PROTOSTARS PLANETS, V5; Goldreich P, 2004, ASTROPHYS J, V614, P497, DOI 10.1086/423612; Grady CA, 2005, ASTROPHYS J, V630, P958, DOI 10.1086/430731; Greaves JS, 2005, SCIENCE, V307, P68, DOI 10.1126/science.1101979; Henning T, 1998, ASTRON ASTROPHYS, V336, P565; Ida S, 2004, ASTROPHYS J, V604, P388, DOI 10.1086/381724; Kuchner MJ, 2004, ASTROPHYS J, V612, P1147, DOI 10.1086/422577; LISSAUER JJ, 1993, ANNU REV ASTRON ASTR, V31, P129, DOI 10.1146/annurev.aa.31.090193.001021; Mannings V, 2000, ASTROPHYS J, V529, P391, DOI 10.1086/308253; Meeus G, 2001, ASTRON ASTROPHYS, V365, P476, DOI 10.1051/0004-6361:20000144; ODell CR, 1997, SCIENCE, V276, P1355, DOI 10.1126/science.276.5317.1355; OSSENKOPF V, 1994, ASTRON ASTROPHYS, V291, P943; PRUSTI T, 1994, ASTRON ASTROPHYS, V292, P593; PUGET JL, 1989, ANNU REV ASTRON ASTR, V27, P161; Setiawan J, 2005, ASTRON ASTROPHYS, V437, pL31, DOI 10.1051/0004-6361:200500133; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Takeuchi T, 2005, ASTROPHYS J, V627, P286, DOI 10.1086/430393; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; van Boekel R, 2004, ASTRON ASTROPHYS, V418, P177, DOI 10.1051/0004-6361:20034331; van den Ancker ME, 1998, ASTRON ASTROPHYS, V330, P145; Van Kerckhoven C, 2002, ASTRON ASTROPHYS, V384, P568, DOI 10.1051/0004-6361:20011814; WEIDENSCHILLING SJ, 1977, ASTROPHYS SPACE SCI, V51, P153, DOI 10.1007/BF00642464; WEINTRAUB JS, 2006, P PROT PLAN 5 C WAIK, P8197	27	74	74	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					621	623		10.1126/science.1131436	http://dx.doi.org/10.1126/science.1131436			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17008490				2022-12-01	WOS:000241557800038
J	Armstrong, N; Jasti, J; Beich-Frandsen, M; Gouaux, E				Armstrong, Neali; Jasti, Jaysankar; Beich-Frandsen, Mads; Gouaux, Eric			Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor	CELL			English	Article							LIGAND-BINDING CORE; CRYSTAL-STRUCTURES; ION-CHANNEL; KINETIC-PROPERTIES; POINT MUTATION; AMPA; CYCLOTHIAZIDE; GLUR2; ACTIVATION; SITE	The canonical conformational states occupied by most ligand-gated ion channels, and many cell-surface receptors, are the resting, activated, and desensitized states. While the resting and activated states of multiple receptors are well characterized, elaboration of the structural properties of the desensitized state, a state that is by definition inactive, has proven difficult. Here we use electrical, chemical, and crystallographic experiments on the AMPA-sensitive GluR2 receptor, defining the conformational rearrangements of the agonist binding cores that occur upon desensitization of this ligand-gated ion channel. These studies demonstrate that desensitization involves the rupture of an extensive interface between domain 1 of 2-fold related glutamate-binding core subunits, compensating for the ca. 21 degrees of domain closure induced by glutamate binding. The rupture of the domain 1 interface allows the ion channel to close and thereby provides a simple explanation to the long-standing question of how agonist binding is decoupled from ion channel gating upon receptor desensitization.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Armstrong, N (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Beich-Frandsen, Mads/H-7689-2014	Gouaux, Eric/0000-0002-8549-2360; Beich-Frandsen, Mads/0000-0002-9573-5119				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOWIE D, 1993, BRIT J PHARMACOL, V109, P779, DOI 10.1111/j.1476-5381.1993.tb13642.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dingledine R, 1999, PHARMACOL REV, V51, P7; Donevan SD, 1998, NEUROSCIENCE, V87, P615, DOI 10.1016/S0306-4522(98)00109-2; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; HALL RA, 1993, BRAIN RES, V628, P345, DOI 10.1016/0006-8993(93)90978-V; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kessler M, 1996, MOL PHARMACOL, V49, P123; Koike M, 2000, J NEUROSCI, V20, P2166; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oswald RE, 2004, ADV PROTEIN CHEM, V68, P313; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2003, J NEUROSCI, V23, P847; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	41	176	179	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					85	97		10.1016/j.cell.2006.08.037	http://dx.doi.org/10.1016/j.cell.2006.08.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018279	Bronze			2022-12-01	WOS:000241445800016
J	Caraveo, G; van Rossum, DB; Patterson, RL; Snyder, SH; Desiderio, S				Caraveo, Gabriela; van Rossum, Damian B.; Patterson, Randen L.; Snyder, Solomon H.; Desiderio, Stephen			Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry	SCIENCE			English	Article							BRUTONS TYROSINE KINASE; CELL-RECEPTOR ENGAGEMENT; PHOSPHOLIPASE-C-GAMMA; INDUCED CA2+ ENTRY; ACTIVATION; EXPRESSION; GENE; IDENTIFICATION; RECOGNITION; CHANNELS	TFII-I is a transcription factor and a target of phosphorylation by Bruton's tyrosine kinase. In humans, deletions spanning the TFII-I locus are associated with a cognitive defect, the Williams-Beuren cognitive profile. We report an unanticipated role of TFII-I outside the nucleus as a negative regulator of agonist-induced calcium entry (ACE) that suppresses surface accumulation of TRPC3 ( transient receptor potential C3) channels. Inhibition of ACE by TFII-I requires phosphotyrosine residues that engage the SH2 (Src-homology 2) domains of phospholipase C - gamma (PLC-gamma) and an interrupted, pleckstrin homology (PH) - like domain that binds the split PH domain of PLC-gamma. Our observations suggest a model in which TFII-I suppresses ACE by competing with TRPC3 for binding to PLC-gamma.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sdesider@jhmi.edu		van Rossum, Damian/0000-0003-1011-2586				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bussolino DF, 2001, FASEB J, V15, P556; Cheriyath V, 2000, J BIOL CHEM, V275, P26300, DOI 10.1074/jbc.M002980200; Cheriyath V, 2002, J BIOL CHEM, V277, P22798, DOI 10.1074/jbc.M202956200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Danoff SK, 2004, NEUROSCIENCE, V123, P931, DOI 10.1016/j.neuroscience.2003.08.038; Egloff AM, 2001, J BIOL CHEM, V276, P27806, DOI 10.1074/jbc.M103692200; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Osborne LR, 1999, GENOMICS, V57, P279, DOI 10.1006/geno.1999.5784; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Peppiatt CM, 2004, BIOCHEM J, V381, P929, DOI 10.1042/BJ20040097; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Utzny C, 2005, BIOPHYS J, V88, P1, DOI 10.1529/biophysj.103.038216; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a	30	69	69	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					122	125		10.1126/science.1127815	http://dx.doi.org/10.1126/science.1127815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023658				2022-12-01	WOS:000241031200050
J	Chien, YC; Kim, S; Bumeister, R; Loo, YM; Kwon, SW; Johnson, CL; Balakireva, MG; Romeo, Y; Kopelovich, L; Gale, M; Yeaman, C; Camonis, JH; Zhao, YM; White, MA				Chien, Yuchen; Kim, Sungchan; Bumeister, Ron; Loo, Yueh-Ming; Kwon, Sung Won; Johnson, Cynthia L.; Balakireva, Mirey G.; Romeo, Yves; Kopelovich, Levy; Gale, Michael, Jr.; Yeaman, Charles; Camonis, Jacques H.; Zhao, Yingming; White, Michael A.			RaIB GTPase-mediated activation of the I kappa B family kinase TBK1 couples innate immune signaling to tumor cell survival	CELL			English	Article							DOUBLE-STRANDED-RNA; RAL-GTPASES; REGULATORY FACTOR-3; IKK-EPSILON; EXOCYST; MEMBRANE; IDENTIFICATION; PROLIFERATION; EFFECTOR; REQUIREMENTS	The monomeric RaIGTPases, RaIA and RalB are recognized as components of a regulatory framework supporting tumorigenic transformation. Specifically, RaIB is required to suppress apoptotic checkpoint activation, the mechanistic basis of which is unknown. Reported effector proteins of RaIB include the Sec5 component of the exocyst, an octameric protein complex implicated in tethering of vesicles to membranes. Surprisingly, we find that the RaIB/Sec5 effector complex directly recruits and activates the atypical I kappa B kinase family member TBK1. In cancer cells, constitutive engagement of this pathway, via chronic RalB activation, restricts initiation of apoptotic programs typically engaged in the context of oncogenic stress. Although dispensable for survival in a nontumorigenic context, this pathway helps mount an innate immune response to virus exposure. These observations define the mechanistic contribution of RaIGTPases to cancer cell survival and reveal the RaIB/Sec5 effector complex as a component of TBK1-dependent innate immune signaling.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Inst Curie, INSERM, U548, Paris, France; NCI, Div Canc Prevent, NIH, Bethesda, MD 20892 USA; Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa	Chien, YC (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Yeaman, Charles A/A-1624-2009; Romeo, Yves/AAC-1669-2021	Yeaman, Charles/0000-0001-6149-628X; Monaco, Cynthia/0000-0003-3093-5563; Loo, Yueh-Ming/0000-0001-6294-7273; Gale, Michael/0000-0002-6332-7436	NCI NIH HHS [CN35132, R01 CA071443, CA71443, CA107943] Funding Source: Medline; NIGMS NIH HHS [R01 GM067002] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA107943, R21CA107943, R01CA071443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrams JM, 2004, CURR OPIN CELL BIOL, V16, P634, DOI 10.1016/j.ceb.2004.09.010; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hiscott J, 2004, NAT STRUCT MOL BIOL, V11, P1028, DOI 10.1038/nsmb1104-1028; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; MITLN N, 2005, CURR BIOL, V15, pR563; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Park SH, 1995, ONCOGENE, V11, P2349; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	51	274	291	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					157	170		10.1016/j.cell.2006.08.034	http://dx.doi.org/10.1016/j.cell.2006.08.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018283	Bronze			2022-12-01	WOS:000241445800021
J	Heit, JJ; Apelqvist, AA; Gu, XY; Winslow, MM; Neilson, JR; Crabtree, GR; Kim, SK				Heit, Jeremy J.; Apelqvist, Asa A.; Gu, Xueying; Winslow, Monte M.; Neilson, Joel R.; Crabtree, Gerald R.; Kim, Seung K.			Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function	NATURE			English	Article							INSULIN GENE-EXPRESSION; DIABETES-MELLITUS; GLUCOSE; SECRETION; MICE; PROLIFERATION; TRANSCRIPTION; HYPERPLASIA; PROGRESSION; ACTIVATION	The growth and function of organs such as pancreatic islets adapt to meet physiological challenges and maintain metabolic balance, but the mechanisms controlling these facultative responses are unclear(1,2). Diabetes in patients treated with calcineurin inhibitors such as cyclosporin A indicates that calcineurin/nuclear factor of activated T-cells ( NFAT) signalling might control adaptive islet responses(3), but the roles of this pathway in beta-cells in vivo are not understood. Here we show that mice with a beta-cell-specific deletion of the calcineurin phosphatase regulatory subunit, calcineurin b1 (Cnb1), develop age-dependent diabetes characterized by decreased beta-cell proliferation and mass, reduced pancreatic insulin content and hypoinsulinaemia. Moreover, beta-cells lacking Cnb1 have a reduced expression of established regulators of beta-cell proliferation(1,4,5). Conditional expression of active NFATc1 in Cnb1-deficient beta-cells rescues these defects and prevents diabetes. In normal adult beta-cells, conditional NFAT activation promotes the expression of cell-cycle regulators and increases beta-cell proliferation and mass, resulting in hyperinsulinaemia. Conditional NFAT activation also induces the expression of genes critical for beta-cell endocrine function, including all six genes mutated in hereditary forms of monogenic type 2 diabetes. Thus, calcineurin/ NFAT signalling regulates multiple factors that control growth and hallmark beta-cell functions, revealing unique models for the pathogenesis and therapy of diabetes.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu		Heit, Jeremy/0000-0003-1055-8000; Neilson, Joel R./0000-0002-3408-608X; Kim, Seung/0000-0001-6135-7810				Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Redmon JB, 1996, J CLIN INVEST, V98, P2786, DOI 10.1172/JCI119105; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; Weir MR, 1999, AM J KIDNEY DIS, V34, P1, DOI 10.1016/S0272-6386(99)70101-0; Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006	29	333	351	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					345	349		10.1038/nature05097	http://dx.doi.org/10.1038/nature05097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988714				2022-12-01	WOS:000240622000048
J	McKern, NM; Lawrence, MC; Streltsov, VA; Lou, MZ; Adams, TE; Lovrecz, GO; Elleman, TC; Richards, KM; Bentley, JD; Pilling, PA; Hoyne, PA; Cartledge, KA; Pham, TM; Lewis, JL; Sankovich, SE; Stoichevska, V; Da Silva, E; Robinson, CP; Frenkel, MJ; Sparrow, LG; Fernley, RT; Epa, VC; Ward, CW				McKern, Neil M.; Lawrence, Michael C.; Streltsov, Victor A.; Lou, Mei-Zhen; Adams, Timothy E.; Lovrecz, George O.; Elleman, Thomas C.; Richards, Kim M.; Bentley, John D.; Pilling, Patricia A.; Hoyne, Peter A.; Cartledge, Kellie A.; Pham, Tam M.; Lewis, Jennifer L.; Sankovich, Sonia E.; Stoichevska, Violet; Da Silva, Elizabeth; Robinson, Christine P.; Frenkel, Maurice J.; Sparrow, Lindsay G.; Fernley, Ross T.; Epa, V. Chandana; Ward, Colin W.			Structure of the insulin receptor ectodomain reveals a folded-over conformation	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; 1ST 3 DOMAINS; ALPHA-SUBUNIT; MONOCLONAL-ANTIBODIES; BINDING DOMAIN; SPECIFICITY; ACTIVATION; REGION	The insulin receptor is a phylogenetically ancient tyrosine kinase receptor found in organisms as primitive as cnidarians and insects. In higher organisms it is essential for glucose homeostasis(1), whereas the closely related insulin-like growth factor receptor (IGF-1R) is involved in normal growth and development(2). The insulin receptor is expressed in two isoforms, IR-A and IR-B; the former also functions as a high-affinity receptor for IGF-II and is implicated, along with IGF-1R, in malignant transformation(3). Here we present the crystal structure at 3.8 angstrom resolution of the IR-A ectodomain dimer, complexed with four Fabs from the monoclonal antibodies 83-7 and 83-14 ( ref. 4), grown in the presence of a fragment of an insulin mimetic peptide(5). The structure reveals the domain arrangement in the disulphide-linked ectodomain dimer, showing that the insulin receptor adopts a folded-over conformation that places the ligand-binding regions in juxtaposition. This arrangement is very different from previous models(6). It shows that the two L1 domains are on opposite sides of the dimer, too far apart to allow insulin to bind both L1 domains simultaneously as previously proposed(7). Instead, the structure implicates the carboxy-terminal surface of the first fibronectin type III domain as the second binding site involved in high-affinity binding.	CSIRO Mol & Hlth Technol, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lawrence, MC (corresponding author), CSIRO Mol & Hlth Technol, 343 Royal Parade, Parkville, Vic 3052, Australia.	Mike.Lawrence@csiro.au; Colin.Ward@csiro.au	Pilling, Patricia/AAT-7845-2021; Epa, Vidana C./D-2320-2013; Streltsov, Victor/M-9446-2019; Lovrecz, George/H-8602-2013; Adams, Timothy E/I-6231-2012; Lawrence, Michael C/A-5357-2009	Streltsov, Victor/0000-0002-7846-4396; Adams, Timothy E/0000-0003-3436-0066; Lawrence, Michael/0000-0003-1999-0801				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CHEATHAM B, 1992, J BIOL CHEM, V267, P7108; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2003, HORM METAB RES, V35, P778; FABRY M, 1992, J BIOL CHEM, V267, P8950; Florke RR, 2001, BIOCHEM J, V360, P189, DOI 10.1042/0264-6021:3600189; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Hoyne PA, 2000, FEBS LETT, V479, P15, DOI 10.1016/S0014-5793(00)01872-X; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Marino-Buslje C, 1999, BIOCHEM SOC T, V27, P715, DOI 10.1042/bst0270715; Ottensmeyer FP, 2000, BIOCHEMISTRY-US, V39, P12103, DOI 10.1021/bi0015921; Ottensmeyer FP, 2001, BIOCHEMISTRY-US, V40, P6988, DOI 10.1021/bi015135b; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; SCHAEFER EM, 1992, J BIOL CHEM, V267, P23393; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; Tulloch PA, 1999, J STRUCT BIOL, V125, P11, DOI 10.1006/jsbi.1998.4066; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858	31	225	265	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					218	221		10.1038/nature05106	http://dx.doi.org/10.1038/nature05106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16957736				2022-12-01	WOS:000240467000048
J	Hamilton, SR; Davidson, RC; Sethuraman, N; Nett, JH; Jiang, YW; Rios, S; Bobrowicz, P; Stadheim, TA; Li, HJ; Choi, BK; Hopkins, D; Wischnewski, H; Roser, J; Mitchell, T; Strawbridge, RR; Hoopes, J; Wildt, S; Gerngross, TU				Hamilton, Stephen R.; Davidson, Robert C.; Sethuraman, Natarajan; Nett, Juergen H.; Jiang, Youwei; Rios, Sandra; Bobrowicz, Piotr; Stadheim, Terrance A.; Li, Huijuan; Choi, Byung-Kwon; Hopkins, Daniel; Wischnewski, Harry; Roser, Jessica; Mitchell, Teresa; Strawbridge, Rendall R.; Hoopes, Jack; Wildt, Stefan; Gerngross, Tillman U.			Humanization of yeast to produce complex terminally sialylated glycoproteins	SCIENCE			English	Article							PICHIA-PASTORIS; HUMAN-ERYTHROPOIETIN; GLYCOSYLATION	Yeast is a widely used recombinant protein expression system. We expanded its utility by engineering the yeast Pichia pastoris to secrete human glycoproteins with fully complex terminally sialylated N-glycans. After the knockout of four genes to eliminate yeast-specific glycosylation, we introduced 14 heterologous genes, allowing us to replicate the sequential steps of human glycosylation. The reported cell lines produce complex glycoproteins with greater than 90% terminal sialylation. Finally, to demonstrate the utility of these yeast strains, functional recombinant erythropoietin was produced.	GlycoFi Inc, Lebanon, NH 03766 USA; Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03766 USA; Dartmouth Coll, Thayer Sch Engn, Dept Biol Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Gerngross, TU (corresponding author), GlycoFi Inc, 21 Lafayette St,Suite 200, Lebanon, NH 03766 USA.	tillman.gerngross@dartmouth.edu						ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Bobrowicz P, 2004, GLYCOBIOLOGY, V14, P757, DOI 10.1093/glycob/cwh104; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; DAVIS JM, 1987, BIOCHEMISTRY-US, V26, P2633, DOI 10.1021/bi00383a034; FUKUDA MN, 1989, BLOOD, V73, P84; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; LAI PH, 1986, J BIOL CHEM, V261, P3116; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; SPIVAK JL, 1989, BLOOD REV, V3, P130, DOI 10.1016/0268-960X(89)90008-8; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591	11	360	446	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1441	1443		10.1126/science.1130256	http://dx.doi.org/10.1126/science.1130256			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960007				2022-12-01	WOS:000240348700044
J	Warren, EH; Vigneron, NJ; Gavin, MA; Coulie, PG; Stroobant, V; Dalet, A; Tykodi, SS; Xuereb, SM; Mito, JK; Riddell, SR; Van den Eynde, BJ				Warren, Edus H.; Vigneron, Nathalie J.; Gavin, Marc A.; Coulie, Pierre G.; Stroobant, Vincent; Dalet, Alexandre; Tykodi, Scott S.; Xuereb, Suzanne M.; Mito, Jeffrey K.; Riddell, Stanley R.; Van den Eynde, Benoit J.			An antigen produced by splicing of noncontiguous peptides in the reverse order	SCIENCE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; PROTEASOME; ACTIVATION; PROTEIN	CD8-positive T lymphocytes recognize peptides that are usually derived from the degradation of cellular proteins and are presented by class I molecules of the major histocompatibility complex. Here we describe a human minor histocompatibility antigen created by a polymorphism in the SP110 nuclear phosphoprotein gene. The antigenic peptide comprises two noncontiguous SP110 peptide segments spliced together in reverse order to that in which they occur in the predicted SP110 protein. The antigenic peptide could be produced in vitro by incubation of precursor peptides with highly purified 20S proteasomes. Cutting and splicing probably occur within the proteasome by transpeptidation.	Ludwig Inst Canc Res, Brussels Ranch, B-1200 Brussels, Belgium; Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, Seattle, WA 98109 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Catholique Louvain, Cellular Genet Unit, Inst Cellular Pathol, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universite Catholique Louvain	Van den Eynde, BJ (corresponding author), Ludwig Inst Canc Res, Brussels Ranch, B-1200 Brussels, Belgium.	benoit.vandeneynde@bru.licr.org		Warren, Edus/0000-0002-9570-2755	NCI NIH HHS [CA18029, CA106512] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106512, P01CA018029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; DIBRINO M, 1993, P NATL ACAD SCI USA, V90, P1508, DOI 10.1073/pnas.90.4.1508; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; KADEREIT S, 1993, J BIOL CHEM, V268, P24432; KUBO RT, 1994, J IMMUNOL, V152, P3913; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Warren EH, 1998, BLOOD, V91, P2197, DOI 10.1182/blood.V91.6.2197; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	16	153	161	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1444	1447		10.1126/science.1130660	http://dx.doi.org/10.1126/science.1130660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960008				2022-12-01	WOS:000240348700045
J	Chu, DS; Liu, HB; Nix, P; Wu, TF; Ralston, EJ; Yates, JR; Meyer, BJ				Chu, Diana S.; Liu, Hongbin; Nix, Paola; Wu, Tammy F.; Ralston, Edward J.; Yates, John R., III; Meyer, Barbara J.			Sperm chromatin proteomics identifies evolutionarily conserved fertility factors	NATURE			English	Article							DNA TOPOISOMERASE-I; CAENORHABDITIS-ELEGANS; FUNCTIONAL-ANALYSIS; SHOTGUN PROTEOMICS; SR PROTEINS; GERM-CELLS; HISTONE H1; SPERMIOGENESIS; EMBRYOGENESIS; LOCALIZATION	Male infertility is a long-standing enigma of significant medical concern. The integrity of sperm chromatin is a clinical indicator of male fertility and in vitro fertilization potential(1): chromosome aneuploidy and DNA decondensation or damage are correlated with reproductive failure. Identifying conserved proteins important for sperm chromatin structure and packaging can reveal universal causes of infertility. Here we combine proteomics, cytology and functional analysis in Caenorhabditis elegans to identify spermatogenic chromatin-associated proteins that are important for fertility. Our strategy employed multiple steps: purification of chromatin from comparable meiotic cell types, namely those undergoing spermatogenesis or oogenesis; proteomic analysis by multidimensional protein identification technology (MudPIT) of factors that co-purify with chromatin; prioritization of sperm proteins based on abundance; and subtraction of common proteins to eliminate general chromatin and meiotic factors. Our approach reduced 1,099 proteins co-purified with spermatogenic chromatin, currently the most extensive catalogue, to 132 proteins for functional analysis. Reduction of gene function through RNA interference coupled with protein localization studies revealed conserved spermatogenesis-specific proteins vital for DNA compaction, chromosome segregation, and fertility. Unexpected roles in spermatogenesis were also detected for factors involved in other processes. Our strategy to find fertility factors conserved from C. elegans to mammals achieved its goal: of mouse gene knockouts corresponding to nematode proteins, 37% (7/19) cause male sterility. Our list therefore provides significant opportunity to identify causes of male infertility and targets for male contraceptives.	San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Agilent Technol, Wilmington, DE 19808 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	California State University System; San Francisco State University; Scripps Research Institute; Agilent Technologies; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Chu, DS (corresponding author), San Francisco State Univ, Dept Biol, 1600 Holloway Ave, San Francisco, CA 94132 USA.	chud@sfsu.edu		Meyer, Barbara/0000-0002-6530-4588	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030702] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM030702-28, R01 GM030702] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal A, 2003, HUM REPROD UPDATE, V9, P331, DOI 10.1093/humupd/dmg027; Boag PR, 2003, INT J PARASITOL, V33, P313, DOI 10.1016/S0020-7519(02)00263-1; Browning H, 1996, DEVELOPMENT, V122, P391; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Hanazawa M, 2001, P NATL ACAD SCI USA, V98, P8686, DOI 10.1073/pnas.141004698; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawano T, 2000, MECH DEVELOP, V95, P67, DOI 10.1016/S0925-4773(00)00339-7; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Lee MH, 2001, GENES CELLS, V6, P303, DOI 10.1046/j.1365-2443.2001.00423.x; Lewis JD, 2004, BIOCHEMISTRY-US, V43, P7766, DOI 10.1021/bi0360455; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanaka SS, 2000, GENE DEV, V14, P841; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vogt PH, 2005, REPROD BIOMED ONLINE, V10, P81, DOI 10.1016/S1472-6483(10)60807-3; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WARD S, 1982, DEV BIOL, V92, P203, DOI 10.1016/0012-1606(82)90164-6; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	30	136	177	3	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					101	105		10.1038/nature05050	http://dx.doi.org/10.1038/nature05050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16943775	Green Accepted			2022-12-01	WOS:000240313900048
J	Lu, LF; Lind, EF; Gondek, DC; Bennett, KA; Gleeson, MW; Pino-Lagos, K; Scott, ZA; Coyle, AJ; Reed, JL; Van Snick, J; Strom, TB; Zheng, XX; Noelle, RJ				Lu, Li-Fan; Lind, Evan F.; Gondek, David C.; Bennett, Kathy A.; Gleeson, Michael W.; Pino-Lagos, Karina; Scott, Zachary A.; Coyle, Anthony J.; Reed, Jennifer L.; Van Snick, Jacques; Strom, Terry B.; Zheng, Xin Xiao; Noelle, Randolph J.			Mast cells are essential intermediaries in regulatory T-cell tolerance	NATURE			English	Article							GRANZYME-B; MICE; INDUCTION; KIT; INTERLEUKIN-9; ACTIVATION; EXPRESSION; REJECTION; RESPONSES; GROWTH	Contrary to the proinflammatory role of mast cells in allergic disorders, the results obtained in this study establish that mast cells are essential in CD4(+)CD25(+)Foxp3(+) regulatory T (T-Reg)-cell-dependent peripheral tolerance. Here we confirm that tolerant allografts, which are sustained owing to the immunosuppressive effects of T-Reg cells, acquire a unique genetic signature dominated by the expression of mast-cell-gene products. We also show that mast cells are crucial for allograft tolerance, through the inability to induce tolerance in mast-cell-deficient mice. High levels of interleukin (IL)-9 - a mast cell growth and activation factor - are produced by activated T-Reg cells, and IL-9 production seems important in mast cell recruitment to, and activation in, tolerant tissue. Our data indicate that IL-9 represents the functional link through which activated T-Reg cells recruit and activate mast cells to mediate regional immune suppression, because neutralization of IL-9 greatly accelerates allograft rejection in tolerant mice. Finally, immunohistochemical analysis clearly demonstrates the existence of this novel T-Reg - IL-9-mast cell relationship within tolerant allografts.	Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; Medimmune Inc, Dept Autoimmun & Inflammat, Gaithersburg, MD 20878 USA; Ludwig Inst Canc Res Brussels Branch, B-1200 Brussels, Belgium; Univ Louvain, Expt Med Unit, Brussels Branch, B-1200 Brussels, Belgium; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Dartmouth College; Norris Cotton Cancer Center; AstraZeneca; Medimmune; Universite Catholique Louvain; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Noelle, RJ (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	rjn@dartmouth.edu	Strom, Terry B./E-9268-2010; Pino-Lagos, Karina/C-9583-2017; Pino-Lagos, Karina/H-7581-2013	Strom, Terry B./0000-0002-7570-0736; Pino-Lagos, Karina/0000-0002-4070-6169; Pino-Lagos, Karina/0000-0002-4070-6169; Lu, Li-Fan/0000-0002-9727-0036; Lind, Evan/0000-0001-7026-2012				Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Corti B, 2005, TRANSPL P, V37, P4467, DOI 10.1016/j.transproceed.2005.11.035; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Harada Akihisa, 1996, Methods (Orlando), V10, P166, DOI 10.1006/meth.1996.0091; Jarnicki AG, 2003, CURR OPIN PHARMACOL, V3, P449, DOI 10.1016/S1471-4892(03)00077-8; Jarvinen LZ, 2003, TRANSPLANTATION, V76, P1375, DOI 10.1097/01.TP.0000093462.16309.73; Khan WI, 2003, INFECT IMMUN, V71, P2430, DOI 10.1128/IAI.71.5.2430-2438.2003; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Mesples B, 2005, NEUROBIOL DIS, V18, P193, DOI 10.1016/j.nbd.2004.09.018; Quezada SA, 2005, J IMMUNOL, V175, P771, DOI 10.4049/jimmunol.175.2.771; RAZIN E, 1990, METHOD ENZYMOL, V187, P514; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Wang HW, 1998, J CLIN INVEST, V102, P1617, DOI 10.1172/JCI3704; Wedemeyer J, 2005, LAB INVEST, V85, P388, DOI 10.1038/labinvest.3700232; YAMAZAKI M, 1994, BLOOD, V83, P3509; Zelenika D, 2001, IMMUNOL REV, V182, P164, DOI 10.1034/j.1600-065X.2001.1820113.x; Zhou YH, 2001, RESP RES, V2, P80, DOI 10.1186/rr42	30	599	630	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					997	1002		10.1038/nature05010	http://dx.doi.org/10.1038/nature05010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16921386				2022-12-01	WOS:000240142000039
J	Thompson, BJ; Cohen, SM				Thompson, Barry J.; Cohen, Stephen M.			The hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila	CELL			English	Article							PROMOTES APOPTOSIS; TUMOR-SUPPRESSOR; CYCLE EXIT; ENCODES; SALVADOR; GROWTH; EYE; MORPHOGENS; HOMOLOG; PATTERN	The Hippo signaling pathway acts upon the Yorkie transcriptional activator to control tissue growth in Drosophila. Activated Yorkie drives growth by stimulating cell proliferation and inhibiting apoptosis, but how it achieves this is not understood. Yorkie is known to activate Cyclin E (CycE) and the apoptosis inhibitor DIAP1. However, overexpression of these targets is not sufficient to cause tissue overgrowth. Here we show that Yorkie also activates expression of the bantam microRNA, a known regulator of both proliferation and apoptosis. bantam overexpression mimics Yorkie activation while loss of bantam function slows the rate of cell proliferation. bantam is necessary for Yorkie-induced overproliferation and bantam overexpression is sufficient to rescue survival and proliferation of yorkie mutant cells. Finally, we show that bantam levels are regulated during both developmentally programmed proliferation arrest and apoptosis. In summary, the results show that the Hippo pathway regulates expression of bantam to control tissue growth in Drosophila.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cohen@embl.de	Cohen, Stephen M/G-9930-2011	Cohen, Stephen M/0000-0003-2858-9163; Thompson, Barry/0000-0002-0103-040X				Brachmann CB, 2003, TRENDS GENET, V19, P91, DOI 10.1016/S0168-9525(02)00041-0; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hipfner DR, 2002, GENETICS, V161, P1527; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lin HV, 2004, DEVELOPMENT, V131, P2409, DOI 10.1242/dev.01104; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X	26	316	325	2	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 25	2006	126	4					767	774		10.1016/j.cell.2006.07.013	http://dx.doi.org/10.1016/j.cell.2006.07.013			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923395	Bronze			2022-12-01	WOS:000240276700024
J	Hackam, DG; Thiruchelvam, D; Redelmeier, DA				Hackam, Daniel G.; Thiruchelvam, Deva; Redelmeier, Donald A.			Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study	LANCET			English	Article							II-INDUCED ATHEROSCLEROSIS; ELDERLY-PATIENTS; COMORBIDITY ADJUSTMENT; ADMINISTRATIVE DATA; ACE-INHIBITORS; HEART-FAILURE; ANEURYSM; DISEASE; RISK; GENOTYPE	Background Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and rupture of aortic aneurysms in animals. We investigated the association between ACE inhibitors and rupture in patients with abdominal aortic aneurysms. Methods We did a population-based case-control study of linked administrative databases in Ontario, Canada. The sample included consecutive patients older than 65 (n=15326) admitted to hospital with a primary diagnosis of ruptured or intact abdominal aortic aneurysm between April 1, 1992, and April 1, 2002. Findings Patients who received ACE inhibitors before admission were significantly less likely to present with ruptured aneurysm (odds ratio [OR] 0.82, 95% CI 0.74-0.90) than those who did not receive ACE inhibitors. Adjustment for demographic characteristics, risk factors for rupture, comorbidities, contraindications to ACE inhibitors, measures of health-care use, and aneurysm screening yielded similar results (0.83, 0.73-0.95). Consistent findings were noted in subgroups at high risk of rupture, including patients older than 75 years and those with a history of hypertension. Conversely, such protective associations were not observed for beta blockers (1.02, 0.89-1.17), calcium channel blockers (1.01, 0.89-1.14), alpha blockers (1.15, 0.86-1.54), angiotensin receptor blockers (1.24, 0.71-2.18), or thiazide diuretics (0.91, 0.78-1.07). Interpretation ACE inhibitors are associated with a reduced risk of ruptured abdominal aortic aneurysm, unlike other antihypertensive agents. Randomised trials of ACE inhibitors for prevention of aortic rupture might be warranted.	Univ Toronto, Dept Hlth Policy Management & Evaluat, Clin Epidemiol & Hlth Care Res Program, Toronto, ON, Canada; Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Toronto Rehabil Inst, Secondary Prevent & Cardiac Rehabil Program, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Patient Safety Serv, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Hackam, DG (corresponding author), Sunnybrook Hlth Sci Ctr, Patient Safety Serv, Room G-157,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	daniel.hackam@ices.on.ca	Hackam, Dan G/A-1143-2009					Adam DJ, 1999, J VASC SURG, V30, P922, DOI 10.1016/S0741-5214(99)70018-2; Ahimastos AA, 2005, HYPERTENSION, V45, P1194, DOI 10.1161/01.HYP.0000168945.44069.aa; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; BENGTSSON H, 1993, J VASC SURG, V18, P74, DOI 10.1067/mva.1993.42107; Bown MJ, 2002, BRIT J SURG, V89, P714, DOI 10.1046/j.1365-2168.2002.02122.x; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Cassis LA, 2005, BRIT J PHARMACOL, V144, P443, DOI 10.1038/sj.bjp.0706098; Chan B., 1999, SUPPLY PHYS SERVICES; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Claridge MW, 2004, EUR J VASC ENDOVASC, V28, P67, DOI 10.1016/j.ejvs.2004.01.021; CRONENWETT JL, 1985, SURGERY, V98, P472; da Cunha V, 2005, ATHEROSCLEROSIS, V178, P9, DOI 10.1016/j.atherosclerosis.2004.08.023; DARLING RC, 1977, CIRCULATION, V56, P161; Daugherty A, 2004, CURR HYPERTENS REP, V6, P442, DOI 10.1007/s11906-004-0038-0; Fatini C, 2005, EUR J VASC ENDOVASC, V29, P227, DOI 10.1016/j.ejvs.2004.12.018; Greenhalgh RM, 2000, EUR J VASC ENDOVASC, V19, P636; Huang W, 1998, CIRC RES, V82, P879; Huber TS, 2001, J VASC SURG, V33, P304, DOI 10.1067/mva.2001.112703; Ihara M, 1999, HYPERTENSION, V33, P1399, DOI 10.1161/01.HYP.33.6.1399; Jacoby DS, 2003, ARCH INTERN MED, V163, P1155, DOI 10.1001/archinte.163.10.1155; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Keramatipour M, 2000, J MED GENET, V37, P498, DOI 10.1136/jmg.37.7.498; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lindholt JS, 1999, INT ANGIOL, V18, P52; Lopez-Sendon J, 2004, EUR HEART J, V25, P1454, DOI 10.1016/j.ehj.2004.06.003; MACSWEENEY STR, 1994, LANCET, V344, P651, DOI 10.1016/S0140-6736(94)92087-7; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Nagashima H, 2002, J VASC SURG, V36, P818, DOI 10.1067/mva.2002.126091; Naylor CD, 1999, CARDIOVASCULAR HLTH; Nishimoto M, 2002, LIFE SCI, V71, P2195, DOI 10.1016/S0024-3205(02)01998-7; OSBORNEPELLEGRIN MJ, 1994, INT J EXP PATHOL, V75, P179; Pola R, 2001, EUR J VASC ENDOVASC, V21, P445, DOI 10.1053/ejvs.2001.1339; Powell JT, 2001, ACTA CHIR BELG, V101, P11; Redelmeier DA, 2005, BRIT MED J, V331, P932, DOI 10.1136/bmj.38603.746944.3A; Rochon PA, 2004, J GEN INTERN MED, V19, P676, DOI 10.1111/j.1525-1497.2004.30328.x; Sakomura Y, 1999, CIRCULATION, V100, P319; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Schneeweiss S, 2004, J GEN INTERN MED, V19, P444, DOI 10.1111/j.1525-1497.2004.30109.x; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Slowik A, 2004, STROKE, V35, P1594, DOI 10.1161/01.STR.0000131655.45227.f7; Steinmetz Eric F, 2003, Vasc Endovascular Surg, V37, P151, DOI 10.1177/153857440303700301; STERPETTI AV, 1991, SURG GYNECOL OBSTET, V173, P175; STRACHAN DP, 1991, BRIT J SURG, V78, P401, DOI 10.1002/bjs.1800780407; Takeda K, 1997, NEPHROL DIAL TRANSPL, V12, P952, DOI 10.1093/ndt/12.5.952; Takenaka K, 1998, NEUROL RES, V20, P607; Takeuchi K, 1997, EUR J PEDIATR, V156, P266, DOI 10.1007/s004310050597; Tham DM, 2002, AM J PHYSIOL-REG I, V283, pR1442, DOI 10.1152/ajpregu.00295.2002; Tsunemi K, 2002, HYPERTENS RES, V25, P817; Wilmink A.B.M., 2002, BRIT J SURG, V87, P499, DOI [10.1046/j.1365-2168.2000.01420-23.x, DOI 10.1046/J.1365-2168.2000.01420-23.X]; Wilmink ABM, 2003, J VASC SURG, V38, P72, DOI 10.1016/S0741-5214(03)00135-6; WOLF YG, 1994, J VASC SURG, V20, P529, DOI 10.1016/0741-5214(94)90277-1; *WRIT COMM DEV GUI, 2005, CIRCULATION, V113, P463	59	219	233	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2006	368	9536					659	665		10.1016/S0140-6736(06)69250-7	http://dx.doi.org/10.1016/S0140-6736(06)69250-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074YT	16920471				2022-12-01	WOS:000239849200033
J	Teo, KK; Ounpuu, S; Hawken, S; Pandey, MR; Valentin, V; Hunt, D; Diaz, R; Rashed, W; Freeman, R; Jiang, LX; Zhang, XF; Yusuf, S				Teo, Koon K.; Ounpuu, Stephanie; Hawken, Steven; Pandey, M. R.; Valentin, Vicent; Hunt, David; Diaz, Rafael; Rashed, Wafa; Freeman, Rosario; Jiang, Lixin; Zhang, Xiaofei; Yusuf, Salim		INTERHEART Study Investigators	Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study	LANCET			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; SMOKELESS TOBACCO; ATTRIBUTABLE RISKS; CIGARETTE-SMOKING; PASSIVE SMOKING; UNITED-STATES; MORTALITY; HEALTH; POPULATION	Background Tobacco use is one of the major avoidable causes of cardiovascular diseases. We aimed to assess the risks associated with tobacco use (both smoking and non-smoking) and second hand tobacco smoke (SHS) worldwide. Methods We did a standardised case-control study of acute myocardial infarction (AMI) with 27089 participants in 52 countries (12461 cases, 14637 controls). We assessed relation between risk of AMI and current or former smoking, type of tobacco, amount smoked, effect of smokeless tobacco, and exposure to SHS. We controlled for confounders such as differences in lifestyles between smokers and non-smokers. Findings Current smoking was associated with a greater risk of non-fatal AMI (odds ratio [OR] 2.95, 95% CI 2.77-3.14, p<0.0001) compared with never smoking; risk increased by 5.6% for every additional cigarette smoked. The OR associated with former smoking fell to 1.87 (95% CI 1.55-2.24) within 3 years of quitting. A residual excess risk remained 20 or more years after quitting (1.22, 1.09-1.37). Exclusion of individuals exposed to SHS in the never smoker reference group raised the risk in former smokers by about 10%. Smoking beedies alone (indigenous to South Asia) was associated with increased risk (2.89, 2.11-3.96) similar to that associated with cigarette smoking. Chewing tobacco alone was associated with OR 2.23 (1.41-3.52), and smokers who also chewed tobacco had the highest increase in risk (4.09, 2.98-5.61). SHS was associated with a graded increase in risk related to exposure; OR was 1.24 (1.17-1.32) in individuals who were least exposed (1-7 h per week) and 1.62 (1.45-1.81) in people who were most exposed (>21 h per week). Young male current smokers had the highest population attributable risk (58.3%; 95% CI 55.0-61.6) and older women the lowest (6.2%, 4.1-9.2). Population attributable risk for exposure to SHS for more than l h per week in never smokers was 15.4% (12.1-19.3). Conclusion Tobacco use is one of the most important causes of AMI globally, especially in men. All forms of tobacco use, including different types of smoking and chewing tobacco and inhalation of SHS, should be discouraged to prevent cardiovascular diseases.	McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; Nepal Hlth Res Council, Kathmandu, Nepal; Hosp Univ Dr Peset, Valencia, Spain; Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; Inst Cardiovasc Rosario, Dept Cardiol, Rosario, Santa Fe, Argentina; Kuwait Univ, Kuwait, Kuwait; Univ Washington, Seattle, WA 98195 USA; Cardiovasc Inst, Beijing, Peoples R China	McMaster University; Population Health Research Institute; Royal Melbourne Hospital; University of Melbourne; Kuwait University; University of Washington; University of Washington Seattle	Yusuf, S (corresponding author), McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601; Hawken, Steven/0000-0002-3341-9022				*AUSTR I HLTH WELF, 2002, DRUG STAT SER, V9; Bolinder G, 1997, ATHEROSCLEROSIS, V132, P95, DOI 10.1016/S0021-9150(97)00075-0; Bolinder G, 1998, AM J HYPERTENS, V11, P1153, DOI 10.1016/S0895-7061(98)00137-X; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; Breslow NE, 1980, STAT METHODS CANC RE; Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Diethelm PA, 2005, LANCET, V366, P86, DOI 10.1016/S0140-6736(05)66474-4; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Glantz SA., 1996, CIGARETTE PAPERS; GUINDON GE, 2003, PAST CURRENT FUTURE; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Gupta PC, 2000, B WORLD HEALTH ORGAN, V78, P877; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Hergens MP, 2005, EPIDEMIOLOGY, V16, P12, DOI 10.1097/01.ede.0000147108.92895.ba; Huhtasaari F, 1999, J AM COLL CARDIOL, V34, P1784, DOI 10.1016/S0735-1097(99)00409-X; KIYOHARA Y, 1990, J HYPERTENS, V8, pS9; Kumra V, 2000, CLIN CHEST MED, V21, P1, DOI 10.1016/S0272-5231(05)70004-6; Lam TH, 1997, JAMA-J AM MED ASSOC, V278, P1505, DOI 10.1001/jama.278.18.1505; Law MR, 2003, PROG CARDIOVASC DIS, V46, P31, DOI 10.1016/S0033-0620(03)00078-1; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Mackay J, 1998, PUBLIC HEALTH REP, V113, P14; Mackay J, 2002, TOBACCO ATLAS; McKee M, 2000, EUR J PUBLIC HEALTH, V10, P161, DOI 10.1093/eurpub/10.3.161; McKee M, 1998, TOB CONTROL, V7, P22, DOI 10.1136/tc.7.1.22; NEGRI E, 1995, PREV MED, V24, P603, DOI 10.1006/pmed.1995.1095; Ounpuu S, 2001, AM HEART J, V141, P711, DOI 10.1067/mhj.2001.114974; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Pechacek TF, 2003, EVIDENCE BASED CARDI, P103; Peto RLA, 2001, CRITICAL ISSUES GLOB; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; *SCOTH, SEC SMOK REV EV 1998; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; Thun M, 2003, TOBACCO CONTROL COUN; WALTER SD, 1975, BIOMETRIKA, V62, P371, DOI 10.2307/2335374; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; *WHO, 1997, SMOK CHIN TIM BOMB 2; WOODWARD M, 1992, EUR HEART J, V13, P160, DOI 10.1093/oxfordjournals.eurheartj.a060140; World Bank, 1999, CURB EP GOV EC TOB C; World Health Organization, 2003, FRAM CONV TOB CONTR; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	43	671	713	2	81	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2006	368	9536					647	658		10.1016/S0140-6736(06)69249-0	http://dx.doi.org/10.1016/S0140-6736(06)69249-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074YT	16920470				2022-12-01	WOS:000239849200032
J	Helms, B; Meijer, EW				Helms, Brett; Meijer, E. W.			Dendrimers at work	SCIENCE			English	Editorial Material							POLYAMIDOAMINE DENDRIMERS; DENDRITIC MACROMOLECULES; IN-VITRO; POLYMERS; TRANSFECTION; MOLECULES; DELIVERY		Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands; Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology	Meijer, EW (corresponding author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.	e.w.meijer@tue.nl	Meijer, E.W./K-7632-2013	Meijer, E.W./0000-0003-4126-7492; Helms, Brett/0000-0003-3925-4174				Altinier S, 2000, CLIN CHEM, V46, P991; De Brabander-van den Berg E.M.M., 1993, ANGEW CHEM INT EDIT, V105, P1370; Denkewalter R.G., 1981, US. Patent, Patent No. [4 289 872, 4289872, 4,289,872]; Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061; Froehling P, 2004, J POLYM SCI POL CHEM, V42, P3110, DOI 10.1002/pola.20113; GRIES H, 1990, Patent No. 4957939; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027; Hudde T, 1999, GENE THER, V6, P939, DOI 10.1038/sj.gt.3300886; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; Ma DG, 2002, APPL PHYS LETT, V81, P2285, DOI 10.1063/1.1507826; Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1; Mynar JL, 2006, J AM CHEM SOC, V128, P6334, DOI 10.1021/ja061735s; NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052; Smith DK, 2006, CHEM COMMUN, P34, DOI 10.1039/b507416a; Tack F, 2006, J DRUG TARGET, V14, P69, DOI 10.1080/10611860600635665; Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630; TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117; Tomalia DA, 2006, U.S. Patents, Patent No. 7005124; Yin R., 2001, POLYM MAT SCI ENG, V84, P856; Zhou JH, 2006, CHEM COMMUN, P2362, DOI 10.1039/b601381c	22	180	184	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2006	313	5789					929	930		10.1126/science.1130639	http://dx.doi.org/10.1126/science.1130639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917051				2022-12-01	WOS:000239817000031
J	Rakic, P				Rakic, Pasko			No more cortical neurons for you	SCIENCE			English	Editorial Material							NEUROGENESIS; NEOCORTEX; CORTEX; CELLS		Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	pasko.rakic@yale.edun						ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Kempermann G, 2006, ADULT NEUROGENESIS; Koketsu D, 2003, J NEUROSCI, V23, P937; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Nowakowski R S, 2000, Science, V288, P771; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028	18	47	48	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2006	313	5789					928	929		10.1126/science.1131713	http://dx.doi.org/10.1126/science.1131713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917050				2022-12-01	WOS:000239817000030
J	Leininger, S; Urich, T; Schloter, M; Schwark, L; Qi, J; Nicol, GW; Prosser, JI; Schuster, SC; Schleper, C				Leininger, S.; Urich, T.; Schloter, M.; Schwark, L.; Qi, J.; Nicol, G. W.; Prosser, J. I.; Schuster, S. C.; Schleper, C.			Archaea predominate among ammonia-oxidizing prokaryotes in soils	NATURE			English	Article							REAL-TIME PCR; 16S RIBOSOMAL-RNA; POPULATION-SIZE; BACTERIA; CRENARCHAEOTA; DIVERSITY; LIPIDS; TERRESTRIAL; QUANTIFICATION; AMOA	Ammonia oxidation is the first step in nitrification, a key process in the global nitrogen cycle that results in the formation of nitrate through microbial activity(1,2). The increase in nitrate availability in soils is important for plant nutrition, but it also has considerable impact on groundwater pollution owing to leaching. Here we show that archaeal ammonia oxidizers are more abundant in soils than their well-known bacterial counterparts. We investigated the abundance of the gene encoding a subunit of the key enzyme ammonia monooxygenase (amoA) in 12 pristine and agricultural soils of three climatic zones. amoA gene copies of Crenarchaeota ( Archaea) were up to 3,000-fold more abundant than bacterial amoA genes. High amounts of crenarchaeota-specific lipids, including crenarchaeol, correlated with the abundance of archaeal amoA gene copies. Furthermore, reverse transcription quantitative PCR studies and complementary DNA analysis using novel cloning-independent pyrosequencing technology demonstrated the activity of the archaea in situ and supported the numerical dominance of archaeal over bacterial ammonia oxidizers. Our results indicate that crenarchaeota may be the most abundant ammonia-oxidizing organisms in soil ecosystems on Earth.	Univ Bergen, Dept Biol, N-5020 Bergen, Norway; GSF Natl Res Ctr Environm & Hlth, Inst Soil Ecol, D-85764 Neuherberg, Germany; Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland	University of Bergen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Aberdeen	Schleper, C (corresponding author), Univ Bergen, Dept Biol, Jahnebakken 5, N-5020 Bergen, Norway.	christa.schleper@bio.uib.no	Urich, Tim/C-2887-2013; Prosser, Jim/F-5280-2010; Schleper, Christa M/C-2567-2013; Nicol, Graeme/E-4902-2011; Urich, Tim/J-8241-2016; Schloter, 1Michael/H-9151-2013; QI, JI/E-2797-2016; Schwark, Lorenz/AAF-1902-2021; Nicol, Graeme/AFM-9614-2022	Prosser, Jim/0000-0003-1757-5102; Nicol, Graeme/0000-0002-3876-022X; Urich, Tim/0000-0002-5718-1354; Nicol, Graeme/0000-0002-3876-022X; Schwark, Lorenz/0000-0003-0683-0817; Schleper, Christa/0000-0002-1918-2735				BOCK E, 2001, PROKARYOTES EVOLVING; Damste JSS, 2002, J LIPID RES, V43, P1641, DOI 10.1194/jlr.M200148-JLR200; DeLong EF, 1998, APPL ENVIRON MICROB, V64, P1133; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HALLAM SJ, 2006, PLOS BIOL, V4, P520, DOI ARTN E95; Hermansson A, 2001, APPL ENVIRON MICROB, V67, P972, DOI 10.1128/AEM.67.2.972-976.2001; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kurola J, 2005, FEMS MICROBIOL LETT, V250, P33, DOI 10.1016/j.femsle.2005.06.057; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mendum TA, 1999, APPL ENVIRON MICROB, V65, P4155; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Okano Y, 2004, APPL ENVIRON MICROB, V70, P1008, DOI 10.1128/AEM.70.2.1008-1016.2004; Ovreas L, 1998, MICROB ECOL, V36, P303, DOI 10.1007/s002489900117; Phillips CJ, 2000, FEMS MICROBIOL ECOL, V32, P167, DOI 10.1111/j.1574-6941.2000.tb00710.x; Prosser JI, 2002, ANTON LEEUW INT J G, V81, P165, DOI 10.1023/A:1020598114104; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Stephen JR, 1998, APPL ENVIRON MICROB, V64, P2958; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Weigel A, 2000, J PLANT NUTR SOIL SC, V163, P261; Weijers JWH, 2006, ENVIRON MICROBIOL, V8, P648, DOI 10.1111/j.1462-2920.2005.00941.x	27	1738	1952	21	1142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					806	809		10.1038/nature04983	http://dx.doi.org/10.1038/nature04983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16915287				2022-12-01	WOS:000239792700044
J	Didelot, G; Molinari, F; Tchenio, P; Comas, D; Milhiet, E; Munnich, A; Colleaux, L; Preat, T				Didelot, Gerard; Molinari, Florence; Tchenio, Paul; Comas, Daniel; Milhiet, Elodie; Munnich, Arnold; Colleaux, Laurence; Preat, Thomas			Tequila, a neurotrypsin ortholog, regulates long-term memory formation in Drosophila	SCIENCE			English	Article							CONSOLIDATED MEMORY; MENTAL-RETARDATION; MUSHROOM BODIES; NERVOUS-SYSTEM; INHIBITORS; EXPRESSION; PROTEASES	Mutations in the human neurotrypsin gene are associated with autosomal recessive mental retardation. To further understand the pathophysiological consequences of the lack of this serine protease, we studied Tequila (Teq), the Drosophila neurotrypsin ortholog, using associative memory as a behavioral readout. We found that teq inactivation resulted in a long-term memory (LTM) specific defect. After LTM conditioning of wild-type flies, teq expression transiently increased in the mushroom bodies. Moreover, specific inhibition of teq expression in adult mushroom bodies resulted in a reversible LTM defect. Hence, the Teq pathway is essential for information processing in Drosophila.	Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, F-75005 Paris, France; CNRS, F-91198 Gif Sur Yvette, France; Hop Necker Enfants Malad, INSERM, U781, Unite Rech Handicaps Genet Enfant, F-75743 Paris, France; Hop Necker Enfants Malad, Dept Genet, F-75743 Paris 15, France; CNRS, UPR 3321, Aime Cotton Lab, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, 10 Rue Vauquelin, F-75005 Paris, France.	thomas.preat@espci.fr	COLLEAUX, Laurence/H-6455-2017; COLLEAUX, LAURENCE/AAA-8144-2022; Molinari, Florence/M-7683-2016	COLLEAUX, LAURENCE/0000-0002-0987-7648; Molinari, Florence/0000-0001-5111-7215; Preat, Thomas/0000-0001-9976-1763				Armstrong JD, 1998, LEARN MEMORY, V5, P102; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Molinari F, 2003, HUM MOL GENET, V12, pR195, DOI 10.1093/hmg/ddg276; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Shiosaka S, 2000, NEUROSCI RES, V37, P85, DOI 10.1016/S0168-0102(00)00115-2; Shiosaka Sadao, 2004, Anatomical Science International, V79, P137, DOI 10.1111/j.1447-073x.2004.00080.x; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	19	67	68	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2006	313	5788					851	853		10.1126/science.1127215	http://dx.doi.org/10.1126/science.1127215			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902143				2022-12-01	WOS:000239671300065
J	Greenleaf, WJ; Block, SM				Greenleaf, William J.; Block, Steven M.			Single-molecule, motion-based DNA sequencing using RNA polymerase	SCIENCE			English	Article							DISCRIMINATION		Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	sblock@stanford.edu			NIGMS NIH HHS [R01 GM057035, GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035, R37GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696	6	90	103	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2006	313	5788					801	801		10.1126/science.1130105	http://dx.doi.org/10.1126/science.1130105			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902131	Green Accepted			2022-12-01	WOS:000239671300049
J	Taylor, BW; Flecker, AS; Hall, RO				Taylor, Brad W.; Flecker, Alexander S.; Hall, Robert O., Jr.			Loss of a harvested fish species disrupts carbon flow in a diverse tropical river	SCIENCE			English	Article							STREAMS; DYNAMICS	Harvesting threatens many vertebrate species, yet few whole-system manipulations have been conducted to predict the consequences of vertebrate losses on ecosystem function. Here, we show that a harvested migratory detrital-feeding fish (Prochilodontidae: Prochilodus mariae) modulates carbon flow and ecosystem metabolism. Natural declines in and experimental removal of Prochilodus decreased downstream transport of organic carbon and increased primary production and respiration. Thus, besides its economic value, Prochilodus is a critical ecological component of South American rivers. Lack of functional redundancy for this species highlights the importance of individual species and, contrary to theory, suggests that losing one species from lower trophic levels can affect ecosystem functioning even in species-rich ecosystems.	Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	University of Wyoming; Cornell University	Taylor, BW (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	brad.taylor@dartmouth.edu		Taylor, Brad/0000-0002-7824-2304				Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; [Anonymous], 2005, EC HUM WELL BEING BI; Barbarino A., 1998, ENVIRON BIOL FISH, V53, P33, DOI DOI 10.1023/A:1007447004451; BAYLEY P B, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P385; Castillo MM, 2004, FRESHWATER BIOL, V49, P1400, DOI 10.1111/j.1365-2427.2004.01277.x; FIGUEREDO D, COMMUNICATION; Flecker AS, 1997, J N AM BENTHOL SOC, V16, P286, DOI 10.2307/1468258; Flecker AS, 2002, ECOLOGY, V83, P1831, DOI 10.1890/0012-9658(2002)083[1831:IBHFAL]2.0.CO;2; Flecker AS, 1996, ECOLOGY, V77, P1845, DOI 10.2307/2265788; GELWICK FP, 1992, ECOLOGY, V73, P1630, DOI 10.2307/1940016; Huryn AD, 1998, OECOLOGIA, V115, P173, DOI 10.1007/s004420050505; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Lewis W. M., 1995, RIVER STREAM ECOSYST, P219; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; NEWBOLD JD, 1982, OIKOS, V38, P266, DOI 10.2307/3544663; NEWBOLD JD, 1982, AM NAT, V120, P628, DOI 10.1086/284017; Power ME, 2003, CATFISHES, VOLS 1-2, P581; Pringle CM, 1999, ECOLOGY, V80, P1860, DOI 10.1890/0012-9658(1999)080[1860:LSAEDB]2.0.CO;2; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Simon KS, 2004, ECOSYSTEMS, V7, P777, DOI 10.1007/s10021-004-0024-z; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WALLACE JB, 1991, LIMNOL OCEANOGR, V36, P670, DOI 10.4319/lo.1991.36.4.0670; Winemiller Kirk O., 1996, P99, DOI 10.1016/B978-012178075-3/50006-4; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Wright JP, 2004, BIOL CONSERV, V120, P439, DOI 10.1016/j.biocon.2004.02.022	27	227	237	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					833	836		10.1126/science.1128223	http://dx.doi.org/10.1126/science.1128223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902137				2022-12-01	WOS:000239671300059
J	Babenko, AP; Polak, M; Cave, H; Busiah, K; Czernichow, P; Scharfmann, R; Bryan, J; Aguilar-Bryan, L; Vaxillaire, M; Froguel, P				Babenko, Andrey P.; Polak, Michel; Cave, Helene; Busiah, Kanetee; Czernichow, Paul; Scharfmann, Raphael; Bryan, Joseph; Aguilar-Bryan, Lydia; Vaxillaire, Martine; Froguel, Philippe			Activating mutations in the ABCC8 gene in neonatal diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							K-ATP CHANNELS; SULFONYLUREA RECEPTOR; IMMUNE DYSREGULATION; INSULIN-SECRETION; KIR6.2 MUTATIONS; STOICHIOMETRY; NUCLEOTIDES; REGULATOR; MECHANISM; TRANSIENT	BACKGROUND: The ATP-sensitive potassium (K(sub ATP)) channel, composed of the beta-cell proteins sulfonylurea receptor (SUR1) and inward-rectifying potassium channel subunit Kir6.2, is a key regulator of insulin release. It is inhibited by the binding of adenine nucleotides to subunit Kir6.2, which closes the channel, and activated by nucleotide binding or hydrolysis on SUR1, which opens the channel. The balance of these opposing actions determines the low open-channel probability, P(sub O), which controls the excitability of pancreatic beta cells. We hypothesized that activating mutations in ABCC8, which encodes SUR1, cause neonatal diabetes. METHODS: We screened the 39 exons of ABCC8 in 34 patients with permanent or transient neonatal diabetes of unknown origin. We assayed the electrophysiologic activity of mutant and wild-type K(sub ATP) channels. RESULTS: We identified seven missense mutations in nine patients. Four mutations were familial and showed vertical transmission with neonatal and adult-onset diabetes; the remaining mutations were not transmitted and not found in more than 300 patients without diabetes or with early-onset diabetes of similar genetic background. Mutant channels in intact cells and in physiologic concentrations of magnesium ATP had a markedly higher P(sub O) than did wild-type channels. These overactive channels remained sensitive to sulfonylurea, and treatment with sulfonylureas resulted in euglycemia. CONCLUSIONS: Dominant mutations in ABCC8 accounted for 12 percent of cases of neonatal diabetes in the study group. Diabetes results from a newly discovered mechanism whereby the basal magnesium-nucleotide-dependent stimulatory action of SUR1 on the Kir pore is elevated and blockade by sulfonylureas is preserved.	Hop Necker Enfants Malad, INSERM, U0363, Fac Med, Paris, France; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Hop Robert Debre, Dept Biochem Genet, F-75019 Paris, France; Hop Robert Debre, Dept Pediat Endocrinol, F-75019 Paris, France; Inst Pasteur, CNRS, U8090, Lille, France; Univ London Imperial Coll Sci & Technol, Hammersmith Hosp, Dept Genom Med, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Baylor College of Medicine; Baylor College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Imperial College London	Polak, M (corresponding author), Hop Necker Enfants Malad, INSERM, U0363, Fac Med, Paris, France.	michel.polak@nck.aphp.fr	FROGUEL, Philippe/O-6799-2017; Kanetee, BUSIAH/AAP-8292-2020; scharfmann, raphael/L-3296-2017	FROGUEL, Philippe/0000-0003-2972-0784; Kanetee, BUSIAH/0000-0002-1059-0791; Cave, Helene/0000-0003-2840-1511; Scharfmann, Raphael/0000-0001-7619-337X	MRC [G0000477] Funding Source: UKRI; Medical Research Council [G0000477] Funding Source: Medline; NIDDK NIH HHS [DK44311, DK52771] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044311, R01DK052771] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Babenko ADP, 2005, J MOL CELL CARDIOL, V39, P79, DOI 10.1016/j.yjmcc.2004.12.004; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Gloyn AL, 2004, NEW ENGL J MED, V351, P1470; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Klupa T, 2005, DIABETOLOGIA, V48, P1029, DOI 10.1007/s00125-005-1731-5; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Metz C, 2002, J PEDIATR-US, V141, P483, DOI 10.1067/mpd.2002.127089; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Peake JE, 1996, ARCH DIS CHILD-FETAL, V74, pF195, DOI 10.1136/fn.74.3.F195; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vaxillaire M, 2004, DIABETES, V53, P2719, DOI 10.2337/diabetes.53.10.2719	33	456	487	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2006	355	5					456	466		10.1056/NEJMoa055068	http://dx.doi.org/10.1056/NEJMoa055068			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FT	16885549				2022-12-01	WOS:000239432500005
J	Martini, E; Diaz, RL; Hunter, N; Keeney, S				Martini, Emmanuelle; Diaz, Robert L.; Hunter, Neil; Keeney, Scott			Crossover homeostasis in yeast meiosis	CELL			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CROSSING-OVER; GENE CONVERSION; BUDDING YEAST; C-ELEGANS; INTERFERENCE; CHROMOSOME; INITIATION	Crossovers produced by homologous recombination promote accurate chromosome segregation in meiosis and are controlled such that at least one forms per chromosome pair and multiple crossovers are widely spaced. Recombination initiates with an excess number of double-strand breaks made by Spo11 protein. Thus, crossover control involves a decision by which some breaks give crossovers while others follow a predominantly noncrossover pathway(s). To understand this decision, we examined recombination when breaks are reduced in yeast spo11 hypomorphs. We find that crossover levels tend to be maintained at the expense of noncrossovers and that genomic loci differ in expression of this "crossover homeostasis." These findings define a previously unsuspected manifestation of crossover control, i.e., that the crossover/noncrossover ratio can change to maintain crossovers. Our results distinguish between existing models of crossover control and support the hypothesis that an obligate crossover is a genetically programmed event tied to crossover interference.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; CEA, CNRS, UMR 217, DSV,SRMC,LRD, F-92265 Fontenay Aux Roses, France; Univ Calif Davis, Genet & Dev Sect, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Genet & Dev Sect, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Memorial Sloan Kettering Cancer Center; CEA; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Davis; University of California System; University of California Davis	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673, R01GM074223] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM58673, R01 GM058673, R01 GM058673-06A1, R01 GM058673-09, R01 GM058673-07, R01 GM74223, R01 GM074223, R01 GM058673-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Copenhaver GP, 2002, GENETICS, V160, P1631; de los Santos T, 2003, GENETICS, V164, P81; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; FOSS E, 1993, GENETICS, V133, P681; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hoffmann ER, 2003, GENETICS, V163, P515; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; MCPEEK MS, 1995, GENETICS, V139, P1031; Moens PB, 2002, J CELL SCI, V115, P1611; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; MUNZ P, 1994, GENETICS, V137, P701; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PAPAZIAN HP, 1952, GENETICS, V37, P175; PERKINS DD, 1949, GENETICS, V34, P607; RAHN MI, 1986, CYTOGENET CELL GENET, V43, P187, DOI 10.1159/000132319; Shinohara M, 2003, GENETICS, V163, P1273; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Turney D, 2004, GENETICS, V168, P2421, DOI 10.1534/genetics.104.033555; VILLENEUVE AM, 1994, GENETICS, V136, P887	37	231	236	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					285	295		10.1016/j.cell.2006.05.044	http://dx.doi.org/10.1016/j.cell.2006.05.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873061	Green Accepted, Bronze			2022-12-01	WOS:000239552600015
J	Alleman, M; Sidorenko, L; McGinnis, K; Seshadri, V; Dorweiler, JE; White, J; Sikkink, K; Chandler, VL				Alleman, Mary; Sidorenko, Lyudmila; McGinnis, Karen; Seshadri, Vishwas; Dorweiler, Jane E.; White, Joshua; Sikkink, Kristin; Chandler, Vicki L.			An RNA-dependent RNA polymerase is required for paramutation in maize	NATURE			English	Article							UNPAIRED DNA; METHYLATION; HETEROCHROMATIN; CHROMATIN; GENE; ARABIDOPSIS; MAINTENANCE; TRANSCRIPTION; UPSTREAM; SEQUENCE	Paramutation is an allele-dependent transfer of epigenetic information, which results in the heritable silencing of one allele by another(1). Paramutation at the b1 locus in maize is mediated by unique tandem repeats that communicate in trans to establish and maintain meiotically heritable transcriptional silencing(2). The mop1 ( mediator of paramutation1) gene is required for paramutation(3), and mop1 mutations reactivate silenced Mutator elements(4). Plants carrying mutations in the mop1 gene also stochastically exhibit pleiotropic developmental phenotypes(3). Here we report the map-based cloning of mop1, an RNA-dependent RNA polymerase gene (RDRP), most similar to the RDRP in plants that is associated with the production of short interfering RNA ( siRNA) targeting chromatin(5,6). Nuclear run-on assays reveal that the tandem repeats required for b1 paramutation are transcribed from both strands, but siRNAs were not detected. We propose that the mop1 RDRP is required to maintain a threshold level of repeat RNA, which functions in trans to establish and maintain the heritable chromatin states associated with paramutation.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	University of Arizona	Chandler, VL (corresponding author), Univ Arizona, Dept Plant Sci, 303 Forbes Hall, Tucson, AZ 85721 USA.	chandler@ag.arizona.edu	Dorweiler, Jane/K-3116-2019					Bennetzen JL, 2003, CURR OPIN PLANT BIOL, V6, P128, DOI 10.1016/S1369-5266(03)00015-3; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hollick JB, 2001, GENETICS, V157, P369; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; KOHALMI SE, 1988, J MOL BIOL, V204, P561, DOI 10.1016/0022-2836(88)90355-5; Lee DW, 2004, GENETICS, V167, P131, DOI 10.1534/genetics.167.1.131; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lisch D, 2002, P NATL ACAD SCI USA, V99, P6130, DOI 10.1073/pnas.052152199; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Martienssen RA, 2005, CHROMOSOME RES, V13, P299, DOI 10.1007/s10577-005-1507-2; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; May BP, 2005, PLOS GENET, V1, P705, DOI 10.1371/journal.pgen.0010079; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; PATTERSON GI, 1993, GENETICS, V135, P881; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	31	281	300	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					295	298		10.1038/nature04884	http://dx.doi.org/10.1038/nature04884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855589				2022-12-01	WOS:000239122100037
J	Zhu, JL; Basso, O; Obel, C; Bille, C; Olsen, J				Zhu, Jin Liang; Basso, Olga; Obel, Carsten; Bille, Camilla; Olsen, Jorn			Infertility, infertility treatment, and congenital malformations: Danish national birth cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; RISK; REGISTRY; CHILDREN; SWEDEN; IVF	Objectives To examine whether infertile couples (with a time to pregnancy of >12 months), who conceive naturally or after treatment, give birth to children with an increased prevalence of congenital malformations. Design Longitudinal study. Setting Danish national birth cohort. Participants Three groups of liveborn children and their mothers: 50 897 singletons and 1366 twins born to fertile couples (time to pregnancy : 12 months), 5764 singletons and 100 twins born to infertile couples who conceived naturally (time to pregnancy >12 months), and 4588 singletons and 1690 twins born after infertility treatment. Main outcome measures Prevalence of congenital malformations determined from hospital discharge diagnoses. Results Compared with singletons born to fertile couples, singletons born to infertile couples who conceived naturally or after treatment had a higher prevalence of congenital malformations-hazard ratios 1.20 (95% confidence interval 1.07 to 1.35) and 1.39 (1.23 to 1.57). The overall prevalence of congenital malformations increased with increasing time to pregnancy. When the analysis was restricted to singletons born to infertile couples, babies born after treatment had an increased prevalence of genital organ malformations (hazard ratio 2.32, 1.24 to 4.35) compared with babies conceived naturally. No significant differences existed in the overall prevalence of congenital malformations among twins. Conclusions Hormonal treatment for infertility may be related to the occurrence of malformations of genital organs, but our results suggest that the reported increased prevalence of congenital malformations seen in singletons born after assisted reproductive technology is partly the result of the underlying infertility or its determinants. The association between untreated infertility and congenital malformations warrants further examination.	Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol, Inst Publ Hlth, DK-8000 Aarhus C, Denmark; NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC USA; Aarhus Univ Hosp, Dept Obstet & Gynaecol, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark; Univ So Denmark, Ctr Prevent Congenital Malformat, Inst Publ Hlth, DK-5000 Odense C, Denmark; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA	Aarhus University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Aarhus University; University of Southern Denmark; University of California System; University of California Los Angeles	Zhu, JL (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol, Inst Publ Hlth, DK-8000 Aarhus C, Denmark.	zjl@soci.au.dk	Basso, Olga/E-5384-2010; Olsen, Jørn/F-8801-2015; Obel, Carsten/H-9605-2016	Basso, Olga/0000-0001-9298-4921; Olsen, Jørn/0000-0001-7462-5140; Obel, Carsten/0000-0001-5004-1933	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andersen AN, 2005, HUM REPROD, V20, P1158, DOI 10.1093/humrep/deh755; Andersen TF, 1999, DAN MED BULL, V46, P263; BILLE C, 2005, THESIS U SO DENMARK; Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Juul S, 1999, HUM REPROD, V14, P1250, DOI 10.1093/humrep/14.5.1250; Kallen B, 2005, BIRTH DEFECTS RES A, V73, P162, DOI 10.1002/bdra.20107; Klemetti R, 2005, FERTIL STERIL, V84, P1300, DOI 10.1016/j.fertnstert.2005.03.085; Knudsen LB, 1998, DAN MED BULL, V45, P320; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; McDonald S, 2005, AM J OBSTET GYNECOL, V193, P141, DOI 10.1016/j.ajog.2004.11.064; McDonald SD, 2005, J OBSTET GYNAECOL CA, V27, P449, DOI 10.1016/S1701-2163(16)30527-8; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Rimm AA, 2004, J ASSIST REPROD GEN, V21, P437, DOI 10.1007/s10815-004-8760-8; RINUM AA, 2004, J ASSIST REPROD GEN, V21, P437; Schmidt L, 2006, LANCET, V367, P379, DOI 10.1016/S0140-6736(06)68117-8; Silver RI, 1999, J UROLOGY, V161, P1954, DOI 10.1016/S0022-5347(05)68863-5; Westergaard HB, 1999, HUM REPROD, V14, P1896, DOI 10.1093/humrep/14.7.1896; Wright Victoria Clay, 2005, Morbidity and Mortality Weekly Report, V54, P1	19	234	236	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2006	333	7570					679	+		10.1136/bmj.38919.495718.AE	http://dx.doi.org/10.1136/bmj.38919.495718.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092AA	16893903	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000241068200017
J	Nkomo, VT; Gardin, JM; Skelton, TN; Gottdiener, JS; Scott, CG; Enriquez-Sarano, M				Nkomo, Vuyisile T.; Gardin, Julius M.; Skelton, Thomas N.; Gottdiener, John S.; Scott, Christopher G.; Enriquez-Sarano, Maurice			Burden of valvular heart diseases: a population-based study	LANCET			English	Article							AORTIC REGURGITATION; DOPPLER-ECHOCARDIOGRAPHY; MITRAL REGURGITATION; PREVALENCE; VALVE; RECOMMENDATIONS; COMMITTEE; WOMEN	Background Valvular heart diseases are not usually regarded as a major public-health problem. Our aim was to assess their prevalence and effect on overall survival in the general population. Methods We pooled population-based studies to obtain data for 11911 randomly selected adults from the general population who had been assessed prospectively with echocardiography. We also analysed data from a community study of 16 501 adults who had been assessed by clinically indicated echocardiography. Findings In the general population group, moderate or severe valve disease was identified in 615 adults. There was no difference in the frequency of such diseases between men and women (p=0.90). Prevalence increased with age, from 0.7% (95% CI 0.5-1.0) in 18-44 year olds to 13.3% (11.7-15.0) in the 75 years and older group (p<0.0001). The national prevalence of valve disease, corrected for age and sex distribution from the US 2000 population, is 2.5% (2.2-2.7). In the community group, valve disease was diagnosed in 1505 (1.8% adjusted) adults and frequency increased considerably with age, from 0.3% (0.2-0.3) of the 18-44 year olds to 11.7% (11.0-12.5) of those aged 75 years and older, but was diagnosed less often in women than in men (odds ratio 0.90, 0.81-1.01; p=0.07). The adjusted mortality risk ratio associated with valve disease was 1.36 (1.15-1.62; p=0.0005) in the population and 1.75 (1.61-1.90; p<0.0001) in the community. Interpretation Moderate or severe valvular diseases: are notably common in this population and increase with age. In the community women are less often diagnosed than are men, which could indicate an important imbalance in view of the associated lower survival. Valve diseases thus represent an important public-health problem.	Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; St Johns Hosp, Detroit, MI USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Univ Maryland, Baltimore, MD 21201 USA	Mayo Clinic; University of Mississippi; University of Mississippi Medical Center; University System of Maryland; University of Maryland Baltimore	Enriquez-Sarano, M (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu		Scott, Christopher/0000-0003-1340-0647	NHLBI NIH HHS [HL 64928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKASAKA T, 1987, CIRCULATION, V76, P262, DOI 10.1161/01.CIR.76.2.262; Aronow WS, 1997, AM J CARDIOL, V79, P379, DOI 10.1016/S0002-9149(96)00769-2; Bonow R O, 1998, J Heart Valve Dis, V7, P672; Carabello BA, 2002, J CARD FAIL, V8, pS258, DOI 10.1054/jcaf.2002.129250; Chen LW, 1998, CURR OPIN CARDIOL, V13, P397, DOI 10.1097/00001573-199811000-00003; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Gardin J M, 1992, J Am Soc Echocardiogr, V5, P63; HATLE L, 1984, HERZ, V9, P213; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Jost CHA, 2000, AM J MED, V108, P614, DOI 10.1016/S0002-9343(00)00361-2; Klein A L, 1990, J Am Soc Echocardiogr, V3, P54; Klodas E, 1996, CIRCULATION, V94, P2472, DOI 10.1161/01.CIR.94.10.2472; Lebowitz NE, 2000, J AM COLL CARDIOL, V36, P461, DOI 10.1016/S0735-1097(00)00744-0; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Lucas G, 2000, Rev Prat, V50, P1642; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MOHTY D, 2001, CIRCULATION S1, V104, P1, DOI 10.1161/hc37t1.094903; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952, DOI 10.1016/S0735-1097(87)80254-1; POMERANCE A, 1967, BRIT HEART J, V29, P222; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; *SOC THOR SURG, STS NAT DAT SPRING 2; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; U. S. Bureau of the Census, 2001, US CENS 2000; who, 2004, WHO TECH REP SER, V923, P1; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	35	2777	2959	6	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					1005	1011		10.1016/S0140-6736(06)69208-8	http://dx.doi.org/10.1016/S0140-6736(06)69208-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980116				2022-12-01	WOS:000240698700029
J	Banaszynski, LA; Chen, LC; Maynard-Smith, LA; Ooi, AGL; Wandless, TJ				Banaszynski, Laura A.; Chen, Lin-chun; Maynard-Smith, Lystranne A.; Ooi, A. G. Lisa; Wandless, Thomas J.			A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules	CELL			English	Article							KINASE INHIBITORS; RNA INTERFERENCE; MAMMALIAN-CELLS; GENE-EXPRESSION; HALF-LIFE; IN-VIVO; SPECIFICITY; UBIQUITIN; DIFFERENTIATION; LOCALIZATION	Rapid and reversible methods for perturbing the function of specific proteins are desirable tools for probing complex biological systems. We have developed a general technique to regulate the stability of specific proteins in mammalian cells using cell-permeable, synthetic molecules. We engineered mutants of the human FKBP12 protein that are rapidly and constitutively degraded when expressed in mammalian cells, and this instability is conferred to other proteins fused to these destabilizing domains. Addition of a synthetic ligand that binds to the destabilizing domains shields them from degradation, allowing fused proteins to perform their cellular functions. Genetic fusion of the destabilizing domain to a gene of interest ensures specificity, and the attendant small-molecule control confers speed, reversibility, and dose-dependence to this method. This general strategy for regulating protein stability should enable conditional perturbation of specific proteins with unprecedented control in a variety of experimental settings.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wandless, TJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	wandless@stanford.edu	Banaszynski, Laura/B-9612-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046, R01GM068589] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068589, GM068589, R01 GM068589-02, GM073046, R01 GM073046, R01 GM068589-01, R01 GM073046-02, R01 GM073046-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Heo WD, 2003, CELL, V113, P315; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kohler JJ, 2003, CHEM BIOL, V10, P1303, DOI 10.1016/j.chembiol.2003.11.018; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Medema RH, 2004, BIOCHEM J, V380, P593, DOI 10.1042/BJ20040260; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pan XQ, 2005, J BIOL CHEM, V280, P22385, DOI 10.1074/jbc.M500081200; PARK EC, 1992, P NATL ACAD SCI USA, V89, P1249, DOI 10.1073/pnas.89.4.1249; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Raab RM, 2004, BIOTECHNOL BIOENG, V88, P121, DOI 10.1002/bit.20216; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	42	585	640	7	110	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 8	2006	126	5					995	1004		10.1016/j.cell.2006.07.025	http://dx.doi.org/10.1016/j.cell.2006.07.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959577	Green Accepted, Bronze			2022-12-01	WOS:000240675000025
J	Maffei, A; Nataraj, K; Nelson, SB; Turrigiano, GG				Maffei, Arianna; Nataraj, Kiran; Nelson, Sacha B.; Turrigiano, Gina G.			Potentiation of cortical inhibition by visual deprivation	NATURE			English	Article							MONOCULAR DEPRIVATION; NEOCORTICAL SYNAPSES; OCULAR DOMINANCE; CORTEX; PLASTICITY; EXPERIENCE; NEURONS; ORIENTATION; AMBLYOPIA; CIRCUITS	The fine-tuning of circuits in sensory cortex requires sensory experience during an early critical period. Visual deprivation during the critical period has catastrophic effects on visual function, including loss of visual responsiveness to the deprived eye(1-3), reduced visual acuity(4), and loss of tuning to many stimulus characteristics(2,5). These changes occur faster than the remodelling of thalamocortical axons(6), but the intracortical plasticity mechanisms that underlie them are incompletely understood. Longterm depression of excitatory intracortical synapses has been proposed as a general candidate mechanism for the loss of cortical responsiveness after visual deprivation(7,8). Alternatively (or in addition), the decreased ability of the deprived eye to activate cortical neurons could be due to enhanced intracortical inhibition(9,10). Here we show that visual deprivation leaves excitatory connections in layer 4 (the primary input layer to cortex) unaffected, but markedly potentiates inhibitory feedback between fast-spiking basket cells (FS cells) and star pyramidal neurons (star pyramids). Further, a previously undescribed form of long-term potentiation of inhibition (LTPi) could be induced at synapses from FS cells to star pyramids, and was occluded by previous visual deprivation. These data suggest that potentiation of inhibition is a major cellular mechanism underlying the deprivation-induced degradation of visual function, and that this form of LTPi is important in fine-tuning cortical circuitry in response to visual experience.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	turrigiano@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599; Maffei, Arianna/0000-0001-6755-8904				Antonini A, 1996, J COMP NEUROL, V369, P64; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Barrett BT, 2004, NEUROSCIENTIST, V10, P106, DOI 10.1177/1073858403262153; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; Contreras D, 2003, J NEUROSCI, V23, P6936; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Holmgren CD, 2001, J NEUROSCI, V21, P8270; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kayser AS, 2002, NEURON, V33, P131, DOI 10.1016/S0896-6273(01)00570-0; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Prusky GT, 2000, BEHAV BRAIN RES, V116, P135, DOI 10.1016/S0166-4328(00)00267-9; Rauschecker JP, 2002, PROG BRAIN RES, V138, P73, DOI 10.1016/S0079-6123(02)38072-5; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Thomson AM, 2002, PHILOS T R SOC B, V357, P1781, DOI 10.1098/rstb.2002.1163; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	30	281	284	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					81	84		10.1038/nature05079	http://dx.doi.org/10.1038/nature05079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16929304				2022-12-01	WOS:000240313900043
J	Thompson, RH				Thompson, R. Houston			Radical nephrectomy: too radical for small renal masses?	LANCET			English	Editorial Material							NEPHRON-SPARING SURGERY; CELL CARCINOMA; EXPERIENCE; TUMORS		Mayo Clin, Dept Urol, Rochester, MN 55905 USA	Mayo Clinic	Thompson, RH (corresponding author), Mayo Clin, Dept Urol, Rochester, MN 55905 USA.	Thompson.robert@mayo.edu						Becker F, 2006, EUR UROL, V49, P308, DOI 10.1016/j.eururo.2005.10.020; Gill IS, 2003, J UROLOGY, V170, P64, DOI 10.1097/01.ju.0000072272.02322.ff; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Lau WKO, 2000, MAYO CLIN PROC, V75, P1236; Leibovich BC, 2004, J UROLOGY, V171, P1066, DOI 10.1097/01.ju.0000113274.40885.db; Miller DC, 2006, J UROLOGY, V175, P853, DOI 10.1016/S0022-5347(05)00422-2; NOVICK AC, 1989, J UROLOGY, V141, P835, DOI 10.1016/S0022-5347(17)41026-3; Nuttall M, 2005, BJU INT, V96, P58, DOI 10.1111/j.1464-410X.2005.05567.x; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; ROBSON CJ, 1969, J UROLOGY, V101, P297, DOI 10.1016/S0022-5347(17)62331-0; Russo P, 2000, SEMIN ONCOL, V27, P160; Thompson RH, 2005, J UROLOGY, V174, P855, DOI 10.1097/01.ju.0000169453.29706.42; ZINCKE H, 1985, MAYO CLIN PROC, V60, P651, DOI 10.1016/S0025-6196(12)60739-3	13	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					823	824		10.1016/S0140-6736(06)69302-1	http://dx.doi.org/10.1016/S0140-6736(06)69302-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950341				2022-12-01	WOS:000240371200007
J	Jenkins, N; Saam, JR; Mango, SE				Jenkins, Noah; Saam, Jennifer R.; Mango, Susan E.			CYK-4/GAP provides a localized cue to initiate anteroposterior polarity upon fertilization	SCIENCE			English	Article							ANTERIOR-POSTERIOR POLARITY; C-ELEGANS EMBRYOS; CAENORHABDITIS-ELEGANS; CELL POLARITY; PAR PROTEINS; CYTOKINESIS; ESTABLISHMENT; MORPHOGENESIS; POLARIZATION; ZYGOTE	The Caenorhabditis elegans anteroposterior axis is established in response to fertilization by sperm. Here we present evidence that RhoA, the guanine nucleotide-exchange factor ECT-2, and the Rho guanosine triphosphatase-activating protein CYK-4 modulate myosin light-chain activity to create a gradient of actomyosin, which establishes the anterior domain. CYK-4 is enriched within sperm, and paternally donated CYK-4 is required for polarity. These data suggest that CYK-4 provides a molecular link between fertilization and polarity establishment in the one-cell embryo. Orthologs of CYK-4 are expressed in sperm of other species, which suggests that this cue may be evolutionarily conserved.	Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NCI NIH HHS [2P30CA42014] Funding Source: Medline; NIDDK NIH HHS [K01DK02966-2] Funding Source: Medline; NIGMS NIH HHS [R01 GM056264, R01 GM056264-10, R01 GM056264-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGNEL M, 1992, MOL CELL BIOL, V12, P5111, DOI 10.1128/MCB.12.11.5111; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; L'Hernault SW, 1997, C ELEGANS, P271; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; OKAMOTO H, 1985, J NEUROSCI, V5, P643; Portereiko MF, 2004, CURR BIOL, V14, P932, DOI 10.1016/j.cub.2004.05.052; Portereiko MF, 2001, DEV BIOL, V233, P482, DOI 10.1006/dbio.2001.0235; Prodon F, 2004, M S-MED SCI, V20, P526, DOI 10.1051/medsci/2004205526; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sadler PL, 2000, DEVELOPMENT, V127, P355; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Toure A, 2001, J BIOL CHEM, V276, P20309, DOI 10.1074/jbc.M011740200; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	24	98	103	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1298	1301		10.1126/science.1130291	http://dx.doi.org/10.1126/science.1130291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16873611				2022-12-01	WOS:000240313500044
J	van Maldegem, BT; Duran, M; Wanders, RJA; Niezen-Koning, KE; Hogeveen, M; Ijlst, L; Waterham, HR; Wijburg, FA				van Maldegem, Bianca T.; Duran, Marinus; Wanders, Ronald J. A.; Niezen-Koning, Klary E.; Hogeveen, Marije; Ijlst, Lodewijk; Waterham, Hans R.; Wijburg, Frits A.			Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TANDEM MASS-SPECTROMETRY; COA DEHYDROGENASE; INBORN-ERRORS; ETHYLMALONIC ACIDURIA; SCAD GENE; VARIANT; METABOLISM; DISORDERS; MUTATIONS; PATIENT	Context Short-chain acyl-coenzyme A (CoA) dehydrogenase (SCAD) deficiency (SCADD) is an autosomal recessive, clinically heterogeneous disorder with only 22 case reports published so far. Screening for SCADD is included in expanded newborn screening programs in most US and Australian states. Objectives To describe the genetic, biochemical, and clinical characteristics of SCADD patients in the Netherlands and their SCADD relatives and to explore the genotype to phenotype relation. Design, Setting, and Participants Retrospective study involving 31 Dutch SCADD patients diagnosed between January 1987 and January 2006 and 8 SCADD relatives. SCADD was defined by the presence of (1) increased butyrylcarnitine (C4-C) levels in plasma and/or increased ethylmalonic acid (EMA) levels in urine under nonstressed conditions on at least 2 occasions, in combination with (2) a mutation and/or the c.511C> T or c. 625G>A susceptibility variants on each SCAD-encoding (ACADS) allele. Patients were included only if the SCAD-encoding (ACADS) was fully sequenced and if current clinical information could be obtained. Relatives were included when they carried the same ACADS genotype as the proband, and had increased C4-C and/or EMA. Main Outcome Measures Prevalence, genotype (mutation/mutation, mutation/variant, variant/variant), C4-C and EMA levels, clinical signs and symptoms, and clinical course. Results A birth-prevalence of at least 1: 50 000 was calculated. Most patients presented before the age of 3 years, with nonspecific, generally uncomplicated, and often transient symptoms. Developmental delay, epilepsy, behavioral disturbances, and hypoglycemia were the most frequently reported symptoms. The ACADS genotype showed a statistically significant association with EMA and C4-C levels, but not with clinical characteristics. Seven out of 8 SCADD relatives were free of symptoms. Conclusions SCADD is far more common than assumed previously, and clinical symptoms in SCADD are nonspecific, generally uncomplicated, often transient, and not correlated with specific ACADS genotypes. Because SCADD does not meet major newborn screening criteria, including a lack of clinical significance in many patients and that it is not possible to differentiate diseased and nondiseased individuals, it is not suited for inclusion in newborn screening programs at the present time.	Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; Univ Groningen, Univ Med Ctr, Dept Pediat, Res Lab, Groningen, Netherlands; Univ Med Ctr Nijmegen, Dept Metab Dis, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Radboud University Nijmegen	van Maldegem, BT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.t.vanmaldegem@amc.uva.nl	Hogeveen, M./L-4381-2015	Wijburg, Frits/0000-0002-0950-1368; Niezen-Koning, Klary E/0000-0002-9384-4354				AMENDT BA, 1987, J CLIN INVEST, V79, P1303, DOI 10.1172/JCI112953; BHALA A, 1995, J PEDIATR-US, V126, P910, DOI 10.1016/S0022-3476(95)70207-5; Birkebaek NH, 2002, ACTA PAEDIATR, V91, P480, DOI 10.1080/080352502317371751; Bok LA, 2003, PEDIATRICS, V112, P1152, DOI 10.1542/peds.112.5.1152; Corydon MJ, 1997, MAMM GENOME, V8, P922, DOI 10.1007/s003359900612; Corydon MJ, 2001, PEDIATR RES, V49, P18; Corydon MJ, 1996, PEDIATR RES, V39, P1059, DOI 10.1203/00006450-199606000-00021; DAWSON DB, 1995, J PEDIATR-US, V126, P69, DOI 10.1016/S0022-3476(95)70505-8; FRANKENB.WK, 1974, PEDIATRICS, V54, P612; Gregersen N, 1998, HUM MOL GENET, V7, P619, DOI 10.1093/hmg/7.4.619; Gregersen N, 2001, J INHERIT METAB DIS, V24, P189, DOI 10.1023/A:1010319001722; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174; Gregersen N, 2000, EUR J PEDIATR, V159, pS213, DOI 10.1007/PL00014406; Holtzman NA, 2003, JAMA-J AM MED ASSOC, V290, P2606, DOI 10.1001/jama.290.19.2606; HOWELL R, 2005, NEWBORN SCREENING UN; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Koeberl DD, 2003, PEDIATR RES, V54, P219, DOI 10.1203/01.PDR.0000074972.36356.89; KRISTENSEN MJ, 1994, HUM MOL GENET, V3, P1711, DOI 10.1093/hmg/3.9.1711-a; Kurian MA, 2004, NEUROPEDIATRICS, V35, P312, DOI 10.1055/s-2004-830371; Leipnitz G, 2003, NEUROCHEM RES, V28, P771, DOI 10.1023/A:1022874103630; Mann MY, 2006, PEDIATRICS, V117, pS296, DOI 10.1542/peds.2005-26331; Matern D, 2001, J PEDIATR-US, V138, P585, DOI 10.1067/mpd.2001.111814; Nagan N, 2003, MOL GENET METAB, V78, P239, DOI 10.1016/S1096-7192(03)00034-9; NAITO E, 1990, J CLIN INVEST, V85, P1575, DOI 10.1172/JCI114607; *NAT PUBL HLTH PAR, 2002, OV PUBL HLTH SURV GE; NIEZENKONING KE, 1994, CLIN CHIM ACTA, V229, P99, DOI 10.1016/0009-8981(94)90232-1; Pollitt RJ, 2006, J INHERIT METAB DIS, V29, P390, DOI 10.1007/s10545-006-0259-2; Rhead W. J., 2002, Journal of Inherited Metabolic Disease, V25, P4; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Seidel J, 2003, J INHERIT METAB DIS, V26, P37, DOI 10.1023/A:1024019311933; SEWELL AC, 1993, EUR J PEDIATR, V152, P922, DOI 10.1007/BF01957531; THERELL BL, 2006, US NATL NEWBORN SCRE; Therrell BL, 2001, MOL GENET METAB, V74, P64, DOI 10.1006/mgme.2001.3238; van Maldegem BT, 2005, J INHERIT METAB DIS, V28, P557, DOI 10.1007/s10545-005-0557-0; Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745; Waisbren SE, 2003, JAMA-J AM MED ASSOC, V290, P2564, DOI 10.1001/jama.290.19.2564; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Wilson JM, 1968, PUBLIC HLTH PAPERS W, V34; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	39	91	94	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2006	296	8					943	952		10.1001/jama.296.8.943	http://dx.doi.org/10.1001/jama.296.8.943			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076AL	16926354				2022-12-01	WOS:000239929300024
J	Mathews, DJH; Donovan, P; Harris, J; Lovell-Badge, R; Savulescu, J; Faden, R				Mathews, Debra J. H.; Donovan, Peter; Harris, John; Lovell-Badge, Robin; Savulescu, Julian; Faden, Ruth			Science and law - Integrity in international stem cell research collaborations	SCIENCE			English	Editorial Material									Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21205 USA; Univ Calif Irvine, Stem Cell Res Ctr, Irvine, CA 92697 USA; Univ Manchester, Inst Med Law & Bioeth, Manchester M13 9PL, Lancs, England; Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; Univ Oxford, Oxford Uehiro Ctr Practical Eth, Oxford OX1 1P, England	Johns Hopkins University; University of California System; University of California Irvine; University of Manchester; MRC National Institute for Medical Research; University of Oxford	Mathews, DJH (corresponding author), Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21205 USA.	dmathews@jhmi.edu		Mathews, Debra/0000-0002-4897-7617; Lovell-Badge, Robin/0000-0001-9364-4179	Medical Research Council [MC_U117562207] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U117562207] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Hansen Bart, 2004, Med Law, V23, P19; *INT SOC STEM CELL, INT HESCR GUID; Wilmut I, 2005, SCIENCE, V310, P1903; INT STEM CELL FORUM	4	15	15	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2006	313	5789					921	922		10.1126/science.1127990	http://dx.doi.org/10.1126/science.1127990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	074MR	16917046	Green Submitted			2022-12-01	WOS:000239817000025
J	Zhang, D; Zaugg, K; Mak, TW; Elledge, SJ				Zhang, Dong; Zaugg, Kathrin; Mak, Tak W.; Elledge, Stephen J.			A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; P53-DEPENDENT APOPTOSIS; REGULATES APOPTOSIS; BETA-TRCP; P53; CHECKPOINT; PROTEIN; CANCER	The Chk2-p53-PUMA pathway is a major regulator of DNA-damage-induced apoptosis in response to double-strand breaks in vivo. Through analysis of 5313131 complexes we have discovered a new ubiquitin protease, USP28, which regulates this pathway. Using a human cell line that faithfully recapitulated the Chk2-p53-PUMA pathway, we show that USP28 is required to stabilize Chk2 and 5313131 in response to DNA damage. In this cell line, both USP28 and Chk2 are required for DNA-damage-induced apoptosis, and they accomplish this in part through regulation of the p53 induction of proapoptotic genes like PUMA. Our studies implicate DNA-damage-induced ubiquitination and deubiquitination as a major regulator of the DNA-damage response for Chk2, 5313131, and a number of other proteins in the DNA-damage checkpoint pathway, including several mediators, such as Mdc1, Claspin, and TopBP1.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Univ Hlth Network, Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON M5G 2C1, Canada	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Zhang, Dong/0000-0002-4515-2070	NCI NIH HHS [T32 CA90221] Funding Source: Medline; NIAID NIH HHS [U19 AI067751] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA090221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn JW, 2003, J BIOL CHEM, V278, P20480, DOI 10.1074/jbc.M213185200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Almog N, 2000, ONCOGENE, V19, P3395, DOI 10.1038/sj.onc.1203673; ARNERIK AY, 2004, BIOCHIM BIOPHYS ACTA, V1695, P189; Aurelio ON, 2000, MOL CELL BIOL, V20, P770, DOI 10.1128/MCB.20.3.770-778.2000; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fei PW, 2002, CANCER RES, V62, P7316; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang J, 2002, GENE DEV, V16, P2315, DOI 10.1101/gad.1027902; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; VALERO R, 2001, GENOME BIOL, P2; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	47	248	260	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 11	2006	126	3					529	542		10.1016/j.cell.2006.06.039	http://dx.doi.org/10.1016/j.cell.2006.06.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901786	Bronze			2022-12-01	WOS:000239883400013
J	Rose, SH; Elliott, BA				Rose, Steven H.; Elliott, Beth A.			In only an instant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rose.steve@mayo.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2006	296	6					631	632		10.1001/jama.296.6.631	http://dx.doi.org/10.1001/jama.296.6.631			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	071LN	16896094				2022-12-01	WOS:000239603800001
J	Li, CF; Pontes, O; El-Shami, M; Henderson, IR; Bernatavichute, YV; Chan, SWL; Lagrange, T; Pikaard, CS; Jacobsen, SE				Li, Carey Fei; Pontes, Olga; El-Shami, Mahmoud; Henderson, Ian R.; Bernatavichute, Yana V.; Chan, Simon W. -L.; Lagrange, Thierry; Pikaard, Craig S.; Jacobsen, Steven E.			An ARGONAUTE4-containing nuclear processing center colocalized with Cajal bodies in Arabidopsis thaliana	CELL			English	Article							RNA-POLYMERASE-II; DIRECTED DNA METHYLATION; H3 LYSINE-9 METHYLATION; LIVING PLANT-CELLS; HETEROCHROMATIN FORMATION; HISTONE METHYLATION; FLUORESCENT PROTEIN; TERMINAL DOMAIN; SIRNA; CHROMATIN	ARGONAUTE4 (AGO4) and RNA polymerase IV (Pol IV) are required for DNA methylation guided by 24 nucleotide small interfering RNAs (siRNAs) in Arabidopsis thaliana. Here we show that AGO4 localizes to nucleolus-associated bodies along with the Pol IV subunit NRPD1b; the small nuclear RNA (snRNA) binding protein SmD3; and two markers of Cajal bodies, trimethylguanosine-capped snRNAs and the U2 snRNA binding protein U2B". AGO4 interacts with the C-terminal domain of NRPD1b, and AGO(4) protein stability depends on upstream factors that synthesize siRNAs. AGO(4) is also found, along with the DNA methyltransferase DRM2, throughout the nucleus at presumed DNA methylation target sites. Cajal bodies are conserved sites for the maturation of ribonucleoprotein complexes. Our results suggest a function for Cajal bodies as a center for the assembly of an AGO(4)/NRPD1b/siRNA complex, facilitating its function in RNA-directed gene silencing at target loci.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Perpignan, UMR 5096, LGDP, F-66860 Perpignan, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Henderson, Ian/A-2174-2012; Pontes, Olga MF/F-9768-2011; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459; Lagrange, Thierry/0000-0003-3090-0918; Henderson, Ian/0000-0001-5066-1489; Henderson, Ian/0000-0002-9954-4977	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM077590, R01GM060380, R01GM060398] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM60380, R01GM077590, GM60398, GM07104, R01 GM077590, GM07185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Bechtold N, 1998, METH MOL B, V82, P259; BEVEN AF, 1995, J CELL SCI, V108, P509; Boudonck K, 1998, J CELL SCI, V111, P3687; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CHAMBERLAND H, 1993, CHROMOSOMA, V102, P220, DOI 10.1007/BF00352395; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Docquier S, 2004, CHROMOSOMA, V112, P255, DOI 10.1007/s00412-003-0271-3; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Fu D, 2006, GENE DEV, V20, P531, DOI 10.1101/gad.1390306; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jabri E, 2005, NAT STRUCT MOL BIOL, V12, P564, DOI 10.1038/nsmb0705-564; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Johnson J., 2002, EUR CELLS MATER, V3, P12; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lorkovic ZJ, 2004, MOL BIOL CELL, V15, P3233, DOI 10.1091/mbc.E04-01-0055; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; VANKAN P, 1988, EMBO J, V7, P791, DOI 10.1002/j.1460-2075.1988.tb02877.x; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	53	291	311	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					93	106		10.1016/j.cell.2006.05.032	http://dx.doi.org/10.1016/j.cell.2006.05.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839879	Bronze			2022-12-01	WOS:000239224800019
J	Hatziioannou, T; Princiotta, M; Piatak, M; Yuan, F; Zhang, FW; Lifson, JD; Bieniasz, PD				Hatziioannou, Theodora; Princiotta, Michael; Piatak, Michael, Jr.; Yuan, Fang; Zhang, Fengwen; Lifson, Jeffrey D.; Bieniasz, Paul D.			Generation of simian-tropic HIV-1 by restriction factor evasion	SCIENCE			English	Article							INFECTION; VIF		Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Rockefeller Univ, New York, NY 10016 USA; NCI, AIDS Vaccine Program, SAIC Frederick Inc, Frederick, MD 21702 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bieniasz, PD (corresponding author), Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	pbienias@adarc.org	Liu, FL/D-1795-2009					Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343	4	128	133	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					95	95		10.1126/science.1130994	http://dx.doi.org/10.1126/science.1130994			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023652				2022-12-01	WOS:000241031200042
J	Ganguly-Fitzgerald, I; Donlea, J; Shaw, PJ				Ganguly-Fitzgerald, Indrani; Donlea, Jeff; Shaw, Paul J.			Waking experience affects sleep need in Drosophila	SCIENCE			English	Article							LONG-TERM-MEMORY; MUSHROOM BODIES; GENE-EXPRESSION; REM-SLEEP; MELANOGASTER; BRAIN	Sleep is a vital, evolutionarily conserved phenomenon, whose function is unclear. Although mounting evidence supports a role for sleep in the consolidation of memories, until now, a molecular connection between sleep, plasticity, and memory formation has been difficult to demonstrate. We establish Drosophila as a model to investigate this relation and demonstrate that the intensity and/or complexity of prior social experience stably modifies sleep need and architecture. Furthermore, this experience-dependent plasticity in sleep need is subserved by the dopaminergic and adenosine 3', 5'-monophosphate signaling pathways and a particular subset of 17 long-term memory genes.	Inst Neurosci, San Diego, CA 92101 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Ganguly-Fitzgerald, I (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92101 USA.	transposase@gmail.com			NINDS NIH HHS [R01-NS051305-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051305] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; DAUWALDER B, 1995, J NEUROSCI, V15, P3490; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SIWICKI K, COMMUNICATION; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1	26	206	212	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1775	1781		10.1126/science.1130408	http://dx.doi.org/10.1126/science.1130408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990546				2022-12-01	WOS:000240655700046
J	Korostelev, A; Trakhanov, S; Laurberg, M; Noller, HF				Korostelev, Andrei; Trakhanov, Sergei; Laurberg, Martin; Noller, Harry F.			Crystal structure of a 70S ribosome-tRNA complex reveals functional interactions and rearrangements	CELL			English	Article							PEPTIDE-BOND FORMATION; TRANSFER RIBONUCLEIC-ACID; THERMUS-THERMOPHILUS HB8; REAL-SPACE REFINEMENT; SITE TRANSFER-RNA; P-SITE; ANGSTROM RESOLUTION; MESSENGER-RNA; DATA QUALITY; A-SITES	Our understanding of the mechanism of protein synthesis has undergone rapid progress in recent years as a result of low-resolution X-ray and cryo-EM structures of ribosome functional complexes and high-resolution structures of ribosomal subunits and vacant ribosomes. Here, we present the crystal structure of the Thermus thermophilus 70S ribosome containing a model mRNA and two tRNAs at 3.7 angstrom resolution. Many structural details of the interactions between the ribosome, tRNA, and mRNA in the P and E sites and the ways in which tRNA structure is distorted by its interactions with the ribosome are seen. Differences between the conformations of vacant and tRNA-bound 70S ribosomes suggest an induced fit of the ribosome structure in response to tRNA binding, including significant changes in the peptidyl-transferase catalytic site.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu		Korostelev, Andrei/0000-0003-1588-717X				Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Auffinger P, 1999, BIOPHYS J, V76, P50, DOI 10.1016/S0006-3495(99)77177-8; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; Bocchetta M, 2001, RNA, V7, P54, DOI 10.1017/S1355838201001650; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chang KY, 1999, P NATL ACAD SCI USA, V96, P11764, DOI 10.1073/pnas.96.21.11764; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Dorner S, 2003, NUCLEIC ACIDS RES, V31, P6536, DOI 10.1093/nar/gkg842; EHRENBERG M, 1979, BIOCHEMISTRY-US, V18, P4588, DOI 10.1021/bi00588a020; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FAHNESTOCK S, 1970, BIOCHEMISTRY-US, V9, P2477, DOI 10.1021/bi00814a013; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Friederich MW, 1998, P NATL ACAD SCI USA, V95, P3572, DOI 10.1073/pnas.95.7.3572; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Guymon R, 2006, BIOCHEMISTRY-US, V45, P4888, DOI 10.1021/bi052579p; GUYMON R, 2006, ANNU REV BIOCHEM, V45, P4888; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hesslein AE, 2004, NUCLEIC ACIDS RES, V32, P3760, DOI 10.1093/nar/gkh672; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; Kirillov SV, 2002, FEBS LETT, V514, P60, DOI 10.1016/S0014-5793(02)02302-5; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; LILL R, 1988, J MOL BIOL, V203, P699, DOI 10.1016/0022-2836(88)90203-3; LILLO C, 1989, Norwegian Journal of Agricultural Sciences, V3, P23; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Nishimura M, 2004, J MOL BIOL, V344, P1369, DOI 10.1016/j.jmb.2004.10.011; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Ohman A, 2003, J BIOMOL NMR, V26, P131, DOI 10.1023/A:1023502307069; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; PRINCE JB, 1982, P NATL ACAD SCI-BIOL, V79, P5450, DOI 10.1073/pnas.79.18.5450; QUIGGLE K, 1981, BIOCHEMISTRY-US, V20, P3480, DOI 10.1021/bi00515a027; Ramos A, 1997, NUCLEIC ACIDS RES, V25, P2083, DOI 10.1093/nar/25.11.2083; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Tung CS, 2004, BIOPHYS J, V87, P2714, DOI 10.1529/biophysj.104.040162; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wang HF, 2004, PROTEIN SCI, V13, P2806, DOI 10.1110/ps.04864904; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilson DN, 2005, EMBO J, V24, P251, DOI 10.1038/sj.emboj.7600525; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woestenenk EA, 2002, BIOCHEM J, V363, P553, DOI 10.1042/0264-6021:3630553; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	80	399	416	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1065	1077		10.1016/j.cell.2006.08.032	http://dx.doi.org/10.1016/j.cell.2006.08.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16962654	Bronze			2022-12-01	WOS:000240897600014
J	Meyer-Luehmann, M; Coomaraswamy, J; Bolmont, T; Kaeser, S; Schaefer, C; Kilger, E; Neuenschwander, A; Abramowski, D; Frey, P; Jaton, AL; Vigouret, JM; Paganetti, P; Walsh, DM; Mathews, PM; Ghiso, J; Staufenbiel, M; Walker, LC; Jucker, M				Meyer-Luehmann, Melanie; Coomaraswamy, Janaky; Bolmont, Tristan; Kaeser, Stephan; Schaefer, Claudia; Kilger, Ellen; Neuenschwander, Anton; Abramowski, Dorothee; Frey, Peter; Jaton, Anneliese L.; Vigouret, Jean-Marie; Paganetti, Paolo; Walsh, Dominic M.; Mathews, Paul M.; Ghiso, Jorge; Staufenbiel, Matthias; Walker, Lary C.; Jucker, Mathias			Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host	SCIENCE			English	Article							DISEASE-LIKE PATHOLOGY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LONG-TERM; IN-VIVO; PROTEIN; DEPOSITION; OLIGOMERS; MOUSE; CONFORMATION	Protein aggregation is an established pathogenic mechanism in Alzheimer's disease, but little is known about the initiation of this process in vivo. Intracerebral injection of dilute, amyloid-beta (A beta)-containing brain extracts from humans with Alzheimer's disease or beta-amyloid precursor protein (APP) transgenic mice induced cerebral beta-amyloidosis and associated pathology in APP transgenic mice in a time- and concentration-dependent manner. The seeding activity of brain extracts was reduced or abolished by A beta immunodepletion, protein denaturation, or by A beta immunization of the host. The phenotype of the exogenously induced amyloidosis depended on both the host and the source of the agent, suggesting the existence of polymorphic A beta strains with varying biological activities reminiscent of prion strains.	Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland; Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; NYU, Sch Med, Nathan Kline Inst, Orangeburg, NY 10962 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Emory University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel; Novartis; University College Dublin; Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Emory University	Walker, LC (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	lary.walker@emory.edu; mathias.jucker@uni-tuebingen.de	Walker, L C/J-6541-2015; Paganetti, Paolo/AAF-8039-2020	Walker, L C/0000-0001-9166-3261; Jucker, Mathias/0000-0001-9045-1072; Mathews, Paul/0000-0003-1742-7687; Meyer-Luehmann, Melanie/0000-0003-3661-2220; Paganetti, Paolo/0000-0003-1896-6324	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS045357] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00165] Funding Source: Medline; NINDS NIH HHS [NS45357] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Demattos RB, 2004, J MOL NEUROSCI, V23, P255, DOI 10.1385/JMN:23:3:255; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mohajeri MH, 2002, J BIOL CHEM, V277, P35460, DOI 10.1074/jbc.M202899200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	31	729	746	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1781	1784		10.1126/science.1131864	http://dx.doi.org/10.1126/science.1131864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990547				2022-12-01	WOS:000240655700047
J	Nieder, A; Diester, I; Tudusciuc, O				Nieder, Andreas; Diester, Ilka; Tudusciuc, Oana			Temporal and spatial enumeration processes in the primate parietal cortex	SCIENCE			English	Article							PREFRONTAL CORTEX; NUMBER REPRESENTATION; NUMERICAL INFORMATION; MONKEY; DISSOCIATION; COGNITION; CHILDREN; ADULTS; MODEL	Humans and animals can nonverbally enumerate visual items across time in a sequence or rapidly estimate the set size of spatial dot patterns at a single glance. We found that temporal and spatial enumeration processes engaged different populations of neurons in the intraparietal sulcus of behaving monkeys. Once the enumeration process was completed, however, another neuronal population represented the cardinality of a set irrespective of whether it had been cued in a spatial layout or across time. These data suggest distinct neural processing stages for different numerical formats, but also a final convergence of the segregated information to form most abstract quantity representations.	Univ Tubingen, Dept Cognit Neurosci, Hertie Inst Clin Brain Res, Primate NeuroCognit Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Nieder, A (corresponding author), Univ Tubingen, Dept Cognit Neurosci, Hertie Inst Clin Brain Res, Primate NeuroCognit Lab, Otfried Muller Str 27, D-72076 Tubingen, Germany.	andreas.nieder@uni-tuebingen.de	Tudusciuc, Oana/C-1339-2011					ANSARI D, IN PRESS BRAIN RES; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Delazer M, 1997, COGN NEUROPSYCHOL, V14, P613; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; HAUSER MD, 2004, COGNITIVE NEUROSCIEN, V3; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2004, J COGNITIVE NEUROSCI, V16, P889, DOI 10.1162/089892904970807; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Turconi E, 2004, COGNITIVE BRAIN RES, V21, P22, DOI 10.1016/j.cogbrainres.2004.05.003; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Wood JN, 2005, COGNITION, V97, P23, DOI 10.1016/j.cognition.2004.06.007	28	220	222	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1431	1435		10.1126/science.1130308	http://dx.doi.org/10.1126/science.1130308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081WQ	16960005				2022-12-01	WOS:000240348700041
J	Lee, JW; Beebe, K; Nangle, LA; Jang, JS; Longo-Guess, CM; Cook, SA; Davisson, MT; Sundberg, JP; Schimmel, P; Ackerman, SL				Lee, Jeong Woong; Beebe, Kirk; Nangle, Leslie A.; Jang, Jaeseon; Longo-Guess, Chantal M.; Cook, Susan A.; Davisson, Muriel T.; Sundberg, John P.; Schimmel, Paul; Ackerman, Susan L.			Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration	NATURE			English	Article							MARINESCO-SJOGREN-SYNDROME; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; MAJOR DETERMINANT; ESCHERICHIA-COLI; CELL VIABILITY; DISEASES; SIL1; DISCRIMINATION; AGGREGATION	Misfolded proteins are associated with several pathological conditions including neurodegeneration. Although some of these abnormally folded proteins result from mutations in genes encoding disease-associated proteins (for example, repeat-expansion diseases), more general mechanisms that lead to misfolded proteins in neurons remain largely unknown. Here we demonstrate that low levels of mischarged transfer RNAs (tRNAs) can lead to an intracellular accumulation of misfolded proteins in neurons. These accumulations are accompanied by upregulation of cytoplasmic protein chaperones and by induction of the unfolded protein response. We report that the mouse sticky mutation, which causes cerebellar Purkinje cell loss and ataxia, is a missense mutation in the editing domain of the alanyl-tRNA synthetase gene that compromises the proofreading activity of this enzyme during aminoacylation of tRNAs. These findings demonstrate that disruption of translational fidelity in terminally differentiated neurons leads to the accumulation of misfolded proteins and cell death, and provide a novel mechanism underlying neurodegeneration.	Jackson Lab, Bar Harbor, ME 04609 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA	Jackson Laboratory; Scripps Research Institute; Howard Hughes Medical Institute	Ackerman, SL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	susan.ackerman@jax.org			NINDS NIH HHS [R01 NS042613] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042613] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Beebe K, 2004, P NATL ACAD SCI USA, V101, P5958, DOI 10.1073/pnas.0401530101; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hogan B., 1986, MANIPULATING MOUSE E; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; NANGLE LA, IN PRESS CHEM BIOL; Pezo V, 2004, P NATL ACAD SCI USA, V101, P8593, DOI 10.1073/pnas.0402893101; Pleiss JA, 2001, J MOL BIOL, V308, P895, DOI 10.1006/jmbi.2001.4612; RIPMASTER TL, 1995, P NATL ACAD SCI USA, V92, P4932, DOI 10.1073/pnas.92.11.4932; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; XUE H, 1993, J CHROMATOGR-BIOMED, V613, P247, DOI 10.1016/0378-4347(93)80139-U; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	35	428	451	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					50	55		10.1038/nature05096	http://dx.doi.org/10.1038/nature05096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16906134				2022-12-01	WOS:000240313900036
J	Li, H; Tsang, CK; Watkins, M; Bertram, PG; Zheng, XFS				Li, Hong; Tsang, Chi Kwan; Watkins, Marcus; Bertram, Paula G.; Zheng, X. F. Steven			Nutrient regulates Tor1 nuclear localization and association with rDNA promoter	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; CELL-GROWTH; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; GENE-EXPRESSION; RAPAMYCIN; YEAST; RECRUITMENT; INTEGRATION; COMPLEXES	TOR is the target of the immunosuppressant rapamycin and a key regulator of cell growth. It modulates diverse cellular processes in the cytoplasm and nucleus(1-5), including the expression of amino acid transporters, ribosomal RNAs and ribosomal proteins. Despite considerable recent progress, little is known about the spatial and temporal regulation of TOR signalling, particularly that leading into the nucleus. Here we show that Tor1 is dynamically distributed in the cytoplasm and nucleus in yeast. Tor1 nuclear localization is nutrient dependent and rapamycin sensitive: starvation or treatment with rapamycin causes Tor1 to exit from the nucleus. Tor1 nuclear localization is critical for 35S rRNA synthesis, but not for the expression of amino acid transporters and ribosomal protein genes. We show further that Tor1 is associated with 35S ribosomal DNA ( rDNA) promoter chromatin in a rapamycin- and starvation-sensitive manner; this association is necessary for 35S rRNA synthesis and cell growth. These results indicate that the spatial regulation of TOR complex 1 (TORC1) might be involved in differential control of its target genes. TOR is known as a classic cytoplasmic kinase that mediates the cytoplasm-to-nucleus signalling by controlling the localization of transcription factors. Our data indicate that TOR might be more intimately involved in gene regulation than previously thought.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Washington University (WUSTL)	Zheng, XFS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	zhengst@umdnj.edu	Tsang, Chi Kwan/AAD-6819-2020; Watkins, Marcus/V-8817-2019	Tsang, Chi Kwan/0000-0002-0133-1544; Watkins, Marcus/0000-0002-1224-3478				Abraham RT, 2005, CURR BIOL, V15, pR139, DOI 10.1016/j.cub.2005.02.015; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Rout MP, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P120; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	30	173	176	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1058	1061		10.1038/nature05020	http://dx.doi.org/10.1038/nature05020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16900101				2022-12-01	WOS:000240142000054
J	Crowder, LB; Osherenko, G; Young, OR; Airame, S; Norse, EA; Baron, N; Day, JC; Bouvere, F; Ehler, CN; Halpern, BS; Langdon, SJ; McLeod, KL; Ogden, JC; Peach, RE; Rosenberg, AA; Wilson, JA				Crowder, L. B.; Osherenko, G.; Young, O. R.; Airame, S.; Norse, E. A.; Baron, N.; Day, J. C.; Bouvere, F.; Ehler, C. N.; Halpern, B. S.; Langdon, S. J.; McLeod, K. L.; Ogden, J. C.; Peach, R. E.; Rosenberg, A. A.; Wilson, J. A.			Sustainability - Resolving mismatches in US ocean governance	SCIENCE			English	Editorial Material							GULF-OF-MEXICO; CONSEQUENCES; MANAGEMENT; FISHERIES	Problems in ocean resource management derive from governance, not science. Ocean zoning would replace mismatched and fragmented approaches with integrated regulatory domains.	Duke Univ, Marine Lab, Nicholas Sch Environm & Earth Sci, Ctr Marine Conservat, Beaufort, NC 28516 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Donald Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; Marine Conservat Biol Inst, Bellevue, WA 98004 USA; Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Great Barrier Reef Marine Pk Author, Townsville, Qld 4810, Australia; UNESCO, Man & Biosphere Program, F-75732 Paris 15, France; Univ Alaska, Dept Anthropol, Anchorage, AK 99508 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Florida Inst Oceanog, St Petersburg, FL 33701 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	Duke University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of Alaska System; University of Alaska Anchorage; Oregon State University; Harvard University; University System Of New Hampshire; University of New Hampshire; University of Maine System; University of Maine Orono	Crowder, LB (corresponding author), Duke Univ, Marine Lab, Nicholas Sch Environm & Earth Sci, Ctr Marine Conservat, Beaufort, NC 28516 USA.	lcrowder@duke.edu	Day, Jon C/H-3276-2016	Day, Jon C/0000-0003-3906-0759				Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Craig JK, 2005, MAR ECOL PROG SER, V294, P79, DOI 10.3354/meps294079; Davis GE, 1996, T AM FISH SOC, V125, P42, DOI 10.1577/1548-8659(1996)125<0042:SATOWA>2.3.CO;2; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; DOUVERE F, 2006, IN PRESS MAR POLICY; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; McLeod K.L., 2005, SCI CONSENSUS STATEM; *MEA UN ENV PROGR, 2005, LIV OUR MEANS NAT AS; Norse Elliott A., 2005, P422; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Rosenberg AA, 2005, MAR ECOL PROG SER, V300, P270; YOUNG OR, 2002, MATCHING I ECOSYSTEM; Young OR., 2002, I DIMENSIONS ENV CHA, DOI [10.7551/mitpress/3807.001.0001, DOI 10.7551/MITPRESS/3807.001.0001]	17	324	333	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2006	313	5787					617	618		10.1126/science.1129706	http://dx.doi.org/10.1126/science.1129706			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072IQ	16888124				2022-12-01	WOS:000239667500024
J	Cui, LB; Jeong, H; Borovecki, F; Parkhurst, CN; Tanese, N; Krainc, D				Cui, Libin; Jeong, Hyunkyung; Borovecki, Fran; Parkhurst, Christopher N.; Tanese, Naoko; Krainc, Dimitri			Transcriptional repression of PGC-alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration	CELL			English	Article							ENERGY-METABOLISM; MOUSE MODEL; STRIATAL NEURONS; DISEASE; EXPRESSION; DEFECTS; SUSCEPTIBILITY; COACTIVATOR; PGC-1-ALPHA; DISRUPTION	Huntington's disease (HID) is an inherited neurodegenerative disease caused by a glutamine repeat expansion in huntingtin protein. Transcriptional deregulation and altered energy metabolism have been implicated in HID pathogenesis. We report here that mutant huntingtin causes disruption of mitochondrial function by inhibiting expression of PGC-1 alpha, a transcriptional coactivator that regulates several metabolic processes, including mitochondrial biogenesis and respiration. Mutant huntingtin represses PGC-1 alpha gene transcription by associating with the promoter and interfering with the CREB/TAF4-dependent transcriptional pathway critical for the regulation of PGC-1 alpha gene expression. Crossbreeding of PGC-1 alpha knockout (KO) mice with HID knockin (KI) mice leads to increased neurodegeneration of striatal neurons and motor abnormalities in the HID mice. Importantly, expression of PGC-1 alpha partially reverses the toxic effects of mutant huntingtin in cultured striatal neurons. Moreover, lentiviral-mediated delivery of PGC-1 alpha in the striatum provides neuroprotection in the transgenic HID mice. These studies suggest a key role for PGC-1 alpha in the control of energy metabolism in the early stages of HID pathogenesis.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; New York University	Cui, LB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu		Tanese, Naoko/0000-0002-1946-3211	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050352, P01NS045242] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS050352, P01NS045242] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Antonini A, 1996, BRAIN, V119, P2085, DOI 10.1093/brain/119.6.2085; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Furukawa T, 2000, J BIOL CHEM, V275, P29847, DOI 10.1074/jbc.M002989200; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Koroshetz WJ, 1997, ANN NEUROL, V41, P160, DOI 10.1002/ana.410410206; KUWERT T, 1993, J NEUROL, V241, P31, DOI 10.1007/BF00870669; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; SANDOVAL J, 2004, NUCLEIC ACIDS RES, V32, P1; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Takahashi Y, 2000, GENE DEV, V14, P804; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zucker B, 2005, HUM MOL GENET, V14, P179, DOI 10.1093/hmg/ddi014	42	786	797	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					59	69		10.1016/j.cell.2006.09.015	http://dx.doi.org/10.1016/j.cell.2006.09.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018277	Bronze			2022-12-01	WOS:000241445800014
J	Kraft, ML; Weber, PK; Longo, ML; Hutcheon, ID; Boxer, SG				Kraft, Mary L.; Weber, Peter K.; Longo, Marjorie L.; Hutcheon, Ian D.; Boxer, Steven G.			Phase separation of lipid membranes analyzed with high-resolution secondary ion mass spectrometry	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; DOMAIN FORMATION; CHOLESTEROL; BILAYERS; RAFTS; CELL; PHOSPHOLIPIDS; TRANSITIONS; MIXTURES	Lateral variations in membrane composition are postulated to play a central role in many cellular events, but it has been difficult to probe membrane composition and organization on length scales of tens to hundreds of nanometers. We present a high-resolution imaging secondary ion mass spectrometry technique to reveal the lipid distribution within a phase-separated membrane with a lateral resolution of similar to 100 nanometers. Quantitative information about the chemical composition within small lipid domains was obtained with the use of isotopic labels to identify each molecular species. Composition variations were detected within some domains.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94551 USA; Lawrence Livermore Natl Lab, Biosecur & Nanosci Lab, Livermore, CA 94551 USA; Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis	Boxer, SG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	sboxer@stanford.edu	Weber, Peter Kilian/AAP-9517-2020	Weber, Peter Kilian/0000-0001-6022-6050; Boxer, Steven/0000-0001-9167-4286	NIGMS NIH HHS [GM06930] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanchette CD, 2006, BIOPHYS J, V90, P4466, DOI 10.1529/biophysj.105.072744; Bourdos N, 2000, BIOPHYS J, V79, P357, DOI 10.1016/S0006-3495(00)76297-7; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Burns AR, 2003, LANGMUIR, V19, P8358, DOI 10.1021/la030175x; Drees Frauke, 2004, V294, P303; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Frolov VAJ, 2006, BIOPHYS J, V91, P189, DOI 10.1529/biophysj.105.068502; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; IPSEN JH, 1988, BIOCHIM BIOPHYS ACTA, V944, P121, DOI 10.1016/0005-2736(88)90425-7; JACOBS RE, 1977, BIOCHEMISTRY-US, V16, P4349, DOI 10.1021/bi00639a004; Kahya N, 2004, J STRUCT BIOL, V147, P77, DOI 10.1016/j.jsb.2003.09.021; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Lawrence JC, 2003, BIOPHYS J, V84, P1827, DOI 10.1016/S0006-3495(03)74990-X; Lin WC, 2006, BIOPHYS J, V90, P228, DOI 10.1529/biophysj.105.067066; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Marxer CG, 2005, BIOPHYS J, V88, P2965, DOI 10.1529/biophysj.104.057257; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Pacholski ML, 1999, J AM CHEM SOC, V121, P4716, DOI 10.1021/ja983022i; Perez JB, 2006, ADV FUNCT MATER, V16, P306, DOI 10.1002/adfm.200500236; Peteranderl R, 2004, J AM SOC MASS SPECTR, V15, P478, DOI 10.1016/j.jasms.2003.11.019; Potma EO, 2005, CHEMPHYSCHEM, V6, P77, DOI 10.1002/cphc.200400390; Ratto TV, 2002, BIOPHYS J, V83, P3380, DOI 10.1016/S0006-3495(02)75338-1; Shaw JE, 2006, BIOPHYS J, V90, P2170, DOI 10.1529/biophysj.105.073510; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sostarecz AG, 2004, J AM CHEM SOC, V126, P13882, DOI 10.1021/ja0472127; Stottrup BL, 2005, BIOPHYS J, V88, P269, DOI [10.1529/biophysj.104.048439, 10.1529/biophysj.104.049439]; VANECHTEN G, 1990, J BIOL CHEM, V265, P9333; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3	35	215	222	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1948	1951		10.1126/science.1130279	http://dx.doi.org/10.1126/science.1130279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008528	Green Submitted			2022-12-01	WOS:000240832200047
J	Lu, CL; Michaud, CM; Gakidou, E; Khan, K; Murray, CJL				Lu, Chunling; Michaud, Catherine M.; Gakidou, Emmanuela; Khan, Kashif; Murray, Christopher J. L.			Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment	LANCET			English	Article							DEVELOPING-COUNTRIES; GAVI; STRATEGIES; PROGRAMS; COSTS; FUND	Background The Global Alliance for Vaccines and Immunisation (GAVI) was created in 1999 to enable even the poorest countries to provide vaccines to all children. We aimed to assess the effect of GAVI on combined diphtheria, tetanus, and pertussis vaccine (DTP3) coverage. Methods We examined the relation between DTP3 coverage for GAVI recipient countries from 1995 to 2004 and immunisation services support (ISS) and non-ISS expenditure per surviving child, controlling for income per head and local political governance variables. We analysed DTP3 coverage reported by governments and estimated by WHO/UNICEF. We also investigated the effect of GAVI on country reporting behaviour. Results In countries with DTP3 coverage of 65% or less at baseline, IS S spending per surviving child had a significant positive effect on DTP3 coverage (p=0.0005). This effect was not present in countries with DTP3 coverage of 65-80% or 80% or more at baseline. If IS S expenditure only is assessed, the estimated cost per additional child immunised in countries with baseline coverage of 65% or less is US$14 and if ISS and non-ISS expenditures are included the cost per child is almost $20. Interpretation The success of ISS funding in countries with baseline DTP3 coverage of 65% or less provides evidence that a public-private partnership can work to reverse a negative trend in global health and that performance-related disbursement can work in some settings. Because ISS funding seems to have no effect in countries with baseline coverage greater than 65%, GAVI should consider redistributing its resources to countries with the lowest coverage.	Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Murray, CJL (corresponding author), Harvard Univ, Initiat Global Hlth, 104 Mt Auburn St, Cambridge, MA 02138 USA.	christopher_murray@harvard.edu						BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Beck N, 2001, INT ORGAN, V55, P487, DOI 10.1162/00208180151140658; Beck N., 1996, POLIT ANAL, V6, P1, DOI 10.1093/pan/6.1.1; BHAWALKAR M, 2004, COMP METHODOLOGIES N; Bishai D, 2006, HEALTH AFFAIR, V25, P348, DOI 10.1377/hlthaff.25.2.348; BRENZEL L, 1994, SOC SCI MED, V39, P527, DOI 10.1016/0277-9536(94)90095-7; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Burnside C, 2000, AM ECON REV, V90, P847, DOI 10.1257/aer.90.4.847; Chee G, 2004, EVALUATION GAVI IMMU; Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; FLECK F, 2002, BRIT MED J, V324, P974; FOXRUSHBY JA, 2004, B WORLD HEALTH ORGAN, V82, P9; *GAVI, 11 GAVI BOARD M ANN; *GAVI, 7 GAVI BOARD M ANN 1; *GAVI, INT FIN FAC IMM IFFI; *GAVI, 17 GAVI BOARD M SUMM; Godal T, 2000, TROP MED INT HEALTH, V5, P160, DOI 10.1046/j.1365-3156.2000.00534.x; GREEN DP, 2003, INT ORGAN, V55, P441; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; Kaddar M, 2004, B WORLD HEALTH ORGAN, V82, P697; Kaufmann Daniel, 2005, GOVERNANCE MATTERS, VIV; KRISTENSEN IP, LAGGING DOG ROBUSTNE; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; Mahoney RT, 2000, VACCINE, V18, P2625, DOI 10.1016/S0264-410X(00)00073-6; Martin JF, 2003, VACCINE, V21, P587, DOI 10.1016/S0264-410X(02)00564-9; Muraskin W, 2004, AM J PUBLIC HEALTH, V94, P1922, DOI 10.2105/AJPH.94.11.1922; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Peny JM, 2005, VACCINE, V23, P4610, DOI 10.1016/j.vaccine.2005.04.044; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; Starling M., 2002, NEW PRODUCTS OLD SYS; Waters HR, 2004, B WORLD HEALTH ORGAN, V82, P668; *WHO, IMM FIN; *WHO UNICEF, WHO UNICEF EST COV T; *WHO UNICEF, WHO UNICEF REP EST I; Wittet S, 2000, VACCINE, V19, P385, DOI 10.1016/S0264-410X(00)00196-1	35	54	54	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1088	1095		10.1016/S0140-6736(06)69337-9	http://dx.doi.org/10.1016/S0140-6736(06)69337-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997663				2022-12-01	WOS:000240873000024
J	Basso, O; Rasmussen, S; Weinberg, CR; Wilcox, AJ; Irgens, LM; Skjaerven, R				Basso, Olga; Rasmussen, Svein; Weinberg, Clarice R.; Wilcox, Allen J.; Irgens, Lorentz M.; Skjaerven, Rolv			Trends in fetal and infant survival following preeclampsia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRETERM BIRTH; MANAGEMENT; SMOKING; PATHOGENESIS	Context Management of preeclampsia often culminates in induced delivery of a very preterm infant. While early termination protects the fetus from an intrauterine death, the newborn then faces increased risks associated with preterm delivery. This practice has increased in recent decades, but its net effect on fetal and infant survival has not been assessed. Objective To assess the effect on fetal and infant survival of increased rates of early delivery of preeclamptic pregnancies. Design, Setting, and Participants Population-based observational longitudinal study using registry data from 804 448 singleton first-born infants with Norwegian-born mothers and registered in the Medical Birth Registry of Norway between 1967 and 2003. Main Outcome Measures Odds ratio ( OR) of fetal and early childhood death in relation to preeclampsia. Results Among preeclamptic pregnancies, inductions before 37 weeks increased from 8% in 1967- 1978 to nearly 20% in 1991- 2003. During this period, the adjusted OR for stillbirth decreased from 4.2 (95% confidence interval [CI], 3.8-4.7) to 1.3 ( 95% CI, 1.1-1.7) for preeclamptic compared with nonpreeclamptic pregnancies. During the same period, the OR for neonatal death after preeclamptic pregnancy remained relatively stable (1.7 in 1967- 1978 vs 2.0 in 1991- 2003). Later infant and childhood mortality also showed little change. Conclusions Fetal survival in preeclamptic pregnancies has vastly improved over the past 35 years in Norway, presumably because of more aggressive clinical management. However, the relative risk of neonatal death following a preeclamptic pregnancy has not changed over time.	NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; NIEHS, Biostat Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; Univ Bergen, Locus Registry Based Epidemiol, Med Birth Registry Norway, Bergen, Norway; Norwegian Inst Publ Hlth, Bergen, Norway; Univ Bergen, Dept Obstet & Gynaecol, Inst Clin Med, N-5020 Bergen, Norway	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; Norwegian Institute of Public Health (NIPH); University of Bergen	Basso, O (corresponding author), NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, MD A3-05,POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	bassoo2@niehs.nih.gov	Basso, Olga/E-5384-2010; Wilcox, Allen J/C-7723-2019	Basso, Olga/0000-0001-9298-4921; Wilcox, Allen J/0000-0002-3376-1311; Weinberg, Clarice/0000-0002-7713-8556	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003, ZIAES045005, Z01ES044003, Z01ES045005] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7; [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Eriksson KM, 1996, ACTA OBSTET GYN SCAN, V75, P355, DOI 10.3109/00016349609033331; Friedman SA, 1999, CLIN OBSTET GYNECOL, V42, P470, DOI 10.1097/00003081-199909000-00005; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Haug K, 2000, ACTA OBSTET GYN SCAN, V79, P485, DOI 10.1034/j.1600-0412.2000.079006485.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813; OIAN P, 1999, NORWEGIAN SOC OBSTET, P101; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; WEINBERG CR, 1993, AM J EPIDEMIOL, V137, P1; *WORLD BANK GROUP, 2005 WORLD DEV IND P	18	112	115	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1357	1362		10.1001/jama.296.11.1357	http://dx.doi.org/10.1001/jama.296.11.1357			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985227	Bronze			2022-12-01	WOS:000240595800022
J	Cohen, E; Bieschke, J; Perciavalle, RM; Kelly, JW; Dillin, A				Cohen, Ehud; Bieschke, Jan; Perciavalle, Rhonda M.; Kelly, Jeffery W.; Dillin, Andrew			Opposing activities protect against age-onset proteotoxicity	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; A-BETA; LONGEVITY; DAF-16; MUTANT; BRAIN; LONG; NEURODEGENERATION; INSULIN/IGF-1	Aberrant protein aggregation is a common feature of late-onset neurodegenerative diseases, including Alzheimer's disease, which is associated with themisassembly of the A beta(1-42) peptide. Aggregation-mediated A beta(1-42) toxicity was reduced in Caenorhabiditis elegans when aging was slowed by decreased insulin/ insulin growth factor - 1 - like signaling (IIS). The downstream transcription factors, heat shock factor 1, and DAF-16 regulate opposing disaggregation and aggregation activities to promote cellular survival in response to constitutive toxic protein aggregation. Because the IIS pathway is central to the regulation of longevity and youthfulness in worms, flies, and mammals, these results suggest a mechanistic link between the aging process and aggregation-mediated proteotoxicity.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Longo, Kenneth A/A-5631-2010; Bieschke, Jan/AAG-2705-2019	Bieschke, Jan/0000-0002-3485-9767; Cohen, Ehud/0000-0001-5552-7086	NIDDK NIH HHS [DK 46335] Funding Source: Medline; NINDS NIH HHS [NS 50636] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046335, R01DK046335, R37DK046335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050636] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; TOWNSEND M, 2006, J PHYSL; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	34	649	678	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1604	1610		10.1126/science.1124646	http://dx.doi.org/10.1126/science.1124646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16902091				2022-12-01	WOS:000240498900036
J	Yoshida, Y; Kuroiwa, H; Misumi, O; Nishida, K; Yagisawa, F; Fujiwara, T; Nanamiya, H; Kawamura, F; Kuroiwa, T				Yoshida, Yamato; Kuroiwa, Haruko; Misumi, Osami; Nishida, Keiji; Yagisawa, Fumi; Fujiwara, Takayuki; Nanamiya, Hideaki; Kawamura, Fujio; Kuroiwa, Tsuneyoshi			Isolated chloroplast division machinery can actively constrict after stretching	SCIENCE			English	Article							PLASTID DIVISION; RED ALGA; DYNAMIN; ORGANELLES; APPARATUS; PROTEIN; RING	Chloroplast division involves plastid-dividing, dynamin, and FtsZ (PDF) rings. We isolated intact supertwisted ( or spiral) and circular PDF machineries from chloroplasts of the red alga Cyanidioschyzon merolae. After individual intact PDF machineries were stretched to four times their original lengths with optical tweezers, they spontaneously returned to their original sizes. Dynamin-released PDF machineries did not retain the spiral structure and could not be stretched. Thus, dynamin may generate the motive force for contraction by filament sliding in dividing chloroplasts, in addition to pinching-off the membranes.	Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Cell Biol Lab, Tokyo 1718501, Japan; Rikkyo St Pauls Univ, Res Informat Ctr Extremophile, Tokyo 1718501, Japan	Rikkyo University; Rikkyo University	Kuroiwa, T (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Cell Biol Lab, Tokyo 1718501, Japan.	tsune@rikkyo.ne.jp						Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; GILLHUM NW, 1994, ORGANELLE GENES GENO; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2001, PLANT CELL, V13, P2257, DOI 10.1105/tpc.010185; Miyagishima SY, 2001, PLANT CELL, V13, P707; Nishida K, 2003, P NATL ACAD SCI USA, V100, P2146, DOI 10.1073/pnas.0436886100; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6	14	72	83	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1435	1438		10.1126/science.1129689	http://dx.doi.org/10.1126/science.1129689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960006				2022-12-01	WOS:000240348700042
J	Ozcan, U; Yilmaz, E; Ozcan, L; Furuhashi, M; Vaillancourt, E; Smith, RO; Gorgun, CZ; Hotamisligil, GS				Oezcan, Umut; Yilmaz, Erkan; Oezcan, Lale; Furuhashi, Masato; Vaillancourt, Eric; Smith, Ross O.; Goerguen, Cem Z.; Hotamisligil, Goekhan S.			Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PRIMARY BILIARY-CIRRHOSIS; INSULIN-RESISTANCE; DEFICIENCY	Endoplasmic reticulum ( ER) stress is a key link between obesity, insulin resistance, and type 2 diabetes. Here, we provide evidence that this mechanistic link can be exploited for therapeutic purposes with orally active chemical chaperones. 4-Phenyl butyric acid and taurine-conjugated ursodeoxycholic acid alleviated ER stress in cells and whole animals. Treatment of obese and diabetic mice with these compounds resulted in normalization of hyperglycemia, restoration of systemic insulin sensitivity, resolution of fatty liver disease, and enhancement of insulin action in liver, muscle, and adipose tissues. Our results demonstrate that chemical chaperones enhance the adaptive capacity of the ER and act as potent antidiabetic modalities with potential application in the treatment of type 2 diabetes.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Furuhashi, Masato/AAT-5518-2021; Longo, Kenneth A/A-5631-2010; YILMAZ, ERKAN/O-1592-2014	Furuhashi, Masato/0000-0002-0145-3541; YILMAZ, ERKAN/0000-0001-7355-3878; Vaillancourt, Eric/0000-0002-1810-126X; Ozcan, Lale/0000-0002-2710-7057	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R01DK052539] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK040561, R01 DK052539, P30 DK040561-11, DK52539] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Poupon RE, 1999, HEPATOLOGY, V29, P1668, DOI 10.1002/hep.510290603; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441	14	1897	2005	8	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1137	1140		10.1126/science.1128294	http://dx.doi.org/10.1126/science.1128294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931765	Green Accepted			2022-12-01	WOS:000239998200051
J	Mehdiabadi, NJ; Jack, CN; Farnham, TT; Platt, TG; Kalla, SE; Shaulsky, G; Queller, DC; Strassmann, JE				Mehdiabadi, Natasha J.; Jack, Chandra N.; Farnham, Tiffany Talley; Platt, Thomas G.; Kalla, Sara E.; Shaulsky, Gad; Queller, David C.; Strassmann, Joan E.			Kin preference in a social microbe - Given the right circumstances, even an amoeba chooses to be altruistic towards its relatives.	NATURE			English	Article							EVOLUTION; BEHAVIOR		Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Rice University; Baylor College of Medicine	Mehdiabadi, NJ (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA.	njum@rice.edu	Jack, Chandra/ABD-8387-2021	Strassmann, Joan/0000-0003-0638-8440; Shaulsky, Gad/0000-0002-0532-0551; Platt, Thomas/0000-0003-0082-1127; Jack, Chandra/0000-0003-0167-1271				BONNER JT, 1958, J EMBRYOL EXP MORPH, V6, P346; BONNER JT, 1967, CELLULAR SLIME MOLDS; BUSS LW, 1982, P NATL ACAD SCI-BIOL, V79, P5337, DOI 10.1073/pnas.79.17.5337; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Fletcher DJ., 1987, KIN RECOGNITION ANIM; FOSTER KR, 2004, P ROY SOC LOND B BIO, V269, P2357; Kaushik S, 2006, BEHAV ECOL SOCIOBIOL, V59, P521, DOI 10.1007/s00265-005-0077-9; Kessin RH., 2001, DICTYOSTELIUM EVOLUT; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087	10	119	121	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2006	442	7105					881	882		10.1038/442881a	http://dx.doi.org/10.1038/442881a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16929288				2022-12-01	WOS:000239960500025
J	Hicks, CB; Cahn, P; Cooper, DA; Walmsley, SL; Katlama, C; Clotet, B; Lazzarin, A; Johnson, MA; Neubacher, D; Mayers, D; Valdez, H				Hicks, Charles B.; Cahn, Pedro; Cooper, David A.; Walmsley, Sharon L.; Katlama, Christine; Clotet, Bonaventura; Lazzarin, Adriano; Johnson, Margaret A.; Neubacher, Dietmar; Mayers, Douglas; Valdez, Hernan		RESIST investigator grp	Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug resistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials	LANCET			English	Article							PROTEASE INHIBITOR TIPRANAVIR; REDUCED SUSCEPTIBILITY; VIROLOGICAL FAILURE; FUSION INHIBITOR; THERAPY; HIV-1; ENFUVIRTIDE; PNU-140690	Background Treatment options for HIV-1 infected individuals who have received extensive previous antiretroviral therapy are limited. We compared efficacy and safety of the novel non-peptidic protease inhibitor tipranavir co-administered with ritonavir plus an optimised background regimen with that of an investigator-selected ritonavir-boosted comparator protease inhibitor (CPI-ritonavir) in such patients. Methods We did a combined analysis of 48-week data from two ongoing, randomised, open-label, multinational, phase III, RESIST studies. HIV-1-infected adults with 3 months or longer previous triple antiretroviral class experience, two or more previous protease inhibitor regimens, HIV-1 RNA 1000 copies per mL or greater, and genotypically demonstrated primary resistance to protease inhibitor, were eligible. Primary endpoints were proportion of treatment responders (with reduction in viral load of 1 log,, copies per mL or greater below baseline without treatment change) at 48 weeks and time to treatment failure through 48 weeks (intention-to-treat analysis). The RESIST studies are registered with ClinicalTrials.gov, numbers NCT00054717 (RESIST-1) and NCT00144170 (RESIST-2). Findings 3324 patients were screened; 746 received tipranavir-ritonavir and 737 CPI-ritonavir. 486 (65.1%) patients on tipranavir-ritonavir and 192 (26.1%) on CPI-ritonavir remained on assigned treatment until week 48. At week 48, more patients achieved and maintained treatment response in the tipranavir-ritonavir group than in the CPI-ritonavir group (251 [33.6%] vs 113 [15.3%]; p<0.0001). Median time to treatment failure was significantly longer in the tipranavir-ritonavir group than in the CPI-ritonavir group (113 days vs 0 days; p<0.0001). Gastrointestinal system disorders and raised transaminase, cholesterol, and triglycerides were more frequent in the tipranavir-ritonavir group than in the CPI-ritonavir group. Interpretation Compared with CPI-ritonavir, tipranavir-ritonavir with an optimised background regimen provides better virological and immunological responses over 48 weeks in patients who have received extensive previous antiretroviral treatment.	Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC 27710 USA; Fdn Huesped, Buenos Aires, DF, Argentina; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Univ Toronto, Toronto, ON, Canada; Hop La Pitie Salpetriere, Paris, France; Hosp Univ Germans Trias & Pujol, Barcelona, Spain; Vita Salute San Raffaele Univ, Milan, Italy; Royal Free Hosp, London NW3 2QG, England; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	Duke University; University of New South Wales Sydney; Kirby Institute; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Germans Trias i Pujol; Vita-Salute San Raffaele University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Boehringer Ingelheim; Boehringer Ingelheim	Hicks, CB (corresponding author), Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.	charies.hicks@duke.edu	LAZZARIN, Adriano/K-3607-2018	LAZZARIN, Adriano/0000-0003-2551-7754; Walmsley, Sharon/0000-0002-3959-5692				*AD AIDS CLIN TRIA, 1992, TABL GRAD SEV AD ADV; Back NKT, 2000, AIDS, V14, P101, DOI 10.1097/00002030-200001070-00019; Cahn P, 2004, 7 INT C DRUG THER HI; Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855; *DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1; Doyon L, 2005, ANTIVIR RES, V68, P27, DOI 10.1016/j.antiviral.2005.07.003; GATHE J, 2003, 10 C RETR OPP INF; Gulick RM, 2002, J INFECT DIS, V186, P626, DOI 10.1086/342681; Hammer SM, 2002, JAMA-J AM MED ASSOC, V288, P169, DOI 10.1001/jama.288.2.169; Hicks C, 2004, 44 INT C ANT AG CHEM; Johnson Victoria A, 2003, Top HIV Med, V11, P215; KATLAMA C, 2005, 3 IAS C HIV PATH TRE; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; MacGregor TR, 2004, HIV CLIN TRIALS, V5, P371, DOI 10.1310/RRX7-49ME-27V7-MWWV; McCallister S, 2004, JAIDS-J ACQ IMM DEF, V35, P376, DOI 10.1097/00126334-200404010-00007; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; Poppe SM, 1997, ANTIMICROB AGENTS CH, V41, P1058, DOI 10.1128/AAC.41.5.1058; Raffi F, 2006, CLIN INFECT DIS, V42, P870, DOI 10.1086/500206; SABO J, 2006, 7 INT WORKSH CLIN PH; Turner SR, 1998, J MED CHEM, V41, P3467, DOI 10.1021/jm9802158; WILKIN T, 2005, 45 INT C ANT AG CHEM	23	255	261	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2006	368	9534					466	475		10.1016/S0140-6736(06)69154-X	http://dx.doi.org/10.1016/S0140-6736(06)69154-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	071AL	16890833				2022-12-01	WOS:000239569000029
J	Szathmary, E				Szathmary, Eoers			Darwin for all seasons	SCIENCE			English	Editorial Material									Eotvos Lorand Univ, Inst Biol, H-1014 Budapest, Hungary; Coll Budapest, Inst Adv Study, H-1014 Budapest, Hungary	Eotvos Lorand University	Szathmary, E (corresponding author), Eotvos Lorand Univ, Inst Biol, 2 Szentharomsag Utca, H-1014 Budapest, Hungary.	szathmary@colbud.hu	Szathmary, Eors/AAS-1202-2021; Szathmáry, Eörs/A-5007-2011	Szathmary, Eors/0000-0001-5227-2997; 				Bryson B., 2003, SHORT HIST NEARLY EV; Christiansen M.H., 2003, LANGUAGE EVOLUTION E, P1, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0001; DARWIN C, 1969, AUTOBIOGRAPHY C DARW, P139; Dennett DC., 1996, DARWINS DANGEROUS ID; 2006, DARW 21ST CENT SCI S	5	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					306	307		10.1126/science.1128901	http://dx.doi.org/10.1126/science.1128901			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857926				2022-12-01	WOS:000239154300028
J	Wong, TY; Klein, R; Cong, S; Mitchell, P; Couper, DJ; Hong, L; Hubbard, LD; Sharrett, AR				Wong, Tien Yin; Klein, Ronald; Cong Sun; Mitchell, Paul; Couper, David J.; Hong Lai; Hubbard, Larry D.; Sharrett, A. Richey		Atherosclerosis Risk Communities S	Age-related macular degeneration and risk for stroke	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; MACULOPATHY; THERAPY; HYPERTENSION; ANTIOXIDANTS; ASSOCIATION; CHOLESTEROL; INFARCTION; ASPIRIN	Background: Age-related macular degeneration (AMD) affects 7 million persons 40 years of age and older in the United States. Risk factors for the disease are similar to those for stroke. Objective: To determine what relationship, if any, exists between AMD and incident clinical stroke. Design: Prospective cohort study. Setting: The population-based Atherosclerosis Risk in Communities Study, which was conducted in Minnesota, Maryland, Mississippi, and North Carolina. Patients: 10405 persons between 49 and 73 years of age who had no history of stroke or coronary heart disease. Measurements: Participants had retinal photographs taken between 1993 and 1995. A standardized protocol was used to evaluate the photographs for the presence of drusen and other signs of AMD. Incident stroke events were identified and validated by reviewing case records. Results: There were 498 early-stage and 10 late-stage cases of AMD in the cohort (n = 508). Over a 10-year period, 241 persons had an incident stroke event. After adjusting for age, sex, ethnicity, and site, the authors found that persons with early-stage AMD had a higher cumulative incidence of stroke than those without disease (4.08% vs. 2.14%). The presence of early-stage AMD was associated with a higher adjusted risk for stroke (hazard ratio, 1.87 [95% CI, 1.21 to 2.88]). Further adjustment for systolic blood pressure, diabetes, cigarette smoking, and use of anti hypertensive medications did not substantially alter this association (hazard ratio, 1.85 [CI, 1.19 to 2.87]). The authors found that the association between early-stage AMD and stroke varied by study site and patient ethnicity. Multivariable-adjusted hazard ratios were 3.15 and 1.07 in samples of white patients in Minnesota and Maryland, respectively; 3.77 in a sample of African-American patients in Mississippi; and 0.33 in a sample of mostly white patients (91 %) in North Carolina. No site included sufficient numbers of both African-American and white patients to determine whether ethnicity contributed to the observed differences by study site. Limitations: There were few cases of late-stage AMD, and the cohort assembly method prohibited full understanding of variation by ethnicity and site. Conclusion: Middle-aged persons with signs of early-stage AMD have a higher risk for stroke independent of traditional stroke risk factors.	Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Univ Wisconsin, Madison, WI 53706 USA; Univ Sydney, Sydney, NSW 2006, Australia; Univ N Carolina, Chapel Hill, NC 27515 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA	Centre for Eye Research Australia; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; University of Sydney; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res Australia, 32 Gisborne St, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014	Wong, Tien Yin/0000-0002-8448-1264; Couper, David/0000-0002-4313-9235	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055020, N01HC055022, N01HC055021, N01HC055019, N01HC055016, N01HC055015] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55016, N01-HC-55022, N01-HC-55021, N01-HC-55019, N01-HC-55015, N01-HC-55018, N01-HC-55020] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2004, HEART DIS STROK STAT; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Di Napoli M, 2001, STROKE, V32, P1444, DOI 10.1161/01.STR.32.6.1443-a; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klaver CCW, 1999, AM J EPIDEMIOL, V150, P963; KLEIN R, 1992, OPHTHALMOLOGY, V99, P1686; Klein R, 2003, OPHTHALMOLOGY, V110, P25, DOI 10.1016/S0161-6420(02)01565-8; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1203; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 1999, OPHTHALMOLOGY, V106, P1056, DOI 10.1016/S0161-6420(99)90255-5; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Lindsberg PJ, 1996, ANN NEUROL, V40, P587, DOI 10.1002/ana.410400408; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McGwin G, 2005, OPHTHALMOLOGY, V112, P488, DOI 10.1016/j.ophtha.2004.10.027; *NAT HEART LUNG BL, 1988, ATH RISK COMM STUD O; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P211, DOI 10.1016/S0002-9394(14)75989-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; SCHNEIDER R, 1993, STROKE, V24, P1874, DOI 10.1161/01.STR.24.12.1874; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; SPERDUTO RD, 1986, ARCH OPHTHALMOL-CHIC, V104, P216; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; VINGERLING JR, 1995, AM J EPIDEMIOL, V142, P404, DOI 10.1093/oxfordjournals.aje.a117648; Voko Z, 2003, NEUROLOGY, V61, P1273, DOI 10.1212/01.WNL.0000090458.67821.A3; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson HL, 2004, AM J OPHTHALMOL, V137, P615, DOI 10.1016/j.ajo.2003.10.025; Wong TY, 2002, AM J OPHTHALMOL, V134, P828; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	45	111	114	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					98	106		10.7326/0003-4819-145-2-200607180-00007	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16847292				2022-12-01	WOS:000239051400003
J	Nandakumar, J; Shuman, S; Lima, CD				Nandakumar, Jayakrishnan; Shuman, Stewart; Lima, Christopher D.			RNA ligase structures reveal the basis for RNA specificity and conformational changes that drive ligation forward	CELL			English	Article							DNA-LIGASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; MUTATIONAL ANALYSIS; MECHANISM; NICK; ASSOCIATION; ENZYME	T4 RNA ligase 2 (Rnl2) and kinetoplastid RNA editing ligases exemplify a family of RNA repair enzymes that seal 3'OH/5'PO4 nicks in duplex RNAs via ligase adenylylation (step 1), AMP transfer to the nick 5'PO4 (step 2), and attack by the nick 3'OH on the 5'-adenylylated strand to form a phosphodiester (step 3). Crystal structures are reported for Rnl2 at discrete steps along this pathway: the covalent Rnl2-AMP intermediate; Rnl2 bound to an adenylylated nicked duplex, captured immediately following step 2; and Rnl2 at an adenylylated nick in a state poised for step 3. These structures illuminate the stereochemistry of nucleotidyl transfer and reveal how remodeling of active-site contacts and conformational changes propel the ligation reaction forward. Mutational analysis and comparison of nick-bound structures of Rnl2 and human DNA ligase I highlight common and divergent themes of substrate recognition that can explain their specialization for RNA versus DNA repair.	Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA; Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Sloan Kettering Inst, Training Program Chem Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Nandakumar, J (corresponding author), Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA.	limac@mskcc.edu		Lima, Christopher/0000-0002-9163-6092; Nandakumar, Jayakrishnan/0000-0001-9146-2785	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611, R01GM061906] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-15301] Funding Source: Medline; NIGMS NIH HHS [GM61906, GM63611] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc V, 1999, J BIOL CHEM, V274, P24289, DOI 10.1074/jbc.274.34.24289; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; GUPTA G, 1985, J MOL BIOL, V186, P463, DOI 10.1016/0022-2836(85)90118-4; Ho CK, 2004, STRUCTURE, V12, P327, DOI 10.1016/j.str.2004.01.011; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEHMAN IR, 1974, SCIENCE, V186, P790; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MODRICH P, 1972, J BIOL CHEM, V247, P6370; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nandakumar J, 2005, J BIOL CHEM, V280, P23484, DOI 10.1074/jbc.M500831200; Nandakumar J, 2004, MOL CELL, V16, P211, DOI 10.1016/j.molcel.2004.09.022; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzo SS, 2003, MOL BIOCHEM PARASIT, V127, P161, DOI 10.1016/S0166-6851(02)00333-X; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Sekiguchi J, 1997, J VIROL, V71, P9679, DOI 10.1128/JVI.71.12.9679-9684.1997; Sekiguchi J, 1997, BIOCHEMISTRY-US, V36, P9073, DOI 10.1021/bi970705m; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SILBER R, 1972, P NATL ACAD SCI USA, V69, P3009, DOI 10.1073/pnas.69.10.3009; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; TOMKINSON AE, 1991, J BIOL CHEM, V266, P21728; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Uhlenbeck O.C., 1982, ENZYMES, V15, P31, DOI [10.1016/s1874-6047(08)60274-7, DOI 10.1016/S1874-6047(08)60274-7]; Wang LK, 2005, RNA, V11, P966, DOI 10.1261/rna.2170305; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; YANG SW, 1992, J BIOL CHEM, V267, P8117; Yin SM, 2003, J BIOL CHEM, V278, P17601, DOI 10.1074/jbc.M300817200	47	67	69	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					71	84		10.1016/j.cell.2006.08.038	http://dx.doi.org/10.1016/j.cell.2006.08.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018278	Bronze			2022-12-01	WOS:000241445800015
J	Rothenfluh, A; Threlkeld, RJ; Bainton, RJ; Tsai, LTY; Lasek, AW; Heberlein, U				Rothenfluh, Adrian; Threlkeld, Robert J.; Bainton, Roland J.; Tsai, Linus T. -Y.; Lasek, Amy W.; Heberlein, Ulrike			Distinct behavioral responses to ethanol are regulated by alternate RhoGAP18B lsoforms	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; RHO-GTPASES; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; NERVOUS-SYSTEM; NEUROPEPTIDE-Y; KNOCKOUT MICE; P190 RHOGAP; ALCOHOLISM; RECEPTOR	In most organisms, low ethanol doses induce increased activity, while high doses are sedating. To investigate the underlying mechanisms, we isolated Drosophila mutants with altered ethanol responsiveness. Mutations in white rabbit (whir), disrupting RhoGAP18B, are strongly resistant to the sedating effects of ethanol. This resistance can be suppressed by reducing the levels of Rho1 or Rac, implicating these GTPases in the behavioral response to ethanol. Indeed, expression of constitutively active forms of Rho1 or Rac1 in adult flies results in ethanol resistance similar to that observed in whir mutants. The whir locus produces several transcripts, RA-RD, which are predicted to encode three distinct RhoGAPs that share only the GAP domain. The RC transcript mediates the sedating effects of ethanol, while the RA transcript regulates its stimulant effects. Thus, distinct RhoGAPs, encoded by the same gene, regulate different manifestations of acute ethanol intoxication.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Rothenfluh, A (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	adrian.rothenfluh@ucsf.edu; ulrike.heberlein@ucsf.edu	Lasek, Amy/AAV-7606-2020	Lasek, Amy/0000-0002-7099-2442; Tsai, Linus/0000-0002-0134-6949; Rothenfluh, Adrian/0000-0002-3813-5723	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035, R01AA013105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014809] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA10035, AA13105] Funding Source: Medline; NIDA NIH HHS [DA14809] Funding Source: Medline; NIGMS NIH HHS [T32 GM007618] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Dash PK, 2004, BIOCHEM BIOPH RES CO, V322, P893, DOI 10.1016/j.bbrc.2004.08.004; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Enoch MA, 1999, PSYCHIAT CLIN N AM, V22, P289, DOI 10.1016/S0193-953X(05)70077-0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Furuta B, 2002, J NEUROCHEM, V82, P1018, DOI 10.1046/j.1471-4159.2002.01021.x; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Humeau Y, 2002, J NEUROSCI, V22, P7968; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Parr J, 2001, J NEUROSCI METH, V107, P93, DOI 10.1016/S0165-0270(01)00357-0; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schuckit MA, 2000, AM J ADDICTION, V9, P103, DOI 10.1080/10550490050173172; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Scott EK, 2003, J NEUROSCI, V23, P3118; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1097/00000374-200008000-00001; Thiele TE, 2004, NEUROPEPTIDES, V38, P235, DOI 10.1016/j.npep.2004.04.005; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wolf FW, 2002, J NEUROSCI, V22, P11035	60	97	97	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					199	211		10.1016/j.cell.2006.09.010	http://dx.doi.org/10.1016/j.cell.2006.09.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018286	Bronze			2022-12-01	WOS:000241445800024
J	Paton, AW; Beddoe, T; Thorpe, CM; Whisstock, JC; Wilce, MCJ; Rossjohn, J; Talbot, UM; Paton, JC				Paton, Adrienne W.; Beddoe, Travis; Thorpe, Cheleste M.; Whisstock, James C.; Wilce, Matthew C. J.; Rossjohn, Jamie; Talbot, Ursula M.; Paton, James C.			AB(5) subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP	NATURE			English	Article							TOXIGENIC ESCHERICHIA-COLI; CELL-DEATH PROGRAM; ER CHAPERONE; SHIGA TOXIN; STRESS; PROTEINS; REGULATOR; STRAINS; FAMILY	AB(5) toxins are produced by pathogenic bacteria and consist of enzymatic A subunits that corrupt essential eukaryotic cell functions, and pentameric B subunits that mediate uptake into the target cell. AB(5) toxins include the Shiga, cholera and pertussis toxins and a recently discovered fourth family, subtilase cytotoxin, which is produced by certain Shiga toxigenic strains of Escherichia coli. Here we show that the extreme cytotoxicity of this toxin for eukaryotic cells is due to a specific single-site cleavage of the essential endoplasmic reticulum chaperone BiP/GRP78. The A subunit is a subtilase-like serine protease; structural studies revealed an unusually deep active-site cleft, which accounts for its exquisite substrate specificity. A single amino-acid substitution in the BiP target site prevented cleavage, and coexpression of this resistant protein protected transfected cells against the toxin. BiP is a master regulator of endoplasmic reticulum function, and its cleavage by subtilase cytotoxin represents a previously unknown trigger for cell death.	Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; Monash Univ, Prot Crystallog Unit, Clayton, Vic 3800, Australia; Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA	University of Adelaide; Monash University; Monash University; Tufts Medical Center; Tufts University	Paton, AW (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	adrienne.paton@adelaide.edu.au; james.paton@adelaide.edu.au	Paton, James C/A-9920-2008; Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013	Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Whisstock, James/0000-0003-4200-5611				Fan EK, 2000, CURR OPIN STRUC BIOL, V10, P680, DOI 10.1016/S0959-440X(00)00152-4; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; KOZUTSUMI Y, 1989, J CELL SCI, P115; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Maniatis T, 1982, MOL CLONING; Paton AW, 2005, J CLIN MICROBIOL, V43, P2944, DOI 10.1128/JCM.43.6.2944-2947.2005; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005	24	284	287	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					548	552		10.1038/nature05124	http://dx.doi.org/10.1038/nature05124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024087				2022-12-01	WOS:000240988200037
J	Solomon, JH; Hartmann, MJ				Solomon, Joseph H.; Hartmann, Mitra J.			Robotic whiskers used to sense features	NATURE			English	Article							CONTACT		Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Solomon, JH (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	m-hartmann@northwestern.edu	Hartmann, Mitra/B-6766-2009; Hartmann, Mitra/A-8150-2008					Clements TN, 2006, IEEE T ROBOT, V22, P844, DOI 10.1109/TRO.2006.878950; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Kaneko M, 1998, IEEE T ROBOTIC AUTOM, V14, P278, DOI 10.1109/70.681246; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Neimark MA, 2003, J NEUROSCI, V23, P6499; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005	7	105	111	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					525	525		10.1038/443525a	http://dx.doi.org/10.1038/443525a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024083	Bronze			2022-12-01	WOS:000240988200032
J	Corrado, D; Basso, C; Pavei, A; Michieli, P; Schiavon, M; Thiene, G				Corrado, Domenico; Basso, Cristina; Pavei, Andrea; Michieli, Pierantonio; Schiavon, Maurizio; Thiene, Gaetano			Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	78th Annual Scientific Session of the American-Heart-Association	NOV 13-16, 2005	Dallas, TX	Amer Heart Assoc			RIGHT-VENTRICULAR CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC DEATH; OF-CARDIOLOGY; HIGH-SCHOOL; ADULTS; HEART; DISEASE; PEOPLE; ABNORMALITIES	Context A nationwide systematic preparticipation athletic screening was introduced in Italy in 1982. The impact of such a program on prevention of sudden cardiovascular death in the athlete remains to be determined. Objective To analyze trends in incidence rates and cardiovascular causes of sudden death in young competitive athletes in relation to preparticipation screening. Design, Setting, and Participants A population-based study of trends in sudden cardiovascular death in athletic and nonathletic populations aged 12 to 35 years in the Veneto region of Italy between 1979 and 2004. A parallel study examined trends in cardiovascular causes of disqualification from competitive sports in 42 386 athletes undergoing preparticipation screening at the Center for Sports Medicine in Padua ( 22 312 in the early screening period [1982-1992] and 20 074 in the late screening period [1993-2004]). Main Outcome Measures Incidence trends of total cardiovascular and cause-specific sudden death in screened athletes and unscreened nonathletes of the same age range over a 26-year period. Results During the study period, 55 sudden cardiovascular deaths occurred in screened athletes (1.9 deaths/100 000 person-years) and 265 sudden deaths in unscreened nonathletes (0.79 deaths/100 000 person-years). The annual incidence of sudden cardiovascular death in athletes decreased by 89% ( from 3.6/100 000 person-years in 19791980 to 0.4/100 000 person-years in 2003-2004; P for trend <. 001), whereas the incidence of sudden death among the unscreened nonathletic population did not change significantly. The mortality decline started after mandatory screening was implemented and persisted to the late screening period. Compared with the prescreening period ( 19791981), the relative risk of sudden cardiovascular death in athletes was 0.56 in the early screening period (95% CI, 0.29-1.15; P=. 04) and 0.21 in the late screening period ( 95% CI, 0.09-0.48; P=. 001). Most of the reduced mortality was due to fewer cases of sudden death from cardiomyopathies ( from 1.50/100 000 person-years in the prescreening period to 0.15/100 000 person-years in the late screening period; P for trend=.002). During the study period, 879 athletes (2.0%) were disqualified from competition due to cardiovascular causes at the Center for Sports Medicine: 455 ( 2.0%) in the early screening period and 424 (2.1%) in the late screening period. The proportion of athletes who were disqualified for cardiomyopathies increased from 20 (4.4%) of 455 in the early screening period to 40 (9.4%) of 424 in the late screening period ( P=. 005). Conclusions The incidence of sudden cardiovascular death in young competitive athletes has substantially declined in the Veneto region of Italy since the introduction of a nationwide systematic screening. Mortality reduction was predominantly due to a lower incidence of sudden death from cardiomyopathies that paralleled the increasing identification of athletes with cardiomyopathies at preparticipation screening.	Univ Padua, Sch Med, Inst Pathol Anat, I-35121 Padua, Italy; Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Sci, I-35121 Padua, Italy; Ctr Sports Med & Phys Act, Padua, Italy	University of Padua; University of Padua	Thiene, G (corresponding author), Univ Padua, Sch Med, Inst Pathol Anat, Via A Gabelli 61, I-35121 Padua, Italy.	gaetano.thiene@unipd.it	Schiavon, Maurizio/AAU-9558-2021; Fahimifar, Sepideh/M-5303-2019	basso, cristina/0000-0002-0195-9753; CORRADO, DOMENICO/0000-0003-1487-0392				[Anonymous], 1994, J Am Coll Cardiol, V24, P845; BASSO C, 1995, HUM PATHOL, V26, P1065, DOI 10.1016/0046-8177(95)90267-8; Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0; Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983; Basso C, 2001, CIRCULATION, V103, P269; Basso C, 2001, CARDIOVASC RES, V50, P290, DOI 10.1016/S0008-6363(01)00261-9; Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; Comitato Organizzativo Cardiologico per l'Idoneita Allo Sport (COCIS), 1989, G ITAL CARDIOL, V19, P250; Corrado D, 2005, LANCET, V366, pS47, DOI 10.1016/S0140-6736(05)67847-6; CORRADO D, 1994, CIRCULATION, V90, P2315, DOI 10.1161/01.CIR.90.5.2315; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; CORRADO D, 1992, BRIT HEART J, V68, P601; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Corrado D, 2001, CIRCULATION, V103, P710; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; FRANK S, 1968, CIRCULATION, V37, P759, DOI 10.1161/01.CIR.37.5.759; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; MARON BJ, 1985, J AM COLL CARDIOL, V6, P1189; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARON BJ, 1980, CIRCULATION, V62, P218, DOI 10.1161/01.CIR.62.2.218; Nistri S, 2003, AM J CARDIOL, V91, P1021, DOI 10.1016/S0002-9149(03)00132-2; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Selvin S, 1995, PRACTICAL BIOSTATIST, P455; TEARE D, 1958, BRIT HEART J, V20, P1; THIENE G, 1983, HUM PATHOL, V14, P704, DOI 10.1016/S0046-8177(83)80143-9; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; 1982, GAZZETTA UFFICI 0305, P63; 1971, GAZZETTA UFFICI 1223, P8162	40	994	1038	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1593	1601		10.1001/jama.296.13.1593	http://dx.doi.org/10.1001/jama.296.13.1593			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	090JS	17018804	Bronze			2022-12-01	WOS:000240948200019
J	Beeson, D; Higuchi, O; Palace, J; Cossins, J; Spearman, H; Maxwell, S; Newsom-Davis, J; Burke, G; Fawcett, P; Motomura, M; Muller, JS; Lochmuller, H; Slater, C; Vincent, A; Yamanashi, Y				Beeson, David; Higuchi, Osamu; Palace, Jackie; Cossins, Judy; Spearman, Hayley; Maxwell, Susan; Newsom-Davis, John; Burke, Georgina; Fawcett, Peter; Motomura, Masakatsu; Mueller, Juliane S.; Lochmueller, Hanns; Slater, Clarke; Vincent, Angela; Yamanashi, Yuji			Dok-7 mutations underlie a neuromuscular junction synaptopathy	SCIENCE			English	Article							LIMB-GIRDLE MYASTHENIA; POSTSYNAPTIC APPARATUS; MUSCLE; TRANSMISSION; KINASES; NERVE	Congenital myasthenic syndromes (CMSs) are a group of inherited disorders of neuromuscular transmission characterized by fatigable muscle weakness. One major subgroup of patients shows a characteristic "limb girdle'' pattern of muscle weakness, in which the muscles have small, simplified neuromuscular junctions but normal acetylcholine receptor and acetylcholinesterase function. We showed that recessive inheritance of mutations in Dok-7, which result in a defective structure of the neuromuscular junction, is a cause of CMS with proximal muscle weakness.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Neurosci Grp, Oxford OX3 9DS, England; Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Newcastle Univ, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Tokyo Med & Dent Univ, Med Res Inst, Dept Cell Regulat, Tokyo 1138510, Japan; Nagasaki Univ, Dept Internal Med 1, Nagasaki 8528501, Japan; Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany	University of Oxford; Radcliffe Infirmary; University of Oxford; Newcastle University - UK; Tokyo Medical & Dental University (TMDU); Nagasaki University; University of Munich	Beeson, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Neurosci Grp, Oxford OX3 9DS, England.	dbeeson@hammer.imm.ox.ac.uk	Vincent, Angela/AAE-7310-2019	Lochmuller, Hanns/0000-0003-2324-8001	Medical Research Council [G117/490] Funding Source: Medline; MRC [G117/490] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antolik C, 2006, NEUROSCIENCE, V141, P87, DOI 10.1016/j.neuroscience.2006.03.035; Beeson David, 2005, Neuromuscul Disord, V15, P498, DOI 10.1016/j.nmd.2005.05.001; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001; OH SJ, 1992, NEUROLOGY, V42, P1153, DOI 10.1212/WNL.42.6.1153; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Rodolico C, 2002, NEUROMUSCULAR DISORD, V12, P964, DOI 10.1016/S0960-8966(02)00137-2; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Shankar A, 2002, NEUROL INDIA, V50, P500; Slater CR, 2006, BRAIN, V129, P2061, DOI 10.1093/brain/awl200; Slater CR, 2003, J NEUROCYTOL, V32, P505, DOI 10.1023/B:NEUR.0000020607.17881.9b; VINCENT A, 1993, ANN NY ACAD SCI, V681, P451, DOI 10.1111/j.1749-6632.1993.tb22929.x; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	18	181	189	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1975	1978		10.1126/science.1130837	http://dx.doi.org/10.1126/science.1130837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	16917026				2022-12-01	WOS:000240832200055
J	Krishnamurthy, J; Ramsey, MR; Ligon, KL; Torrice, C; Koh, A; Bonner-Weir, S; Sharpless, NE				Krishnamurthy, Janakiraman; Ramsey, Matthew R.; Ligon, Keith L.; Torrice, Chad; Koh, Angela; Bonner-Weir, Susan; Sharpless, Norman E.			p16(INK4a) induces an age-dependent decline in islet regenerative potential	NATURE			English	Article							PANCREATIC BETA-CELLS; PREMATURE SENESCENCE; TRANSGENIC MICE; DIABETIC MICE; EXPRESSION; CDK4; STREPTOZOTOCIN; GROWTH; ADULT; DIFFERENTIATION	The p16(INK4a) tumour suppressor accumulates in many tissues as a function of advancing age(1-3). p16(INK4a) is an effector of senescence(4,5) and a potent inhibitor of the proliferative kinase Cdk4 (ref. 6), which is essential for pancreatic beta-cell proliferation in adult mammals(7,8). Here we show that p16(INK4a) constrains islet proliferation and regeneration in an age-dependent manner. Expression of the p16(INK4a) transcript is enriched in purified islets compared with the exocrine pancreas, and islet-specific expression of p16(INK4a), but not other cyclin-dependent kinase inhibitors, increases markedly with ageing. To determine the physiological significance of p16(INK4a) accumulation on islet function, we assessed the impact of p16(INK4a) deficiency and overexpression with increasing age and in the regenerative response after exposure to a specific beta-cell toxin. Transgenic mice that overexpress p16(INK4a) to a degree seen with ageing demonstrated decreased islet proliferation. Similarly, islet proliferation was unaffected by p16(INK4a) deficiency in young mice, but was relatively increased in p16(INK4a)-deficient old mice. Survival after toxin-mediated ablation of beta-cells, which requires islet proliferation, declined with advancing age; however, mice lacking p16(INK4a) demonstrated enhanced islet proliferation and survival after beta-cell ablation. These genetic data support the view that an age-induced increase of p16(INK4a) expression limits the regenerative capacity of beta-cells with ageing.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA.	NES@med.unc.edu		Ligon, Keith/0000-0002-7733-600X; Ramsey, Matthew/0000-0003-2402-8502; Sharpless, Norman/0000-0001-7078-9455; Bonner-Weir, Susan/0000-0003-4682-0656				Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1981, DIABETES, V30, P64, DOI 10.2337/diabetes.30.1.64; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; Gu DL, 1997, PANCREAS, V15, P246, DOI 10.1097/00006676-199710000-00005; Halvorsen TL, 2000, J ENDOCRINOL, V166, P103, DOI 10.1677/joe.0.1660103; Hino S, 2004, DIABETOLOGIA, V47, P1819, DOI 10.1007/s00125-004-1522-4; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; JANZEN V, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05159; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Marzo N, 2004, DIABETOLOGIA, V47, P686, DOI 10.1007/s00125-004-1372-0; Meng AM, 2003, CANCER RES, V63, P5414; MOLOFSKY AV, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05091; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Nielsen GP, 1999, LAB INVEST, V79, P1137; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Pei XH, 2004, MOL CELL BIOL, V24, P6653, DOI 10.1128/mcb.24.15.6653-6664.2004; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; RILEY WJ, 1981, DIABETES, V30, P718, DOI 10.2337/diabetes.30.9.718; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	32	715	753	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					453	457		10.1038/nature05092	http://dx.doi.org/10.1038/nature05092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	16957737				2022-12-01	WOS:000240798800045
J	Petronczki, M; Matos, J; Mori, S; Gregan, J; Bogdanova, A; Schwickart, M; Mechtler, K; Shirahige, K; Zachariae, W; Nasmyth, K				Petronczki, Mark; Matos, Joao; Mori, Saori; Gregan, Juraj; Bogdanova, Aliona; Schwickart, Martin; Mechtler, Karl; Shirahige, Katsuhiko; Zachariae, Wolfgang; Nasmyth, Kim			Monopolar attachment of sister kinetochores at meiosis I requires casein kinase 1	CELL			English	Article							REDUCTIONAL CHROMOSOME SEGREGATION; PROTEIN PHOSPHATASE 2A; CHROMATID COHESION; S-PHASE; CLEAVAGE; YEAST; REC8; ORIENTATION; HOMOLOGS	In meiosis, a single round of DNA replication is followed by two consecutive rounds of chromosome segregation, called meiosis I and II. Disjunction of maternal from paternal centromeres during meiosis I depends on the attachment of sister kinetochores to microtubules emanating from the same pole. In budding yeast, monopolar attachment requires recruitment to kinetochores of the monopolin complex. How monopolin promotes monopolar attachment was unclear, as its subunits are poorly conserved and lack similarities to proteins with known functions. We show here that the monopolin subunit Mam1 binds tightly to Hrr25, a highly conserved casein kinase 1 delta/epsilon (CK1 delta/epsilon), and recruits it to meiosis I centromeres. Hrr25 kinase activity and Mam1 binding are both essential for monopolar attachment. Since CK1 delta/epsilon activity is important for accurate chromosome segregation during meiosis I also in fission yeast, phosphorylation of kinetochore proteins by CK1 delta/epsilon might be an evolutionary conserved process required for monopolar attachment.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Tokyo Inst Technol, Ctr Biol Resources & Informat, Lab Genome Struct & Funct, Div Gene Res,Midori Ku, Yokohama, Kanagawa 2268501, Japan; Genentech Inc, San Francisco, CA 94080 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; Tokyo Institute of Technology; Roche Holding; Genentech; University of Oxford	Zachariae, W (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	zachariae@mpi-cbg.de; kim.nasmyth@bioch.ox.ac.uk	Mechtler, Karl/AAF-2717-2019; Gregan, Juraj/I-4161-2014; Matos, Joao/C-1488-2014	Mechtler, Karl/0000-0002-3392-9946; Gregan, Juraj/0000-0002-2989-8374; Matos, Joao/0000-0002-3754-3709; Nasmyth, Kim/0000-0001-7030-4403; Petronczki, Mark/0000-0003-0139-5692; Shirahige, Katsuhiko/0000-0002-7862-1144				Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knop M, 2000, EMBO J, V19, P3657, DOI 10.1093/emboj/19.14.3657; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 2000, CURR OPIN CELL BIOL, V12, P752, DOI 10.1016/S0955-0674(00)00165-4; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Watanabe Y, 2005, TRENDS GENET, V21, P405, DOI 10.1016/j.tig.2005.05.009; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	32	133	137	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1049	1064		10.1016/j.cell.2006.07.029	http://dx.doi.org/10.1016/j.cell.2006.07.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990132	Bronze			2022-12-01	WOS:000240897600013
J	Wolk, A; Larsson, SC; Johansson, JE; Ekman, P				Wolk, Alicja; Larsson, Susanna C.; Johansson, Jan-Erik; Ekman, Peter			Long-term fatty fish consumption and renal cell carcinoma incidence in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-D-RECEPTOR; RISK-FACTORS; CANCER; PREVENTION; ACTIVATION; ACIDS; DIET	Context The epidemiological evidence that fatty fish consumption may be associated with the lower risk of several cancers is not consistent and no studies of renal cell carcinoma (RCC) exist. Objective To examine the association between fatty and lean fish consumption and risk of RCC in women. Design, Setting, and Participants The Swedish Mammography Cohort, a population-based prospective cohort study of 61 433 women aged 40 to 76 years without previous diagnosis of cancer at baseline ( March 1, 1987-December 14, 1990). Participants filled in a food frequency questionnaire at baseline and in September 1997. Main Outcome Measure Incident renal cell carcinoma. Results During a mean of 15.3 years ( 940 357 person-years) of follow-up between 1987 and 2004, 150 incident RCC cases were diagnosed. After adjustment for potential confounders, an inverse association of fatty fish consumption with the risk of RCC was found ( P for trend=.02), but no association was found with lean fish consumption. Compared with no consumption, the multivariate rate ratio (RR) was 0.56 ( 95% confidence interval [CI], 0.35-0.91) for women eating fatty fish once a week or more. Compared with women consistently reporting no fish consumption, the multivariate RR was 0.26 ( 95% CI, 0.10-0.67) for those women reporting consistent consumption of fatty fish at baseline and 1997 ( based on a subset of 36 664 women who filled in the baseline and 1997 questionnaires, with 40 incident RCC cases during the 1998-2004 follow-up period). Conclusion Our study suggests that consumption of fatty fish may reduce the occurrence of RCC in women.	Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, SE-17177 Stockholm, Sweden; Univ Hosp, Dept Urol, Orebro, Sweden; Univ Hosp, Ctr Assessment Med Technol, Orebro, Sweden; Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital	Wolk, A (corresponding author), Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, POB 210, SE-17177 Stockholm, Sweden.	alicja.wolk@ki.se	Larsson, Susanna C./F-6065-2015	Larsson, Susanna C./0000-0003-0118-0341				Bergstrom L., 1991, Var Foda, V43, P439; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Cox DR., 1984, ANAL SURVIVAL DATA; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Fujioka T, 2000, WORLD J SURG, V24, P1205, DOI 10.1007/s002680010206; Healy KD, 2005, ARCH BIOCHEM BIOPHYS, V433, P466, DOI 10.1016/j.abb.2004.10.001; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Hu JF, 2003, CANCER CAUSE CONTROL, V14, P705, DOI 10.1023/A:1026310323882; Ikuyama T, 2002, ENDOCR J, V49, P433, DOI 10.1507/endocrj.49.433; Inoue K, 2001, BIOCHEM BIOPH RES CO, V287, P727, DOI 10.1006/bbrc.2001.5640; *INT AG RES CANC, 2000, INT ANN REP, V15; KREIGER N, 1993, CANCER CAUSE CONTROL, V4, P101, DOI 10.1007/BF00053150; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LYNCH CF, 1995, CANCER, V75, P316, DOI 10.1002/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; McCabe AJ, 2005, J NUTR BIOCHEM, V16, P17, DOI 10.1016/j.jnutbio.2004.07.006; MCLAUGHLIN JK, 1992, INT J CANCER, V52, P562, DOI 10.1002/ijc.2910520411; *NAT CANC I CANC S, 2001, SEER 9 REG PUBL US F; *NAT CANC I CANC S, 2001, SEER 11 REG PUBL US; Skopinska-Rozewska E, 1999, ONCOL REP, V6, P1341; *SWED CANC REG CTR, 2006, STAT HLTH DIS 2005, V9; Terry PD, 2003, AM J CLIN NUTR, V77, P532, DOI 10.1093/ajcn/77.3.532; Wolk A, 1996, INT J CANCER, V65, P67, DOI 10.1002/(SICI)1097-0215(19960103)65:1&lt;67::AID-IJC12&gt;3.0.CO;2-F; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	25	87	88	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1371	1376		10.1001/jama.296.11.1371	http://dx.doi.org/10.1001/jama.296.11.1371			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985229	Bronze			2022-12-01	WOS:000240595800024
J	Canolty, RT; Edwards, E; Dalal, SS; Soltani, M; Nagarajan, SS; Kirsch, HE; Berger, MS; Barbaro, NM; Knight, RT				Canolty, R. T.; Edwards, E.; Dalal, S. S.; Soltani, M.; Nagarajan, S. S.; Kirsch, H. E.; Berger, M. S.; Barbaro, N. M.; Knight, R. T.			High gamma power is phase-locked to theta oscillations in human neocortex	SCIENCE			English	Article							NEURONAL OSCILLATIONS; CORTEX; SYNCHRONIZATION; MECHANISM; DYNAMICS; LOCKING; MEMORY	We observed robust coupling between the high- and low-frequency bands of ongoing electrical activity in the human brain. In particular, the phase of the low-frequency theta ( 4 to 8 hertz) rhythm modulates power in the high gamma ( 80 to 150 hertz) band of the electrocorticogram, with stronger modulation occurring at higher theta amplitudes. Furthermore, different behavioral tasks evoke distinct patterns of theta/high gamma coupling across the cortex. The results indicate that transient coupling between low- and high-frequency brain rhythms coordinates activity in distributed cortical areas, providing a mechanism for effective communication during cognitive processing in humans.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Canolty, RT (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	rcanolty@berkeley.edu		Dalal, Sarang/0000-0002-1699-7218; Kirsch, Heidi/0000-0002-3144-2085	NIDCD NIH HHS [R01 DC004855, F31DC006762, R01 DC004855-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS021135-20, R01 NS021135, NS21135] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021135, R56NS021135, R01NS021135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004855, F31DC006762] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Miller R., 1991, CORTICO HIPPOCAMPAL; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	27	1659	1730	20	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1626	1628		10.1126/science.1128115	http://dx.doi.org/10.1126/science.1128115			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973878	Green Accepted			2022-12-01	WOS:000240498900042
J	Dawson, RJP; Locher, KP				Dawson, Roger J. P.; Locher, Kaspar P.			Structure of a bacterial multidrug ABC transporter	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN P-GLYCOPROTEIN; BINDING CASSETTE TRANSPORTER; CATALYTIC TRANSITION-STATE; ATP-BINDING; CLOSED CONFORMATION; MALTOSE TRANSPORT; ESCHERICHIA-COLI; DRUG TRANSPORT; MECHANISM	Multidrug transporters of the ABC family facilitate the export of diverse cytotoxic drugs across cell membranes. This is clinically relevant, as tumour cells may become resistant to agents used in chemotherapy. To understand the molecular basis of this process, we have determined the 3.0 angstrom crystal structure of a bacterial ABC transporter (Sav1866) from Staphylococcus aureus. The homodimeric protein consists of 12 transmembrane helices in an arrangement that is consistent with cross-linking studies and electron microscopic imaging of the human multidrug resistance protein MDR1, but critically different from that reported for the bacterial lipid flippase MsbA. The observed, outward-facing conformation reflects the ATP-bound state, with the two nucleotide-binding domains in close contact and the two transmembrane domains forming a central cavity - presumably the drug translocation pathway - that is shielded from the inner leaflet of the lipid bilayer and from the cytoplasm, but exposed to the outer leaflet and the extracellular space.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch		Dawson, Roger/0000-0003-2161-5883				Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Awayn NH, 2005, BIOCHEM SOC T, V33, P996, DOI 10.1042/BST0330996; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I. B., 2003, ABC PROTEINS BACTERI; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Mannering DE, 2001, J BIOL CHEM, V276, P12362, DOI 10.1074/jbc.M011686200; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; SHAPIRO AB, 1995, J BIOL CHEM, V270, P16167, DOI 10.1074/jbc.270.27.16167; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Stroud RM, 2003, CURR OPIN STRUC BIOL, V13, P424, DOI 10.1016/S0959-440X(03)00114-3; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Zelcer N, 2003, J BIOL CHEM, V278, P23538, DOI 10.1074/jbc.M303504200	45	1024	1059	5	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					180	185		10.1038/nature05155	http://dx.doi.org/10.1038/nature05155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16943773				2022-12-01	WOS:000240467000039
J	Pryor, JL; Althof, SE; Steidle, C; Rosen, RC; Hellstrom, WJG; Shabsigh, R; Miloslavsky, M; Kell, S				Pryor, Jon L.; Althof, Stanley E.; Steidle, Christopher; Rosen, Raymond C.; Hellstrom, Wayne J. G.; Shabsigh, Ridwan; Miloslavsky, Maja; Kell, Sherron		Dapoxetine Study Grp	Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials	LANCET			English	Article							SEROTONIN REUPTAKE INHIBITORS; INDUCED SEXUAL DYSFUNCTION; QUALITY-OF-LIFE; RAPID EJACULATION; MEN; HYDROCHLORIDE; PREVALENCE; PAROXETINE; PHARMACOKINETICS; SERTRALINE	Background No drugs are approved for treatment of premature ejaculation. Our aim was to determine the efficacy and tolerability of on-demand dapoxetine in patients with severe premature ejaculation. Methods We determined the efficacy of dapoxetine in a prospectively predefined integrated analysis of two 12-week randomised, double-blind, placebo-controlled, phase III trials of identical design done independently, in parallel, at 121 sites in the USA. Men with moderate-to-severe premature ejaculation in stable, heterosexual relationships took placebo (n=870), 30 mg dapoxetine (874), or 60 mg dapoxetine (870) on-demand (as needed, 1-3 h before anticipated sexual activity). The primary endpoint was intravaginal ejaculatory latency time (IELT) measured by stopwatch. Safety and tolerability were assessed. All analyses were done on an intention-to-treat basis. The trials are registered at ClinicalTrials.gov, numbers NCT00211107 and NCT00211094. Findings 672, 676, and 610 patients completed in the placebo, 30 mg dapoxetine, and 60 mg dapoxetine groups, respectively. Dapoxetine significantly prolonged IELT (p<0.0001, all doses vs placebo). Mean IELT at baseline was 0.90 (SD 0.47) minute, 0.92 (0.50) minute, and 0.91 (0.48) minute, and at study endpoint (week 12 or final visit) was 1.75 (2.21) minutes for placebo, 2.78 (3.48) minutes for 30 mg dapoxetine, and 3.32 (3.68) minutes for 60 mg dapoxetine. Both dapoxetine doses were effective on the first dose. Common adverse events (30 mg and 60 mg dapoxetine, respectively) were nausea (8.7%, 20.1%), diarrhoea (3.9%, 6.8%), headache (5.9%, 6.8%), and dizziness (3.0%, 6.2%). Interpretation On-demand dapoxetine is an effective and generally well tolerated treatment for men with moderate-to-severe premature ejaculation.	Univ Minnesota, Dept Urol Surg, Minneapolis, MN 55455 USA; Case Med Sch, Cleveland, OH USA; NE Indiana Res LLC, Ft Wayne, IN USA; Robert Wood Johnson Med Sch, Piscataway, NJ USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; Columbia Univ, New York Ctr Human Sexual, New York, NY USA; ALZA Corp, Mountain View, CA USA	University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tulane University; Columbia University; Johnson & Johnson; Johnson & Johnson USA	Pryor, JL (corresponding author), Univ Minnesota, Dept Urol Surg, 420 Delaware St SE,MMC 394, Minneapolis, MN 55455 USA.	pryor001@umn.edu		Hellstrom, Wayne/0000-0003-1284-959X				*AM UR ASS, PHARM TREATM PREM EJ; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Byers ES, 2003, ARCH SEX BEHAV, V32, P261, DOI 10.1023/A:1023417718557; Gengo PJ, 2005, J UROLOGY, V173, P239; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; GRENIER G, 1995, ARCH SEX BEHAV, V24, P447, DOI 10.1007/BF01541858; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Hellstrom WJG, 2005, J UROLOGY, V173, P238, DOI 10.1016/S0022-5347(18)35046-8; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Hu XH, 2004, J CLIN PSYCHIAT, V65, P959; Kara H, 1996, J UROLOGY, V156, P1631, DOI 10.1016/S0022-5347(01)65467-3; Lane R, 1997, J CLIN PSYCHOPHARM, V17, P208, DOI 10.1097/00004714-199706000-00012; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; McCabe MP, 1997, J SEX MARITAL THER, V23, P276, DOI 10.1080/00926239708403932; McMahon CG, 1999, J UROLOGY, V161, P1826, DOI 10.1016/S0022-5347(05)68816-7; McMahon CG, 1998, J UROLOGY, V159, P1935, DOI 10.1016/S0022-5347(01)63201-4; McMahon CG, 1999, INT J IMPOT RES, V11, P241, DOI 10.1038/sj.ijir.3900415; Modi NB, 2006, J CLIN PHARMACOL, V46, P301, DOI 10.1177/0091270005284850; Montague DK, 2004, J UROLOGY, V172, P290, DOI 10.1097/01.ju.0000132159.61156.ea; MontejoGonzalez AL, 1997, J SEX MARITAL THER, V23, P176; Patrick DL, 2005, J SEX MED, V2, P358, DOI 10.1111/j.1743-6109.2005.20353.x; Patrick DL, 1999, UROLOGY, V53, P71, DOI 10.1016/S0090-4295(98)00454-3; Rosen RC, 2004, J SEX MED, V1, P57; Rosen RC, 1999, J CLIN PSYCHOPHARM, V19, P67, DOI 10.1097/00004714-199902000-00013; Rowland D, 2004, J SEX MED, V1, P225, DOI 10.1111/j.1743-6109.2004.04033.x; Rowland DL, 2000, J PSYCHOSOM RES, V48, P69, DOI 10.1016/S0022-3999(99)00078-1; Spigset O, 1999, DRUG SAFETY, V20, P277, DOI 10.2165/00002018-199920030-00007; Symonds T, 2003, J SEX MARITAL THER, V29, P361, DOI 10.1080/00926230390224738; Waldinger MD, 2004, INT J IMPOT RES, V16, P369, DOI 10.1038/sj.ijir.3901172; Waldinger MD, 2005, WORLD J UROL, V23, P102, DOI 10.1007/s00345-004-0491-z; Waldinger MD, 1998, J CLIN PSYCHOPHARM, V18, P274, DOI 10.1097/00004714-199808000-00004; Waldinger MD, 2002, J UROLOGY, V168, P2359, DOI 10.1016/S0022-5347(05)64146-8; Waldinger MD, 1998, BEHAV BRAIN RES, V92, P111, DOI 10.1016/S0166-4328(97)00183-6; Williams VSL, 2006, J CLIN PSYCHIAT, V67, P204, DOI 10.4088/JCP.v67n0205; 2005, PAXIL PAROXETINE HYD; 2005, VIAGRA SILDENAFIL CI; 2004, PHYS DESK REFERENCE; 2005, LEVITRA VARDENAFIL H	38	233	257	2	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					929	937		10.1016/S0140-6736(06)69373-2	http://dx.doi.org/10.1016/S0140-6736(06)69373-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962882				2022-12-01	WOS:000240502300030
J	Nelson, CJ; Santos-Rosa, H; Kouzarides, T				Nelson, Christopher J.; Santos-Rosa, Helena; Kouzarides, Tony			Proline isomerization of histone H3 regulates lysine methylation and gene expression	CELL			English	Article							NUCLEOSOME CORE PARTICLE; CIS PEPTIDE-BONDS; SACCHAROMYCES-CEREVISIAE; FK506-BINDING PROTEIN; PROLYL ISOMERIZATION; JMJD2 FAMILY; SET2; ISOMERASES; METHYLTRANSFERASE; ASSOCIATION	The cis-trans isomerization of proline serves as a regulatory switch in signaling pathways. We identify the proline isomerase Fpr4, a member of the FK506 binding protein family in Saccharomyces cerevisiae, as an enzyme which binds the amino-terminal tail of histones H3 and H4 and catalyses the isomerization of H3 proline P30 and P38 in vitro. We show that P38 is necessary for methylation of K36 and that isomerization by Fpr4 inhibits the ability of Set2 to methylate H3 K36 in vitro. These results suggest that the conformational state of P38, controlled by Fpr4, is important for methylation of H3K36 by Set2. Consistent with such an antagonistic role, abrogation of Fpr4 catalytic activity in vivo results in increased levels of H3K36 methylation and delayed transcriptional induction kinetics of specific genes in yeast. These results identify proline isomerization as a novel noncovalent histone modification that regulates transcription and provides evidence for crosstalk between histone lysine methylation and proline isomerization.	Gurdon Inst, Cambridge CB2 1QR, England; Dept Pathol, Cambridge CB2 1QR, England		Kouzarides, T (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	t.kouzarides@gurdon.cam.ac.uk		Kouzarides, Tony/0000-0002-8918-4162				Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; BENTON BM, 1994, J CELL BIOL, V127, P623, DOI 10.1083/jcb.127.3.623; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Davey M, 2000, MOL GEN GENET, V263, P520, DOI 10.1007/s004380051197; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Duina AA, 1996, YEAST, V12, P943, DOI 10.1002/(SICI)1097-0061(199608)12:10<943::AID-YEA997>3.0.CO;2-3; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; HEITMAN J, 1992, NEW BIOL, V4, P448; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; JIN YJ, 1993, P NATL ACAD SCI USA, V90, P7769, DOI 10.1073/pnas.90.16.7769; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; JUSTICE RM, 1990, BIOCHEM BIOPH RES CO, V171, P445, DOI 10.1016/0006-291X(90)91413-M; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kuzuhara T, 2004, NAT STRUCT MOL BIOL, V11, P275, DOI 10.1038/nsmb733; Landry J, 2003, MOL CELL BIOL, V23, P5972, DOI 10.1128/MCB.23.17.5972-5978.2003; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANNINGKRIEG UC, 1994, FEBS LETT, V352, P98, DOI 10.1016/0014-5793(94)00927-9; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RAMACHANDRAN GN, 1976, J MOL BIOL, V107, P85, DOI 10.1016/S0022-2836(76)80019-8; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; SCHMID FX, 1995, CURR BIOL, V5, P993, DOI 10.1016/S0960-9822(95)00197-7; SHAN XY, 1994, J CELL BIOL, V126, P853, DOI 10.1083/jcb.126.4.853; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Weiss MS, 1998, NAT STRUCT BIOL, V5, P676, DOI 10.1038/1368; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(05)00083-3; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	51	227	233	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					905	916		10.1016/j.cell.2006.07.026	http://dx.doi.org/10.1016/j.cell.2006.07.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959570	Bronze			2022-12-01	WOS:000240675000018
J	Gilboa, L; Lehmann, R				Gilboa, Lilach; Lehmann, Ruth			Soma-germline interactions coordinate homeostasis and growth in the Drosophila gonad	NATURE			English	Article							STEM-CELLS; SUPPORT CELLS; OVARY; DIFFERENTIATION; MORPHOGENESIS; OOGENESIS; SURVIVAL; LINEAGE; NUMBER	The ability of organs such as the liver or the lymphoid system to maintain their original size or regain it after injury is well documented(1,2). However, little is known about how these organs sense that equilibrium is breached, and how they cease changing when homeostasis is reached. Similarly, it remains unclear how, during normal development, different cell types within an organ coordinate their growth. Here we show that during gonad development in the fruitfly Drosophila melanogaster the proliferation of primordial germ cells (PGCs) and survival of the somatic intermingled cells (ICs) that contact them are coordinated by means of a feedback mechanism composed of a positive signal and a negative signal. PGCs express the EGF receptor (EGFR) ligand Spitz, which is required for IC survival. In turn, ICs inhibit PGC proliferation. Thus, homeostasis and coordination of growth between soma and germ line in the larval ovary is achieved by using a sensor of PGC numbers (EGFR-mediated survival of ICs) coupled to a correction mechanism inhibiting PGC proliferation. This feedback loop ensures that sufficient numbers of PGCs exist to fill all the stem-cell niches that form at the end of larval development. We propose that similar feedback mechanisms might be generally used for coordinated growth, regeneration and homeostasis.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Lehmann, R (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu		Lehmann, Ruth/0000-0002-8454-5651				Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; GODT D, 1995, DEVELOPMENT, V121, P173; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; POIRIE M, 1995, DEVELOPMENT, V121, P1867; Robertson SE, 1999, DEV BIOL, V215, P288, DOI 10.1006/dbio.1999.9453; Rodrigues AB, 2005, DEVELOPMENT, V132, P4697, DOI 10.1242/dev.02058; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Schulz C, 2002, DEVELOPMENT, V129, P4523; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; Van Doren M, 1998, CURR BIOL, V8, P243; Yohn CB, 2003, GENETICS, V165, P1889; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	24	98	100	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					97	100		10.1038/nature05068	http://dx.doi.org/10.1038/nature05068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16936717				2022-12-01	WOS:000240313900047
J	Risgaard-Petersen, N; Langezaal, AM; Ingvardsen, S; Schmid, MC; Jetten, MSM; Op den Camp, HJM; Derksen, JWM; Pina-Ochoa, E; Eriksson, SP; Nielsen, LP; Revsbech, NP; Cedhagen, T; van der Zwaan, GJ				Risgaard-Petersen, Nils; Langezaal, Alexandra M.; Ingvardsen, Signe; Schmid, Markus C.; Jetten, Mike S. M.; Op den Camp, Huub J. M.; Derksen, Jan W. M.; Pina-Ochoa, Elisa; Eriksson, Susanne P.; Nielsen, Lars Peter; Revsbech, Niels Peter; Cedhagen, Tomas; van der Zwaan, Gijsbert J.			Evidence for complete denitrification in a benthic foraminifer	NATURE			English	Article							ANAEROBIC AMMONIUM OXIDATION; OXYGEN MINIMUM ZONE; SULFUR BACTERIA; N-2 PRODUCTION; NITRATE; ANAMMOX; THIOPLOCA; NITRITE	Benthic foraminifera are unicellular eukaryotes found abundantly in many types of marine sediments. Many species survive and possibly reproduce in anoxic habitats(1), but sustainable anaerobic metabolism has not been previously described. Here we demonstrate that the foraminifer Globobulimina pseudospinescens accumulates intracellular nitrate stores and that these can be respired to dinitrogen gas. The amounts of nitrate detected are estimated to be sufficient to support respiration for over a month. In a Swedish fjord sediment where G. pseudospinescens is the dominant foraminifer, the intracellular nitrate pool in this species accounted for 20% of the large, cell-bound, nitrate pool present in an oxygen-free zone. Similarly high nitrate concentrations were also detected in foraminifera Nonionella cf. stella and a Stainforthia species, the two dominant benthic taxa occurring within the oxygen minimum zone of the continental shelf off Chile. Given the high abundance of foraminifera in anoxic marine environments(1-3), these new findings suggest that foraminifera may play an important role in global nitrogen cycling and indicate that our understanding of the complexity of the marine nitrogen cycle is far from complete.	Natl Environm Res Inst, Dept Marine Ecol, DK-8600 Silkeborg, Denmark; Univ Utrecht, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; Aarhus Univ, Dept Biol Sci, DK-8000 Aarhus C, Denmark; Radboud Univ Nijmegen, IWWR, Dept Plant Cell Biol, NL-6525 ED Nijmegen, Netherlands; CSIC, Ctr Environm Sci, Dept Aquat Ecol, E-28006 Madrid, Spain; Univ Gothenburg, Kristineberg Marine Res Stn, Dept Marine Ecol, S-45034 Fiskebackskil, Sweden; Radboud Univ Nijmegen, IWWR, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands	Aarhus University; Utrecht University; Aarhus University; Radboud University Nijmegen; Consejo Superior de Investigaciones Cientificas (CSIC); University of Gothenburg; Radboud University Nijmegen	Risgaard-Petersen, N (corresponding author), Natl Environm Res Inst, Dept Marine Ecol, Vejlsovej 25, DK-8600 Silkeborg, Denmark.	nri@dmu.dk	Jetten, Mike/B-8834-2011; Nielsen, Lars Peter/AAL-6274-2021; Nielsen, Lars Peter/J-7401-2013; Camp, Huub J.M. Op den/F-5114-2011; Cedhagen, Tomas/J-6426-2013; Schmid, Markus C/D-2669-2012; Risgaard-Petersen, Nils/AAX-6747-2021; Risgaard-Petersen, Nils/J-2479-2013; Revsbech, Niels P/I-8040-2013	Jetten, Mike/0000-0002-4691-7039; Nielsen, Lars Peter/0000-0002-7269-4860; Nielsen, Lars Peter/0000-0002-7269-4860; Camp, Huub J.M. Op den/0000-0003-1990-9030; Cedhagen, Tomas/0000-0003-4550-8177; Risgaard-Petersen, Nils/0000-0002-2767-2080; Risgaard-Petersen, Nils/0000-0002-2767-2080; Hogslund, Signe/0000-0001-5926-8464; Revsbech, Niels Peter/0000-0002-2193-262X				Alberts B., 2002, MOL BIOL CELL; BERNHARD JM, 1991, BIOGEOCHEMISTRY, V15, P127; Bernhard JM, 2000, MICROPALEONTOLOGY, V46, P38; Bernhard Joan M., 1996, Revue de Paleobiologie, V15, P261; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Chen F, 2003, APPL ENVIRON MICROB, V69, P6715, DOI 10.1128/AEM.69.11.6715-6722.2003; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Engstrom P, 2005, GEOCHIM COSMOCHIM AC, V69, P2057, DOI 10.1016/j.gca.2004.09.032; FINLAY BJ, 1983, NATURE, V303, P333, DOI 10.1038/303333a0; Fontanier C, 2003, DEEP-SEA RES PT I, V50, P457, DOI 10.1016/S0967-0637(02)00167-X; Geslin E, 2004, MAR MICROPALEONTOL, V53, P227, DOI 10.1016/j.marmicro.2004.05.010; Gooday AJ, 2000, DEEP-SEA RES PT II, V47, P25, DOI 10.1016/S0967-0645(99)00099-5; Huettel M, 1996, APPL ENVIRON MICROB, V62, P1863, DOI 10.1128/AEM.62.6.1863-1872.1996; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Larsen LH, 1997, ANAL CHEM, V69, P3527, DOI 10.1021/ac9700890; Levin L, 2002, PROG OCEANOGR, V53, P1, DOI 10.1016/S0079-6611(02)00022-8; Meyer RL, 2001, AQUAT MICROB ECOL, V26, P181, DOI 10.3354/ame026181; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Risgaard-Petersen N., 1995, METHODS APPL SOIL MI, P287; RISGAARDPETERSEN N, 1993, J MICROBIOL METH, V17, P155, DOI 10.1016/0167-7012(93)90009-7; Sayama M, 2001, APPL ENVIRON MICROB, V67, P3481, DOI 10.1128/AEM.67.8.3481-3487.2001; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Vester F, 1998, APPL ENVIRON MICROB, V64, P1700; Zopfi J, 2001, APPL ENVIRON MICROB, V67, P5530, DOI 10.1128/AEM.67.12.5530-5537.2001	26	305	324	4	167	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					93	96		10.1038/nature05070	http://dx.doi.org/10.1038/nature05070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957731				2022-12-01	WOS:000240313900046
J	Yamamoto-Kawai, M; Carmack, E; McLaughlin, F				Yamamoto-Kawai, Michiyo; Carmack, Eddy; McLaughlin, Fiona			Nitrogen balance and Arctic throughflow	NATURE			English	Article							WORLDS OCEANS; DENITRIFICATION; WATER; SEDIMENTS; FIXATION; SHELF		Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada	Fisheries & Oceans Canada	Yamamoto-Kawai, M (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada.	kawaim@pac.dfo-mpo.gc.ca	Yamamoto-Kawai, Michiyo/F-7611-2013	Yamamoto-Kawai, Michiyo/0000-0002-1035-2179				Devol AH, 1997, CONT SHELF RES, V17, P1029, DOI 10.1016/S0278-4343(97)00003-4; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Jones EP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001141; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Loeng Harald, 2005, P453; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Tanaka T, 2004, CONT SHELF RES, V24, P1271, DOI 10.1016/j.csr.2004.04.004; Taylor JR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001635; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Woodgate RA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021747	12	99	101	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					43	43		10.1038/443043a	http://dx.doi.org/10.1038/443043a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957723				2022-12-01	WOS:000240313900032
J	Nicastro, D; Schwartz, C; Pierson, J; Gaudette, R; Porter, ME; McIntosh, JR				Nicastro, Daniela; Schwartz, Cindi; Pierson, Jason; Gaudette, Richard; Porter, Mary E.; McIntosh, J. Richard			The molecular architecture of axonemes revealed by cryoelectron tomography	SCIENCE			English	Article							DYNEIN-REGULATORY-COMPLEX; RADIAL SPOKES; ARM DYNEIN; CHLAMYDOMONAS-FLAGELLA; ELECTRON TOMOGRAPHY; MUTANTS LACKING; SPERM FLAGELLUM; HEAVY-CHAIN; MOTOR; COMPONENTS	Eukaryotic flagella and cilia are built on a 9 + 2 array of microtubules plus 9250 accessory proteins, forming a biological machine called the axoneme. Here we describe the three-dimensional structure of rapidly frozen axonemes from Chlamydomonas and sea urchin sperm, using cryoelectron tomography and image processing to focus on the motor enzyme dynein. Our images suggest a model for the way dynein generates force to slide microtubules. They also reveal two dynein linkers that may provide "hard-wiring'' to coordinate motor enzyme action, both circumferentially and along the axoneme. Periodic densities were also observed inside doublet microtubules; these may contribute to doublet stability.	Univ Colorado, Dept Mol Cellular & Dev Biol, Lab 3D Electron Microscopy Cells, Boulder, CO 80309 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities	Nicastro, D (corresponding author), Brandeis Univ, 415 South St, Waltham, MA 02454 USA.	nicastro@colorado.edu	McIntosh, Richard/GLN-3533-2022	McIntosh, Richard/0000-0002-7165-9748; Nicastro, Daniela/0000-0002-0122-7173	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055667] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 000592] Funding Source: Medline; NIGMS NIH HHS [R37 GM055667, 2R37-GM55667] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFZELIUS BA, 1995, TISSUE CELL, V27, P241, DOI 10.1016/S0040-8166(95)80044-1; Burgess SA, 2004, CURR OPIN STRUC BIOL, V14, P138, DOI 10.1016/j.sbi.2004.03.013; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; BURGESS SA, 1991, J CELL SCI, V98, P17; DiBella LM, 2004, MOL BIOL CELL, V15, P4633, DOI 10.1091/mbc.E04-06-0461; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; GIBBONS IR, 1981, J CELL BIOL, V91, pS107, DOI 10.1083/jcb.91.3.107s; GOODENOUGH UW, 1989, CELL MOVEMENT, V1; Kamiya R, 2002, INT REV CYTOL, V219, P115; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; Lindemann CB, 2005, BIOPHYS J, V89, P1165, DOI 10.1529/biophysj.105.060681; Lupetti P, 2005, CELL MOTIL CYTOSKEL, V62, P69, DOI 10.1002/cm.20084; Luther P.K., 1992, ELECT TOMOGRAPHY 3 D, P39; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Myster SH, 1997, MOL BIOL CELL, V8, P607, DOI 10.1091/mbc.8.4.607; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; NOJIMA D, 1995, CURR BIOL, V5, P158, DOI 10.1016/S0960-9822(95)00037-6; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; SAKAKIBARA H, 1993, J CELL BIOL, V122, P653, DOI 10.1083/jcb.122.3.653; Sakato M, 2004, J STRUCT BIOL, V146, P58, DOI 10.1016/j.jsb.2003.09.026; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; WITMAN GB, 1982, SYM SOC EXP BIOL, P203; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Woolley DM, 1997, J CELL SCI, V110, P85; Yanagisawa H, 2004, MOL BIOL CELL, V15, P2105, DOI 10.1091/mbc.E03-11-0854	32	589	593	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2006	313	5789					944	948		10.1126/science.1128618	http://dx.doi.org/10.1126/science.1128618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917055				2022-12-01	WOS:000239817000036
J	Stringer, JSA; Zulu, I; Levy, J; Stringer, EM; Mwango, A; Chi, BH; Mtonga, V; Reid, S; Cantrell, RA; Bulterys, M; Saag, MS; Marlink, RG; Mwinga, A; Ellerbrock, TV; Sinkala, M				Stringer, Jeffrey S. A.; Zulu, Isaac; Levy, Jens; Stringer, Elizabeth M.; Mwango, Albert; Chi, Benjamin H.; Mtonga, Vilepe; Reid, Stewart; Cantrell, Ronald A.; Bulterys, Marc; Saag, Michael S.; Marlink, Richard G.; Mwinga, Alwyn; Ellerbrock, Tedd V.; Sinkala, Moses			Rapid scale-up of Antiretroviral therapy at primary care sites in Zambia - Feasibility and early outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNOLOGICAL RESPONSE; TUBERCULOSIS PATIENTS; RURAL DISTRICT; SURVIVAL; AFRICA; COHORT; INFECTION; MALAWI; HIV; PROGRESSION	Context The Zambian Ministry of Health has scaled-up human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) care and treatment services at primary care clinics in Lusaka, using predominately nonphysician clinicians. Objective To report on the feasibility and early outcomes of the program. Design, Setting, and Patients Open cohort evaluation of antiretroviral-naive adults treated at 18 primary care facilities between April 26, 2004, and November 5, 2005. Data were entered in real time into an electronic patient tracking system. Intervention Those meeting criteria for antiretroviral therapy ( ART) received drugs according to Zambian national guidelines. Main Outcome Measures Survival, regimen failure rates, and CD4 cell response. Results We enrolled 21 755 adults into HIV care, and 16 198 (75%) started ART. Among those starting ART, 9864 (61%) were women. Of 15 866 patients with documented World Health Organization ( WHO) staging, 11 573 (73%) were stage III or IV, and the mean (SD) entry CD4 cell count among the 15 336 patients with a baseline result was 143/mu L (123/mu L). Of 1142 patients receiving ART who died, 1120 had a reliable date of death. Of these patients, 792 (71%) died within 90 days of starting therapy ( early mortality rate: 26 per 100 patient-years), and 328 (29%) died after 90 days (post-90-day mortality rate: 5.0 per 100 patient-years). In multivariable analysis, mortality was strongly associated with CD4 cell count between 50/mu L and 199/mu L ( adjusted hazard ratio [AHR], 1.4; 95% confidence interval [CI], 1.0-2.0), CD4 cell count less than 50/mu L ( AHR, 2.2; 95% CI, 1.5-3.1), WHO stage III disease ( AHR, 1.8; 95% CI, 1.3-2.4), WHO stage IV disease ( AHR, 2.9; 95% CI, 2.0-4.3), low body mass index ( <16; AHR, 2.4; 95% CI, 1.8-3.2), severe anemia (<8.0 g/ dL; AHR, 3.1; 95% CI, 2.3-4.0), and poor adherence to therapy ( AHR, 2.9; 95% CI, 2.2-3.9). Of 11 714 patients at risk, 861 failed therapy by clinical criteria ( rate, 13 per 100 patient-years). The mean ( SD) CD4 cell count increase was 175/mu L (174/mu L) in 1361 of 1519 patients (90%) receiving treatment long enough to have a 12-month repeat. Conclusion Massive scale-up of HIV and AIDS treatment services with good clinical outcomes is feasible in primary care settings in sub-Saharan Africa. Most mortality occurs early, suggesting that earlier diagnosis and treatment may improve outcomes.	Ctr Infect Dis Res Zambia, Lusaka, Zambia; Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; Univ Teaching Hosp, Lusaka, Zambia; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; Zambian Minist Hlth, Lusaka, Zambia; US Ctr Dis Control & Prevent, Global AIDS Program, Lusaka, Zambia; Elizabeth Glaser Pediat AIDS Fdn, Santa Monica, CA USA; US Ctr Dis Control & Prevent, Global AIDS Program, Atlanta, GA USA; Lusaka Urban Dist Hlth Management Board, Lusaka, Zambia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Stringer, JSA (corresponding author), Ctr Infect Dis Res Zambia, Plot 1275 Lubutu Rd,POB 34681, Lusaka, Zambia.	stringer@uab.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Reid, Stewart/0000-0001-7779-4820; Stringer, Jeffrey/0000-0002-9590-7216	FIC NIH HHS [K01-TW05708, K01-TW06670] Funding Source: Medline; NIAID NIH HHS [K23-AI01411, P30-AI027767] Funding Source: Medline; PHS HHS [U62/CCU12354] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [K01TW006670, K01TW005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, K08AI001411] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allison P.D., 2010, SURVIVAL ANAL USING; Anabwani G, 2005, NUTRITION, V21, P96, DOI 10.1016/j.nut.2004.09.013; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chi BH, 2005, JAIDS-J ACQ IMM DEF, V40, P381, DOI 10.1097/01.qai.0000159515.39982.c0; *CLINT HIV AIDS IN, CHANG EC CAR TREATM; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cozzi-Lepri A, 2002, J INFECT DIS, V185, P1062, DOI 10.1086/339821; De Cock KM, 2003, LANCET, V362, P1847, DOI 10.1016/S0140-6736(03)14906-9; DeSimone JA, 2000, ANN INTERN MED, V133, P447, DOI 10.7326/0003-4819-133-6-200009190-00013; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; FUSCO H, 2005, 3 IAS C HIV PATH TRE; *GLOB FUND, FIGHT AIDS TUB MAL Z; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Harries AD, 2004, BMJ-BRIT MED J, V329, P1163, DOI 10.1136/bmj.329.7475.1163; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; Kitchen CM, 2001, CLIN INFECT DIS, V33, P466, DOI 10.1086/321900; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Langford K, 2003, Lab Hematol, V9, P29; Leroy V, 1997, AM J EPIDEMIOL, V145, P293; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Mayo J, 2002, ARCH INTERN MED, V162, P1095, DOI 10.1001/archinte.162.10.1095; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V22, P369; MQHAYI M, 2006, 13 C RETR OPP INF FE; PERNEGER TV, 1995, BMJ-BRIT MED J, V311, P1468, DOI 10.1136/bmj.311.7018.1468; SINKALA M, 2006, 13 C RETR OPP INF FE; STONEBURNER R, 1992, ARCH INTERN MED, V152, P2033, DOI 10.1001/archinte.152.10.2033; STRINGER JSA, 2005, 12 C RETR OPP INF FE; UNAIDS, 2004, 4 UNAIDS; *UNAIDS, LIV POS HIV AIDS; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WORLD BANK, REG FACT SHEET WORLD; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238; Zambian National AIDS Council, 2004, NAT GUID MAN CAR PAT; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	534	548	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2006	296	7					782	793		10.1001/jama.296.7.782	http://dx.doi.org/10.1001/jama.296.7.782			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073SR	16905784	Bronze			2022-12-01	WOS:000239763400019
J	Ngondi, J; Onsarigo, A; Matthews, F; Reacher, M; Brayne, C; Baba, S; Solomon, AW; Zingeser, J; Emerson, PM				Ngondi, Jeremiah; Onsarigo, Alice; Matthews, Fiona; Reacher, Mark; Brayne, Carol; Baba, Samson; Solomon, Anthony W.; Zingeser, James; Emerson, Paul M.			Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study	LANCET			English	Article							BLINDING TRACHOMA; PROGRAM; TESTS	Background A trachoma control programme was started in southern Sudan in 2001. We did a 3-year evaluation to quantify uptake of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) interventions, and to assess the prevalence of active trachoma and unclean faces. Methods Cross-sectional surveys, including clinical assessment of trachoma (WHO simplified system) and structured questionnaires, were done in four intervention areas at baseline and follow-up. Process indicators were uptake of SAFE components; primary outcome indicators included trachomatous inflammation-follicular (TF) and unclean face in children aged 1-9 years. Findings There was heterogeneous uptake of SAFE between intervention areas. Surgical coverage was low in all areas (range 0.5% of 428 individuals in Katigiri to 6% of 5002 in Kiech Kuon), antibiotic uptake ranged from 14% of 1257 individuals in Kiech Kuon to 75% of 954 in Katigiri, health education ranged from 49% of 190 households in Kiech Kuon to 90% of 182 in Padak, and latrine coverage from 3% of households in Tali to 16% in Katigiri. Substantial decreases in prevalence of TF and unclean faces were recorded in Katigiri and Tali, two of three sites where uptake of antibiotics and health education was high: TF decreased by 92% (95% Cl 87-96) and 91% (86-95), respectively, and unclean face decreased by 87% (78-94) and 38% (22-52), respectively. Moderate effects were recorded in Padak, an area with high coverage, with a 28% (14-41) decrease in TF and a 16% (7-25) decrease in unclean face. No evidence of decline was seen in Kiech Kuon, where uptake of antibiotics and health education was low, with a 2% (-10 to 12) decrease in TF and a 10% (-3 to 23) decrease in unclean face. Interpretation Our results show that substantial falls in active trachoma can occur where SAFE is implemented, and that good results could be achieved with the SAFE strategy in other trachoma-endemic areas.	Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Carter Ctr, Nairobi, Kenya; Govt S Sudan, Minist Hlth, Juba, Sudan; London Sch Hyg & Trop Med, London WC1, England; Emory Univ, Carter Ctr, Atlanta, GA 30322 USA	University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Emory University	Ngondi, J (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Robinson Way, Cambridge CB2 2SR, England.	jn250@cam.ac.uk	Brayne, Carol/AAA-4285-2020; Reacher, Mark/Y-6979-2018; Matthews, Fiona/O-6932-2015	Brayne, Carol/0000-0001-5307-663X; Reacher, Mark/0000-0001-6871-7903; Matthews, Fiona/0000-0002-1728-2388; Emerson, Paul/0000-0002-6478-8816; Solomon, Anthony/0000-0001-7101-6649; Ngondi, Jeremiah/0000-0003-4357-4816	Medical Research Council [MC_U105292687] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2004, 8 M WHO ALL GLOB EL; Armitage P, 2002, STAT METHODS MED RES, P648; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dawson CR, 1997, CLIN INFECT DIS, V24, P363, DOI 10.1093/clinids/24.3.363; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Ewald DP, 2003, MED J AUSTRALIA, V178, P65, DOI 10.5694/j.1326-5377.2003.tb05065.x; Francis V., 1995, ACHIEVING COMMUNITY; *INT TRACH IN, 2002, ZITHR CONTR TRACH PR; Kumaresan JA, 2003, AM J TROP MED HYG, V69, P24, DOI 10.4269/ajtmh.2003.69.24; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Mariotti S. P., 2001, WHOPBDGET007REV1; Mariotti SP, 2004, NEW ENGL J MED, V351, P2004, DOI 10.1056/NEJMe048205; Munoz B, 1997, EPIDEMIOL REV, V19, P205, DOI 10.1093/oxfordjournals.epirev.a017953; Ngondi J, 2005, B WORLD HEALTH ORGAN, V83, P904; REACHER M, 1998, WHOPBL9329; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Solomon AW, 2004, CLIN MICROBIOL REV, V17, P982, DOI 10.1128/CMR.17.4.982-1011.2004; *STARBASE, WHO POL CAMP NIDS 20; *STAT CORP, 2003, STAT 8 US GUID, P270; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; West SK, 2005, LANCET, V366, P1296, DOI 10.1016/S0140-6736(05)67529-0; *WHO, 1997, WHOPBL9656; Woodard S.H., 2001, DESCRIPTION COMP MET; World Health Organization, 1997, WHOPBL9760; *WORLD HLTH ASS, 1998, 51 WORLD HLTH ASS; Wright HR, 2005, LANCET INFECT DIS, V5, P313, DOI 10.1016/S1473-3099(05)70116-X; [No title captured]	29	44	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2006	368	9535					589	595		10.1016/S0140-6736(06)69202-7	http://dx.doi.org/10.1016/S0140-6736(06)69202-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074OF	16905023				2022-12-01	WOS:000239821000032
J	Taylor, R				Taylor, Rosie			Revenge of the hymenoptera	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Taylor, R (corresponding author), The Lancet, London NW1 7BY, England.							Goetz J., 2003, P 12 IEEE INT WORKSH; POPPLE S, 1999, ACTA HORTIC, V495, P491; *UK PARL HOUS COMM, 2006, HANS UK PARL HOUS CO	3	0	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					272	272		10.1016/S0140-6736(06)69055-7	http://dx.doi.org/10.1016/S0140-6736(06)69055-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860684				2022-12-01	WOS:000239314400009
J	Cipolat, S; Rudka, T; Hartmann, D; Costa, V; Serneels, L; Craessaerts, K; Metzger, K; Frezza, C; Annaert, W; D'Adamio, L; Derks, C; Dejaegere, T; Pellegrini, L; D'Hooge, R; Scorrano, L; De Strooper, B				Cipolat, Sara; Rudka, Tomasz; Hartmann, Dieter; Costa, Veronica; Serneels, Lutgarde; Craessaerts, Katleen; Metzger, Kristine; Frezza, Christian; Annaert, Wim; D'Adamio, Luciano; Derks, Carmen; Dejaegere, Tim; Pellegrini, Luca; D'Hooge, Rudi; Scorrano, Luca; De Strooper, Bart			Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling	CELL			English	Article							DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; INTRAMEMBRANE PROTEOLYSIS; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; OPA1; MEMBRANE; MECHANISM; FISSION; FUSION	Rhomboids, evolutionarily conserved integral membrane proteases, participate in crucial signaling pathways. Presenilin-associated rhomboid-like (PARL) is an inner mitochondrial membrane rhomboid of unknown function, whose yeast ortholog is involved in mitochondrial fusion. Parl(-/-) mice display normal intrauterine development but from the fourth postnatal week undergo progressive multisystemic atrophy leading to cachectic death. Atrophy is sustained by increased apoptosis, both in and ex vivo. Parl(-/-) cells display normal mitochondrial morphology and function but are no longer protected against intrinsic apoptotic death stimuli by the dynamin-related mitochondrial protein OPA1. Parl(-/-) mitochondria display reduced levels of a soluble, intermembrane space (IMS) form of OPA1, and OPA1 specifically targeted to IMS complements Parl(-/-) cells, substantiating the importance of PARL in OPA1 processing. Parl(-/-) mitochondria. undergo faster apoptotic cristae remodeling and cytochrome c release. These findings implicate regulated intramembrane proteolysis in controlling apoptosis.	Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; Flanders Interuniv Inst Biotechnol, VIB4, Neuronal Cell Biol & Gene Transfer Lab, Louvain, Belgium; Flanders Interuniv Inst Biotechnol, VIB4, Membrane Trafficking Lab, Louvain, Belgium; Flanders Interuniv Inst Biotechnol, VIB4, Ctr Human Genet, Louvain, Belgium; Katholieke Univ Leuven, Lab Biol Psychol, Louvain, Belgium; Albert Einstein Coll Med, Bronx, NY 10461 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; KU Leuven; Yeshiva University; Albert Einstein College of Medicine	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.	luca.scorrano@unipd.it; bart.destrooper@med.kuleuven.be	Scorrano, Luca/A-6652-2008; De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019; Frezza, Christian/G-2174-2010; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; De Strooper, Bart/0000-0001-5455-5819; Frezza, Christian/0000-0002-3293-7397; Scorrano, Luca/0000-0002-8515-8928; Pellegrini, Luca/0000-0002-4235-7708; D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	Telethon [TCP02016] Funding Source: Medline	Telethon(Fondazione Telethon)		Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; JACOBS EE, 1960, J BIOL CHEM, V235, P531; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pellegrini L, 2001, J ALZHEIMERS DIS, V3, P181; PEROTTI ME, 1983, J HISTOCHEM CYTOCHEM, V31, P351, DOI 10.1177/31.3.6186730; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Sik A, 2004, J BIOL CHEM, V279, P15323, DOI 10.1074/jbc.M313756200; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	45	560	577	2	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					163	175		10.1016/j.cell.2006.06.021	http://dx.doi.org/10.1016/j.cell.2006.06.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839884	Bronze			2022-12-01	WOS:000239224800024
J	Raab-Graham, KF; Haddick, PCG; Jan, YN; Jan, LY				Raab-Graham, Kimberly F.; Haddick, Patrick C. G.; Jan, Yuh Nung; Jan, Lily Yeh			Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites	SCIENCE			English	Article							LONG-TERM POTENTIATION; SIGNALING PATHWAY; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; EXPRESSION; ACTIVATION; MECHANISMS; DISTINCT; CONTRIBUTES; PLASTICITY	Mammalian target of rapamycin ( mTOR) is implicated in synaptic plasticity and local translation in dendrites. We found that the mTOR inhibitor, rapamycin, increased the Kv1.1 voltage-gated potassium channel protein in hippocampal neurons and promoted Kv1.1 surface expression on dendrites without altering its axonal expression. Moreover, endogenous Kv1.1 mRNA was detected in dendrites. Using Kv1.1 fused to the photoconvertible fluorescence protein Kaede as a reporter for local synthesis, we observed Kv1.1 synthesis in dendrites upon inhibition of mTOR or the N-methyl-D-aspartate (NMDA) glutamate receptor. Thus, synaptic excitation may cause local suppression of dendritic Kv1 channels by reducing their local synthesis.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; Raab-Graham, Kimberly/0000-0001-6502-057X	NIMH NIH HHS [MH13010, MH65334] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334, R01MH065334] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Chen XX, 2006, PFLUG ARCH EUR J PHY, V453, P397, DOI 10.1007/s00424-006-0097-y; Frick A, 2005, J NEUROBIOL, V64, P100, DOI 10.1002/neu.20148; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; JAKOI ER, 1995, BRAIN RES, V693, P124, DOI 10.1016/0006-8993(95)00599-L; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328	28	207	213	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					144	148		10.1126/science.1131693	http://dx.doi.org/10.1126/science.1131693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023663				2022-12-01	WOS:000241031200056
J	Rokas, A				Rokas, Antonis			Genomics and the Tree of Life	SCIENCE			English	Editorial Material									MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Rokas, A (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	arokas@mit.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551				Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cracraft J., 2004, ASSEMBLING TREE LIFE; Doolittle WF, 2003, PHILOS T R SOC B, V358, P39, DOI 10.1098/rstb.2002.1185; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Larget B, 2005, MOL PHYLOGENET EVOL, V36, P214, DOI 10.1016/j.ympev.2005.03.026; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; ROSHAN UW, 2004, P 2004 IEEE COMP SYS; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7	12	15	15	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1897	+		10.1126/science.1134490	http://dx.doi.org/10.1126/science.1134490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008515				2022-12-01	WOS:000240832200033
J	Selmer, M; Dunham, CM; Murphy, FV; Weixlbaumer, A; Petry, S; Kelley, AC; Weir, JR; Ramakrishnan, V				Selmer, Maria; Dunham, Christine M.; Murphy, Frank V.; Weixlbaumer, Albert; Petry, Sabine; Kelley, Ann C.; Weir, John R.; Ramakrishnan, V.			Structure of the 70S ribosome complexed with mRNA and tRNA	SCIENCE			English	Article							PEPTIDE-BOND FORMATION; PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI RIBOSOME; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; P-SITE; BACTERIAL RIBOSOME; ATOMIC-STRUCTURE; 50S SUBUNITS; PROTEIN L27	The crystal structure of the bacterial 70S ribosome refined to 2.8 angstrom resolution reveals atomic details of its interactions with messenger RNA ( mRNA) and transfer RNA ( tRNA). A metal ion stabilizes a kink in the mRNA that demarcates the boundary between A and P sites, which is potentially important to prevent slippage of mRNA. Metal ions also stabilize the intersubunit interface. The interactions of E-site tRNA with the 50S subunit have both similarities and differences compared to those in the archaeal ribosome. The structure also rationalizes much biochemical and genetic data on translation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Weixlbaumer, Albert/AAI-8474-2021; Weixlbaumer, Albert/P-3587-2016; Weir, John R./AAF-5435-2020	Weixlbaumer, Albert/0000-0001-9635-3844; Weixlbaumer, Albert/0000-0001-9635-3844; Weir, John R./0000-0002-6904-0284; Selmer, Maria/0000-0001-9079-2774; Ramakrishnan, V/0000-0002-4699-2194	Medical Research Council [MC_U105184332] Funding Source: Medline; NIGMS NIH HHS [GM67624] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067624] Funding Source: NIH RePORTER; MRC [MC_U105184332] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdi NM, 2005, RNA, V11, P1624, DOI 10.1261/rna.2118105; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CHAO FC, 1957, ARCH BIOCHEM BIOPHYS, V70, P426, DOI 10.1016/0003-9861(57)90130-3; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Eistetter AJ, 1999, FEMS MICROBIOL LETT, V180, P345, DOI 10.1016/S0378-1097(99)00505-4; Erlacher MD, 2005, NUCLEIC ACIDS RES, V33, P1618, DOI 10.1093/nar/gki308; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; Ghosh S, 2005, RNA, V11, P657, DOI 10.1261/rna.7224305; Hard T, 2000, J MOL BIOL, V296, P169, DOI 10.1006/jmbi.1999.3433; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; KENNY JW, 1979, J MOL BIOL, V127, P243, DOI 10.1016/0022-2836(79)90328-0; Kirillov SV, 2002, FEBS LETT, V514, P60, DOI 10.1016/S0014-5793(02)02302-5; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Maguire BA, 2005, MOL CELL, V20, P427, DOI 10.1016/j.molcel.2005.09.009; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OSSWALD M, 1990, NUCLEIC ACIDS RES, V18, P6755; Rajbhandary Uttam L., 1995, P511; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wang HF, 2004, PROTEIN SCI, V13, P2806, DOI 10.1110/ps.04864904; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; YUSUPOVA GZ, 2002, SCIENCE         0329, V292, P883, DOI DOI 10.1126/SCIENCE.1060089	45	1016	1051	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1935	1942		10.1126/science.1131127	http://dx.doi.org/10.1126/science.1131127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	16959973				2022-12-01	WOS:000240832200044
J	Marsden, PA				Marsden, Philip A.			RNA interference as potential therapy - Not so fast.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Marsden, PA (corresponding author), St Michaels Hosp, Div Nephrol, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Marsden, Philip A/B-1441-2012					Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806	4	22	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					953	954		10.1056/NEJMcibr063864	http://dx.doi.org/10.1056/NEJMcibr063864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943409				2022-12-01	WOS:000240113100015
J	Savukov, IM; Lee, SK; Romalis, MV				Savukov, I. M.; Lee, S. -K.; Romalis, M. V.			Optical detection of liquid-state NMR	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CIRCULARLY-POLARIZED LIGHT; SPECTROSCOPY; SPECTRA; GASES; HG-199; VAPORS; VACUUM; XE-129; PHASE	Nuclear magnetic resonance (NMR) in liquids and solids is primarily detected by recording the net dipolar magnetic field outside the spin-polarized sample. But the recorded bulk magnetic field itself provides only limited spatial or structural information about the sample. Most NMR applications rely therefore on more elaborate techniques such as magnetic field gradient encoding(1) or spin correlation spectroscopy(2), which enable spatially resolved imaging and molecular structure analysis, respectively. Here we demonstrate a fundamentally different and intrinsically information-richer modality of detecting NMR, based on the rotation of the polarization of a laser beam by the nuclear spins in a liquid sample. Optical NMR detection has in fact a long history in atomic vapours with narrow resonance lines(3,4), but has so far only been applied to highly specialized condensed matter systems such as quantum dots(5). It has been predicted(6) that laser illumination can shift NMR frequencies and thus aid detection, but the effect is very small and has never been observed. In contrast, our measurements on water and liquid Xe-129 show that the complementary effect the rotation of light polarization by nuclear spins - is readily measurable, and that it is enhanced dramatically in samples containing heavy nuclei. This approach to optical NMR detection should allow correlated optical and NMR spectroscopy on complex molecules, and continuous two-dimensional imaging of nuclear magnetization with spatial resolution limited only by light diffraction.	Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University	Romalis, MV (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	romalis@princeton.edu	lee, seungkyun/A-3464-2008	lee, seungkyun/0000-0001-7625-3141				AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Barron L. D., 1982, MOL LIGHT SCATTERING; Buckingham A. D., 1967, ADV CHEM PHYS, V12, P107; Buckingham AD, 1997, MOL PHYS, V91, P805, DOI 10.1080/00268979709482771; BUCKINGHAM AD, 1994, SCIENCE, V264, P1748, DOI 10.1126/science.264.5166.1748; Cox FM, 2006, OPT EXPRESS, V14, P4135, DOI 10.1364/OE.14.004135; Driehuys B, 1996, APPL PHYS LETT, V69, P1668, DOI 10.1063/1.117022; EVANS MW, 1991, J PHYS CHEM-US, V95, P2256, DOI 10.1021/j100159a030; Fini JM, 2004, MEAS SCI TECHNOL, V15, P1120, DOI 10.1088/0957-0233/15/6/011; HAPPER W, 1967, PHYS REV, V163, P12, DOI 10.1103/PhysRev.163.12; HARRIS RA, 1994, J CHEM PHYS, V101, P9289, DOI 10.1063/1.467959; INGERSOLL LR, 1956, J OPT SOC AM, V46, P538, DOI 10.1364/JOSA.46.000538; Jaszunski M, 1999, MOL PHYS, V96, P855, DOI 10.1080/002689799165242; Kikkawa JM, 2000, SCIENCE, V287, P473, DOI 10.1126/science.287.5452.473; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Ledbetter MP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.287601; Li L, 1998, J PHYS CHEM A, V102, P10385, DOI 10.1021/jp982748y; LUCKOENIG E, 1972, J PHYS-PARIS, V33, P847, DOI 10.1051/jphys:019720033010084700; MANUEL J, 1963, CR HEBD ACAD SCI, V257, P413; MAYSTRE F, 1989, OPT LETT, V14, P587, DOI 10.1364/OL.14.000587; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; Romalis MV, 2001, PHYS REV LETT, V86, P2505, DOI 10.1103/PhysRevLett.86.2505; Romero RH, 2004, CHEM PHYS LETT, V400, P226, DOI 10.1016/j.cplett.2004.10.113; SCHAEFER SR, 1989, PHYS REV A, V39, P5613, DOI 10.1103/PhysRevA.39.5613; VANDERZIEL JP, 1965, PHYS REV LETT, V15, P190, DOI 10.1103/PhysRevLett.15.190; WARREN WS, 1992, SCIENCE, V255, P1683, DOI 10.1126/science.1553555; Warren WS, 1998, MOL PHYS, V93, P371, DOI 10.1080/002689798169041; Xu SC, 2002, REV SCI INSTRUM, V73, P255, DOI 10.1063/1.1430729; YOSHINO K, 1985, J OPT SOC AM B, V2, P1268, DOI 10.1364/JOSAB.2.001268; Zavattini E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.110406	30	74	75	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1021	1024		10.1038/nature05088	http://dx.doi.org/10.1038/nature05088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943834				2022-12-01	WOS:000240142000045
J	Dornan, D; Shimizu, H; Mah, A; Dudhela, T; Eby, M; O'Rourke, K; Seshagiri, S; Dixit, VM				Dornan, David; Shimizu, Harumi; Mah, Angie; Dudhela, Tanay; Eby, Michael; O'Rourke, Karen; Seshagiri, Somasekar; Dixit, Vishva M.			ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage	SCIENCE			English	Article							DEPENDENT PHOSPHORYLATION; NEGATIVE REGULATOR; P53 PROTEIN; MDM2	The ataxia telangiectasia mutated (ATM) protein kinase is a critical component of a DNA-damage response network configured to maintain genomic integrity. The abundance of an essential downstream effecter of this pathway, the tumor suppressor protein p53, is tightly regulated by controlled degradation through COP1 and other E3 ubiquitin ligases, such as MDM2 and Pirh2; however, the signal transduction pathway that regulates the COP1-p53 axis following DNA damage remains enigmatic. We observed that in response to DNA damage, ATM phosphorylated COP1 on Ser(387) and stimulated a rapid autodegradation mechanism. Ionizing radiation triggered an ATM-dependent movement of COP1 from the nucleus to the cytoplasm, and ATM-dependent phosphorylation of COP1 on Ser(387) was both necessary and sufficient to disrupt the COP1-p53 complex and subsequently to abrogate the ubiquitination and degradation of p53. Furthermore, phosphorylation of COP1 on Ser(387) was required to permit p53 to become stabilized and to exert its tumor suppressor properties in response to DNA damage.	Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Seshagiri, Somasekar/0000-0003-4272-6443				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; KASTAN MB, 1991, CANCER RES, V51, P6304; KASTAN MB, 1991, CANCER RES, V51, P4279; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94	17	114	119	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1122	1126		10.1126/science.1127335	http://dx.doi.org/10.1126/science.1127335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931761				2022-12-01	WOS:000239998200047
J	Jee, SH; Sull, JW; Park, J; Lee, S; Ohrr, H; Guallar, E; Samet, JM				Jee, Sun Ha; Sull, Jae Woong; Park, Jungyong; Lee, Sang-Yi; Ohrr, Heechoul; Guallar, Eliseo; Samet, Jonathan M.			Body-mass index and mortality in Korean men and women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PROGNOSTIC VALUE; WEIGHT; US; OVERWEIGHT; DEATHS; CANCER; RISK; METAANALYSIS; OBESITY	Background: Obesity is associated with diverse health risks, but the role of body weight as a risk factor for death remains controversial. Methods: We examined the association between body weight and the risk of death in a 12-year prospective cohort study of 1,213,829 Koreans between the ages of 30 and 95 years. We examined 82,372 deaths from any cause and 48,731 deaths from specific diseases (including 29,123 from cancer, 16,426 from atherosclerotic cardiovascular disease, and 3362 from respiratory disease) in relation to the body-mass index (BMI) (the weight in kilograms divided by the square of the height in meters). Results: In both sexes, the average baseline BMI was 23.2, and the rate of death from any cause had a J-shaped association with the BMI, regardless of cigarette-smoking history. The risk of death from any cause was lowest among patients with a BMI of 23.0 to 24.9. In all groups, the risk of death from respiratory causes was higher among subjects with a lower BMI, and the risk of death from atherosclerotic cardiovascular disease or cancer was higher among subjects with a higher BMI. The relative risk of death associated with BMI declined with increasing age. Conclusions: Underweight, overweight, and obese men and women had higher rates of death than men and women of normal weight. The association of BMI with death varied according to the cause of death and was modified by age, sex, and smoking history.	Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; Natl Hlth Insurance Corp, Seoul, South Korea; Jeju Natl Univ, Coll Med, Dept Hlth Policy & Management, Cheju, South Korea; Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Yonsei University; Yonsei University Health System; Jeju National University; Yonsei University; Yonsei University Health System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea.	jsunha@yumc.yonsei.ac.kr	Guallar, Eliseo/D-3807-2014	Guallar, Eliseo/0000-0002-4471-9565; Jee, Sun Ha/0000-0001-9519-3068	NATIONAL CANCER INSTITUTE [R03CA094771] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Allison DB, 1997, AM J EPIDEMIOL, V146, P672; [Anonymous], PREV CHILDH OB HLTH; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; COX DR, 1972, J R STAT SOC B, V34, P187; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Dorn JM, 1997, AM J EPIDEMIOL, V146, P919, DOI 10.1093/oxfordjournals.aje.a009218; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Gomez SL, 2003, CANCER CAUSE CONTROL, V14, P167, DOI 10.1023/A:1023046121214; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; *INT STAT CLASS DI, 1992, INT CLASS DIS REL HL; Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166; Jee SH, 2004, JNCI-J NATL CANCER I, V96, P1851, DOI 10.1093/jnci/djh334; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Prescott E, 2002, EUR RESPIR J, V20, P539, DOI 10.1183/09031936.02.00532002; Sacks LV, 1998, ARCH INTERN MED, V158, P1916, DOI 10.1001/archinte.158.17.1916; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stevens J, 2003, INT J OBESITY, V27, P1297, DOI 10.1038/sj.ijo.0802417; STEVENS J, 2003, PROGR OBESITY RES, P554; Thorogood M, 2003, J EPIDEMIOL COMMUN H, V57, P130, DOI 10.1136/jech.57.2.130; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; WHO, 2004, LANCET, V363, P902; Widlansky ME, 2004, ARCH INTERN MED, V164, P2326, DOI 10.1001/archinte.164.21.2326; WILSON DO, 1989, AM REV RESPIR DIS, V139, P1435, DOI 10.1164/ajrccm/139.6.1435; World Health Organization, 2000, AIR QUAL GUID EUR 2	38	620	632	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2006	355	8					779	787		10.1056/NEJMoa054017	http://dx.doi.org/10.1056/NEJMoa054017			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076KA	16926276	Bronze			2022-12-01	WOS:000239955200006
J	Sharp, D				Sharp, David			Ethics at Porton Down	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Allender S, 2006, OCCUP MED-OXFORD, V56, P329, DOI 10.1093/occmed/kql059; CARE A, 2005, PI FOCUS ASS PER JAN, P1; *CROWN PROS SERV, 2006, CPS DEC NO PROS RER; Evans R., 2000, GASSED BRIT CHEM WAR; *MIN DEF, 2006, NEWS ART MOD PUBL PO; *MIN DEF, 2006, HIST SURV PORT DOWN; Sharp D, 2006, LANCET, V367, P95, DOI 10.1016/S0140-6736(06)67942-7	7	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2006	368	9536					631	632		10.1016/S0140-6736(06)69227-1	http://dx.doi.org/10.1016/S0140-6736(06)69227-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074YT	16920454				2022-12-01	WOS:000239849200011
J	Crutsinger, GM; Collins, MD; Fordyce, JA; Gompert, Z; Nice, CC; Sanders, NJ				Crutsinger, Gregory M.; Collins, Michael D.; Fordyce, James A.; Gompert, Zachariah; Nice, Chris C.; Sanders, Nathan J.			Plant genotypic diversity predicts community structure and governs an ecosystem process	SCIENCE			English	Article							GENETIC DIVERSITY	Theory predicts, and recent empirical studies have shown, that the diversity of plant species determines the diversity of associated herbivores and mediates ecosystem processes, such as aboveground net primary productivity ( ANPP). However, an often-overlooked component of plant diversity, namely population genotypic diversity, may also have wide-ranging effects on community structure and ecosystem processes. We showed experimentally that increasing population genotypic diversity in a dominant old-field plant species, Solidago altissima, determined arthropod diversity and community structure and increased ANPP. The effects of genotypic diversity on arthropod diversity and ANPP were comparable to the effects of plant species diversity measured in other studies.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA	University of Tennessee System; University of Tennessee Knoxville; Texas State University System; Texas State University San Marcos	Crutsinger, GM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	gcrutsin@utk.edu	Sanders, Nathan/A-6945-2009; Sanders, Nathan/ABE-4335-2020	Sanders, Nathan/0000-0001-6220-6731; Fordyce, James/0000-0002-2731-0418; Gompert, Zachariah/0000-0003-2248-2488				BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Gotelli N. J., 1996, NULL MODELS ECOLOGY, P21; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell Stephen P., 2001, V32, pi; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; HUNTER MD, 1992, ECOLOGY, V73, P724; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P237; Loreau M, 2001, NATURE, V413, P548, DOI 10.1038/35097128; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; MacArthur R.H., 1972, pvii; Price P.W., 1983, P559; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; SCHEINER SM, 1993, DESIGN ANAL ECOLOGIC, P347; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	23	571	593	3	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2006	313	5789					966	968		10.1126/science.1128326	http://dx.doi.org/10.1126/science.1128326			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917062				2022-12-01	WOS:000239817000043
J	Teodoro, JG; Parker, AE; Zhu, XC; Green, MR				Teodoro, Jose G.; Parker, Albert E.; Zhu, Xiaochun; Green, Michael R.			p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase	SCIENCE			English	Article							P53; SUPPRESSION; EXPRESSION; GROWTH	Recent evidence suggests that antiangiogenic therapy is sensitive to p53 status in tumors, implicating a role for p53 in the regulation of angiogenesis. Here we show that p53 transcriptionally activates the alpha(II) collagen prolyl-4-hydroxylase [alpha(II) PH] gene, resulting in the extracellular release of antiangiogenic fragments of collagen type 4 and 18. Conditioned media from cells ectopically expressing either p53 or alpha(II) PH selectively inhibited growth of primary human endothelial cells. When expressed intracellularly or exogenously delivered, alpha(II) PH significantly inhibited tumor growth in mice. Our results reveal a genetic and biochemical linkage between the p53 tumor suppressor pathway and the synthesis of antiangiogenic collagen fragments.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Teodoro, Joe/AFT-2440-2022	Teodoro, Joe/0000-0002-3713-6839				Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FIDLER IJ, 1975, CANCER RES, V35, P218; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ravi R, 2000, GENE DEV, V14, P34; Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Zhang LL, 2000, CANCER RES, V60, P3655	14	143	148	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2006	313	5789					968	971		10.1126/science.1126391	http://dx.doi.org/10.1126/science.1126391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917063				2022-12-01	WOS:000239817000044
J	Liu, AY; Grant, RM; Buchbinder, SP				Liu, Albert Y.; Grant, Robert M.; Buchbinder, Susan P.			Preexposure prophylaxis for HIV - Unproven promise and potential pitfalls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMMUNODEFICIENCY VIRUS-INFECTION; PROTECT NEWBORN MACAQUES; HEPATITIS-B; TENOFOVIR; PREVENTION; TRIALS		San Francisco Dept Publ Hlth, AIDS Off, HIV Res Sect, San Francisco, CA 94102 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Liu, AY (corresponding author), San Francisco Dept Publ Hlth, AIDS Off, HIV Res Sect, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA.	albert.liu@sfdph.org		Grant, Robert/0000-0002-0851-7085	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI064002, R01AI062333] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI062333, UO1 AI064002] Funding Source: Medline; PHS HHS [200-2003-03007] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AIDS VACC CLEAR, PREP WATCH; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; COHEN J, 2006, NY TIMES MAGAZI 0122; COSTELLO D, 2005, LOS ANGELES TIM 1219, pF1; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; GARCIALERMA J, 2006, 13 C RETR OPP INF FE; GUEST J, 2006, 13 C RETR OPP INF FE; HEFFELFINGER J, 2006, 13 C RETR OPP INF FE; JOHNSON J, 2006, 13 C RETR OPP INF FE; KEEGAN A, 2006, SO VOICE        0407; Kindrick A., 2006, 13 C RETR OPP INF FE; Lim SG, 2006, ARCH INTERN MED, V166, P49, DOI 10.1001/archinte.166.1.49; MARCHIONE M, 2006, AIDS DRUGS SHOW PREV; Mondou E, 2005, CLIN INFECT DIS, V41, pE45, DOI 10.1086/432581; OSBORNE D, 2006, GAY CITY NEWS   0427; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Schechter M, 2002, 9 C RETR OPP INF FEB; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; U. S. Food and Drug Administration, VIR; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Van Rompay KKA, 1998, AIDS, V12, pF79, DOI 10.1097/00002030-199809000-00001; Van Rompay KKA, 2001, J INFECT DIS, V184, P429, DOI 10.1086/322781; *WHO JOINT UN PROG, 2006, 2006 REP GLOB AIDS E; Youle Mike, 2003, J Int Assoc Physicians AIDS Care (Chic), V2, P102, DOI 10.1177/154510970300200302; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	27	51	60	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2006	296	7					863	865		10.1001/jama.296.7.863	http://dx.doi.org/10.1001/jama.296.7.863			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073SR	16905792				2022-12-01	WOS:000239763400027
J	Kuranaga, E; Kanuka, H; Tonoki, A; Takemoto, K; Tomioka, T; Kobayashi, M; Hayashi, S; Miura, M				Kuranaga, Erina; Kanuka, Hirotaka; Tonoki, Ayako; Takemoto, Kiwamu; Tomioka, Takeyasu; Kobayashi, Masatomo; Hayashi, Shigeo; Miura, Masayuki			Drosophila IKK-related kinase regulates nonapoptotic function of caspases, via degradation of IAPs	CELL			English	Article							PROGRAMMED CELL-DEATH; DOUBLE-STRANDED-RNA; PROMOTES APOPTOSIS; WING DISC; DIAP1; PROLIFERATION; REAPER; ACTIVATION; PATHWAY; PROTEIN	Caspase activation has been extensively studied in the context of apoptosis. However, caspases also control other cellular functions, although the mechanisms regulating caspases in nonapoptotic contexts remain obscure. Drosophila IAP1 (DIAP1) is an endogenous caspase inhibitor that is crucial for regulating cell death during development. Here we describe Drosophila IKK-related kinase (DmIKK epsilon) as a regulator of caspase activation in a nonapoptotic context. We show that DmIKK epsilon promotes degradation of DIAP1 through direct phosphorylation. Knockdown of DmIKK epsilon in the proneural clusters of the wing imaginal disc, in which nonapoptotic caspase activity is required for proper sensory organ precursor (SOP) development, stabilizes endogenous DIAP1 and affects Drosophila SOP development. Our results demonstrate that DmIKK epsilon is a determinant of DIAP1 protein levels and that it establishes the threshold of activity required for the execution of nonapoptotic caspase functions.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, Tokyo 1130033, Japan; Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600808, Japan; Natl Inst Genet, Gene Network Lab, Mishima, Shizuoka 4118540, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Tokyo; Obihiro University of Agriculture & Veterinary Medicine; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN	Miura, M (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miura@mol.f.u-tokyo.ac.jp	Hayashi, Shigeo/N-5128-2015; Hayashi, Shigeo/J-9628-2019; Takemoto, Kiwamu/AAE-9926-2019; Kuranaga, Erina/AAE-4309-2019	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290; Kuranaga, Erina/0000-0001-6300-2087; Takemoto, Kiwamu/0000-0002-3301-3268				Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2004, NAT REV GENET, V5, P911, DOI 10.1038/nrg1491; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Igaki T, 2002, J BIOL CHEM, V277, P23103, DOI 10.1074/jbc.C200222200; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Ito K, 1997, DEVELOPMENT, V124, P761; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kanuka H, 2005, EMBO J, V24, P3793, DOI 10.1038/sj.emboj.7600822; Kanuka H, 2005, BBA-GEN SUBJECTS, V1726, P225, DOI 10.1016/j.bbagen.2005.06.020; Kanuka H, 1999, P NATL ACAD SCI USA, V96, P145, DOI 10.1073/pnas.96.1.145; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kozlova T, 1998, GENETICS, V149, P1465; Kuranaga E, 2002, NAT CELL BIOL, V4, P705, DOI 10.1038/ncb842; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; Reddy GV, 1999, DEVELOPMENT, V126, P2083; Rodriguez A, 2002, EMBO J, V21, P2189, DOI 10.1093/emboj/21.9.2189; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Sanna MG, 2002, J BIOL CHEM, V277, P30454, DOI 10.1074/jbc.M203312200; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yanagawa SI, 1997, J BIOL CHEM, V272, P25243, DOI 10.1074/jbc.272.40.25243; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	49	109	110	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 11	2006	126	3					583	596		10.1016/j.cell.2006.05.048	http://dx.doi.org/10.1016/j.cell.2006.05.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16887178	Bronze			2022-12-01	WOS:000239883400017
J	Van der Borght, S; de Wit, TFR; Janssens, V; van der Loeff, MFS; Rijckborst, H; Lange, JMA				Van der Borght, Stefaan; de Wit, Tobias F. Rinke; Janssens, Vincent; van der Loeff, Maarten F. Schim; Rijckborst, Henk; Lange, Joep M. A.			HAART for the HIV-infected employees of large companies in Africa	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; AIDS; MORTALITY; COSTS		Heineken Int Hlth Affairs, NL-1017 HL Amsterdam, Netherlands; PharmAccess Fdn, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Van der Borght, S (corresponding author), Heineken Int Hlth Affairs, Vijzelstr 72, NL-1017 HL Amsterdam, Netherlands.	S.vanderBorght@heineken.com	de Wit, Tobias TF Rinke/A-1224-2013					Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; BLOOM DE, 2006, BUISNESS HIV AIDS HL; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Dror DM., 2002, SOCIAL REINSURANCE N; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Kimball AM, 2005, LANCET, V365, P1213, DOI 10.1016/S0140-6736(05)74792-9; Lavalle C, 2000, ARCH MED RES, V31, P515, DOI 10.1016/S0188-4409(00)00097-7; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Marseille E, 2006, AIDS, V20, P907, DOI 10.1097/01.aids.0000218556.36661.47; Mocroft A, 2004, HIV MED, V5, P437, DOI 10.1111/j.1468-1293.2004.00250.x; Orrell Catherine, 2005, Curr HIV/AIDS Rep, V2, P171, DOI 10.1007/s11904-005-0012-8; Paul S, 2002, AIDS RES HUM RETROV, V18, P501, DOI 10.1089/088922202317406646; Piot P, 2004, SCIENCE, V304, P1909, DOI 10.1126/science.1101137; Stevens W, 2004, BMJ-BRIT MED J, V328, P280, DOI 10.1136/bmj.328.7434.280; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; Venter L, 2005, LANCET, V365, P1215, DOI 10.1016/S0140-6736(05)74793-0; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; *WORLD BANK, 1999, MILL DEV GOALS MDG; World Health Organization, 2003, SCAL ANT THER RES LT; 2001, BOSTON GLOBE    0607, pA8	22	16	16	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2006	368	9534					547	550		10.1016/S0140-6736(06)69165-4	http://dx.doi.org/10.1016/S0140-6736(06)69165-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890844				2022-12-01	WOS:000239569000040
J	Mair, GR; Braks, JAM; Garver, LS; Wiegant, LCAG; Hall, N; Dirks, RW; Khan, SM; Dimopoulos, G; Janse, CJ; Waters, AP				Mair, Gunnar R.; Braks, Joanna A. M.; Garver, Lindsey S.; Wiegant, Loop C. A. G.; Hall, Neil; Dirks, Roeland W.; Khan, Shahid M.; Dimopoulos, George; Janse, Chris J.; Waters, Andrew P.			Regulation of sexual development of Plasmodium by translational repression	SCIENCE			English	Article							CYTOPLASMIC PROCESSING BODIES; IN-SITU HYBRIDIZATION; DEAD BOX HELICASE; MESSENGER-RNA; MALARIA PARASITE; SURFACE PROTEIN; BERGHEI; EXPRESSION; OOKINETE; PBS21	Translational repression of messenger RNAs (mRNAs) plays an important role in sexual differentiation and gametogenesis in multicellular eukaryotes. Translational repression and mRNA turnover were shown to influence stage-specific gene expression in the protozoan Plasmodium. The DDX6-class RNA helicase, DOZI (development of zygote inhibited), is found in a complex with mRNA species in cytoplasmic bodies of female, blood-stage gametocytes. These translationally repressed complexes are normally stored for translation after fertilization Genetic disruption of pbdozi inhibits the formation of the ribonucleoprotein complexes, and instead, at least 370 transcripts are diverted to a degradation pathway.	Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands; Johns Hopkins Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 ZA Leiden, Netherlands; Inst Genom Res, Rockville, MD 20850 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; J. Craig Venter Institute	Waters, AP (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands.	waters@lumc.nl	Hall, Neil/A-8717-2013; Waters, Andy P/C-9377-2009	Hall, Neil/0000-0002-7995-3810; Waters, Andy P/0000-0001-8900-2982; Khan, Shahid/0000-0002-0533-4670; Dimopoulos, George/0000-0001-6755-8111; Janse, Chris J/0000-0002-6410-6205; Hall, Neil/0000-0003-2808-0009; Mair, Gunnar/0000-0002-5187-3691	NIAID NIH HHS [1R01AI061576-01A1] Funding Source: Medline; Wellcome Trust [066742] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; ALMOUZNI G, 1995, EMBO J, V14, P1752, DOI 10.1002/j.1460-2075.1995.tb07164.x; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CORDIN O, 2005, GENE; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Nakamura A, 2001, DEVELOPMENT, V128, P3233; PATON MG, 1993, MOL BIOCHEM PARASIT, V59, P263, DOI 10.1016/0166-6851(93)90224-L; Rodriguez MD, 2000, MOL BIOCHEM PARASIT, V110, P147, DOI 10.1016/S0166-6851(00)00265-6; Shaw MK, 1996, EUR J CELL BIOL, V71, P270; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; THOMPSON J, 1994, MOL BIOCHEM PARASIT, V68, P189, DOI 10.1016/0166-6851(94)90164-3; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; VANDIJK M, COMMUNICATION; VERVENNE RAW, 1994, MOL BIOCHEM PARASIT, V68, P259, DOI 10.1016/0166-6851(94)90170-8; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8	24	321	325	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2006	313	5787					667	669		10.1126/science.1125129	http://dx.doi.org/10.1126/science.1125129			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16888139	Green Accepted			2022-12-01	WOS:000239667500043
J	Kitsis, RN; Jialal, I				Kitsis, Richard N.; Jialal, Ishwarlal			Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COMPLEMENT		Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Cardiovasc Res Ctr, Bronx, NY 10467 USA; Albert Einstein Coll Med, Ctr Canc, Bronx, NY 10467 USA; Montefiore Med Ctr, Bronx, NY 10467 USA; Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA; Univ Calif Davis, Dept Med, Davis, CA 95616 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Davis; University of California System; University of California Davis	Kitsis, RN (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.		Jialal, Ishwarlal/AAG-6218-2019					Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Lagrand WK, 1997, CIRCULATION, V95, P97, DOI 10.1161/01.CIR.95.1.97; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Suleiman M, 2006, J AM COLL CARDIOL, V47, P962, DOI 10.1016/j.jacc.2005.10.055	4	29	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2006	355	5					513	515		10.1056/NEJMcibr063197	http://dx.doi.org/10.1056/NEJMcibr063197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FT	16885557				2022-12-01	WOS:000239432500014
J	Parker, AA; Staggs, W; Dayan, GH; Ortega-Sanchez, IR; Rota, PA; Lowe, L; Boardman, P; Teclaw, R; Graves, C; LeBaron, CW				Parker, Amy A.; Staggs, Wayne; Dayan, Gustavo H.; Ortega-Sanchez, Ismael R.; Rota, Paul A.; Lowe, Luis; Boardman, Patricia; Teclaw, Robert; Graves, Charlene; LeBaron, Charles W.			Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE FAILURES; IMMUNIZATION; IMPACT; TRANSMISSION; POLICY	BACKGROUND: Measles was declared eliminated from the United States in 2000 but remains endemic worldwide. In 2005, a 17-year-old unvaccinated girl who was incubating measles returned from Romania, creating the largest documented outbreak of measles in the United States since 1996. METHODS: We conducted a case-series investigation, molecular typing of viral isolates, surveys of rates of vaccination coverage, interviews regarding attitudes toward vaccination, and cost surveys. RESULTS: Approximately 500 persons attended a gathering with the index patient one day after her return home. Approximately 50 lacked evidence of measles immunity, of whom 16 (32 percent) acquired measles at the gathering. During the six weeks after the gathering, a total of 34 cases of measles were confirmed. Of the patients with confirmed measles, 94 percent were unvaccinated, 88 percent were less than 20 years of age, and 9 percent were hospitalized. Of the 28 patients who were 5 to 19 years of age, 71 percent were home-schooled. Vaccine failure occurred in two persons. The virus strain was genotype D4, which is endemic in Romania. Although containment measures began after 20 persons were already infectious, measles remained confined mostly to children whose parents had refused to have them vaccinated, primarily out of concern for adverse events from the vaccine. Seventy-one percent of patients were from four households. Levels of measles-vaccination coverage in Indiana were 92 percent for preschoolers and 98 percent for sixth graders. Estimated costs of containing the disease were at least $167,685, including $113,647 at a hospital with an infected employee. CONCLUSIONS: This outbreak was caused by the importation of measles into a population of children whose parents had refused to have them vaccinated because of safety concerns about the vaccine. High vaccination levels in the surrounding community and low rates of vaccine failure averted an epidemic. Maintenance of high rates of vaccination coverage, including improved strategies of communication with persons who refuse vaccination, is necessary to prevent future outbreaks and sustain the elimination of measles in the United States.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; Indiana State Dept Hlth, Indianapolis, IN 46202 USA; Home Hosp, Lafaeytte, IN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Parker, AA (corresponding author), CDC, NCIRD, MS A-47,1600 Clifton Rd, Atlanta, GA 30333 USA.							Abramson JS, 2002, JAMA-J AM MED ASSOC, V287, P505, DOI 10.1001/jama.287.4.505; [Anonymous], 2005, WKLY EPIDEMIOL REC, V80, P347; [Anonymous], 1998, MMWR MORB MORTAL WKL, V47, P1; ATKINSON WL, 1992, ANNU REV MED, V43, P451, DOI 10.1146/annurev.me.43.020192.002315; Bellini WJ, 2005, J INFECT DIS, V192, P1686, DOI 10.1086/497169; Centers for Disease Control and Prevention, TRAV HLTH; Centers for Disease Control and Prevention, NAT IMM SURV; COHN ML, 1994, PEDIATR INFECT DIS J, V13, P34, DOI 10.1097/00006454-199401000-00008; CUTTS FT, 1992, ANNU REV PUBL HEALTH, V13, P385, DOI 10.1146/annurev.pu.13.050192.002125; Dayan GH, 2005, PEDIATRICS, V116, pE1, DOI 10.1542/peds.2004-2512; *EPI, 1998, WKLY EPIDEMIOL REC, V73, P265; FARIZO KM, 1991, PEDIATRICS, V87, P74; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; GINDLER JS, 1992, PEDIATR INFECT DIS J, V11, P841, DOI 10.1097/00006454-199210000-00007; HENKE RR, 2001, ED STAT Q, V2; Hyde TB, 2006, INT J EPIDEMIOL, V35, P299, DOI 10.1093/ije/dyi222; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; KLICKA C, 2005, IMMUNIZATIONS PARENT; Marin M, 2006, CLIN INFECT DIS, V42, P315, DOI 10.1086/498902; McBrien J, 2003, PEDIATR INFECT DIS J, V22, P580, DOI 10.1097/00006454-200307000-00002; Mossong J, 1999, AM J EPIDEMIOL, V150, P1238, DOI 10.1093/oxfordjournals.aje.a009951; Orenstein W A, 1990, J Health Care Poor Underserved, V1, P315; Oster NV, 2004, J INFECT DIS, V189, pS48, DOI 10.1086/374854; PAPANIA M, 2002, VPD SURVEILLANCE MAN; Paunio M, 2000, EPIDEMIOL INFECT, V124, P263, DOI 10.1017/S0950268899003222; PICKERING LK, 2000, RED BOOK REPORT COMM, P386; Ratnam S, 2000, J CLIN MICROBIOL, V38, P99; SMITH PJ, 2005, VITAL HLTH STAT 2, V138, P1; 1997, MMWR MORB MORTAL WKL, V46, P766; 2000, MMWR MORB MORTAL WKL, V49, P299; 2005, MEASLES HITS ROMANIA; 2004, MMWR MORB MORTAL WKL, V53, P309	33	190	202	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2006	355	5					447	455		10.1056/NEJMoa060775	http://dx.doi.org/10.1056/NEJMoa060775			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FT	16885548				2022-12-01	WOS:000239432500004
J	Zenkin, N; Yuzenkova, Y; Severinov, K				Zenkin, Nikolay; Yuzenkova, Yulia; Severinov, Konstantin			Transcript-assisted transcriptional proofreading	SCIENCE			English	Article							RNA-POLYMERASE-II; STRUCTURAL BASIS; MECHANISM; ELONGATION; CLEAVAGE; FIDELITY; RESOLUTION; CATALYSIS; COMPLEXES; TFIIS	Fidelity of template-dependent nucleic acid synthesis is the main determinant of stable heredity and error-free gene expression. The mechanism ( or mechanisms) ensuring fidelity of transcription by DNA-dependent RNA polymerases (RNAPs) is not fully understood. Here, we show that the 3' end - proximal nucleotide of the nascent transcript stimulates hydrolysis of the penultimate phosphodiester bond by providing active groups and coordination bonds to the RNAP active center. This stimulation is much higher in the case of misincorporated nucleotide. We show that during transcription elongation, the hydrolytic reaction stimulated by misincorporated nucleotides proofreads most of the misincorporation events and thus serves as an intrinsic mechanism of transcription fidelity.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Russian Academy of Sciences	Zenkin, N (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	nicserzen@mail.ru; severik@waksman.rutgers.edu	Severinov, Konstantin/C-8545-2016	Zenkin, Nikolay/0000-0003-2212-9545; yuzenkova, yulia/0000-0003-4036-9235				Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; GUO HL, 1993, J BIOL CHEM, V268, P18762; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; LAZCANO A, 1988, J MOL EVOL, V27, P365, DOI 10.1007/BF02101199; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299	24	114	121	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					518	520		10.1126/science.1127422	http://dx.doi.org/10.1126/science.1127422			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873663				2022-12-01	WOS:000239308600061
J	Erkel, C; Kube, M; Reinhardt, R; Liesack, W				Erkel, Christoph; Kube, Michael; Reinhardt, Richard; Liesack, Werner			Genome of Rice Cluster I archaea - the key methane producers in the rice rhizosphere	SCIENCE			English	Article							DEPENDENT PHOSPHOFRUCTOKINASE; ACETATE; ASSIMILATION; SULFATE	Rice fields are a global source of the greenhouse gas methane, which is produced by methanogenic archaea, and by methanogens of Rice Cluster I (RC-I) in particular. RC-I methanogens are not yet available in pure culture, and the mechanistic reasons for their prevalence in rice fields are unknown. We reconstructed a complete RC-I genome (3.18 megabases) using a metagenomic approach. Sequence analysis demonstrated an aerotolerant, H-2/CO2-dependent lifestyle and enzymatic capacities for carbohydrate metabolism and assimilatory sulfate reduction, hitherto unknown among methanogens. These capacities and a unique set of antioxidant enzymes and DNA repair mechanisms as well as oxygen-insensitive enzymes provide RC-I with a selective advantage over other methanogens in its habitats, thereby explaining the prevalence of RC-I methanogens in the rice rhizosphere.	Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society	Liesack, W (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str, D-35043 Marburg, Germany.	liesack@mpi-marburg.mpg.de		Liesack, Werner/0000-0002-9533-1552; Kuba, Michael J/0000-0003-2688-736X	Direct For Biological Sciences [0946430] Funding Source: National Science Foundation; Directorate For Geosciences [1204254] Funding Source: National Science Foundation; Division Of Earth Sciences [1614855] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1456778] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Baumer Sebastian, 2002, Archaea, V1, P1, DOI 10.1155/2002/371325; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; DANIELS L, 1986, APPL ENVIRON MICROB, V51, P703, DOI 10.1128/AEM.51.4.703-709.1986; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Donovan SE, 2004, APPL ENVIRON MICROB, V70, P3884, DOI 10.1128/AEM.70.7.3884-3892.2004; Erkel C, 2005, FEMS MICROBIOL ECOL, V53, P187, DOI 10.1016/j.femsec.2004.12.004; Fournier M, 2003, J BACTERIOL, V185, P71, DOI 10.1128/JB.185.1.71-79.2003; Galand PE, 2005, MICROB ECOL, V49, P209, DOI 10.1007/s00248-003-0229-2; Hansen T, 2001, ARCH MICROBIOL, V177, P62, DOI 10.1007/s00203-001-0359-1; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lu YH, 2005, ENVIRON MICROBIOL, V7, P326, DOI 10.1111/j.1462-2920.2005.00697.x; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; NOUCHI I, 1990, PLANT PHYSIOL, V94, P59, DOI 10.1104/pp.94.1.59; OBERLIES G, 1980, ARCH MICROBIOL, V128, P248, DOI 10.1007/BF00406167; Ramakrishnan B, 2001, FEMS MICROBIOL ECOL, V37, P175, DOI 10.1111/j.1574-6941.2001.tb00865.x; SCHAFER T, 1993, ARCH MICROBIOL, V159, P72, DOI 10.1007/BF00244267; SHIEH J, 1988, J BACTERIOL, V170, P3072, DOI 10.1128/jb.170.7.3072-3079.1988; SHIEH JS, 1987, J BACTERIOL, V169, P5327, DOI 10.1128/jb.169.11.5327-5329.1987; Siebers B, 1998, J BACTERIOL, V180, P2137, DOI 10.1128/JB.180.8.2137-2143.1998; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Verhees CH, 2001, J BACTERIOL, V183, P7145, DOI 10.1128/JB.183.24.7145-7153.2001; Watanabe A, 1999, J GEOPHYS RES-ATMOS, V104, P23623, DOI 10.1029/1999JD900467; ZEIKUS JG, 1977, J BACTERIOL, V132, P604, DOI 10.1128/JB.132.2.604-613.1977	26	138	331	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					370	372		10.1126/science.1127062	http://dx.doi.org/10.1126/science.1127062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857943				2022-12-01	WOS:000239154300050
J	Andersen, CBF; Becker, T; Blau, M; Anand, M; Halic, M; Balar, B; Mielke, T; Boesen, T; Pedersen, JS; Spahn, CMT; Kinzy, TG; Andersen, GR; Beckmann, R				Andersen, Christian B. F.; Becker, Thomas; Blau, Michael; Anand, Monika; Halic, Mario; Balar, Bharvi; Mielke, Thorsten; Boesen, Thomas; Pedersen, Jan Skov; Spahn, Christian M. T.; Kinzy, Terri Goss; Andersen, Gregers R.; Beckmann, Roland			Structure of eEF3 and the mechanism of transfer RNA release from the E-site	NATURE			English	Article							ATP-BINDING CASSETTE; ELONGATION-FACTOR 3; RAY SOLUTION SCATTERING; ANGSTROM RESOLUTION; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; ABC TRANSPORTERS; 80S RIBOSOME; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE	Elongation factor eEF3 is an ATPase that, in addition to the two canonical factors eEF1A and eEF2, serves an essential function in the translation cycle of fungi. eEF3 is required for the binding of the aminoacyl-tRNA-eEF1A-GTP ternary complex to the ribosomal A-site and has been suggested to facilitate the clearance of deacyl-tRNA from the E-site. Here we present the crystal structure of Saccharomyces cerevisiae eEF3, showing that it consists of an amino-terminal HEAT repeat domain, followed by a four-helix bundle and two ABC-type ATPase domains, with a chromodomain inserted in ABC2. Moreover, we present the cryo-electron microscopy structure of the ATP-bound form of eEF3 in complex with the post-translocational-state 80S ribosome from yeast. eEF3 uses an entirely new factor binding site near the ribosomal E-site, with the chromodomain likely to stabilize the ribosomal L1 stalk in an open conformation, thus allowing tRNA release.	Humboldt Univ, Inst Biochem, Charite, Univ Med Sch, D-10117 Berlin, Germany; Aarhus Univ, Dept Mol Biol, Ctr Struct Biol, DK-8000 Aarhus, Denmark; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; Max Planck Inst Mol Genet, UltraStruct Network, D-14195 Berlin, Germany; Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; Humboldt Univ, Inst Med Phys & Biophys, Charite, Univ Med Sch, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Aarhus University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Max Planck Society; Aarhus University; Aarhus University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Beckmann, R (corresponding author), Humboldt Univ, Inst Biochem, Charite, Univ Med Sch, Monbijoustr 2, D-10117 Berlin, Germany.	gra@mb.au.dk; beckmann@lmb.uni-muenchen.de	Pedersen, Jan Skov/A-8346-2008; Halic, Mario/X-2163-2018; Andersen, Christian/G-9954-2011	Pedersen, Jan Skov/0000-0002-7768-0206; Boesen, Thomas/0000-0002-5633-6844; Kinzy, Terri/0000-0003-1394-9226; Andersen, Gregers Rom/0000-0001-6292-3319	NIGMS NIH HHS [R01 GM062789, R01 GM057483] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483, R01GM062789] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen CF, 2004, ACTA CRYSTALLOGR D, V60, P1304, DOI 10.1107/S0907444904010716; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; DeLano WL., 2002, PYMOL USERS MANUAL D; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Gontarek RR, 1998, J BIOL CHEM, V273, P10249, DOI 10.1074/jbc.273.17.10249; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 2001, INT TABLES CRYSTALLO; KAMATH A, 1989, J BIOL CHEM, V264, P15423; Kambampati R, 1997, J BIOL CHEM, V272, P6377, DOI 10.1074/jbc.272.10.6377; Kambampati R, 2000, J BIOL CHEM, V275, P16963, DOI 10.1074/jbc.M001157200; Karcher A, 2005, STRUCTURE, V13, P649, DOI 10.1016/j.str.2005.02.008; Kovalchuke O, 1998, EUR J BIOCHEM, V258, P986, DOI 10.1046/j.1432-1327.1998.2580986.x; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Mueller F, 1995, BIOCHEM CELL BIOL, V73, P767, DOI 10.1139/o95-085; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Sarthy AV, 1997, ANAL BIOCHEM, V254, P288, DOI 10.1006/abio.1997.2456; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	49	109	110	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					663	668		10.1038/nature05126	http://dx.doi.org/10.1038/nature05126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	16929303	Green Published			2022-12-01	WOS:000241160500039
J	Davidoff, F; Trussell, J				Davidoff, Frank; Trussell, James			Plan B and the politics of doubt	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EMERGENCY CONTRACEPTION; OVARIAN-FUNCTION; YUZPE REGIMEN; LEVONORGESTREL; PREGNANCY; MIFEPRISTONE; MECHANISMS; CYCLE		Inst Healthcare Improvement, Cambridge, MA USA; Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA	Institute for Healthcare Improvement; Princeton University	Davidoff, F (corresponding author), 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net						BEREK JS, 2002, NOVAKS GYNECOLOGY, P249; BOSSOM E, CONTRACEPTION DECEPT; Brito KS, 2005, CONTRACEPTION, V72, P225, DOI 10.1016/j.contraception.2005.04.005; Croxatto HB, 2004, CONTRACEPTION, V70, P442, DOI 10.1016/j.contraception.2004.05.007; CROXATTO HB, 2002, IPPF MED B, P36; *DIV REPR UR PROD, MED OFF SAF REV SUPP; Durand M, 2005, CONTRACEPTION, V71, P451, DOI 10.1016/j.contraception.2005.01.003; Durand M, 2001, CONTRACEPTION, V64, P227, DOI 10.1016/S0010-7824(01)00250-5; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Gemzell-Danielsson K, 2004, HUM REPROD UPDATE, V10, P341, DOI 10.1093/humupd/dmh027; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Marions L, 2004, CONTRACEPTION, V69, P373, DOI 10.1016/j.contraception.2003.11.018; NOVIKOVA N, IN PRESS CONTRACEPTI; Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3; Raymond EG, 2006, CONTRACEPTION, V73, P376, DOI 10.1016/j.contraception.2005.10.006; Rosenstock L, 2006, JAMA-J AM MED ASSOC, V295, P2407, DOI 10.1001/jama.295.20.2407; SALETAN W, 2006, WASH POST       0806, pB2; SHORTO R, 2006, NY TIMES SUNDAY 0507, P49; Stewart FH, 2000, AM J PREV MED, V19, P228, DOI 10.1016/S0749-3797(00)00243-9; Trussell J, 2003, J FAM PLAN REPROD H, V29, P249, DOI 10.1783/147118903101197944; Trussell J, 2003, CONTRACEPTION, V67, P167, DOI 10.1016/S0010-7824(02)00486-9; *US GOV ACC OFF, GAO06109; Verpoest WMJA, 2000, FERTIL STERIL, V73, P75, DOI 10.1016/S0015-0282(99)00481-1; *WOM CAP CORP, 2003, NONPR DRUGS REPR HLT, P63	24	35	36	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1775	1778		10.1001/jama.296.14.1775	http://dx.doi.org/10.1001/jama.296.14.1775			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092NH	17032991				2022-12-01	WOS:000241103400026
J	Andersen, CBF; Ballut, L; Johansen, JS; Chamieh, H; Nielsen, KH; Oliveira, CLP; Pedersen, JS; Seraphin, B; Le Hir, H; Andersen, GR				Andersen, Christian B. F.; Ballut, Lionel; Johansen, Jesper S.; Chamieh, Hala; Nielsen, Klaus H.; Oliveira, Cristiano L. P.; Pedersen, Jan Skov; Seraphin, Bertrand; Le Hir, Herve; Andersen, Gregers Rom			Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA	SCIENCE			English	Article							MESSENGER-RNA; HELICASE ACTIVITY; MOLECULAR INSIGHTS; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; BINDING; DECAY; TRANSLATION; EIF4A; DISTINCT	In higher eukaryotes, a multiprotein exon junction complex is deposited on spliced messenger RNAs. The complex is organized around a stable core, which serves as a binding platform for numerous factors that influence messenger RNA function. Here, we present the crystal structure of a tetrameric exon junction core complex containing the DEAD-box adenosine triphosphatase ( ATPase) eukaryotic initiation factor 4AIII (eIF4AIII) bound to an ATP analog, MAGOH, Y14, a fragment of MLN51, and a polyuracil mRNA mimic. eIF4AIII interacts with the phosphate-ribose backbone of six consecutive nucleotides and prevents part of the bound RNA from being double stranded. The MAGOH and Y14 subunits lock eIF4AIII in a prehydrolysis state, and activation of the ATPase probably requires only modest conformational changes in eIF4AIII motif I.	Univ Paris 06, Ctr Genet Mol, Equipe Labelisee Ligue, CNRS,UPR2167, F-91198 Gif Sur Yvette, France; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; Aarhus Univ, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark; Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Andersen, GR (corresponding author), Univ Paris 06, Ctr Genet Mol, Equipe Labelisee Ligue, CNRS,UPR2167, Ave Terrasse, F-91198 Gif Sur Yvette, France.	herve.lehir@cgm.cnrs-gif.fr; gra@mb.au.dk	Andersen, Christian/G-9954-2011; Pedersen, Jan Skov/A-8346-2008; Oliveira, Cristiano L P/B-4403-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Oliveira, Cristiano L P/0000-0002-3426-6507; Le Hir, Herve/0000-0001-7964-9221; Seraphin, Bertrand/0000-0002-5168-1921; Andersen, Gregers Rom/0000-0001-6292-3319; Ballut, Lionel/0000-0002-3982-9321				ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li QY, 1999, MOL CELL BIOL, V19, P7336; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012	27	306	312	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1968	1972		10.1126/science.1131981	http://dx.doi.org/10.1126/science.1131981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	16931718				2022-12-01	WOS:000240832200053
J	ter Steege, H; Pitman, NCA; Phillips, OL; Chave, J; Sabatier, D; Duque, A; Molino, JF; Prevost, MF; Spichiger, R; Castellanos, H; von Hildebrand, P; Vasquez, R				ter Steege, Hans; Pitman, Nigel C. A.; Phillips, Oliver L.; Chave, Jerome; Sabatier, Daniel; Duque, Alvaro; Molino, Jean-Francois; Prevost, Marie-Francois; Spichiger, Rodolphe; Castellanos, Hernan; von Hildebrand, Patricio; Vasquez, Rodolfo			Continental-scale patterns of canopy tree composition and function across Amazonia	NATURE			English	Article							FOREST; DIVERSITY; DISTURBANCE; DENSITY	The world's greatest terrestrial stores of biodiversity and carbon are found in the forests of northern South America, where large-scale biogeographic patterns and processes have recently begun to be described(1-4). Seven of the nine countries with territory in the Amazon basin and the Guiana shield have carried out large-scale forest inventories, but such massive data sets have been little exploited by tropical plant ecologists(5-8). Although forest inventories often lack the species-level identifications favoured by tropical plant ecologists, their consistency of measurement and vast spatial coverage make them ideally suited for numerical analyses at large scales, and a valuable resource to describe the still poorly understood spatial variation of biomass, diversity, community composition and forest functioning across the South American tropics(9). Here we show, by using the seven forest inventories complemented with trait and inventory data collected elsewhere, two dominant gradients in tree composition and function across the Amazon, one paralleling a major gradient in soil fertility and the other paralleling a gradient in dry season length. The data set also indicates that the dominance of Fabaceae in the Guiana shield is not necessarily the result of root adaptations to poor soils ( nodulation or ectomycorrhizal associations) but perhaps also the result of their remarkably high seed mass there as a potential adaptation to low rates of disturbance.	Inst Environm Biol, Sect Plant Ecol & Biodivers, NL-3584 CA Utrecht, Netherlands; Natl Herbarium Netherlands, Utrecht Univ Branch, NL-3584 CA Utrecht, Netherlands; Amazon Conservat Assoc, Washington, DC 20009 USA; Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England; Univ Toulouse 3, CNRS, UMR 5174, F-31062 Toulouse, France; IRD, UMR AMAP, F-34398 Montpellier 5, France; Univ Nacl Colombia, Dept Ciencias Forestales, Medellin 1027, Colombia; IRD, UMR AMAP, Cayenne 97323, French Guiana; Conservatoire & Jardin Bot Ville Geneve, CH-1292 Geneva, Switzerland; UNEG, Puerto Ordaz, Edo Bolivar, Venezuela; Fdn Puerto Rastrojo, Bogota 241438, Colombia; Jardin Bot Missouri, Proyecto Flora Peru, Jaen, Cajamarca, Peru	Utrecht University; University of Leeds; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad Nacional de Colombia; Institut de Recherche pour le Developpement (IRD)	ter Steege, H (corresponding author), Inst Environm Biol, Sect Plant Ecol & Biodivers, Sorbonnelaan 14-16, NL-3584 CA Utrecht, Netherlands.	h.tersteege@bio.uu.nl	Molino, Jean-François/C-5011-2009; Steege, Hans ter/B-5866-2011; Phillips, Oliver L/A-1523-2011; Pitman, Nigel C A/A-7681-2008; Sabatier, Daniel/D-9117-2011	Molino, Jean-François/0000-0001-8853-7133; Steege, Hans ter/0000-0002-8738-2659; Phillips, Oliver L/0000-0002-8993-6168; Pitman, Nigel C A/0000-0002-9211-2880; Sabatier, Daniel/0000-0003-0883-1530	Natural Environment Research Council [NE/B504630/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bongers F., 2004, Biodiversity of West African forests: an ecological atlas of woody plant species, P41, DOI 10.1079/9780851997346.0041; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; CASPER BB, 1992, OECOLOGIA, V90, P212, DOI 10.1007/BF00317178; CHAVE J, IN PRESS ECOL APPL; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; HAMMOND DS, 1995, ECOLOGY, V76, P2544, DOI 10.2307/2265827; Hirsch P., 2001, ANN BOT-LONDON, V89; Houghton J. T., 2001, CLIMATE CHANGE 2001; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; *RADAMBRASIL, 1968, LEV REC NAT; RANKIN JM, 1978, THESIS U MICHIGAN; *SEED INF DAT, SID REL 6 0; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Stevens P.F., 2005, ANGIOSPERM PHYLOGENY; Ter Steege H, 2001, ECOLOGY, V82, P3197, DOI 10.1890/0012-9658(2001)082[3197:CCDADI]2.0.CO;2; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Ter Steege H, 2000, J TROP ECOL, V16, P801, DOI 10.1017/S0266467400001735; Ter Steege H, 1998, BIODIVERS CONSERV, V7, P1457, DOI 10.1023/A:1008893920157; Ter Steege H., 2003, TROPENBOS SERIES, V22; Terborgh J, 1998, J TROP ECOL, V14, P645, DOI 10.1017/S0266467498000455; TERSTEEGE H, 2000, TROPENBOS SERIES, V18, P35; Van Roosmalen M.G.M., 1985, FRUITS GUIANAN FLORA; VONROMPAEY RSA, 1993, THESIS WAGENINGEN U	27	506	520	5	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					444	447		10.1038/nature05134	http://dx.doi.org/10.1038/nature05134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006512				2022-12-01	WOS:000240798800043
J	Ye, S; Li, Y; Chen, LP; Jiang, YX				Ye, Sheng; Li, Yang; Chen, Liping; Jiang, Youxing			Crystal structures of a ligand-free MthK gating ring: Insights into the ligand gating mechanism of K+ channels	CELL			English	Article							RCK DOMAIN; BINDING; HINGE; GATE; PORE; SEQUENCE; COMPLEX; SYSTEM; KTRAB; FLUX	MthK is a prokaryotic Ca2+-gated K+ channel that, like other ligand-gated channels, converts the chemical energy of ligand binding to the mechanical force of channel opening. The channel's eight ligand-binding domains, the RCK domains, form an octameric gating ring in which Ca2+ binding induces conformational changes that open the channel. Here we present the crystal structures of the MthK gating ring in closed and partially open states at 2.8 angstrom, both obtained from the same crystal grown in the absence of Ca2+. Furthermore, our biochemical and electrophysiological analyses demonstrate that MthK is regulated by both Ca2+ and pH. Ca2+ regulates the channel by changing the equilibrium of the gating ring between closed and open states, while pH regulates channel gating by affecting gating-ring stability. Our findings, along with the previously determined open MthK structure, allow us to elucidate the ligand gating mechanism of RCK-regulated K+ channels.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, YX (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071621] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071621] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKKER EP, 1987, J BACTERIOL, V169, P3743, DOI 10.1128/jb.169.8.3743-3749.1987; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hellmer J, 2003, FEBS LETT, V547, P165, DOI 10.1016/S0014-5793(03)00706-3; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Kuo MMC, 2003, EMBO J, V22, P4049, DOI 10.1093/emboj/cdg409; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MUNRO AW, 1991, MOL MICROBIOL, V5, P607, DOI 10.1111/j.1365-2958.1991.tb00731.x; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; PICO A, 2003, THESIS ROCKEFLLER U; Ptak CP, 2005, BIOCHEMISTRY-US, V44, P62, DOI 10.1021/bi048390f; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	84	86	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1161	1173		10.1016/j.cell.2006.08.029	http://dx.doi.org/10.1016/j.cell.2006.08.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990139	Bronze			2022-12-01	WOS:000240897600021
J	Prehna, G; Ivanov, MI; Bliska, JB; Stebbins, CE				Prehna, Gerd; Ivanov, Maya I.; Bliska, James B.; Stebbins, C. Erec			Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors	CELL			English	Article							SER/THR PROTEIN-KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SALMONELLA-TYPHIMURIUM; EFFECTOR DOMAIN; EXCHANGE FACTOR; PSEUDOTUBERCULOSIS; COMPLEX; REFINEMENT; ACTIVATION	Yersinia spp. cause gastroenteritis and the plague, representing historically devastating pathogens that are currently an important biodefense and antibiotic resistance concern. A critical virulence determinant is the Yersinia protein kinase A, or YpkA, a multidomain protein that disrupts the eukaryotic actin cytoskeleton. Here we solve the crystal structure of a YpkA-Rac1 complex and find that YpkA possesses a Rac1 binding domain that mimics host guanidine nucleotide dissociation inhibitors (GDIs) of the Rho GTPases. YpkA inhibits nucleotide exchange in Rac1 and RhoA, and mutations that disrupt the YpkA-GTPase interface abolish this activity in vitro and impair in vivo YpkA-induced cytoskeletal disruption. In cell culture experiments, the kinase and the GDI domains of YpkA act synergistically to promote cytoskeletal disruption, and a Y. pseudotuberculosis mutant lacking YpkA GDI activity shows attenuated virulence in a mouse infection assay. We conclude that virulence in Yersinia depends strongly upon mimicry of host GDI proteins by YpkA.	Rockefeller Univ, Lab Struct Microbiol, New York, NY 10021 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	Rockefeller University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Stebbins, CE (corresponding author), Rockefeller Univ, Lab Struct Microbiol, 1230 York Ave, New York, NY 10021 USA.	stebbins@rockefeller.edu	Stebbins, Erec/N-2565-2018	Stebbins, Erec/0000-0001-6229-5308; Prehna, Gerd/0000-0001-5539-7533	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056510] Funding Source: NIH RePORTER; NIAID NIH HHS [1U19AI056510, R01AI433890] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aepfelbacher M, 1999, BIOL CHEM, V380, P795, DOI 10.1515/BC.1999.099; Aepfelbacher M, 2004, Rev Physiol Biochem Pharmacol, V152, P65; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Friebel A, 2000, METHOD ENZYMOL, V325, P82; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Logsdon LK, 2003, INFECT IMMUN, V71, P4595, DOI 10.1128/IAI.71.8.4595-4607.2003; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Maesaki R, 1999, J STRUCT BIOL, V126, P166, DOI 10.1006/jsbi.1999.4114; McCormick JB, 1998, CURR OPIN MICROBIOL, V1, P125, DOI 10.1016/S1369-5274(98)80152-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nejedlik L, 2004, YEAST, V21, P759, DOI 10.1002/yea.1135; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	44	93	97	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					869	880		10.1016/j.cell.2006.06.056	http://dx.doi.org/10.1016/j.cell.2006.06.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959567	Bronze			2022-12-01	WOS:000240675000015
J	Axelrod, JD				Axelrod, Jeffrey D.			Cell shape in proliferating epithelia: A multifaceted problem	CELL			English	Editorial Material							DROSOPHILA; SIZE		Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Axelrod, JD (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	jaxelrod@stanford.edu						Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; GIBSON MC, 2006, IN PRESS NATURE; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Resino J, 2002, P NATL ACAD SCI USA, V99, P7502, DOI 10.1073/pnas.072208199; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; TAYLOR JE, 1976, ANN MATH, V103, P489, DOI 10.2307/1970949; Zallen JA, 2004, J PHYS-CONDENS MAT, V16, pS5073, DOI 10.1088/0953-8984/16/44/005	10	19	19	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 25	2006	126	4					643	645		10.1016/j.cell.2006.07.018	http://dx.doi.org/10.1016/j.cell.2006.07.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923381	Bronze			2022-12-01	WOS:000240276700009
J	Lee, SH; Stephens, JL; Paul, KS; Englund, PT				Lee, Soo Hee; Stephens, Jennifer L.; Paul, Kimberly S.; Englund, Paul T.			Fatty acid synthesis by elongases in trypanosomes.	CELL			English	Article							VARIANT SURFACE GLYCOPROTEIN; SACCHAROMYCES-CEREVISIAE; AFRICAN TRYPANOSOMES; CULTURE FORMS; BRUCEI; ELONGATION; GENE; MYRISTATE; BIOSYNTHESIS; EXPRESSION	All eukaryotic and prokaryotic organisms are thought to synthesize fatty acids using a type I or type II synthase. In addition, eukaryotes extend pre-existing long chain fatty acids using microsomal elongases (ELOs). We have found that Trypanosoma brucei, a eukaryotic human parasite that causes sleeping sickness, uses three elongases instead of type I or type II synthases for the synthesis of nearly all its fatty acids. Trypanosomes encounter diverse environments during their life cycle with different fatty acid requirements. The tsetse vector form requires synthesis of stearate (C18), whereas the bloodstream form needs myristate (C14). We find that trypanosome fatty acid synthesis is modular, with EL01 converting C4 to C10, EL02 extending C1 0 to C14, and EL03 elongating C14 to C18. In blood, EL03 downregulation favors myristate synthesis, whereas low concentrations of exogenous fatty acids in cultured parasites cause upregulation of the entire pathway, allowing the parasite to adapt to different environments.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Englund, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	penglund@jhmi.edu	Lee, Soo Hee/E-9494-2012; Paul, Kimberly/AAO-4275-2020	Guler, Jennifer/0000-0001-6301-4563	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021334] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21334] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRUN R, 1979, ACTA TROP, V36, P289; Dittrich F, 1998, EUR J BIOCHEM, V252, P477, DOI 10.1046/j.1432-1327.1998.2520477.x; DIXON H, 1971, COMP BIOCHEM PHYSIOL, V39, P247, DOI 10.1016/0305-0491(71)90168-4; DOERING TL, 1993, J BIOL CHEM, V268, P9215; Donelson JE, 2003, ACTA TROP, V85, P391, DOI 10.1016/S0001-706X(02)00237-1; Duffieux F, 2000, J BIOL CHEM, V275, P27559; Ferguson MAJ, 1997, PHILOS T ROY SOC B, V352, P1295, DOI 10.1098/rstb.1997.0113; FERGUSON MAJ, 1984, J BIOL CHEM, V259, P3011; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; FOSBROOKE AS, 1968, CLIN CHIM ACTA, V20, P517, DOI 10.1016/0009-8981(68)90311-2; GRAB DJ, 1982, ACTA TROP, V39, P363; Gu PD, 1997, COMP BIOCHEM PHYS B, V118, P447, DOI 10.1016/S0305-0491(97)00112-0; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; JUAREZ P, 1992, ARCH BIOCHEM BIOPHYS, V293, P333, DOI 10.1016/0003-9861(92)90403-J; KLEIN RA, 1976, BIOCHEM SOC T, V4, P48, DOI 10.1042/bst0040048; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lentner C, 1981, GEIGY SCI TABLES UNI, V1; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Marchetti MA, 2000, J CELL SCI, V113, P899; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MCCARTHYBURKE C, 1991, EXP PARASITOL, V73, P385, DOI 10.1016/0014-4894(91)90112-A; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Morita YS, 2000, SCIENCE, V288, P140, DOI 10.1126/science.288.5463.140; Morita YS, 2001, MOL BIOCHEM PARASIT, V115, P157, DOI 10.1016/S0166-6851(01)00279-1; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; PARSONS M, 1990, MOL BIOCHEM PARASIT, V42, P197, DOI 10.1016/0166-6851(90)90162-F; Paul KS, 2004, EUKARYOT CELL, V3, P855, DOI 10.1128/EC.3.4.855-861.2004; Paul KS, 2001, TRENDS PARASITOL, V17, P381, DOI 10.1016/S1471-4922(01)01984-5; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016	38	104	119	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2006	126	4					691	699		10.1016/j.cell.2006.06.045	http://dx.doi.org/10.1016/j.cell.2006.06.045			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923389	Bronze			2022-12-01	WOS:000240276700018
J	Tal, A				Tal, Alon			Seeking sustainability: Israel's evolving water management strategy	SCIENCE			English	Editorial Material								The water management policies adopted to address Israel's chronic scarcity have not been without environmental consequences. Yet, through a trial-and-error process, a combined strategy of water transport, rainwater harvesting, and wastewater reuse and desalination, along with a variety of water conservation measures, have put the country on a more sustainable path for the future.	Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84990 Sede Boqer, Israel	Ben Gurion University	Tal, A (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84990 Sede Boqer, Israel.	alontal@bgu.ac.il						BECKER N, 2004, INITIAL ASSESSMENT Q; Ben-Gal A, 2004, VADOSE ZONE J, V3, P1407; Dalhuisen JM, 2003, LAND ECON, V79, P292, DOI 10.2307/3146872; DEVILLIERS M, 1999, WATER; DREIZIN Y, 2004, WAT LIF MIDDL E C AN; FALKENMARK M, 1989, NAT RESOUR FORUM, V13, P258, DOI 10.1111/j.1477-8947.1989.tb00348.x; FATTAL B, 1981, DEV ARID ZONE ECOLOG; FEDLER J, 2002, ISRAELS AGR 21 CENTU; Feitelson E, 2002, POLIT GEOGR, V21, P293, DOI 10.1016/S0962-6298(01)00038-5; *FRIENDS EARTH MID, 2005, LET JORD RIV FLOW; GABBAY S, 2002, ENV ISRAEL; GLEICK P, 2002, WORLDS WATER BIENNIA; Glennon Robert Jerome, 2002, WATER FOLLIES GROUND; GVIRTSMAN C, 2002, WATER RESOURCES ISRA; HASSON N, 2006, HAARETZ         0412, P1; Hillel D., 2000, SALINITY MANAGEMENT; *ISR MIN ENV PROT, 2006, SOURC WAT POLL; *ISR UN ENV DEF, 2005, ENV POV REP; *JEW NAT FUND, 2004, WAT LIF KKL POL EST; Juanico M, 1999, WATER SCI TECHNOL, V40, P43, DOI 10.1016/S0273-1223(99)00484-9; Kronenberg G, 2004, DESALINATION, V166, P457, DOI 10.1016/S0011-9164(04)00329-7; MUSZKOT L, 1990, ADV MASS SPECTROM, V11, P1728; National Research Council, 1996, USE RECLAIMED WATER, DOI [10.17226/5175, DOI 10.17226/5175]; Pearce F, 2006, RIVERS RUN DRY WATER; Resiner Marc., 1993, CADILLAC DESERT AM W; Shamir U, 1999, IAHS-AISH P, P409; Shuval H., 1980, WATER QUALITY MANAGE; Tal A, 2002, POLLUTION PROMISED L; TAL A, 2005, SUSTAINABLE WATER MA; Ward D.R., 2002, WATER WARS DROUGHT F; ZASLAVSKY D, 2002, BELOW RED LINE REGAR; 2006, AGAMIT, V176, P4	32	146	150	7	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1081	1084		10.1126/science.1126011	http://dx.doi.org/10.1126/science.1126011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	076ZT	16931752				2022-12-01	WOS:000239998200034
J	Bernhard, H; Fischbacher, U; Fehr, E				Bernhard, Helen; Fischbacher, Urs; Fehr, Ernst			Parochial altruism in humans	NATURE			English	Article							INDIRECT RECIPROCITY; SOCIAL NORMS; EVOLUTION; PUNISHMENT; ENFORCEMENT; BEHAVIOR	Social norms and the associated altruistic behaviours are decisive for the evolution of human cooperation(1-9) and the maintenance of social order(10), and they affect family life, politics(11) and economic interactions(12). However, as altruistic norm compliance and norm enforcement often emerge in the context of inter-group conflicts(13,14), they are likely to be shaped by parochialism(15) - a preference for favouring the members of one's ethnic, racial or language group. We have conducted punishment experiments(16), which allow 'impartial' observers to punish norm violators, with indigenous groups in Papua New Guinea. Here we show that these experiments confirm the prediction of parochialism. We found that punishers protect ingroup victims - who suffer from a norm violation - much more than they do outgroup victims, regardless of the norm violator's group affiliation. Norm violators also expect that punishers will be lenient if the latter belong to their social group. As a consequence, norm violations occur more often if the punisher and the norm violator belong to the same group. Our results are puzzling for evolutionary multi-level selection theories based on selective group extinction(2-5) as well as for theories of individual selection(17-19); they also indicate the need to explicitly examine the interactions between individuals stemming from different groups in evolutionary models.	Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Coll Helveticum, CH-8092 Zurich, Switzerland	University of Zurich	Fehr, E (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.	fiba@iew.unizh.ch; efehr@iew.unizh.ch	Fischbacher, Urs/H-2693-2014	Fischbacher, Urs/0000-0002-5115-8815				BOEHM C, 1993, CURR ANTHROPOL, V34, P227, DOI 10.1086/204166; Bornstein G, 2003, PERS SOC PSYCHOL REV, V7, P129, DOI 10.1207/S15327957PSPR0702_129-145; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; BOWLES S, 2004, CULTURAL DIVERSITY V, P81; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Elster J., 1989, CEMENT SOC STUDY SOC, DOI [10.1017/CBO9780511624995, DOI 10.1017/CBO9780511624995]; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HAMILTON WD, 1964, J THEOR BIOL, V7, P26; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; HENRICH J, IN PRESS SCIENCE; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Kaplan H., 2005, MORAL SENTIMENTS MAT, V6, P75; Lindbeck A, 1999, Q J ECON, V114, P1, DOI 10.1162/003355399555936; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Otterbein KF., 1985, EVOLUTION WAR CROSS, V2nd edn; RABBIE JM, 1989, EUR J SOC PSYCHOL, V19, P171, DOI 10.1002/ejsp.2420190302; Shinada M, 2004, EVOL HUM BEHAV, V25, P379, DOI 10.1016/j.evolhumbehav.2004.08.001; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sober E., 1998, POPUL ENVIRON; Stutzer A, 2004, J EUR ECON ASSOC, V2, P696, DOI 10.1162/1542476041423331; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wiessner P, 2005, HUM NATURE-INT BIOS, V16, P115, DOI 10.1007/s12110-005-1000-9; WIESSNER P, 1998, HIST VINES EGNA NETW; Yamagishi T, 1999, ADV GROUP, V16, P161	33	436	444	8	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2006	442	7105					912	915		10.1038/nature04981	http://dx.doi.org/10.1038/nature04981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	076LT	16929297				2022-12-01	WOS:000239960500036
J	Moran, GJ; Krishnadasan, A; Gorwitz, RJ; Fosheim, GE; McDougal, LK; Carey, RB; Talan, DA				Moran, Gregory J.; Krishnadasan, Anusha; Gorwitz, Rachel J.; Fosheim, Gregory E.; McDougal, Linda K.; Carey, Roberta B.; Talan, David A.		EMERGEncy ID Net Study Grp	Methicillin-resistant S-aureus infections among patients in the emergency department	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCIBLE CLINDAMYCIN RESISTANCE; VALENTINE LEUKOCIDIN GENES; SOFT-TISSUE INFECTIONS; SKIN INFECTIONS; CHILDREN; PNEUMONIA; ABSCESSES; STRAINS; DISEASE; SEPSIS	BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA. METHODS: We enrolled adult patients with acute, purulent skin and soft-tissue infections presenting to 11 university-affiliated emergency departments during the month of August 2004. Cultures were obtained, and clinical information was collected. Available S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel electrophoresis, and detection of toxin genes. On MRSA isolates, we performed typing of the staphylococcal cassette chromosome mec (SCCmec), the genetic element that carries the mecA gene encoding methicillin resistance. RESULTS S. aureus: was isolated from 320 of 422 patients with skin and soft-tissue infections (76 percent). The prevalence of MRSA was 59 percent overall and ranged from 15 to 74 percent. Pulsed-field type USA300 isolates accounted for 97 percent of MRSA isolates; 74 percent of these were a single strain (USA300-0114). SCCmec type IV and the Panton-Valentine leukocidin toxin gene were detected in 98 percent of MRSA isolates. Other toxin genes were detected rarely. Among the MRSA isolates, 95 percent were susceptible to clindamycin, 6 percent to erythromycin, 60 percent to fluoroquinolones, 100 percent to rifampin and trimethoprim-sulfamethoxazole, and 92 percent to tetracycline. Antibiotic therapy was not concordant with the results of susceptibility testing in 100 of 175 patients with MRSA infection who received antibiotics (57 percent). Among methicillin-susceptible S. aureus isolates, 31 percent were USA300 and 42 percent contained pvl genes. CONCLUSIONS: MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the treatment of skin and soft-tissue infections, clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage.	Olive View UCLA Med Ctr, Dept Emergency Med, Sylmar, CA 91342 USA; Olive View UCLA Med Ctr, Div Infect Dis, Sylmar, CA 91342 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centers for Disease Control & Prevention - USA	Moran, GJ (corresponding author), Olive View UCLA Med Ctr, Dept Emergency Med, 14445 Olive View Dr,N Annex, Sylmar, CA 91342 USA.	idnet@ucla.edu		Sullivan, D. Matthew/0000-0001-5537-6986; Chiang, William/0000-0003-3562-8896	PHS HHS [U50/CCU912342] Funding Source: Medline; NCPDCID CDC HHS [U01 CI000353] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NCPDCID CDC HHS		Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Bannerman TM, 2003, MANUAL CLIN MICROBIO, P384; BERNARD P, 1989, ARCH DERMATOL, V125, P779, DOI 10.1001/archderm.125.6.779; Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472; CHAMBERS HF, 1991, INFECT CONT HOSP EP, V12, P29, DOI 10.2307/30147086; Chavez-Bueno S, 2005, ANTIMICROB AGENTS CH, V49, P2283, DOI 10.1128/AAC.49.6.2283-2288.2005; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Drinkovic D, 2001, J ANTIMICROB CHEMOTH, V48, P315, DOI 10.1093/jac/48.2.315; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Frazee BW, 2005, ANN EMERG MED, V45, P311, DOI 10.1016/j.annemergmed.2004.10.011; Fridkin SK, 2005, NEW ENGL J MED, V352, P2362; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Garner JS, 1996, AM J INFECT CONTROL, V24, P24; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Issartel B, 2005, J CLIN MICROBIOL, V43, P3203, DOI 10.1128/JCM.43.7.3203-3207.2005; Kaplan SL, 2005, PEDIATR INFECT DIS J, V24, P457, DOI 10.1097/01.inf.0000164162.00163.9d; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mishaan AMA, 2005, PEDIATR INFECT DIS J, V24, P201, DOI 10.1097/01.inf.0000151107.29132.70; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Moran GJ, 2005, EMERG INFECT DIS, V11, P928; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; *NAT COMM CLIN LAB, 2004, M1000S14 NAT COMM CL; *NAT COMM CLIN LAB, 2006, M100S16 NAT COMM CL; Nathwani D, 2005, INT J ANTIMICROB AG, V25, P185, DOI 10.1016/j.ijantimicag.2004.11.006; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Rybak MJ, 2005, PHARMACOTHERAPY, V25, P74, DOI 10.1592/phco.25.1.74.55620; Siberry GK, 2003, CLIN INFECT DIS, V37, P1257, DOI 10.1086/377501; Talan DA, 1998, ANN EMERG MED, V32, P703, DOI 10.1016/S0196-0644(98)70071-X; Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005; Yamasaki O, 2005, CLIN INFECT DIS, V40, P381, DOI 10.1086/427290; Zinderman CE, 2004, EMERG INFECT DIS, V10, P941, DOI 10.3201/eid1005.030604; 2003, MMWR MORB MORTAL WK, V52, P88	39	1777	1837	1	332	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2006	355	7					666	674		10.1056/NEJMoa055356	http://dx.doi.org/10.1056/NEJMoa055356			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074AN	16914702	Bronze			2022-12-01	WOS:000239784500005
J	Marum, E; Taegtmeyer, M; Chebet, K				Marum, Elizabeth; Taegtmeyer, Miriam; Chebet, Kenneth			Scale-up of voluntary HIV counseling and testing in Kenya	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Ctr Dis Control & Prevent, US Hlth & Human Serv, Global AIDS Program, Nairobi, Kenya; Liverpool Voluntary Counseling & Testing & Care, Nairobi, Kenya; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Natl AIDS & STD Control Programme, Nairobi, Kenya	Liverpool School of Tropical Medicine; University of Liverpool	Marum, E (corresponding author), Ctr Dis Control & Prevent, US Hlth & Human Serv, Global AIDS Program, POB 606,00621 Village Market, Nairobi, Kenya.	emarum@ke.cdc.gov		Taegtmeyer, Miriam/0000-0002-5377-2536				Arthur GR, 2005, JAIDS-J ACQ IMM DEF, V40, P329, DOI 10.1097/01.qai.0000166376.23846.38; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Forsythe S, 2002, HEALTH POLICY PLANN, V17, P187, DOI 10.1093/heapol/17.2.187; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; *GOV KEN, 2001, NAT GUID VOL COUNS T; *GOV KEN MIN HLTH, 2001, AIDS KEN BACKGR PROJ; *GOV KEN MIN PLANN, 2003, DEM HLTH SURV; Kanal Koum, 2005, AIDS Res Ther, V2, P5, DOI 10.1186/1742-6405-2-5; Kim JY, 2005, NEW ENGL J MED, V353, P2392, DOI 10.1056/NEJMe058261; LARA AM, 2004, INT AIDS EC NETW 3 I; MARUM E, 2002, AIDS AFRICA, P527; MUTURA C, 2005, CDC HIV DIAGN C MARC; *NAT AIDS STD CONT, 2005, NAT REG VCT SIT KEN; *NAT AIDS STD CONT, 2004, KEN NAT STRAT VCT SC; *NAT COUNC POP DEV, 1999, DEM HLTH SURV 1998; National AIDS and STD Control Programme (NASCOP)/Ministry of Health, 2005, AIDS KEN TRENDS INT; OCHIENG E, 2005, INT C AIDS STDS AFR; *POP COUNC FAM HLT, 1999, HIV AIDS COUNS TEST; Taegtmeyer M, 2006, T ROY SOC TROP MED H, V100, P305, DOI 10.1016/j.trstmh.2005.06.001; Taegtmeyer M, 2003, INT C AIDS STDS AFR; Taegtmeyer M., 2003, QUALITY ASSURANCE RE; TUKEI P, 2002, 12 ASS KEN MED LAB S; *WHO, 1997, JOINT UN PROGR HIV A, P72	23	51	52	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2006	296	7					859	862		10.1001/jama.296.7.859	http://dx.doi.org/10.1001/jama.296.7.859			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	073SR	16905791				2022-12-01	WOS:000239763400026
J	Guo, WJ; Pylayeva, Y; Pepe, A; Yoshioka, T; Muller, WJ; Inghirami, G; Giancotti, FG				Guo, Wenjun; Pylayeva, Yuliya; Pepe, Angela; Yoshioka, Toshiaki; Muller, William J.; Inghirami, Giorgio; Giancotti, Filippo G.			beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis	CELL			English	Article							HUMAN-BREAST-CANCER; NF-KAPPA-B; ALPHA-6-BETA-4 INTEGRIN; C-JUN; ALPHA(6)BETA(4) INTEGRIN; CARCINOMA INVASION; NEU ONCOGENE; CELLS; STAT3; PROLIFERATION	Amplification of the ErbB2 locus, which encodes a receptor tyrosine kinase, is common in aggressive breast tumors and correlates with poor prognosis. The mechanisms underlying ErbB2-mediated breast carcinoma progression remain incompletely defined. To examine the role of the signaling and cell-adhesion receptor beta 4 integrin during ErbB2-mediated tumorigenesis, we introduced a targeted deletion of the beta 4 signaling domain into a mouse model of ErbB2-induced mammary carcinoma. Loss of beta 4 signaling suppresses mammary tumor onset and invasive growth. Ex vivo studies indicate that beta 4 forms a complex with ErbB2 and enhances activation of the transcription factors STAT3 and c-Jun. STAT3 contributes to disruption of epithelial adhesion and polarity, while c-Jun is required for hyperproliferation. Finally, deletion of the beta 4 signaling domain enhances the efficacy of ErbB2-targeted therapy. These results indicate that beta 4 integrin promotes tumor progression by amplifying ErbB2 signaling and identify beta 4 as a potential target for molecular therapy of breast cancer.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Cornell Univ, Sloan Kettering Div, Weill Grad Sch Med Sci, New York, NY 10021 USA; McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; Univ Turin, Dept Pathol, I-10060 Turin, Italy; Univ Turin, Ctr Expt Res & Med Studies, I-10060 Turin, Italy; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Inst Canc, New York, NY 10016 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; McGill University; Royal Victoria Hospital; University of Turin; University of Turin; New York University; New York University	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	f-giancotti@ski.mskcc.org			NCI NIH HHS [R37 CA58976, P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, R37CA058976] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bachelder RE, 1999, J BIOL CHEM, V274, P20733, DOI 10.1074/jbc.274.29.20733; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; BERGER MS, 1988, CANCER RES, V48, P1238; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; GARNALLO C, 1993, AM J PATHOL, V142, P987; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Ludes-Meyers JH, 2001, ONCOGENE, V20, P2771, DOI 10.1038/sj.onc.1204377; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Moasser MM, 2001, CANCER RES, V61, P7184; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023	46	358	374	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 11	2006	126	3					489	502		10.1016/j.cell.2006.05.047	http://dx.doi.org/10.1016/j.cell.2006.05.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901783	Bronze			2022-12-01	WOS:000239883400010
J	Feachem, RGA; Sabot, OJ				Feachem, Richard G. A.; Sabot, Oliver J.			An examination of the Global Fund at 5 years	LANCET			English	Editorial Material									Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland; Univ Calif San Francisco & Berkeley, Inst Global Hlth, San Francisco, CA USA	University of California System; University of California San Francisco	Sabot, OJ (corresponding author), Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1214 Geneva, Switzerland.	oliver.sabot@theglobalfund.org						*AFR DEV BANK, 2006, 2004 ANN PORTF PERF; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2004, HUM RES HLTH OV CRIS; Brugha R., 2005, GLOBAL FUND TRACKING; Chen L, 2005, B WORLD HEALTH ORGAN, V83, P243; *GOV ACC OFF, 2005, GAO05639; Komatsu R, 2006, INVESTING IMPACT MID; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; *POL STRAT COMM GL, 2006, BOARD M DOC 13 BOARD; SHAKOW A, GLOBAL FUND WORLD BA; Stillman K, 2005, SYSTEMWIDE EFFECTS G	11	22	24	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2006	368	9534					537	540		10.1016/S0140-6736(06)69163-0	http://dx.doi.org/10.1016/S0140-6736(06)69163-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	071AL	16890842				2022-12-01	WOS:000239569000038
J	Freedman, J				Freedman, Julie			Heart opening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												julie.freedman@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2006	296	5					483	484		10.1001/jama.296.5.483	http://dx.doi.org/10.1001/jama.296.5.483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069YW	16882949				2022-12-01	WOS:000239486900001
J	Carlson, CM; Endrizzi, BT; Wu, JH; Ding, XJ; Weinreich, MA; Walsh, ER; Wani, MA; Lingrel, JB; Hogquist, KA; Jameson, SC				Carlson, Corey M.; Endrizzi, Bart T.; Wu, Jinghai; Ding, Xiaojie; Weinreich, Michael A.; Walsh, Elizabeth R.; Wani, Maqsood A.; Lingrel, Jerry B.; Hogquist, Kristin A.; Jameson, Stephen C.			Kruppel-like factor 2 regulates thymocyte and T-cell migration	NATURE			English	Article							TRANSCRIPTION FACTOR; LYMPHOCYTE EGRESS; THYMIC EMIGRANTS; L-SELECTIN; EXPRESSION; LKLF; CD69; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; QUIESCENCE	Mammalian Kruppel-like transcription factors are implicated in regulating terminal differentiation of several tissue types(1-3). Deficiency in Kruppel-like factor (KLF) 2 ( also known as LKLF) leads to a massive loss of the peripheral T-cell pool(4), suggesting KLF2 regulates T-cell quiescence and survival(4-7). Here we show, however, that KLF2 is essential for T-cell trafficking. KLF2-deficient (Klf2(-/-)) thymocytes show impaired expression of several receptors required for thymocyte emigration and peripheral trafficking, including the sphingosine-1-phosphate (S1P) receptor S1P(1), CD62L and beta(7) integrin. Furthermore, KLF2 both binds and transactivates the promoter for S1P(1) - a receptor that is critical for thymocyte egress and recirculation through peripheral lymphoid organs. Our findings suggest that KLF2 serves to license mature T cells for trafficking from the thymus and recirculation through secondary lymphoid tissues.	Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati	Hogquist, KA (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu; james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687				Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Di Santo JP, 2001, NAT IMMUNOL, V2, P667, DOI 10.1038/90598; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Haaland RE, 2005, MOL IMMUNOL, V42, P627, DOI 10.1016/j.molimm.2004.09.012; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Schober SL, 1999, J IMMUNOL, V163, P3662; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Wagner N, 1998, EUR J IMMUNOL, V28, P3832, DOI 10.1002/(SICI)1521-4141(199811)28:11<3832::AID-IMMU3832>3.0.CO;2-J; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060	30	405	420	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					299	302		10.1038/nature04882	http://dx.doi.org/10.1038/nature04882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855590	Bronze			2022-12-01	WOS:000239122100038
J	Dellis, O; Dedos, SG; Tovey, SC; Taufiq-Ur-Rahman; Dubel, SJ; Taylor, CW				Dellis, Olivier; Dedos, Skarlatos G.; Tovey, Stephen C.; Taufiq-Ur-Rahman; Dubel, Stefan J.; Taylor, Colin W.			Ca2+ entry through plasma membrane IP3 receptors	SCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; DT40 B-LYMPHOCYTES; SIGNAL-TRANSDUCTION; CHANNELS; CALCIUM; RELEASE; TRISPHOSPHATE; INHIBITION; RETICULUM; MEDIATE	Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) release calcium ions, Ca2+, from intracellular stores, but their roles in mediating Ca2+ entry are unclear. IP3 stimulated opening of very few (1.9 +/- 0.2 per cell) Ca2+-permeable channels in whole-cell patch-clamp recording of DT40 chicken or mouse B cells. Activation of the B cell receptor (BCR) in perforated-patch recordings evoked the same response. IP3 failed to stimulate intracellular or plasma membrane ( PM) channels in cells lacking IP3 R. Expression of IP3R restored both responses. Mutations within the pore affected the conductances of IP3-activated PM and intracellular channels similarly. An impermeant pore mutant abolished BCR-evoked Ca2+ signals, and PM IP(3)Rs were undetectable. After introduction of an alpha-bungarotoxin binding site near the pore, PM IP(3)Rs were modulated by extracellular alpha-bungarotoxin. IP(3)Rs are unusual among endoplasmic reticulum proteins in being also functionally expressed at the PM, where very few IP(3)Rs contribute substantially to the Ca2+ entry evoked by the BCR.	Dept Pharmacol, Cambridge CB2 1PD, England		Taylor, CW (corresponding author), Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Dedos, Skarlatos G./A-5345-2008; rahman, taufiq/E-9806-2013; Dellis, Olivier/E-8501-2011; Taylor, Colin/G-2447-2010	Dedos, Skarlatos G./0000-0002-0432-338X; rahman, taufiq/0000-0003-3830-5160; Dellis, Olivier/0000-0003-0377-9163; Taylor, Colin/0000-0001-7771-1044	Biotechnology and Biological Sciences Research Council [BB/C005201/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Dalbey R.E., 2002, PROTEIN TARGETING TR; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; KALINOSKI DL, 1992, BIOCHEM J, V281, P449, DOI 10.1042/bj2810449; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; MARSHALL ICB, 1994, BIOCHEM J, V301, P591, DOI 10.1042/bj3010591; Morita T, 2004, BIOCHEM J, V382, P793, DOI 10.1042/BJ20031970; PALADE P, 1989, MOL PHARMACOL, V36, P664; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Riley AM, 2004, BIOCONJUGATE CHEM, V15, P278, DOI 10.1021/bc034214s; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TAKAHASHI M, 1994, J BIOL CHEM, V269, P369; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; VACA L, 1995, AM J PHYSIOL-CELL PH, V269, pC733, DOI 10.1152/ajpcell.1995.269.3.C733; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Vazquez G, 2002, EMBO J, V21, P4531, DOI 10.1093/emboj/cdf467; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	28	148	153	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					229	233		10.1126/science.1125203	http://dx.doi.org/10.1126/science.1125203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840702				2022-12-01	WOS:000239008000046
J	Grant, PR; Grant, BR				Grant, Peter R.; Grant, B. Rosemary			Evolution of character displacement in Darwin's finches	SCIENCE			English	Article							ISLA DAPHNE MAJOR; VARIABLE ENVIRONMENT; ADAPTIVE RADIATION; NATURAL-SELECTION; POPULATION; GALAPAGOS; GEOSPIZA; HERITABILITY; DIVERGENCE; RELEASE	Competitor species can have evolutionary effects on each other that result in ecological character displacement; that is, divergence in resource-exploiting traits such as jaws and beaks. Nevertheless, the process of character displacement occurring in nature, from the initial encounter of competitors to the evolutionary change in one or more of them, has not previously been investigated. Here we report that a Darwin's finch species (Geospiza fortis) on an undisturbed Galapagos island diverged in beak size from a competitor species ( G. magnirostris) 22 years after the competitor's arrival, when they jointly and severely depleted the food supply. The observed evolutionary response to natural selection was the strongest recorded in 33 years of study, and close to the value predicted from the high heritability of beak size. These findings support the role of competition in models of community assembly, speciation, and adaptive radiations.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Grant, PR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	prgrant@princeton.edu						Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; BENKMAN CW, 1987, ECOL MONOGR, V57, P251, DOI 10.2307/2937083; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; BOAG PT, 1984, ECOL MONOGR, V54, P463, DOI 10.2307/1942596; BOAG PT, 1983, EVOLUTION, V37, P877, DOI 10.1111/j.1558-5646.1983.tb05618.x; BOAG PT, 1984, BIOL J LINN SOC, V22, P243, DOI 10.1111/j.1095-8312.1984.tb01679.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; GIBBS HL, 1987, J ANIM ECOL, V56, P797, DOI 10.2307/4949; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Grant P.R., 1999, ECOLOGY EVOLUTION DA; Grant Peter R., 1996, P343, DOI 10.1016/B978-012178075-3/50013-1; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, 1995, EVOLUTION, V49, P229, DOI 10.1111/j.1558-5646.1995.tb02235.x; Grant PR, 2001, GENETICA, V112, P359, DOI 10.1023/A:1013363032724; GRANT PR, 1981, ANIM BEHAV, V29, P785, DOI 10.1016/S0003-3472(81)80012-7; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; GRANT PR, 1994, SCIENCE, V266, P802; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Lack D., 1947, DARWINS FINCHES; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.2307/2408842, 10.1111/j.1558-5646.1983.tb00236.x]; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; LOSOS JB, 1990, EVOLUTION, V44, P588; Pfennig DW, 2003, ECOLOGY, V84, P1288, DOI 10.1890/0012-9658(2003)084[1288:ATOAHF]2.0.CO;2; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; PRICE TD, 1984, NATURE, V309, P787, DOI 10.1038/309787a0; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; SCHLUTER D, 1985, SCIENCE, V227, P1056, DOI 10.1126/science.227.4690.1056; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schoener T.W., 1984, P254	32	613	631	6	702	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					224	226		10.1126/science.1128374	http://dx.doi.org/10.1126/science.1128374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840700				2022-12-01	WOS:000239008000044
J	Karbowski, M; Norris, KL; Cleland, MM; Jeong, SY; Youle, RJ				Karbowski, Mariusz; Norris, Kristi L.; Cleland, Megan M.; Jeong, Seon-Yong; Youle, Richard J.			Role of Bax and Bak in mitochondrial morphogenesis	NATURE			English	Article							CELL-SURVIVAL; APOPTOSIS; FUSION; DYNAMICS; DIVISION; FISSION; DEATH; ACTIVATION; PROTEIN; ABSENCE	Bcl-2 family proteins are potent regulators of programmed cell death. Although their intracellular localization to mitochondria and the endoplasmic reticulum has focused research on these organelles, how they function remains unknown. Two members of the Bcl-2 family, Bax and Bak, change intracellular location early in the promotion of apoptosis to concentrate in focal clusters at sites of mitochondrial division. Here we report that in healthy cells Bax or Bak is required for normal fusion of mitochondria into elongated tubules. Bax seems to induce mitochondrial fusion by activating assembly of the large GTPase Mfn2 and changing its submitochondrial distribution and membrane mobility properties that correlate with different GTP-bound states of Mfn2. Our results show that Bax and Bak regulate mitochondrial dynamics in healthy cells and indicate that Bcl-2 family members may also regulate apoptosis through organelle morphogenesis machineries.	NINCDS, Biochem Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Karbowski, M (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, UMBI Bldg,725 W Lombard St, Baltimore, MD 21201 USA.	karbowsm@ninds.nih.gov; youler@ninds.nih.gov		Harwig, Megan/0000-0003-2140-5739	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002859, Z01NS002859] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; McCormick AL, 2003, J VIROL, V77, P631, DOI 10.1128/JVI.77.1.631-641.2003; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Poncet D, 2004, J BIOL CHEM, V279, P22605, DOI 10.1074/jbc.M308408200; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; van der Bliek AM, 2000, J CELL BIOL, V151, pF1, DOI 10.1083/jcb.151.2.F1; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	24	504	524	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					658	662		10.1038/nature05111	http://dx.doi.org/10.1038/nature05111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035996				2022-12-01	WOS:000241160500038
J	Badri, M; D Lawn, S; Wood, R				Badri, Motasim; D Lawn, Stephen; Wood, Robin			Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study	LANCET			English	Article							RESOURCE-POOR SETTINGS; PLASMA VIRAL LOAD; PROGNOSTIC VALUE; GAMBIAN PATIENTS; CELL COUNT; SURVIVAL; MORTALITY; RNA; SEROCONVERSION; PREDICTORS	Background In sub-Saharan Africa, data for short-term risk of AIDS or death, which might inform decisions about when to start antiretroviral therapy (ART), are scarce. Our aim was to investigate these risks in patients who had no access to ART or who were given zidovudine alone. Methods 6-month risks (%) of death, AIDS, and combined risk of AIDS and death (AIDS/death) were calculated according to CD4-cell count category of less than 200 cells per mu L, 200-350 cells per mu L, or greater than 350 cells per mu L, stratified by WHO clinical stages I and 2 combined, 3, or 4 in untreated patients (n=1399) seeking care in tertiary public-sector HIV clinics before widespread availability of ART in Cape Town, South Africa. Findings Risk of death for WHO stages 1 and 2 was 3.5% for those with less than 200 cells per mu L, 2.8% for 200-350 cells per mu L, and 1.2% for greater than 350 cells per mu L. The corresponding rates for WHO stage 3 were 10.8%, 4.3%, and 4.9% and for stage 4, 22.2%, 10.3%, and 13.8%. 52% (90) of deaths took place in patients without AIDS. 6-month risk of AIDS for WHO stages 1 and 2 was 3.5% for those with less than 200 cells per mu L, 1.6% for 200-350 cells per mu L, and zero for greater than 350 cells per mu L. The corresponding rates for those with WHO stage 3 disease were 17.4%, 7.0%, and 2.2%. Interpretation In this study, risk of AIDS in patients with a CD4-cell count of less than 200 cells per mu L or greater than 350 cells per mu L was similar to that previously reported from European cohorts, but was 1.9 times greater for those with CD4-cell counts of between 200 and 350 cells per mu L. The high death rate before development of AIDS and a high risk of AIDS in those with CD4-cell counts of 200-350 cells per mu L indicate that delay in initiation of ART is associated with increased morbidity and mortality. These findings might help to amend criteria for start of ART in resource-limited settings.	Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Clin Res Unit, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Badri, M (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	motasim.badri@hiv-research.org.za	Wood, Robin/G-8509-2011; Badri, Motasim/E-1141-2013	Badri, Motasim/0000-0002-5268-6492	Wellcome Trust [074641/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alabi AS, 2003, AIDS, V17, P1513, DOI 10.1097/00002030-200307040-00012; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/01.aids.0000096908.73209.5d, 10.1097/00002030-200401020-00006]; Bodri M, 2006, ANTIVIR THER, V11, P63; Bogaards JA, 2006, JAIDS-J ACQ IMM DEF, V41, P232, DOI 10.1097/01.qai.0000179457.46809.42; *BRIT HIV ASS, 2005, BHIVA GUID TREATM HI; CLEARY S, 2004, COST EFFECTIVENESS A; COLEBUNDERS R, 1991, J INFECT DIS, V164, P450, DOI 10.1093/infdis/164.3.450; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; European AIDS Clinical Society, EUR GUID CLIN MAN TR; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lepri AC, 1998, AIDS, V12, P1639, DOI 10.1097/00002030-199813000-00011; LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320; Malamba SS, 1999, AIDS, V13, P2555, DOI 10.1097/00002030-199912240-00009; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Operskalski EA, 1997, J ACQ IMMUN DEF SYND, V15, P243; Post FA, 2001, S AFR MED J, V91, P583; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; Ruiz L, 1996, AIDS, V10, pF39, DOI 10.1097/00002030-199609000-00001; Sabin CA, 1998, AIDS, V12, P1347, DOI 10.1097/00002030-199811000-00017; SCHLUCHTER MD, 1992, STAT MED, V11, P1861, DOI 10.1002/sim.4780111408; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; *US DEP HHS PAN CL, 2005, GUID US ANT AG HIV 1; WHITTLE H, 1992, AIDS, V6, P685, DOI 10.1097/00002030-199207000-00011; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; *WHO GUID DEV GROU, 2005, ANT DRUGS TREATM HIV; *WHO UNAIDS, 2005, PRESS REL HIV INF RA; WHO/UNAIDS, 2005, PROGR GLOB ACC HIV A; Wood R, 2005, SAMJ S AFR MED J, V95, P926; World Health Organization, 2003, SCAL ANT THER RES LT	34	81	87	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1254	1259		10.1016/S0140-6736(06)69117-4	http://dx.doi.org/10.1016/S0140-6736(06)69117-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027731				2022-12-01	WOS:000241058300032
J	Schmidt, MW; Vautravers, MJ; Spero, HJ				Schmidt, Matthew W.; Vautravers, Maryline J.; Spero, Howard J.			Rapid subtropical North Atlantic salinity oscillations across Dansgaard-Oeschger cycles	NATURE			English	Article							FRESH-WATER BALANCE; THERMOHALINE CIRCULATION; OXYGEN-ISOTOPE; TRANSPORT; OCEAN	Geochemical and sedimentological evidence suggest that the rapid climate warming oscillations of the last ice age, the Dansgaard - Oeschger cycles(1), were coupled to fluctuations in North Atlantic meridional overturning circulation through its regulation of poleward heat flux(2). The balance between cold meltwater from the north and warm, salty subtropical gyre waters from the south influenced the strength and location of North Atlantic overturning circulation during this period of highly variable climate(3-5). Here we investigate how rapid reorganizations of the ocean atmosphere system across these cycles are linked to salinity changes in the subtropical North Atlantic gyre. We combine Mg/Ca palaeothermometry and oxygen isotope ratio measurements on planktonic foraminifera across four Dansgaard - Oeschger cycles (spanning 45.9 - 59.2 kyr ago) to generate a seawater salinity proxy record from a subtropical gyre deep-sea sediment core. We show that North Atlantic gyre surface salinities oscillated rapidly between saltier stadial conditions and fresher interstadials, covarying with inferred shifts in the Tropical Atlantic hydrologic cycle(6) and North Atlantic overturning circulation. These salinity oscillations suggest a reduction in precipitation into the North Atlantic and/or reduced export of deep salty thermohaline waters during stadials. We hypothesize that increased stadial salinities preconditioned the North Atlantic Ocean for a rapid return to deep overturning circulation and high-latitude warming by contributing to increased North Atlantic surface-water density on interstadial transitions.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Cambridge, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England	University of California System; University of California Davis; University of Cambridge	Schmidt, MW (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	mschmidt@eas.gatech.edu		Mleneck-Vautravers, Maryline/0000-0003-2534-219X; Spero, Howard/0000-0001-5465-8607				Boyle EA, 2000, QUATERNARY SCI REV, V19, P255, DOI 10.1016/S0277-3791(99)00065-7; Broecker WS, 1989, PALEOCEANOGRAPHY, V4, P207, DOI 10.1029/PA004i002p00207; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI [DOI 10.5670/0CEAN0G.1991.07, 10.5670/oceanog.1991.07, DOI 10.5670/OCEANOG.1991.07]; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Craig H., 1965, STABLE ISOTOPES OCEA, P9, DOI DOI 10.1109/ISSRE.1993.624301; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; DEUSER WG, 1981, PALAEOGEOGR PALAEOCL, V33, P103, DOI 10.1016/0031-0182(81)90034-1; Hastenrath S, 2002, INT J CLIMATOL, V22, P347, DOI 10.1002/joc.739; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Latif M, 2000, J CLIMATE, V13, P1809, DOI 10.1175/1520-0442(2000)013<1809:L>2.0.CO;2; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lohmann G, 2003, TELLUS A, V55, P438, DOI 10.1034/j.1600-0870.2003.00028.x; OPPO DW, 1995, PALEOCEANOGRAPHY, V10, P901, DOI 10.1029/95PA02089; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Prange M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015337; Rasmussen TL, 2004, PALAEOGEOGR PALAEOCL, V210, P101, DOI 10.1016/j.palaeo.2004.04.005; Romanova V, 2004, CLIM DYNAM, V22, P527, DOI 10.1007/s00382-004-0395-z; Schmidt G. A., 1999, GLOBAL SEAWATER OXYG; Schmidt MW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC000957; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Schmittner A, 2000, GEOPHYS RES LETT, V27, P1163, DOI 10.1029/1999GL011048; SCHMITTNER A, 2002, PALEOCEANOGRAPHY, V17, DOI DOI 10.1029/2000PA; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Thunell R, 1999, GEOLOGY, V27, P843, DOI 10.1130/0091-7613(1999)027<0843:SSTAAW>2.3.CO;2; Vautravers MJ, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000966; Vellinga M, 2004, J CLIMATE, V17, P4498, DOI 10.1175/3219.1; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; ZAUCKER F, 1992, J GEOPHYS RES-ATMOS, V97, P2765, DOI 10.1029/91JD01699	30	70	73	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					561	564		10.1038/nature05121	http://dx.doi.org/10.1038/nature05121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024090				2022-12-01	WOS:000240988200040
J	Mouchel, CF; Osmont, KS; Hardtke, CS				Mouchel, Celine F.; Osmont, Karen S.; Hardtke, Christian S.			BRX mediates feedback between brassinosteroid levels and auxin signalling in root growth	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; CELL-PROLIFERATION; REGULATED GENES; BREVIS-RADIX; ELONGATION; EFFLUX; CYTOCHROME-P450; CYTOKININ; DIVISION	Brassinosteroid and auxin decisively influence plant development, and overlapping transcriptional responses to these phytohormones suggest an interaction between the two pathways(1-3). However, whether this reflects direct feedback or merely parallel inputs on common targets is unclear. Here we show that in Arabidopsis roots, this interaction is mediated by BREVIS RADIX (BRX), which is required for optimal root growth(4). We demonstrate that the brx phenotype results from a root-specific deficiency of brassinosteroid and is due to reduced, BRX-dependent expression of a rate-limiting enzyme in brassinosteroid biosynthesis. Unexpectedly, this deficiency affects the root expression level of similar to 15% of all Arabidopsis genes, but the transcriptome profile can be restored to wild type by brassinosteroid treatment. Thus, proper brassinosteroid levels are required for the correct expression of many more genes than previously suspected. Moreover, embryonic or post-embryonic brassinosteroid application fully or partially, respectively, rescues the brx phenotype. Further, auxin-responsive gene expression is globally impaired in brx, demonstrating that brassinosteroid levels are rate-limiting for auxin-responsive transcription. BRX expression is strongly induced by auxin and mildly repressed by brassinolide, which means that BRX acts at the nexus of a feedback loop that maintains threshold brassinosteroid levels to permit optimal auxin action.	Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	University of Lausanne	Hardtke, CS (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore Bldg, CH-1015 Lausanne, Switzerland.	christian.hardtke@unil.ch	Hardtke, Christian S/B-5861-2009	Hardtke, Christian S./0000-0003-3203-1058				Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Briggs GC, 2006, PLANT PHYSIOL, V140, P1306, DOI 10.1104/pp.105.075382; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Leyser O, 2002, ANNU REV PLANT BIOL, V53, P377, DOI 10.1146/annurev.arplant.53.100301.135227; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Mussig C, 2002, PLANT PHYSIOL, V129, P1241, DOI 10.1104/pp.011003; Nakamura A, 2003, PLANT PHYSIOL, V133, P1843, DOI 10.1104/pp.103.030031; Nakamura A, 2006, PLANT J, V45, P193, DOI 10.1111/j.1365-313X.2005.02582.x; NERNHAUSER JL, 2004, PLOS BIOL, V2, pE258; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Sieberer T, 2003, CURR BIOL, V13, P837, DOI 10.1016/S0960-9822(03)00327-0; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang SC, 2005, PLANT CELL, V17, P1979, DOI 10.1105/tpc.105.031096; ZUREK DM, 1994, PLANT PHYSIOL, V104, P505, DOI 10.1104/pp.104.2.505	30	196	211	7	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					458	461		10.1038/nature05130	http://dx.doi.org/10.1038/nature05130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006513				2022-12-01	WOS:000240798800046
J	O'Malley, BW				O'Malley, Bert W.			Little molecules with big goals	SCIENCE			English	Editorial Material							COACTIVATOR		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu						Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; ONATE SA, 1995, SCIENCE, V270, P1354; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019	7	55	56	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1749	1750		10.1126/science.1132509	http://dx.doi.org/10.1126/science.1132509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990541				2022-12-01	WOS:000240655700036
J	Raghu, S; Anderson, RC; Daehler, CC; Davis, AS; Wiedenmann, RN; Simberloff, D; Mack, RN				Raghu, S.; Anderson, R. C.; Daehler, C. C.; Davis, A. S.; Wiedenmann, R. N.; Simberloff, D.; Mack, R. N.			Adding biofuels to the invasive species fire?	SCIENCE			English	Editorial Material							GRASSES		Illinois Nat Hist Survey, Champaign, IL 61820 USA; Illinois State Univ, Normal, IL 61709 USA; Univ Hawaii Manoa, Honolulu, HI 96822 USA; ARS, USDA, Invas Weed Management Unit, Urbana, IL 61801 USA; Univ Arkansas, Fayetteville, AR 72701 USA; Univ Tennessee, Knoxville, TN 37996 USA; Washington State Univ, Pullman, WA 99164 USA	Illinois Natural History Survey; Illinois State University; University of Hawaii System; University of Hawaii Manoa; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville; University of Tennessee System; University of Tennessee Knoxville; Washington State University	Raghu, S (corresponding author), Illinois Nat Hist Survey, Champaign, IL 61820 USA.	raghu@uiuc.edu	Raghu, S./A-1281-2010	Raghu, S./0000-0001-5843-5435; Davis, Adam/0000-0002-7196-1197				[Anonymous], JOURNAL, V38, P705, DOI [10.1016/j.ijforecast.2021.11.001, DOI 10.1016/J.IJFORECAST.2021.11.001, DOI 10.1016/B978-012257305-7/50081-3]; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dudley T. L., 2000, INVASIVE PLANTS CALI, P53; Ewel JJ, 1999, BIOSCIENCE, V49, P619, DOI 10.2307/1313438; Forman J, 2003, PLANT INVASIONS: ECOLOGICAL THREATS AND MANAGEMENT SOLUTIONS, P17; GRAY AJ, 1991, ADV ECOL RES, V21, P1, DOI 10.1016/S0065-2504(08)60096-3; Heaton E. A., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P433, DOI 10.1023/B:MITI.0000038848.94134.be; Hilbeck A., 2004, ENV RISK ASSESSMENT; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; MCWHORTER CG, 1993, WEED SCI, V41, P669, DOI 10.1017/S0043174500076499; Molofsky J., 1999, Biological Invasions, V1, P181, DOI 10.1023/A:1010091227793; Moody ML, 2002, P NATL ACAD SCI USA, V99, P14867, DOI 10.1073/pnas.172391499; *NAT EN POL DEV GR, REL AFF ENV SOUND EN; *NAT RES COUNC, 2002, PRED INV NON PLANTS, P194; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Randall JM, 1996, INVASIVE PLANTS WEED; Sheppard A. W., 2003, Biocontrol News and Information, V24, p91N	20	243	250	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1742	1742		10.1126/science.1129313	http://dx.doi.org/10.1126/science.1129313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990536				2022-12-01	WOS:000240655700030
J	Amin, J; Law, MG; Bartlett, M; Kaldor, JM; Dore, GJ				Amin, Janaki; Law, Matthew G.; Bartlett, Mark; Kaldor, John M.; Dore, Gregory J.			Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study	LANCET			English	Article							LIVER-RELATED MORTALITY; POSITIVE BLOOD-DONORS; HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; NATURAL-HISTORY; FOLLOW-UP; NON-A; COHORT; PREVALENCE; AUSTRALIA	Background Hepatitis B and hepatitis C virus infections are common causes of death related to liver disease. In this large study, we aimed to investigate all cause mortality of the viruses in a community-based setting. Methods In the study population, 39 109 people had hepatitis B, 75 834 had hepatitis C, and 2604 had hepatitis B and hepatitis C co-infection, notified to the New South Wales state health department, Australia, between 1990 and 2002. Their data were probabilistically linked to the National Death Index. Standardised mortality ratios for all causes of death were calculated and adjusted for age, sex, and calendar year. Results The number of deaths identified by the linkage were 1233 (3.2%) for hepatitis B, 4008 (5.3)% for hepatitis C, and 186 (7.1)% for hepatitis B and C co-infection. Raised risk of liver-related death (standardised mortality ratios 12.2, 95% CI 10.7-13.9; 16.8, 15.4-18.3, and 32.9, 23.1-46.7, for hepatitis B, hepatitis Q and hepatitis B and C co-infected patients, respectively) and drug-induced death (1.4, 1.0-2.0; 19.3, 18.1-20.5; and 24.7, 18.2-33.5, respectively) were detected. In people with hepatitis C, raised risk of dying from drug-related causes was significantly greater than from liver-related causes (p=0.012), with the greatest excess risk in women aged 15-24 years (56.9, 39.2-79.9). Interpretation All groups had increased risk of liver-related death compared with the standard population, with the greatest excess in people diagnosed with hepatitis B and hepatitis C co-infection. Our data highlight that young people with hepatitis C and with co-infection face a higher mortality risk from continued drug use than from their infection, whereas the main cause of hepatitis B death was liver related.	Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute	Amin, J (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia.	jamin@nchecr.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; Kaldor, John M/D-4545-2011	Dore, Gregory John/0000-0002-4741-2622; Amin, Janaki/0000-0003-2161-9366; Law, Matthew/0000-0002-3540-8837				*AUSTR BUR STAT, 2002, DRUG IND DEATHS GUID; Backmund M, 2003, EUR ADDICT RES, V9, P45, DOI 10.1159/000067733; BEASLEY RP, 1981, LANCET, V2, P1129; Breslow NE., 1987, STATISTICAL METHODS, P48; BRUIX J, 1989, LANCET, V2, P1004; Chen G, 2005, INT J EPIDEMIOL, V34, P132, DOI 10.1093/ije/dyh339; COLOMBO M, 1989, LANCET, V2, P1006; Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214; Crook PD, 2003, INT J EPIDEMIOL, V32, P118, DOI 10.1093/ije/dyg039; Day C, 2003, ADDICTION, V98, P93, DOI 10.1046/j.1360-0443.2003.00266.x; Di Marco V, 1999, HEPATOLOGY, V30, P257, DOI 10.1002/hep.510300109; Dore GJ, 2003, J CLIN VIROL, V26, P171, DOI 10.1016/S1386-6532(02)00116-6; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; Gronbaek K, 1999, J HEPATOL, V31, P800, DOI 10.1016/S0168-8278(99)80280-3; Harris HE, 2002, BMJ-BRIT MED J, V324, P450, DOI 10.1136/bmj.324.7335.450; *IARC, 1994, HEP VIR; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kaldor JM, 1996, MED J AUSTRALIA, V165, P322, DOI 10.5694/j.1326-5377.1996.tb124993.x; Kamitsukasa H, 2005, HEPATOLOGY, V41, P819, DOI 10.1002/hep.20648; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Law MG, 2003, INT J EPIDEMIOL, V32, P717, DOI 10.1093/ije/dyg101; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; *NAT CTR HIV EP CL, HIV AIDS VIR HEP SEX; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; *NSW HLTH, NOT DIS RESP PROT NS; O'Sullivan BG, 2004, AUST NZ J PUBL HEAL, V28, P212, DOI 10.1111/j.1467-842X.2004.tb00697.x; Osella AR, 2000, INT J EPIDEMIOL, V29, P922, DOI 10.1093/ije/29.5.922; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; SIMONETTI RG, 1989, LANCET, V2, P1338; Tanaka H, 2004, INT J CANCER, V112, P1075, DOI 10.1002/ijc.20507; US Department of Energy, 2018, AV ANN FUEL US VEH T; Weatherburn D, 2003, ADDICTION, V98, P83, DOI 10.1046/j.1360-0443.2003.00248.x; Xu B, 2003, J GASTROEN HEPATOL, V18, P1345, DOI 10.1046/j.1440-1746.2003.03187.x	39	198	202	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					938	945		10.1016/S0140-6736(06)69374-4	http://dx.doi.org/10.1016/S0140-6736(06)69374-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962883				2022-12-01	WOS:000240502300031
J	King, DA; Peckham, C; Waage, JK; Brownlie, J; Woolhouse, MEJ				King, D. A.; Peckham, C.; Waage, J. K.; Brownlie, J.; Woolhouse, M. E. J.			Infectious diseases: Preparing for the future	SCIENCE			English	Editorial Material									Univ Edinburgh, Ctr Infect Dis, Edinburgh EH9 3JT, Midlothian, Scotland; Dept Trade & Ind, Off Sci & Innovat, London SW1H 0ET, England; Inst Child Hlth, London WC1N 1EH, England; Univ London Imperial Coll Sci & Technol, Dept Agr Sci, London SW7 2AZ, England; Univ London Royal Vet Coll, Hatfield AL9 7TA, Herts, England; Univ Edinburgh, Ctr Infect Dis, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh; University of London; University College London; Imperial College London; University of London; University of London Royal Veterinary College; University of Edinburgh	Woolhouse, MEJ (corresponding author), Univ Edinburgh, Ctr Infect Dis, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk	peckham, catherine s/I-6300-2013					[Anonymous], 2005, MILLENNIUM DEV GOALS; BRAHMBHATT M, AVIAN HUMAN PANDEMIC; Enserink M, 2003, SCIENCE, V302, P2045, DOI 10.1126/science.302.5653.2045; Fouchier R, 2005, NATURE, V435, P419, DOI 10.1038/435419a; World Health Organisation (WHO), DAT; 2006, INFECT DIS PREPARING	6	116	125	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1392	1393		10.1126/science.1129134	http://dx.doi.org/10.1126/science.1129134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081WQ	16959992				2022-12-01	WOS:000240348700025
J	Yi, P; Han, Z; Li, XM; Olson, EN				Yi, Peng; Han, Zhe; Li, Xiumin; Olson, Eric N.			The mevalonate pathway controls heart formation in Drosophila by isoprenylation of G gamma 1	SCIENCE			English	Article							G-PROTEIN; NETWORK	The early morphogenetic mechanisms involved in heart formation are evolutionarily conserved. A screen for genes that control Drosophila heart development revealed a cardiac defect in which pericardial and cardial cells dissociate, which causes loss of cardiac function and embryonic lethality. This phenotype resulted from mutations in the genes encoding HMG-CoA reductase, downstream enzymes in the mevalonate pathway, and G protein G gamma 1, which is geranylgeranylated, thus representing an end point of isoprenoid biosynthesis. Our findings reveal a cardial cell-autonomous requirement of G gamma 1 geranylgeranylation for heart formation and suggest the involvement of the mevalonate pathway in congenital heart disease.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Han, Z (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	zhe.han@utsouthwestern.edu; eric.olson@utsouthwestern.edu	li, xiu/GXV-1745-2022; Yi, Peng/C-3057-2012	Han, Zhe/0000-0002-5177-7798				Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Edison RJ, 2005, NEW ENGL J MED, V352, P2759, DOI 10.1056/NEJM200506303522622; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; MUNTZ KH, 1992, MOL BIOL CELL, V3, P49, DOI 10.1091/mbc.3.1.49; OHASHI M, 1994, J BIOL CHEM, V269, P24897; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871	13	66	67	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1301	1303		10.1126/science.1127704	http://dx.doi.org/10.1126/science.1127704			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16857902				2022-12-01	WOS:000240313500045
J	Chourrout, D; Delsuc, F; Chourrout, P; Edvardsen, RB; Rentzsch, F; Renfer, E; Jensen, MF; Zhu, B; de Jong, P; Steele, RE; Technau, U				Chourrout, D.; Delsuc, F.; Chourrout, P.; Edvardsen, R. B.; Rentzsch, F.; Renfer, E.; Jensen, M. F.; Zhu, B.; de Jong, P.; Steele, R. E.; Technau, U.			Minimal ProtoHox cluster inferred from bilaterian and cnidarian Hox complements	NATURE			English	Article							CLASS HOMEOBOX GENES; EARLY EVOLUTION; SEA-ANEMONE; ORIGIN; EXPRESSION; ZOOTYPE; HYDRA	Bilaterian animals have a Hox gene cluster essential for patterning the main body axis, and a ParaHox gene cluster. Comparison of Hox and ParaHox genes has led workers to postulate that both clusters originated from the duplication of an ancient cluster named ProtoHox, which contained up to four genes with at least the precursors of anterior and posterior Hox/ ParaHox genes(1-3). However, the way in which genes diversified within the ProtoHox, Hox and ParaHox clusters remains unclear because no systematic study of non- bilaterian animals exists. Here we characterize the full Hox/ ParaHox gene complements and genomic organization in two cnidarian species ( Nematostella vectensis and Hydra magnipapillata), and suggest a ProtoHox cluster simpler than originally thought on the basis of three arguments. First, both species possess bilaterian- like anterior Hox genes, but their non-anterior genes do not appear as counterparts of either bilaterian central or posterior genes; second, two clustered ParaHox genes, Gsx and a gene related to Xlox and Cdx, are found in Nematostella vectensis; and third, we do not find clear phylogenetic support for a common origin of bilaterian Cdx and posterior genes, which might therefore have appeared after the ProtoHox cluster duplication. Consequently, the ProtoHox cluster might have consisted of only two anterior genes. Non- anterior genes could have appeared independently in the Hox and ParaHox clusters, possibly after the separation of bilaterians and cnidarians.	Univ Bergen, Sars Inst Ctr Marine Mol Biol, N-5008 Bergen, Norway; Univ Montpellier 2, CNRS, UMR5554,Inst Sci Evolut, Lab Paleontol Phylogenie & Paleobiol, F-34095 Montpellier 05, France; Amer Hosp Paris, F-92202 Neuilly Sur Seine, France; Childrens Hosp & Res Ctr Oakland, Oakland, CA 94609 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Irvine	Chourrout, D (corresponding author), Univ Bergen, Sars Inst Ctr Marine Mol Biol, Thormoehlengst 55, N-5008 Bergen, Norway.	Daniel.chourrout@sars.uib.no; Ulrich.technau@sars.uib.no	Delsuc, Frederic/B-4381-2009	Delsuc, Frederic/0000-0002-6501-6287; Edvardsen, Rolf/0000-0001-8430-8042; Technau, Ulrich/0000-0003-4472-8258				Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Castro LFC, 2003, EVOL DEV, V5, P459, DOI 10.1046/j.1525-142X.2003.03052.x; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x; GARCIACALLEJA JM, 1992, AIDS, V6, P881, DOI 10.1097/00002030-199208000-00020; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Kuhn K, 1996, MOL PHYLOGENET EVOL, V6, P30, DOI 10.1006/mpev.1996.0055; Martinez DE, 1998, NATURE, V393, P748, DOI 10.1038/31616; MILLER DJ, 1993, NATURE, V365, P215, DOI 10.1038/365215b0; Monteiro AS, 2006, EVOL DEV, V8, P174, DOI 10.1111/j.1525-142X.2006.00087.x; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032; SHENK MA, 1993, DEVELOPMENT, V117, P657; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007	20	144	146	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					684	687		10.1038/nature04863	http://dx.doi.org/10.1038/nature04863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16900199	Green Submitted			2022-12-01	WOS:000239630200045
J	Brown, K				Brown, Kevin			Anaemia, parvovirus, and malaria	LANCET			English	Editorial Material							INFECTION; B19; PREVALENCE; CHILDREN		Hlth Protect Agcy, London NW9 5EQ, England	Health Protection Agency	Brown, K (corresponding author), Hlth Protect Agcy, London NW9 5EQ, England.	Kevin.Brown@HPA.org.uk		Brown, Kevin/0000-0002-1568-683X				ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257; Ballou WR, 2003, J INFECT DIS, V187, P675, DOI 10.1086/368382; COHEN BJ, 1988, J MED MICROBIOL, V25, P151, DOI 10.1099/00222615-25-2-151; COSSART YE, 1975, LANCET, V1, P72; JONES PH, 1990, J TROP MED HYG, V93, P67; Kelly HA, 2000, EPIDEMIOL INFECT, V124, P449, DOI 10.1017/S0950268899003817; POTTER CG, 1987, J CLIN INVEST, V79, P1486, DOI 10.1172/JCI112978; SERJEANT GR, 1981, LANCET, V2, P595; Wildig J, 2006, J INFECT DIS, V194, P146, DOI 10.1086/505082; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	10	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG-SEP	2006	368	9537					714	716		10.1016/S0140-6736(06)69265-9	http://dx.doi.org/10.1016/S0140-6736(06)69265-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080ID	16935671				2022-12-01	WOS:000240240200009
J	Doan, T; Mendez, A; Detwiler, PB; Chen, J; Rieke, F				Doan, Thuy; Mendez, Ana; Detwiler, Peter B.; Chen, Jeannie; Rieke, Fred			Multiple phosphorylation sites confer reproducibility of the rod's single-photon responses	SCIENCE			English	Article							MAMMALIAN VOMERONASAL NEURONS; RETINAL RODS; ACTIVATED RHODOPSIN; PHEROMONE DETECTION; G-PROTEIN; IN-VIVO; ARRESTIN; PHOTORECEPTORS; PHOTORESPONSES; VARIABILITY	Although signals controlled by single molecules are expected to be inherently variable, rod photoreceptors generate reproducible responses to single absorbed photons. We show that this unexpected reproducibility - the consistency of amplitude and duration of rhodopsin activity varies in a graded and systematic manner with the number but not the identity of phosphorylation sites on rhodopsin's C terminus. These results indicate that each phosphorylation site provides an independent step in rhodopsin deactivation and that collectively these steps tightly control rhodopsin's active lifetime. Other G protein cascades may exploit a similar mechanism to encode accurately the timing and number of receptor activation.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Program Neurobiol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ So Calif, Dept Ophthalmol & Cell & Neurobiol, Los Angeles, CA 90089 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Southern California	Chen, J (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	jeannie@usc.edu; rieke@u.washington.edu	Méndez, Ana/F-9729-2016	Méndez, Ana/0000-0001-6393-1644; Detwiler, Peter/0000-0003-3910-2023	NEI NIH HHS [T32EY-07031, EY-11850, EY-12155, EY-02048] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011850, T32EY007031, R01EY012155, R01EY002048] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hamer RD, 2003, J GEN PHYSIOL, V122, P419, DOI 10.1085/jgp.200308832; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Ramanathan S, 2005, BIOPHYS J, V88, P3063, DOI 10.1529/biophysj.103.039321; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zufall F, 2002, MICROSC RES TECHNIQ, V58, P251, DOI 10.1002/jemt.10152	19	93	97	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					530	533		10.1126/science.1126612	http://dx.doi.org/10.1126/science.1126612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873665				2022-12-01	WOS:000239308600065
J	Devauchelle, B; Badet, L; Lengele, B; Morelon, E; Testelin, S; Michallet, M; D'Hauthuille, C; Dubernard, JM				Devauchelle, Bernard; Badet, Lionel; Lengele, Benoit; Morelon, Emmanuel; Testelin, Sylvie; Michallet, Mauricette; D'Hauthuille, Cedric; Dubernard, Jean-Michel			First human face allograft: early report	LANCET			English	Article							DONOR BONE-MARROW; FREE-FLAP; TRANSPLANT RECIPIENTS; SCALP TRANSPLANTATION; IMMUNE-RESPONSES; CELL CHIMERISM; RECONSTRUCTION; TOLERANCE; PANCREAS; ORGAN	Background Extended soft tissue defects of the face are difficult to reconstruct, and autologous tissue transfers usually lead to poor cosmetic and functional outcomes. We judged that composite tissue transplantation could be valuable in facial reconstructive surgery. Methods We transplanted the central and lower face of a brain-dead woman onto a woman aged 38 years who had suffered amputation of distal nose, both lips, chin, and adjacent parts of the cheeks. Transplantation consisted of revascularisation of right and left facial arteries and veins (ischaemic time 4 h), mucosal repair of oral and nasal vestibules, bilateral anastomoses of infraorbital and mental sensitive nerves, joining of mimic muscles with motor nerve suture on mandibular branch of the left facial nerve, and skin closure. Immunosuppressive treatment was with thymoglobulin, tacrolimus, mycophenolate mofetil, and prednisone. Two infusions of donor bone-marrow cells were given. Follow-up included routine tests, biopsies, physiotherapy, and psychological support. Findings The initial postoperative course was uneventful. No surgical complication occurred. Bone-marrow graft and immunosuppression were well tolerated. Mild clinical signs of rejection were seen at day 20. Increased corticoids initially did not reverse rejection, but signs of rejection disappeared after three boluses of prednisone. Anatomical and psychological integration and recovery of sensation were excellent. At the end of the first postoperative week, the patient could eat, and speech improved quickly. Passive transmission of muscle contractions to the graft already exists; physiotherapy is being done to restore dynamic motions around the lips. Interpretation The 4-month outcome demonstrates the feasibility of this procedure. The functional result will be assessed in the future, but this graft can already be deemed successful with respect to appearance, sensitivity, and acceptance by the patient.	Ctr Hosp Univ Amiens, Dept Maxillofacial Surg, Amiens, France; Hosp Edouard Herriot, Ctr Hosp Univ Lyon, Lyon, France; Univ Catholique Louvain, Expt Morphol Dept, B-1200 Brussels, Belgium	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; bioMerieux; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Catholique Louvain	Devauchelle, B (corresponding author), Univ Hosp, North Hosp, Dept Maxillofacial Surg, F-80054 Amiens, France.	devauchelle.bernard@chu-amiens.fr						Angrigiani C, 1997, PLAST RECONSTR SURG, V99, P1566, DOI 10.1097/00006534-199705000-00014; Corry RJ, 1999, ANN SURG, V230, P372, DOI 10.1097/00000658-199909000-00010; Delis S, 2006, PANCREAS, V32, P1, DOI 10.1097/01.mpa.0000188307.67420.46; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; FONTES P, 1994, LANCET, V344, P151, DOI 10.1016/S0140-6736(94)92756-1; GarciaMorales R, 1996, TRANSPLANTATION, V62, P1149, DOI 10.1097/00007890-199610270-00021; Kanitakis J, 2005, EUR J DERMATOL, V15, P235; KAWASHIMA T, 1994, PLAST RECONSTR SURG, V94, P944, DOI 10.1097/00006534-199412000-00007; Latifoglu O, 1999, PLAST RECONSTR SURG, V103, P1076, DOI 10.1097/00006534-199903000-00059; Lengele BG, 2004, INT J ORAL MAX SURG, V33, P396, DOI 10.1016/j.ijom.2003.11.004; Mathew JM, 2003, TRANSPL IMMUNOL, V11, P307, DOI 10.1016/S0966-3274(03)00056-X; Mathew JM, 2000, TRANSPLANTATION, V70, P1675, DOI 10.1097/00007890-200012270-00003; Miller J, 1999, TRANSPLANTATION, V68, P1079, DOI 10.1097/00007890-199910270-00001; MONACO AP, 1976, SURGERY, V79, P384; Monaco AP, 2001, TRANSPLANT P, V33, P3837, DOI 10.1016/S0041-1345(01)02625-2; Petruzzo P, 2003, CLIN TRANSPLANT, V17, P455, DOI 10.1034/j.1399-0012.2003.00005.x; Pham SM, 2000, J THORAC CARDIOV SUR, V119, P673, DOI 10.1016/S0022-5223(00)70001-8; Pribaz JJ, 1999, PLAST RECONSTR SURG, V103, P808, DOI 10.1097/00006534-199903000-00006; Prigozhina T, 2004, SPRINGER SEMIN IMMUN, V26, P169, DOI 10.1007/s00281-004-0171-5; Ricordi C, 1997, TRANSPLANTATION, V63, P7, DOI 10.1097/00007890-199701150-00003; Siemionow M, 2005, CLIN PLAST SURG, V32, P401, DOI 10.1016/j.cps.2005.02.003; Siemionow M, 2003, TRANSPLANTATION, V75, P1607, DOI 10.1097/01.TP.0000068870.71053.29; Teot L, 2000, LANCET, V355, P1695, DOI 10.1016/S0140-6736(00)02245-5; Thomas A, 1998, PLAST RECONSTR SURG, V102, P2085, DOI 10.1097/00006534-199811000-00041; Ulusal BG, 2003, PLAST RECONSTR SURG, V112, P1302, DOI 10.1097/01.PRS.0000079823.84984.BB; Unal S, 2005, ANN PLAS SURG, V55, P297, DOI 10.1097/01.sap.0000168693.25306.79; Wilhelmi BJ, 2003, ANN PLAS SURG, V50, P535, DOI 10.1097/01.SAP.0000037875.69379.56	27	445	464	0	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					203	209		10.1016/S0140-6736(06)68935-6	http://dx.doi.org/10.1016/S0140-6736(06)68935-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844489				2022-12-01	WOS:000239095000031
J	Crighton, D; Wilkinson, S; O'Prey, J; Syed, N; Smith, P; Harrison, PR; Gasco, M; Garrone, O; Crook, T; Ryan, KM				Crighton, Diane; Wilkinson, Simon; O'Prey, Jim; Syed, Nelofer; Smith, Paul; Harrison, Paul R.; Gasco, Milena; Garrone, Ornella; Crook, Tim; Ryan, Kevin M.			DRAM, a p53-induced modulator of autophagy, is critical for apoptosis	CELL			English	Article							PROGRAMMED CELL-DEATH; DNA-DAMAGE; IN-VIVO; GENE; P53; CANCER; PROTEINS; INACTIVATION; ASSOCIATION; DEGRADATION	Inactivation of cell death is a major step in tumor development, and p53, a tumor suppressor frequently mutated in cancer, is a critical mediator of cell death. While a role for p53 in apoptosis is well established, direct links to other pathways controlling cell death are unknown. Here we describe DRAM (damage-regulated autophagy modulator), a p53 target gene encoding a lysosomal protein that induces macroautophagy, as an effector of p53-mediated death. We show that p53 induces autophagy in a DRAM-dependent manner and, while overexpression of DRAM alone causes minimal cell death, DRAM is essential for p53-mediated apoptosis. Moreover, analysis of DRAM in primary tumors revealed frequent decreased expression often accompanied by retention of wildtype p53. Collectively therefore, these studies not only report a stress-induced regulator of autophagy but also highlight the relationship of DRAM and autophagy to p53 function and damage-induced programmed cell death.	Beatson Inst Canc Res, Canc Res UK Beatson Labs, Tumour Cell Death Lab, Glasgow G61 1BD, Lanark, Scotland; Beatson Inst Canc Res, Canc Res UK Beatson Labs, Oral Canc Mol Genet Lab, Glasgow G61 1BD, Lanark, Scotland; Inst Canc Res, Chester Beatty Labs, Breakthrough toby Robins Breast Canc Res Ctr, London SW3 6JB, England; Osped San Croce & Carle, Dept Med Oncol, Cuneo, Italy	Beatson Institute; Beatson Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ryan, KM (corresponding author), Beatson Inst Canc Res, Canc Res UK Beatson Labs, Tumour Cell Death Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.ryan@beatson.gla.ac.uk	Garrone, Ornella/AAC-5978-2022	Garrone, Ornella/0000-0001-7359-5410; Ryan, Kevin M./0000-0002-1059-9681; Wilkinson, Simon/0000-0003-1082-8218	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Crighton D, 2004, BBA-REV CANCER, V1705, P3, DOI 10.1016/j.bbcan.2004.09.001; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; EDINGTON KG, 1995, MOL CARCINOGEN, V13, P254, DOI 10.1002/mc.2940130408; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gasco M, 2002, CANCER RES, V62, P2072; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee CY, 2001, DEVELOPMENT, V128, P1443; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; McGregor F, 2002, CANCER RES, V62, P4757; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Moll UM, 2001, FEBS LETT, V493, P65, DOI 10.1016/S0014-5793(01)02284-0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Wilson A, 1996, J CELL BIOCHEM, V60, P458, DOI 10.1002/(SICI)1097-4644(19960315)60:4<458::AID-JCB3>3.0.CO;2-R; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	41	1029	1104	2	84	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					121	134		10.1016/j.cell.2006.05.034	http://dx.doi.org/10.1016/j.cell.2006.05.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839881	Bronze			2022-12-01	WOS:000239224800021
J	Qi, YJ; He, XY; Wang, XJ; Kohany, O; Jurka, J; Hannon, GJ				Qi, Yijun; He, Xingyue; Wang, Xiu-Jie; Kohany, Oleksiy; Jurka, Jerzy; Hannon, Gregory J.			Distinct catalytic and non-catalytic roles of ARGONAUTE4 in RNA-directed DNA methylation	NATURE			English	Article							SIRNA; HETEROCHROMATIN	DNA methylation has important functions in stable, transcriptional gene silencing, immobilization of transposable elements and genome organization(1). In Arabidopsis, DNA methylation can be induced by double-stranded RNA through the RNA interference (RNAi) pathway, a response known as RNA-directed DNA methylation(2). This requires a specialized set of RNAi components, including ARGONAUTE4 (AGO4)(3-6). Here we show that AGO4 binds to small RNAs including small interfering RNAs (siRNAs) originating from transposable and repetitive elements, and cleaves target RNA transcripts. Single mutations in the Asp-Asp-His catalytic motif of AGO4 do not affect siRNA-binding activity but abolish its catalytic potential. siRNA accumulation and non-CpG DNA methylation at some loci require the catalytic activity of AGO4, whereas others are less dependent on this activity. Our results are consistent with a model in which AGO4 can function at target loci through two distinct and separable mechanisms. First, AGO4 can recruit components that signal DNA methylation in a manner independent of its catalytic activity. Second, AGO4 catalytic activity can be crucial for the generation of secondary siRNAs that reinforce its repressive effects.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; Genet Informat Res Inst, Mountain View, CA 94043 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Qi, Yijun/AAE-8797-2019; Hu, Ruogu/B-2203-2008; Wang, Xiu-Jie/L-1312-2019; Hannon, Gregory/AAB-3568-2019					Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qi YJ, 2005, FEBS LETT, V579, P5899, DOI 10.1016/j.febslet.2005.08.035; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	27	330	358	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					1008	1012		10.1038/nature05198	http://dx.doi.org/10.1038/nature05198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	16998468				2022-12-01	WOS:000241523400058
J	Offenhauser, N; Castelletti, D; Mapelli, L; Soppo, BE; Regondi, MC; Rossi, P; D'Angelo, E; Frassoni, C; Amadeo, A; Tocchetti, A; Pozzi, B; Disanza, A; Guarnieri, D; Betsholtz, C; Scita, G; Helberlein, U; Di Fiore, PP				Offenhauser, Nina; Castelletti, Daniela; Mapelli, Lisa; Soppo, Blanche Ekalle; Regondi, Maria Cristina; Rossi, Paola; D'Angelo, Egidio; Frassoni, Carolina; Amadeo, Alida; Tocchetti, Arianna; Pozzi, Benedetta; Disanza, Andrea; Guarnieri, Douglas; Betsholtz, Christer; Scita, Giorgio; Helberlein, Ulrike; Di Fiore, Pier Paolo			Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics	CELL			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; DENDRITIC SPINES; GLUTAMATE RECEPTORS; NMDA RECEPTORS; IN-VITRO; ALCOHOL; REORGANIZATION; PLASTICITY; TRANSMISSION	Dynamic modulation of the actin cytoskeleton is critical for synaptic plasticity, abnormalities of which are thought to contribute to mental illness and addiction. Here we report that mice lacking Eps8, a regulator of actin dynamics, are resistant to some acute intoxicating effects of ethanol and show increased ethanol consumption. In the brain, the N-methyl-D-aspartate (NMDA) receptor is a major target of ethanol. We show that Eps8 is localized to postsynaptic structures and is part of the NMDA receptor complex. Moreover, in Eps8 null mice, NMDA receptor currents and their sensitivity to inhibition by ethanol are abnormal. In addition, Eps8 null neurons are resistant to the actin-remodeling activities of NMDA and ethanol. We propose that proper regulation of the actin cytoskeleton is a key determinant of cellular and behavioral responses to ethanol.	Fdn Ist FIRC Oncol Mol, I-20139 Milan, Italy; Univ Pavia, Dipartimento Sci Fisiol & Farmacol Cellulari & Mo, I-27100 Pavia, Italy; Ist Nazl Neurol, Dipartimento Epilettol Clin & Neurofisiol Sperime, I-20133 Milan, Italy; Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; Ist Europeo Oncol, Dipartimento Oncol Sperimentale, I-20141 Milan, Italy; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Pavia; University of Milan; IRCCS European Institute of Oncology (IEO); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; University of Milan	Offenhauser, N (corresponding author), Fdn Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	nina.offenhauser@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Amadeo, Alida/C-3158-2016; Mapelli, Lisa/GSI-4507-2022; Regondi, Maria Cristina/AAJ-5601-2021; Scita, Giorgio/J-9670-2012; AMADEO, ALIDA/AAG-5110-2020; Di Fiore, Pier Paolo/K-2130-2012; D'Angelo, Egidio/AAC-3846-2022; Frassoni, Carolina CF/J-8337-2016; Mapelli, Lisa/J-9802-2019	Amadeo, Alida/0000-0002-7581-8339; Regondi, Maria Cristina/0000-0002-1398-7591; AMADEO, ALIDA/0000-0002-7581-8339; Di Fiore, Pier Paolo/0000-0002-2252-0950; D'Angelo, Egidio/0000-0002-6007-7187; Frassoni, Carolina CF/0000-0002-9300-5139; Mapelli, Lisa/0000-0002-5048-0458; Disanza, Andrea/0000-0001-5101-2907; Offenhauser, Nina/0000-0002-3316-3047; Scita, Giorgio/0000-0001-7984-1889; ROSSI, Paola/0000-0002-1134-4111; Tocchetti, Arianna/0000-0001-7004-7582	NIAAA NIH HHS [AA13105, AA10035] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035, R01AA013105] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Allansson L, 2001, J NEUROCHEM, V76, P472, DOI 10.1046/j.1471-4159.2001.00097.x; Bachmanov AA, 1996, BEHAV GENET, V26, P563, DOI 10.1007/BF02361229; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Berry RB, 2004, ALCOHOL, V32, P9, DOI 10.1016/j.alcohol.2003.09.005; BLITZER RD, 1990, BRAIN RES, V537, P203, DOI 10.1016/0006-8993(90)90359-J; Bowers BJ, 2000, ALCOHOL RES HEALTH, V24, P175; Capani F, 2001, BRAIN RES, V923, P1, DOI 10.1016/S0006-8993(01)03189-4; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Chandler LJ, 2003, PHARMACOL THERAPEUT, V99, P311, DOI 10.1016/S0163-7258(03)00096-2; Crabbe JC, 2005, NEUROSCI BIOBEHAV R, V28, P785, DOI 10.1016/j.neubiorev.2004.08.002; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; Halpain S, 1998, J NEUROSCI, V18, P9835; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hoffman PL, 2003, INT REV NEUROBIOL, V56, P35, DOI 10.1016/S0074-7742(03)56002-0; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; Honse Y, 2004, NEUROPHARMACOLOGY, V46, P647, DOI 10.1016/j.neuropharm.2003.11.006; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kampov-Polevoy AB, 1999, ALCOHOL ALCOHOLISM, V34, P386, DOI 10.1093/alcalc/34.3.386; Krazem A, 2003, BEHAV BRAIN RES, V147, P17, DOI 10.1016/S0166-4328(03)00113-X; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; LI TK, 1993, BEHAV GENET, V23, P163, DOI 10.1007/BF01067421; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Peoples RW, 2000, NEUROPHARMACOLOGY, V39, P1681, DOI 10.1016/S0028-3908(00)00067-8; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qian Y, 2003, J BIOL CHEM, V278, P16189, DOI 10.1074/jbc.M207517200; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Rossi P, 2002, J NEUROSCI, V22, P9687; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Rustay NR, 2003, P NATL ACAD SCI USA, V100, P2917, DOI 10.1073/pnas.0437273100; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schuckit MA, 2000, J STUD ALCOHOL, V61, P827, DOI 10.15288/jsa.2000.61.827; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shiraishi Y, 2003, J NEUROCHEM, V87, P364, DOI 10.1046/j.1471-4159.2003.02003.x; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Tabakoff B, 2003, J NEUROSCI, V23, P4491; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Woodward JJ, 2000, CRIT REV NEUROBIOL, V14, P69; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yamada K, 2001, EUR J NEUROSCI, V13, P2025, DOI 10.1046/j.0953-816x.2001.01580.x; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	64	91	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					213	226		10.1016/j.cell.2006.09.011	http://dx.doi.org/10.1016/j.cell.2006.09.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018287	Bronze			2022-12-01	WOS:000241445800025
J	Kash, JC; Tumpey, TM; Proll, SC; Carter, V; Perwitasari, O; Thomas, MJ; Basler, CF; Palese, P; Taubenberger, JK; Garcia-Sastre, A; Swayne, DE; Katze, MG				Kash, John C.; Tumpey, Terrence M.; Proll, Sean C.; Carter, Victoria; Perwitasari, Olivia; Thomas, Matthew J.; Basler, Christopher F.; Palese, Peter; Taubenberger, Jeffery K.; Garcia-Sastre, Adolfo; Swayne, David E.; Katze, Michael G.			Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus	NATURE			English	Article							PANDEMIC VIRUS; A VIRUSES; ENHANCED VIRULENCE; GENES; MACROPHAGES; HEMAGGLUTININ; MICE; PATHOGENESIS; MORTALITY; SEGMENT	The influenza pandemic of 1918 - 19 was responsible for about 50 million deaths worldwide(1). Modern histopathological analysis of autopsy samples from human influenza cases from 1918 revealed significant damage to the lungs with acute, focal bronchitis and alveolitis associated with massive pulmonary oedema, haemorrhage and rapid destruction of the respiratory epithelium(2). The contribution of the host immune response leading to this severe pathology remains largely unknown. Here we show, in a comprehensive analysis of the global host response induced by the 1918 influenza virus, that mice infected with the reconstructed 1918 influenza virus displayed an increased and accelerated activation of host immune response genes associated with severe pulmonary pathology. We found that mice infected with a virus containing all eight genes from the pandemic virus showed marked activation of pro-inflammatory and cell-death pathways by 24 h after infection that remained unabated until death on day 5. This was in contrast with smaller host immune responses as measured at the genomic level, accompanied by less severe disease pathology and delays in death in mice infected with influenza viruses containing only subsets of 1918 genes. The results indicate a cooperative interaction between the 1918 influenza genes and show that study of the virulence of the 1918 influenza virus requires the use of the fully reconstructed virus. With recent concerns about the introduction of highly pathogenic avian influenza viruses into humans and their potential to cause a worldwide pandemic with disastrous health and economic consequences, a comprehensive understanding of the global host response to the 1918 virus is crucial. Moreover, understanding the contribution of host immune responses to virulent influenza virus infections is an important starting point for the identification of prognostic indicators and the development of novel antiviral therapies.	Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; NCID, Influenza Branch, DVRD, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Armed Forces Inst Pathol, Dept Mol Pathol, Dept Cellular Pathol & Genet, Rockville, MD 20850 USA; USDA, SE Poultry Res Lab, Agr Res Lab, Athens, GA 30606 USA	University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; United States Department of Defense; United States Department of Agriculture (USDA)	Kash, JC (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	jkash@u.washington.edu	Kash, John/ABE-8280-2021; Taubenberger, Jeffery/AAQ-1407-2021; Basler, Christopher/AAG-8346-2019; Swayne, David/AAP-7166-2020	Basler, Christopher/0000-0003-4195-425X; Palese, Peter/0000-0002-0337-5823; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Swayne, David/0000-0001-7472-1992	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000986] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000986-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Reid AH, 2002, J VIROL, V76, P10717, DOI 10.1128/JVI.76.21.10717-10723.2002; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zhou JF, 2006, J INFECT DIS, V193, P945, DOI 10.1086/500954; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	26	436	456	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					578	581		10.1038/nature05181	http://dx.doi.org/10.1038/nature05181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006449	Green Accepted, Bronze			2022-12-01	WOS:000240988200044
J	Lamb, J; Crawford, ED; Peck, D; Modell, JW; Blat, IC; Wrobel, MJ; Lerner, J; Brunet, JP; Subramanian, A; Ross, KN; Reich, M; Hieronymus, H; Wei, G; Armstrong, SA; Haggarty, SJ; Clemons, PA; Wei, R; Carr, SA; Lander, ES; Golub, TR				Lamb, Justin; Crawford, Emily D.; Peck, David; Modell, Joshua W.; Blat, Irene C.; Wrobel, Matthew J.; Lerner, Jim; Brunet, Jean-Philippe; Subramanian, Aravind; Ross, Kenneth N.; Reich, Michael; Hieronymus, Haley; Wei, Guo; Armstrong, Scott A.; Haggarty, Stephen J.; Clemons, Paul A.; Wei, Ru; Carr, Steven A.; Lander, Eric S.; Golub, Todd R.			The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER-CELLS; CELLULAR-DRUG RESISTANCE; ALZHEIMERS-DISEASE; IN-VITRO; CHAPERONE HEAT-SHOCK-PROTEIN-90; MICROARRAY ANALYSIS; INHIBITORS; TOXICITY; ESTROGEN	To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this "Connectivity Map'' resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02144 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute	Golub, TR (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	justin@broad.mit.edu; golub@broad.harvard.edu	Crawford, Emily/AAP-9565-2020; Haggarty, Stephen J/M-9495-2016; Crawford, Emily/AAA-9674-2019; Carr, Steven A./AAH-8366-2019	Crawford, Emily/0000-0003-4182-2337; Haggarty, Stephen J/0000-0002-7872-168X; Crawford, Emily/0000-0003-4182-2337; Reich, Michael/0000-0003-4735-5514				Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; EDWARDS DP, 1980, ENDOCRINOLOGY, V107, P884, DOI 10.1210/endo-107-4-884; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Glaser KB, 2003, MOL CANCER THER, V2, P151; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Hata R, 2001, BIOCHEM BIOPH RES CO, V284, P310, DOI 10.1006/bbrc.2001.4968; Hennessy EJ, 2005, J ORG CHEM, V70, P7371, DOI 10.1021/jo051096o; HIERONYMUS H, IN PRESS CANC RES; Hollander M, 1999, NONPARAMETRIC STAT M, P178; Hongo T, 1997, BLOOD, V89, P2959, DOI 10.1182/blood.V89.8.2959; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kaspers GJL, 1997, BLOOD, V90, P2723, DOI 10.1182/blood.V90.7.2723.2723_2723_2729; Kaspers GJL, 1998, BLOOD, V92, P259, DOI 10.1182/blood.V92.1.259.413k21_259_266; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; Kubota T, 1998, CANCER RES, V58, P3344; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lopez IP, 2003, OBES RES, V11, P188, DOI 10.1038/oby.2003.30; MARTIN PM, 1978, ENDOCRINOLOGY, V103, P1860, DOI 10.1210/endo-103-5-1860; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MYLARI BL, 1990, J MED CHEM, V33, P2019, DOI 10.1021/jm00169a035; Natsoulis G, 2005, GENOME RES, V15, P724, DOI 10.1101/gr.2807605; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tissing WJE, 2003, LEUKEMIA, V17, P17, DOI 10.1038/sj.leu.2402733; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDERHOEK JY, 1979, MOL PHARMACOL, V16, P171; WAKELING AE, 1991, CANCER RES, V51, P3867; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; WEI G, IN PRESS CANC CELL; Yao Q, 2003, CLIN CANCER RES, V9, P4483	41	3259	3387	22	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1929	1935		10.1126/science.1132939	http://dx.doi.org/10.1126/science.1132939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008526				2022-12-01	WOS:000240832200043
J	Annas, GJ				Annas, George J.			Hunger strikes at Guantanamo - Medical ethics and human rights in a "legal black hole''	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2005, NEW ENGL J MED, V352, P2127, DOI 10.1056/NEJMlim044131; ANNAS GJ, 1982, HASTINGS CENT REP, V12, P21, DOI 10.2307/3561359; ANNAS GJ, 1995, BRIT MED J, V311, P1114, DOI 10.1136/bmj.311.7013.1114; Beam TE, 2003, MILITARY MED ETHICS; BUKOVSKY V, 2003, BEING HUMAN READINGS, P218; Center for Constitutional Rights, 2005, GUANT PRIS HUNG STRI; *DEP DEF, 2006, 231008E DOD; *DEP DEF ASS SECR, 2006, MED ROUNDT; Golden Tim, 2006, N Y Times Web, pA20; Gordan England Memorandum for Secretaries of the Military Departments, 2006, COMMUNICATION   0707; *J WIER FDN HLTH H, 1995, ASS HUNG STRIK MAN P; Nicholl DJ, 2006, LANCET, V367, P811, DOI 10.1016/S0140-6736(06)68326-8; Oguz NY, 2005, J MED ETHICS, V31, P169, DOI 10.1136/jme.2004.006973; Okie S, 2005, NEW ENGL J MED, V353, P2529, DOI 10.1056/NEJMp058296; Reyes Hernan, 1998, MED ETHICAL ASPECTS, P291; SCHMITT E, 2006, NY TIMES        0222, pA5; Silove D, 1996, JAMA-J AM MED ASSOC, V276, P410; Silver M, 2005, STANFORD LAW REV, V58, P631; Situation of Detainees at Guant anamo Bay, 2006, SIT DET GUANT BAY; Wilks M, 2006, BRIT MED J, V332, P560, DOI 10.1136/bmj.332.7541.560; *WORLD MED ASS, 1991, DECL HUNG STRIK	21	39	40	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1377	1382		10.1056/NEJMhle062316	http://dx.doi.org/10.1056/NEJMhle062316			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088EF	17005959	Green Published			2022-12-01	WOS:000240793600017
J	Shuchman, M				Shuchman, Miriam			Delaying generic competition - Corporate payoffs and the future of plavix	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Buffalo Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shuchman, M (corresponding author), Univ Buffalo Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA.								0	14	14	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1297	1300		10.1056/NEJMp068193	http://dx.doi.org/10.1056/NEJMp068193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005945				2022-12-01	WOS:000240793600001
J	Cash, HL; Whitham, CV; Behrendt, CL; Hooper, LV				Cash, Heather L.; Whitham, Cecilia V.; Behrendt, Cassie L.; Hooper, Lora V.			Symbiotic bacteria direct expression of an intestinal bactericidal lectin	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MANNOSE-BINDING LECTIN; ALPHA-DEFENSINS; PEPTIDOGLYCAN; PANETH; FAMILY; RESPONSES; PROTEINS; HIP/PAP; CELLS	The mammalian intestine harbors complex societies of beneficial bacteria that are maintained in the lumen with minimal penetration of mucosal surfaces. Microbial colonization of germ-free mice triggers epithelial expression of RegIII gamma, a secreted C-type lectin. RegIII gamma binds intestinal bacteria but lacks the complement recruitment domains present in other microbe-binding mammalian C-type lectins. We show that RegIII gamma and its human counterpart, HIP/PAP, are directly antimicrobial proteins that bind their bacterial targets via interactions with peptidoglycan carbohydrate. We propose that these proteins represent an evolutionarily primitive form of lectin-mediated innate immunity, and that they reveal intestinal strategies for maintaining symbiotic host-microbial relationships.	Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas, SW Med Ctr, Ctr Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Lora.Hooper@UTSouthwestern.edu	Eckhardt, Erik/G-1567-2010		NIAID NIH HHS [T32-AI007520] Funding Source: Medline; NIDDK NIH HHS [R01 DK070855, R01 DK070855-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Christa L, 1996, AM J PHYSIOL-GASTR L, V271, pG993, DOI 10.1152/ajpgi.1996.271.6.G993; Dieckgraefe BK, 2002, J INVEST MED, V50, P421, DOI 10.1136/jim-50-06-02; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 1999, GLYCOBIOLOGY, V9, P1357, DOI 10.1093/glycob/9.12.1357; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Holm C, 2003, APPL ENVIRON MICROB, V69, P2857, DOI 10.1128/AEM.69.5.2857-2863.2003; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Miyashita H, 1995, FEBS LETT, V377, P429, DOI 10.1016/0014-5793(95)01381-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Syder AJ, 2003, P NATL ACAD SCI USA, V100, P3467, DOI 10.1073/pnas.0230380100; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	27	982	1033	5	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1126	1130		10.1126/science.1127119	http://dx.doi.org/10.1126/science.1127119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931762	Green Accepted, Green Submitted			2022-12-01	WOS:000239998200048
J	Ohki, K; Chung, SY; Kara, P; Hubener, M; Bonhoeffer, T; Reid, RC				Ohki, Kenichi; Chung, Sooyoung; Kara, Prakash; Huebener, Mark; Bonhoeffer, Tobias; Reid, R. Clay			Highly ordered arrangement of single neurons in orientation pinwheels	NATURE			English	Article							MONKEY STRIATE CORTEX; PRIMARY VISUAL-CORTEX; IN-VIVO; FUNCTIONAL ARCHITECTURE; OCULAR DOMINANCE; PREFERENCE MAPS; DEPRIVED CATS; DIRECTION; COLUMNS; ORGANIZATION	In the visual cortex of higher mammals, neurons are arranged across the cortical surface in an orderly map of preferred stimulus orientations(1,2). This map contains 'orientation pinwheels', structures that are arranged like the spokes of a wheel such that orientation changes continuously around a centre. Conventional optical imaging(3,4) first demonstrated these pinwheels(3,5), but the technique lacked the spatial resolution to determine the response properties and arrangement of cells near pinwheel centres. Electrophysiological recordings later demonstrated sharply selective neurons near pinwheel centres(6,7), but it remained unclear whether they were arranged randomly or in an orderly fashion. Here we use two-photon calcium imaging in vivo(8-12) to determine the microstructure of pinwheel centres in cat visual cortex with single-cell resolution. We find that pinwheel centres are highly ordered: neurons selective to different orientations are clearly segregated even in the very centre. Thus, pinwheel centres truly represent singularities in the cortical map. This highly ordered arrangement at the level of single cells suggests great precision in the development of cortical circuits underlying orientation selectivity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Max Planck Inst Neurobiol, D-82152 Munich, Germany	Harvard University; Harvard Medical School; Max Planck Society	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu	Aunins, Ainars/H-4927-2011; Bonhoeffer, Tobias/B-9481-2009	Aunins, Ainars/0000-0002-6051-1879; Bonhoeffer, Tobias/0000-0001-7897-6634				BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hickmott PW, 1999, J COMP NEUROL, V409, P385; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; HUBENER M, 1992, J COMP NEUROL, V324, P67, DOI 10.1002/cne.903240106; KATZ LC, 1989, J NEUROSCI, V9, P1389; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Meister M, 2001, J NEUROSCI, V21, P1351; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; Shmuel A, 1996, J NEUROSCI, V16, P6945; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sullivan MR, 2005, J NEUROPHYSIOL, V94, P1636, DOI 10.1152/jn.01013.2004; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0	30	227	230	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					925	928		10.1038/nature05019	http://dx.doi.org/10.1038/nature05019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16906137				2022-12-01	WOS:000239960500039
J	Joo, C; McKinney, SA; Nakamura, M; Rasnik, I; Myong, S; Ha, T				Joo, Chirlmin; McKinney, Sean A.; Nakamura, Muneaki; Rasnik, Ivan; Myong, Sua; Ha, Taekjip			Real-time observation of RecA filament dynamics with single monomer resolution	CELL			English	Article							DNA STRAND EXCHANGE; RESONANCE ENERGY-TRANSFER; ESCHERICHIA-COLI; ATP HYDROLYSIS; DUPLEX DNA; FLUORESCENCE SPECTROSCOPY; HOMOLOGOUS RECOMBINATION; RAD51 FILAMENT; MOTOR PROTEIN; BINDING	RecA and its homologs help maintain genomic integrity through recombination. Using singlemolecule fluorescence assays and hidden Markov modeling, we show the most direct evidence that a RecA filament grows and shrinks primarily one monomer at a time and only at the extremities. Both ends grow and shrink, contrary to expectation, but a higher binding rate at one end is responsible for directional filament growth. Quantitative rate determination also provides insights into how RecA might control DNA accessibility in vivo. We find that about five monomers are sufficient for filament nucleation. Although ordinarily single-stranded DNA binding protein (SSB) prevents filament nucleation, single RecA monomers can easily be added to an existing filament and displace SSB from DNA at the rate of filament extension. This supports the proposal for a passive role of RecA-loading machineries in SSB removal.	Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Emory University	Ha, T (corresponding author), Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA.	tjha@uiuc.edu	Ha, Taekjip/B-9506-2009; Joo, Chirlmin/B-9294-2008	Ha, Taekjip/0000-0003-2195-6258; Joo, Chirlmin/0000-0003-2803-0335; McKinney, Sean/0000-0002-9740-6247	NIGMS NIH HHS [R01 GM065367, GM065367] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Bianco PR, 1996, NUCLEIC ACIDS RES, V24, P4933, DOI 10.1093/nar/24.24.4933; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; BRENNER SL, 1990, J MOL BIOL, V216, P949, DOI 10.1016/S0022-2836(99)80013-8; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; EGELMAN EH, 1989, SCIENCE, V245, P404, DOI 10.1126/science.2667137; Fulconis R, 2004, BIOPHYS J, V87, P2552, DOI 10.1529/biophysj.104.043059; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, CURR OPIN STRUC BIOL, V11, P287, DOI 10.1016/S0959-440X(00)00204-9; Ha TJ, 1999, CHEM PHYS, V247, P107, DOI 10.1016/S0301-0104(99)00149-4; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; LEAHY MC, 1986, J BIOL CHEM, V261, P6954; Lee JY, 2005, P NATL ACAD SCI USA, V102, P18938, DOI 10.1073/pnas.0506144102; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; McKinney SA, 2005, P NATL ACAD SCI USA, V102, P5715, DOI 10.1073/pnas.0409328102; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Prevost C, 2003, Q REV BIOPHYS, V36, P429, DOI 10.1017/S0033583504003956; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; REGISTER JC, 1985, J BIOL CHEM, V260, P12306; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; SHANER SL, 1987, J BIOL CHEM, V262, P9211; SHANER SL, 1987, J BIOL CHEM, V262, P9220; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; THRESHER RJ, 1988, J MOL BIOL, V201, P101, DOI 10.1016/0022-2836(88)90442-1; Tlusty T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.258103; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; van der Heijden T, 2005, NUCLEIC ACIDS RES, V33, P2099, DOI 10.1093/nar/gki512; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; WEGNER A, 1982, J MOL BIOL, V161, P607, DOI 10.1016/0022-2836(82)90411-9; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhuang XW, 2005, ANNU REV BIOPH BIOM, V34, P399, DOI 10.1146/annurev.biophys.34.040204.144641; ZLOTNICK A, 1993, J BIOL CHEM, V268, P22525	58	227	227	4	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2006	126	3					515	527		10.1016/j.cell.2006.06.042	http://dx.doi.org/10.1016/j.cell.2006.06.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901785	Bronze			2022-12-01	WOS:000239883400012
J	Nougayrede, JP; Homburg, S; Taieb, F; Boury, M; Brzuszkiewicz, E; Gottschalk, G; Buchrieser, C; Hacker, J; Dobrindt, U; Oswald, E				Nougayrede, Jean-Philippe; Homburg, Stefan; Taieb, Frederic; Boury, Michele; Brzuszkiewicz, Elzbieta; Gottschalk, Gerhard; Buchrieser, Carmen; Hacker, Joerg; Dobrindt, Ulrich; Oswald, Eric			Escherichia coli induces DNA double-strand breaks in eukaryotic cells	SCIENCE			English	Article							ULCERATIVE-COLITIS; POLYKETIDE; VIRULENCE; CYCLE; BIOSYNTHESIS; NISSLE-1917; MESALAZINE; REMISSION; DISEASE; PROTEIN	Transient infection of eukaryotic cells with commensal and extraintestinal pathogenic Escherichia coli of phylogenetic group B2 blocks mitosis and induces megalocytosis. This trait is linked to a widely spread genomic island that encodes giant modular nonribosomal peptide and polyketide synthases. Contact with E. coli expressing this gene cluster causes DNA double-strand breaks and activation of the DNA damage checkpoint pathway, leading to cell cycle arrest and eventually to cell death. Discovery of hybrid peptide-polyketide genotoxins in E. coli will change our view on pathogenesis and commensalism and open new biotechnological applications.	Ecole Natl Vet Toulouse, INRA, UMR 1225, F-31076 Toulouse, France; Univ Wurzburg, Inst Mol Infekt Biol, D-97070 Wurzburg, Germany; Univ Gottingen, Gottingen Genom Lab, D-37077 Gottingen, Germany; Inst Pasteur, Unite Genom Microorganismes Pathogenes, F-75724 Paris, France; CNRS, URA 2171, F-75724 Paris, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; University of Wurzburg; University of Gottingen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Oswald, E (corresponding author), Ecole Natl Vet Toulouse, INRA, UMR 1225, F-31076 Toulouse, France.	e.oswald@envt.fr	Dobrindt, Ulrich/AEU-2378-2022; Nougayrede, Jean-Philippe/I-6362-2019	Dobrindt, Ulrich/0000-0001-9949-1898; Nougayrede, Jean-Philippe/0000-0002-6802-1890; Oswald, Eric/0000-0002-3017-0081; Buchrieser, Carmen/0000-0003-3477-9190; taieb, frederic/0000-0001-9612-2069				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Johnson JR, 2002, J INFECT DIS, V185, P774, DOI 10.1086/339343; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130; Malchow HA, 1997, J CLIN GASTROENTEROL, V25, P653, DOI 10.1097/00004836-199712000-00021; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; OSWALD E, 1994, P NATL ACAD SCI USA, V91, P3814, DOI 10.1073/pnas.91.9.3814; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; WELCH RA, 1981, NATURE, V294, P665, DOI 10.1038/294665a0; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	28	636	681	10	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2006	313	5788					848	851		10.1126/science.1127059	http://dx.doi.org/10.1126/science.1127059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902142				2022-12-01	WOS:000239671300064
J	Kadyrov, FA; Dzantiev, L; Constantin, N; Modrich, P				Kadyrov, Farid A.; Dzantiev, Leonid; Constantin, Nicoleta; Modrich, Paul			Endonucleolytic function of MutL alpha in human mismatch repair	CELL			English	Article							DNA MISMATCH; RNA-POLYMERASE; COMPLEXES; INITIATION; EXCISION; PCNA; RECONSTITUTION; HETERODIMER; MECHANISM; PROTEINS	Half of hereditary nonpolyposis colon cancer kindreds harbor mutations that inactivate MutlL alpha (MLH1 circle PMS2 heterodimer). MutL alpha is required for mismatch repair, but its function in this process is unclear. We show that human MutL alpha is a latent endonuclease that is activated in a mismatch-, MutS alpha-, RFC-, PCNA-, and ATP-dependent manner. Incision of a nicked mismatch-containing DNA heteroduplex by this four-protein system is strongly biased to the nicked strand. A mismatch-containing DNA segment spanned by two strand breaks is removed by the 5'-to-3' activity of MutS alpha-activated exonuclease I. The probable endonuclease active site has been localized to a PMS2 DQHA(X)(2)E(X)(4)E motif. This motif is conserved in eukaryotic PMS2 homologs and in MutL proteins from a number of bacterial species but is lacking in MutL proteins from bacteria that rely on d(GATC) methylation for strand discrimination in mismatch repair. Therefore, the mode of excision initiation may differ in these organisms.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	modrich@biochem.duke.edu		Modrich, Paul/0000-0001-8708-9885	NIGMS NIH HHS [GM45190] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASH DE, 1982, J BIOL CHEM, V257, P9261; AU KG, 1992, J BIOL CHEM, V267, P12142; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowers J, 2001, J MOL BIOL, V306, P957, DOI 10.1006/jmbi.2001.4467; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; FANG WH, 1993, J BIOL CHEM, V268, P11838; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Miyaki M, 1997, ONCOGENE, V15, P2877, DOI 10.1038/sj.onc.1201668; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; SU SS, 1988, J BIOL CHEM, V263, P6829; Surtees JA, 2004, CYTOGENET GENOME RES, V107, P146, DOI 10.1159/000080593; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	34	447	463	2	54	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					297	308		10.1016/j.cell.2006.05.039	http://dx.doi.org/10.1016/j.cell.2006.05.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873062	Bronze			2022-12-01	WOS:000239552600016
J	Metz, M; Piliponsky, AM; Chen, CC; Lammel, V; Abrink, M; Pejler, G; Tsai, M; Galli, SJ				Metz, Martin; Piliponsky, Adrian M.; Chen, Ching-Cheng; Lammel, Verena; Abrink, Magnus; Pejler, Gunnar; Tsai, Mindy; Galli, Stephen J.			Mast cells can enhance resistance to snake and honeybee venoms	SCIENCE			English	Article							PEPTIDE; MICE; PROTEASES; TOXICITY; IMMUNITY; TISSUE; BITES; APIS	Snake or honeybee envenomation can cause substantial morbidity and mortality, and it has been proposed that the activation of mast cells by snake or insect venoms can contribute to these effects. We show, in contrast, that mast cells can significantly reduce snake-venom - induced pathology in mice, at least in part by releasing carboxypeptidase A and possibly other proteases, which can degrade venom components. Mast cells also significantly reduced the morbidity and mortality induced by honeybee venom. These findings identify a new biological function for mast cells in enhancing resistance to the morbidity and mortality induced by animal venoms.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Swedish Univ Agr Sci, Dept Mol Biosci, Biomed Ctr, Uppsala, Sweden	Stanford University; Swedish University of Agricultural Sciences	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu	Chen, Ching-Cheng/C-1259-2009; Metz, Martin/B-8799-2009; Åbrink, Magnus/AAK-8346-2020; Maurer, Marcus/ABG-2174-2020; Metz, Martin/M-5237-2013	Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X; Metz, Martin/0000-0002-4070-9976; Tsai, Mindy/0000-0002-8421-4721; Abrink, Magnus/0000-0002-1335-3927	NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL067674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023990, R01AI023990] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA072074, R01 CA72074] Funding Source: Medline; NHLBI NIH HHS [P50 HL67674, P50 HL067674] Funding Source: Medline; NIAID NIH HHS [R01 AI023990, R37 AI23990] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Calixto MC, 2003, INFLAMM RES, V52, P132, DOI 10.1007/s000110300026; Caughey GH, 2002, MOL IMMUNOL, V38, P1353, DOI 10.1016/S0161-5890(02)00087-1; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; DUTTA NK, 1952, NATURE, V169, P1064, DOI 10.1038/1691064b0; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Harrison RA, 2003, TOXICON, V41, P441, DOI 10.1016/S0041-0101(02)00360-4; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Huang CF, 1998, J CLIN IMMUNOL, V18, P169, DOI 10.1023/A:1020574820797; KLOOG Y, 1988, SCIENCE, V242, P268, DOI 10.1126/science.2845579; Kochva E, 1998, Public Health Rev, V26, P209; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McNamee D, 2001, LANCET, V357, P1680, DOI 10.1016/S0140-6736(00)04868-6; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metsarinne KP, 2002, ARTERIOSCL THROM VAS, V22, P268, DOI 10.1161/hq0202.103994; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; Rucavado A, 2004, TOXICON, V43, P417, DOI 10.1016/j.toxicon.2004.01.016; SCHMIDT JO, 1995, TOXICON, V33, P917, DOI 10.1016/0041-0101(95)00011-A; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tsai M, 2000, P NATL ACAD SCI USA, V97, P9186, DOI 10.1073/pnas.160254997; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Weisel-Eichler A, 2004, J COMP PHYSIOL A, V190, P683, DOI 10.1007/s00359-004-0526-3; White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030; ZIAI MR, 1990, J PHARM PHARMACOL, V42, P457, DOI 10.1111/j.2042-7158.1990.tb06595.x	30	263	272	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					526	530		10.1126/science.1128877	http://dx.doi.org/10.1126/science.1128877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873664				2022-12-01	WOS:000239308600064
J	Numata, T; Ikeuchi, Y; Fukai, S; Suzuki, T; Nureki, O				Numata, Tomoyuki; Ikeuchi, Yoshiho; Fukai, Shuya; Suzuki, Tsutomu; Nureki, Osamu			Snapshots of tRNA sulphuration via an adenylated intermediate	NATURE			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-MECHANISM; BIOSYNTHESIS; 4-THIOURIDINE; SYNTHETASE; INITIATION; COMPLEX; MNMA; LOOP; THII		Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Kanagawa 2268501, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; PRESTO, JST, Kawaguchi, Saitama 3320012, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Tokyo Institute of Technology; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN	Nureki, O (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta Cho, Kanagawa 2268501, Japan.	nureki@bio.titech.ac.jp	Numata, Tomoyuki/L-6952-2018; Suzuki, Tsutomu/J-1776-2015; NUREKI, OSAMU/G-4960-2014; ikeuchi, yoshiho/C-1713-2014; Ikeuchi, Yoshiho/N-1057-2019; Fukai, Shuya/X-4838-2018	Numata, Tomoyuki/0000-0002-4244-8829; Suzuki, Tsutomu/0000-0002-9731-1731; ikeuchi, yoshiho/0000-0002-2829-3840; Fukai, Shuya/0000-0002-1241-1443				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjork Glenn R., 1995, P165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; ISEL C, 1993, J BIOL CHEM, V268, P25269; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISHITANI R, 2006, CUEMOL MOL VISUALIZA; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Numata T, 2006, ACTA CRYSTALLOGR F, V62, P368, DOI 10.1107/S174430910600738X; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Rizzi M, 1996, EMBO J, V15, P5125, DOI 10.1002/j.1460-2075.1996.tb00896.x; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; SULLIVAN MA, 1985, J BACTERIOL, V161, P368, DOI 10.1128/JB.161.1.368-376.1985; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Yokoyama Shigeyuki, 1995, P207	30	105	108	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					419	424		10.1038/nature04896	http://dx.doi.org/10.1038/nature04896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871210				2022-12-01	WOS:000239278900035
J	Carosella, ED; Pradeu, T				Carosella, Edgardo D.; Pradeu, Thomas			Transplantation and identity: a dangerous split?	LANCET			English	Editorial Material							HAND TRANSPLANTATION; FACE		Univ Paris 04, Dept Philosophy, IHPST, F-75006 Paris, France; Hop St Louis, CEA, DRM, DSV,Serv Rech Hematoimmunol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite	Pradeu, T (corresponding author), Univ Paris 04, Dept Philosophy, IHPST, F-75006 Paris, France.	thomas.pradeu@ens.fr						Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Hovius SER, 2001, J HAND SURG-BRIT EUR, V26, P519, DOI 10.1054/jhsb.2001.0673; Huxtable R, 2005, BIOETHICS, V19, P505, DOI 10.1111/j.1467-8519.2005.00461.x; Meyer VE, 2001, J HAND SURG-BRIT EUR, V26, P509, DOI 10.1054/jhsb.2001.0670; Okie S, 2006, NEW ENGL J MED, V354, P889, DOI 10.1056/NEJMp068005; 2005, LANCET, V366, P1984	7	21	23	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					183	184		10.1016/S0140-6736(06)68938-1	http://dx.doi.org/10.1016/S0140-6736(06)68938-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844470	Green Submitted			2022-12-01	WOS:000239095000007
J	Suydam, IT; Snow, CD; Pande, VS; Boxer, SG				Suydam, Ian T.; Snow, Christopher D.; Pande, Vijay S.; Boxer, Steven G.			Electric fields at the active site of an enzyme: Direct comparison of experiment with theory	SCIENCE			English	Article							VIBRATIONAL STARK SPECTROSCOPY; HUMAN ALDOSE REDUCTASE; CHEMICAL-SHIFTS; AMINO-ACIDS; DRUG DESIGN; PROTEINS; ELECTROSTATICS; CHEMISTRY; SENSITIVITY; DYNAMICS	The electric fields produced in folded proteins influence nearly every aspect of protein function. We present a vibrational spectroscopy technique that measures changes in electric field at a specific site of a protein as shifts in frequency ( Stark shifts) of a calibrated nitrile vibration. A nitrile-containing inhibitor is used to deliver a unique probe vibration to the active site of human aldose reductase, and the response of the nitrile stretch frequency is measured for a series of mutations in the enzyme active site. These shifts yield quantitative information on electric fields that can be directly compared with electrostatics calculations. We show that extensive molecular dynamics simulations and ensemble averaging are required to reproduce the observed changes in field.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Boxer, SG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	sboxer@stanford.edu	Snow, Christopher/L-5624-2013; Pande, Vijay/ABE-8145-2020	Snow, Christopher/0000-0002-7690-3519; Boxer, Steven/0000-0001-9167-4286				Andrews SS, 2002, J PHYS CHEM A, V106, P469, DOI 10.1021/jp011724f; Andrews SS, 2000, J PHYS CHEM A, V104, P11853, DOI 10.1021/jp002242r; Bublitz GU, 1997, ANNU REV PHYS CHEM, V48, P213, DOI 10.1146/annurev.physchem.48.1.213; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Getahun Z, 2003, J AM CHEM SOC, V125, P405, DOI 10.1021/ja0285262; GILSON MK, 1986, BIOPOLYMERS, V25, P2097, DOI 10.1002/bip.360251106; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Howard EI, 2004, PROTEINS, V55, P792, DOI 10.1002/prot.20015; Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7; Lamour V, 1999, ACTA CRYSTALLOGR D, V55, P721, DOI 10.1107/S0907444998013365; Lehle H, 2005, BIOPHYS J, V88, P1978, DOI 10.1529/biophysj.104.048140; Muzet N, 2003, P NATL ACAD SCI USA, V100, P8742, DOI 10.1073/pnas.1432955100; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Park ES, 2002, J PHYS CHEM B, V106, P5800, DOI 10.1021/jp0203043; PEARSON JG, 1993, J AM CHEM SOC, V115, P6851, DOI 10.1021/ja00068a049; Podjarny A, 2004, CELL MOL LIFE SCI, V61, P763, DOI 10.1007/s00018-003-3404-1; Reimers JR, 1996, J PHYS CHEM-US, V100, P1498, DOI 10.1021/jp9523985; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Simonson T, 2001, CURR OPIN STRUC BIOL, V11, P243, DOI 10.1016/S0959-440X(00)00197-4; Snow CD, 2005, ANNU REV BIOPH BIOM, V34, P43, DOI 10.1146/annurev.biophys.34.040204.144447; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Suydam IT, 2003, BIOCHEMISTRY-US, V42, P12050, DOI 10.1021/bi0352926; Van Zandt MC, 2004, BIOORGAN MED CHEM, V12, P5661, DOI 10.1016/j.bmc.2004.07.062; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Warshel A, 1998, CURR OPIN STRUC BIOL, V8, P211, DOI 10.1016/S0959-440X(98)80041-9	26	256	256	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					200	204		10.1126/science.1127159	http://dx.doi.org/10.1126/science.1127159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840693				2022-12-01	WOS:000239008000037
J	Woyke, T; Teeling, H; Ivanova, NN; Huntemann, M; Richter, M; Gloeckner, FO; Boffelli, D; Anderson, IJ; Barry, KW; Shapiro, HJ; Szeto, E; Kyrpides, NC; Mussmann, M; Amann, R; Bergin, C; Ruehland, C; Rubin, EM; Dubilier, N				Woyke, Tanja; Teeling, Hanno; Ivanova, Natalia N.; Huntemann, Marcel; Richter, Michael; Gloeckner, Frank Oliver; Boffelli, Dario; Anderson, Iain J.; Barry, Kerrie W.; Shapiro, Harris J.; Szeto, Ernest; Kyrpides, Nikos C.; Mussmann, Marc; Amann, Rudolf; Bergin, Claudia; Ruehland, Caroline; Rubin, Edward M.; Dubilier, Nicole			Symbiosis insights through metagenomic analysis of a microbial consortium	NATURE			English	Article							BACTERIA; GENOME; GENE; OLIGOCHAETA; COMMUNITIES; SYSTEM; WORM; SEA	Symbioses between bacteria and eukaryotes are ubiquitous, yet our understanding of the interactions driving these associations is hampered by our inability to cultivate most host-associated microbes. Here we use a metagenomic approach to describe four co-occurring symbionts from the marine oligochaete Olavius algarvensis, a worm lacking a mouth, gut and nephridia. Shotgun sequencing and metabolic pathway reconstruction revealed that the symbionts are sulphur-oxidizing and sulphate-reducing bacteria, all of which are capable of carbon fixation, thus providing the host with multiple sources of nutrition. Molecular evidence for the uptake and recycling of wormwaste products by the symbionts suggests how the worm could eliminate its excretory system, an adaptation unique among annelid worms. We propose a model that describes how the versatile metabolism within this symbiotic consortium provides the host with an optimal energy supply as it shuttles between the upper oxic and lower anoxic coastal sediments that it inhabits.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Int Jacobs Univ Bremen, D-28759 Bremen, Germany	Max Planck Society; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Rubin, EM (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	EMRubin@lbl.gov; ndubilie@mpi-bremen.de	Amann, Rudolf I/C-6534-2014; Huntemann, Marcel/HCH-8928-2022; Mussmann, Marc/AAA-6108-2021; Barry, Kerrie Whitelaw/AAA-5500-2020; Kyrpides, Nikos C./A-6305-2014; Dubilier, Nicole/I-8203-2018; Mussmann, Marc/A-8649-2017	Amann, Rudolf I/0000-0002-0846-7372; Huntemann, Marcel/0000-0002-1284-3748; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Kyrpides, Nikos C./0000-0002-6131-0462; Dubilier, Nicole/0000-0002-9394-825X; Mussmann, Marc/0000-0003-3102-8703; , Marc/0000-0003-2785-2521; Ivanova, Natalia/0000-0002-5802-9485				[Anonymous], 2002, HIST PHIL LIFE SCI; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Blazejak A, 2005, APPL ENVIRON MICROB, V71, P1553, DOI 10.1128/AEM.71.3.1553-1561.2005; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; Cohen S.S., 1998, GUIDE POLYAMINES; De Cian MC, 2000, J EXP BIOL, V203, P2907; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Denger K, 2004, MICROBIOL-SGM, V150, P1859, DOI 10.1099/mic.0.27077-0; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Dubilier Nicole, 2006, V41, P251; Giere O, 2002, ORG DIVERS EVOL, V2, P289, DOI 10.1078/1439-6092-00044; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HUNTEMANN M, 2006, THESIS U BREMEN; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kletzin A, 1996, J BACTERIOL, V178, P248, DOI 10.1128/jb.178.1.248-257.1996; Liu JY, 1999, MOL MICROBIOL, V31, P1845, DOI 10.1046/j.1365-2958.1999.01321.x; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Matias PM, 2005, PROG BIOPHYS MOL BIO, V89, P292, DOI 10.1016/j.pbiomolbio.2004.11.003; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Quast C, 2006, THESIS U BREMEN; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Yancey PH, 2002, COMP BIOCHEM PHYS A, V133, P667, DOI 10.1016/S1095-6433(02)00182-4; YANG CC, 1995, EUR J BIOCHEM, V232, P264, DOI 10.1111/j.1432-1033.1995.tb20808.x	39	309	325	3	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					950	955		10.1038/nature05192	http://dx.doi.org/10.1038/nature05192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	16980956	Green Submitted			2022-12-01	WOS:000241523400045
J	Janzen, V; Forkert, R; Fleming, HE; Saito, Y; Waring, MT; Dombkowski, DM; Cheng, T; DePinho, RA; Sharpless, NE; Scadden, DT				Janzen, Viktor; Forkert, Randolf; Fleming, Heather E.; Saito, Yoriko; Waring, Michael T.; Dombkowski, David M.; Cheng, Tao; DePinho, Ronald A.; Sharpless, Norman E.; Scadden, David T.			Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16(INK4a)	NATURE			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; IN-VIVO; EXPRESSION; ENGRAFTMENT; SENESCENCE; INCREASES; P19(ARF); YOUNG; MICE	Stem-cell ageing is thought to contribute to altered tissue maintenance and repair. Older humans experience increased bone marrow failure and poorer haematologic tolerance of cytotoxic injury. Haematopoietic stem cells (HSCs) in older mice have decreased per-cell repopulating activity, self-renewal and homing abilities, myeloid skewing of differentiation, and increased apoptosis with stress. Here we report that the cyclin-dependent kinase inhibitor p16(INK4a), the level of which was previously noted to increase in other cell types with age, accumulates and modulates specific age-associated HSC functions. Notably, in the absence of p16(INK4a), HSC repopulating defects and apoptosis were mitigated, improving the stress tolerance of cells and the survival of animals in successive transplants, a stem- cell-autonomous tissue regeneration model. Inhibition of p16(INK4a) may ameliorate the physiological impact of ageing on stem cells and thereby improve injury repair in aged tissue.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Ctr Regenerat Med, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Ctr Appl Canc Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu		Sharpless, Norman/0000-0001-7078-9455; DePinho, Ronald/0000-0002-5625-577X; Cheng, Tao/0000-0002-5925-2769				Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; HARRISON DE, 1972, NATURE-NEW BIOL, V237, P220, DOI 10.1038/newbio237220a0; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; KRISHNAMURTHY J, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05092; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; MOLOFSKY AV, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05091; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	33	836	898	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					421	426		10.1038/nature05159	http://dx.doi.org/10.1038/nature05159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	16957735				2022-12-01	WOS:000240798800038
J	Vrabioiu, AM; Mitchison, TJ				Vrabioiu, Alina M.; Mitchison, Timothy J.			Structural insights into yeast septin organization from polarized fluorescence microscopy	NATURE			English	Article							BUDDING YEAST; CELL CORTEX; PROTEIN; CYTOKINESIS; MEMBRANE; RING; ORIENTATION; DYNAMICS; ACTIN; CYCLE	Septins are polymerizing GTPases(1) that function in cortical organization and cell division(2-4). In Saccharomyces cerevisiae they localize at the isthmus between the mother and the daughter cells, where they undergo a transition from a non-dynamic hourglass-shaped assembly(5) to two separate rings, at the onset of cytokinesis(6,7). Septins form filaments as pure protein(8) and in vivo(9), but the filament organization within the hourglass and ring structures is controversial(9,10). Here, we use polarized fluorescence microscopy(11) of orientationally constrained green fluorescent protein to determine septin filament organization and dynamics in living yeast. We found that the hourglass is made of filaments aligned along the yeast bud neck. During the transition from hourglass to rings the filaments rotate through 90 degrees in the membrane plane and become circumferential. These data resolve a long-standing controversy in the field and provide strong evidence that septins have a mechanical function in cell division.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Vrabioiu, AM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	alina_vrabioiu@student.hms.harvard.edu						AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; BURGHARDT TP, 1984, BIOPOLYMERS, V23, P2383; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Cid VJ, 2001, MICROBIOL-SGM, V147, P1437, DOI 10.1099/00221287-147-6-1437; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Dale RE, 1999, BIOPHYS J, V76, P1606, DOI 10.1016/S0006-3495(99)77320-0; DESPER CR, 1967, J APPL PHYS, V38, P4225, DOI 10.1063/1.1709109; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Inoue S, 2002, P NATL ACAD SCI USA, V99, P4272, DOI 10.1073/pnas.062065199; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lippincott J, 2001, J CELL SCI, V114, P1379; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Picart C, 1999, BIOPHYS J, V77, P865, DOI 10.1016/S0006-3495(99)76938-9; Rocheleau JV, 2003, BIOPHYS J, V84, P4078, DOI 10.1016/S0006-3495(03)75133-9; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.E04-08-0734; Schmidt M, 2002, J CELL SCI, V115, P293; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Tatchell K, 2002, METHOD ENZYMOL, V351, P661; Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	29	155	157	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					466	469		10.1038/nature05109	http://dx.doi.org/10.1038/nature05109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006515				2022-12-01	WOS:000240798800048
J	Danik, JS; Rifai, N; Buring, JE; Ridker, PM				Danik, Jacqueline Suk; Rifai, Nader; Buring, Julie E.; Ridker, Paul M.			Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE ASPIRIN; MIDDLE-AGED MEN; PLASMA LIPOPROTEIN(A); MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; ELEVATED LIPOPROTEIN(A); LP(A) LIPOPROTEIN; ARTERY-DISEASE	Context Controversy exists as to whether lipoprotein( a), a lipoprotein with homology to plasminogen, is a clinically meaningful cardiovascular risk marker in women. There is also poor agreement among lipoprotein( a) levels obtained by different assays. Objective To determine the association of lipoprotein( a) levels, measured with an assay independent of apolipoprotein( a) isoform size, with the incidence of future cardiovascular events. Design, Setting, and Participants Prospective study of 27 791 initially healthy women in the Women's Health Study, enrolled between November 1992 and July 1995 and followed up for 10 years. Lipoprotein( a) level was measured in blood samples obtained at baseline with an assay independent of apolipoprotein( a) isoform size. Main Outcome Measure Hazard ratios (HRs) for first-ever major cardiovascular events (nonfatal myocardial infarction, nonfatal cerebrovascular event, coronary revascularization, or cardiovascular deaths). Results During follow-up, there were 899 incident cardiovascular events. After adjusting for age, smoking, blood pressure, body mass index, total cholesterol, high-density lipoprotein cholesterol, diabetes, hormone use, C-reactive protein, and randomization treatment groups, women in the highest quintile of lipoprotein( a) ( >= 44.0 mg/dL) were 1.47 times more likely (95% CI, 1.21- 1.79; P for trend <. 001) to develop cardiovascular events than women in the lowest quintile ( <= 3.4 mg/dL). This association, however, was due almost entirely to a threshold effect among those with the highest lipoprotein ( a) levels. After adjusting for all of the variables listed above, the HR associated with lipoprotein( a) levels exceeding the 90th percentile ( >= 65.5 mg/dL) was 1.66 ( 95% CI, 1.38-1.99); 95th percentile ( >= 83 mg/dL), 1.87 ( 95% CI, 1.50-2.34); and 99th percentile ( >= 130.7 mg/dL), 1.99 ( 95% CI, 1.32-3.00), with almost no risk gradient at lower levels. Associations were strongest among women with low-density lipoprotein cholesterol (LDL-C) above the median level. In this subgroup, the adjusted HR associated with lipoprotein( a) levels exceeding the 90th percentile was 1.81 ( 95% CI, 1.48-2.23); 95th percentile, 1.93 ( 95% CI, 1.51-2.48); and 99th percentile, 1.93 ( 95% CI, 1.21-3.05) ( P value for interaction with LDL-C=. 001). Conclusions In this cohort of initially healthy women, extremely high levels of lipoprotein( a) (>= 90th percentile), measured with an assay independent of apolipoprotein( a) isoform size, were associated with increased cardiovascular risk, particularly in women with high levels of LDL-C. However, the threshold and interaction effects observed do not support routine measurement of lipoprotein( a) for cardiovascular stratification in women.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Donald W Reynolds Ctr Cardiovasc Res, Boston, MA USA; Leducq Fdn Ctr Vasc Res, Boston, MA USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Lab Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Danik, JS (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	jdanik@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076443, R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-076443, HL-43851] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; ARMSTRONG VW, 1986, ATHEROSCLEROSIS, V62, P249, DOI 10.1016/0021-9150(86)90099-7; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Baldassarre D, 1996, STROKE, V27, P1044, DOI 10.1161/01.STR.27.6.1044; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; Cantin B, 2002, AM J CARDIOL, V89, P662, DOI 10.1016/S0002-9149(01)02336-0; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; Caplice NM, 2001, BLOOD, V98, P2980, DOI 10.1182/blood.V98.10.2980; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Craig WY, 1998, CLIN CHEM, V44, P2301; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; EZRATTY A, 1993, BIOCHEMISTRY-US, V32, P4628, DOI 10.1021/bi00068a021; Guerra R, 2005, CIRCULATION, V111, P1471, DOI 10.1161/01.CIR.0000159263.50305.BD; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hobbs HH, 1999, CURR OPIN LIPIDOL, V10, P225, DOI 10.1097/00041433-199906000-00005; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; KOSTNER GM, 1981, ATHEROSCLEROSIS, V38, P51, DOI 10.1016/0021-9150(81)90103-9; Kronenberg F, 1999, CIRCULATION, V100, P1154, DOI 10.1161/01.CIR.100.11.1154; Kronenberg F, 1996, ARTERIOSCL THROM VAS, V16, P1568, DOI 10.1161/01.ATV.16.12.1568; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LaRosa J C, 1992, Womens Health Issues, V2, P102, DOI 10.1016/S1049-3867(05)80278-6; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P240, DOI 10.1161/01.ATV.10.2.240; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; MAHER VMG, 1995, JAMA-J AM MED ASSOC, V274, P1771, DOI 10.1001/jama.274.22.1771; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; Marcovina SM, 2000, CLIN CHEM, V46, P1956; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Poon M, 1997, CIRCULATION, V96, P2514, DOI 10.1161/01.CIR.96.8.2514; RADER DJ, 1992, JAMA-J AM MED ASSOC, V267, P1109, DOI 10.1001/jama.267.8.1109; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; RIDKER PM, 1995, JAMA-J AM MED ASSOC, V273, P1269, DOI 10.1001/jama.273.16.1269; Rifai N, 2004, CLIN CHEM, V50, P1364, DOI 10.1373/clinchem.2003.030031; Roberts WL, 2001, CLIN CHEM, V47, P418; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; SCHWARTZKOPFF W, 1990, ATHEROSCLEROSIS, V82, P253, DOI 10.1016/0021-9150(90)90047-M; Seman LJ, 1999, CLIN CHEM, V45, P1039; SGOUTAS DS, 1992, CLIN CHEM, V38, P1873; Shai I, 2005, EUR HEART J, V26, P1633, DOI 10.1093/eurheartj/ehi222; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SIGURDSSON G, 1992, AM J CARDIOL, V69, P1251, DOI 10.1016/0002-9149(92)91215-P; Sunayama S, 1996, CIRCULATION, V94, P1263, DOI 10.1161/01.CIR.94.6.1263; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; von Eckardstein A, 2001, J AM COLL CARDIOL, V37, P434, DOI 10.1016/S0735-1097(00)01126-8; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1	53	155	168	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1363	1370						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985228	Bronze			2022-12-01	WOS:000240595800023
J	Hasper, HE; Kramer, NE; Smith, JL; Hillman, JD; Zachariah, C; Kuipers, OP; de Kruijff, B; Breukink, E				Hasper, Hester E.; Kramer, Naomi E.; Smith, James L.; Hillman, J. D.; Zachariah, Cherian; Kuipers, Oscar P.; de Kruijff, Ben; Breukink, Eefjan			An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II	SCIENCE			English	Article							NISIN; BIOSYNTHESIS; ANTIBIOTICS; MODE; WALL; CELL; MORPHOGENESIS; PURIFICATION; GALLIDERMIN; EPIDERMIN	Lantibiotics are polycyclic peptides containing unusual amino acids, which have binding specificity for bacterial cells, targeting the bacterial cell wall component lipid II to form pores and thereby lyse the cells. Yet several members of these lipid II - targeted lantibiotics are too short to be able to span the lipid bilayer and cannot form pores, but somehow they maintain their antibacterial efficacy. We describe an alternative mechanism by which members of the lantibiotic family kill Gram-positive bacteria by removing lipid II from the cell division site ( or septum) and thus block cell wall synthesis.	Univ Utrecht, Dept Membrane Biochem, Bijvoet Ctr Biomol Res, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands; Univ Groningen, Dept Genet, Groningne Biomol Sci & Biotechnol Inst, NL-9750 AA Haren, Netherlands; Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; Oragen Inc, Alachua, FL 32615 USA; Banyon Biomarkers, Alachua, FL 32615 USA	Utrecht University; University of Groningen; Mississippi State University	Breukink, E (corresponding author), Univ Utrecht, Dept Membrane Biochem, Bijvoet Ctr Biomol Res, Biomembrane Inst, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	e.j.breukink@chem.uu.nl	Breukink, Eefjan/I-3039-2016; Kuipers, Oscar/B-6752-2009	Breukink, Eefjan/0000-0002-7311-0660; Kuipers, Oscar/0000-0001-5596-7735; Smith, James/0000-0002-0876-7260				Bonelli RR, 2006, ANTIMICROB AGENTS CH, V50, P1449, DOI 10.1128/AAC.50.4.1449-1457.2006; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Furmanek B, 1999, J APPL MICROBIOL, V87, P856, DOI 10.1046/j.1365-2672.1999.00937.x; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Koch AL, 2003, CLIN MICROBIOL REV, V16, P673, DOI 10.1128/CMR.16.4.673-687.2003; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; McAuliffe O, 2001, FEMS MICROBIOL REV, V25, P285, DOI 10.1016/S0168-6445(00)00065-6; Morency H, 2001, CAN J MICROBIOL, V47, P322, DOI 10.1139/w01-013; Stein T, 2002, J BACTERIOL, V184, P1703, DOI 10.1128/JB.184.6.1703-1711.2002; VANHEIJENOORT Y, 1992, J BACTERIOL, V174, P3549, DOI 10.1128/JB.174.11.3549-3557.1992; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wescombe PA, 2003, APPL ENVIRON MICROB, V69, P2737, DOI 10.1128/AEM.69.5.2737-2747.2003; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600	20	371	380	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1636	1637		10.1126/science.1129818	http://dx.doi.org/10.1126/science.1129818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973881	Green Submitted			2022-12-01	WOS:000240498900045
J	List, B; Yang, JW				List, Benjamin; Yang, Jung Woon			The organic approach to asymmetric catalysis	SCIENCE			English	Editorial Material							CHIRAL BRONSTED ACID; ALDOL REACTIONS		Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany	Max Planck Society	List, B (corresponding author), Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany.	list@mpi-muelheim.mpg.de	Yang, Jung Woon/A-5072-2013; List, Benjamin/A-2121-2014; Yang, Jung Woon/N-6725-2019	Yang, Jung Woon/0000-0001-8636-0901; Yang, Jung Woon/0000-0001-8636-0901				Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677; Bredig G, 1912, BIOCHEM Z, V46, P7; Enders D, 2006, NATURE, V441, P861, DOI 10.1038/nature04820; Itoh J, 2006, ANGEW CHEM INT EDIT, V45, P4796, DOI 10.1002/anie.200601345; Kano T, 2005, J AM CHEM SOC, V127, P16408, DOI 10.1021/ja056008w; Knowles WS, 2003, ADV SYNTH CATAL, V345, P3, DOI 10.1002/adsc.200390028; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Movassaghi M, 2002, SCIENCE, V298, P1904, DOI 10.1126/science.1076547; NICOLAOU KC, 1996, CLASICS TOTAL SYNTHE, P344; Northrup AB, 2004, SCIENCE, V305, P1752, DOI 10.1126/science.1101710; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Terada M, 2006, ANGEW CHEM INT EDIT, V45, P2254, DOI 10.1002/anie.200503477; Vachal P, 2002, J AM CHEM SOC, V124, P10012, DOI 10.1021/ja027246j	13	283	286	12	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1584	1586		10.1126/science.1131945	http://dx.doi.org/10.1126/science.1131945			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973867				2022-12-01	WOS:000240498900030
J	Pollard, KS; Salama, SR; Lambert, N; Lambot, MA; Coppens, S; Pedersen, JS; Katzman, S; King, B; Onodera, C; Siepel, A; Kern, AD; Dehay, C; Igel, H; Ares, M; Vanderhaeghen, P; Haussler, D				Pollard, Katherine S.; Salama, Sofie R.; Lambert, Nelle; Lambot, Marie-Alexandra; Coppens, Sandra; Pedersen, Jakob S.; Katzman, Sol; King, Bryan; Onodera, Courtney; Siepel, Adam; Kern, Andrew D.; Dehay, Colette; Igel, Haller; Ares, Manuel, Jr.; Vanderhaeghen, Pierre; Haussler, David			An RNA gene expressed during cortical development evolved rapidly in humans	NATURE			English	Article							MARGINAL ZONE; LAYER-I; EVOLUTION; REELIN; NEURONS; VERTEBRATE; MOUSE; ISOCHORES; ORIGIN; SYSTEM	The developmental and evolutionary mechanisms behind the emergence of human-specific brain features remain largely unknown. However, the recent ability to compare our genome to that of our closest relative, the chimpanzee, provides new avenues to link genetic and phenotypic changes in the evolution of the human brain. We devised a ranking of regions in the human genome that show significant evolutionary acceleration. Here we report that the most dramatic of these 'human accelerated regions', HAR1, is part of a novel RNA gene (HAR1F) that is expressed specifically in Cajal Retzius neurons in the developing human neocortex from 7 to 19 gestational weeks, a crucial period for cortical neuron specification and migration. HAR1F is co-expressed with reelin, a product of Cajal - Retzius neurons that is of fundamental importance in specifying the six-layer structure of the human cortex. HAR1 and the other human accelerated regions provide new candidates in the search for uniquely human biology.	Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Mol Biol RNA, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Free Univ Brussels, IRIBHM, B-1070 Brussels, Belgium; Free Univ Brussels, Erasme Hosp, Dept Psychiat, B-1070 Brussels, Belgium; INSERM, U371, F-69500 Bron, France; Univ Lyon 1, F-69500 Bron, France	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Haussler, D (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu	Pedersen, Jakob/G-3382-2012; Salama, Sofie/K-6412-2019; Pedersen, Jakob/C-4985-2009; Dehay, Colette/H-4437-2014	Pedersen, Jakob/0000-0002-7236-4001; Dehay, Colette/0000-0002-5196-1464; , Nelle/0000-0003-1137-9725; Ares, Manny/0000-0002-2552-9168; Vanderhaeghen, Pierre/0000-0001-7899-5720; Salama, Sofie/0000-0001-6999-7193; Coppens, Sandra/0000-0001-9155-7506; Siepel, Adam/0000-0002-3557-7219	NIGMS NIH HHS [R01 GM040478] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Duret L, 2002, GENETICS, V162, P1837; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hedges SB, 2002, SCIENCE, V297, P1283; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimura M., 1983, NEUTRAL THEORY MOL E; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lambot MA, 2005, J NEUROSCI, V25, P7232, DOI 10.1523/JNEUROSCI.0802-05.2005; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Merryman C, 1998, PRACT APPROACH SER, V192, P237; Meyer G, 1999, EUR J NEUROSCI, V11, P3937, DOI 10.1046/j.1460-9568.1999.00818.x; Meyer G, 1998, J COMP NEUROL, V397, P493; Meyer G, 1998, J COMP NEUROL, V397, P29; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Perez-Garcia CG, 2004, EUR J NEUROSCI, V20, P2827, DOI 10.1111/j.1460-9568.2004.03733.x; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rakic S, 2003, CEREB CORTEX, V13, P1072, DOI 10.1093/cercor/13.10.1072; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001	41	633	664	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					167	172		10.1038/nature05113	http://dx.doi.org/10.1038/nature05113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16915236				2022-12-01	WOS:000240467000037
J	Cronberg, N; Natcheva, R; Hedlund, K				Cronberg, Nils; Natcheva, Rayna; Hedlund, Katarina			Microarthropods mediate sperm transfer in mosses	SCIENCE			English	Article									Lund Univ, Dept Ecol, S-22362 Lund, Sweden; Bulgarian Acad Sci, BU-1113 Sofia, Bulgaria	Lund University; Bulgarian Academy of Sciences	Cronberg, N (corresponding author), Lund Univ, Dept Ecol, S-22362 Lund, Sweden.	Nils.Cronberg@ekol.lu.se	Hedlund, Katarina/AAC-3333-2022; Cronberg, Nils/D-3275-2013	Cronberg, Nils/0000-0002-3369-8420; Natcheva, Rayna/0000-0001-7873-5523				Harvey-Gibson RJ, 1927, ANN BOT-LONDON, V41, P190; Labandeira CC, 1998, SCIENCE, V280, P57, DOI 10.1126/science.280.5360.57; PAOLILLO DJ, 1979, BRYOLOGIST, V82, P93, DOI 10.2307/3241977; Pfeffer W., 1884, UNTERS BOT I T BINGE, V1, P363; Renzaglia KS, 2001, CRIT REV PLANT SCI, V20, P107, DOI 10.1016/S0735-2689(01)80034-4; Willis K.J., 2002, EVOLUTION PLANTS	6	62	65	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1255	1255		10.1126/science.1128707	http://dx.doi.org/10.1126/science.1128707			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946062				2022-12-01	WOS:000240313500031
J	Villamor, E; Cnattingius, S				Villamor, Eduardo; Cnattingius, Sven			Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study	LANCET			English	Article							PREPREGNANCY WEIGHT; PHYSICAL-ACTIVITY; MATERNAL OBESITY; OVERWEIGHT; COMPLICATIONS; TRENDS; PREVALENCE; WOMEN; DIET	Background Maternal obesity has been positively associated with risk of adverse pregnancy outcomes, but evidence of a causal relation is scarce. Causality would be lent support if temporal changes in weight affected risk of adverse pregnancy outcomes. Methods We examined the associations between change in prepregnancy body-mass index (BMI) from the first to the second pregnancies, and the risk of adverse outcomes during the second pregnancy in a nationwide Swedish study of 151025 women who had their first two consecutive singleton births between 1992 and 2001. Findings Compared with women whose BMI changed between -1.0 and 0.9 units, the adjusted odds ratios for adverse pregnancy outcomes for those who gained 3 or more units during an average 2 years were: pre-eclampsia, 1.78 (95% CI 1.52-2.08); gestational hypertension 1.76 (1.39-2.23); gestational diabetes 2.09 (1.68-2.61); Caesarean delivery 1.32 (1.22-1.44); stillbirth 1.63 (1.20-2.21); and large-for-gestational-age birth 1.87 (1.72-2.04). The associations were linearly related to the amount of weight change and were also noted in women who had a healthy prepregnancy BMI for both pregnancies. Interpretation These findings lend support to a causal relation between being overweight or obese and risks of adverse pregnancy outcomes. Additionally they suggest that modest increases in BMI before pregnancy could result in perinatal complications, even if a woman does not become overweight. Our results provide robust epidemiological evidence for advocating weight loss in overweight and obese women who are planning to become pregnant and, to prevent weight gain before pregnancy in women with healthy BMIs.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet	Villamor, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	evillamo@hsph.harvard.edu						Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Delvaux T, 2001, AM J PREV MED, V21, P52, DOI 10.1016/S0749-3797(01)00315-4; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Jeffery RW, 2003, AM J CLIN NUTR, V78, P684, DOI 10.1093/ajcn/78.4.684; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Lindmark G, 1991, Acta Obstet Gynecol Scand, V70, P105, DOI 10.3109/00016349109006190; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; *NAT BOARD HLTH WE, EV SWED MED BIRTH RE; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; O'Toole ML, 2003, J WOMENS HEALTH, V12, P991, DOI 10.1089/154099903322643910; ODELL LD, 1945, JAMA-J AM MED ASSOC, V128, P87, DOI 10.1001/jama.1945.02860190023006; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Retnakaran R, 2003, J CLIN ENDOCR METAB, V88, P3507, DOI 10.1210/jc.2003-030186; Rosenberg TJ, 2003, OBSTET GYNECOL, V102, P1022, DOI 10.1016/S0029-7844(03)00878-0; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Smith GCS, 2004, JAMA-J AM MED ASSOC, V292, P2249, DOI 10.1001/jama.292.18.2249; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; WHO, 1995, PHYS STAT US INT ANT; WHO Consultation, 2000, WHO TECH REP SER, V894, P1	29	517	539	1	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1164	1170		10.1016/S0140-6736(06)69473-7	http://dx.doi.org/10.1016/S0140-6736(06)69473-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011943				2022-12-01	WOS:000240916000028
J	Boyle, P				Boyle, Peter			The globalisation of cancer	LANCET			English	Editorial Material									Int Agcy Res Canc, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Boyle, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	director@iarc.fr	Boyle, Peter/A-4380-2014	Boyle, Peter/0000-0001-6251-0610				[Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; [Anonymous], 2005, MILLENNIUM DEV GOALS; Ferlay J, 2004, GLOBOCAN 2002 CANC I; International Agency for Research on Cancer, 2004, MON EV CARC RISKS HU, V83; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9	5	40	43	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2006	368	9536					629	630		10.1016/S0140-6736(06)69225-8	http://dx.doi.org/10.1016/S0140-6736(06)69225-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074YT	16920452				2022-12-01	WOS:000239849200009
J	Younger, JM; Chen, LL; Ren, HY; Rosser, MFN; Turnbull, EL; Fan, CY; Patterson, C; Cyr, DM				Younger, J. Michael; Chen, Liling; Ren, Hong-Yu; Rosser, Meredith F. N.; Turnbull, Emma L.; Fan, Chun-Yang; Patterson, Cam; Cyr, Douglas M.			Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator	CELL			English	Article							RING FINGER PROTEIN; UBIQUITIN LIGASES; WILD-TYPE; CFTR; DEGRADATION; RETROTRANSLOCATION; DISLOCATION; PROTEASOME; COMPLEXES; P97	Cystic fibrosis arises from the misfolding and premature degradation of CFTRAF508, a Cl(-)ion channel with a single amino acid deletion. Yet, the quality-control machinery that selects CFTRAF508 for degradation and the mechanism for its misfolding are not well defined. We identified an ER membrane-associated ubiquitin ligase complex containing the E3 RMA1, the E2 Ubc6e, and Derlin-1 that cooperates with the cytosolic Hsc70/CHIP E3 complex to triage CFTR and CFTRAF508. Derlin-1 serves to retain CFTR in the ER membrane and interacts with RMA1 and Ubc6e to promote CFTIR's proteasomal degradation. RMA1 is capable of recognizing folding defects in CFTRAF508 coincident with translation, whereas the CHIP E3 appears to act posttranslationally. A folding defect in CFTR Delta F508 detected by RMA1 involves the inability of CFTR's second membrane-spanning domain to productively interact with amino-terminal domains. Thus, the RMA1 and CHIP E3 ubiquitin ligases act sequentially in ER membrane and cytosol to monitor the folding status of CFTR and CFTRAF508.	Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cyr, DM (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	dmcyr@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414	NIGMS NIH HHS [R01 GM056981] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cyr DM, 2005, NAT STRUCT MOL BIOL, V12, P2, DOI 10.1038/nsmb0105-2; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dalbey RE, 2004, J CELL BIOL, V166, P769, DOI 10.1083/jcb.200405161; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Lenk U, 2002, J CELL SCI, V115, P3007; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lord JM, 2005, CURR BIOL, V15, pR169, DOI 10.1016/j.cub.2005.02.043; Matsuda N, 2001, J CELL SCI, V114, P1949; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meacham Geoffrey C, 2002, Methods Mol Med, V70, P245; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Welsh MJ, 1998, NAT STRUCT BIOL, V5, P167, DOI 10.1038/nsb0398-167; Xiong XM, 1997, J CLIN INVEST, V100, P1079, DOI 10.1172/JCI119618; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger J. Michael, 2005, V301, P293; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	44	349	356	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2006	126	3					571	582		10.1016/j.cell.2006.06.041	http://dx.doi.org/10.1016/j.cell.2006.06.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901789	Bronze, Green Submitted			2022-12-01	WOS:000239883400016
J	Maraganore, DM; de Andrade, M; Elbaz, A; Farrer, MJ; Ioannidis, JPA; Kruger, R; Rocca, WA; Schneider, NK; Lesnick, TG; Lincoln, SJ; Hulihan, MM; Aasly, JO; Ashizawa, T; Chartier-Harlin, MC; Checkoway, H; Ferrarese, C; Hadjigeorgiou, G; Hattori, N; Kawakami, H; Lambert, JC; Lynch, T; Mellick, GD; Papapetropoulos, S; Parsian, A; Quattrone, A; Riess, O; Tan, EK; Van Broeckhoven, C				Maraganore, Demetrius M.; de Andrade, Mariza; Elbaz, Alexis; Farrer, Matthew J.; Ioannidis, John P.A.; Krueger, Rejko; Rocca, Walter A.; Schneider, Nicole K.; Lesnick, Timothy G.; Lincoln, Sarah J.; Hulihan, Mary M.; Aasly, Jan O.; Ashizawa, Tetsuo; Chartier-Harlin, Marie-Christine; Checkoway, Harvey; Ferrarese, Carlo; Hadjigeorgiou, Georgios; Hattori, Nobutaka; Kawakami, Hideshi; Lambert, Jean-Charles; Lynch, Timothy; Mellick, George D.; Papapetropoulos, Spiridon; Parsian, Abbas; Quattrone, Aldo; Riess, Olaf; Tan, Eng-King; Van Broeckhoven, Christine		GEO-PD Consortium	Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	58th Annual Meeting of the American-Academy-of-Neurology	APR 01-08, 2006	San Diego, CA	Amer Acad Neurol			HARDY-WEINBERG EQUILIBRIUM; MAYO-CLINIC FAMILY; DIAGNOSTIC-CRITERIA; SEQUENCE-ANALYSIS; ALLELIC VARIATION; OLMSTED COUNTY; LEWY BODY; ASSOCIATION; METAANALYSIS; SUSCEPTIBILITY	Context Identification and replication of susceptibility genes for Parkinson disease at the population level have been hampered by small studies with potential biases. alpha-Synuclein (SNCA) has been one of the most promising susceptibility genes, but largescale studies have been lacking. Objective To determine whether allele-length variability in the dinucleotide repeat sequence (REP1) of the SNCA gene promoter is associated with Parkinson disease susceptibility, whether SNCA promoter haplotypes are associated with Parkinson disease, and whether REP1 variability modifies age at onset. Design, Setting, and Participants We performed a collaborative analysis of individual-level data on SNCA REP1 and flanking markers in patients with Parkinson disease and controls. Study site recruitment, data collection, and analyses were performed between April 5, 2004, and December 31, 2005. Eighteen participating sites of a global genetics consortium provided clinical data. Genotyping was performed for SNCA REP1, -770, and -116 markers at individual sites; however, each site also provided 20 DNA samples for regenotyping centrally. Main Outcome Measures Measures included estimations of Hardy-Weinberg equilibrium in controls; a test of heterogeneity; analyses for association of single variants or haplotypes; and survival analyses for age at onset. Results Of the 18 sites, 11 met stringent criteria for concordance with Hardy-Weinberg equilibrium and low genotyping error rate. These 11 sites provided complete data for 2692 cases and 2652 controls. There was no heterogeneity across studies (P > .60). The SNCA REP1 alleles differed in frequency for cases and controls (P < .001). Genotypes defined by the 263 base-pair allele were associated with Parkinson disease (odds ratio, 1.43; 95% confidence interval, 1.22-1.69; P < .001 for trend). Multilocus haplotypes differed in frequency for cases and controls (global score statistic, P < .001). Two- loci haplotypes were associated with Parkinson disease only when they included REP1 as one of the loci. However, genotypes defined by REP1 alleles did not modify age at onset (P = .55). Conclusion This large-scale collaborative analysis demonstrates that SNCA REP1 allele-length variability is associated with an increased risk of Parkinson disease.	Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; Univ Paris 06, Inst Natl Sante, Paris, France; Univ Paris 06, Rech Med Unit 708, Paris, France; Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL USA; [Ioannidis, John P.A.] Univ Ioannina, Sch Med, Inst Biomed Res, Fdn Res & Technol Hellas, GR-45110 Ioannina, Greece; [Ioannidis, John P.A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Univ Tubingen, Ctr Neurol, Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; Univ Trondheim Hosp, Dept Neurol, Trondheim, Norway; Univ Texas, Med Branch, Galveston, TX 77550 USA; Inst Rech Canc, Lille, France; Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; Univ Milano Bicocca, Dept Neurol, Monza, Italy; Univ Thessaly, Sch Med, Larisa, Greece; Juntendo Univ, Sch Med, Tokyo 113, Japan; Hiroshima Univ, Dept Epidemiol, Res Inst Radiat Biol & Med, Hiroshima, Japan; Univ Lille 2, Inst Natl Sante, Lille, France; Univ Lille 2, Rech Med Unit 744, Inst Pasteur Lille, Lille, France; Univ Coll Dublin, Dept Neurol, Mater Misericordiae Univ Hosp, Dublin 2, Ireland; Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; Univ Queensland, Dept Neurol, Brisbane, Qld, Australia; Univ Miami, Dept Neurol, Miami, FL 33152 USA; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; CNR, Inst Neurol Sci, Cosenza, Italy; Magna Graecia Univ Catanzaro, Neurol Inst, Catanzaro, Italy; Univ Tubingen, Dept Med Genet, Tubingen, Germany; Singapore Gen Hosp, Dept Neurol, Singapore 0316, Singapore; Univ Antwerp VIB, Neurodegenerat Brain Dis Grp, B-2020 Antwerp, Belgium	Mayo Clinic; Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Mayo Clinic; Foundation for Research & Technology - Hellas (FORTH); University of Ioannina; University of Ioannina; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Norwegian University of Science & Technology (NTNU); University of Texas System; University of Texas Medical Branch Galveston; University of Washington; University of Washington Seattle; University of Milano-Bicocca; University of Thessaly; Juntendo University; Hiroshima University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Mater Misericordiae University Hospital; University College Dublin; University College Dublin; University of Queensland; University of Miami; University of Arkansas System; University of Arkansas Medical Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); Magna Graecia University of Catanzaro; Eberhard Karls University of Tubingen; Singapore General Hospital; Flanders Institute for Biotechnology (VIB); University of Antwerp	Maraganore, DM (corresponding author), Mayo Clin, Coll Med, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	dmaraganore@mayo.edu	Van Broeckhoven, Christine/M-7853-2019; Chartier-Harlin, Marie-Christine/L-4527-2018; Hattori, Nobutaka/ACR-0069-2022; Ferrarese, Carlo/AAC-4903-2022; Van Broeckhoven, Christine/G-8362-2017; Lambert, jean-charles/A-9553-2014; QUATTRONE, Aldo/A-6734-2016; Mellick, George D./A-7650-2010; Kawakami, Hideshi/ABE-4077-2021; Rocca, Walter/Z-5335-2019; Elbaz, Alexis/F-8952-2017; Kawakami, Hideshi/A-2086-2009; Morino, Hiroyuki/H-9583-2013; LICEND, CEMND/F-1296-2015; Ioannidis, John P. A./G-9836-2011; lambert, jean-charles/F-8787-2013; Lynch, Timothy/M-1316-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; Van Broeckhoven, Christine/0000-0003-0183-7665; Lambert, jean-charles/0000-0003-0829-7817; QUATTRONE, Aldo/0000-0003-2001-957X; Mellick, George D./0000-0002-7211-4651; Kawakami, Hideshi/0000-0002-1405-0901; Elbaz, Alexis/0000-0001-9724-5490; Kawakami, Hideshi/0000-0002-1405-0901; Morino, Hiroyuki/0000-0002-5190-3547; lambert, jean-charles/0000-0003-0829-7817; Krueger, Rejko/0000-0003-4258-6241; Farrer, Matthew/0000-0003-1159-5321	NIAAA NIH HHS [AA09515] Funding Source: Medline; NIEHS NIH HHS [ES10751, ES10750, ES04696] Funding Source: Medline; NINDS NIH HHS [NS33978, NS41509, NS39913] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010751, R01ES010750, P42ES004696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033978, R01NS039913, R01NS041509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R29AA009515] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; Bower JH, 2000, MOVEMENT DISORD, V15, P819, DOI 10.1002/1531-8257(200009)15:5<819::AID-MDS1009>3.0.CO;2-P; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbaz A, 2003, ARCH NEUROL-CHICAGO, V60, P91, DOI 10.1001/archneur.60.1.91; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hadjigeorgiou GM, 2006, MOVEMENT DISORD, V21, P534, DOI 10.1002/mds.20752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Izumi Y, 2001, NEUROSCI LETT, V300, P125, DOI 10.1016/S0304-3940(01)01557-9; Khan N, 2001, ANN NEUROL, V49, P665; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Mamah CE, 2005, ANN NEUROL, V57, P439, DOI 10.1002/ana.20387; Maraganore DM, 2004, ANN NEUROL, V55, P512, DOI 10.1002/ana.20017; Maraganore DM, 2003, MOVEMENT DISORD, V18, P631, DOI 10.1002/mds.10431; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; McDonnell SK, 2006, ANN NEUROL, V59, P788, DOI 10.1002/ana.20844; Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078; Mizuta I, 2002, J NEUROL NEUROSUR PS, V73, P350, DOI 10.1136/jnnp.73.3.350; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Pals P, 2003, EUR J EPIDEMIOL, V18, P1133, DOI 10.1023/B:EJEP.0000006639.05690.92; Parashos SA, 2002, MAYO CLIN PROC, V77, P918; Parsian A, 1998, NEUROLOGY, V51, P1757, DOI 10.1212/WNL.51.6.1757; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rocca WA, 2004, ANN NEUROL, V56, P495, DOI 10.1002/ana.20228; Rocca WA, 2001, INVESTIGATING NEUROLOGICAL DISEASE, P26, DOI 10.1017/CBO9780511526909.005; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Sapru MK, 2006, EXP NEUROL, V198, P382, DOI 10.1016/j.expneurol.2005.12.024; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spadafora P, 2003, NEUROSCI LETT, V351, P75, DOI 10.1016/S0304-3940(03)00859-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tan EK, 2004, NEUROLOGY, V62, P128, DOI 10.1212/01.WNL.0000101721.25345.DC; Tan EK, 2003, NEUROSCI LETT, V336, P70, DOI 10.1016/S0304-3940(02)01178-3; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	56	401	411	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2006	296	6					661	670		10.1001/jama.296.6.661	http://dx.doi.org/10.1001/jama.296.6.661			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	071LN	16896109	Bronze			2022-12-01	WOS:000239603800028
J	Jayaraman, KS				Jayaraman, K. S.			Break with tradition	NATURE			English	News Item																			0	3	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					342	343		10.1038/442342a	http://dx.doi.org/10.1038/442342a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871181				2022-12-01	WOS:000239278900010
J	Florez, JC; Jablonski, KA; Bayley, N; Pollin, TI; de Bakker, PIW; Shuldiner, AR; Knowler, WC; Nathan, DM; Altshuler, D				Florez, Jose C.; Jablonski, Kathleen A.; Bayley, Nick; Pollin, Toni I.; de Bakker, Paul I. W.; Shuldiner, Alan R.; Knowler, William C.; Nathan, David M.; Altshuler, David		Diabet Prevention Program Res Grp	TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; VARIANT; RISK	Background: Common polymorphisms of the transcription factor 7-like 2 gene (TCF7L2) have recently been associated with type 2 diabetes. We examined whether the two most strongly associated variants (rs12255372 and rs7903146) predict the progression to diabetes in persons with impaired glucose tolerance who were enrolled in the Diabetes Prevention Program, in which lifestyle intervention or treatment with metformin was compared with placebo. Methods: We genotyped these variants in 3548 participants and performed Cox regression analysis using genotype, intervention, and their interactions as predictors. We assessed the effect of genotype on measures of insulin secretion and insulin sensitivity at baseline and at one year. Results: Over an average period of three years, participants with the risk-conferring TT genotype at rs7903146 were more likely to have progression from impaired glucose tolerance to diabetes than were CC homozygotes (hazard ratio, 1.55; 95 percent confidence interval, 1.20 to 2.01; P < 0.001). The effect of genotype was stronger in the placebo group (hazard ratio, 1.81; 95 percent confidence interval, 1.21 to 2.70; P=0.004) than in the metformin and lifestyle-intervention groups (hazard ratios, 1.62 and 1.15, respectively; P for the interaction between genotype and intervention not significant). The TT genotype was associated with decreased insulin secretion but not increased insulin resistance at baseline. Similar results were obtained for rs12255372. Conclusions: Common variants in TCF7L2 seem to be associated with an increased risk of diabetes among persons with impaired glucose tolerance. The risk-conferring genotypes in TCF7L2 are associated with impaired beta-cell function but not with insulin resistance. (ClinicalTrials.gov number, NTC00004992.)	George Washington Univ, Diabet Prevent Program Outcomes Study Coordinatin, Rockville, MD USA	George Washington University	Florez, JC (corresponding author), George Washington Univ, Ctr Biostat, Diabet Prevent Program Coordinating Ctr, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA.	dppmail@biostat.bsc.gwu.edu	Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009	Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Shuldiner, Alan/0000-0001-9921-4305	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069000, U01DK048489, R01DK072041, K23DK065978, Z01DK069051] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [U01 DK048489, K23 DK65978-03, R01 DK072041, K23 DK065978, R01DK072041-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1999, NAT GENET, V22, P1; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Bray GA, 1999, DIABETES CARE, V22, P623; *DIAB PREV PROGR, 1999, DIABETES CARE, V22, P1389; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; GREENBERG RS, 1985, ANNU REV PUBL HEALTH, V6, P223; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; HOLM S, 1979, SCAND J STAT, V6, P65; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200	27	643	724	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					241	250		10.1056/NEJMoa062418	http://dx.doi.org/10.1056/NEJMoa062418			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855264	Green Accepted			2022-12-01	WOS:000239097600005
J	Sawyers, CL				Sawyers, Charles L.			Will kinase inhibitors have a dark side?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INVASION; AKT		Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Mol Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sawyers, CL (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.		Sawyers, Charles/G-5327-2016					Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	5	32	32	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					313	315		10.1056/NEJMcibr062354	http://dx.doi.org/10.1056/NEJMcibr062354			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855275				2022-12-01	WOS:000239097600017
J	Puthenveedu, MA; von Zastrow, M				Puthenveedu, Manojkumar A.; von Zastrow, Mark			Cargo regulates clathrin-coated pit dynamics	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; MEDIATED ENDOCYTOSIS; RECRUITMENT; ACTIN; INTERNALIZATION; BINDING; ADAPTER; DOMAIN; DESENSITIZATION; INVAGINATION	Clathrin-coated pits (CCPs) are generally considered a uniform population of endocytic machines containing mixed constitutive and regulated membrane cargo. Contrary to this view, we show that regulated endocytosis of G protein-coupled receptors (GPCRs) occurs preferentially through a subset of CCPs. Significantly, GPCR-containing CCPs are also functionally distinct, as their surface residence time is regulated locally by GPCR cargo via PDZ-dependent linkage to the actin cytoskeleton. Such cargo-regulated CCPs show delayed recruitment of dynamin and can undergo an abortive event in which clathrin coats separate from the plasma membrane without concomitant receptor endocytosis. Segregation of cargo into CCP subsets, combined with cargo-dependent control of CCP dynamics, suggests a simple kinetic mechanism to generate functional specialization early in the endocytic pathway and reduce competition between diverse endocytic cargo.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Puthenveedu, MA (corresponding author), Univ Calif San Francisco, Dept Psychiat, 600 16th St, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu	Puthenveedu, Manojkumar/A-3795-2016	Puthenveedu, Manojkumar/0000-0002-3177-4231				Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.E04-07-0596; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rappoport JZ, 2005, TRAFFIC, V6, P539, DOI 10.1111/j.1600-0854.2005.00280.x; Santini F, 2002, J CELL BIOL, V156, P665, DOI 10.1083/jcb.200110132; Santini F, 1998, MOL BIOL CELL, V9, P1177, DOI 10.1091/mbc.9.5.1177; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Warren RA, 1997, J BIOL CHEM, V272, P2116; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; WARREN RA, 2006, J BIOL CHEM, V103, P1295; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	53	195	198	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					113	124		10.1016/j.cell.2006.08.035	http://dx.doi.org/10.1016/j.cell.2006.08.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018281	Bronze			2022-12-01	WOS:000241445800018
J	Tabin, CJ				Tabin, Clifford J.			The key to left-right asymmetry	CELL			English	Editorial Material							LEFT-RIGHT AXIS; MOUSE EMBRYO; NODAL FLOW; SPECIFICATION; GENERATION; INHIBITION; PROTEINS	Establishment of left-right asymmetry in vertebrates involves cilia as essential components in the breaking of symmetry, an asymmetric signaling cascade, and a midline barrier that helps to maintain asymmetry. A new study suggests that a reaction-diffusion mechanism also plays a key role.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu						Brueckner M, 2001, AM J MED GENET, V101, P339, DOI 10.1002/1096-8628(20010715)101:4<339::AID-AJMG1442>3.0.CO;2-P; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Danos MC, 1996, DEV BIOL, V177, P96, DOI 10.1006/dbio.1996.0148; DUBOC V, 2006, IN PRESS J EXP ZOO B; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 1996, NATURE, V384, P321, DOI 10.1038/384321a0; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Qiu DY, 2005, DEV DYNAM, V234, P176, DOI 10.1002/dvdy.20509; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Tabin C, 2005, J MOL HISTOL, V36, P317, DOI 10.1007/s10735-005-9000-y; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	21	78	82	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					27	32		10.1016/j.cell.2006.09.018	http://dx.doi.org/10.1016/j.cell.2006.09.018			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018270	Bronze			2022-12-01	WOS:000241445800007
J	Galon, J; Costes, A; Sanchez-Cabo, F; Kirilovsky, A; Mlecnik, B; Lagorce-Pages, C; Tosolini, M; Camus, M; Berger, A; Wind, P; Zinzindohoue, F; Bruneval, P; Cugnenc, PH; Trajanoski, Z; Fridman, WH; Pages, F				Galon, Jerom; Costes, Anne; Sanchez-Cabo, Fatima; Kirilovsky, Amos; Mlecnik, Bernhard; Lagorce-Pages, Christine; Tosolini, Marie; Camus, Matthieu; Berger, Anne; Wind, Philippe; Zinzindohoue, Franck; Bruneval, Patrick; Cugnenc, Paul-Henri; Trajanoski, Zlatko; Fridman, Wolf-Herman; Pages, Franck			Type, density, and location of immune cells within human colorectal tumors predict clinical outcome	SCIENCE			English	Article							INFILTRATING LYMPHOCYTES; T-CELLS; PROGNOSTIC-FACTOR; OPTIMAL CUTPOINT; OVARIAN-CANCER; INFLAMMATION; SURVIVAL; ANTIGEN; MEMORY; PROGRESSION	The role of the adaptive immune response in controlling the growth and recurrence of human tumors has been controversial. We characterized the tumor-infiltrating immune cells in large cohorts of human colorectal cancers by gene expression profiling and in situ immunohistochemical staining. Collectively, the immunological data ( the type, density, and location of immune cells within the tumor samples) were found to be a better predictor of patient survival than the histopathological methods currently used to stage colorectal cancer. The results were validated in two additional patient populations. These data support the hypothesis that the adaptive immune response influences the behavior of human tumors. In situ analysis of tumor-infiltrating immune cells may therefore be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.	INSERM, U255, F-75006 Paris, France; Univ Paris 05, Fac Med, F-75006 Paris, France; Univ Paris 06, Inst Cordeliers, F-75006 Paris, France; Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; Avicenne Hosp, Dept Digest Surg, F-93017 Bobigny, France; Georges Pompidou European Hosp, AP HP, Dept Gen & Digest Surg, F-75015 Paris, France; Georges Pompidou European Hosp, AP HP, Dept Pathol, F-75015 Paris, France; Georges Pompidou European Hosp, AP HP, Dept Immunol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Graz University of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Galon, J (corresponding author), INSERM, U255, F-75006 Paris, France.	jerome.galon@u255.bhdc.jussieu.fr	Tosolini, Marie/A-6653-2009; Tosolini, Marie/AAL-5941-2020; COLENO-COSTES, Anne/K-3176-2015; mlecnik, bernhard/AAT-7467-2021; Sanchez-Cabo, Fatima/AAC-5563-2020; Sanchez-Cabo, Fatima/N-5030-2014; Galon, Jerome/G-9838-2019; Trajanoski, Zlatko/AAT-6703-2021; costes, anne/A-1564-2010	Tosolini, Marie/0000-0001-5278-5952; Tosolini, Marie/0000-0001-5278-5952; COLENO-COSTES, Anne/0000-0002-1775-682X; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Galon, Jerome/0000-0001-9635-1339; fridman, wolf herman/0000-0002-1332-0973				ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Baier PK, 1998, TUMOR BIOL, V19, P205, DOI 10.1159/000030008; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Faraggi D, 1996, STAT MED, V15, P2203, DOI 10.1002/(SICI)1097-0258(19961030)15:20<2203::AID-SIM357>3.0.CO;2-G; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hollander N, 2004, STAT MED, V23, P1701, DOI 10.1002/sim.1611; Naito Y, 1998, CANCER RES, V58, P3491; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2005, BLOOD, V105, P1632, DOI 10.1182/blood-2004-08-3196; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Pardoll D, 2001, NATURE, V411, P1010, DOI 10.1038/35082676; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sobin LH, 2009, UICC TNM CLASSIFICAT; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Xiang R, 1999, J IMMUNOL, V163, P3676; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhou G, 2004, J EXP MED, V200, P1581, DOI 10.1084/jem.20041240	30	4326	4500	21	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1960	1964		10.1126/science.1129139	http://dx.doi.org/10.1126/science.1129139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008531				2022-12-01	WOS:000240832200051
J	Dalmiya, N; Palmer, A; Darnton-Hill, I				Dalmiya, Nita; Palmer, Amanda; Darnton-Hill, Ian			Sustaining vitamin A supplementation requires a new vision	LANCET			English	Editorial Material									UNICEF, Nutr Sect, New York, NY 10017 USA	UNICEF	Dalmiya, N (corresponding author), UNICEF, Nutr Sect, New York, NY 10017 USA.	ndalmiya@unicef.org		Palmer, Amanda/0000-0002-3212-955X				BENDECH MA, 2005, SIGHT LIFE NEWSLETTE, V3, P42; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; *UNICEF, 2006, UNICEF JOINT HLTH NU; *UNICEF, 2006, MON SIT CHILDR WOM V; *UNICEF CAN, 2006, GLOB CHILD SURV HLTH; UNICEF data, 2006, PROGR CHILDR REP CAR; United Nations Childrens Fund (UNICEF), 1999, STAT WORLDS CHILDR 2	7	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1052	1054		10.1016/S0140-6736(06)69336-7	http://dx.doi.org/10.1016/S0140-6736(06)69336-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997651				2022-12-01	WOS:000240873000009
J	Lee, KH; Piao, HL; Kim, HY; Choi, SM; Jiang, F; Hartung, W; Hwang, I; Kwak, JM; Lee, IJ; Hwang, I				Lee, Kwang Hee; Piao, Hai Lan; Kim, Ho-Youn; Choi, Sang Mi; Jiang, Fan; Hartung, Wolfram; Hwang, Ildoo; Kwak, June M.; Lee, In-Jung; Hwang, Inhwan			Activation of glucosidase via stress-induced polymerization rapidly increases active pools of abscisic acid	CELL			English	Article							ZEAXANTHIN EPOXIDASE; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; GENE; BIOSYNTHESIS; IDENTIFICATION; RESPONSES; DROUGHT; PROTEIN; SALT	Abscisic acid (ABA) is a phytohormone critical for plant growth, development, and adaptation to various stress conditions. Plants have to adjust ABA levels constantly to respond to changing physiological and environmental conditions. To date, the mechanisms for fine-tuning ABA levels remain elusive. Here we report that AtBG1, a beta-glucosidase, hydrolyzes glucose-conjugated, biologically inactive ABA to produce active ABA. Loss of AtBG1 causes defective stomatal movement, early germination, abiotic stress-sensitive phenotypes, and lower ABA levels, whereas plants with ectopic AtBG1 accumulate higher ABA levels and display enhanced tolerance to abiotic stress. Dehydration rapidly induces polymerization of AtBG1, resulting in a 4-fold increase in enzymatic activity. Furthermore, diurnal increases in ABA levels are attributable to polymerization-mediated AtBG1 activation. We propose that the activation of inactive ABA pools by polymerized AtBG1 is a mechanism by which plants rapidly adjust ABA levels and respond to changing environmental cues.	Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; Pohang Univ Sci & Technol, Ctr Plant Intracellular Trafficking, Pohang 790784, South Korea; Kyungpook Natl Univ, Coll Agr & Life Sci, Div Plant Biosci, Taegu 702701, South Korea; Univ Wurzburg, Julius von Sachs Inst Biowissensch, D-97082 Wurzburg, Germany; Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Kyungpook National University; University of Wurzburg; University System of Maryland; University of Maryland College Park	Hwang, I (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea.	jhhwang@postech.ac.kr	Kwak, June M/G-8332-2011; Lee, In-Jung/GLS-0432-2022	Kwak, June M/0000-0001-6948-5155; Lee, In-Jung/0000-0001-7154-4820				Ali-Rachedi S, 2004, PLANTA, V219, P479, DOI 10.1007/s00425-004-1251-4; ALLAN AC, 1994, PLANT CELL, V6, P1319; ANDERSON BE, 1994, PLANT PHYSIOL, V104, P1177, DOI 10.1104/pp.104.4.1177; Audran C, 1998, PLANT PHYSIOL, V118, P1021, DOI 10.1104/pp.118.3.1021; BAIER M, 1988, J EXPT BOT, V41, P351; BANOWETZ GM, 1994, HYBRIDOMA, V13, P537, DOI 10.1089/hyb.1994.13.537; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Cutler Paul, 2004, Methods Mol Biol, V244, P167; Dietz KJ, 2000, J EXP BOT, V51, P937, DOI 10.1093/jexbot/51.346.937; GAMBLE PE, 1986, EUR J BIOCHEM, V160, P117, DOI 10.1111/j.1432-1033.1986.tb09947.x; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Hartung W, 2002, J EXP BOT, V53, P27, DOI 10.1093/jexbot/53.366.27; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kim YW, 1998, BBA-PROTEIN STRUCT M, V1388, P457, DOI 10.1016/S0167-4838(98)00209-X; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; KUZNETSOV G, 1993, J BIOL CHEM, V268, P2001; LeonKloosterziel KM, 1996, PLANT PHYSIOL, V110, P233, DOI 10.1104/pp.110.1.233; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Park M, 2004, PLANT PHYSIOL, V134, P625, DOI 10.1104/pp.103.030635; Pih KT, 1997, MOL CELLS, V7, P567; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; ROCK CD, 1991, P NATL ACAD SCI USA, V88, P7496, DOI 10.1073/pnas.88.17.7496; Sauter A, 2002, PLANT CELL ENVIRON, V25, P223, DOI 10.1046/j.1365-3040.2002.00747.x; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Seo M, 2000, PLANT J, V23, P481, DOI 10.1046/j.1365-313x.2000.00812.x; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Takeuchi M, 2000, PLANT J, V23, P517, DOI 10.1046/j.1365-313x.2000.00823.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; ZEEVAART JAD, 1999, BIOCH MOL BIOL PLANT, P189; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	44	458	498	8	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1109	1120		10.1016/j.cell.2006.07.034	http://dx.doi.org/10.1016/j.cell.2006.07.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990135	Bronze			2022-12-01	WOS:000240897600017
J	Leake, MC; Chandler, JH; Wadhams, GH; Bai, F; Berry, RM; Armitage, JP				Leake, Mark C.; Chandler, Jennifer H.; Wadhams, George H.; Bai, Fan; Berry, Richard M.; Armitage, Judith P.			Stoichiometry and turnover in single, functioning membrane protein complexes	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; FLAGELLAR MOTOR; BACTERIAL FLAGELLA; GENERATING UNITS; PLASMA-MEMBRANE; ROTARY MOTOR; LIVING CELLS; MOLECULES; DYNAMICS	Many essential cellular processes are carried out by complex biological machines located in the cell membrane. The bacterial flagellar motor is a large membrane-spanning protein complex that functions as an ion-driven rotary motor to propel cells through liquid media(1-3). Within the motor, MotB is a component of the stator that couples ion flow to torque generation and anchors the stator to the cell wall(4,5). Here we have investigated the protein stoichiometry, dynamics and turnover of MotB with single-molecule precision in functioning bacterial flagellar motors in Escherichia coli. We monitored motor function by rotation of a tethered cell body(6), and simultaneously measured the number and dynamics of MotB molecules labelled with green fluorescent protein (GFP - MotB) in the motor by total internal reflection fluorescence microscopy. Counting fluorophores by the stepwise photobleaching of single GFP molecules showed that each motor contains similar to 22 copies of GFP - MotB, consistent with similar to 11 stators each containing two MotB molecules. We also observed a membrane pool of similar to 200 GFP - MotB molecules diffusing at similar to 0.008 mu m(2) s(-1). Fluorescence recovery after photobleaching and fluorescence loss in photobleaching showed turnover of GFP MotB between the membrane pool and motor with a rate constant of the order of 0.04 s(-1): the dwell time of a given stator in the motor is only similar to 0.5 min. This is the first direct measurement of the number and rapid turnover of protein subunits within a functioning molecular machine.	Univ Oxford, Dept Biochem, Microbiol Unit, Oxford OX1 3QU, England; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford; University of Oxford	Armitage, JP (corresponding author), Univ Oxford, Dept Biochem, Microbiol Unit, S Parks Rd, Oxford OX1 3QU, England.	judith.armitage@bioch.ox.ac.uk	Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249; Bai, Fan/0000-0001-6119-8936	Engineering and Physical Sciences Research Council [GR/R45659/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berry RM, 1999, ADV MICROB PHYSIOL, V41, P291, DOI 10.1016/S0065-2911(08)60169-1; BERRY RM, 1995, BIOPHYS J, V69, P280, DOI 10.1016/S0006-3495(95)79900-3; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; Chu S, 2003, PHILOS T R SOC A, V361, P689, DOI 10.1098/rsta.2002.1157; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; KHAN S, 1988, J MOL BIOL, V202, P575, DOI 10.1016/0022-2836(88)90287-2; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Leake MC, 2004, BIOPHYS J, V87, P1112, DOI 10.1529/biophysj.103.033571; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Mullineaux CW, 2002, TRENDS PLANT SCI, V7, P237, DOI 10.1016/S1360-1385(02)02283-5; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sowa Y, 2005, NATURE, V437, P916, DOI 10.1038/nature04003; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Van Way SM, 2000, J MOL BIOL, V297, P7, DOI 10.1006/jmbi.2000.3548	27	423	429	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					355	358		10.1038/nature05135	http://dx.doi.org/10.1038/nature05135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16971952				2022-12-01	WOS:000240622000050
J	Efeyan, A; Garcia-Cao, I; Herranz, D; Velasco-Miguel, S; Serrano, M				Efeyan, Alejo; Garcia-Cao, Isabel; Herranz, Daniel; Velasco-Miguel, Susana; Serrano, Manuel			Policing of oncogene activity by p53	NATURE			English	Article							TUMOR-SUPPRESSOR; P19(ARF); LOCUS; PRODUCT		Spanish Natl Canc Ctr, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Efeyan, A (corresponding author), Spanish Natl Canc Ctr, Madrid 28029, Spain.	mserrano@cnio.es	Herranz, Daniel/L-6986-2017; Herranz, Daniel/D-8121-2011; Efeyan, Alejo/J-8197-2016; Serrano, Manuel/H-2634-2015	Herranz, Daniel/0000-0003-1768-5969; Efeyan, Alejo/0000-0002-3806-6799; Serrano, Manuel/0000-0001-7177-9312				Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kamijo T, 1999, CANCER RES, V59, P2464; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	10	100	102	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					159	159		10.1038/443159a	http://dx.doi.org/10.1038/443159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971940				2022-12-01	WOS:000240467000033
J	Benjamin, DK; Smith, PB; Murphy, MD; Roberts, R; Mathis, L; Avant, D; Califf, RM; Li, JS				Benjamin, Daniel K., Jr.; Smith, Philip Brian; Murphy, M. Dianne; Roberts, Rosemary; Mathis, Lisa; Avant, Debbie; Califf, Robert M.; Li, Jennifer S.			Peer-reviewed publication of clinical trials completed for pediatric exclusivity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PLASMODIUM-FALCIPARUM MALARIA; JUVENILE RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; OPEN-LABEL; CHILDREN; ADOLESCENTS; EFFICACY; PHARMACOKINETICS; ATOVAQUONE	Context Much of pediatric drug use is off-label because appropriate pediatric studies have not been conducted and the drugs have not been labeled by the US Food and Drug Administration (FDA) for use in children. In 1997, Congress authorized the FDA to grant extensions of marketing rights known as "pediatric exclusivity" if FDA-requested pediatric trials were conducted. As a result, there have been over 100 product labeling changes. The publication status of studies completed for pediatric exclusivity has not been evaluated. Objective To quantify the dissemination of results of studies conducted for pediatric exclusivity into the peer-review literature. Design Cohort study of all trials conducted for pediatric exclusivity between 1998 and 2004 as determined by MEDLINE and EMBASE searches through 2005, the subsequent labeling changes, and the publication of those studies in peer-reviewed journals. We categorized any labeling changes resulting from the studies as positive or negative for the drug under study. We then evaluated aspects of the studies and product label changes that were associated with subsequent publication in peer-reviewed medical journals. Main Outcome Measures Publication of the trial data in peer-reviewed journals. Results Between 1998 and 2004, 253 studies were submitted to the FDA for pediatric exclusivity: 125 (50%) evaluated efficacy, 51 (20%) were multi-dose pharmacokinetic, 34 (13%) were single-dose pharmacokinetic, and 43 (17%) were safety studies. Labeling changes were positive for 127/253 (50%) of studies; only 113/253 (45%) were published. Efficacy studies and those with a positive labeling change were more likely to be published. Conclusions The pediatric exclusivity program has been successful in encouraging drug studies in children. However, the dissemination of these results in the peer-reviewed literature is limited. Mechanisms to more widely disperse this information through publication warrant further evaluation.	Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; Duke Univ, Dept Pediat, Durham, NC 27705 USA; Duke Univ, Dept Med, Durham, NC 27705 USA; US FDA, Ctr Drug Evaluat & Res, Off Counter Terrorism & Pediat Drug Dev, Rockville, MD 20857 USA; US FDA, Ctr Drug Evaluat & Res, Off Commissioner, Rockville, MD 20857 USA; US FDA, Ctr Drug Evaluat & Res, Off Pediat Therapeut, Rockville, MD 20857 USA	Duke University; Duke University; Duke University; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Benjamin, DK (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27705 USA.	danny.benjamin@duke.edu	Smith, Phillip B/I-5565-2014		NICHD NIH HHS [U10 HD045962-04, 1U10-HD45962-03, U10 HD045962] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD045962] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*AAMC EX COMM, 2005, PRINC PROT INT COND; Anabwani G, 1999, PEDIATR INFECT DIS J, V18, P456, DOI 10.1097/00006454-199905000-00011; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Camus D, 2004, CLIN INFECT DIS, V38, P1716, DOI 10.1086/421086; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Emslie G J, 1998, Depress Anxiety, V7, P32, DOI 10.1002/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0.CO;2-7; Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Faucher JF, 2002, CLIN INFECT DIS, V35, P1147, DOI 10.1086/342908; Findling RL, 2000, J AM ACAD CHILD PSY, V39, P1008, DOI 10.1097/00004583-200008000-00016; Foster KW, 2005, J AM ACAD DERMATOL, V53, P798, DOI 10.1016/j.jaad.2005.07.028; Geller DA, 2001, J AM ACAD CHILD PSY, V40, P773, DOI 10.1097/00004583-200107000-00011; Haidich AB, 2001, AM J EPIDEMIOL, V154, P873, DOI 10.1093/aje/154.9.873; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Lell B, 1998, LANCET, V351, P709, DOI 10.1016/S0140-6736(97)09222-2; *MCKESS PHARM SYST, DRUGT; Michelson D, 2002, AM J PSYCHIAT, V159, P1896, DOI 10.1176/appi.ajp.159.11.1896; Michelson D, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e83; *NIH, WORLD MED ASS DECL H; NIH, BELM REP ETH PRINC G; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Roberts R, 2003, JAMA-J AM MED ASSOC, V290, P905, DOI 10.1001/jama.290.7.905; Rongkavilit C, 2001, ANTIMICROB AGENTS CH, V45, P3585, DOI 10.1128/AAC.45.12.3585-3590.2001; Sabchareon A, 1998, T ROY SOC TROP MED H, V92, P201, DOI 10.1016/S0035-9203(98)90749-0; Silverman E, 2005, NEW ENGL J MED, V352, P1655, DOI 10.1056/NEJMoa041810; Silverman E, 2005, ARTHRITIS RHEUM-US, V52, P554, DOI 10.1002/art.20861; Sorof JM, 2002, PEDIATR NEPHROL, V17, P345, DOI 10.1007/s00467-002-0851-0; Spencer T, 2002, J CLIN PSYCHIAT, V63, P1140, DOI 10.4088/JCP.v63n1209; Steinherz PG, 2002, LEUKEMIA LYMPHOMA, V43, P1945, DOI 10.1080/1042819021000015880; Wilens TE, 2002, J CLIN PSYCHOPHARM, V22, P568, DOI 10.1097/00004714-200212000-00006; Wilson JT, 1975, BASIC THERAPEUTIC AS, P411; Winner P, 2000, PEDIATRICS, V106, P989, DOI 10.1542/peds.106.5.989; WOLF AR, 2004, PEDIAT ANESTESIA, V14, P505; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; 2001, PUBLIC CITIZENS PATE	37	111	112	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1266	1273		10.1001/jama.296.10.1266	http://dx.doi.org/10.1001/jama.296.10.1266			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968851	Green Accepted			2022-12-01	WOS:000240437500029
J	Zhao, Y; Rodrigo, J; Hoveyda, AH; Snapper, ML				Zhao, Yu; Rodrigo, Jason; Hoveyda, Amir H.; Snapper, Marc L.			Enantioselective silyl protection of alcohols catalysed by an amino-acid-based small molecule	NATURE			English	Article							KINETIC RESOLUTION; ASYMMETRIC CATALYSIS; SECONDARY ALCOHOLS; CHIRAL CATALYSTS; DISCOVERY; ALDEHYDES; SILANES	Reliable, selective and environmentally friendly chemical transformations are crucial to the development of new therapeutics and the design of novel materials. Chiral catalysts that can be easily prepared and used to obtain organic molecules of high enantiomeric purity are critical to modern chemical synthesis(1). The development of protecting groups that shield reactive functionalities has also proved indispensable in the preparation of complex biologically active molecules(2). Here we present a chiral catalyst that promotes the enantioselective protection of a secondary alcohol as one of the most commonly used protected forms of an alcohol: a silyl ether. The catalyst is a small, simple molecule that can be prepared in three steps from commercial materials without the need for rigorously controlled conditions. Enantioselective silylations are performed with commercial silyl chlorides and produce yields of up to 96 per cent at an enantiomeric ratio of up to 98:2. Chiral catalysts for selective formation of commonly used protecting groups such as silyl ethers should significantly enhance the ability of chemical synthesis to deliver, in a more practical and efficient manner, important organic molecules.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu; marc.snapper@bc.edu						BASSINDALE AR, 1985, TETRAHEDRON LETT, V26, P3403, DOI 10.1016/S0040-4039(00)98309-6; Blackmond DG, 2000, ACCOUNTS CHEM RES, V33, P402, DOI 10.1021/ar990083s; Cole BM, 1996, ANGEW CHEM INT EDIT, V35, P1668, DOI 10.1002/anie.199616681; Corey E. J., 1989, LOGIC CHEM SYNTHESIS; COREY EJ, 1972, J AM CHEM SOC, V94, P6190, DOI 10.1021/ja00772a043; Denmark SE, 2005, J AM CHEM SOC, V127, P3774, DOI 10.1021/ja047339w; Evans JW, 2004, J AM CHEM SOC, V126, P8134, DOI 10.1021/ja047845l; Gutmann V., 1978, DONOR ACCEPTOR APPRO; Isobe T, 2001, CHEM COMMUN, P243, DOI 10.1039/b009173l; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME; Jarvo E. R., 2004, COMPREHENSIVE ASYMME, P189; Jarvo ER, 1999, J AM CHEM SOC, V121, P11638, DOI 10.1021/ja9931776; KELLY TR, 1989, J AM CHEM SOC, V111, P3744, DOI 10.1021/ja00192a039; Kocienski P. J, 2005, PROTECTING GROUPS; Miller SJ, 1998, J AM CHEM SOC, V120, P1629, DOI 10.1021/ja973892k; Myers AG, 1996, TETRAHEDRON LETT, V37, P3083, DOI 10.1016/0040-4039(96)00501-1; Porter JR, 2001, J AM CHEM SOC, V123, P984, DOI 10.1021/ja003747y; Rendler S, 2005, ANGEW CHEM INT EDIT, V44, P7620, DOI 10.1002/ANIE.200502631; Sculimbrene BR, 2001, J AM CHEM SOC, V123, P10125, DOI 10.1021/ja016779+; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Thayer AM, 2005, CHEM ENG NEWS, V83, P40, DOI 10.1021/cen-v083n036.p040; Traverse JF, 2005, ORG LETT, V7, P3151, DOI 10.1021/ol050814q; Vasbinder MM, 2001, ANGEW CHEM INT EDIT, V40, P2824, DOI 10.1002/1521-3773(20010803)40:15<2824::AID-ANIE2824>3.0.CO;2-J; Vedejs E, 2005, ANGEW CHEM INT EDIT, V44, P3974, DOI 10.1002/anie.200460842; [No title captured]	25	163	163	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					67	70		10.1038/nature05102	http://dx.doi.org/10.1038/nature05102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	081JM	16957727				2022-12-01	WOS:000240313900040
J	Hornberger, J; Robertus, K				Hornberger, John; Robertus, Katherine			Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults	ANNALS OF INTERNAL MEDICINE			English	Article							NATURAL-HISTORY; VARICELLA; EPIDEMIOLOGY; IMMUNIZATION; INFECTIONS	Background: The Shingles Prevention Study showed that a varicella-zoster virus (VZV) vaccine administered to adults 60 years of age or older reduced the incidence of herpes zoster from 11.12 to 5.42 cases per 1000 person-years. Median follow-up was 3.1 years, and relative risk reduction was 51.3% (95% CI, 44.2% to 57.6%). Objective: To assess the extent to which clinical and cost variables influence the cost-effectiveness of VZV vaccination for preventing herpes zoster in immunocompetent older adults. Design: Decision theoretical model. Data Sources: English-language data published to March 2006 identified from MEDLINE on herpes zoster rates, vaccine effectiveness, quality of life, medical resource use, and unit costs. Target Population: Immunocompetent adults 60 years of age or older with a history of VZV infection. Time Horizon: Lifetime. Perspective: U.S. societal. Interventions: Varicella-zoster virus vaccination versus no vaccination. Outcome Measures: Incremental quality-adjusted survival and cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: By reducing incidence and severity of herpes zoster, vaccination can increase quality-adjusted survival by 0.6 day compared with no vaccination. One scenario in which vaccination costs less than $100000 per QALY gained is when 1) the unit cost of vaccination is less than $200, 2) the age at vaccination is less than 70 years, and 3) the duration of vaccine efficacy is more than 30 years. Results of Sensitivity Analysis: Vaccination would be more cost-effective in "younger" older adults (age 60 to 64 years) than in "older" older adults (age >= 80 years). Longer life expectancy and a higher level of vaccine efficacy offset a lower risk for herpes zoster in the younger group. Other factors influencing cost-effectiveness include quality-of-life adjustments for acute zoster, unit cost of the vaccine, risk for herpes zoster, and duration of vaccine efficacy. Limitations: The effectiveness of VZV vaccination remains uncertain beyond the median 3.1-year duration of follow-up in the Shingles Prevention Study. Conclusions: Varicella-zoster virus vaccination to prevent herpes zoster in older adults would increase QALYs compared with no vaccination. Resolution of uncertainties about the average quality-of-life effects of acute zoster and the duration of vaccine efficacy is needed to better determine the cost-effectiveness of zoster vaccination in older adults.	Acumen LLC, Burlingame, CA 94010 USA; SPHERE Inst, Burlingame, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Hornberger, J (corresponding author), Acumen LLC, 500 Airport Blvd,Suite 365, Burlingame, CA 94010 USA.	jhornberger@acumen-llc.com	Hornberger, John/M-4932-2019					Brisson M, 2000, VACCINE, V18, P2775, DOI 10.1016/S0264-410X(00)00100-6; *BUR LAB STAT US D, 2006, Q CENS WAG EMPL; *BUR LAB STAT US D, 2003, NONF CAS INV DAYS AW; *CDCP, 2006, VAR VACC CLIN QUEST; *CDCP NAT IMM PROG, 2006, PED VFC VACC PRIC LI; Coleman MS, 2005, VACCINE, V23, P915, DOI 10.1016/j.vaccine.2004.07.028; Coplan PM, 2004, J PAIN, V5, P344, DOI 10.1016/j.jpain.2004.06.001; *CTR MED MED SERV, 2006, MED FEE SERV PARTS A; *CTR MED MED SERV, 2005, PRIC 2006 1 PSF 10 2; *CTR MED MED SERV, 2006, ICD 9 PROV DIAGN COD; *CTR MED MED SERV, 2004, NAT HLTH CAR EXP PRO; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5; Galil K, 1997, ARCH INTERN MED, V157, P1209, DOI 10.1001/archinte.157.11.1209; GARBER AM, 2004, HLTH AFF MILLWOOD S; Gilden DH, 2005, NEW ENGL J MED, V352, P2344, DOI 10.1056/NEJMe058090; *HGSADMINISTRATORS, 2005, 2005 MED FEE SCHED; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lin F, 2000, J INFECT DIS, V181, P1897, DOI 10.1086/315492; LIPSCOMB J, 1989, MED CARE, V27, pS233, DOI 10.1097/00005650-198903001-00019; MCCORMICK A, 1995, MORBIDITY STAT GEN P; MOLIN L, 1969, ACTA DERM-VENEREOL, V49, P569; Mukamel DB, 2001, AM J PREV MED, V21, P29, DOI 10.1016/S0749-3797(01)00312-9; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Oxman MN, 1995, NEUROLOGY, V45, pS41, DOI 10.1212/WNL.45.12_Suppl_8.S41; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Rohan P, 2005, FDA CLIN BRIEFING DO; SCHMADER K, 1995, J INFECT DIS, V171, P701, DOI 10.1093/infdis/171.3.701; Schmader K, 2001, CLIN INFECT DIS, V32, P1481, DOI 10.1086/320169; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; Smith KJ, 2000, AM J MED, V108, P723, DOI 10.1016/S0002-9343(00)00445-9; Smith KJ, 2000, PHARMACOECONOMICS, V18, P95, DOI 10.2165/00019053-200018020-00001; STRAUS SE, 1988, ANN INTERN MED, V108, P221, DOI 10.7326/0003-4819-108-2-221; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Weaver M, 2001, ARCH INTERN MED, V161, P111, DOI 10.1001/archinte.161.1.111; 2006, MOSBYS DRUG CONSULT	37	92	96	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2006	145	5					317	325		10.7326/0003-4819-145-5-200609050-00004	http://dx.doi.org/10.7326/0003-4819-145-5-200609050-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080NZ	16954357				2022-12-01	WOS:000240255900001
J	Yao, J; Munson, KM; Webb, WW; Lis, JT				Yao, Jie; Munson, Katherine M.; Webb, Watt W.; Lis, John T.			Dynamics of heat shock factor association with native gene loci in living cells	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION; ARCHITECTURE; PROMOTER; OLIGOMERIZATION; CHROMOSOMES; EXPRESSION; ACTIVATOR; TURNOVER; EXCHANGE	Direct observation of transcription factor action in the living cell nucleus can provide important insights into gene regulatory mechanisms(1,2). Live-cell imaging techniques have enabled the visualization of a variety of intranuclear activities, from chromosome dynamics(3) to gene expression(4). However, progress in studying transcription regulation of specific native genes has been limited, primarily as a result of difficulties in resolving individual gene loci and in detecting the small number of protein molecules functioning within active transcription units. Here we report that multiphoton microscopy imaging(5) of polytene nuclei in living Drosophila salivary glands allows real-time analysis of transcription factor recruitment and exchange on specific native genes. After heat shock, we have visualized the recruitment of RNA polymerase II (Pol II) to native hsp70 gene loci 87A and 87C in real time. We show that heat shock factor (HSF), the transcription activator of hsp70, is localized to the nucleus before heat shock and translocates from nucleoplasm to chromosomal loci after heat shock. Assays based on fluorescence recovery after photobleaching(6) show a rapid exchange of HSF at chromosomal loci under non-heat-shock conditions but a very slow exchange after heat shock. However, this is not a consequence of a change of HSF diffusibility, as shown here directly by fluorescence correlation spectroscopy(7). Our results provide strong evidence that activated HSF is stably bound to DNA in vivo and that turnover or disassembly of transcription activator is not required for rounds of hsp70 transcription. This and previous studies(8,9) indicate that transcription activators display diverse dynamic behaviours in their associations with targeted loci in living cells. Our method can be applied to study the dynamics of many factors involved in transcription and RNA processing, and in their regulation at native heat shock genes in vivo.	Cornell Univ, Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Lis, JT (corresponding author), Cornell Univ, Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA.	www2@cornell.edu; jtl10@cornell.edu	Webb, Watt W./B-5905-2011; Munson, Katherine M/P-2462-2015; Yao, Jie/E-2229-2017	Munson, Katherine M/0000-0001-8413-6498; Yao, Jie/0000-0002-7640-4840				AGARD DA, 1983, NATURE, V302, P676, DOI 10.1038/302676a0; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Belmont AS, 2001, TRENDS CELL BIOL, V11, P250, DOI 10.1016/S0962-8924(01)02000-1; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Green MR, 2005, MOL CELL, V18, P399, DOI 10.1016/j.molcel.2005.04.017; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Larson DR, 2003, J CELL BIOL, V162, P1233, DOI 10.1083/jcb.200303200; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Schwartz BE, 2004, METHOD ENZYMOL, V376, P393; Shav-Tal Y, 2004, NAT REV MOL CELL BIO, V5, P855, DOI 10.1038/nrm1494; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cb.11.110195.002301; Zandi E, 1997, GENE DEV, V11, P1299, DOI 10.1101/gad.11.10.1299; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	30	159	162	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1050	1053		10.1038/nature05025	http://dx.doi.org/10.1038/nature05025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16929308				2022-12-01	WOS:000240142000052
J	Bookout, AL; Jeong, Y; Downes, M; Yu, RT; Evans, RM; Mangelsdorf, DJ				Bookout, Angie L.; Jeong, Yangsik; Downes, Michael; Yu, Ruth T.; Evans, Ronald M.; Mangelsdorf, David J.			Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network	CELL			English	Article							VITAMIN-D-RECEPTOR; THYROID-HORMONE; MOLECULAR DETERMINANTS; ALPHA; GENE; MOUSE; BETA; IDENTIFICATION; DEGENERATION; METABOLISM	In multicellular organisms, the ability to regulate reproduction, development, and nutrient utilization coincided with the evolution of nuclear receptors (NRs), transcription factors that utilize lipophilic ligands to mediate their function. Studying the expression profile of NRs offers a simple, powerful way to obtain highly relational information about their physiologic functions as individual proteins and as a superfamily. We surveyed the expression of all 49 mouse NR mRNAs in 39 tissues, representing diverse anatomical systems. The resulting data set uncovers several NR clades whose patterns of expression indicate their ability to coordinate the transcriptional programs necessary to affect distinct physiologic pathways. Remarkably, this regulatory network divides along the following two physiologic paradigms: (1) reproduction, development, and growth and (2) nutrient uptake, metabolism, and excretion. These data reveal a hierarchical transcriptional circuitry that extends beyond individual tissues to form a meganetwork governing physiology on an organismal scale.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Salk Institute	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Mangelsdorf, David/0000-0002-4355-0796; Yu, Ruth/0000-0002-9527-9627	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [U19DK62434, U19 DK062434] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Beland M, 2005, J BIOL CHEM, V280, P13858, DOI 10.1074/jbc.M412981200; Beuschlein F, 2002, ENDOCR RES, V28, P597, DOI 10.1081/ERC-120016972; BOOKOUT AL, 2005, CURRENT PROTOCOLS MO; BOOKOUT AL, 2003, NUCL RECEPT SIGNAL, V1, DOI DOI 10.1621/NRS.01012; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Chung SSW, 2004, DEV DYNAM, V230, P754, DOI 10.1002/dvdy.20083; Cooney AJ, 2001, TRENDS ENDOCRIN MET, V12, P247, DOI 10.1016/S1043-2760(01)00424-6; Cupp AS, 1999, ENDOCRINOLOGY, V140, P2343, DOI 10.1210/en.140.5.2343; Dixit SG, 2005, CURR DRUG METAB, V6, P385, DOI 10.2174/1389200054633907; Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200; Edwards PA, 2002, J LIPID RES, V43, P2; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; GomezSanchez EP, 1996, STEROIDS, V61, P184, DOI 10.1016/0039-128X(96)00010-4; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haussler MR, 1997, J ENDOCRINOL, V154, pS57; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He YW, 2000, IMMUNOL RES, V22, P71, DOI 10.1385/IR:22:2-3:71; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Iwaki T, 2001, COLOR ATLAS SECTIONA; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kallay E, 2001, CARCINOGENESIS, V22, P1429, DOI 10.1093/carcin/22.9.1429; Kato S, 2000, J BIOCHEM, V127, P717, DOI 10.1093/oxfordjournals.jbchem.a022662; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Le Menuet D, 2004, MOL CELL ENDOCRINOL, V217, P127, DOI 10.1016/j.mce.2003.10.045; Lee M, 2002, J COMMUN NETW-S KOR, V4, P81, DOI 10.1109/JCN.2002.6596898; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marrif H, 2005, ENDOCRINOLOGY, V146, P2872, DOI 10.1210/en.2004-1544; *MGD, 2003, MOUS GEN INF WEBS; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Otte K, 2003, MOL CELL BIOL, V23, P864, DOI 10.1128/MCB.23.3.864-872.2003; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Parker KL, 2002, ANN MED, V34, P171, DOI 10.1080/713782137; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; Qiu Y, 1996, J STEROID BIOCHEM, V56, P81, DOI 10.1016/0960-0760(95)00225-1; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; STEKEL D, 2003, MICROARRY BIOINFORMA; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; WILSON JD, 1992, WILLIAMS TXB ENDOCRI; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Wintermantel TM, 2004, HORM METAB RES, V36, P387, DOI 10.1055/s-2004-814567; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	66	768	787	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2006	126	4					789	799		10.1016/j.cell.2006.06.049	http://dx.doi.org/10.1016/j.cell.2006.06.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923397	Green Accepted, Bronze			2022-12-01	WOS:000240276700026
J	Carlsson, F; Stalhammar-Carlemalm, M; Flardh, K; Sandin, C; Carlemalm, E; Lindahl, G				Carlsson, Fredric; Stalhammar-Carlemalm, Margaretha; Flaerdh, Klas; Sandin, Charlotta; Carlemalm, Eric; Lindahl, Gunnar			Signal sequence directs localized secretion of bacterial surface proteins	NATURE			English	Article							GRAM-POSITIVE BACTERIA; PYOGENES M-PROTEIN; STREPTOCOCCUS-PYOGENES; CELL-WALL; STAPHYLOCOCCUS-AUREUS; PATHWAY; TRANSLOCATION; ENVELOPE; SORTASE; PEPTIDE	All living cells require specific mechanisms that target proteins to the cell surface. In eukaryotes, the first part of this process involves recognition in the endoplasmic reticulum of amino-terminal signal sequences and translocation through Sec translocons, whereas subsequent targeting to different surface locations is promoted by internal sorting signals(1). In bacteria, N-terminal signal sequences promote translocation across the cytoplasmic membrane, which surrounds the entire cell, but some proteins are nevertheless secreted in one part of the cell by poorly understood mechanisms(2,3). Here we analyse localized secretion in the Gram-positive pathogen Streptococcus pyogenes, and show that the signal sequences of two surface proteins, M protein and protein F ( PrtF), direct secretion to different subcellular regions. The signal sequence of M protein promotes secretion at the division septum, whereas that of PrtF preferentially promotes secretion at the old pole. Our work therefore shows that a signal sequence may contain information that directs the secretion of a protein to one subcellular region, in addition to its classical role in promoting secretion. This finding identifies a new level of complexity in protein translocation and emphasizes the potential of bacterial systems for the analysis of fundamental cell-biological problems(4).	Lund Univ, Dept Lab Med, SE-22362 Lund, Sweden; Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden; Lund Univ, Dept Clin Sci, SE-22362 Lund, Sweden	Lund University; Lund University; Lund University	Lindahl, G (corresponding author), Lund Univ, Dept Lab Med, SE-22362 Lund, Sweden.	gunnar.lindahl@med.lu.se	Flärdh, Klas/H-6584-2019	Flärdh, Klas/0000-0002-7131-9743; Carlsson, Fredric/0000-0003-0875-4395				Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; COLE RM, 1962, SCIENCE, V135, P722, DOI 10.1126/science.135.3505.722; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Gitai Z, 2005, CELL, V120, P577, DOI 10.1016/j.cell.2005.02.026; HAANESFRITZ E, 1988, NUCLEIC ACIDS RES, V16, P4667, DOI 10.1093/nar/16.10.4667; HOLLINGSHEAD SK, 1986, J BIOL CHEM, V261, P1677; Janakiraman A, 2004, TRENDS MICROBIOL, V12, P518, DOI 10.1016/j.tim.2004.09.003; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; OTOOLE P, 1992, P NATL ACAD SCI USA, V89, P8661, DOI 10.1073/pnas.89.18.8661; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Rafelski SM, 2006, MOL MICROBIOL, V59, P1262, DOI 10.1111/j.1365-2958.2006.05025.x; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Rosenstein R, 2000, BIOCHIMIE, V82, P1005, DOI 10.1016/S0300-9084(00)01180-9; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SELA S, 1993, MOL MICROBIOL, V10, P1049, DOI 10.1111/j.1365-2958.1993.tb00975.x; SWANSON J, 1969, J EXP MED, V130, P1063, DOI 10.1084/jem.130.5.1063; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6	28	90	92	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					943	946		10.1038/nature05021	http://dx.doi.org/10.1038/nature05021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16929299				2022-12-01	WOS:000239960500043
J	Goldbach-Mansky, R; Dailey, NJ; Canna, SW; Gelabert, A; Jones, J; Rubin, BI; Kim, HJ; Brewer, C; Zalewski, C; Wiggs, E; Hill, S; Turner, ML; Karp, BI; Aksentijevich, I; Pucino, F; Penzak, SR; Haverkamp, MH; Stein, L; Adams, BS; Moore, TL; Fuhlbrigge, RC; Shaham, B; Jarvis, JN; O'Neil, K; Vehe, RK; Beitz, LO; Gardner, G; Hannan, WP; Warren, RW; Horn, W; Cole, JL; Paul, SM; Hawkins, PN; Pham, TH; Snyder, C; Wesley, RA; Hoffmann, SC; Holland, SM; Butman, JA; Kastner, DL				Goldbach-Mansky, Raphaela; Dailey, Natalie J.; Canna, Scott W.; Gelabert, Ana; Jones, Janet; Rubin, Benjamin I.; Kim, H. Jeffrey; Brewer, Carmen; Zalewski, Christopher; Wiggs, Edythe; Hill, Suvimol; Turner, Maria L.; Karp, Barbara I.; Aksentijevich, Ivona; Pucino, Frank; Penzak, Scott R.; Haverkamp, Margje H.; Stein, Leonard; Adams, Barbara S.; Moore, Terry L.; Fuhlbrigge, Robert C.; Shaham, Bracha; Jarvis, James N.; O'Neil, Kathleen; Vehe, Richard K.; Beitz, Laurie O.; Gardner, Gregory; Hannan, William P.; Warren, Robert W.; Horn, William; Cole, Joe L.; Paul, Scott M.; Hawkins, Philip N.; Pham, Tuyet Hang; Snyder, Christopher; Wesley, Robert A.; Hoffmann, Steven C.; Holland, Steven M.; Butman, John A.; Kastner, Daniel L.			Neonatal-onset multisystem inflammatory disease responsive to interleukin-1 beta inhibition	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NF-KAPPA-B; MUCKLE-WELLS-SYNDROME; AUTOINFLAMMATORY DISEASES; ACTIVATE CASPASE-1; FEBRILE RESPONSE; ANAKINRA; MUTATIONS; CYTOKINES; GENE; ASC	BACKGROUND: Neonatal-onset multisystem inflammatory disease is characterized by fever, urticarial rash, aseptic meningitis, deforming arthropathy, hearing loss, and mental retardation. Many patients have mutations in the cold-induced autoinflammatory syndrome 1 (CIAS1) gene, encoding cryopyrin, a protein that regulates inflammation. METHODS: We selected 18 patients with neonatal-onset multisystem inflammatory disease (12 with identifiable CIAS1 mutations) to receive anakinra, an interleukin-1-receptor antagonist (1 to 2 mg per kilogram of body weight per day subcutaneously). In 11 patients, anakinra was withdrawn at three months until a flare occurred. The primary end points included changes in scores in a daily diary of symptoms, serum levels of amyloid A and C-reactive protein, and the erythrocyte sedimentation rate from baseline to month 3 and from month 3 until a disease flare. RESULTS: All 18 patients had a rapid response to anakinra, with disappearance of rash. Diary scores improved (P<0.001) and serum amyloid A (from a median of 174 mg to 8 mg per liter), C-reactive protein (from a median of 5.29 mg to 0.34 mg per deciliter), and the erythrocyte sedimentation rate decreased at month 3 (all P<0.001), and remained low at month 6. Magnetic resonance imaging showed improvement in cochlear and leptomeningeal lesions as compared with baseline. Withdrawal of anakinra uniformly resulted in relapse within days; retreatment led to rapid improvement. There were no drug-related serious adverse events. CONCLUSIONS: Daily injections of anakinra markedly improved clinical and laboratory manifestations in patients with neonatal-onset multisystem inflammatory disease, with or without CIAS1 mutations.	NIAMSD, NIH, Bethesda, MD 20892 USA; NEI, NIH, Bethesda, MD 20892 USA; NIDCD, NIH, Bethesda, MD 20892 USA; NINDS, Ctr Clin, NIH, Bethesda, MD 20892 USA; NCI, NIH, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA; NIDDKD, NIH, Bethesda, MD 20892 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Michigan, Ann Arbor, MI 48109 USA; St Louis Univ, St Louis, MO 63103 USA; Childrens Hosp, Boston, MA 02115 USA; Childrens Hosp, Los Angeles, CA 90027 USA; Univ Oklahoma Coll, Oklahoma City, OK USA; Univ Minnesota, Minneapolis, MN USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; Univ Washington, Ctr Bone & Joint, Seattle, WA 98195 USA; SUNY Hosp, Syracuse, NY USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; Watauga Med Ctr, Boone, NC USA; Adult & Pediat Rheumatol, San Antonio, TX USA; UCL Royal Free Univ Coll Med Sch, London, England	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Saint Louis University; Harvard University; Boston Children's Hospital; Children's Hospital Los Angeles; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Minnesota System; University of Minnesota Twin Cities; Seattle Children's Hospital; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; Baylor College of Medicine; University of London; University College London; UCL Medical School	Goldbach-Mansky, R (corresponding author), NIAMS, Bldg 10,Rm 9S-205,10 Ctr Dr, Bethesda, MD 20892 USA.	goldbacr@mail.nih.gov	Aksentijevich, Ivona/AAF-1335-2019; Butman, John/J-2780-2013; Butman, John A/A-2694-2008; Hawkins, Philip N/C-5573-2008; Goldbach-Mansky, Raphaela/N-5917-2017	Butman, John/0000-0002-1547-9195; Dailey Garnes, Natalie/0000-0002-4016-4929; Canna, Scott/0000-0003-3837-5337; Paul, Scott/0000-0003-1274-6670; Vehe, Richard/0000-0003-4679-8305	NATIONAL CANCER INSTITUTE [Z01BC010688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000646, Z01AI000647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041138, Z01AR041123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000064] Funding Source: NIH RePORTER; MRC [G7900510] Funding Source: UKRI; Intramural NIH HHS [ZIA AR041138-11] Funding Source: Medline; Medical Research Council [G7900510] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; AGANNA E, 2002, ARTHRITIS RHEUM, V46, P3398; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Anderson JP, 2004, GENE, V338, P25, DOI 10.1016/j.gene.2004.05.002; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; Brekenfeld C, 2001, INVEST RADIOL, V36, P266, DOI 10.1097/00004424-200105000-00004; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Frenkel J, 2004, ARTHRITIS RHEUM-US, V50, P3738, DOI 10.1002/art.20497; Frosch M., 2005, ROBBINS COTRAN PATHO, V7th, P1347; Granel B, 2005, RHEUMATOLOGY, V44, P689, DOI 10.1093/rheumatology/keh547; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; GRIPSHOVER NM, 2000, MANDELL DOUGLAS BENN, P998; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hoffmann SC, 2002, TRANSPLANTATION, V74, P916, DOI 10.1097/00007890-200210150-00003; Kagiwada K, 2004, ENDOCRINOLOGY, V145, P5044, DOI 10.1210/en.2004-0054; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Li S, 2001, BRAIN RES, V910, P163, DOI 10.1016/S0006-8993(01)02707-X; Lovell DJ, 2005, ARTHRITIS RHEUM-US, V52, P1283, DOI 10.1002/art.20953; Luheshi GN, 1998, ANN NY ACAD SCI, V856, P83, DOI 10.1111/j.1749-6632.1998.tb08316.x; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; *NAT CTR BIOT INF, 2006, OMIM ONL MEND HER MA; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Prieur A M, 1987, Scand J Rheumatol Suppl, V66, P57; PRIEUR AM, 1981, J PEDIATR-US, V99, P79, DOI 10.1016/S0022-3476(81)80961-4; RUSSELL EJ, 1987, RADIOLOGY, V165, P609, DOI 10.1148/radiology.165.3.3317495; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Wang E, 2001, EXPERT OPIN BIOL TH, V1, P277, DOI 10.1517/14712598.1.2.277; WILKINS J, 1994, CLIN CHEM, V40, P1284; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	37	655	692	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2006	355	6					581	592		10.1056/NEJMoa055137	http://dx.doi.org/10.1056/NEJMoa055137			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	071QM	16899778	Green Published, Green Accepted			2022-12-01	WOS:000239616700008
J	Horton, R				Horton, Richard			A prescription for AIDS 2006-10	LANCET			English	Editorial Material							HIV/AIDS		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Gruber J, 2005, SOC SCI MED, V60, P1209, DOI 10.1016/j.socscimed.2004.06.053; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Morrow OI, 2004, AIDS BEHAV, V8, P365, DOI 10.1007/s10461-004-7321-6; Muturi NW, 2005, J HEALTH COMMUN, V10, P77, DOI 10.1080/10810730590904607; PICARD A, 2001, GLOBE MAIL      0815, pA1; PICARD A, 2006, GLOBE MAIL      0818, pA7; *UNICEF UNAIDS PEP, 2006, AFR ORPH VULN GEN; 2006, GLOBE MAIL      0817, pA14	9	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2006	368	9537					716	718		10.1016/S0140-6736(06)69266-0	http://dx.doi.org/10.1016/S0140-6736(06)69266-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080ID	16935672				2022-12-01	WOS:000240240200010
J	Dykxhoorn, DM; Lieberman, J				Dykxhoorn, Derek M.; Lieberman, Judy			Knocking down disease with siRNAs	CELL			English	Editorial Material							SMALL INTERFERING RNA; FAS PROTECTS MICE; IN-VIVO; GENE; INHIBITION; EXPRESSION; MICRORNAS		Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Dykxhoorn, Derek M/D-1357-2015; Lieberman, Judy/A-2717-2015		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056900] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI056900] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	23	169	179	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					231	235		10.1016/j.cell.2006.07.007	http://dx.doi.org/10.1016/j.cell.2006.07.007			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873051	Green Published, Bronze			2022-12-01	WOS:000239552600005
J	Biesmeijer, JC; Roberts, SPM; Reemer, M; Ohlemuller, R; Edwards, M; Peeters, T; Schaffers, AP; Potts, SG; Kleukers, R; Thomas, CD; Settele, J; Kunin, WE				Biesmeijer, J. C.; Roberts, S. P. M.; Reemer, M.; Ohlemueller, R.; Edwards, M.; Peeters, T.; Schaffers, A. P.; Potts, S. G.; Kleukers, R.; Thomas, C. D.; Settele, J.; Kunin, W. E.			Parallel declines in pollinators and insect-pollinated plants in Britain and the Netherlands	SCIENCE			English	Article							BRITISH BUTTERFLIES; CLIMATE	Despite widespread concern about declines in pollination services, little is known about the patterns of change in most pollinator assemblages. By studying bee and hoverfly assemblages in Britain and the Netherlands, we found evidence of declines (pre- versus post-1980) in local bee diversity in both countries; however, divergent trends were observed in hoverflies. Depending on the assemblage and location, pollinator declines were most frequent in habitat and flower specialists, in univoltine species, and/or in nonmigrants. In conjunction with this evidence, outcrossing plant species that are reliant on the declining pollinators have themselves declined relative to other plant species. Taken together, these findings strongly suggest a causal connection between local extinctions of functionally linked plant and pollinator species.	Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England; Univ Reading, Ctr Agrienvironm Res, Reading RG6 6AR, Berks, England; Natl Museum Nat Hist Naturalis, European Invertebrate Survey Netherlands, NL-2300 RA Leiden, Netherlands; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Lea Side, Midhurst GU29 9LB, W Sussex, England; Radboud Univ Nijmegen, Bargerveen Fdn, Dept Anim Ecol, NL-6500 GL Nijmegen, Netherlands; Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, NL-6708 PD Wageningen, Netherlands; Umweltforschungszentrum Ctr Environm Res Leipzig, D-06120 Halle, Germany	University of Leeds; University of Leeds; University of Reading; Naturalis Biodiversity Center; University of York - UK; Radboud University Nijmegen; Wageningen University & Research; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Biesmeijer, JC (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England.	j.c.biesmeijer@leeds.ac.uk	Thomas, Chris D/A-1460-2014; Potts, Simon G/C-7250-2008; Settele, Josef/A-6371-2009; Thomas, Chris D/A-1894-2012; Potts, Simon/ABF-9221-2020	Thomas, Chris D/0000-0003-2822-1334; Potts, Simon G/0000-0002-2045-980X; Settele, Josef/0000-0002-8624-4983; Thomas, Chris D/0000-0003-2822-1334; Potts, Simon/0000-0002-2045-980X; Biesmeijer, Koos/0000-0003-0328-0573; Ohlemuller, Ralf/0000-0001-9102-6481				Banaszak J., 1995, CHANGES FAUNA WILD B; *CENTR BUR VOORD, 2003, BIOB 2003; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; DIAZ S., 2005, ECOSYSTEMS HUMAN WEL, P297, DOI DOI 10.1021/JF020083Y; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; KEVAN P G, 1975, Biological Conservation, V7, P301, DOI 10.1016/0006-3207(75)90045-2; Klotz S., 2002, BIOLFLOR DATABASE BI; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Preston C.D., 2002, NEW ATLAS BRIT IRISH; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; SPEIGHT M, 2004, SYRPH NET CD ISSUE 2; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	19	1872	1971	51	1543	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					351	354		10.1126/science.1127863	http://dx.doi.org/10.1126/science.1127863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857940				2022-12-01	WOS:000239154300044
J	Fairchild, AL				Fairchild, Amy L.			Public health - Diabetes and disease surveillance	SCIENCE			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10502 USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10502 USA.	alf4@columbia.edu	Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				BREWIN B, 2005, GOV HLTH IT     0713; CARDWELL D, 2006, NY TIMES        0615, P83; FAIRCHILD AL, IN PRESS SEARCHING E; FRIEDEN T, 2006, COMMUNICATION   0306; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; KAZON PM, 2005, COMMUNICATION   0816; KLEINFIELD NR, 2006, NY TIMES        0109; KLEINFIELD NR, 2006, NY TIMES        0110; MACLEAN CD, 2004, CLIN TRIALS, V1, P534; *MED SOC STAT NEW, 2005, UPDATE NEW YORK STAT, V5, P28; *NEW YORK CIT DEP, DIAB PREV CONTR PROG; Piwernetz K, 2001, INT CLIN PSYCHOPHARM, V16, pS5, DOI 10.1097/00004850-200104003-00002; SCHLAFLY A, 2005, COMMUNICATION   0817; Spero M, 1998, Eff Clin Pract, V1, P90; STEIN R, 2006, WASHINGTON POST 0111, pA3	15	13	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					175	176		10.1126/science.1127610	http://dx.doi.org/10.1126/science.1127610			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063GZ	16840684				2022-12-01	WOS:000239008000026
J	Savina, A; Jancic, C; Hugues, S; Guermonprez, P; Vargas, P; Moura, IC; Lennon-Dumenil, AM; Seabra, MC; Raposo, G; Amigorena, S				Savina, Ariel; Jancic, Carolina; Hugues, Stephanie; Guermonprez, Pierre; Vargas, Pablo; Moura, Ivan Cruz; Lennon-Dumenil, Ana-Maria; Seabra, Miguel C.; Raposo, Graca; Amigorena, Sebastian			NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells	CELL			English	Article							RESPIRATORY BURST OXIDASE; NADPH OXIDASE; CROSS-PRESENTATION; PRESENTING CELLS; ACTIVATION; NEUTROPHILS; PHAGOCYTES; STIMULATION; GENERATION; ENDOSOMES	To initiate adaptative cytotoxic immune responses, proteolytic peptides derived from phagocytosed antigens are presented by dendritic cells (DCs) to CD8(+) T lymphocytes through a process called antigen "crosspresentation." The partial degradation of antigens mediated by lysosomal proteases in an acidic environment must be tightly controlled to prevent destruction of potential peptides for T cell recognition. We now describe a specialization of the phagocytic pathway of DCs that allows a fine control of antigen processing. The NADPH oxidase NOX2 is recruited to the DC's early phagosomes and mediates the sustained production of low levels of reactive oxygen species, causing active and maintained alkalinization of the phagosomal lumen. DCs lacking NOX2 show enhanced phagosomal acidification and increased antigen degradation, resulting in impaired crosspresentation. Therefore, NOX2 plays a critical role in conferring DCs the ability to function as specialized phagocytes adapted to process antigens rather than kill pathogens.	Inst Curie, INSERM, U653, F-75248 Paris 05, France; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; Inst Curie, INSERM, U520, F-75248 Paris 05, France; Inst Curie, CNRS, UMR144, F-75248 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite	Amigorena, S (corresponding author), Inst Curie, INSERM, U653, 26 Rue Ulm, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr	Guermonprez, Pierre/ABE-7718-2020; Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019; Vargas, Pablo/L-9858-2017; Moura, Ivan C/A-9510-2013; Lennon-Dumenil, Ana-Maria/I-6716-2016; Cruz Moura, Ivan/A-9510-2013	Guermonprez, Pierre/0000-0001-5621-2262; Seabra, Miguel C/0000-0002-6404-4892; Vargas, Pablo/0000-0002-6475-494X; Moura, Ivan C/0000-0002-2977-0354; Amigorena, Sebastian/0000-0001-8583-8416; hugues, stephanie/0000-0002-1031-5909; Cruz Moura, Ivan/0000-0002-8418-2803; Raposo, graca/0000-0001-9590-1298	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; CALAFAT J, 1993, BLOOD, V81, P3122; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; CROSS AR, 2004, BIOCHIM BIOPHYS ACTA, V1654, P1; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Elsen S, 2004, J CELL SCI, V117, P2215, DOI 10.1242/jcs.01085; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; NANDA A, 1994, J CLIN INVEST, V93, P1770, DOI 10.1172/JCI117162; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RAPOSO G, 1997, HDB EXPT IMMUNOLOGY, P1; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SEGAL AW, 1978, BIOCHEM BIOPH RES CO, V84, P611, DOI 10.1016/0006-291X(78)90749-0; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; YILLA M, 1993, J BIOL CHEM, V268, P19092	42	616	626	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					205	218		10.1016/j.cell.2006.05.035	http://dx.doi.org/10.1016/j.cell.2006.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839887	Bronze			2022-12-01	WOS:000239224800027
J	Klimanskaya, I; Chung, Y; Becker, S; Lu, SJ; Lanza, R				Klimanskaya, Irina; Chung, Young; Becker, Sandy; Lu, Shi-Jiang; Lanza, Robert			Human embryonic stem cell lines derived from single blastomeres	NATURE			English	Article							MOUSE BLASTOMERES; HUMAN BLASTOCYSTS; IN-VITRO; STAGE; DERIVATION; EXPRESSION; DIAGNOSIS; BIOPSY; DNA	The derivation of human embryonic stem (hES) cells currently requires the destruction of ex utero embryos(1-4). A previous study in mice indicates that it might be possible to generate embryonic stem (ES) cells using a single-cell biopsy similar to that used in preimplantation genetic diagnosis (PGD), which does not interfere with the embryo's developmental potential(5). By growing the single blastomere overnight, the resulting cells could be used for both genetic testing and stem cell derivation without affecting the clinical outcome of the procedure. Here we report a series of ten separate experiments demonstrating that hES cells can be derived from single blastomeres. In this proof-of-principle study, multiple biopsies were taken from each embryo using micromanipulation techniques and none of the biopsied embryos were allowed to develop in culture. Nineteen ES-cell-like outgrowths and two stable hES cell lines were obtained. The latter hES cell lines maintained undifferentiated proliferation for more than eight months, and showed normal karyotype and expression of markers of pluri-potency, including Oct-4, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, nanog and alkaline phosphatase. These cells retained the potential to form derivatives of all three embryonic germ layers both in vitro and in teratomas. The ability to create new stem cell lines and therapies without destroying embryos would address the ethical concerns of many, and allow the generation of matched tissue for children and siblings born from transferred PGD embryos.	Adv Cell Technol, Worcester, MA 01605 USA		Lanza, R (corresponding author), Adv Cell Technol, 381 Plantat St, Worcester, MA 01605 USA.	rlanza@advancedcell.com	Chung, Young Gie/AAC-8149-2020	Lanza, Robert/0000-0002-3047-3074				Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Deb K, 2006, SCIENCE, V311, P992, DOI 10.1126/science.1120925; Fredsted T, 2004, AM J PRIMATOL, V64, P345, DOI 10.1002/ajp.20083; GEBER S, 1995, HUM REPROD, V10, P1492, DOI 10.1093/HUMREP/10.6.1492; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Hansis C, 2001, MOL HUM REPROD, V7, P155, DOI 10.1093/molehr/7.2.155; HARDY K, 1990, HUM REPROD, V5, P708, DOI 10.1093/oxfordjournals.humrep.a137173; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Klimanskaya I, 2004, HDB STEM CELLS, V1, P437; KLIMANSKAYA I, 2005, LANCET, V361, P1496; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lanza R., 2006, ESSENTIALS STEM CELL; Lanzendorf SE, 2001, FERTIL STERIL, V76, P132, DOI 10.1016/S0015-0282(01)01825-8; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Magli MC, 2006, HUM REPROD, V21, P2656, DOI 10.1093/humrep/del228; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Nagy A, 2002, MANIPULATING MOUSE E, V3rd; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Sills ES, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-25; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Veeck LL., 1999, ATLAS HUMAN GAMETES; WEBER DJ, IN PRESS METHODS ENZ, V420; YOUNG H, 2006, ESSENTIALS STEM CELL, P317	27	367	428	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					481	485		10.1038/nature05142	http://dx.doi.org/10.1038/nature05142			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	16929302				2022-12-01	WOS:000242215700045
J	Imai, T; Suzuki, M; Sakano, H				Imai, Takeshi; Suzuki, Misao; Sakano, Hitoshi			Odorant receptor-derived cAMP signals direct axonal targeting	SCIENCE			English	Article							MICE DEFICIENT; OLFACTORY-BULB; EXPRESSION; GUIDANCE; ORGANIZATION; PROJECTIONS; SUBUNIT; NEURONS	In mammals, odorant receptors (ORs) direct the axons of olfactory sensory neurons (OSNs) toward targets in the olfactory bulb. We show that cyclic adenosine monophosphate ( cAMP) signals that regulate the expression of axon guidance molecules are essential for the OR-instructed axonal projection. Genetic manipulations of ORs, stimulatory G protein, cAMP-dependent protein kinase, and cAMP response element - binding protein shifted the axonal projection sites along the anterior-posterior axis in the olfactory bulb. Thus, it is the OR-derived cAMP signals, rather than direct action of OR molecules, that determine the target destinations of OSNs.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1030027, Japan; Kumamoto Univ, Ctr Anim Resources, Div Transgen Technol, Kumamoto 8600811, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Imai, Takeshi/L-2201-2013	Imai, Takeshi/0000-0002-8449-0080				Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, J NEUROSCI, V16, P909; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Luo AH, 2002, BRAIN RES, V941, P62, DOI 10.1016/S0006-8993(02)02566-0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	27	232	235	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					657	661		10.1126/science.1131794	http://dx.doi.org/10.1126/science.1131794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	16990513				2022-12-01	WOS:000241557800051
J	Borchelt, DR				Borchelt, David R.			Amyotrophic lateral sclerosis - Are microglia killing motor neurons?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Florida, Dept Neurosci, McKnight Brain Inst, SantaFe Hlth Alzheimers Dis Res Ctr, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, SantaFe Hlth Alzheimers Dis Res Ctr, Gainesville, FL 32610 USA.							Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Watanabe Y, 2005, MOL BRAIN RES, V135, P12, DOI 10.1016/j.molbrainres.2004.11.019	4	21	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1611	1613		10.1056/NEJMcibr064358	http://dx.doi.org/10.1056/NEJMcibr064358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035656				2022-12-01	WOS:000241160400016
J	Omer, SB; Pan, WKY; Halsey, NA; Stokley, S; Moulton, LH; Navar, AM; Pierce, M; Salmon, DA				Omer, Saad B.; Pan, William K. Y.; Halsey, Neal A.; Stokley, Shannon; Moulton, Lawrence H.; Navar, Ann Marie; Pierce, Mathew; Salmon, Daniel A.			Nonmedical exemptions to school immunization requirements - Secular trends and association of state policies with pertussis incidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SAMPLE-SIZE; PHILOSOPHICAL EXEMPTIONS; MEASLES; VACCINES; CHILDREN	Context School immunization requirements have played a major role in controlling vaccine-preventable diseases in the United States. Most states offer nonmedical exemptions to school requirements (religious or personal belief). Exemptors are at increased risk of acquiring and transmitting disease. The role of exemption policies may be especially important for pertussis, which is endemic in the United States. Objective To determine if (1) the rates of nonmedical exemptions differ and have been increasing in states that offer only religious vs personal belief exemptions; (2) the rates of nonmedical exemptions differ and have been increasing in states that have easy vs medium and easy vs difficult processes for obtaining exemptions; and (3) pertussis incidence is associated with policies of granting personal belief exemptions, ease of obtaining exemptions, and acceptance of parental signature as sufficient proof of compliance with school immunization requirements. Design, Setting, and Participants We analyzed 1991 through 2004 state-level rates of nonmedical exemptions at school entry and 1986 through 2004 pertussis incidence data for individuals aged 18 years or younger. Main Outcome Measures State-level exemption rates and pertussis incidence. Results From 2001 through 2004, states that permitted personal belief exemptions had higher nonmedical exemption rates than states that offered only religious exemptions, and states that easily granted exemptions had higher nonmedical exemption rates in 2002 through 2003 compared with states with medium and difficult exemption processes. The mean exemption rate increased an average of 6% per year, from 0.99% in 1991 to 2.54% in 2004, among states that offered personal belief exemptions. In states that easily granted exemptions, the rate increased 5% per year, from 1.26% in 1991 to 2.51% in 2004. No statistically significant change was seen in states that offered only religious exemptions or that had medium and difficult exemption processes. In multivariate analyses adjusting for demographics, easier granting of exemptions (incidence rate ratio = 1.53; 95% confidence interval, 1.10-2.14) and availability of personal belief exemptions (incidence rate ratio = 1.48; 95% confidence interval, 1.03-2.13) were associated with increased pertussis incidence. Conclusions Permitting personal belief exemptions and easily granting exemptions are associated with higher and increasing nonmedical US exemption rates. State policies granting personal belief exemptions and states that easily grant exemptions are associated with increased pertussis incidence. States should examine their exemption policies to ensure control of pertussis and other vaccine-preventable diseases.	Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL 32608 USA; Duke Univ, Sch Med, Durham, NC USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Vaccine Safety, Baltimore, MD USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	State University System of Florida; University of Florida; Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Salmon, DA (corresponding author), Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, 1329 SW 16th St,Room 5239,POB 100177, Gainesville, FL 32608 USA.	das@ehpr.ufl.edu	Omer, Saad B/K-1182-2012; Petri, William/AAL-3642-2020	Omer, Saad B/0000-0002-5383-3474; Petri, William/0000-0002-7268-1218; salmon, daniel/0000-0002-1035-4422; Pan, William/0000-0002-7407-7399; Moulton, Lawrence/0000-0001-7041-7387	PHS HHS [UIP000032A] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDC, 2005, MMWR-MORBID MORTAL W, V52, P1; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P241; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P73; Centers for Disease Control and Prevention (CDC), 1999, MMWR-MORBID MORTAL W, V48, P243; Chen RT, 1998, PEDIATR ANN, V27, P445, DOI 10.3928/0090-4481-19980701-11; Cherry J D, 1984, Curr Probl Pediatr, V14, P1; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Immunization Action Coalition, STAT MAND IMM VACC P; *J HOPK BLOOMB SCH, VACC EX; McNeil Jr. D. G., 2002, NY TIMES        1130; *NAT NETW IMM INF, VACC INF; Orenstein WA, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00290-X; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Plotkin S.L., 2004, VACCINES-BASEL, P1, DOI DOI 10.1016/B978-1-4557-0090-5.00017-3; ROBBINS KB, 1981, AM J PUBLIC HEALTH, V71, P270, DOI 10.2105/AJPH.71.3.270; ROBISON G, 2003, 37 NAT IMM C MARC 18; Rota JS, 2001, AM J PUBLIC HEALTH, V91, P645, DOI 10.2105/AJPH.91.4.645; Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470; Salmon DA, 2001, PUBLIC HEALTH REP, V116, P289, DOI 10.1016/S0033-3549(04)50050-X; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Salmon DA, 2006, EPIDEMIOL REV, V28, P27, DOI 10.1093/epirev/mxj001; SIGNORINI DF, 1991, BIOMETRIKA, V78, P446; U.S. Census Bureau, POP EST PROGR; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; Willis Bayo C., 2005, Morbidity and Mortality Weekly Report, V54, P1; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	289	292	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1757	1763		10.1001/jama.296.14.1757	http://dx.doi.org/10.1001/jama.296.14.1757			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032989	Bronze			2022-12-01	WOS:000241103400024
J	Jablonski, D; Roy, K; Valentine, JW				Jablonski, David; Roy, Kaustuv; Valentine, James W.			Out of the tropics: Evolutionary dynamics of the latitudinal diversity gradient	SCIENCE			English	Article							GLOBAL BIODIVERSITY; SPECIES-DIVERSITY; EXTINCTION RATES; FOSSIL RECORD; MARINE REALM; PATTERNS; SCALE; ENERGY; HISTORY; WATER	The evolutionary dynamics underlying the latitudinal gradient in biodiversity have been controversial for over a century. Using a spatially explicit approach that incorporates not only origination and extinction but immigration, a global analysis of genera and subgenera of marine bivalves over the past 11 million years supports an "out of the tropics'' model, in which taxa preferentially originate in the tropics and expand toward the poles without losing their tropical presence. The tropics are thus both a cradle and a museum of biodversity, contrary to the conceptual dichotomy dominant since 1974; a tropical diversity crisis would thus have profound evolutionary effects at all latitudes.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Chicago; University of California System; University of California San Diego; University of California System; University of California Berkeley	Jablonski, D (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	djablons@uchicago.edu						Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; Beu A.G., 2005, Scripta Geologica (Leiden), V130, P1; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Brown JM, 2005, EVOLUTION, V59, P238; CAMPBELL C A, 1977, Paleobiology, V3, P49; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cardillo M, 1999, P ROY SOC B-BIOL SCI, V266, P1221, DOI 10.1098/rspb.1999.0766; Case TJ, 2005, OIKOS, V108, P28, DOI 10.1111/j.0030-1299.2005.13148.x; Cecca F, 2005, J BIOGEOGR, V32, P535, DOI 10.1111/j.1365-2699.2005.01176.x; Cecca F., 2002, PALAEOBIOGEOGRAPHY M, P273; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Cooper RA, 2006, GEOLOGY, V34, P241, DOI 10.1130/G22206.1; Crame J. Alistair, 2001, Diversity and Distributions, V7, P175, DOI 10.1111/j.1472-4642.2001.00106.x; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; DARLINGTON PJ, 1959, EVOLUTION, V13, P488, DOI 10.2307/2406131; Ferraz E, 1998, DIS AQUAT ORGAN, V33, P43, DOI 10.3354/dao033043; Ferrero Elena, 1992, Bollettino Malacologico, V28, P101; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 1996, P ROY SOC B-BIOL SCI, V263, P63, DOI 10.1098/rspb.1996.0011; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Goldberg EE, 2005, AM NAT, V165, P623, DOI 10.1086/430012; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; Hawkins BA, 2005, J BIOGEOGR, V32, P1035, DOI 10.1111/j.1365-2699.2004.01238.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; HECHT AD, 1972, SYST ZOOL, V21, P308, DOI 10.2307/2412169; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; JABLONSKI D, 1993, NATURE, V364, P142, DOI 10.1038/364142a0; Jablonski David, 2003, P368; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Judd WS., 1994, HARVARD PAPERS BOTAN, V5, P1; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Leighton LR, 2005, EVOL ECOL, V19, P563, DOI 10.1007/s10682-005-1021-1; LEWIN R, 1989, SCIENCE, V244, P527, DOI 10.1126/science.244.4904.527; Martin PR, 2004, EVOLUTION, V58, P938; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Paradis E, 2004, J THEOR BIOL, V229, P19, DOI 10.1016/j.jtbi.2004.02.018; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Pavia G., 1976, B SOC PALEONTOLOGICA, V14, P99; Pawar SS, 2005, EVOLUTION, V59, P234; Ree RH, 2005, EVOLUTION, V59, P2299; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs Robert E., 1993, P350; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P151; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Schemske D.W., 2002, FDN TROPICAL FOREST, P163; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shen SZ, 2004, PALAEOGEOGR PALAEOCL, V208, P235, DOI 10.1016/j.palaeo.2004.03.009; STANLEY SM, 1980, GEOLOGY, V8, P422, DOI 10.1130/0091-7613(1980)8<422:LCIPPA>2.0.CO;2; Stebbins G.L., 1974, FLOWERING PLANTS EVO; STENSETH NC, 1984, OIKOS, V43, P417, DOI 10.2307/3544168; Todd JA, 2002, P ROY SOC B-BIOL SCI, V269, P571, DOI 10.1098/rspb.2001.1923; Turner JRG, 2004, BASIC APPL ECOL, V5, P435, DOI 10.1016/j.baae.2004.08.004; Valentine James W., 1993, P341; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Wallace AR, 1878, TROPICAL NATURE OTHE; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WOOD SLB, 2006, THESIS VIRGINIA POLY; Wright SD, 2003, EVOLUTION, V57, P2893	72	573	593	11	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					102	106		10.1126/science.1130880	http://dx.doi.org/10.1126/science.1130880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023653				2022-12-01	WOS:000241031200044
J	Gorb, SN; Niederegger, S; Hayashi, CY; Summers, AP; Voetsch, W; Walther, P				Gorb, Stanislav N.; Niederegger, Senta; Hayashi, Cheryl Y.; Summers, Adam P.; Voetsch, Walter; Walther, Paul			Silk-like secretion from tarantula feet	NATURE			English	Article							SPIDER SILK; ORIGIN; EVOLUTION; ARANEAE		Max Planck Inst Met Res, Evolutionary Biomat Grp, D-70569 Stuttgart, Germany; Max Planck Inst Dev Biol, D-71076 Tubingen, Germany; Univ Jena, Inst Forens Med, D-07743 Jena, Germany; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Ulm, Dept Electron Microscopy, D-89069 Ulm, Germany	Max Planck Society; Max Planck Society; Friedrich Schiller University of Jena; University of California System; University of California Riverside; Ulm University	Gorb, SN (corresponding author), Max Planck Inst Met Res, Evolutionary Biomat Grp, D-70569 Stuttgart, Germany.	s.gorb@mf.mpg.de	Summers, Adam/A-9060-2013	Summers, Adam/0000-0003-1930-9748; Niederegger, Senta/0000-0001-8784-8570				Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Bristowe W.S., 1932, P ZOOL SOC LOND, V103, P1015; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Damen WGM, 2002, CURR BIOL, V12, P1711, DOI 10.1016/S0960-9822(02)01126-0; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	11	45	47	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					407	407		10.1038/443407a	http://dx.doi.org/10.1038/443407a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006505	Bronze			2022-12-01	WOS:000240798800033
J	Neiditch, MB; Federle, MJ; Pompeani, AJ; Kelly, RC; Swem, DL; Jeffrey, PD; Bassler, BL; Hughson, FM				Neiditch, Matthew B.; Federle, Michael J.; Pompeani, Audra J.; Kelly, Robert C.; Swem, Danielle L.; Jeffrey, Philip D.; Bassler, Bonnie L.; Hughson, Frederick M.			Ligand-induced asymmetry in histidine sensor kinase complex regulates quorum sensing	CELL			English	Article							VIBRIO-HARVEYI; ESCHERICHIA-COLI; STRUCTURAL IDENTIFICATION; GENETIC-ANALYSIS; BINDING DOMAIN; SIGNAL; PROTEIN; EXPRESSION; RECEPTORS; SEQUENCE	Bacteria sense their environment using receptors of the histidine sensor kinase family, but how kinase activity is regulated by ligand binding is not well understood. Autoinducer-2 (Al-2), a secreted signaling molecule originally identified in studies of the marine bacterium Vibrio harveyi, regulates quorum-sensing responses and allows communication between different bacterial species. Al-2 signal transduction in V. harveyi requires the integral membrane receptor LuxPQ, comprised of periplasmic binding protein (LuxP) and histidine sensor kinase (LuxQ) subunits. Combined X-ray crystallographic and functional studies show that Al-2 binding causes a major conformational change within LuxP, which in turn stabilizes a quaternary arrangement in which two LuxPQ monomers are asymmetrically associated. We propose that formation of this asymmetric quaternary structure is responsible for repressing the kinase activity of both LuxQ subunits and triggering the transition of V. harveyi into quorum-sensing mode.	Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Hughson, FM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Federle, Michael J./E-5522-2017	Neiditch, Matthew/0000-0002-7039-4469; Bassler, Bonnie/0000-0002-0043-746X; Jeffrey, Philip/0000-0002-4351-5341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068371, R01GM065859] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054442, AI-054442] Funding Source: Medline; NIGMS NIH HHS [R01 GM065859, R37 GM065859, GM-065859, F32 GM068371] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAO JG, 1989, J BIOL CHEM, V264, P21670; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Heermann R, 1998, BBA-BIOMEMBRANES, V1415, P114, DOI 10.1016/S0005-2736(98)00181-3; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MADDOCK JR, 1993, SCIENCE, V259, P1717; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; MULLERDIECKMANN HJ, 2003, HISTIDINE KINASES SI, P123; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappas KM, 2004, MOL MICROBIOL, V53, P755, DOI 10.1111/j.1365-2958.2004.04212.x; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Semmelhack MF, 2005, ORG LETT, V7, P569, DOI 10.1021/ol047695j; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; Tomomori C., 2003, HISTIDINE KINASES SI, P11, DOI [10.1016/B978-012372484-7/50003-5, DOI 10.1016/B978-012372484-7/50003-5]; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang L, 2001, J BACTERIOL, V183, P2795, DOI 10.1128/JB.183.9.2795-2802.2001; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WOLANIN PM, 2003, HISTIDINE KINASES SI, P73; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	58	205	211	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1095	1108		10.1016/j.cell.2006.07.032	http://dx.doi.org/10.1016/j.cell.2006.07.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990134	Bronze, Green Accepted			2022-12-01	WOS:000240897600016
J	Boehr, DD; McElheny, D; Dyson, HJ; Wright, PE				Boehr, David D.; McElheny, Dan; Dyson, H. Jane; Wright, Peter E.			The dynamic energy landscape of dihydrofolate reductase catalysis	SCIENCE			English	Article							ESCHERICHIA-COLI; NMR-SPECTROSCOPY; ENZYME CATALYSIS; BINDING; STATES; LOOP; FLUCTUATIONS; MECHANISM; SUBSTRATE; PROTEINS	We used nuclear magnetic resonance relaxation dispersion to characterize higher energy conformational substates of Escherichia coli dihydrofolate reductase. Each intermediate in the catalytic cycle samples low-lying excited states whose conformations resemble the ground-state structures of preceding and following intermediates. Substrate and cofactor exchange occurs through these excited substates. The maximum hydride transfer and steady-state turnover rates are governed by the dynamics of transitions between ground and excited states of the intermediates. Thus, the modulation of the energy landscape by the bound ligands funnels the enzyme through its reaction cycle along a preferred kinetic path.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Boehr, David/A-2068-2010; Dyson, Jane/D-4160-2011	Dyson, Jane/0000-0001-6855-3398	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075995, P01GM056879] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM75995, GM56879] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; CARERI G, 1979, ANNU REV BIOPHYS BIO, V8, P69, DOI 10.1146/annurev.bb.08.060179.000441; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; GAVISH B, 1979, BIOCHEMISTRY-US, V18, P1269, DOI 10.1021/bi00574a023; HAMMES GG, 1964, NATURE, V204, P342, DOI 10.1038/204342a0; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kumar S, 2000, PROTEIN SCI, V9, P10; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	28	737	750	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1638	1642		10.1126/science.1130258	http://dx.doi.org/10.1126/science.1130258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973882				2022-12-01	WOS:000240498900046
J	Fernandez, MA; Albor, C; Ingelmo-Torres, M; Nixon, SJ; Ferguson, C; Kurzchalia, T; Tebar, F; Enrich, C; Parton, RG; Pol, A				Fernandez, Manuel A.; Albor, Cecilia; Ingelmo-Torres, Mercedes; Nixon, Susan J.; Ferguson, Charles; Kurzchalia, Teymuras; Tebar, Francesc; Enrich, Carlos; Parton, Robert G.; Pol, Albert			Caveolin-1 is essential for liver regeneration	SCIENCE			English	Article							DOMINANT-NEGATIVE MUTANT; PARTIAL-HEPATECTOMY; LIPID BODIES; GLUCOSE; RATS; FAT	Liver regeneration is an orchestrated cellular response that coordinates cell activation, lipid metabolism, and cell division. We found that caveolin-1 gene - disrupted mice (cav1(-/-) mice) exhibited impaired liver regeneration and low survival after a partial hepatectomy. Hepatocytes showed dramatically reduced lipid droplet accumulation and did not advance through the cell division cycle. Treatment of cav1(-/-) mice with glucose ( which is a predominant energy substrate when compared to lipids) drastically increased survival and reestablished progression of the cell cycle. Thus, caveolin-1 plays a crucial role in the mechanisms that coordinate lipid metabolism with the proliferative response occurring in the liver after cellular injury.	Univ Queensland, Inst Mol Biosci, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Fac Med, Dept Cellular Biol, E-08036 Barcelona, Spain; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Queensland; University of Queensland; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Max Planck Society	Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia.	R.Parton@imb.uq.edu.au; apols@ub.edu	Fernandez-Rojo, Manuel Alejandro/P-2981-2014; Tebar, Francesc/H-1498-2015; Parton, Robert G/C-5673-2009; Pol, Albert/M-1865-2014; Nixon, Susan/D-4588-2017	Fernandez-Rojo, Manuel Alejandro/0000-0002-2240-1951; Tebar, Francesc/0000-0002-9522-9726; Parton, Robert G/0000-0002-7494-5248; Pol, Albert/0000-0002-1750-1085; Nixon, Susan/0000-0003-0346-9683; Ingelmo, Mercedes/0000-0002-7116-2045; Enrich, Carlos/0000-0003-0382-2993				Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Bucher N.L.R., 1971, REGENERATION LIVER K; CARUANA JA, 1986, ENDOCR RES, V12, P147, DOI 10.1080/07435808609035434; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; GLENDE EA, 1968, EXP MOL PATHOL, V8, P190, DOI 10.1016/0014-4800(68)90015-4; HOLECEK M, 1988, EXP PATHOL-JENA, V33, P257; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; LAI HS, 1992, JPEN-PARENTER ENTER, V16, P152, DOI 10.1177/0148607192016002152; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; SIMEK J, 1967, NATURE, V213, P910, DOI 10.1038/213910a0; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489	16	202	212	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1628	1632		10.1126/science.1130773	http://dx.doi.org/10.1126/science.1130773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973879				2022-12-01	WOS:000240498900043
J	Murakami, S; Nakashima, R; Yamashita, E; Matsumoto, T; Yamaguchi, A				Murakami, Satoshi; Nakashima, Ryosuke; Yamashita, Eiki; Matsumoto, Takashi; Yamaguchi, Akihito			Crystal structures of a multidrug transporter reveal a functionally rotating mechanism	NATURE			English	Article							EFFLUX PUMP; PROTEIN; ACRB; RESISTANCE; TOLC; REFINEMENT; SOFTWARE; SYSTEM; GENES; PERIPLASM	AcrB is a principal multidrug efflux transporter in Escherichia coli that cooperates with an outer-membrane channel, TolC, and a membrane-fusion protein, AcrA. Here we describe crystal structures of AcrB with and without substrates. The AcrB - drug complex consists of three protomers, each of which has a different conformation corresponding to one of the three functional states of the transport cycle. Bound substrate was found in the periplasmic domain of one of the three protomers. The voluminous binding pocket is aromatic and allows multi-site binding. The structures indicate that drugs are exported by a three-step functionally rotating mechanism in which substrates undergo ordered binding change.	Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan; SOSHO Inc, Osaka 5410053, Japan	Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University; Osaka University	Murakami, S (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan.	mura@sanken.osaka-u.ac.jp	Murakami, Satoshi/E-8155-2015; Yamashita, Eiki/V-6758-2019	Murakami, Satoshi/0000-0001-5553-7663; Yamashita, Eiki/0000-0002-4278-0039				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Grkovic S, 2003, BIOCHEMISTRY-US, V42, P15226, DOI 10.1021/bi035447+; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2003, CURR OPIN STRUC BIOL, V13, P443, DOI 10.1016/S0959-440X(03)00109-X; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nikaido H, 2000, TRENDS MICROBIOL, V8, P481, DOI 10.1016/S0966-842X(00)01864-3; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	43	542	565	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					173	179		10.1038/nature05076	http://dx.doi.org/10.1038/nature05076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16915237				2022-12-01	WOS:000240467000038
J	Haigis, MC; Mostoslavsky, R; Haigis, KM; Fahie, K; Christodoulou, DC; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Karow, M; Blander, G; Wolberger, C; Prolla, TA; Weindruch, R; Alt, FW; Guarente, L				Haigis, Marcia C.; Mostoslavsky, Raul; Haigis, Kevin M.; Fahie, Kamau; Christodoulou, Danos C.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Karow, Margaret; Blander, Gil; Wolberger, Cynthia; Prolla, Tomas A.; Weindruch, Richard; Alt, Frederick W.; Guarente, Leonard			SIRT4 inhibits glutamate dehydrogehase and opposes the effects of calorie restriction in pancreatic beta cells	CELL			English	Article							STIMULATED INSULIN-SECRETION; LIFE-SPAN EXTENSION; ADP-RIBOSYLATION; SACCHAROMYCES-CEREVISIAE; DEPENDENT DEACETYLASE; TRANSCRIPTION FACTORS; PROTEIN DEACETYLASES; ENZYME-ACTIVITIES; MAMMALIAN SIR2; MOUSE-LIVER	Sir2 is an NAD-dependent deacetylase that connects metabolism with longevity in yeast, flies, and worms. Mammals have seven Sir2 homologs (SIRT1-7). We show that SIRT4 is a mitochondrial enzyme that uses NAD to ADP-ribosylate and downregulate glutamate dehydrogenase (GDH) activity. GDH is known to promote the metabolism of glutamate and glutamine, generating ATP, which promotes insulin secretion. Loss of SIRT4 in insulinoma cells activates GDH, thereby upregulating amino acid-stimulated insulin secretion. A similar effect is observed in pancreatic beta cells from mice deficient in SIRT4 or on the dietary regimen of calorie restriction (CR). Furthermore, GDH from SIRT4-deficient or CR mice is insensitive to phosphodiesterase, an enzyme that cleaves ADP-ribose, suggesting the absence of ADP-ribosylation. These results indicate that SIRT4 functions in beta cell mitochondria to repress the activity of GDH by ADP-ribosylation, thereby downregulating insulin secretion in response to amino acids, effects that are alleviated during CR.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Canc Res Ctr, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, CBR Inst Biomed Res, Howard Hughes Med Inst, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Wisconsin, Vet Adm Hosp, Madison, WI 53705 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University; Regeneron; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu		Murphy, Andrew/0000-0003-4152-4081; Wolberger, Cynthia/0000-0001-8578-2969				Armstrong CM, 2002, MOL BIOL CELL, V13, P1427, DOI 10.1091/mbc.01-10-0482; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hagopian K, 2005, FEBS LETT, V579, P2009, DOI 10.1016/j.febslet.2005.02.062; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jorcke D, 1998, BIOCHEM J, V332, P189, DOI 10.1042/bj3320189; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kelly A, 2001, MENT RETARD DEV D R, V7, P287, DOI 10.1002/mrdd.1040; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MEYER T, 1986, EUR J BIOCHEM, V155, P157, DOI 10.1111/j.1432-1033.1986.tb09471.x; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schwab CJ, 2000, P SOC EXP BIOL MED, V223, P389, DOI 10.1046/j.1525-1373.2000.22355.x; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WITTERS LA, 1986, BIOCHEMISTRY-US, V25, P7216, DOI 10.1021/bi00370a067; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	55	880	929	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					941	954		10.1016/j.cell.2006.06.057	http://dx.doi.org/10.1016/j.cell.2006.06.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959573	Bronze			2022-12-01	WOS:000240675000021
J	Frazao, C; Mcvey, CE; Amblar, M; Barbas, A; Vonrhein, C; Arraiano, CM; Carrondo, MA				Frazao, Carlos; McVey, Colin E.; Amblar, Monica; Barbas, Ana; Vonrhein, Clemens; Arraiano, Cecilia M.; Carrondo, Maria A.			Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex	NATURE			English	Article							MESSENGER-RNAS; EXOSOME; SUPERFAMILY; MECHANISM; RECOGNITION; PROTEINS; PROGRAM; DENSITY; BINDING; DOMAIN	RNA degradation is a determining factor in the control of gene expression. The maturation, turnover and quality control of RNA is performed by many different classes of ribonucleases(1). Ribonuclease II (RNase II) is a major exoribonuclease that intervenes in all of these fundamental processes(1); it can act independently or as a component of the exosome, an essential RNA-degrading multiprotein complex(2). RNase II-like enzymes are found in all three kingdoms of life, but there are no structural data for any of the proteins of this family(1-5). Here we report the X-ray crystallographic structures of both the ligand-free (at 2.44 angstrom resolution) and RNA-bound (at 2.74 angstrom resolution) forms of Escherichia coli RNase II. In contrast to sequence predictions, the structures show that RNase II is organized into four domains: two cold-shock domains, one RNB catalytic domain, which has an unprecedented alpha beta-fold, and one S1 domain. The enzyme establishes contacts with RNA in two distinct regions, the 'anchor' and the 'catalytic' regions, which act synergistically to provide catalysis(6). The active site is buried within the RNB catalytic domain, in a pocket formed by four conserved sequence motifs. The structure shows that the catalytic pocket is only accessible to single-stranded RNA, and explains the specificity for RNA versus DNA cleavage. It also explains the dynamic mechanism of RNA degradation by providing the structural basis for RNA translocation and enzyme processivity. We propose a reaction mechanism for exonucleolytic RNA degradation involving key conserved residues. Our three-dimensional model corroborates all existing biochemical data for RNase II, and elucidates the general basis for RNA degradation. Moreover, it reveals important structural features that can be extrapolated to other members of this family.	Univ Nova Lisboa, Inst Tecnol Quim & Biol, Div Biol Chem, P-2781901 Oeiras, Portugal; Univ Nova Lisboa, Inst Tecnol Quim & Biol, Div Biol, P-2781901 Oeiras, Portugal; Global Phasing Ltd, Cambridge CB3 0AX, England	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Global Phasing Limited	Carrondo, MA (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Div Biol Chem, Apt 127, P-2781901 Oeiras, Portugal.	cecilia@itqb.unl.pt; carrondo@itqb.unl.pt	McVey, Colin E/C-2110-2008; Amblar, 2405/C-3941-2011; Amblar, Monica/E-2366-2016; Frazao, Carlos/C-1965-2008	McVey, Colin E/0000-0001-7457-2130; Amblar, Monica/0000-0003-3530-615X; Carrondo, Maria Armenia/0000-0002-1261-1162; Frazao, Carlos/0000-0002-7725-1671; Arraiano, Cecilia/0000-0003-1934-9301; Barbas, Ana/0000-0002-6245-8549				Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cairrao F, 2005, DEV DYNAM, V232, P733, DOI 10.1002/dvdy.20269; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cassano AG, 2004, BIOPOLYMERS, V73, P110, DOI 10.1002/bip.10517; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lim JT, 1997, CANCER RES, V57, P921; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; McVey CE, 2006, ACTA CRYSTALLOGR F, V62, P684, DOI 10.1107/S1744309106021506; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272	30	179	184	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					110	114		10.1038/nature05080	http://dx.doi.org/10.1038/nature05080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957732				2022-12-01	WOS:000240313900050
J	Jaillais, Y; Fobis-Loisy, I; Miege, C; Rollin, C; Gaude, T				Jaillais, Yvon; Fobis-Loisy, Isabelle; Miege, Christine; Rollin, Claire; Gaude, Thierry			AtSNX1 defines an endosome for auxin-carrier trafficking in Arabidopsis	NATURE			English	Article							GNOM ARF-GEF; PERMEASE AUX1; PIN PROTEINS; EFFLUX; TRANSPORT; LOCALIZATION; ENDOCYTOSIS; EXPRESSION; GRADIENTS; GOLGI	Polarized cellular distribution of the phytohormone auxin and its carriers is essential for normal plant growth and development. Polar auxin transport(1,2) is maintained by a network of auxin influx (AUX)(3) and efflux (PIN)(1,2,4-6) carriers. Both auxin transport and PIN protein cycling between the plasma membrane and endosomes require the activity of the endosomal GNOM(1,2,7,8); however, intracellular routes taken by these carriers remain largely unknown. Here we show that Arabidopsis thaliana SORTING NEXIN 1 (AtSNX1) is involved in the auxin pathway and that PIN2, but not PIN1 or AUX1, is transported through AtSNX1-containing endosomes. We demonstrate that the snx1-null mutant exhibits multiple auxin-related defects and that loss of function of AtSNX1 severely enhances the phenotype of a weak gnom mutant. In root cells, we further show that AtSNX1 localizes to an endosomal compartment distinct from GNOM-containing endosomes, and that PIN2 accumulates in this compartment after treatment with the phosphatidylinositol-3-OH kinase inhibitor wortmannin or after a gravity stimulus. Our data reveal the existence of a novel endosomal compartment involved in PIN2 endocytic sorting and plant development.	Univ Lyon 1, Ecole Normale Super Lyon, Inst Natl Rech Agron, CNRS,IFR Biosci Lyon Gerland 128, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gaude, T (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Natl Rech Agron, CNRS,IFR Biosci Lyon Gerland 128, 46 Allee Italie, F-69364 Lyon 07, France.	thierry.gaude@ens-lyon.fr	JAILLAIS, Yvon/U-3223-2018	JAILLAIS, Yvon/0000-0003-4923-883X; GAUDE, Thierry/0000-0002-0804-9445				Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Brandizzi F, 2002, PLANT CELL, V14, P1293, DOI 10.1105/tpc.001586; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	27	273	285	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					106	109		10.1038/nature05046	http://dx.doi.org/10.1038/nature05046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16936718				2022-12-01	WOS:000240313900049
J	Russell, RJ; Haire, LF; Stevens, DJ; Collins, PJ; Lin, YP; Blackburn, GM; Hay, AJ; Gamblin, SJ; Skehel, JJ				Russell, Rupert J.; Haire, Lesley F.; Stevens, David J.; Collins, Patrick J.; Lin, Yi Pu; Blackburn, G. Michael; Hay, Alan J.; Gamblin, Steven J.; Skehel, John J.			The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design	NATURE			English	Article							OSELTAMIVIR CARBOXYLATE; 3-DIMENSIONAL STRUCTURE; VIRUS NEURAMINIDASE; INHIBITORS; SENSITIVITY; POTENT; RESISTANCE; COMPLEX	The worldwide spread of H5N1 avian influenza has raised concerns that this virus might acquire the ability to pass readily among humans and cause a pandemic. Two anti-influenza drugs currently being used to treat infected patients are oseltamivir (Tamiflu) and zanamivir (Relenza), both of which target the neuraminidase enzyme of the virus. Reports of the emergence of drug resistance make the development of new anti-influenza molecules a priority. Neuraminidases from influenza type A viruses form two genetically distinct groups: group-1 contains the N1 neuraminidase of the H5N1 avian virus and group-2 contains the N2 and N9 enzymes used for the structure-based design of current drugs. Here we show by X-ray crystallography that these two groups are structurally distinct. Group-1 neuraminidases contain a cavity adjacent to their active sites that closes on ligand binding. Our analysis suggests that it may be possible to exploit the size and location of the group-1 cavity to develop new anti-influenza drugs.	MRC, Natl Inst Med Res, London NW7 1AA, England; Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England	MRC National Institute for Medical Research; University of Sheffield	Skehel, JJ (corresponding author), MRC, Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	mbrenna@nimr.mrc.ac.uk		Gamblin, Steve/0000-0001-5331-639X	MRC [MC_U117512711, MC_U117512708, MC_U117584222] Funding Source: UKRI; Medical Research Council [MC_U117584222, MC_U117512711, MC_U117512708] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		[Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER AT, 1987, PROTEINS, V2, P111, DOI 10.1002/prot.340020205; Bender C, 1999, VIROLOGY, V254, P115, DOI 10.1006/viro.1998.9529; BOSSARTWHITAKER P, 1993, J MOL BIOL, V232, P1069, DOI 10.1006/jmbi.1993.1461; Brouillette WJ, 2003, BIOORGAN MED CHEM, V11, P2739, DOI 10.1016/S0968-0896(03)00271-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Ives J, 2000, J CLIN VIROL, V18, P251; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; MEINDL P, 1974, VIROLOGY, V58, P457, DOI 10.1016/0042-6822(74)90080-4; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Murphy B.R, 1996, FIELDS VIROLOGY, P1397; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005	34	627	708	4	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					45	49		10.1038/nature05114	http://dx.doi.org/10.1038/nature05114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16915235				2022-12-01	WOS:000240313900035
J	Popesco, MC; MacLaren, EJ; Hopkins, J; Dumas, L; Cox, M; Meltesen, L; McGavran, L; Wyckoff, GJ; Sikela, JM				Popesco, Magdalena C.; MacLaren, Erik J.; Hopkins, Janet; Dumas, Laura; Cox, Michael; Meltesen, Lynne; McGavran, Loris; Wyckoff, Gerald J.; Sikela, James M.			Human lineage-specific amplification, selection, and neuronal expression of DUF1220 domains	SCIENCE			English	Article							PROTEIN; IDENTIFICATION; DUPLICATION; GENOME; PFAM	Extreme gene duplication is a major source of evolutionary novelty. A genome-wide survey of gene copy number variation among human and great ape lineages revealed that the most striking human lineage-specific amplification was due to an unknown gene, MGC8902, which is predicted to encode multiple copies of a protein domain of unknown function (DUF1220). Sequences encoding these domains are virtually all primate-specific, show signs of positive selection, and are increasingly amplified generally as a function of a species' evolutionary proximity to humans, where the greatest number of copies (212) is found. DUF1220 domains are highly expressed in brain regions associated with higher cognitive function, and in brain show neuron-specific expression preferentially in cell bodies and dendrites.	Univ Colorado Denver, Human Med Genet Program, Aurora, CO 80045 USA; Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA; Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA; Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Missouri System; University of Missouri Kansas City	Sikela, JM (corresponding author), Univ Colorado Denver, Human Med Genet Program, Aurora, CO 80045 USA.	james.sikela@uchsc.edu		Wyckoff, Gerald/0000-0003-2604-2666	NIAAA NIH HHS [AA11853] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011853] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		*BAYL COLL MED HUM, RHES MONK GEN PROJ; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Goidts V, 2006, HUM GENET, V119, P185, DOI 10.1007/s00439-005-0130-9; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Horvath JE, 2005, GENOME RES, V15, P914, DOI 10.1101/gr.3916405; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Ohno S, 1970, EVOLUTION GENE GENOM; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; SWOFFORD DL, 1998, PAUP VERSION 4; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006	20	141	146	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1304	1307		10.1126/science.1127980	http://dx.doi.org/10.1126/science.1127980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946073				2022-12-01	WOS:000240313500046
J	Rosato, M; Mwansambo, CW; Kazembe, PN; Phiri, T; Soko, QS; Lewycka, S; Kunyenge, BE; Vergnano, S; Osrin, D; Newell, ML; Costello, AMD				Rosato, Mikey; Mwansambo, Charles W.; Kazembe, Peter N.; Phiri, Tambosi; Soko, Queen S.; Lewycka, Sonia; Kunyenge, Beata E.; Vergnano, Stefania; Osrin, David; Newell, Marie-Louise; Costello, Anthony M. de L.			Women's groups' perceptions of maternal health issues in rural Malawi	LANCET			English	Article							NEONATAL-MORTALITY; CARE; INTERVENTIONS; DISTRICT; CONTEXT; TRIAL	Background Improvements in preventive and care-seeking behaviours to reduce maternal mortality in rural Africa depend on the knowledge and attitudes of women and communities. Surveys have indicated a poor awareness of maternal health problems by individual women. We report the perceptions of women's groups to such issues in the rural Mchinji district of Malawi. Methods Participatory women's groups in the Mchinji district identified maternal health problems (172 groups, 3171 women) and prioritised problems they considered most important (171 groups, 2833 women). In-depth qualitative data was obtained through six focus-group discussions with the women's groups, three with women's group facilitators, and four interviews with facilitator supervisors. Findings The maternal health problems most commonly identified by more than half the groups were anaemia (87%), malaria (80%), retained placenta (77%), obstructed labour (76%), malpresentation (71%), antepartum and postpartum haemorrhage (70% each), and pre-eclampsia (56%). The five problems prioritised as most important were anaemia (sum of rank score 304), malpresentation (295), retained placenta (277), obstructed labour (276). and postpartum haemorrhage (275). HIV/AIDS and sepsis were identified or prioritised much less because complexity and contextual factors hindered their consideration. Interpretation Rural Malawian women meeting in participatory groups showed a developed awareness of maternal health problems and the concern and motivation to address them. Community mobilisation strategies, such as women's groups, might be effective at reducing maternal mortality because they can draw on the collective capacity in communities to solve problems and make women's voices heard by decision-makers.	MaiMwana Project, Mchinji, Malawi; UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London WC1E 6BT, England; Kamuzu Cent Hosp, Dept Paediat, Lilongwe, Malawi; Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkbele, South Africa	University of London; University College London; University of Kwazulu Natal	Rosato, M (corresponding author), MaiMwana Project, Box 2, Mchinji, Malawi.	m.rosato@ich.ucl.ac.uk	Newell, Marie-Louise/AAE-8222-2019; Vergnano, Stefi/AAR-3647-2020; Lewycka, Sonia/G-4698-2012; Lewycka, Sonia/J-1234-2019	Newell, Marie-Louise/0000-0002-1074-7699; Lewycka, Sonia/0000-0002-5923-9468; Osrin, David/0000-0001-9691-9684				ABOUZAHR C, 2003, MATERNAL MORTALITY 2; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; CHISALE CB, 2002, GOSPEL SEED CULTURE; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; ERICKSON N, 1995, WHAT HLTH CARE LIT R; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Freda M C, 1991, J Obstet Gynecol Neonatal Nurs, V20, P140, DOI 10.1111/j.1552-6909.1991.tb01686.x; Hasan I J, 2002, J Pak Med Assoc, V52, P148; Heggenhougen H. K., 2003, BEHAV SOCIAL ASPECTS; Helitzer-Allen DL, 1993, RES SOCIOL HLTH CARE, V10, P269; HOWARDGRABMAN L, 2002, WARMI PROJECT PARTIC; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kumbani L, 2002, Curationis, V25, P43; LEMA VM, 2005, E AFR MED J, V82, P1; Lofland J., 2006, ANAL SOCIAL SETTINGS; MACCORMACK C, 1992, SOC SCI MED, V35, P831, DOI 10.1016/0277-9536(92)90083-3; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McCoy D., 2004, REPORT COMMISSIONED; Morrison Joanna, 2005, BMC Pregnancy Childbirth, V5, P6, DOI 10.1186/1471-2393-5-6; Mubyazi G, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-31; MWANSAMBO CW, 2006, REPR HLTH C AS MOTH; National Statistical Office Malawi and ORC Macro, 2005, MAL DEM HLTH SURV 20; Soltani M S, 1999, Sante Publique, V11, P203; Tadesse E, 2004, Cent Afr J Med, V50, P29; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Van Breugel J. W. M., 2001, KACHERE MONOGRAPH, V13; Waltensperger K., 2001, CULTURAL BELIEFS SOC; WONG GC, 1995, SOC SCI MED, V41, P1147, DOI 10.1016/0277-9536(94)00430-2	29	54	55	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1180	1188		10.1016/S0140-6736(06)69475-0	http://dx.doi.org/10.1016/S0140-6736(06)69475-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089XU	17011945				2022-12-01	WOS:000240916000030
J	Freitas, R; Zhang, GJ; Cohn, MJ				Freitas, Renata; Zhang, GuangJun; Cohn, Martin J.			Evidence that mechanisms of fin development evolved in the midline of early vertebrates	NATURE			English	Article							HOX GENE-EXPRESSION; TRUNK NEURAL CREST; PETROMYZON-MARINUS; ZEBRAFISH; ORIGIN; LAMPREY; EMBRYOS; REGENERATION; ORGANIZATION; MESENCHYME	The origin of paired appendages was a major evolutionary innovation for vertebrates, marking the first step towards fin( and later limb-) driven locomotion. The earliest vertebrate fossils lack paired fins but have well-developed median fins(1,2), suggesting that the mechanisms of fin development were assembled first in the midline. Here we show that shark median fin development involves the same genetic programs that operate in paired appendages. Using molecular markers for different cell types, we show that median fins arise predominantly from somitic ( paraxial) mesoderm, whereas paired appendages develop from lateral plate mesoderm. Expression of Hoxd and Tbx18 genes, which specify paired limb positions(3,4), also delineates the positions of median fins. Proximodistal development of median fins occurs beneath an apical ectodermal ridge, the structure that controls outgrowth of paired appendages(5-7). Each median fin bud then acquires an anteroposteriorly-nested pattern of Hoxd expression similar to that which establishes skeletal polarity in limbs(8,9). Thus, despite their different embryonic origins, paired and median fins utilize a common suite of developmental mechanisms. We extended our analysis to lampreys, which diverged from the lineage leading to gnathostomes before the origin of paired appendages(2,10), and show that their median fins also develop from somites and express orthologous Hox and Tbx genes. Together these results suggest that the molecular mechanisms for fin development originated in somitic mesoderm of early vertebrates, and that the origin of paired appendages was associated with re-deployment of these mechanisms to lateral plate mesoderm.	Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cohn, MJ (corresponding author), Univ Florida, Dept Zool, POB 118525, Gainesville, FL 32611 USA.	cohn@zoo.ufl.edu	Freitas, Renata/I-5917-2013; Zhang, GuangJun/K-2056-2012	Freitas, Renata/0000-0002-0123-7232; Zhang, GuangJun/0000-0002-0839-5161				AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; ATCHINI B, 2006, DEV CELL, V10, P93; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; COATES MI, 1994, DEVELOPMENT, P169; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Donoghue PCJ, 2000, BIOL REV, V75, P191, DOI 10.1017/S0006323199005472; Force A, 2002, J EXP ZOOL, V294, P30, DOI 10.1002/jez.10091; Freitas R, 2004, DEV GENES EVOL, V214, P466, DOI 10.1007/s00427-004-0426-0; Furukawa S, 1999, NUTRITION, V15, P29; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Grandel H, 2000, DEVELOPMENT, V127, P4169; Hirata M, 1997, ZOOL SCI, V14, P305, DOI 10.2108/zsj.14.305; Lacosta AM, 2005, PIGM CELL RES, V18, P243, DOI 10.1111/j.1600-0749.2005.00238.x; Mabee PM, 2002, J EXP ZOOL, V294, P77, DOI 10.1002/JEZ.10076; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Rhodes LSS, 2006, GENE EXPR PATTERNS, V6, P539, DOI 10.1016/j.modgep.2005.10.006; Richardson MK, 2003, J MORPHOL, V257, P348, DOI 10.1002/jmor.10119; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SMITH M, 1994, P ROY SOC B-BIOL SCI, V256, P137, DOI 10.1098/rspb.1994.0061; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tanaka M, 2004, DEV BIOL, V268, P470, DOI 10.1016/j.ydbio.2003.12.036; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tucker AS, 2004, DEV DYNAM, V230, P461, DOI 10.1002/dvdy.20071; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhang XG, 2004, J EVOLUTION BIOL, V17, P1162, DOI 10.1111/j.1420-9101.2004.00741.x	30	148	157	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1033	1037		10.1038/nature04984	http://dx.doi.org/10.1038/nature04984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16878142				2022-12-01	WOS:000240142000048
J	Molinier, J; Ries, G; Zipfel, C; Hohn, B				Molinier, Jean; Ries, Gerhard; Zipfel, Cyril; Hohn, Barbara			Transgeneration memory of stress in plants	NATURE			English	Article							INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; GENOME; ARABIDOPSIS; FREQUENCY; MUTATIONS; MAIZE	Owing to their sessile nature, plants are constantly exposed to a multitude of environmental stresses to which they react with a battery of responses. The result is plant tolerance to conditions such as excessive or inadequate light, water, salt and temperature, and resistance to pathogens. Not only is plant physiology known to change under abiotic or biotic stress, but changes in the genome have also been identified(1-5). However, it was not determined whether plants from successive generations of the original, stressed plants inherited the capacity for genomic change. Here we show that in Arabidopsis thaliana plants treated with short-wavelength radiation (ultraviolet-C) or flagellin ( an elicitor of plant defences(6)), somatic homologous recombination of a transgenic reporter is increased in the treated population and these increased levels of homologous recombination persist in the subsequent, untreated generations. The epigenetic trait of enhanced homologous recombination could be transmitted through both the maternal and the paternal crossing partner, and proved to be dominant. The increase of the hyper-recombination state in generations subsequent to the treated generation was independent of the presence of the transgenic allele ( the recombination substrate under consideration) in the treated plant. We conclude that environmental factors lead to increased genomic flexibility even in successive, untreated generations, and may increase the potential for adaptation.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Hohn, B (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	barbara.hohn@fmi.ch	ZIPFEL, CYRIL B/D-7103-2011; ZIPFEL, CYRIL/ABD-5076-2021	ZIPFEL, CYRIL B/0000-0003-4935-8583; ZIPFEL, CYRIL/0000-0003-4935-8583				Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Cullis CA, 2005, ANN BOT-LONDON, V95, P201, DOI 10.1093/aob/mci013; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gherbi H, 2001, EMBO REP, V2, P287, DOI 10.1093/embo-reports/kve069; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; JABLONKA ELM, 1995, EPIGENETIC INHERITAN; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jefferson RA., 1987, PLANT MOL BIOL REP, V5, P387, DOI DOI 10.1007/BF02667740; Jorgensen RA, 2004, COLD SPRING HARB SYM, V69, P349, DOI 10.1101/sqb.2004.69.349; Klumpp A, 2004, HEREDITAS, V141, P142, DOI 10.1111/j.1601-5223.2004.01806.x; Kovalchuk I, 2000, EMBO J, V19, P4431, DOI 10.1093/emboj/19.17.4431; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; LEBEL EG, 1993, P NATL ACAD SCI USA, V90, P422, DOI 10.1073/pnas.90.2.422; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Molinier J, 2004, PLANT CELL, V16, P342, DOI 10.1105/tpc.019042; MOTTINGER JP, 1984, MOL GEN GENET, V195, P367, DOI 10.1007/BF00332775; PUCHTA H, 1995, PLANT J, V7, P203, DOI 10.1046/j.1365-313X.1995.7020203.x; PUCHTA H, 1995, PLANT MOL BIOL, V28, P281, DOI 10.1007/BF00020247; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Schuermann D, 2005, TRENDS GENET, V21, P172, DOI 10.1016/j.tig.2005.01.002; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Walbot V, 1996, TRENDS PLANT SCI, V1, P27, DOI 10.1016/S1360-1385(96)80020-3; WALBOT V, 1992, MOL GEN GENET, V234, P353, DOI 10.1007/BF00538694; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	26	454	491	3	255	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1046	1049		10.1038/nature05022	http://dx.doi.org/10.1038/nature05022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16892047				2022-12-01	WOS:000240142000051
J	Schumacher, MA; Karamooz, E; Zikova, A; Trantirek, L; Lukes, J				Schumacher, Maria A.; Karamooz, Ellharn; Zikova, Alena; Trantirek, Lukas; Lukes, Julius			Crystal structures of T-brucei MRP1/MRP2 guide-RNA binding complex reveal RNA matchmaking mechanism	CELL			English	Article							KINETOPLASTID MITOCHONDRIA; MESSENGER-RNA; CYTOCHROME-B; IN-VITRO; PROTEIN; LEISHMANIA; TRANSCRIPT; GRNA; INTERFERENCE; RECOGNITION	The mitochondrial RNA binding proteins MRP1 and MRP2 form a heteromeric complex that functions in kinetoplastid RNA editing. In this process, MRPl/MRP2 serves as a matchmaker by binding to guide RNAs and facilitating their hybridization with cognate preedited rnRNAs. To understand the mechanism by which this complex performs RNA matchmaking, we determined structures of Trypanosoma brucei apoMRPl/MRP2 and an MRPl/MRP2-gRNA complex. The structures show that MRP1/ MRP2 is a heterotetramer and, despite little sequence homology, each MRP subunit exhibits the same "Whirly" transcription-factor fold. The gRNA molecule binds to the highly basic beta sheet surface of the MRP complex via nonspecific, electrostatic contacts. Strikingly, while the gRNA stem/loop II base is anchored to the basic surface, stem/loop I (the anchor sequence) is unfolded and its bases exposed to solvent. Thus, MRPl/MRP2 acts as an RNA matchmaker by stabilizing the RNA molecule in an unfolded conformation suitable for RNARNA hybridization.	Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Czech Acad Sci, Inst Parasitol, Ctr Biol, Ceske Budejovice 37005, Budweis, Czech Republic; Univ S Bohemia, Fac Biol, Ceske Budejovice 37005, Budweis, Czech Republic; Univ Illinois, Coll Med, Urbana, IL 61801 USA; Seattle Biomed Res Inst, Seattle, WA 98103 USA	University of Texas System; UTMD Anderson Cancer Center; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Illinois System; University of Illinois Urbana-Champaign; Center for Infectious Disease Research	Schumacher, MA (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA.	maschuma@mdanderson.org	Lukes, Julius/H-6760-2012; Trantirek, Lukas/F-9923-2014; Zikova, Alena/G-7855-2014	Lukes, Julius/0000-0002-0578-6618; Zikova, Alena/0000-0002-8686-0225; Karamooz, Elham/0000-0002-7185-5490	FIC NIH HHS [5R03TW6445] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW006445] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; BAEYENS KJ, 1995, NAT STRUCT BIOL, V2, P56, DOI 10.1038/nsb0195-56; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Blom D, 2001, NUCLEIC ACIDS RES, V29, P2950, DOI 10.1093/nar/29.14.2950; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen XG, 2004, J MOL MED, V82, P232, DOI 10.1007/s00109-004-0529-0; CORELL RA, 1993, NUCLEIC ACIDS RES, V21, P4313, DOI 10.1093/nar/21.18.4313; Corell RA, 1996, MOL CELL BIOL, V16, P1410; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Desveaux D, 2002, NAT STRUCT BIOL, V9, P512, DOI 10.1038/nsb814; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Hoffmann KM, 2005, J BACTERIOL, V187, P5008, DOI 10.1128/JB.187.14.5008-5012.2005; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hong M, 2003, PROTIST, V154, P265, DOI 10.1078/143446103322166554; Horvath A, 2000, SCIENCE, V287, P1639, DOI 10.1126/science.287.5458.1639; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; Krause K, 2005, FEBS LETT, V579, P3707, DOI 10.1016/j.febslet.2005.05.059; Lambert L, 1999, NUCLEIC ACIDS RES, V27, P1429, DOI 10.1093/nar/27.6.1429; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu YN, 2005, J BIOL CHEM, V280, P35513, DOI 10.1074/jbc.M507296200; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Madison-Antenucci S, 2002, CELL, V108, P435, DOI 10.1016/S0092-8674(02)00653-0; MASLOV DA, 1992, CELL, V70, P459, DOI 10.1016/0092-8674(92)90170-H; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; Muller UF, 2001, EMBO J, V20, P1394, DOI 10.1093/emboj/20.6.1394; Nagai K, 1996, CURR OPIN STRUC BIOL, V6, P53, DOI 10.1016/S0959-440X(96)80095-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; SCHMID B, 1995, NUCLEIC ACIDS RES, V23, P3093, DOI 10.1093/nar/23.16.3093; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; SIMPSON AGB, 2006, IN PRESS TRENDS PARA; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; STURM NR, 1990, CELL, V61, P879, DOI 10.1016/0092-8674(90)90198-N; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200	50	96	102	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2006	126	4					701	711		10.1016/j.cell.2006.06.047	http://dx.doi.org/10.1016/j.cell.2006.06.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923390	Bronze			2022-12-01	WOS:000240276700019
J	Whibley, AC; Langlade, NB; Andalo, C; Hanna, AI; Bangham, A; Thebaud, C; Coen, E				Whibley, Annabel C.; Langlade, Nicolas B.; Andalo, Christophe; Hanna, Andrew I.; Bangham, Andrew; Thebaud, Christophe; Coen, Enrico			Evolutionary paths underlying flower color variation in Antirrhinum	SCIENCE			English	Article							MONKEYFLOWERS; APPEARANCE; GENES	To understand evolutionary paths connecting diverse biological forms, we defined a three-dimensional genotypic space separating two flower color morphs of Antirrhinum. A hybrid zone between morphs showed a steep cline specifically at genes controlling flower color differences, indicating that these loci are under selection. Antirrhinum species with diverse floral phenotypes formed a U-shaped cloud within the genotypic space. We propose that this cloud defines an evolutionary path that allows flower color to evolve while circumventing less-adaptive regions. Hybridization between morphs located in different arms of the U-shaped path yields low-fitness genotypes, accounting for the observed steep clines at hybrid zones.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse 9, France; Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of East Anglia	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk	Whibley, Annabel/G-2836-2011; Langlade, Nicolas/C-6191-2008; Thébaud, Christophe/N-3916-2016; Whibley, Annabel/P-2509-2017	Langlade, Nicolas/0000-0002-5651-1446; Thébaud, Christophe/0000-0002-8586-1234; Whibley, Annabel/0000-0003-1878-7705				BARTON N, 1986, HEREDITY, V57, P357, DOI 10.1038/hdy.1986.135; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BAUR E, 1924, BIBLIOTHECA GENET, V4, P1; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Chittka L, 2001, COGNITIVE ECOLOGY PO, V108, P287; COEN ES, 1986, CELL, V47, P285, DOI 10.1016/0092-8674(86)90451-4; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Gubitz T, 2003, MOL BIOL EVOL, V20, P1537, DOI 10.1093/molbev/msg166; Hackbarth J., 1942, ZEIT SCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P1, DOI 10.1007/BF01741978; Horgan GW, 2001, COMPUT ELECTRON AGR, V31, P169, DOI 10.1016/S0168-1699(00)00190-3; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; Mateu-Andres I, 2003, ANN BOT-LONDON, V92, P647, DOI 10.1093/aob/mcg184; MOORE WS, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P196; Rothmaler W., 1956, TAXONOMISCHE MONOGRA; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schwarz-Sommer Z, 2003, NAT REV GENET, V4, P657, DOI 10.1038/nrg1127; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; STUBBE H, 1966, GENETIK ZYTOLOGIE AN; Sutton D. A., 1988, REVISION TRIBE ANTIR; Vargas P, 2004, PLANT SYST EVOL, V249, P151, DOI 10.1007/s00606-004-0216-1; Webb DA, 1972, FLORA EUROPAEA, V3; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	25	127	131	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2006	313	5789					963	966		10.1126/science.1129161	http://dx.doi.org/10.1126/science.1129161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16917061				2022-12-01	WOS:000239817000042
J	Shlyk-Kerner, O; Samish, I; Kaftan, D; Holland, N; Sai, PSM; Kless, H; Scherz, A				Shlyk-Kerner, Oksana; Samish, Ilan; Kaftan, David; Holland, Neta; Sai, P. S. Maruthi; Kless, Hadar; Scherz, Avigdor			Protein flexibility acclimatizes photosynthetic energy conversion to the ambient temperature	NATURE			English	Article							HELICAL MEMBRANE-PROTEINS; THERMOPHILIC ALCOHOL-DEHYDROGENASE; OXYGEN-EVOLVING CENTER; ELECTRON-TRANSFER; REACTION CENTERS; PHOTOSYSTEM-II; RHODOBACTER-SPHAEROIDES; PROTON; FLUORESCENCE; ARCHITECTURE	Adjustment of catalytic activity in response to diverse ambient temperatures is fundamental to life on Earth. A crucial example of this is photosynthesis, where solar energy is converted into electrochemical potential that drives oxygen and biomass generation at temperatures ranging from those of frigid Antarctica to those of scalding hot springs. The energy conversion proceeds by concerted mobilization of electrons and protons on photoexcitation of reaction centre protein complexes(1-3). Following physicochemical paradigms, the rates of imperative steps in this process were predicted to increase exponentially with rising temperatures, resulting in different yields of solar energy conversion at the distinct growth temperatures of photosynthetic mesophiles and extremophiles. In contrast, here we show a meticulous adjustment of energy conversion rate, resulting in similar yields from mesophiles and thermophiles. The key molecular players in the temperature adjustment process consist of a cluster of hitherto unrecognized protein cavities and an adjacent packing motif that jointly impart local flexibility crucial to the reaction centre proteins. Mutations within the packing motif of mesophiles that increase the bulkiness of the amino-acid side chains, and thus reduce the size of the cavities, promote thermophilic behaviour. This novel biomechanical mechanism accounts for the slowing of the catalytic reaction above physiological temperatures in contradiction to the classical Arrhenius paradigm. The mechanism provides new guidelines for manipulating the acclimatization of enzymes to the ambient temperatures of diverse habitats. More generally, it reveals novel protein elements that are of potential significance for modulating structure - activity relationships in membrane and globular proteins alike.	Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Scherz, A (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	Avigdor.Scherz@weizmann.ac.il	samish, ilan/B-7980-2016; Kaftan, David/N-6799-2019; Kaftan, David/J-5790-2017	samish, ilan/0000-0002-0299-9124; Kaftan, David/0000-0003-0932-0986				Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; DEISENHOFER J, 1995, J MOL BIOL, V246, P429, DOI 10.1006/jmbi.1994.0097; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Friedman R, 2003, BIOPHYS J, V85, P886, DOI 10.1016/S0006-3495(03)74528-7; Garbers A, 1998, BIOCHEMISTRY-US, V37, P11399, DOI 10.1021/bi980296+; GOLDBERG E, 2004, THESIS WEIZMANN I SC; Hammes-Schiffer S, 2004, BBA-BIOENERGETICS, V1655, P29, DOI 10.1016/j.bbabio.2003.07.009; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Joshi M, 1999, Z NATURFORSCH C, V54, P35; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kohen A, 1998, ACCOUNTS CHEM RES, V31, P397, DOI 10.1021/ar9701225; Li JL, 1998, BIOCHEMISTRY-US, V37, P2818, DOI 10.1021/bi971699x; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.0.CO;2-H; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Moser CC, 2003, ADV PROTEIN CHEM, V63, P71; Nedbal L, 1999, J PHOTOCH PHOTOBIO B, V48, P154, DOI 10.1016/S1011-1344(99)00032-9; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Remy A, 2003, NAT STRUCT BIOL, V10, P637, DOI 10.1038/nsb954; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Somero GN, 2003, COMP BIOCHEM PHYS B, V136, P577, DOI 10.1016/S1096-4959(03)00215-X; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wraight CA, 2004, FRONT BIOSCI-LANDMRK, V9, P309, DOI 10.2741/1236; Xu Q, 2002, BIOCHEMISTRY-US, V41, P2694, DOI 10.1021/bi011834c; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	30	39	40	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					827	830		10.1038/nature04947	http://dx.doi.org/10.1038/nature04947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862124				2022-12-01	WOS:000239792700049
J	MacDonald, R; Das, A				MacDonald, Rhona; Das, Aditi			UK classification of drugs of abuse: an un-evidence-based mess	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England; Univ Manchester, Sch Med, Manchester, Lancs, England	University of Manchester	MacDonald, R (corresponding author), The Lancet, London NW1 7BY, England.							House of Commons Science and Technology Committee, 2006, 5 HOUS COMM SCI TECH; *UN OFF DRUGS CRIM, 2006, UN DRUGS CHIEF SOUND; 2006, RETHINK CANNABIS ED	3	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2006	368	9535					559	561		10.1016/S0140-6736(06)69175-7	http://dx.doi.org/10.1016/S0140-6736(06)69175-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074OF	16905003				2022-12-01	WOS:000239821000007
J	Verhamme, KMC; Mosis, G; Dieleman, JP; Stricker, BHC; Sturkenboom, MCJM				Verhamme, Katia M. C.; Mosis, Georgio; Dieleman, Jeanne P.; Stricker, Bruno H. Ch; Sturkenboom, Miriam C. J. M.			Spironolactone and risk of upper gastrointestinal events: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ULCERATION	Objective To confirm and quantify any association between spironolactone and upper gastrointestinal bleeding and ulcers. Design Population based case-control study. Setting A primary care information database in the Netherlands. Participants All people on the database who were aged 18 or more between 1 January 1996 and 30 September 2003. Patients with a history of alcoholism or gastrointestinal cancer were excluded. Ten controls were matched to each case of gastroduodenal ulcer or upper gastrointestinal bleeding by age (year of birth), sex, and index date. Main outcome measures The occurrence of an upper gastrointestinal event (bleeding or ulcers) adjusted for potential confounders with conditional logistic regression analysis. Results Within the source population of 306 645 patients, 523 cases of gastric or duodenal ulcer or upper gastrointestinal bleeding were identified and matched to 5230 controls. Current use of spironolactone was associated with a 2.7-fold (95% confidence interval 1.2 to 6.0) increased risk of a gastrointestinal event. Conclusion The risk of gastroduodenal ulcers or upper gastrointestinal bleeding is significantly increased in patients using spironolactone.	Erasmus MC, Dept Med Informat, NL-3000 Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Verhamme, KMC (corresponding author), Erasmus MC, Dept Med Informat, POB 1738, NL-3000 Rotterdam, Netherlands.	k.verhamme@erasmusmc.nl	Chin, Shui Hao/V-9070-2019	Chin, Shui Hao/0000-0001-5620-0798; Verhamme, Katia/0000-0001-8162-4904				DOLL R, 1968, GUT, V9, P42, DOI 10.1136/gut.9.1.42; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kato K, 1999, J CLIN ENDOCR METAB, V84, P2568, DOI 10.1210/jc.84.7.2568; KREMER D, 1973, BMJ-BRIT MED J, V2, P216, DOI 10.1136/bmj.2.5860.216; Lijnen P, 2000, J MOL CELL CARDIOL, V32, P865, DOI 10.1006/jmcc.2000.1129; MACKAY A, 1977, LANCET, V1, P481; REED PI, 1980, SCAND J GASTROENTERO, V15, P51; Slight SH, 1998, MOL CELL BIOCHEM, V189, P47, DOI 10.1023/A:1006844010371; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27	9	29	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2006	333	7563					330	333		10.1136/bmj.38883.479549.2F	http://dx.doi.org/10.1136/bmj.38883.479549.2F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073VI	16840442	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000239770300016
J	Razzaghi, E; Nassirimanesh, B; Afshar, P; Ohiri, K; Claeson, M; Power, R				Razzaghi, Emran; Nassirimanesh, Bijan; Afshar, Parviz; Ohiri, Kelechi; Claeson, Mariam; Power, Robert			HIV/AIDS harm reduction in Iran	LANCET			English	Editorial Material									World Bank, Washington, DC 20433 USA; Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Tehran, Iran; Persepolis NGO, Tehran, Iran; Iran Prison Org, Tehran, Iran; Burnet Inst, Melbourne, Vic, Australia	The World Bank; Tehran University of Medical Sciences; Burnet Institute	Claeson, M (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	mclaeson@worldbank.org						Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; NASSIRIMANESH B, 2005, RISE HARM REDUCT ISL; OHIRI K, 2006, PREVENTING HIV AIDS; Razzaghi EM, 2000, RAPID ASSESSMENT DRU; RAZZAGHI EM, 2005, INJECTION DRUG USE T; Razzaghi Emran M, 2006, Harm Reduct J, V3, P12; VAZIRIAN M, 2002, HARM REDUCT J, V2, P19; WHO Regional Office for the Eastern Mediterranean, 2004, BEST PRACT HIV AIDS; 2005, MONITORING AIDS PAND	9	62	62	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2006	368	9534					434	435		10.1016/S0140-6736(06)69132-0	http://dx.doi.org/10.1016/S0140-6736(06)69132-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890814				2022-12-01	WOS:000239569000009
J	Hall, IP; Blakey, JD; Al Balushi, KA; Wheatley, A; Sayers, I; Pembrey, ME; Ring, SM; McArdle, WL; Strachan, DP				Hall, Ian P.; Blakey, John D.; Al Balushi, Khalid A.; Wheatley, Amanda; Sayers, Ian; Pembrey, Marcus E.; Ring, Susan M.; McArdle, Wnedy L.; Strachan, David P.			beta 2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study	LANCET			English	Article							BETA(2)-ADRENERGIC RECEPTOR POLYMORPHISMS; WHEEZING ILLNESS; LUNG-FUNCTION; GENOTYPES; DISEQUILIBRIUM; METAANALYSIS; FREQUENCIES; CHILDREN; ATOPY; IGE	Background Functionally relevant polymorphisms of the beta 2-adrenoceptor gene (ADRB2) are common in white populations, but their contribution to the burden of airways disease in the population is uncertain. We aimed to relate the long-term prevalence of asthma or wheeze to functional coding region polymorphisms in the ADRB2 gene. Methods The British 1958 birth cohort consisted of all people born in Britain during a week in 1958. Asthma, wheezy bronchitis, and wheezing were ascertained by interview at ages 7, 11, 16, 23, 33, and 42 years, and lung function tests at 35 and 45 years. DNA samples from 8018 participants in the 45-year follow-up were genotyped for three coding variants in the ADRB2 gene. We extend the follow-up of this nationwide cohort by a further 10 years and relate asthma prevalence, prognosis, and lung function to functional coding region polymorphisms in the ADRB2 gene in the cohort members who contributed DNA samples. We also compared and combined our findings with those reaching significance in two previous meta-analyses. Findings Half the cohort (4105 of 8018) had some history of wheezing illness by age 42 years. Neither lifetime prevalence nor age at onset were related to ADRB2 coding variants. However, the common polymorphisms Arg16Gly (rs1042713, Arg 16 allele frequency 36.3%) and Gln27Glu (rs1042714, Glu 27 allele frequency 44.6%) were significantly associated with persistence of asthmatic symptoms from childhood to middle age. Among homozygotes for the Arg16-Gln27 haplotype at these loci, 19.3% (41 of 212) childhood wheezers had five or more wheezing episodes in the past year at age 42, compared with 11.9% (71 of 599) with no copy of this haplotype. However, only 3% of all frequent adult wheezing was statistically attributable to this haplotype. The less common Thr164Ile polymorphism (rs1800888, Ile allele frequency 1.5%) was not a major predictor of either frequency or prognosis of asthma. Our data do not support the findings of previous meta-analyses when considered in isolation or when combined with their contributory studies. Interpretation ADRB2 polymorphisms might predict a small component of the long-term prognosis in childhood asthma, but are not important determinants of asthma incidence or prevalence in the British population.	Univ Nottingham, Div Therapeut & Mol Med, Nottingham NG7 2RD, England; Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England; Univ London, St Georges, Div Community Hlth Sci, London WC1E 7HU, England; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England	University of Nottingham; University of Bristol; St Georges University London; University of London; University of London; University College London	Hall, IP (corresponding author), Univ Nottingham Hosp, Div Therapeut & Mol Med, D Floor S Block, Nottingham NG7 2UH, England.	Ian.Hall@nottingham.ac.uk		Henry, Amanda/0000-0001-6299-7676; Sayers, Ian/0000-0001-5601-5410; Hall, Ian/0000-0001-9933-3216	Medical Research Council [G0000934] Funding Source: Medline; Asthma UK [05/055] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON HR, 1992, THORAX, V47, P537, DOI 10.1136/thx.47.7.537; Binaei S, 2003, CHEST, V123, p375S, DOI 10.1016/S0012-3692(15)35221-1; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; Dewar JC, 1997, J ALLERGY CLIN IMMUN, V100, P261, DOI 10.1016/S0091-6749(97)70234-3; Dewar JC, 1998, CLIN EXP ALLERGY, V28, P442; Gao Guangkai, 2000, Zhonghua Jiehe He Huxi Zazhi, V23, P93; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Hakonarson H, 2001, AM J RESP CRIT CARE, V164, P2036, DOI 10.1164/ajrccm.164.11.2101086; HIGGINS JPT, 2005, COCHRANE LIB; Holloway JW, 2000, CLIN EXP ALLERGY, V30, P1097; Hopes E, 1998, BRIT MED J, V316, P664, DOI 10.1136/bmj.316.7132.664; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Johnston IDA, 1998, NEW ENGL J MED, V338, P581, DOI 10.1056/NEJM199802263380904; Leung TF, 2002, PEDIATR PULM, V34, P419, DOI 10.1002/ppul.10210; Lin YC, 2003, J ASTHMA, V40, P265, DOI 10.1081/JAS-120018323; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; Migita O, 2004, INT ARCH ALLERGY IMM, V134, P150, DOI 10.1159/000078648; Nolte H, 1997, ANN ALLERG ASTHMA IM, V79, P27, DOI 10.1016/S1081-1206(10)63080-3; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Santillan AA, 2003, J ALLERGY CLIN IMMUN, V112, P1095, DOI 10.1016/j.jaci.2003.09.029; Sato R, 2000, Hokkaido Igaku Zasshi, V75, P81; Shachor J, 2003, ISRAEL MED ASSOC J, V5, P821; Strachan DP, 1996, BRIT MED J, V312, P1195; Strachan DP, 1996, AM J RESP CRIT CARE, V154, P1629, DOI 10.1164/ajrccm.154.6.8970346; Tattersfield AE, 2004, LANCET, V364, P1464, DOI 10.1016/S0140-6736(04)17286-3; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Turner SW, 2004, CLIN EXP ALLERGY, V34, P1043, DOI 10.1111/j.1365-2222.2004.02001.x; Wang ZX, 2001, AM J RESP CRIT CARE, V163, P1404, DOI 10.1164/ajrccm.163.6.2001101; Weir TD, 1998, AM J RESP CRIT CARE, V158, P787, DOI 10.1164/ajrccm.158.3.9801035	34	87	87	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2006	368	9537					771	779		10.1016/S0140-6736(06)69287-8	http://dx.doi.org/10.1016/S0140-6736(06)69287-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080ID	16935688				2022-12-01	WOS:000240240200029
J	Weisstaub, NV; Zhou, MM; Lira, A; Lambe, E; Gonzalez-Maeso, J; Hornung, JP; Sibille, E; Underwood, M; Itohara, S; Dauer, WT; Ansorge, MS; Morelli, E; Mann, JJ; Toth, M; Aghajanian, G; Sealfon, SC; Hen, R; Gingrich, JA				Weisstaub, Noelia V.; Zhou, Mingming; Lira, Alena; Lambe, Evelyn; Gonzalez-Maeso, Javier; Hornung, Jean-Pierre; Sibille, Etienne; Underwood, Mark; Itohara, Shigeyoshi; Dauer, William T.; Ansorge, Mark S.; Morelli, Emanuela; Mann, J. John; Toth, Miklos; Aghajanian, George; Sealfon, Stuart C.; Hen, Rene; Gingrich, Jay A.			Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice	SCIENCE			English	Article							ELEVATED T-MAZE; SEROTONIN; AMYGDALA; MODELS; TRANSPORTER; ANTAGONISTS; MECHANISMS; DISORDER; ADULT; BRAIN	Serotonin [5-hydroxytryptamine (5-HT)] neurotransmission in the central nervous system modulates depression and anxiety-related behaviors in humans and rodents, but the responsible downstream receptors remain poorly understood. We demonstrate that global disruption of 5-HT2A receptor (5HT2AR) signaling in mice reduces inhibition in conflict anxiety paradigms without affecting fear-conditioned and depression-related behaviors. Selective restoration of 5HT2AR signaling to the cortex normalized conflict anxiety behaviors. These findings indicate a specific role for cortical 5HT2AR function in the modulation of conflict anxiety, consistent with models of cortical, "top-down'' influences on risk assessment.	Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Biol, New York, NY 10032 USA; Columbia Univ, Sackler Inst Labs, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, Lausanne, Switzerland; RIKEN, Lab Behav Genet, Brain Sci Inst, Wako, Saitama 35101, Japan; Cornell Univ, Med Ctr, Dept Pharmacol, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Yale University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Lausanne; RIKEN; Cornell University	Gingrich, JA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	jag46@columbia.edu	Weisstaub, Noelia/ABA-1706-2021; ansorge, mark s/L-1360-2014; Itohara, Shigeyoshi/I-8769-2012; Toth, Miklos/O-3343-2017; Hornung, Jean-Pierre/O-7505-2015; Lambe, Evelyn K/K-3699-2015; Morelli, Emanuela/J-4546-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Hornung, Jean-Pierre/0000-0002-9229-7520; Lambe, Evelyn K/0000-0002-5994-6090; SEALFON, Stuart/0000-0001-5791-1217; Dauer, William/0000-0003-1775-7504; Morelli, Emanuela/0000-0001-8704-9330	NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012923] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA12923] Funding Source: Medline; NIMH NIH HHS [KO8 MH01711] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Artaiz I, 1998, BEHAV PHARMACOL, V9, P103; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; BALLENGER JC, 1979, ARCH GEN PSYCHIAT, V36, P224; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; BJORNTORP P, 1995, METABOLISM, V44, P38, DOI 10.1016/0026-0495(95)90208-2; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; BRIDGES PK, 1976, PSYCHOL MED, V6, P399, DOI 10.1017/S003329170001583X; Cohen H, 2005, DEPRESS ANXIETY, V22, P84, DOI 10.1002/da.20087; GOODWIN FV, 1983, BR J CLIN PHARM, V15, P393; Graeff FG, 2002, PSYCHOPHARMACOLOGY, V163, P467, DOI 10.1007/s00213-002-1112-4; Griebel G, 1997, NEUROPHARMACOLOGY, V36, P793, DOI 10.1016/S0028-3908(97)00034-8; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; HANDLEY SL, 1993, BEHAV BRAIN RES, V58, P203, DOI 10.1016/0166-4328(93)90104-X; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Kent JM, 2005, AM J PSYCHIAT, V162, P1379, DOI 10.1176/appi.ajp.162.7.1379; Luciana M, 2001, J PSYCHOPHARMACOL, V15, P219, DOI 10.1177/026988110101500410; MCFARLAIN RA, 1972, PSYCHOPHARMACOLOGIA, V27, P85, DOI 10.1007/BF00421958; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miyashita T, 2005, NEUROSCIENCE, V136, P487, DOI 10.1016/j.neuroscience.2005.08.025; Mora PO, 1997, PHARMACOL BIOCHEM BE, V58, P1051, DOI 10.1016/S0091-3057(97)00057-9; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SHIBATA S, 1989, PSYCHOPHARMACOLOGY, V98, P38, DOI 10.1007/BF00442003; Soares VD, 2004, BRAIN RES BULL, V64, P181, DOI 10.1016/j.brainresbull.2004.06.007; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Wood MD, 2003, CNS NEUROL DISORD-DR, V2, P383, DOI 10.2174/1568007033482698	31	314	338	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					536	540		10.1126/science.1123432	http://dx.doi.org/10.1126/science.1123432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873667				2022-12-01	WOS:000239308600067
J	Roche, S; Bressanelli, S; Rey, FA; Gaudin, Y				Roche, Stephane; Bressanelli, Stephane; Rey, Felix A.; Gaudin, Yves			Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G	SCIENCE			English	Article							FUSION-INACTIVE CONFORMATION; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; ANGSTROM RESOLUTION; AMINO-ACIDS; PROTEIN; RABIES; MUTATIONS; DOMAIN	The vesicular stomatitis virus has an atypical membrane fusion glycoprotein (G) exhibiting a pH-dependent equilibrium between two forms at the virus surface. Membrane fusion is triggered during the transition from the high- to low-pH form. The structure of G in its low-pH form shows the classic hairpin conformation observed in all other fusion proteins in their postfusion conformation, in spite of a novel fold combining features of fusion proteins from classes I and II. The structure provides a framework for understanding the reversibility of the G conformational change. Unexpectedly, G is homologous to gB of herpesviruses, which raises important questions on viral evolution.	CNRS, UMR 2472, IFR 115, F-91198 Gif Sur Yvette, France; INRA, UMR1157, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE	Gaudin, Y (corresponding author), CNRS, UMR 2472, IFR 115, F-91198 Gif Sur Yvette, France.	gaudin@vms.cnrs-gif.fr	Rey, Felix/B-6497-2012	Bressanelli, Stephane/0000-0002-0921-6727; Gaudin, Yves/0000-0002-0122-2954; Rey, Felix/0000-0002-9953-7988				Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carneiro FA, 2001, J BIOL CHEM, V276, P62, DOI 10.1074/jbc.M008753200; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; CLAGUE MJ, 1990, BIOCHEMISTRY-US, V29, P1303, DOI 10.1021/bi00457a028; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Fredericksen BL, 1996, VIROLOGY, V217, P49, DOI 10.1006/viro.1996.0092; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; Gaudin Y, 1999, J GEN VIROL, V80, P1221, DOI 10.1099/0022-1317-80-5-1221; GAUDIN Y, 1995, J VIROL, V69, P5528, DOI 10.1128/JVI.69.9.5528-5534.1995; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; Gaudin Y, 1996, J VIROL, V70, P7371, DOI 10.1128/JVI.70.11.7371-7378.1996; Gaudin Y, 2000, Subcell Biochem, V34, P379; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Martinez I, 2005, J VIROL, V79, P3578, DOI 10.1128/JVI.79.6.3578-3585.2005; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; VANDEPOL SB, 1986, VIROLOGY, V148, P312, DOI 10.1016/0042-6822(86)90328-4; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WIMLEY WC, 1992, BIOCHEMISTRY-US, V31, P12813, DOI 10.1021/bi00166a015; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yao Y, 2003, VIROLOGY, V310, P319, DOI 10.1016/S0042-6822(03)00146-6; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; ZHANG L, 1994, J VIROL, V68, P2186, DOI 10.1128/JVI.68.4.2186-2193.1994	37	341	357	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					187	191		10.1126/science.1127683	http://dx.doi.org/10.1126/science.1127683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840692				2022-12-01	WOS:000239008000034
J	Isayama, T; Alexeev, D; Makino, CL; Washington, I; Nakanishi, K; Turro, NJ				Isayama, T.; Alexeev, D.; Makino, C. L.; Washington, I.; Nakanishi, K.; Turro, N. J.			An accessory chromophore in red vision	NATURE			English	Article							DRAGON FISH; CHLOROPHYLL		Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Columbia University	Isayama, T (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA.	cmakino@meei.harvard.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; W, I/0000-0002-2238-7918				Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; BOWMAKER JK, 1988, J COMP PHYSIOL A, V163, P685, DOI 10.1007/BF00603853; Douglas RH, 1999, VISION RES, V39, P2817, DOI 10.1016/S0042-6989(98)00332-0; Douglas RH, 1998, NATURE, V393, P423, DOI 10.1038/30871; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; KIRSCHFELD K, 1986, VISION RES, V26, P1771, DOI 10.1016/0042-6989(86)90127-6; Washington I, 2004, J AM CHEM SOC, V126, P9892, DOI 10.1021/ja0486317	7	19	21	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					649	649		10.1038/443649a	http://dx.doi.org/10.1038/443649a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035994	Bronze			2022-12-01	WOS:000241160500035
J	Reyes, N; Gadsby, DC				Reyes, Nicolas; Gadsby, David C.			Ion permeation through the Na+,K+-ATPase	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; BINDING-SITES; SODIUM-PUMP; XENOPUS-LAEVIS; CATION-BINDING; ALPHA-SUBUNIT; NA,K-ATPASE; MECHANISM; OCCLUSION	P-type ATPase pumps generate concentration gradients of cations across membranes in nearly all cells. They provide a polar transmembrane pathway, to which access is strictly controlled by coupled gates that are constrained to open alternately, thereby enabling thermodynamically uphill ion transport ( for example, see ref. 1). Here we examine the ion pathway through the Na+, K+-ATPase, a representative P-type pump, after uncoupling its extra- and intracellular gates with the marine toxin palytoxin(2). We use small hydrophilic thiol-specific reagents(3) as extracellular probes and we monitor their reactions, and the consequences, with cysteine residues introduced along the anticipated cation pathway through the pump. The distinct effects of differently charged reagents indicate that a wide outer vestibule penetrates deep into the Na+, K+-ATPase, where the pathway narrows and leads to a charge-selectivity filter. Acidic residues in this region, which are conserved to coordinate pumped ions, allow the approach of cations but exclude anions. Reversing the charge at just one of those positions converts the pathway from cation selective to anion selective. Close structural homology among the catalytic subunits of Ca2+-, Na+, K+- and H+, K+-ATPases(4-6) argues that their extracytosolic cation exchange pathways all share these physical characteristics.	Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10021 USA	Rockefeller University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.	gadsby@rockefeller.edu		Reyes, Nicolas/0000-0001-6618-8307				Apell HJ, 2004, REV PHYSIOL BIOCH P, V150, P1, DOI 10.1007/s10254-003-0018-9; Artigas P, 2004, J GEN PHYSIOL, V123, P357, DOI 10.1085/jgp.200308964; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; Asano S, 2004, J BIOL CHEM, V279, P13968, DOI 10.1074/jbc.M308934200; GOOD PJ, 1990, P NATL ACAD SCI USA, V87, P9088, DOI 10.1073/pnas.87.23.9088; Grenthe I., 1997, MODELLING AQUEOUS CH, P325; Guennoun S, 2000, FEBS LETT, V482, P144, DOI 10.1016/S0014-5793(00)02050-0; Horisberger JD, 2004, PHYSIOLOGY, V19, P377, DOI 10.1152/physiol.00013.2004; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Lauger P., 1991, ELECTROGENIC ION PUM; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Munson K, 2005, BIOCHEMISTRY-US, V44, P5267, DOI 10.1021/bi047761p; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Qiu LY, 2003, J BIOL CHEM, V278, P47240, DOI 10.1074/jbc.M308833200; Rakowski RF, 2003, NEWS PHYSIOL SCI, V18, P164, DOI 10.1152/nips.01441.2003; SCHEINERBOBIS G, 1994, MOL PHARMACOL, V45, P1132; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VERREY F, 1989, AM J PHYSIOL, V256, pF1034, DOI 10.1152/ajprenal.1989.256.6.F1034; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	30	64	70	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					470	474		10.1038/nature05129	http://dx.doi.org/10.1038/nature05129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006516				2022-12-01	WOS:000240798800049
J	Stinchcombe, JC; Majorovits, E; Bossi, G; Fuller, S; Griffiths, GM				Stinchcombe, Jane C.; Majorovits, Endre; Bossi, Giovanna; Fuller, Stephen; Griffiths, Gillian M.			Centrosome polarization delivers secretory granules to the immunological synapse	NATURE			English	Article							MICROTUBULE; CYTOSKELETON; LYMPHOCYTES; TRANSPORT	Cytotoxic T lymphocytes (CTLs) destroy virally infected and tumorigenic cells by releasing the contents of specialized secretory lysosomes - termed 'lytic granules' - at the immunological synapse formed between the CTL and the target(1). On contact with the target cell, the microtubule organizing centre of the CTL polarizes towards the target(2,3) and granules move along microtubules in a minus-end direction towards the polarized microtubule organizing centre. However, the final steps of secretion have remained unclear. Here we show that CTLs do not require actin or plus-end microtubule motors for secretion, but instead the centrosome moves to and contacts the plasma membrane at the central supramolecular activation cluster of the immunological synapse. Actin and IQGAP1 are cleared away from the synapse, and granules are delivered directly to the plasma membrane. These data show that CTLs use a previously unreported mechanism for delivering secretory granules to the immunological synapse, with granule secretion controlled by centrosome delivery to the plasma membrane.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Griffiths, GM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	gillian.griffiths@path.ox.ac.uk		Griffiths, Gillian/0000-0003-0434-5842; stinchcombe, jane/0000-0003-1459-9299	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; FRUTH U, 1987, EUR J IMMUNOL, V17, P1625, DOI 10.1002/eji.1830171116; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1984, J IMMUNOL, V133, P2762; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Poenie M, 2004, CURR OPIN IMMUNOL, V16, P428, DOI 10.1016/j.coi.2004.05.016; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027	23	449	457	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					462	465		10.1038/nature05071	http://dx.doi.org/10.1038/nature05071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006514				2022-12-01	WOS:000240798800047
J	Day, CL; Kaufmann, DE; Kiepiela, P; Brown, JA; Moodley, ES; Reddy, S; Mackey, EW; Miller, JD; Leslie, AJ; DePierres, C; Mncube, Z; Duraiswamy, J; Zhu, BG; Eichbaum, Q; Altfeld, M; Wherry, EJ; Coovadia, HM; Goulder, PJR; Klenerman, P; Ahmed, R; Freeman, GJ; Walker, BD				Day, Cheryl L.; Kaufmann, Daniel E.; Kiepiela, Photini; Brown, Julia A.; Moodley, Eshia S.; Reddy, Sharon; Mackey, Elizabeth W.; Miller, Joseph D.; Leslie, Alasdair J.; DePierres, Chantal; Mncube, Zenele; Duraiswamy, Jaikumar; Zhu, Baogong; Eichbaum, Quentin; Altfeld, Marcus; Wherry, E. John; Coovadia, Hoosen M.; Goulder, Philip J. R.; Klenerman, Paul; Ahmed, Rafi; Freeman, Gordon J.; Walker, Bruce D.			PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression	NATURE			English	Article							LYMPHOCYTES; INFECTION; PROLIFERATION; PHENOTYPE; RESPONSES; PERFORIN; MARKER	Functional impairment of T cells is characteristic of many chronic mouse and human viral infections. The inhibitory receptor programmed death 1 (PD-1; also known as PDCD1), a negative regulator of activated T cells(1-4), is markedly upregulated on the surface of exhausted virus-specific CD8 T cells in mice(5). Blockade of this pathway using antibodies against the PD ligand 1 (PD-L1, also known as CD274) restores CD8 T-cell function and reduces viral load(5). To investigate the role of PD-1 in a chronic human viral infection, we examined PD-1 expression on human immunodeficiency virus (HIV)-specific CD8 T cells in 71 clade-C-infected people who were naive to anti-HIV treatments, using ten major histocompatibility complex (MHC) class I tetramers specific for frequently targeted epitopes. Here we report that PD-1 is significantly upregulated on these cells, and expression correlates with impaired HIV-specific CD8 T-cell function as well as predictors of disease progression: positively with plasma viral load and inversely with CD4 T-cell count. PD-1 expression on CD4 T cells likewise showed a positive correlation with viral load and an inverse correlation with CD4 T-cell count, and blockade of the pathway augmented HIV-specific CD4 and CD8 T-cell function. These data indicate that the immunoregulatory PD-1/PD-L1 pathway is operative during a persistent viral infection in humans, and define a reversible defect in HIV-specific T-cell function. Moreover, this pathway of reversible T-cell impairment provides a potential target for enhancing the function of exhausted T cells in chronic HIV infection.	Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa; Massachusetts Gen Hosp, Partner AIDS Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA; Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England; Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oxford; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Emory University; Emory University; The Wistar Institute; Howard Hughes Medical Institute	Walker, BD (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa.	bwalker@partners.org	Day, Cheryl L/J-9844-2012; Wherry, John/ABI-1280-2020; Day, Cheryl/GQQ-9720-2022; Freeman, Gordon/AAC-5380-2019; Altfeld, Marcus/AAE-7306-2019	Day, Cheryl L/0000-0002-6497-4846; Freeman, Gordon/0000-0002-7210-5616; Altfeld, Marcus/0000-0001-5972-2997; leslie, alasdair/0000-0003-2538-6467; klenerman, paul/0000-0003-4307-9161				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Goepfert PA, 2000, J VIROL, V74, P10249, DOI 10.1128/JVI.74.21.10249-10255.2000; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kostense S, 2002, BLOOD, V99, P2505, DOI 10.1182/blood.V99.7.2505; Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Loffredo JT, 2005, J VIROL, V79, P14986, DOI 10.1128/JVI.79.23.14986-14991.2005; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Steiner K, 1999, CLIN EXP IMMUNOL, V115, P451; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791	26	1989	2108	1	188	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					350	354		10.1038/nature05115	http://dx.doi.org/10.1038/nature05115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16921384				2022-12-01	WOS:000240622000049
J	Vogeli, KM; Jin, SW; Martin, GR; Stainier, DYR				Vogeli, Kevin M.; Jin, Suk-Won; Martin, Gail R.; Stainier, Didier Y. R.			A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula	NATURE			English	Article							CELLS; HEMANGIOBLAST; ORGANIZATION; COMMITMENT; ORIGIN	It has been proposed that haematopoietic and endothelial cells share a common progenitor, termed the haemangioblast. This idea was initially conceived as a result of the observation that these two cell types develop in close proximity to each other within the embryo(1,2). Support for this hypothesis was provided by studies on single-cell-derived colonies that can produce both haematopoietic and endothelial cells in vitro(3-7). Although these data point towards the existence of a common progenitor for these two lineages, the presence of a bipotential progenitor cell has yet to be demonstrated in vivo. Through the construction of single-cell-resolution fate maps of the zebrafish late blastula and gastrula, we demonstrate that individual cells can give rise to both haematopoietic and endothelial cells. These bipotential progenitors arise along the entire extent of the ventral mesoderm and contribute solely to haematopoietic and endothelial cells. We also find that only a subset of haematopoietic and endothelial cells arise from haemangioblasts. The endothelial descendants of the haemangioblasts all clustered in a specific region of the axial vessels regardless of the location of their progenitors. Our results provide in vivo evidence supporting the existence of the haemangioblast and reveal distinct features of this cell population.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	didier_stainier@biochem.ucsf.edu		Stainier, Didier/0000-0002-0382-0026				Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Choi K, 1998, DEVELOPMENT, V125, P725; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Murray PDF, 1932, P R SOC LOND B-CONTA, V111, P497, DOI 10.1098/rspb.1932.0070; Parker LH, 1999, METHOD CELL BIOL, V59, P313; Sabin FR, 1917, ANAT REC, V13, P199, DOI 10.1002/ar.1090130403; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Warga RM, 1999, DEVELOPMENT, V126, P827; Westerfield M., 1993, ZEBRAFISH BOOK	18	222	227	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					337	339		10.1038/nature05045	http://dx.doi.org/10.1038/nature05045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988712				2022-12-01	WOS:000240622000046
J	Pathela, P; Hajat, A; Schillinger, J; Blank, S; Sell, R; Mostashari, F				Pathela, Preeti; Hajat, Anjum; Schillinger, Julia; Blank, Susan; Sell, Randall; Mostashari, Farzad			Discordance between sexual behavior and self-reported sexual identity: A population-based survey of New York City men	ANNALS OF INTERNAL MEDICINE			English	Article							RISK BEHAVIORS; HIV EPIDEMIC; GAY; PREVENTION; SAMPLE	Background: Persons reporting sexual identity that is discordant with their sexual behavior may engage in riskier sexual behaviors than those with concordant identity and behavior. The former group could play an important role in the spread of sexually transmitted diseases. Objective: To describe discordance between self-described sexual identity and behavior among men who have sex with men and associations between identity-behavior and risk behaviors. Design: Cross-sectional, random digit-dialed telephone survey of health status and risk behaviors. Setting: New York City. Participants: Population-based sample of 4193 men. Measurements: Concurrent measures of sexual identity and sexual behaviors, including number and sex of sex partners, condom use during last sexual encounter, and recent testing for HIV infection . Sex partner information was ascertained in a separate section from sexual identity; all participants were asked about the number of male sex partners and then were asked about the number of female sex partners in the past year. Results: Of New York City men reporting a sexual identity, 12% reported sex with other men. Men who had sex with men exclusively but self-identified as heterosexual were more likely than their gay-identified counterparts to belong to minority racial or ethnic groups, be foreign-born, have lower education and income levels, and be married. These men were more likely than gay-identified men who have sex with men to report having only 1 sexual partner in the previous year. However, they were less likely to have been tested for HIV infection during that time (adjusted prevalence ratio, 0.6 [95% CI, 0.4 to 0.9]) and less likely to have used condoms during their last sexual encounter (adjusted prevalence ratio, 0.5 [CI, 0.3 to 1.0]). Limitations: The survey did not sample groups that cannot be reached by using residential telephone services. Conclusions: Many New York City men who have sex with men do not identify as gay. Medical providers cannot rely on patients' self-reported identities to appropriately assess risk for HIV infection and sexually transmitted diseases; they must inquire about behavior. Public health prevention messages should target risky sexual activities rather than a person's sexual identity.	New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10013 USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA	New York City Department of Health & Mental Hygiene; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Pathela, P (corresponding author), New York City Dept Hlth & Mental Hyg, 125 Worth St,Room 207,CN73, New York, NY 10013 USA.							Agronick G, 2004, AIDS BEHAV, V8, P185, DOI 10.1023/B:AIBE.0000030249.11679.d0; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P45; Behavioral Risk Factors Surveillance System, 2005, OP US GUID VERS 3 0; Blumberg SJ, 2003, J SEX RES, V40, P121, DOI 10.1080/00224490309552173; Caceres CF, 2002, AIDS, V16, pS23, DOI 10.1097/00002030-200212003-00005; CARRIER JM, 1985, BISEXUALITIES THEORY, P75; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Catania Joseph A., 1995, V6, P77; *CDCP, 2004, HIV AIDS SURV REP 20, P10; DOLL LS, 1992, J SEX RES, V29, P1, DOI 10.1080/00224499209551630; EARL WL, 1990, J SEX MARITAL THER, V16, P251; Elford J, 2003, AIDS EDUC PREV, V15, P294, DOI 10.1521/aeap.15.5.294.23825; FAY RE, 1989, SCIENCE, V243, P338, DOI 10.1126/science.2911744; Garofalo R, 1998, PEDIATRICS, V101, P895, DOI 10.1542/peds.101.5.895; Goldbaum G, 1996, PUBLIC HEALTH REP, V111, P36; Goldbaum G, 1998, AIDS BEHAV, V2, P13, DOI DOI 10.1023/A:1022399021926; *I MED, 2000, NO TIM LOS GETT MOR; Kennamer JD, 2000, AIDS EDUC PREV, V12, P519; Kinsey A.C., 1948, SEXUAL BEHAV HUMAN M, V27, P720, DOI 10.1037/t17515-000; Lau JTF, 2004, SEX TRANSM INFECT, V80, P459, DOI 10.1136/sti.2003.008854; Laumann E.O., 2000, SOCIAL ORG SEXUALITY; *NAT CTR HLTH STAT, DAT DEF REL STAND ER; QUAN VM, 2000, 13 INT C AIDS DURB S; *RES TRIANGL I, 2001, SUDAAN US MAN REL 8; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Ross MW, 2003, SEX TRANSM DIS, V30, P110, DOI 10.1097/00007435-200302000-00003; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P138, DOI 10.1111/j.1467-842X.2003.tb00801.x; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883; 2004, MMWR MORB MORTAL WKL, V53, P575; 2003, MMWR MORB MORTAL WKL, V52, P81; 2002, MMWR MORTAL WKLY REP, V51, P853; 1993, MMWR MORB MORTAL WKL, V42, P7; 2004, MMWR MORB MORTAL WKL, V53, P985; 2004, MMWR MORB MORTAL WKL, V53, P731; 2003, MMWR MORB MORTAL WKL, V52, P1145; 1993, MMWR MORB MORTAL WKL, V42, P13; 2002, MMWR RECOMM REP, V51, P7	37	196	199	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					416	425		10.7326/0003-4819-145-6-200609190-00005	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087OU	16983129				2022-12-01	WOS:000240752500003
J	Prakriya, M; Feske, S; Gwack, Y; Srikanth, S; Rao, A; Hogan, PG				Prakriya, Murali; Feske, Stefan; Gwack, Yousang; Srikanth, Sonal; Rao, Anjana; Hogan, Patrick G.			Orai1 is an essential pore subunit of the CRAC channel	NATURE			English	Article							ACTIVATED CA2+ CHANNELS; T-LYMPHOCYTES; CALCIUM-CHANNELS; PLASMA-MEMBRANE; I-CRAC; STORE; SELECTIVITY; PERMEATION; CELLS; STIM1	Stimulation of immune cells causes depletion of Ca2+ from endoplasmic reticulum ( ER) stores, thereby triggering sustained Ca2+ entry through store-operated Ca2+ release-activated Ca2+ ( CRAC) channels, an essential signal for lymphocyte activation and proliferation(1,2). Recent evidence indicates that activation of CRAC current is initiated by STIM proteins, which sense ER Ca2+ levels through an EF-hand located in the ER lumen and relocalize upon store depletion into puncta closely associated with the plasma membrane(3-5). We and others recently identified Drosophila Orai and human Orai1 ( also called TMEM142A) as critical components of store- operated Ca2+ entry downstream of STIM6-8. Combined overexpression of Orai and Stim in Drosophila cells(8), or Orai1 and STIM1 in mammalian cells(9-11), leads to a marked increase in CRAC current. However, these experiments did not establish whether Orai is an essential intracellular link between STIM and the CRAC channel, an accessory protein in the plasma membrane, or an actual pore subunit. Here we show that Orai1 is a plasma membrane protein, and that CRAC channel function is sensitive to mutation of two conserved acidic residues in the transmembrane segments. E106D and E190Q substitutions in transmembrane helices 1 and 3, respectively, diminish Ca2+ influx, increase current carried by monovalent cations, and render the channel permeable to Cs+. These changes in ion selectivity provide strong evidence that Orai1 is a pore subunit of the CRAC channel.	Harvard Univ, Sch Med, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA; Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Northwestern University; Feinberg School of Medicine	Rao, A (corresponding author), Harvard Univ, Sch Med, 200 Longwood Ave, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178; Prakriya, Murali/0000-0003-0781-4480				Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Corry B, 2006, CELL MOL LIFE SCI, V63, P301, DOI 10.1007/s00018-005-5405-8; Eisenberg B, 2003, BIOPHYS CHEM, V100, P507, DOI 10.1016/S0301-4622(02)00302-2; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; MERCER JC, 2006, J BIOL CHEM     0628; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; PRAKRIYA M, IN PRESS J GEN PHYSL; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Su ZC, 2004, BIOPHYS J, V86, P805, DOI 10.1016/S0006-3495(04)74156-9; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YEROMIN AV, 2006, NATURE          0820; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	30	1042	1076	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					230	233		10.1038/nature05122	http://dx.doi.org/10.1038/nature05122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16921383				2022-12-01	WOS:000240467000051
J	Bryce, J; El Arifeen, S; Bhutta, ZA; Black, RE; Claeson, M; Gillespie, D; Gwatkin, DR; Habicht, JP; Jone, G; Lanata, CF; Morris, SS; Mshinda, H; Pariyo, G; Perkin, G; Schellenberg, JA; Steketee, R; Troedsson, H; Victora, CG				Bryce, Jennifer; El Arifeen, Shams; Bhutta, Zulpqar A.; Black, Robert E.; Claeson, Mariam; Gillespie, Duff; Gwatkin, Davidson R.; Habicht, Jean-Pierre; Jone, Gareth; Lanata, Claudio F.; Morris, Saul S.; Mshinda, Hassan; Pariyo, George; Perkin, Gordon; Schellenberg, Joanna Armstrong; W Steketee, Richard; Troedsson, Hans; Victora, Cesar G.			Getting it right for children: a review of UNICEFjoint health and nutrition strategy for 2006-15	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; ICDDR B, Ctr Hlth & Populat Res B, Child Hlth Programme, Dhaka, Bangladesh; Aga Khan Univ, Dept Paediat, Karachi, Pakistan; World Bank, Washington, DC 20433 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Bill & Melinda Gates Inst Populat & Reprod Hlth, Baltimore, MD USA; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Inst Invest Nutr, Lima, Peru; London Sch Hyg & Trop Med, London WC1, England; Ifakara Ctr Res & Dev, Ifakara, Tanzania; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Bill & Melinda Gates Fdn, Seattle, WA USA; PATH, Ferney Voltaire, France; WHO, Hanoi, Vietnam; Univ Fed Pelotas, Pelotas, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Aga Khan University; The World Bank; Bill & Melinda Gates Foundation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Makerere University; Bill & Melinda Gates Foundation; World Health Organization; Universidade Federal de Pelotas	Bryce, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	jbrycedanby@aol.com	Pariyo, George W/K-2335-2017; Lanata, Claudio F./N-7997-2018; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Pariyo, George W/0000-0002-4411-2309; Lanata, Claudio F./0000-0002-6994-7425; Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Arifeen, Shams/0000-0002-5372-5932; Black, Robert/0000-0001-9926-7984; Schellenberg, Joanna/0000-0002-0708-3676; Morris, Saul/0000-0002-9372-7342				Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; BRYCE J, 2006, IN PRESS LANCET; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Freedman LP, 2005, WHOS GOT POWER TRANS; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; POWELLJACKSON T, 2006, IN PRESS LANCET; *UN MILL DEV GOALS, 2005, WHAT AR MILL DEV GOA; United Nations Children's Fund (UNICEF), 2005, UNICEF JOINT HLTH NU; *WORLD BANK, 2005, MILL DEV GOALS HLTH	10	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2006	368	9538					817	819		10.1016/S0140-6736(06)69299-4	http://dx.doi.org/10.1016/S0140-6736(06)69299-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950338				2022-12-01	WOS:000240371200004
J	De Angeli, A; Monachello, D; Ephritikhine, G; Frachisse, JM; Thomine, S; Gambale, F; Barbier-Brygoo, H				De Angeli, A.; Monachello, D.; Ephritikhine, G.; Frachisse, J. M.; Thomine, S.; Gambale, F.; Barbier-Brygoo, H.			The nitrate/proton antiporter AtCLCa mediates nitrate accumulation in plant vacuoles	NATURE			English	Article							TRAIT LOCI ANALYSIS; ANION CHANNEL GENE; CHLORIDE CHANNEL; FUNCTIONAL EXPRESSION; PROKARYOTIC HOMOLOG; ARABIDOPSIS; TRANSPORTER; STORAGE; CLONING	Nitrate, the major nitrogen source for most plants, is widely used as a fertilizer and as a result has become a predominant freshwater pollutant. Plants need nitrate for growth and store most of it in the central vacuole(1). Some members of the chloride channel (CLC) protein family, such as the torpedo-fish ClC-0 and mammalian ClC-1, are anion channels(2,3), whereas the bacterial ClC-ec1 and mammalian ClC-4 and ClC-5 have recently been characterized as Cl-/H+ exchangers with unknown cellular functions(4-6). Plant members of the CLC family are proposed to be anion channels(7,8) involved in nitrate homeostasis(9); however, direct evidence for anion transport mediated by a plant CLC is still lacking. Here we show that Arabidopsis thaliana CLCa (AtCLCa) is localized to an intracellular membrane, the tonoplast of the plant vacuole, which is amenable to electrophysiological studies, and we provide direct evidence for its anion transport ability. We demonstrate that AtCLCa is able to accumulate specifically nitrate in the vacuole and behaves as a NO3-/H+ exchanger. For the first time, to our knowledge, the transport activity of a plant CLC is revealed, the antiporter mechanism of a CLC protein is investigated in a native membrane system, and this property is directly connected with its physiological role.	CNRS, UPR 2355, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; Univ Paris 07, UFR Biol Sci Nat, F-75251 Paris 05, France; CNR, Ist Biofis, I-16149 Genoa, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Barbier-Brygoo, H (corresponding author), CNRS, UPR 2355, Inst Sci Vegetal, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	brygoo@isv.cnrs-gif.fr	Frachisse, Jean Marie/AAY-7177-2020; BARBIER-BRYGOO, HELENE/A-8435-2013; Jean-Marie, Frachisse/AAE-4350-2022; Thomine, Sébastien/V-9029-2019	Frachisse, Jean Marie/0000-0002-9755-6536; Thomine, Sebastien/0000-0003-0045-1701				Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; CERANA R, 1995, AUST J PLANT PHYSIOL, V22, P115, DOI 10.1071/PP9950115; Cookson SJ, 2005, PLANT PHYSIOL, V138, P1097, DOI 10.1104/pp.105.062349; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; Gross E, 1996, J MEMBRANE BIOL, V152, P245, DOI 10.1007/s002329900102; Hafke JB, 2003, PLANT J, V35, P116, DOI 10.1046/j.1365-313X.2003.01781.x; Harada H, 2004, J EXP BOT, V55, P2005, DOI 10.1093/jxb/erh224; Hechenberger M, 1996, J BIOL CHEM, V271, P33632, DOI 10.1074/jbc.271.52.33632; Hurth MA, 2005, PLANT PHYSIOL, V137, P901, DOI 10.1104/pp.104.058453; LANGENHEIM J H, 1973, Acta Amazonica, V3, P5; Loudet O, 2003, GENETICS, V163, P711; Lurin C, 2000, BIOCHEM J, V348, P291, DOI 10.1042/0264-6021:3480291; Lurin C, 1996, PLANT CELL, V8, P701, DOI 10.1105/tpc.8.4.701; MARTINOIA E, 1981, NATURE, V289, P292, DOI 10.1038/289292a0; Miller C., 1980, Annals of the New York Academy of Sciences, V341, P534, DOI 10.1111/j.1749-6632.1980.tb47197.x; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Pei ZM, 1996, EMBO J, V15, P6564, DOI 10.1002/j.1460-2075.1996.tb01047.x; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Song WY, 2003, NAT BIOTECHNOL, V21, P914, DOI 10.1038/nbt850; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Teardo E, 2005, FEBS LETT, V579, P4991, DOI 10.1016/j.febslet.2005.08.005; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x	28	345	352	10	149	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 24	2006	442	7105					939	942		10.1038/nature05013	http://dx.doi.org/10.1038/nature05013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16878138				2022-12-01	WOS:000239960500042
J	Loeys, BL; Schwarze, U; Holm, T; Callewaert, BL; Thomas, GH; Pannu, H; De Backer, JF; Oswald, GL; Symoens, S; Manouvrier, S; Roberts, AE; Faravelli, F; Greco, MA; Pyeritz, RE; Milewicz, DM; Coucke, PJ; Cameron, DE; Braverman, AC; Byers, PH; De Paepe, AM; Dietz, HC				Loeys, Bart L.; Schwarze, Ulrike; Holm, Tammy; Callewaert, Bert L.; Thomas, George H.; Pannu, Hariyadarshi; De Backer, Julie F.; Oswald, Gretchen L.; Symoens, Sofie; Manouvrier, Sylvie; Roberts, Amy E.; Faravelli, Francesca; Greco, M. Alba; Pyeritz, Reed E.; Milewicz, Dianna M.; Coucke, Paul J.; Cameron, Duke E.; Braverman, Alan C.; Byers, Peter H.; De Paepe, Anne M.; Dietz, Harry C.			Aneurysm syndromes caused by mutations in the TGF-beta receptor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNDROME TYPE-IV; THORACIC AORTIC-ANEURYSMS; MARFAN-SYNDROME; GENE; DISSECTIONS; DEFECTS	Background: The Loeys-Dietz syndrome is a recently described autosomal dominant aortic-aneurysm syndrome with widespread systemic involvement. The disease is characterized by the triad of arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate and is caused by heterozygous mutations in the genes encoding transforming growth factor (beta) receptors 1 and 2 (TGFBR1 and TGFBR2, respectively). Methods: We undertook the clinical and molecular characterization of 52 affected families. Forty probands presented with typical manifestations of the Loeys-Dietz syndrome. In view of the phenotypic overlap between this syndrome and vascular Ehlers-Danlos syndrome, we screened an additional cohort of 40 patients who had vascular Ehlers-Danlos syndrome without the characteristic type III collagen abnormalities or the craniofacial features of the Loeys-Dietz syndrome. Results: We found a mutation in TGFBR1 or TGFBR2 in all probands with typical Loeys-Dietz syndrome (type I) and in 12 probands presenting with vascular Ehlers-Danlos syndrome (Loeys-Dietz syndrome type II). The natural history of both types was characterized by aggressive arterial aneurysms (mean age at death, 26.0 years) and a high incidence of pregnancy-related complications (in 6 of 12 women). Patients with Loeys-Dietz syndrome type I, as compared with those with type II, underwent cardiovascular surgery earlier (mean age, 16.9 years vs. 26.9 years) and died earlier (22.6 years vs. 31.8 years). There were 59 vascular surgeries in the cohort, with one death during the procedure. This low rate of intraoperative mortality distinguishes the Loeys-Dietz syndrome from vascular Ehlers-Danlos syndrome. Conclusions: Mutations in either TGFBR1 or TGFBR2 predispose patients to aggressive and widespread vascular disease. The severity of the clinical presentation is predictive of the outcome. Genotyping of patients presenting with symptoms like those of vascular Ehlers-Danlos syndrome may be used to guide therapy, including the use and timing of prophylactic vascular surgery.	State Univ Ghent Hosp, Ctr Genet Med, B-9000 Ghent, Belgium; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; Kennedy Krieger Inst, Baltimore, MD USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Texas, Dept Med, Houston, TX USA; Univ Hosp, Dept Clin Genet, Lille, France; Harvard Univ, Sch Med, Dept Clin Genet, Boston, MA USA; Osped Galliera, Dept Human Genet, Genoa, Italy; NYU, Sch Med, Dept Pathol, New York, NY USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Howard Hughes Med Inst, Chevy Chase, MD USA	Ghent University; Ghent University Hospital; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; Universite de Lille - ISITE; CHU Lille; Harvard University; Harvard Medical School; Ente Ospedaliero Ospedali Galliera; New York University; University of Pennsylvania; Washington University (WUSTL); Howard Hughes Medical Institute	Loeys, BL (corresponding author), State Univ Ghent Hosp, Ctr Genet Med, Bldg 0K5,De Pintelaan 185, B-9000 Ghent, Belgium.	bart.loeys@ugent.be	Loeys, Bart/B-3236-2017; De Backer, Julie/B-2897-2014; Coucke, Paul J/AAO-2954-2020; Callewaert, Bert/J-6357-2014	Loeys, Bart/0000-0003-3703-9518; De Backer, Julie/0000-0001-8878-1507; Coucke, Paul J/0000-0001-7119-586X; Callewaert, Bert/0000-0002-9743-4205; Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR049698, AR41135] Funding Source: Medline; NICHD NIH HHS [HD24061] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Disabella E, 2006, EUR J HUM GENET, V14, P34, DOI 10.1038/sj.ejhg.5201502; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lucke CD, 2001, CANCER RES, V61, P482; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Oderich GS, 2005, J VASC SURG, V42, P98, DOI 10.1016/j.jvs.2005.03.053; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pepin M, 2001, NEW ENGL J MED, V344, P392; Schwarze U, 1997, AM J HUM GENET, V61, P1276, DOI 10.1086/301641; SILVERMAN DI, 1995, AM J CARDIOL, V75, P157, DOI 10.1016/S0002-9149(00)80066-1; Wang D, 1997, CARCINOGENESIS, V18, P2285, DOI 10.1093/carcin/18.11.2285	14	1069	1100	4	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2006	355	8					788	798		10.1056/NEJMoa055695	http://dx.doi.org/10.1056/NEJMoa055695			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076KA	16928994				2022-12-01	WOS:000239955200007
J	Schlacher, K; Cox, MM; Woodgate, R; Goodman, MF				Schlacher, Katharina; Cox, Michael M.; Woodgate, Roger; Goodman, Myron F.			RecA acts in trans to allow replication of damaged DNA by DNA polymerase V	NATURE			English	Article							ESCHERICHIA-COLI; TRANSLESION SYNTHESIS; BIOCHEMICAL BASIS; UV-MUTAGENESIS; LESION BYPASS; IN-VITRO; POL V; PROTEIN; COMPLEX; REPAIR	The DNA polymerase V (pol V) and RecA proteins are essential components of a mutagenic translesion synthesis pathway in Escherichia coli designed to cope with DNA damage. Previously, it has been assumed that RecA binds to the DNA template strand being copied. Here we show, however, that pol-V-catalysed translesion synthesis, in the presence or absence of the beta-processivity-clamp, occurs only when RecA nucleoprotein filaments assemble or RecA protomers bind on separate single-stranded ( ss) DNA molecules in trans. A 3'-proximal RecA filament end on trans DNA is essential for stimulation; however, synthesis is strengthened by further pol V - RecA interactions occurring elsewhere along a trans nucleoprotein filament. We suggest that trans-stimulation of pol V by RecA bound to ssDNA reflects a distinctive regulatory mechanism of mutation that resolves the paradox of RecA filaments assembled in cis on a damaged template strand obstructing translesion DNA synthesis despite the absolute requirement of RecA for SOS mutagenesis.	Univ So Calif, Dept Biol Sci & Chem, Los Angeles, CA 90089 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	University of Southern California; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci & Chem, Univ Pk, Los Angeles, CA 90089 USA.	mgoodman@usc.edu		Woodgate, Roger/0000-0001-5581-4616; SCHLACHER, KATHARINA/0000-0001-7226-6391	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES029680] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BAILONE A, 1991, BIOCHIMIE, V73, P479, DOI 10.1016/0300-9084(91)90115-H; Boudsocq F, 1997, J MOL BIOL, V270, P201, DOI 10.1006/jmbi.1997.1098; BRIDGES BA, 1984, MOL GEN GENET, V196, P364, DOI 10.1007/BF00328073; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Frank EG, 2000, J MOL BIOL, V297, P585, DOI 10.1006/jmbi.2000.3591; Friedberg E.C., 2006, DNA REPAIR MUTAGENES, P461; Fujii S, 2004, J MOL BIOL, V341, P405, DOI 10.1016/j.jmb.2004.06.017; Fujii S, 2004, EMBO J, V23, P4342, DOI 10.1038/sj.emboj.7600438; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; Maor-Shoshani A, 2000, P NATL ACAD SCI USA, V97, P565, DOI 10.1073/pnas.97.2.565; Maor-Shoshani A, 2002, BIOCHEMISTRY-US, V41, P14438, DOI 10.1021/bi0262909; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Pham P, 2001, NATURE, V409, P366, DOI 10.1038/35053116; Pham P, 2002, P NATL ACAD SCI USA, V99, P11061, DOI 10.1073/pnas.172197099; Radman M., 1974, MOL ENV ASPECTS MUTA, P128; Reuven NB, 2001, J BIOL CHEM, V276, P5511, DOI 10.1074/jbc.M006828200; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; SOMMER S, 1993, MOL MICROBIOL, V10, P963, DOI 10.1111/j.1365-2958.1993.tb00968.x; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; SWEASY JB, 1990, J BACTERIOL, V172, P3030, DOI 10.1128/jb.172.6.3030-3036.1990; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976	31	78	78	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					883	887		10.1038/nature05042	http://dx.doi.org/10.1038/nature05042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16929290				2022-12-01	WOS:000239960500029
J	Woodward, LJ; Anderson, PJ; Austin, NC; Howard, K; Inder, TE				Woodward, Lianne J.; Anderson, Peter J.; Austin, Nicola C.; Howard, Kelly; Inder, Terrie E.			Neonatal MRI to predict neurodevelopmental outcomes in preterm infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; WHITE-MATTER INJURY; EARLY BRAIN-INJURY; PREMATURE-INFANT; SCHOOL-AGE; CEREBRAL-PALSY; CRANIAL ULTRASOUND; LUNG-DISEASE; CHILDREN; TERM	BACKGROUND: Very preterm infants are at high risk for adverse neurodevelopmental outcomes. Magnetic resonance imaging (MRI) has been proposed as a means of predicting neurodevelopmental outcomes in this population. METHODS: We studied 167 very preterm infants (gestational age at birth, 30 weeks or less) to assess the associations between qualitatively defined white-matter and gray-matter abnormalities on MRI at term equivalent (gestational age of 40 weeks) and the risks of severe cognitive delay, severe psychomotor delay, cerebral palsy, and neurosensory (hearing or visual) impairment at 2 years of age (corrected for prematurity). RESULTS: At two years of age, 17 percent of infants had severe cognitive delay, 10 percent had severe psychomotor delay, 10 percent had cerebral palsy, and 11 percent had neurosensory impairment. Moderate-to-severe cerebral white-matter abnormalities present in 21 percent of infants at term equivalent were predictive of the following adverse outcomes at two years of age: cognitive delay (odds ratio, 3.6; 95 percent confidence interval, 1.5 to 8.7), motor delay (odds ratio, 10.3; 95 percent confidence interval, 3.5 to 30.8), cerebral palsy (odds ratio, 9.6; 95 percent confidence interval, 3.2 to 28.3), and neurosensory impairment (odds ratio, 4.2; 95 percent confidence interval, 1.6 to 11.3). Gray-matter abnormalities (present in 49 percent of infants) were also associated, but less strongly, with cognitive delay, motor delay, and cerebral palsy. Moderate-to-severe white-matter abnormalities on MRI were significant predictors of severe motor delay and cerebral palsy after adjustment for other measures during the neonatal period, including findings on cranial ultrasonography. CONCLUSIONS: Abnormal findings on MRI at term equivalent in very preterm infants strongly predict adverse neurodevelopmental outcomes at two years of age. These findings suggest a role for MRI at term equivalent in risk stratification for these infants.	Univ Canterbury, Canterbury Child Dev Res Grp, Dept Psychol, Christchurch 1, New Zealand; Van der Veer Inst Parkinsons & Brain Res, Christchurch, New Zealand; Christchurch Womens Hosp, Christchurch, New Zealand; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia; Washington Univ, St Louis Childrens Hosp, Dept Pediat, St Louis, MO USA; Washington Univ, St Louis Childrens Hosp, Dept Neurol, St Louis, MO USA; Washington Univ, St Louis Childrens Hosp, Dept Radiol, St Louis, MO USA	University of Canterbury; Murdoch Children's Research Institute; University of Melbourne; St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Woodward, LJ (corresponding author), Univ Canterbury, Canterbury Child Dev Res Grp, Dept Psychol, Private Bag 4800, Christchurch 1, New Zealand.	lianne.woodward@canterbury.ac.nz	Fahimifar, Sepideh/M-5303-2019; Anderson, Peter J/B-6839-2015; Anderson, Peter John/O-5302-2019	Anderson, Peter J/0000-0001-7430-868X; Anderson, Peter John/0000-0001-7430-868X				Aida N, 1998, AM J NEURORADIOL, V19, P1909; Ajayi-Obe M, 2000, LANCET, V356, P1162, DOI 10.1016/S0140-6736(00)02761-6; Allen MC, 2002, MENT RETARD DEV D R, V8, P221, DOI 10.1002/mrdd.10044; Anderson NG, 2004, ULTRASOUND MED BIOL, V30, P11, DOI 10.1016/j.ultrasmedbio.2003.10.001; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Bayley N., 1993, BAYLEY SCALES INFANT; Bracewell M, 2002, MENT RETARD DEV D R, V8, P241, DOI 10.1002/mrdd.10049; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; Huppi PS, 1996, PEDIATR RES, V39, P895; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Kwong KL, 2004, PEDIATR NEUROL, V31, P172, DOI 10.1016/j.pediatrneurol.2004.02.005; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Maalouf EF, 2001, PEDIATRICS, V107, P719, DOI 10.1542/peds.107.4.719; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mercuri E, 1999, NEUROPEDIATRICS, V30, P83, DOI 10.1055/s-2007-973465; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Mirmiran M, 2004, PEDIATRICS, V114, P992, DOI 10.1542/peds.2003-0772-L; Msall ME, 2002, MENT RETARD DEV D R, V8, P258, DOI 10.1002/mrdd.10046; Murphy BP, 2001, PEDIATRICS, V107, P217, DOI 10.1542/peds.107.2.217; O'Shea TM, 1999, PEDIATRICS, V104, P15, DOI 10.1542/peds.104.1.15; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Shin'oka T, 1998, ANN THORAC SURG, V65, P155, DOI 10.1016/S0003-4975(97)00909-0; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; Woodward LJ, 2004, J DEV BEHAV PEDIATR, V25, P326, DOI 10.1097/00004703-200410000-00004; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	33	872	888	1	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2006	355	7					685	694		10.1056/NEJMoa053792	http://dx.doi.org/10.1056/NEJMoa053792			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074AN	16914704				2022-12-01	WOS:000239784500007
J	Vitetta, ES; Ghetie, VF				Vitetta, Ellen S.; Ghetie, Victor F.			Considering therapeutic antibodies	SCIENCE			English	Editorial Material									Univ Texas, SW Med Ctr, Ctr Canc Immunobiol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Vitetta, ES (corresponding author), Univ Texas, SW Med Ctr, Ctr Canc Immunobiol, 6000 Harry Hines Blvd, Dallas, TX 75235 USA.	ellen.vitetta@utsouthwestern.edu						Beyersdorf N, 2005, ANN RHEUM DIS, V64, P91, DOI 10.1136/ard.2005.042564; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Liu XY, 2006, INT IMMUNOPHARMACOL, V6, P791, DOI 10.1016/j.intimp.2005.11.022; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Marshall E, 2006, SCIENCE, V311, P1688, DOI 10.1126/science.311.5768.1688; Waldmann TA, 2006, ADV IMMUNOL, V90, P83, DOI 10.1016/S0065-2776(06)90003-0	7	26	98	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					308	309		10.1126/science.1130482	http://dx.doi.org/10.1126/science.1130482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857927				2022-12-01	WOS:000239154300029
J	Heldwein, EE; Lou, H; Bender, FC; Cohen, GH; Eisenberg, RJ; Harrison, SC				Heldwein, Ekaterina E.; Lou, Huan; Bender, Florent C.; Cohen, Gary H.; Eisenberg, Roselyn J.; Harrison, Stephen C.			Crystal structure of glycoprotein B from herpes simplex virus 1	SCIENCE			English	Article							PROTEIN-STRUCTURE; FUSION DOMAIN; CELL-FUSION; TYPE-1; ENTRY; MUTATIONS; GB; EPITOPES; MUTANT; IDENTIFICATION	Glycoprotein B (gB) is the most conserved component of the complex cell-entry machinery of herpes viruses. A crystal structure of the gB ectodomain from herpes simplex virus type 1 reveals a multidomain trimer with unexpected homology to glycoprotein G from vesicular stomatitis virus (VSV G). An alpha-helical coiled-coil core relates gB to class I viral membrane fusion glycoproteins; two extended beta hairpins with hydrophobic tips, homologous to fusion peptides in VSV G, relate gB to class II fusion proteins. Members of both classes accomplish fusion through a large-scale conformational change, triggered by a signal from a receptor-binding component. The domain connectivity within a gB monomer would permit such a rearrangement, including long-range translocations linked to viral and cellular membranes.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Heldwein, EE (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 320 Longwood Ave, Boston, MA 02115 USA.	heldwein@crystal.harvard.edu		Heldwein, Ekaterina/0000-0003-3113-6958	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056045, R21AI056045, R01AI049980, R21AI065886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036731] Funding Source: NIH RePORTER; NIAID NIH HHS [AI056045, R21 AI065886, AI065886, AI049980] Funding Source: Medline; NINDS NIH HHS [NS36731] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Britt WJ, 2005, J VIROL, V79, P4066, DOI 10.1128/JVI.79.7.4066-4079.2005; BZIK DJ, 1984, VIROLOGY, V137, P185, DOI 10.1016/0042-6822(84)90022-9; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Foster TF, 2001, VIROLOGY, V287, P18, DOI 10.1006/viro.2001.1004; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; HIGHLANDER SL, 1989, J VIROL, V63, P730, DOI 10.1128/JVI.63.2.730-738.1989; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jones NA, 2004, VIROLOGY, V324, P213, DOI 10.1016/j.virol.2004.03.024; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; KOUSOULAS KG, 1988, VIROLOGY, V166, P423, DOI 10.1016/0042-6822(88)90513-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Norais N, 1996, J VIROL, V70, P7379, DOI 10.1128/JVI.70.11.7379-7387.1996; OHLIN M, 1993, J VIROL, V67, P703, DOI 10.1128/JVI.67.2.703-710.1993; PELLETT PE, 1985, J VIROL, V53, P243, DOI 10.1128/JVI.53.1.243-253.1985; PEREIRA L, 1989, VIROLOGY, V172, P11, DOI 10.1016/0042-6822(89)90102-5; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; UTZ U, 1989, J VIROL, V63, P1995, DOI 10.1128/JVI.63.5.1995-2001.1989; VEY M, 1995, VIROLOGY, V206, P746, DOI 10.1016/S0042-6822(95)80002-6	31	457	482	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					217	220		10.1126/science.1126548	http://dx.doi.org/10.1126/science.1126548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840698				2022-12-01	WOS:000239008000042
J	Shipley, B; Vile, D; Garnier, E				Shipley, Bill; Vile, Denis; Garnier, Eric			From plant traits to plant communities: A statistical mechanistic approach to biodiversity	SCIENCE			English	Article							LOTKA-VOLTERRA EQUATIONS	We developed a quantitative method, analogous to those used in statistical mechanics, to predict how biodiversity will vary across environments, which plant species from a species pool will be found in which relative abundances in a given environment, and which plant traits determine community assembly. This provides a scaling from plant traits to ecological communities while bypassing the complications of population dynamics. Our method treats community development as a sorting process involving species that are ecologically equivalent except with respect to particular functional traits, which leads to a constrained random assembly of species; the relative abundance of each species adheres to a general exponential distribution as a function of its traits. Using data for eight functional traits of 30 herbaceous species and community-aggregated values of these traits in 12 sites along a 42-year chronosequence of secondary succession, we predicted 94% of the variance in the relative abundances.	Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; CNRS, UMR 5175, Ctr Ecol Fonct & Evolut, F-34293 Montpellier 5, France	University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Shipley, B (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	bill.shipley@usherbrooke.ca	Vile, Denis/A-5637-2008; Garnier, Eric/D-1650-2012; Shipley, Bill/A-4578-2011	Vile, Denis/0000-0002-7948-1462; Garnier, Eric/0000-0002-9392-5154; Shipley, Bill/0000-0002-7026-3880				Alexeyev VL, 1997, B MATH BIOL, V59, P649, DOI 10.1007/BF02458424; Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028; DellaPietra S, 1997, IEEE T PATTERN ANAL, V19, P380, DOI 10.1109/34.588021; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Garnier E, 2001, NEW PHYTOL, V152, P69, DOI 10.1046/j.0028-646x.2001.00239.x; Gause G.F., 1934, STRUGGLE EXISTENCE; Grime J. P, 2001, PLANT STRATEGIES VEG; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hubbell Stephen P., 2001, V32, pi; Jaynes E.T., 2003, PROBABILITY THEORY L; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KERNER EH, 1964, GIBBS ENSEMBLE BIOL; Levich AP, 2000, ECOL MODEL, V131, P207, DOI 10.1016/S0304-3800(00)00259-3; LEVICH AP, 1988, LECT THEORETICAL BIO, P121; Lurie D., 1984, THERMODYNAMICS REGUL, P257; MacArthur R.H., 1972, pvii; MAURER BA, 1999, UNTANGLING ECOLOGICA; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; Plank M, 1996, NONLINEARITY, V9, P887, DOI 10.1088/0951-7715/9/4/004; PLANK M, 1995, J MATH PHYS, V36, P3520, DOI 10.1063/1.530978; Plank M, 1999, SIAM J APPL MATH, V59, P1540, DOI 10.1137/S0036139997319463; Roff D.A., 2012, EVOLUTIONARY QUANTIT; Shannon C., 1964, MATH THEORY COMMUNIC; Tilman D., 1982, Monographs in Population Biology, pi; VANDERMEER JH, 1969, ECOLOGY, V50, P362, DOI 10.2307/1933884; Vile D, 2006, ECOLOGY, V87, P504, DOI 10.1890/05-0822; Volterra V., 1931, LE ONS THEORIE MATHE; WEIHER E, 1995, OIKOS, V73, P323, DOI 10.2307/3545956	30	440	460	9	335	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					812	814		10.1126/science.1131344	http://dx.doi.org/10.1126/science.1131344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17023613				2022-12-01	WOS:000241729800045
J	Ivanov, II; McKenzie, BS; Zhou, L; Tadokoro, CE; Lepelley, A; Lafaille, JJ; Cua, DJ; Littman, DR				Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.			The orphan nuclear receptor ROR gamma t directs the differentiation program of proinflammatory IL-17(+) T helper cells	CELL			English	Article							ISOLATED LYMPHOID FOLLICLES; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; TGF-BETA; LINEAGE COMMITMENT; INTERLEUKIN-17; INFLAMMATION; IL-23; IMMUNE; INDUCTION	IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease. We show here that the orphan nuclear receptor ROR gamma t is the key transcription factor that orchestrates the differentiation of this effector cell lineage. ROR gamma t induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4(+) T helper cells and is required for their expression in response to IL-6 and TGF-beta, the cytokines known to induce IL-17. Th17 cells are constitutively present throughout the intestinal lamina propria, express ROR gamma t, and are absent in mice deficient for ROR gamma t or IL-6. Mice with ROR gamma t-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells. Together, these studies suggest that ROR gamma t is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.	NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; Schering Plough BioPharm, DNAX Discovery Res, Palo Alto, CA 94304 USA	New York University; Howard Hughes Medical Institute; New York University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Cua, DJ (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, 550 1St Ave, New York, NY 10016 USA.	daniel.cua@spcorp.com; littman@saturn.med.nyu.edu	Lepelley, Alice/P-1197-2018; Lepelley, Alice/AAX-4611-2021; Tadokoro, Carlos E/D-5111-2011	Lepelley, Alice/0000-0001-8656-7291; Lepelley, Alice/0000-0001-8656-7291; Tadokoro, Carlos Eduardo/0000-0002-7874-5657				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Christen U, 2004, IMMUNOL RES, V30, P309, DOI 10.1385/IR:30:3:309; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Glimcher LH, 2000, GENE DEV, V14, P1693; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M., 2004, Current Drug Targets - Inflammation and Allergy, V3, P395, DOI 10.2174/1568010042634497; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Newberry RD, 2005, IMMUNOL REV, V206, P6, DOI 10.1111/j.0105-2896.2005.00282.x; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.immunol.12.1.635; Stamp LK, 2004, IMMUNOL CELL BIOL, V82, P1, DOI 10.1111/j.1440-1711.2004.01212.x; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taylor RT, 2005, IMMUNOL RES, V33, P167, DOI 10.1385/IR:33:2:167; TREMBLEAU S, 1995, IMMUNOL TODAY, V16, P383, DOI 10.1016/0167-5699(95)80006-9; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	3735	4135	10	202	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1121	1133		10.1016/j.cell.2006.07.035	http://dx.doi.org/10.1016/j.cell.2006.07.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990136	Bronze			2022-12-01	WOS:000240897600018
J	Klein, DJ; Ferre-D'Amare, AR				Klein, Daniel J.; Ferre-D'Amare, Adrian R.			Structural basis of glmS ribozyme activation by glucosamine-6-phosphate	SCIENCE			English	Article							DELTA VIRUS RIBOZYME; SELF-CLEAVAGE ACTIVITY; HAIRPIN RIBOZYME; CRYSTAL-STRUCTURE; GENE-EXPRESSION; LIGAND-BINDING; RNA; RIBOSWITCH; CATALYSIS; PSEUDOKNOT	The glmS ribozyme is the only natural catalytic RNA known to require a small-molecule activator for catalysis. This catalytic RNA functions as a riboswitch, with activator-dependent RNA cleavage regulating glmS messenger RNA expression. We report crystal structures of the glmS ribozyme in precleavage states that are unliganded or bound to the competitive inhibitor glucose-6-phosphate and in the postcleavage state. All structures superimpose closely, revealing a remarkably rigid RNA that contains a preformed active and coenzyme-binding site. Unlike other riboswitches, the glmS ribozyme binds its activator in an open, solvent-accessible pocket. Our structures suggest that the amine group of the glmS ribozyme-bound coenzyme performs general acid-base and electrostatic catalysis.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063576] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63576] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; Carothers JM, 2006, RNA, V12, P567, DOI 10.1261/rna.2251306; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; EDWARDS TE, IN PRESS STRUCTURE; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Hampel KJ, 2006, BIOCHEMISTRY-US, V45, P7861, DOI 10.1021/bi060337z; Jansen JA, 2006, NAT STRUCT MOL BIOL, V13, P517, DOI 10.1038/nsmb1094; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; Kuzmin YI, 2005, J MOL BIOL, V349, P989, DOI 10.1016/j.jmb.2005.04.005; Lebruska LL, 2002, CHEM BIOL, V9, P465, DOI 10.1016/S1074-5521(02)00130-8; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; Roth A, 2006, RNA, V12, P607, DOI 10.1261/rna.2266506; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Salter J, 2006, BIOCHEMISTRY-US, V45, P686, DOI 10.1021/bi051887k; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup GA, 2006, NUCLEIC ACIDS RES, V34, P968, DOI 10.1093/nar/gkj497; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; Wilkinson SR, 2005, RNA, V11, P1788, DOI 10.1261/rna.2203605; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335	36	286	309	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1752	1756		10.1126/science.1129666	http://dx.doi.org/10.1126/science.1129666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990543				2022-12-01	WOS:000240655700038
J	Ma, Y; Creanga, A; Lum, L; Beachy, PA				Ma, Yong; Creanga, Adrian; Lum, Lawrence; Beachy, Philip A.			Prevalence of off-target effects in Drosophila RNA interference screens	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; SIGNALING PATHWAY; CULTURED-CELLS; COMPONENTS; SECRETION; PROTEIN; SIRNAS	RNA interference (RNAi) in both plants and animals is mediated by small RNAs of approximately 21 - 23 nucleotides in length for regulation of target gene expression at multiple levels through partial sequence complementarities(1,2). Combined with widespread genome sequencing, experimental use of RNAi has the potential to interrogate systematically all genes in a given organism with respect to a particular function(3-9). However, owing to a tolerance for mismatches and gaps in base-pairing with targets(10-12), small RNAs could have up to hundreds of potential target sequences in a genome(13,14), and some small RNAs in mammalian systems have been shown to affect the levels of many messenger RNAs besides their intended targets(15,16). The use of long double-stranded RNAs (dsRNAs) in Drosophila, where Dicer-mediated processing produces small RNAs inside cells, has been thought to reduce the probability of such 'off-target effects' (OTEs)(5). Here we show, however, that OTEs mediated by short homology stretches within long dsRNAs are prevalent in Drosophila. We have performed a genome-wide RNAi screen for novel components of Wingless (Wg) signal transduction(17) in Drosophila S2R+ cells, and found few, if any, legitimate candidates. Rather, many of the top candidates exert their effects on Wg response through OTEs on known pathway components or through promiscuous OTEs produced by tandem trinucleotide repeats present in many dsRNAs and genes. Genes containing such repeats are overrepresented in candidate lists from published screens, suggesting that they represent a common class of false positives. Our results suggest simple measures to improve the reliability of genome-wide RNAi screens in Drosophila and other organisms.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Beachy, PA (corresponding author), Stanford Univ, Dept Dev Biol, B300 Beckman Bldg,279 Campus Dr W, W Stanford, CA 94305 USA.	pbeachy@stanford.edu						Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615	26	226	237	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					359	363		10.1038/nature05179	http://dx.doi.org/10.1038/nature05179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16964239				2022-12-01	WOS:000240622000051
J	Agranoff, D; Fernandez-Reyes, D; Papadopoulos, MC; Rojas, SA; Herbster, M; Loosemore, A; Tarelli, E; Sheldon, J; Schwenk, A; Pollak, R; Rayner, CFJ; Krishna, S				Agranoff, Dan; Fernandez-Reyes, Delmiro; Papadopoulos, Marios C.; Rojas, Sergio A.; Herbster, Mark; Loosemore, Alison; Tarelli, Edward; Sheldon, Jo; Schwenk, Achim; Pollak, Richard; Rayner, Charlotte F. J.; Krishna, Sarjeev			Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum	LANCET			English	Article							MASS-SPECTROMETRY; AMYLOID-A; PROTEIN; CANCER; BIOMARKER	Background We investigated the potential of proteomic fingerprinting with mass spectrometric serum profiling, coupled with pattern recognition methods, to identify biomarkers that could improve diagnosis of tuberculosis. Methods We obtained serum proteomic profiles from patients with active tuberculosis and controls by surface-enhanced laser desorption ionisation time of flight mass spectrometry. A supervised machine-learning approach based on the support vector machine (SVM) was used to obtain a classifier that distinguished between the groups in two independent test sets. We used k-fold cross validation and random sampling of the SVM classifier to assess the classifier further. Relevant mass peaks were selected by correlational analysis and assessed with SVM We tested the diagnostic potential of candidate biomarkers, identified by peptide mass fingerprinting, by conventional immunoassays and SVM classifiers trained on these data. Findings Our SVM classifier discriminated the proteomic profile of patients with active tuberculosis from that of controls with overlapping clinical features. Diagnostic accuracy was 94% (sensitivity 93.5%, specificity 94.9%) for patients with tuberculosis and was unaffected by HIV status. A classifier trained on the 20 most informative peaks achieved diagnostic accuracy of 90%. From these peaks, two peptides (serum amyloid A protein and transthyretin) were identified and quantitated by immunoassay. Because these peptides reflect inflammatory states, we also quantitated neopterin and C reactive protein. Application of an SVM classifier using combinations of these values gave diagnostic accuracies of up to 84% for tuberculosis. Validation on a second, prospectively collected testing set gave similar accuracies using the whole proteomic signature and the 20 selected peaks. Using combinations of the four biomarkers, we achieved diagnostic accuracies of up to 78%. Interpretation The potential biomarkers for tuberculosis that we identified through proteomic fingerprinting and pattern recognition have a plausible biological connection with the disease and could be used to develop new diagnostic tests.	Univ London, St Georges, Ctr Infect, Div Cellular & Mol Med, London SW17 0RE, England; Univ London, St Georges, Biom Ctr, London SW17 0RE, England; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Natl Inst Med Res, Div Math Biol, London NW7 1AA, England; UCL, Dept Comp Sci, London WC1E 6BT, England; N Middlesex Univ Hosp NHS Trust, London, England; St Georges Healthcare Trust, London, England	St Georges University London; University of London; St Georges University London; University of London; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; University College London; St Georges University London	Krishna, S (corresponding author), Univ London, St Georges, Ctr Infect, Div Cellular & Mol Med, London SW17 0RE, England.	s.krishna@sgul.ac.uk		Papadopoulos, Marios/0000-0001-9174-4176; Pollok, Richard/0000-0001-6452-6763; Krishna, Sanjeev/0000-0003-0066-0634; Fernandez-Reyes, Delmiro/0000-0001-5070-9198	Medical Research Council [MC_U117585869] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U117585869] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adam BL, 2002, CANCER RES, V62, P3609; [Anonymous], GLOB TUB CONTR SURV; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Cho WCS, 2004, CLIN CANCER RES, V10, P43, DOI 10.1158/1078-0432.CCR-0413-3; Cristianini N, 2000, INTRO SUPPORT VECTOR; CROWLE AJ, 1989, INFECT IMMUN, V57, P840, DOI 10.1128/IAI.57.3.840-844.1989; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; FREUND Y, 1996, BAR 13 INT C MACH LE, P148; Guyon I., 2003, J MACH LEARN RES, V23, P1157, DOI [10.1162/153244303322753616, 10.5555/944919.944968, DOI 10.1162/153244303322753616, 10.1023/A:1024068626366]; Hanekom WA, 1997, J PEDIATR-US, V131, P925, DOI 10.1016/S0022-3476(97)70046-5; Hosp M, 1997, LUNG, V175, P265, DOI 10.1007/PL00007573; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Joachims T., 1999, MAKING LARGE SCALE S; Kiernan UA, 2003, FEBS LETT, V537, P166, DOI 10.1016/S0014-5793(03)00097-8; Koyanagi A, 2004, ANN TROP MED PARASIT, V98, P391, DOI 10.1179/000349804225003424; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; Mwinga A, 2004, TROP MED INT HEALTH, V9, P827, DOI 10.1111/j.1365-3156.2004.01274.x; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perkins MD, 2003, CHEST, V123, P107, DOI 10.1378/chest.123.1.107; Perkins MD, 2002, B WORLD HEALTH ORGAN, V80, P512; PETERSON PA, 1971, J BIOL CHEM, V246, P34; Petricoin EF, 2004, CURR OPIN BIOTECH, V15, P24, DOI 10.1016/j.copbio.2004.01.005; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Quinlan J. R, 2014, C4 5 PROGRAMS MACHIN; Rathman G, 2003, INT J TUBERC LUNG D, V7, P942; *RES TRAIN TROP DI, WHO TDR TB SPEC BANK; Rosenblatt F., 1962, PRINCIPLES NEURODYNA; Salazar A, 2001, EUR J CLIN INVEST, V31, P1070, DOI 10.1046/j.1365-2362.2001.00913.x; SCHWEIGHOFER A, MATLAB INTERFACE SVM; Stork D.G., 2001, PATTERN CLASSIFICATI, V2nd; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097; Vapnik V. N., 1998, STAT LEARNING THEORY; von Eggeling F, 2001, ELECTROPHORESIS, V22, P2898, DOI 10.1002/1522-2683(200108)22:14<2898::AID-ELPS2898>3.0.CO;2-A; WESTON J, SPIDER DEP EMPIRICAL; Witten I., 2000, DATA MINING PRACTICA; Yi R, 2004, PROTEOMICS, V4, P3477, DOI 10.1002/pmic.200400897; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	41	220	244	0	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					1012	1021		10.1016/S0140-6736(06)69342-2	http://dx.doi.org/10.1016/S0140-6736(06)69342-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980117	Green Published, Bronze			2022-12-01	WOS:000240698700030
J	Compston, JE; Seeman, E				Compston, Juliet E.; Seeman, Ego			Compliance with osteoporosis therapy is the weakest link	LANCET			English	Editorial Material							POSTMENOPAUSAL OSTEOPOROSIS; FRACTURE RATES; ADHERENCE; PERSISTENCE; IMPACT; WOMEN		Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Med, Cambridge CB2 2QQ, England; Austin & Repatriat Med Ctr, Dept Endocrinol, Heidelberg, Vic 3084, Australia	Addenbrooke's Hospital; University of Cambridge; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Compston, JE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Med, Cambridge CB2 2QQ, England.	jec1001@cam.ac.uk	Seeman, Ego/AAC-3656-2019	Seeman, Ego/0000-0002-9692-048X				CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Caro JJ, 2004, OSTEOPOROSIS INT, V15, P1003, DOI 10.1007/s00198-004-1652-z; Clowes JA, 2004, J CLIN ENDOCR METAB, V89, P1117, DOI 10.1210/jc.2003-030501; Cooper A, 2006, INT J CLIN PRACT, V60, P896, DOI 10.1111/j.1742-1241.2006.01059.x; Cramer JA, 2005, CURR MED RES OPIN, V21, P1453, DOI 10.1185/030079905X61875; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; GUILERA M, 2005, OSTEOPOROSIS INT, V17, P1; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Huybrechts KF, 2006, BONE, V38, P922, DOI 10.1016/j.bone.2005.10.022; McCombs JS, 2004, MATURITAS, V48, P271, DOI 10.1016/j.maturitas.2004.02.005; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414	12	59	62	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					973	974		10.1016/S0140-6736(06)69394-X	http://dx.doi.org/10.1016/S0140-6736(06)69394-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980096				2022-12-01	WOS:000240698700008
J	Tuskan, GA; DiFazio, S; Jansson, S; Bohlmann, J; Grigoriev, I; Hellsten, U; Putnam, N; Ralph, S; Rombauts, S; Salamov, A; Schein, J; Sterck, L; Aerts, A; Bhalerao, RR; Bhalerao, RP; Blaudez, D; Boerjan, W; Brun, A; Brunner, A; Busov, V; Campbell, M; Carlson, J; Chalot, M; Chapman, J; Chen, GL; Cooper, D; Coutinho, PM; Couturier, J; Covert, S; Cronk, Q; Cunningham, R; Davis, J; Degroeve, S; Dejardin, A; Depamphilis, C; Detter, J; Dirks, B; Dubchak, I; Duplessis, S; Ehlting, J; Ellis, B; Gendler, K; Goodstein, D; Gribskov, M; Grimwood, J; Groover, A; Gunter, L; Hamberger, B; Heinze, B; Helariutta, Y; Henrissat, B; Holligan, D; Holt, R; Huang, W; Islam-Faridi, N; Jones, S; Jones-Rhoades, M; Jorgensen, R; Joshi, C; Kangasjarvi, J; Karlsson, J; Kelleher, C; Kirkpatrick, R; Kirst, M; Kohler, A; Kalluri, U; Larimer, F; Leebens-Mack, J; Leple, JC; Locascio, P; Lou, Y; Lucas, S; Martin, F; Montanini, B; Napoli, C; Nelson, DR; Nelson, C; Nieminen, K; Nilsson, O; Pereda, V; Peter, G; Philippe, R; Pilate, G; Poliakov, A; Razumovskaya, J; Richardson, P; Rinaldi, C; Ritland, K; Rouze, P; Ryaboy, D; Schmutz, J; Schrader, J; Segerman, B; Shin, H; Siddiqui, A; Sterky, F; Terry, A; Tsai, CJ; Uberbacher, E; Unneberg, P; Vahala, J; Wall, K; Wessler, S; Yang, G; Yin, T; Douglas, C; Marra, M; Sandberg, G; Van de Peer, Y; Rokhsar, D				Tuskan, G. A.; DiFazio, S.; Jansson, S.; Bohlmann, J.; Grigoriev, I.; Hellsten, U.; Putnam, N.; Ralph, S.; Rombauts, S.; Salamov, A.; Schein, J.; Sterck, L.; Aerts, A.; Bhalerao, R. R.; Bhalerao, R. P.; Blaudez, D.; Boerjan, W.; Brun, A.; Brunner, A.; Busov, V.; Campbell, M.; Carlson, J.; Chalot, M.; Chapman, J.; Chen, G. -L.; Cooper, D.; Coutinho, P. M.; Couturier, J.; Covert, S.; Cronk, Q.; Cunningham, R.; Davis, J.; Degroeve, S.; Dejardin, A.; dePamphilis, C.; Detter, J.; Dirks, B.; Dubchak, I.; Duplessis, S.; Ehlting, J.; Ellis, B.; Gendler, K.; Goodstein, D.; Gribskov, M.; Grimwood, J.; Groover, A.; Gunter, L.; Hamberger, B.; Heinze, B.; Helariutta, Y.; Henrissat, B.; Holligan, D.; Holt, R.; Huang, W.; Islam-Faridi, N.; Jones, S.; Jones-Rhoades, M.; Jorgensen, R.; Joshi, C.; Kangasjarvi, J.; Karlsson, J.; Kelleher, C.; Kirkpatrick, R.; Kirst, M.; Kohler, A.; Kalluri, U.; Larimer, F.; Leebens-Mack, J.; Leple, J. -C.; Locascio, P.; Lou, Y.; Lucas, S.; Martin, F.; Montanini, B.; Napoli, C.; Nelson, D. R.; Nelson, C.; Nieminen, K.; Nilsson, O.; Pereda, V.; Peter, G.; Philippe, R.; Pilate, G.; Poliakov, A.; Razumovskaya, J.; Richardson, P.; Rinaldi, C.; Ritland, K.; Rouze, P.; Ryaboy, D.; Schmutz, J.; Schrader, J.; Segerman, B.; Shin, H.; Siddiqui, A.; Sterky, F.; Terry, A.; Tsai, C. -J.; Uberbacher, E.; Unneberg, P.; Vahala, J.; Wall, K.; Wessler, S.; Yang, G.; Yin, T.; Douglas, C.; Marra, M.; Sandberg, G.; Van de Peer, Y.; Rokhsar, D.			The genome of black cottonwood, Populus trichocarpa (Torr. & Gray)	SCIENCE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; ARABIDOPSIS-THALIANA; HYBRID POPLAR; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATORS; PHENYLPROPANOID METABOLISM; GRAVITATIONAL INDUCTION; LIGNIN BIOSYNTHESIS; RESISTANCE GENES; QUAKING ASPEN	We report the draft genome of the black cottonwood tree, Populus trichocarpa. Integration of shotgun sequence assembly with genetic mapping enabled chromosome-scale reconstruction of the genome. More than 45,000 putative protein-coding genes were identified. Analysis of the assembled genome revealed a whole-genome duplication event; about 8000 pairs of duplicated genes from that event survived in the Populus genome. A second, older duplication event is indistinguishably coincident with the divergence of the Populus and Arabidopsis lineages. Nucleotide substitution, tandem gene duplication, and gross chromosomal rearrangement appear to proceed substantially more slowly in Populus than in Arabidopsis. Populus has more protein-coding genes than Arabidopsis, ranging on average from 1.4 to 1.6 putative Populus homologs for each Arabidopsis gene. However, the relative frequency of protein domains in the two genomes is similar. Overrepresented exceptions in Populus include genes associated with lignocellulosic wall biosynthesis, meristem development, disease resistance, and metabolite transport.	Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN 37831 USA; Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; Univ Henri Poincare, INRA Nancy, INRA, Tree Microbe Interact Unit, F-54280 Champenoux, France; Virginia Polytech Inst & State Univ, Dept Forestry, Blacksburg, VA 24061 USA; Michigan Technol Univ, Sch Forest Resources & Environm Sci, Biotechnol Res Ctr, Houghton, MI 49931 USA; Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; CNRS, UMR 6098, F-13288 Marseille, France; Univ Aix Marseille 1, F-13288 Marseille, France; Univ Aix Marseille 2, F-13288 Marseille, France; Univ Georgia, Warnell Sch Forest Resources, Athens, GA 30602 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Univ Florida, Sch Forest Resources & Conservat, Inst Genet, Gainesville, FL 32611 USA; Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA; INRA, Unit Forest Improvement Genet & Physiol, F-45166 Olivet, France; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Stanford Univ, Sch Med, Stanford Human Genome Ctr, Palo Alto, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94305 USA; US Forest Serv, Inst Forest Genet, USDA, Davis, CA 95616 USA; Fed Res Ctr Forests, A-1140 Vienna, Austria; Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, FI-00014 Helsinki, Finland; Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland; Univ Turku, Dept Biol, FI-20014 Turku, Finland; Texas A&M Univ, Dept Forest Sci, College Stn, TX 77843 USA; Texas A&M Univ, So Inst Forest Genet, USDA, Forest Serv, College Stn, TX 77843 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; Univ Tennessee, Ctr Excellence Genom & Bioinformat, Memphis, TN 38163 USA; US Forest Serv, So Inst Forest Genet, USDA, Saucier, MS 39574 USA; Univ Tubingen, D-72076 Tubingen, Germany; AlbaNova Univ Ctr, KTH, Dept Biotechnol, SE-10691 Stockholm, Sweden	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; West Virginia University; Umea University; University of British Columbia; University of British Columbia; University of British Columbia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Flanders Institute for Biotechnology (VIB); Ghent University; Swedish University of Agricultural Sciences; Umea University; INRAE; Universite de Lorraine; Virginia Polytechnic Institute & State University; Michigan Technological University; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; State University System of Florida; University of Florida; INRAE; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; Stanford University; United States Department of Agriculture (USDA); United States Forest Service; University of Helsinki; University of Helsinki; University of Turku; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Forest Service; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; United States Department of Agriculture (USDA); United States Forest Service; Eberhard Karls University of Tubingen; Royal Institute of Technology	Tuskan, GA (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	gtk@ornl.gov	Boerjan, Wout/Y-4158-2019; Terry, Astrid Y/A-2538-2011; Pereda-Loth, Veronica/A-1296-2011; Putnam, Nicholas/B-9968-2008; Van de Peer, Yves/AAE-7666-2019; Heinze, Berthold/A-8734-2011; Gribskov, Michael/AAH-5905-2021; Grimwood, Jane/ABD-5737-2021; LEPLE, Jean-Charles/H-4210-2012; KALLURI, UDAYA/A-6218-2011; CHALOT, Michel/A-1113-2012; Nieminen, Kaisa/N-9051-2015; Couturier, Jérémy/AAF-6588-2020; Jansson, Stefan/A-1119-2009; , DUPLESSIS/G-4150-2011; Marra, Marco A/B-5987-2008; Karlsson, Jan/E-7199-2015; Tsai, CJ/C-2450-2009; Leebens-Mack, James/AAF-6770-2019; Gunter, Lee E/L-3480-2016; Helariutta, Yrjo/AAE-8149-2020; Sterck, Lieven/A-9439-2016; Rombauts, Stephane M/D-7640-2014; Pilate, Gilles/E-8784-2017; dePamphilis, Claude W/P-6652-2016; Tuskan, Gerald/A-6225-2011; Holt, Robert A/C-3303-2009; LEPLE, Jean-Charles/AAT-7414-2021; Kangasjärvi, Jaakko/AAP-8639-2021; Blaudez, Damien/AAF-6517-2020; LEPLE, Jean charles/L-9604-2014; Schmutz, Jeremy/N-3173-2013; Pilate, Gilles/D-1666-2011; Rombauts, Stephane/P-2420-2019; Kohler, Annegret/AAD-1876-2019; Jones, Steven J/C-3621-2009; Douglas, Carl J/B-1384-2013; Déjardin, Annabelle/AAU-1840-2021; Van de Peer, Yves/D-4388-2009; Schein, Jacquie E/G-3674-2015; Kangasjärvi, Jaakko/A-3024-2015; Henrissat, Bernard/J-2475-2012; Kelleher, Colin/L-1986-2019; Coutinho, Pedro M/C-4473-2008; Hamberger, Bjoern/I-2122-2012	Boerjan, Wout/0000-0003-1495-510X; Terry, Astrid Y/0000-0002-5234-1224; Putnam, Nicholas/0000-0002-1315-782X; Van de Peer, Yves/0000-0003-4327-3730; Heinze, Berthold/0000-0002-7571-9138; CHALOT, Michel/0000-0001-8614-0917; Couturier, Jérémy/0000-0003-3127-2669; Jansson, Stefan/0000-0002-7906-6891; , DUPLESSIS/0000-0002-2072-2989; Marra, Marco A/0000-0001-7146-7175; Karlsson, Jan/0000-0002-6002-929X; Tsai, CJ/0000-0002-9282-7704; Leebens-Mack, James/0000-0003-4811-2231; Gunter, Lee E/0000-0003-1211-7532; Helariutta, Yrjo/0000-0002-7287-8459; Sterck, Lieven/0000-0001-7116-4000; Rombauts, Stephane M/0000-0002-3985-4981; Pilate, Gilles/0000-0003-4802-8849; Tuskan, Gerald/0000-0003-0106-1289; Holt, Robert A/0000-0002-7259-1247; LEPLE, Jean-Charles/0000-0003-4125-0738; Kangasjärvi, Jaakko/0000-0002-8959-1809; LEPLE, Jean charles/0000-0003-4125-0738; Schmutz, Jeremy/0000-0001-8062-9172; Rombauts, Stephane/0000-0002-3985-4981; Jones, Steven J/0000-0003-3394-2208; Van de Peer, Yves/0000-0003-4327-3730; Kangasjärvi, Jaakko/0000-0002-8959-1809; Henrissat, Bernard/0000-0002-3434-8588; Hamberger, Bjoern/0000-0003-1249-1807; Ehlting, Jurgen/0000-0003-2302-696X; Davis, John/0000-0002-8522-5406; , Dawn/0000-0001-8996-3572; Bhalerao, Rishikesh/0000-0003-4384-7036; Kelleher, Colin/0000-0002-1551-8297; Montanini, Barbara/0000-0002-5419-7975; Degroeve, Sven/0000-0001-8349-3370; KALLURI, UDAYA/0000-0002-5963-8370; Cronk, Quentin/0000-0002-4027-7368; Campbell, Malcolm/0000-0002-1396-6651; Unneberg, Per/0000-0001-5735-3315; Rokhsar, Daniel/0000-0002-8704-2224; /0000-0003-3281-8088; Jorgensen, Richard/0000-0002-0382-2371; Brun-Jacob, Annick/0000-0002-0299-2766; Nelson, David/0000-0003-0583-5421; Dejardin, Annabelle/0000-0002-7576-5476; Grigoriev, Igor/0000-0002-3136-8903; Goodstein, David/0000-0001-6287-2697; Nieminen, Kaisa/0000-0001-7004-9422; Nilsson, Ove/0000-0002-1033-1909; DiFazio, Stephen/0000-0003-4077-1590; Gribskov, Michael/0000-0002-1718-0242; Blaudez, Damien/0000-0003-3287-3482				Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Andersson-Gunneras S, 2003, PLANT J, V34, P339, DOI 10.1046/j.1365-313X.2003.01727.x; Arimura G, 2004, PLANT J, V37, P603, DOI 10.1111/j.1365-313X.2003.01987.x; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BRADSHAW HD, 1993, THEOR APPL GENET, V86, P301, DOI 10.1007/BF00222092; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Cline MG, 2002, ANN BOT-LONDON, V90, P417, DOI 10.1093/aob/mcf195; COLLINSON ME, 1992, P ROY SOC EDINB B, V98, P155, DOI 10.1017/S0269727000007521; Costa MA, 2003, PHYTOCHEMISTRY, V64, P1097, DOI 10.1016/S0031-9422(03)00517-X; Cukovic D, 2001, BIOL CHEM, V382, P645, DOI 10.1515/BC.2001.076; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; DESA MM, 1992, PLANT PHYSIOL, V98, P728, DOI 10.1104/pp.98.2.728; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Djerbi S, 2005, PLANTA, V221, P739, DOI 10.1007/s00425-005-1498-4; Dode L.A., 1905, B SOC HIST NAT AUTUN, V18, P161; ECKENWALDER JE, 1996, BIOL POPULUS ITS IMP, pCH1; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; FAO ( Food and Agriculture Organization of the United Nations), 2003, STAT WORLDS FOR 2003; Gebre GM, 1998, TREE PHYSIOL, V18, P645; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; HANLEY SJ, IN PRESS TREE GENET; Hellgren JM, 2004, PLANT PHYSIOL, V135, P212, DOI 10.1104/pp.104.038927; Hokamp Karsten, 2003, Journal of Structural and Functional Genomics, V3, P95, DOI 10.1023/A:1022661917301; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joshi CP, 2004, NEW PHYTOL, V164, P53, DOI 10.1111/j.1469-8137.2004.01155.x; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koornneef M, 2003, CHROMOSOME RES, V11, P183, DOI 10.1023/A:1022827624082; Li LG, 2001, PLANT CELL, V13, P1567, DOI 10.1105/tpc.13.7.1567; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MACKAY JJ, 1995, MOL GEN GENET, V247, P537, DOI 10.1007/BF00290344; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Meilan Richard, 2006, V344, P143; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Moyle R, 2002, PLANT J, V31, P675, DOI 10.1046/j.1365-313X.2002.01386.x; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; OMALLEY DM, 1992, PLANT PHYSIOL, V98, P1364, DOI 10.1104/pp.98.4.1364; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; REGNIER R, 1956, REV SOC SAVANTES NOR, V1, P1; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; RUONALA R, IN PRESS PLANT J; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Samuga A, 2004, GENE, V334, P73, DOI 10.1016/j.gene.2004.02.057; Santamaria O, 2005, FOREST PATHOL, V35, P95, DOI 10.1111/j.1439-0329.2004.00389.x; SCHIEX T, 2001, LNCS, V2066, P118; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; Stettler R. F., 1996, BIOL POPULUS ITS IMP, P1; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2004, PLANT BIOLOGY, V6, P2, DOI 10.1055/s-2003-44715; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; Tuskan GA, 2001, FOREST CHRON, V77, P259, DOI 10.5558/tfc77259-2; Tuskan GA, 1998, BIOMASS BIOENERG, V14, P307, DOI 10.1016/S0961-9534(97)10065-4; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585; Whitham S, 1996, P NATL ACAD SCI USA, V93, P8776, DOI 10.1073/pnas.93.16.8776; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wullschleger S, 2005, CAN J FOREST RES, V35, P1779, DOI 10.1139/x05-101; Xu Y, 1997, J COMPUT BIOL, V4, P325, DOI 10.1089/cmb.1997.4.325; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Zahn LM, 2005, J HERED, V96, P225, DOI 10.1093/jhered/esi033	79	3060	3665	28	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1596	1604		10.1126/science.1128691	http://dx.doi.org/10.1126/science.1128691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973872	Green Submitted			2022-12-01	WOS:000240498900035
J	Emoto, K; Parrish, JZ; Jan, LY; Jan, YN				Emoto, Kazuo; Parrish, Jay Z.; Jan, Lily Yeh; Jan, Yuh-Nung			The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance	NATURE			English	Article							DROSOPHILA SENSORY NEURONS; CELL-PROLIFERATION; PROMOTES APOPTOSIS; PROTEIN-KINASE; SIGNALING PATHWAY; FAMILY; ENCODES; GROWTH; SHAPE; MORPHOGENESIS	Precise patterning of dendritic fields is essential for neuronal circuit formation and function, but how neurons establish and maintain their dendritic fields during development is poorly understood. In Drosophila class IV dendritic arborization neurons, dendritic tiling, which allows for the complete but nonoverlapping coverage of the dendritic fields(1-3), is established through a 'like-repels-like' behaviour of dendrites mediated by Tricornered (Trc), one of two NDR ( nuclear Dbf2-related) family kinases in Drosophila(4-7). Here we report that the other NDR family kinase, the tumour suppressor Warts/Lats (Wts)(8-10), regulates the maintenance of dendrites; in wts mutants, dendrites initially tile the body wall normally, but progressively lose branches at later larval stages, whereas the axon shows no obvious defects. We further provide biochemical and genetic evidence for the tumour suppressor kinase Hippo (Hpo)(11-15) as an upstream regulator of Wts and Trc for dendrite maintenance and tiling, respectively, thereby revealing important functions of tumour suppressor genes of the Hpo signalling pathway in dendrite morphogenesis.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	EMOTO, KAZUO/G-4992-2014	Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH071101] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH071101-02, F32 MH071101] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Sugimura K, 2003, J NEUROSCI, V23, P3752; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	29	157	160	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					210	213		10.1038/nature05090	http://dx.doi.org/10.1038/nature05090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16906135				2022-12-01	WOS:000240467000046
J	Broder, DH; Pogliano, K				Broder, Dan H.; Pogliano, Kit			Forespore engulfment mediated by a ratchet-like mechanism	CELL			English	Article							BACILLUS-SUBTILIS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; MEMBRANE-FUSION; MOTHER-CELL; SPORULATION; PROTEIN; LOCALIZATION; RECEPTOR; TRANSLOCATION	A key step in bacterial endospore formation is engulfment, during which one bacterial cell engulfs another in a phagocytosis-like process that normally requires SpoIID, SpoIIM, and SpoIIP (DMP). We here describe a second mechanism involving the zipper-like interaction between the forespore protein SpoIIQ and its mother cell ligand SpoIIIAH, which are essential for engulfment when DMP activity is reduced or SpoIIB is absent. They are also required for the rapid engulfment observed during the enzymatic removal of peptidoglycan, a process that does not require DMP. These results suggest the existence of two separate engulfment machineries that compensate for one another in intact cells, thereby rendering engulfment robust. Photobleaching analysis demonstrates that SpoIIQ assembles a stationary structure, suggesting that SpoIIQ and SpoIIIAH function as a ratchet that renders forward membrane movement irreversible. We suggest that ratchet-mediated engulfment minimizes the utilization of chemical energy during this dramatic cellular reorganization, which occurs during starvation.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pogliano, K (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kpogliano@ucsd.edu		Pogliano, Kit/0000-0002-7868-3345	NIGMS NIH HHS [GM 57045, R01 GM057045, R01 GM057045-11] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; ANTAL T, 2005, IN PRESS PHYS E 1006, DOI DOI 10.1103/PHYS-REVE.72.046104; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; CUTTING S, 1991, J MOL BIOL, V221, P1237; Doan T, 2005, MOL MICROBIOL, V55, P1767, DOI 10.1111/j.1365-2958.2005.04501.x; DRIKS A, 1991, P NATL ACAD SCI USA, V88, P9934, DOI 10.1073/pnas.88.22.9934; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; GRIFFIN FM, 1974, J EXP MED, V139, P323, DOI 10.1084/jem.139.2.323; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; ISBERG RR, 1995, TRENDS CELL BIOL, V5, P120, DOI 10.1016/S0962-8924(00)88962-X; Jiang X, 2005, MOL MICROBIOL, V58, P102, DOI 10.1111/j.1365-2958.2005.04811.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Kroos L, 2000, CURR OPIN MICROBIOL, V3, P553, DOI 10.1016/S1369-5274(00)00140-5; Liu NJL, 2006, MOL MICROBIOL, V59, P1097, DOI 10.1111/j.1365-2958.2005.05004.x; LondonoVallejo JA, 1997, MOL MICROBIOL, V24, P29, DOI 10.1046/j.1365-2958.1997.3181680.x; LOPEZDIAZ I, 1986, J GEN MICROBIOL, V132, P341; MAI J, 2001, IN PRESS PHYS E 0611, DOI DOI 10.1103/PHYSREVE.64.011102; MARGOLIS PS, 1993, J BACTERIOL, V175, P528, DOI 10.1128/JB.175.2.528-540.1993; MCABEE DD, 1985, J CELL PHYSIOL, V124, P240, DOI 10.1002/jcp.1041240211; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Perez AR, 2006, J BACTERIOL, V188, P1159, DOI 10.1128/JB.188.3.1159-1164.2006; Perez AR, 2000, J BACTERIOL, V182, P1096, DOI 10.1128/JB.182.4.1096-1108.2000; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; SMITH K, 1993, J BACTERIOL, V175, P3618, DOI 10.1128/jb.175.11.3618-3627.1993; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Sun YL, 2000, J BACTERIOL, V182, P2919, DOI 10.1128/JB.182.10.2919-2927.2000; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439	43	76	79	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					917	928		10.1016/j.cell.2006.06.053	http://dx.doi.org/10.1016/j.cell.2006.06.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959571	Green Accepted, Bronze			2022-12-01	WOS:000240675000019
J	Levine, RJ; Lam, C; Qian, C; Yu, KF; Maynard, SE; Sachs, BP; Sibai, BM; Epstein, FH; Romero, R; Thadhani, R; Karumanchi, SA				Levine, Richard J.; Lam, Chun; Qian, Cong; Yu, Kai F.; Maynard, Sharon E.; Sachs, Benjamin P.; Sibai, Baha M.; Epstein, Franklin H.; Romero, Roberto; Thadhani, Ravi; Karumanchi, S. Ananth		CPEP Study Grp	Soluble endoglin and other circulating antiangiogenic factors in preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENIC FACTORS; PREGNANCY; RISK; RECEPTOR; WOMEN; HYPERTENSION; TRIAL; PATHOPHYSIOLOGY; NICOTINE	Background: Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be involved in the pathogenesis of preeclampsia. Since soluble endoglin, another antiangiogenic protein, acts together with sFlt1 to induce a severe preeclampsia-like syndrome in pregnant rats, we examined whether it is associated with preeclampsia in women. Methods: We performed a nested case-control study of healthy nulliparous women within the Calcium for Preeclampsia Prevention trial. The study included all 72 women who had preterm preeclampsia (<37 weeks), as well as 480 randomly selected women - 120 women with preeclampsia at term (at >= 37 weeks), 120 women with gestational hypertension, 120 normotensive women who delivered infants who were small for gestational age, and 120 normotensive controls who delivered infants who were not small for gestational age. Results: Circulating soluble endoglin levels increased markedly beginning 2 to 3 months before the onset of preeclampsia. After the onset of clinical disease, the mean serum level in women with preterm preeclampsia was 46.4 ng per milliliter, as compared with 9.8 ng per milliliter in controls (P<0.001). The mean serum level in women with preeclampsia at term was 31.0 ng per milliliter, as compared with 13.3 ng per milliliter in controls (P<0.001). Beginning at 17 weeks through 20 weeks of gestation, soluble endoglin levels were significantly higher in women in whom preterm preeclampsia later developed than in controls (10.2 ng per milliliter vs. 5.8 ng per milliliter, P<0.001), and at 25 through 28 weeks of gestation, the levels were significantly higher in women in whom term preeclampsia developed than in controls (8.5 ng per milliliter vs. 5.9 ng per milliliter, P<0.001). An increased level of soluble endoglin was usually accompanied by an increased ratio of sFlt1:PlGF. The risk of preeclampsia was greatest among women in the highest quartile of the control distributions for both biomarkers but not for either biomarker alone. Conclusions: Rising circulating levels of soluble endoglin and ratios of sFlt1:PlGF herald the onset of preeclampsia.	Beth Israel Deaconess Med Ctr, Dept Med, Div Renal, Ctr Vasc Biol, Boston, MA 02215 USA; NICHHD, Div Epidemiol Stat & Prevent Res, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NICHHD, Perinatol Res Branch, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Mol & Vasc Med Div, Ctr Vasc Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Allied Technol Grp, Rockville, MD USA; George Washington Univ, Sch Med, Dept Med, Washington, DC USA; Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; Wayne State Univ, Sch Med, Detroit, MI USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; George Washington University; University System of Ohio; University of Cincinnati; Wayne State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Levine, RJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Renal, Ctr Vasc Biol, 330 Brookline Ave,RW 663B, Boston, MA 02215 USA.	sananth@bidmc.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [R01 HL-079594] Funding Source: Medline; NICHD NIH HHS [N01-HD-3154, R01 HD-39223, N01-HD-3124, N01-HD-3123, N01-HD-3122, N01-HD-1-3121, N01-HD-5-3246, N01-HD-3126, N01-HD-3125] Funding Source: Medline; NIDDK NIH HHS [R01 DK-065997, R01 DK-67397] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000864, Z01HD002400, Z01HD000373, R01HD039223, N01HD053246, N01HD013121] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065997, R01DK067397] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Belgore FM, 2000, BRIT J BIOMED SCI, V57, P207; Buhimschi CS, 2005, AM J OBSTET GYNECOL, V192, P734, DOI 10.1016/j.ajog.2004.12.052; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chappell LC, 2002, AM J OBSTET GYNECOL, V187, P127, DOI 10.1067/mob.2002.122969; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Cooke JP, 2004, ANN MED, V36, P33, DOI 10.1080/07853890310017576; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; GOUGOS A, 1992, INT IMMUNOL, V4, P83, DOI 10.1093/intimm/4.1.83; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levine RJ, 1996, CONTROL CLIN TRIALS, V17, P442, DOI 10.1016/S0197-2456(96)00106-7; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Polliotti BM, 2003, OBSTET GYNECOL, V101, P1266, DOI 10.1016/S0029-7844(03)00338-7; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Schmidt-Lucke C, 2005, INT J CARDIOL, V100, P207, DOI 10.1016/j.ijcard.2004.05.046; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Strevens H, 2003, BJOG-INT J OBSTET GY, V110, P831, DOI 10.1111/j.1471-0528.2003.02162.x; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; 2006, N ENGL J MED, V354, P980	36	1326	1414	6	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					992	1005		10.1056/NEJMoa055352	http://dx.doi.org/10.1056/NEJMoa055352			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957146				2022-12-01	WOS:000240273300005
J	Gong, B; Cao, ZX; Zheng, P; Vitolo, OV; Liu, SM; Staniszewski, A; Moolman, D; Zhang, H; Shelanski, M; Arancio, O				Gong, Bing; Cao, Zixuan; Zheng, Ping; Vitolo, Ottavio V.; Liu, Shumin; Staniszewski, Agnieszka; Moolman, Donna; Zhang, Hong; Shelanski, Michael; Arancio, Ottavio			Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory	CELL			English	Article							LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; ALZHEIMERS-DISEASE; IN-VIVO; PROTEASOME SYSTEM; PRECURSOR PROTEIN; OXIDATIVE STRESS; MOUSE MODEL; DEGRADATION; MICE	The neuronal ubiquitin/proteasomal pathway has been implicated in the pathogenesis of Alzheimer's disease (AD). We now show that a component of the pathway, ubiquitin C-terminal hydrolase L1 (Uch-L1), is required for normal synaptic and cognitive function. Transduction of Uch-L1 protein fused to the transduction domain of HIV-transactivator protein (TAT) restores normal enzymatic activity and synaptic function both in hippocampal slices treated with oligomeric A beta and in the APP/PS1 mouse model of AD. Moreover, intraperitoneal injections with the fusion protein improve the retention of contextual learning in APP/PS1 mice over time. The beneficial effect of the Uch-L1 fusion protein is associated with restoration of normal levels of the PKA-regulatory subunit II alpha, PKA activity, and CREB phosphorylation.	Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Taub Inst, New York, NY 10032 USA; NYU, Sch Med, Dept Rheumatol, Hosp Joint Dis, New York, NY 10003 USA	Columbia University; Columbia University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Shelanski, M (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.	mls7@columbia.edu; oa1@columbia.edu	arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER; NIA NIH HHS [AG008702] Funding Source: Medline; NINDS NIH HHS [NS015076] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Aravamudan B, 2003, J NEUROBIOL, V54, P417, DOI 10.1002/neu.10142; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; CLECHANOVER A, 2003, NEURON, V40, P427; Cullen WK, 1997, NEUROREPORT, V8, P3213, DOI 10.1097/00001756-199710200-00006; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; de Vrij FMS, 2004, PROG NEUROBIOL, V74, P249, DOI 10.1016/j.pneurobio.2004.10.001; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; ICHIHARA N, 1995, BRAIN RES, V695, P173, DOI 10.1016/0006-8993(95)00729-A; Itoh A, 1999, EUR J PHARMACOL, V382, P167, DOI 10.1016/S0014-2999(99)00601-9; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kim TW, 1997, J BIOL CHEM, V272, P11006; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wood MA, 2005, HIPPOCAMPUS, V15, P610, DOI 10.1002/hipo.20082	38	329	351	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2006	126	4					775	788		10.1016/j.cell.2006.06.046	http://dx.doi.org/10.1016/j.cell.2006.06.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923396	Bronze			2022-12-01	WOS:000240276700025
J	Baker, M; Mackenzie, IR; Pickering-Brown, SM; Gass, J; Rademakers, R; Lindholm, C; Snowden, J; Adamson, J; Sadovnick, AD; Rollinson, S; Cannon, A; Dwosh, E; Neary, D; Melquist, S; Richardson, A; Dickson, D; Berger, Z; Eriksen, J; Robinson, T; Zehr, C; Dickey, CA; Crook, R; McGowan, E; Mann, D; Boeve, B; Feldman, H; Hutton, M				Baker, Matt; Mackenzie, Ian R.; Pickering-Brown, Stuart M.; Gass, Jennifer; Rademakers, Rosa; Lindholm, Caroline; Snowden, Julie; Adamson, Jennifer; Sadovnick, A. Dessa; Rollinson, Sara; Cannon, Ashley; Dwosh, Emily; Neary, David; Melquist, Stacey; Richardson, Anna; Dickson, Dennis; Berger, Zdenek; Eriksen, Jason; Robinson, Todd; Zehr, Cynthia; Dickey, Chad A.; Crook, Richard; McGowan, Eileen; Mann, David; Boeve, Bradley; Feldman, Howard; Hutton, Mike			Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17	NATURE			English	Article							GROWTH-FACTOR; INCLUSIONS; EXPRESSION; DISEASE; FAMILY; 17Q21	Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years(1). A large proportion of FTD patients ( 35 - 50%) have a family history of dementia, consistent with a strong genetic component to the disease(2). In 1998, mutations in the gene encoding the microtubule-associated protein tau ( MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP- 17)(3). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau(3,4). However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787 - D17S806), mutations in MAPT have not been found and the patients consistently lack tauimmunoreactive inclusion pathology(5-12). In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions(11-13). Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation(14). PGRN has also been strongly linked to tumorigenesis(14). Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt - Jakob disease, motor neuron disease and Alzheimer's disease(15,16). Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.	Mayo Clin Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Div Neurol, Vancouver, BC V6T 2B5, Canada; Univ Manchester, Dept Med, Div Lab & Regenerat Med, Manchester M13 9PT, Lancs, England; Hope Hosp, Greater Manchester Neurosci Ctr, Ctr Clin Neurosci, Salford M6 8HD, Lancs, England; Mayo Clin Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; University of British Columbia; University of British Columbia; University of British Columbia; University of Manchester; Mayo Clinic	Hutton, M (corresponding author), Mayo Clin Coll Med, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	ian.mackenzie@vch.ca; hutton.michael@mayo.edu	Calabrese, Massimiliano/I-6195-2012; Dickey, Chad A/H-4441-2011; Pickering-Brown, Stuart/D-4008-2009; Eriksen, Jason/A-8054-2008	Pickering-Brown, Stuart/0000-0003-1561-6054; Eriksen, Jason/0000-0003-1549-4165; Dickson, Dennis W/0000-0001-7189-7917; Snowden, Julie/0000-0002-3976-4310; Feldman, Howard/0000-0002-9258-4538	Medical Research Council [G0400356] Funding Source: Medline; MRC [G0400356] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Bird TD, 1997, NEUROLOGY, V48, P949, DOI 10.1212/WNL.48.4.949; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Chow TW, 1999, ARCH NEUROL-CHICAGO, V56, P817, DOI 10.1001/archneur.56.7.817; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; CRUTS M, 2006, NATURE          0716, DOI DOI 10.1038/NATURE05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Froelich S, 1997, AM J MED GENET, V74, P380, DOI 10.1002/(SICI)1096-8628(19970725)74:4<380::AID-AJMG8>3.0.CO;2-T; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Kertesz A, 2000, NEUROLOGY, V54, P818, DOI 10.1212/WNL.54.4.818; Lendon CL, 1998, NEUROLOGY, V50, P1546, DOI 10.1212/WNL.50.6.1546; Lu RQ, 2001, P NATL ACAD SCI USA, V98, P142, DOI 10.1073/pnas.011525198; Mackenzie IR, 2006, BRAIN, V129, P853, DOI 10.1093/brain/awh724; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; Mackenzie IRA, 2003, ACTA NEUROPATHOL, V105, P543, DOI 10.1007/s00401-003-0678-1; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Neary D, 2000, ANN NY ACAD SCI, V920, P46; Rademakers R, 2005, RES PER ALZ, P117; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; Rosso SM, 2001, BRAIN, V124, P1948, DOI 10.1093/brain/124.10.1948; Salehi A, 2004, J NEURAL TRANSM, V111, P323, DOI 10.1007/s00702-003-0091-x; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Trojanowski JQ, 2001, J NEUROPATH EXP NEUR, V60, P1123, DOI 10.1093/jnen/60.12.1123; van der Zee J, 2006, BRAIN, V129, P841, DOI 10.1093/brain/awl029	31	1467	1513	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2006	442	7105					916	919		10.1038/nature05016	http://dx.doi.org/10.1038/nature05016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16862116				2022-12-01	WOS:000239960500037
J	Srivastava, R				Srivastava, Ranjana			No refuge for the ailing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2006	355	5					443	445		10.1056/NEJMp068032	http://dx.doi.org/10.1056/NEJMp068032			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FT	16885547				2022-12-01	WOS:000239432500003
J	Owan, TE; Hodge, DO; Herges, RM; Jacobsen, SJ; Roger, VL; Redfield, MM				Owan, Theophilus E.; Hodge, David O.; Herges, Regina M.; Jacobsen, Steven J.; Roger, Veronique L.; Redfield, Margaret M.			Trends in prevalence and outcome of heart failure with preserved ejection fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CLINICAL-FEATURES; NATURAL-HISTORY; MORTALITY; COMMUNITY; SURVIVAL; EPIDEMIOLOGY; PROGNOSIS	Background: The prevalence of heart failure with preserved ejection fraction may be changing as a result of changes in population demographics and in the prevalence and treatment of risk factors for heart failure. Changes in the prevalence of heart failure with preserved ejection fraction may contribute to changes in the natural history of heart failure. We performed a study to define secular trends in the prevalence of heart failure with preserved ejection fraction among patients at a single institution over a 15-year period. Methods: We studied all consecutive patients hospitalized with decompensated heart failure at Mayo Clinic Hospitals in Olmsted County, Minnesota, from 1987 through 2001. We classified patients as having either preserved or reduced ejection fraction. The patients were also classified as community patients (Olmsted County residents) or referral patients. Secular trends in the type of heart failure, associated cardiovascular disease, and survival were defined. Results: A total of 6076 patients with heart failure were discharged over the 15-year period; data on ejection fraction were available for 4596 of these patients (76 percent). Of these, 53 percent had a reduced ejection fraction and 47 percent had a preserved ejection fraction. The proportion of patients with the diagnosis of heart failure with preserved ejection fraction increased over time and was significantly higher among community patients than among referral patients (55 percent vs. 45 percent). The prevalence rates of hypertension, atrial fibrillation, and diabetes among patients with heart failure increased significantly over time. Survival was slightly better among patients with preserved ejection fraction (adjusted hazard ratio for death, 0.96; P=0.01). Survival improved over time for those with reduced ejection fraction but not for those with preserved ejection fraction. Conclusions: The prevalence of heart failure with preserved ejection fraction increased over a 15-year period, while the rate of death from this disorder remained unchanged. These trends underscore the importance of this growing public health problem.	Mayo Clin, Coll Med, Cardiorenal Res Lab, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Biostat, Rochester, MN USA; Mayo Clin, Coll Med, Sect Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Redfield, MM (corresponding author), Mayo Clin, Coll Med, Cardiorenal Res Lab, Guggenheim 9,200 1st St SW, Rochester, MN 55905 USA.	redfield.margaret@mayo.edu	Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	NHLBI NIH HHS [HL72435, HL64112, T32-HL07111-27] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007111, R01HL072435, R01HL064112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agoston C, 2004, AM J CARDIOL, V94, P1003, DOI 10.1016/j.amjcard.2004.06.054; Banerjee P, 2002, J AM COLL CARDIOL, V39, P138, DOI 10.1016/S0735-1097(01)01704-1; Berry C, 2005, HEART, V91, P907, DOI 10.1136/hrt.2004.041996; Burkhoff D, 2003, CIRCULATION, V107, P656, DOI 10.1161/01.CIR.0000053947.82595.03; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Chen HH, 2002, J CARD FAIL, V8, P279, DOI 10.1054/jcaf.2002.128871; Curtis JP, 2003, J AM COLL CARDIOL, V42, P736, DOI 10.1016/S0735-1097(03)00789-7; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hunt SA, ACC AHA 2005 GUIDELI; Kirk V, 2004, EUR J HEART FAIL, V6, P335, DOI 10.1016/j.ejheart.2004.01.002; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; McCullough Peter A, 2005, Congest Heart Fail, V11, P6, DOI 10.1111/j.1527-5299.2005.03731.x; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Parkash R, 2005, AM HEART J, V150, P701, DOI 10.1016/j.ahj.2004.12.014; Patel JB, 2004, J CARD FAIL, V10, P285, DOI 10.1016/j.cardfail.2003.12.006; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Redfield MM, 2002, NEW ENGL J MED, V347, P1442, DOI 10.1056/NEJMe020115; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; Shahar E, 2004, J CARD FAIL, V10, P374, DOI 10.1016/j.cardfail.2004.02.003; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Tarantini Luigi, 2002, Ital Heart J, V3, P656; Varadarajan P, 2003, J CARD FAIL, V9, P107, DOI 10.1054/jcaf.2003.13; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Zile MR, 2003, J AM COLL CARDIOL, V41, P1519, DOI 10.1016/S0735-1097(03)00186-4	32	2906	3078	3	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					251	259		10.1056/NEJMoa052256	http://dx.doi.org/10.1056/NEJMoa052256			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855265				2022-12-01	WOS:000239097600006
J	Thanbichler, M; Shapiro, L				Thanbichler, Martin; Shapiro, Lucy			MipZ, a spatial regulator coordinating chromosome segregation with cell division in Caulobacter	CELL			English	Article							BACTERIAL-DNA SEGREGATION; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; PARTITIONING PROTEINS; POLAR LOCALIZATION; BACILLUS-SUBTILIS; PROPER PLACEMENT; MIND PROTEIN; FTSZ; CRESCENTUS	Correct positioning of the division plane is a prerequisite for the generation of daughter cells with a normal chromosome complement. Here, we present a mechanism that coordinates assembly and placement of the FtsZ cytokinetic ring with bipolar localization of the newly duplicated chromosomal origins in Caulobacter. After replication of the polarly located origin region, one copy moves rapidly to the opposite end of the cell in an MreB-dependent manner. A previously uncharacterized essential protein, MipZ, forms a complex with the partitioning protein ParB near the origin of replication and localizes with the duplicated origin regions to the cell poles. MipZ directly interferes with FtsZ polymerization, thereby restricting FtsZ ring formation to midcell, the region of lowest MipZ concentration. The cellular localization of MipZ thus serves the dual function of positioning the FtsZ ring and delaying formation of the cell division apparatus until chromosome segregation has initiated.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University	Shapiro, L (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	shapiro@stanford.edu	Thanbichler, Martin/E-6035-2010		NIGMS NIH HHS [GM51426] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Jensen RB, 2001, EMBO J, V20, P4952, DOI 10.1093/emboj/20.17.4952; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Quardokus EM, 2002, MOL MICROBIOL, V45, P605, DOI 10.1046/j.1365-2958.2002.03040.x; Quardokus EM, 2001, MOL MICROBIOL, V39, P949, DOI 10.1046/j.1365-2958.2001.02287.x; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	37	345	349	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					147	162		10.1016/j.cell.2006.05.038	http://dx.doi.org/10.1016/j.cell.2006.05.038			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839883	Bronze			2022-12-01	WOS:000239224800023
J	Menzies, D; Nair, A; Williamson, PA; Schembri, S; Al-Khairalla, MZH; Barnes, M; Fardon, TC; McFarlane, L; Magee, GJ; Lipworth, BJ				Menzies, Daniel; Nair, Arun; Williamson, Peter A.; Schembri, Stuart; Al-Khairalla, Mudher Z. H.; Barnes, Martyn; Fardon, Tom C.; McFarlane, Lesley; Magee, Gareth J.; Lipworth, Brian J.			Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; EXHALED NITRIC-OXIDE; SECONDHAND SMOKE; LUNG-FUNCTION; PASSIVE SMOKING; BRONCHIAL RESPONSIVENESS; AIRWAY INFLAMMATION; PARENTAL SMOKING; EXPOSURE; METHACHOLINE	Context Scotland prohibited smoking in confined public places on March 26, 2006. Objective To investigate the association of smoke-free legislation with symptoms, pulmonary function, and markers of inflammation of bar workers. Design, Setting, and Participants This prospective observational study was conducted in Tayside, Scotland from February-June 2006. One hundred five nonasthmatic and asthmatic nonsmoking bar workers were initially enrolled, of whom 77 completed the study per protocol. Main Outcome Measures Respiratory and sensory symptoms, spirometry measurements, serum cotinine levels, peripheral inflammatory cell count, asthma qualityof-life scores, and exhaled nitric oxide levels were evaluated before and after introduction of the smoking ban. Results For the per-protocol analysis, the percentage of bar workers with respiratory and sensory symptoms decreased from 79.2% (n = 61) before the smoke-free policy to 53.2% (n = 41) (total change, -26%; 95% confidence interval [CI], -13.8% to -38.1%; P < .001) and 46.8% (n = 38) (-32.5%; 95% CI, -19.8% to -45.2%; P < .001) 1 and 2 months afterward. Forced expiratory volume in the first second increased from 96.6% predicted to 104.8% (change, 8.2%; 95% CI, 3.9% to 12.4%; P , .001) and then 101.7% (change, 5.1%; 95% CI, 2.1% to 8.0%; P = .002), and serum cotinine levels decreased from 5.15 ng/mL to 3.22 ng/mL (change, -1.93 ng/mL; 95% CI, -2.83 to -1.03 ng/mL; P < .001) and then 2.93 ng/mL (-2.22 ng/mL; 95% CI, -3.10 to -1.34 ng/ mL; P < .001). The total white blood cell and neutrophil count was reduced from 7610 to 6980 cells/mu L at 2 months (-630 cells/mu L; 95% CI, - 1010 to - 260 cells/mu L; P = .002) and from 4440 to 4030 cells/mu L (-410 cells/mu L; 95% CI, - 740 to - 90 cells/mu L; P = .03), respectively. Asthmatic bar workers also had less airway inflammation, with a reduction in exhaled nitric oxide from 34.3 parts per billion (ppb) to 27.4 ppb 1 month after the ban (0.8-fold change; 95% CI, 0.67 to 0.96 ppb; P = .04), and Juniper quality-of-life scores increased from 80.2 to 87.5 points (7.3 points; 95% CI, 0.1 to 14.6 points; P = .049). Conclusions Smoke-free legislation was associated with significant early improvements in symptoms, spirometry measurements, and systemic inflammation of bar workers. Asthmatic bar workers also had reduced airway inflammation and improved quality of life.	Univ Dundee, Ninewells Hosp & Med Sch, Asthma & Allergy Res Grp, Dept Med & Therapeut, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Asthma & Allergy Res Grp, Dept Resp Med, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Menzies, D (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Asthma & Allergy Res Grp, Dept Med & Therapeut, Dundee DD1 9SY, Scotland.	d.menzies@dundee.ac.uk						Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Alving K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-67; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Berry M, 2005, EUR RESPIR J, V25, P986, DOI 10.1183/09031936.05.00132404; Chaudhuri R, 2006, AM J RESP CRIT CARE, V174, P127, DOI 10.1164/rccm.200510-1589OC; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Cook DG, 1998, THORAX, V53, P884, DOI 10.1136/thx.53.10.884; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Crook MA, 2000, EUR J CLIN INVEST, V30, P861, DOI 10.1046/j.1365-2362.2000.00738.x; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; Fardon TC, 2004, ANN ALLERG ASTHMA IM, V93, P365, DOI 10.1016/S1081-1206(10)61396-8; Farrelly MC, 2005, TOB CONTROL, V14, P236, DOI 10.1136/tc.2004.008839; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Houston TK, 2006, BMJ-BRIT MED J, V332, P1064, DOI 10.1136/bmj.38779.584028.55; Inman MD, 1998, J ALLERGY CLIN IMMUN, V101, P342, DOI 10.1016/S0091-6749(98)70246-5; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; Jones SL, 2002, EUR RESPIR J, V20, P601, DOI 10.1183/09031936.02.00285302; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moshammer H, 2006, AM J RESP CRIT CARE, V173, P1255, DOI 10.1164/rccm.200510-1552OC; Mulcahy M, 2005, TOB CONTROL, V14, P384, DOI 10.1136/tc.2005.011635; Office on Smoking and Health, 2006, HLTH CONS INV EXP TO; Panagiotakos DB, 2004, AM J MED, V116, P145, DOI 10.1016/j.amjmed.2003.07.019; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Sasco AJ, 2004, LUNG CANCER, V45, pS3, DOI 10.1016/j.lungcan.2004.07.998; Tsoukias NM, 1998, J APPL PHYSIOL, V85, P653, DOI 10.1152/jappl.1998.85.2.653; Ward C, 2005, CLIN EXP ALLERGY, V35, P1565, DOI 10.1111/j.1365-2222.2005.02365.x; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Yates DH, 2001, AM J RESP CRIT CARE, V164, P1043, DOI 10.1164/ajrccm.164.6.2005043; [No title captured]	36	205	215	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1742	1748		10.1001/jama.296.14.1742	http://dx.doi.org/10.1001/jama.296.14.1742			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032987	Bronze			2022-12-01	WOS:000241103400022
J	Han, XM; Jin, M; Breuker, K; McLafferty, FW				Han, Xuemei; Jin, Mi; Breuker, Kathrin; McLafferty, Fred W.			Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons	SCIENCE			English	Article							ELECTRON-CAPTURE DISSOCIATION; MULTIPLY-CHARGED IONS; LARGE MOLECULES; SEQUENCE INFORMATION; ESCHERICHIA-COLI; IONIZATION; IDENTIFICATION; PROTEOMICS; SECONDARY; KDA	For characterization of sequence and posttranslational modifications, molecular and fragment ion mass data from ionizing and dissociating a protein in the mass spectrometer are far more specific than are masses of peptides from the protein's digestion. We extend the similar to 500-residue, similar to 50-kilodalton (kD) dissociation limitation of this top-down methodology by using electrospray additives, heated vaporization, and separate noncovalent and covalent bond dissociation. This process can cleave 287 interresidue bonds in the termini of a 1314-residue (144-kD) protein, specify previously unidentified disulfide bonds between 8 of 27 cysteines in a 1714-residue (200-kD) protein, and correct sequence predictions in two proteins, one with 2153 residues ( 229 kD).	Cornell Univ, Dept Chem & Biol Chem, Baker Lab, Ithaca, NY 14853 USA; Univ Innsbruck, Inst Organ Chem, A-6020 Innsbruck, Austria; Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria	Cornell University; University of Innsbruck; University of Innsbruck	McLafferty, FW (corresponding author), Cornell Univ, Dept Chem & Biol Chem, Baker Lab, Ithaca, NY 14853 USA.	fwm5@cornell.edu		Breuker, Kathrin/0000-0002-4978-0883	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016609, R37GM016609] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM16609] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301; Breuker K, 2005, ANGEW CHEM INT EDIT, V44, P4911, DOI 10.1002/anie.200500668; Breuker K, 2002, J AM CHEM SOC, V124, P6407, DOI 10.1021/ja012267j; FENG R, 1992, ANAL CHEM, V64, P2090, DOI 10.1021/ac00042a012; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Ge Y, 2002, J AM CHEM SOC, V124, P672, DOI 10.1021/ja011335z; Gygi SP, 2000, CURR OPIN CHEM BIOL, V4, P489, DOI 10.1016/S1367-5931(00)00121-6; HENRY KD, 1989, P NATL ACAD SCI USA, V86, P9075, DOI 10.1073/pnas.86.23.9075; Henzel WJ, 2003, J AM SOC MASS SPECTR, V14, P931, DOI 10.1016/S1044-0305(03)00214-9; Hoaglund-Hyzer CS, 1999, CHEM REV, V99, P3037, DOI 10.1021/cr980139g; Horn DM, 2000, P NATL ACAD SCI USA, V97, P10313, DOI 10.1073/pnas.97.19.10313; Horn DM, 2000, J AM SOC MASS SPECTR, V11, P320, DOI 10.1016/S1044-0305(99)00157-9; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Kelleher NL, 1998, PROTEIN SCI, V7, P1796, DOI 10.1002/pro.5560070815; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; LITTLE DP, 1994, ANAL CHEM, V66, P2809, DOI 10.1021/ac00090a004; LOO JA, 1991, ANAL CHEM, V63, P2488, DOI 10.1021/ac00021a018; LOO JA, 1990, SCIENCE, V248, P201, DOI 10.1126/science.2326633; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; McLafferty FW, 1999, SCIENCE, V284, P1289, DOI 10.1126/science.284.5418.1289; Oh H, 2002, P NATL ACAD SCI USA, V99, P15863, DOI 10.1073/pnas.212643599; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Qin J, 1997, ANAL CHEM, V69, P4002, DOI 10.1021/ac970489n; SEYA T, 1986, J IMMUNOL, V136, P4152; Zabrouskov V, 2006, BIOCHEMISTRY-US, V45, P987, DOI 10.1021/bi0517584; Zhai H, 2005, ANAL CHEM, V77, P5777, DOI 10.1021/ac0580215	27	266	272	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					109	112		10.1126/science.1128868	http://dx.doi.org/10.1126/science.1128868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023655				2022-12-01	WOS:000241031200046
J	Wardlaw, T; Salama, P; Johansson, EW; Mason, E				Wardlaw, Tessa; Salama, Peter; Johansson, Emily White; Mason, Elizabeth			Pneumonia: the leading killer of children	LANCET			English	Editorial Material							MORTALITY; DEATHS		UNICEF, New York, NY 10017 USA; WHO, CAH Dept, CH-1211 Geneva, Switzerland	UNICEF; World Health Organization	Wardlaw, T (corresponding author), UNICEF, New York, NY 10017 USA.	twardlaw@unicef.org	Johansson, Emily/AAQ-3794-2020					Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2005, HLTH POLICY PLAN S1, V20, pi5, DOI [10.1093/heapol/czi055, DOI 10.1093/HEAPOL/CZI055]; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; PANDEY MR, 1991, LANCET, V338, P993, DOI 10.1016/0140-6736(91)91847-N; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SMITH KR, 2006, INT SOC ENV EP PAR F; [UNICEF WHO], 2006, PNEUM FORG KILL CHIL; *US AG INT DEV BAS, SCAL COMM BAS TREATM; *US AG INT DEV REP, 2004, CHWS SEN CAN APPR TR; VENEMAN AM, 2005, 58 WORLD HLTH ASS MA; *WHO, 2006, M REP WHO EXP CONS C; WHO/UNICEF, 2004, JOINT STAT MAN PNEUM; World Health Organization, 1991, TECHN BAS WHO REC MA; 2006, WKLY EPIDEMIOL REC, V81, P7; 2006, WKLY EPIDEMIOL REC, V81, P9	18	198	213	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1048	1050		10.1016/S0140-6736(06)69334-3	http://dx.doi.org/10.1016/S0140-6736(06)69334-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997649				2022-12-01	WOS:000240873000007
J	Miranda, KC; Huynh, T; Tay, Y; Ang, YS; Tam, WL; Thomson, AM; Lim, B; Rigoutsos, I				Miranda, Kevin C.; Huynh, Tien; Tay, Yvonne; Ang, Yen-Sin; Tam, Wai-Leong; Thomson, Andrew M.; Lim, Bing; Rigoutsos, Isidore			A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes	CELL			English	Article							INSULIN-SECRETION; CAENORHABDITIS-ELEGANS; TARGET PREDICTIONS; RNA INTERFERENCE; DISCOVERY; GENES; NETWORKS; FAMILIES	We present rna22, a method for identifying microRNA binding sites and their corresponding heteroduplexes. Rna22 does not rely upon cross-species conservation, is resilient to noise, and, unlike previous methods, it first finds putative microRNA binding sites in the sequence of interest, then identifies the targeting microRNA. Computationally, we show that rna22 identifies most of the currently known heteroduplexes. Experimentally, with luciferase assays, we demonstrate average repressions of 30% or more for 168 of 226 tested targets. The analysis suggests that some microRNAs may have as many as a few thousand targets, and that between 74% and 92% of the gene transcripts in four model genomes are likely under microRNA control through their untranslated and amino acid coding regions. We also extended the method's key idea to a low-error microRNA-precursor-discovery scheme; our studies suggest that the number of microRNA precursors in mammalian genomes likely ranges in the tens of thousands.	IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA; Genome Inst Singapore, Singapore 138672, Singapore; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	International Business Machines (IBM); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rigoutsos, I (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, POB 218, Yorktown Hts, NY 10598 USA.	rigoutso@us.ibm.com	Tam, Wai Leong/P-1497-2019; Rigoutsos, Isidore/C-5381-2012	Tam, Wai Leong/0000-0003-2365-5264; Rigoutsos, Isidore/0000-0003-1529-8631	NIAID NIH HHS [AI54973] Funding Source: Medline; NIDDK NIH HHS [DK04763] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1996, METHOD ENZYMOL, V266, P460; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brazma A, 1998, J COMPUT BIOL, V5, P279, DOI 10.1089/cmb.1998.5.279; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Darzentas N, 2005, PROTEINS, V61, P926, DOI 10.1002/prot.20608; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Enright AJ, 2004, GENOME BIOL, V5; Ettwiller LM, 2003, GENOME RES, V13, P883, DOI 10.1101/gr.866403; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Gusfield D., 1997, ALGORITHMS STRINGS T, P287; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103; Rigoutsos I, 2003, NUCLEIC ACIDS RES, V31, P4625, DOI 10.1093/nar/gkg639; Rigoutsos I, 2002, NUCLEIC ACIDS RES, V30, P3901, DOI 10.1093/nar/gkf464; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shibuya T, 2002, NUCLEIC ACIDS RES, V30, P2710, DOI 10.1093/nar/gkf338; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	48	1476	1536	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1203	1217		10.1016/j.cell.2006.07.031	http://dx.doi.org/10.1016/j.cell.2006.07.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990141	Green Submitted, Bronze			2022-12-01	WOS:000240897600024
J	Li, Y; Bor, YC; Misawa, Y; Xue, YM; Rekosh, D; Hammarskjold, ML				Li, Ying; Bor, Yeou-cherng; Misawa, Yukiko; Xue, Yuming; Rekosh, David; Hammarskjold, Marie-Louise			An intron with a constitutive transport element is retained in a Tap messenger RNA	NATURE			English	Article							RETENTION EVENTS; MAMMALIAN-CELLS; NUCLEAR EXPORT; EXPRESSION; PROTEIN; CTE; TRANSLATION; PREDICTION; ISOFORM	Alternative splicing is a key factor contributing to genetic diversity and evolution(1). Intron retention, one form of alternative splicing, is common in plants(2) but rare in higher eukaryotes(3-8), because messenger RNAs with retained introns are subject to cellular restriction at the level of cytoplasmic export and expression(9,10). Often, retention of internal introns restricts the export of these mRNAs and makes them the targets for degradation by the cellular nonsense-mediated decay machinery if they contain premature stop codons(11,12). In fact, many of the database entries for complementary DNAs with retained introns represent them as artefacts that would not affect the proteome(11). Retroviruses are important model systems in studies of regulation of RNAs with retained introns, because their genomic and mRNAs contain one or more unspliced introns(10). For example, Mason - Pfizer monkey virus overcomes cellular restrictions by using a cis-acting RNA element known as the constitutive transport element (CTE)(13). The CTE interacts directly with the Tap protein ( also known as nuclear RNA export factor 1, encoded by NXF1), which is thought to be a principal export receptor for cellular mRNA(14), leading to the hypothesis that cellular mRNAs with retained introns use cellular CTE equivalents to overcome restrictions to their expression(10). Here we show that the Tap gene contains a functional CTE in its alternatively spliced intron 10. Tap mRNA containing this intron is exported to the cytoplasm and is present in polyribosomes. A small Tap protein is encoded by this mRNA and can be detected in human and monkey cells. Our results indicate that Tap regulates expression of its own intron-containing RNA through a CTE-mediated mechanism. Thus, CTEs are likely to be important elements that facilitate efficient expression of mammalian mRNAs with retained introns.	Univ Virginia, Myles H thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Hammarskjold, ML (corresponding author), Univ Virginia, Myles H thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22908 USA.	mh7g@virginia.edu						Azios NG, 2001, ONCOGENE, V20, P5199, DOI 10.1038/sj.onc.1204555; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; CHANG DD, 1990, SCIENCE, V249, P614, DOI 10.1126/science.2143313; Coyle JH, 2003, MOL CELL BIOL, V23, P92, DOI 10.1128/MCB.23.1.92-103.2003; Ernst RK, 1997, RNA, V3, P210; Forrest ST, 2004, J BIOL CHEM, V279, P32897, DOI 10.1074/jbc.M404882200; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; Hammarskjold ML, 2001, CURR TOP MICROBIOL, V259, P77; Herold A, 2001, RNA, V7, P1768; Hiller M, 2005, NUCLEIC ACIDS RES, V33, P5611, DOI 10.1093/nar/gki870; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Kang YB, 1999, VIROLOGY, V262, P200, DOI 10.1006/viro.1999.9906; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kreahling J, 2004, TRENDS GENET, V20, P1, DOI 10.1016/j.tig.2003.11.001; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Ohler U, 2005, PLOS COMPUT BIOL, V1, P113, DOI 10.1371/journal.pcbi.0010015; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	93	98	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					234	237		10.1038/nature05107	http://dx.doi.org/10.1038/nature05107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971948				2022-12-01	WOS:000240467000052
J	Urato, AC; Caughey, AB				Urato, Adam C.; Caughey, Aaron B.			Universal prenatal herpes screening is a bad idea in pregnancy	LANCET			English	Editorial Material							TRANSMISSION; DELIVERY; WOMEN; RISK		Univ S Florida, Tampa, FL 33606 USA	State University System of Florida; University of South Florida	Urato, AC (corresponding author), Univ S Florida, Tampa, FL 33606 USA.	aurato@health.usf.edu						ACOG, 2000, INT J GYNECOL OBSTET, V68, P165; Baker DA, 2005, AM J OBSTET GYNECOL, V193, P1887, DOI 10.1016/j.ajog.2005.08.007; Brown ZA, 2005, OBSTET GYNECOL, V106, P845, DOI 10.1097/01.AOG.0000180779.35572.3a; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Casper Corey, 2002, Herpes, V9, P10; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Gaytant M A, 2000, Ned Tijdschr Geneeskd, V144, P1832; Gaytant MA, 2002, SEX TRANSM DIS, V29, P710, DOI 10.1097/00007435-200211000-00015; Glass N, 2005, AHRQ PUBLICATION; Gutierrez KM, 1999, J INFECT DIS, V180, P199, DOI 10.1086/314848; Lindsay MK, 2006, AM J OBSTET GYNECOL, V195, P4, DOI 10.1016/j.ajog.2006.02.014; LOWBEER NM, 2002, CLIN GUIDELINE; Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015	14	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					898	899		10.1016/S0140-6736(06)69348-3	http://dx.doi.org/10.1016/S0140-6736(06)69348-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962863				2022-12-01	WOS:000240502300007
J	Damschen, EI; Haddad, NM; Orrock, JL; Tewksbury, JJ; Levey, DJ				Damschen, Ellen I.; Haddad, Nick M.; Orrock, John L.; Tewksbury, Joshua J.; Levey, Douglas J.			Corridors increase plant species richness at large scales	SCIENCE			English	Article							SEED PREDATION; FRAGMENTED LANDSCAPES; MICROECOSYSTEM; DISPERSAL; ABUNDANCE; ECOSYSTEM	Habitat fragmentation is one of the largest threats to biodiversity. Landscape corridors, which are hypothesized to reduce the negative consequences of fragmentation, have become common features of ecological management plans worldwide. Despite their popularity, there is little evidence documenting the effectiveness of corridors in preserving biodiversity at large scales. Using a large-scale replicated experiment, we showed that habitat patches connected by corridors retain more native plant species than do isolated patches, that this difference increases over time, and that corridors do not promote invasion by exotic species. Our results support the use of corridors in biodiversity conservation.	N Carolina State Univ, Dept Zool, Raleigh, NC 27695 USA; Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50010 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Florida, Dept Zool, Gainesville, FL 32611 USA	University of North Carolina; North Carolina State University; Iowa State University; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida	Damschen, EI (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	damschen@nceas.ucsb.edu	Damschen, Ellen/E-4919-2011	Damschen, Ellen/0000-0001-7435-0669				Balmford A, 2005, ECOL LETT, V8, P1218, DOI 10.1111/j.1461-0248.2005.00814.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Brockway DG, 1998, FOREST ECOL MANAG, V106, P125, DOI 10.1016/S0378-1127(97)00308-3; Collinge SK, 2000, ECOLOGY, V81, P2211, DOI 10.1890/0012-9658(2000)081[2211:EOGFOI]2.0.CO;2; FROST CC, 1993, TALL TIMB FIR EC C T; Gilbert F, 1998, P ROY SOC B-BIOL SCI, V265, P577, DOI 10.1098/rspb.1998.0333; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Haddad NM, 2003, ECOLOGY, V84, P609, DOI 10.1890/0012-9658(2003)084[0609:CUBDT]2.0.CO;2; Hoyle M, 2004, OIKOS, V105, P359, DOI 10.1111/j.0030-1299.2004.12832.x; KILGO JC, 2005, ECOLOGY MANAGEMENT F, P99; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Orrock JL, 2005, ECOL APPL, V15, P793, DOI 10.1890/04-1129; Orrock JL, 2003, ECOLOGY, V84, P2589, DOI 10.1890/02-0439; Orrock JL, 2006, J ECOL, V94, P838, DOI 10.1111/j.1365-2745.2006.01125.x; OUTCALT KW, 1998, LONGLEAF PINE FOREST; Proches S, 2005, SCIENCE, V310, P779, DOI 10.1126/science.310.5749.779; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Van Lear DH, 2005, FOREST ECOL MANAG, V211, P150, DOI 10.1016/j.foreco.2005.02.014; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson EO, 1975, ECOLOGY EVOLUTION CO	23	236	256	13	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1284	1286		10.1126/science.1130098	http://dx.doi.org/10.1126/science.1130098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946070				2022-12-01	WOS:000240313500040
J	Umeda, K; Ikenouchi, J; Katahira-Tayama, S; Furuse, K; Sasaki, H; Nakayama, M; Matsui, T; Tsukita, S; Furuse, M; Tsukita, S				Umeda, Kazuaki; Ikenouchi, Junichi; Katahira-Tayama, Sayaka; Furuse, Kyoko; Sasaki, Hiroyuki; Nakayama, Mayumi; Matsui, Takeshi; Tsukita, Sachiko; Furuse, Mikio; Tsukita, Shoichiro			ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation	CELL			English	Article							TUMOR-SUPPRESSOR PROTEIN; GUANYLATE KINASE DOMAINS; EPITHELIAL-CELLS; INTRAMOLECULAR INTERACTION; INTERCELLULAR-JUNCTIONS; ADHERENS JUNCTIONS; MOLECULAR ARCHITECTURE; PERIPHERAL COMPONENT; ADHESION MOLECULE; ZONULA OCCLUDENS	A fundamental question in cell and developmental biology is how epithelial cells construct the diffusion barrier allowing them to separate different body compartments. Formation of tight junction (TJ) strands, which are crucial for this barrier, involves the polymerization of claudins, TJ adhesion molecules, in temporal and spatial manners. ZO-1 and ZO-2 are major PDZ-domain-containing TJ proteins and bind directly to claudins, yet their functional roles are poorly understood. We established cultured epithelial cells (1(ko)/2(kd)) in which the expression of ZO-1/ZO-2 was suppressed by homologous recombination and RNA interference, respectively. These cells were well polarized, except for a complete lack of TJs. When exogenously expressed in, l(ko)/2(kd) cells, ZO-1 and ZO-2 were recruited to junctional areas where claudins were polymerized, but truncated ZO-1 (NZO-1) containing only domains PDZ1-3 was not. When NZO-1 was forcibly recruited to lateral membranes and dimerized, claudins were dramatically polymerized. These findings indicate that ZO-1 and ZO-2 can independently determine whether and where claudins are polymerized.	Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Sch Hlth Sci, Sakyo Ku, Kyoto 6068501, Japan; KAN Res Inst Inc, Shimogyo Ku, Kyoto 6008515, Japan; Japan Sci & Technol Corp, Sakyo Ku, Kyoto 6068501, Japan; Jikei Univ, Sch Med, Inst DNA Med, Dept Mol Cell Biol,Minato Ku, Tokyo 0158461, Japan	Kyoto University; Kyoto University; KAN Research Institute; Japan Science & Technology Agency (JST); Jikei University	Tsukita, S (corresponding author), Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.	atsukita@mfour.med.kyoto-u.ac.jp	Ikenouchi, Junichi/X-2871-2019; Ikenouchi, Junichi/A-3256-2011; Matsui, Takeshi/C-4730-2017	Ikenouchi, Junichi/0000-0002-2936-3548; Furuse, Mikio/0000-0003-2847-8156; Furuse, Kyoko/0000-0003-4304-6204; Sasaki, Hiroyuki/0000-0002-5358-5853				Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; BALDA MS, 1993, J CELL BIOL, V123, P293, DOI 10.1083/jcb.123.2.293; Balda MS, 1998, J CELL SCI, V111, P541; Baldini A, 2000, ZEI STUD EU ECON LAW, V2, P19; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Cereijido M, 2000, AM J PHYSIOL-GASTR L, V279, pG477, DOI 10.1152/ajpgi.2000.279.3.G477; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; GROVER A, 1983, J CELL BIOL, V96, P1690, DOI 10.1083/jcb.96.6.1690; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; Komiya S, 2005, GENES CELLS, V10, P1065, DOI 10.1111/j.1365-2443.2005.00899.x; Kuhlendahl S, 1998, EUR J BIOCHEM, V252, P305, DOI 10.1046/j.1432-1327.1998.2520305.x; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Nelson W J, 1990, Semin Cell Biol, V1, P359; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; REICHMANN E, 1989, J CELL BIOL, V108, P1127, DOI 10.1083/jcb.108.3.1127; Roh MH, 2003, AM J PHYSIOL-RENAL, V285, pF377, DOI 10.1152/ajprenal.00086.2003; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; VOLK T, 1984, EMBO J, V3, P2249, DOI 10.1002/j.1460-2075.1984.tb02123.x; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; YONEMURA S, 1995, J CELL SCI, V108, P127	66	561	579	2	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 25	2006	126	4					741	754		10.1016/j.cell.2006.06.043	http://dx.doi.org/10.1016/j.cell.2006.06.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923393	Bronze			2022-12-01	WOS:000240276700022
J	Nicolaidis, C				Nicolaidis, Christina			My mother's choice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												nicolaid@ohsu.edu	Nicolaidis, Christina/X-6468-2019; Nicolaidis, Christina/CAC-0028-2022	Nicolaidis, Christina/0000-0002-9394-5956; Nicolaidis, Christina/0000-0002-9394-5956					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2006	296	8					907	908		10.1001/jama.296.8.907	http://dx.doi.org/10.1001/jama.296.8.907			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076AL	16926344				2022-12-01	WOS:000239929300001
J	Dyer, AG; Whitney, HM; Arnold, SEJ; Glover, BJ; Chittka, L				Dyer, Adrian G.; Whitney, Heather M.; Arnold, Sarah E. J.; Glover, Beverley J.; Chittka, Lars			Bees associate warmth with floral colour	NATURE			English	Article							POLLINATION; REWARD; HEAT		Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ London, Queen Mary Coll, London E1 4NS, England	University of Cambridge; University of London; Queen Mary University London	Dyer, AG (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	l.chittka@qmul.ac.uk	Chittka, Lars/C-3110-2012; Arnold, Sarah/H-6490-2019	Chittka, Lars/0000-0001-8153-1732; Arnold, Sarah/0000-0001-7345-0529; Whitney, Heather/0000-0001-6450-8266	Natural Environment Research Council [NE/C000552/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; HEINRICH B, 1994, AM SCI, V82, P164; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; MILLER GA, 1986, OECOLOGIA, V70, P155, DOI 10.1007/BF00377126; Sapir Y, 2006, OECOLOGIA, V147, P53, DOI 10.1007/s00442-005-0246-6; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575; [No title captured]	10	112	118	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					525	525		10.1038/442525a	http://dx.doi.org/10.1038/442525a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16885975	Green Published			2022-12-01	WOS:000239455900032
J	Bhatia, RS; Tu, JV; Lee, DS; Austin, PC; Fang, JM; Haouzi, A; Gong, YY; Liu, PP				Bhatia, R. Sacha; Tu, Jack V.; Lee, Douglas S.; Austin, Peter C.; Fang, Jiming; Haouzi, Annick; Gong, Yanyan; Liu, Peter P.			Outcome of heart failure with preserved ejection fraction in a population-based study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME-INHIBITORS; CLINICAL-FEATURES; PROGNOSIS; MORTALITY; DIAGNOSIS; COMMUNITY; TRIAL; AGE; DETERMINANTS	Background: The importance of heart failure with preserved ejection fraction is increasingly recognized. We conducted a study to evaluate the epidemiologic features and outcomes of patients with heart failure with preserved ejection fraction and to compare the findings with those from patients who had heart failure with reduced ejection fraction. Methods: From April 1, 1999, through March 31, 2001, we studied 2802 patients admitted to 103 hospitals in the province of Ontario, Canada, with a discharge diagnosis of heart failure whose ejection fraction had also been assessed. The patients were categorized in three groups: those with an ejection fraction of less than 40 percent (heart failure with reduced ejection fraction), those with an ejection fraction of 40 to 50 percent (heart failure with borderline ejection fraction), and those with an ejection fraction of more than 50 percent (heart failure with preserved ejection fraction). Two groups were studied in detail: those with an ejection fraction of less than 40 percent and those with an ejection fraction of more than 50 percent. The main outcome measures were death within one year and readmission to the hospital for heart failure. Results: Thirty-one percent of the patients had an ejection fraction of more than 50 percent. Patients with heart failure with preserved ejection fraction were more likely to be older and female and to have a history of hypertension and atrial fibrillation. The presenting history and clinical examination findings were similar for the two groups. The unadjusted mortality rates for patients with an ejection fraction of more than 50 percent were not significantly different from those for patients with an ejection fraction of less than 40 percent at 30 days (5 percent vs. 7 percent, P=0.08) and at 1 year (22 percent vs. 26 percent, P=0.07); the adjusted one-year mortality rates were also not significantly different in the two groups (hazard ratio, 1.13; 95 percent confidence interval, 0.94 to 1.36; P=0.18). The rates of readmission for heart failure and of in-hospital complications did not differ between the two groups. Conclusions: Among patients presenting with new-onset heart failure, a substantial proportion had an ejection fraction of more than 50 percent. The survival of patients with heart failure with preserved ejection fraction was similar to that of patients with reduced ejection fraction.	Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada; Univ Hlth Network, Toronto Gen Hosp, Div Cardiol, Toronto, ON, Canada; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada; NHLBI, Framingham Heart Study, Framingham, MA USA; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Toronto	Liu, PP (corresponding author), Toronto Gen Hosp, Heart & Stroke Richard Lewar Ctr Excellence, NCSB 11-1266,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	peter.liu@utoronto.ca		Lee, Douglas/0000-0001-7078-745X; Austin, Peter/0000-0003-3337-233X; Tu, Jack/0000-0003-0111-722X				Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; COHN JN, 1990, CIRCULATION, V81, P48; *DEP HHS, 1988, INT CLASS DIS; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Hernandez AF, 2005, ARCH INTERN MED, V165, P2162, DOI 10.1001/archinte.165.18.2162; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jones RC, 2004, J AM COLL CARDIOL, V44, P1025, DOI 10.1016/j.jacc.2004.05.077; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; Kitzman Dalane W, 2002, Heart Fail Rev, V7, P17; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Ko DT, 2005, ARCH INTERN MED, V165, P2486, DOI 10.1001/archinte.165.21.2486; Krumholz HM, 1997, ARCH INTERN MED, V157, P2242, DOI 10.1001/archinte.157.19.2242; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Pernenkil R, 1997, AM J CARDIOL, V79, P216, DOI 10.1016/S0002-9149(96)00719-9; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; SETARO JF, 1992, AM J CARDIOL, V69, P1212, DOI 10.1016/0002-9149(92)90938-U; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Steg PG, 2004, CIRCULATION, V109, P494, DOI 10.1161/01.CIR.0000109691.16944.DA; Varadarajan P, 2003, J CARD FAIL, V9, P107, DOI 10.1054/jcaf.2003.13; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	33	1397	1474	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					260	269		10.1056/NEJMoa051530	http://dx.doi.org/10.1056/NEJMoa051530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855266	Bronze			2022-12-01	WOS:000239097600007
J	van Dam, RM; Willett, WC; Manson, JE; Hu, FB				van Dam, Rob M.; Willett, Walter C.; Manson, JoAnn E.; Hu, Frank B.			The relationship between overweight in adolescence and premature death in women	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; FOLLOW-UP; PHYSICAL-ACTIVITY; ADULT MORTALITY; WEIGHT CHANGE; MIDDLE-AGE; OBESITY; COHORT; RISK	Background: The impact of adiposity in adolescence on death during adulthood is uncertain. Objective: To examine the relation between adiposity in adolescence and premature death in women. Design: Prospective cohort study. Setting: United States. Participants: 102400 women from the Nurses' Health Study II who were 24 to 44 years of age and free of cancer at baseline. Ninety percent were of non-Hispanic white ethnicity. Measurements: In 1989, current weight and height and recalled weight at age 18 years were assessed by using validated questionnaires, and body mass index (BMI) was calculated. Hazard ratios for death and 95% Cls were adjusted for potential confounders, including cigarette smoking, alcohol use, and physical activity during adolescence. Results: During 12 years of follow-up, 710 participants died. Compared with a BMI of 18.5 to 21.9 kg/m(2) at age 18 years, the hazard ratio for premature death was 0.98 (95% Cl, 0.78 to 1.23) for a BMI less than 18.5 kg/m(2), 1.18 (Cl, 0.97 to 1.43) for a BMI of 22.0 to 24.9 kg/m(2), 1.66 (Cl, 1.31 to 2.10) for a BMI of 25.0 to 29.9 kg/m(2), and 2.79 (Cl, 2.04 to 3.81) for a BMI of 30 kg/m(2) or greater. Among participants who never smoked, a BMI of 22.0 to 24.9 kg/m2 at age 18 years was also associated with increased premature death (hazard ratio, 1.50 [Cl, 1.16 to 1.94]). Associations between BMI at age 18 years and death could only partly be explained by adult BMI measured in 1989. Limitations: Because of the observational study design, residual confounding by imperfectly measured or unknown confounders may still be present. Conclusion: Moderately higher adiposity at age 18 years is associated with increased premature death in younger and middle-aged U.S. women.	Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Vrije Universiteit Amsterdam	van Dam, RM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bodg 2, Boston, MA 02115 USA.	rvandam@hsph.harvard.edu	van Dam, Rob M/F-9674-2010; Hu, Frank/C-1919-2013	van Dam, Rob M/0000-0002-7354-8734; 	NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NCI NIH HHS [CA50385] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-11, P30 DK040561] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; DIPIETRO L, 1994, INT J OBESITY, V18, P585; Eaton DK, 2005, ARCH PEDIAT ADOL MED, V159, P513, DOI 10.1001/archpedi.159.6.513; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59; Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; HOFFMANS MDAF, 1989, J CLIN EPIDEMIOL, V42, P513, DOI 10.1016/0895-4356(89)90147-9; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; Hunter DJ, 1997, CONTRACEPTION, V56, P373, DOI 10.1016/S0010-7824(97)00172-8; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; MUELLER WH, 1982, SOC SCI MED, V16, P191, DOI 10.1016/0277-9536(82)90022-3; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; NIETO FJ, 1992, AM J EPIDEMIOL, V136, P201, DOI 10.1093/oxfordjournals.aje.a116486; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; RHOADS GG, 1983, LANCET, V1, P492; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Seidell JC, 1999, MED SCI SPORT EXER, V31, pS597, DOI 10.1097/00005768-199911001-00018; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; TROY LM, 1995, INT J OBESITY, V19, P570; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization, 1997, WHONUTNCD981; Yarnell JWG, 2000, J EPIDEMIOL COMMUN H, V54, P344, DOI 10.1136/jech.54.5.344	36	131	139	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					91	97		10.7326/0003-4819-145-2-200607180-00006	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	063WU	16847291				2022-12-01	WOS:000239051400002
J	Chin, RFM; Neville, BGR; Peckham, C; Bedford, H; Wade, A; Scott, RC				Chin, Richard F. M.; Neville, Brian G. R.; Peckham, Catherine; Bedford, Helen; Wade, Angela; Scott, Rod C.		NLSTEPSS Collaborative Grp	Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study	LANCET			English	Article							MORTALITY; EPIDEMIOLOGY; CHILDREN; MANAGEMENT; MINNESOTA; ROCHESTER; EPISODE	Background Convulsive status epilepticus is the most common childhood medical neurological emergency, and is associated with significant morbidity and mortality. Most data for this disorder are from mainly adult populations and might not be relevant to childhood. Thus we undertook the North London Status Epilepticus in Childhood Surveillance Study (NLSTEPSS): a prospective, population-based study of convulsive status epilepticus in childhood, to obtain a uniquely paediatric perspective. Methods Clinical and demographic data for episodes of childhood convulsive status epilepticus that took place in north London were obtained through a clinical network that covered the target population. We obtained these data from anonymised copies of a standardised admission proforma; accident and emergency, nursing, ambulance, and intensive-care unit notes; and interviews with parents, medical, nursing, and paramedic staff. We investigated ascertainment using capture-recapture modelling. Findings Of 226 children enrolled, 176 had a first ever episode of convulsive status epilepticus. We estimated that ascertainment was between 62% and 84%. The ascertainment-adjusted incidence was between 17 and 23 episodes per 100000 per year. 98 (56%, 95% CI 48-63) children were neurologically healthy before their first ever episode and 56 (57%, 47-66) of those children had a prolonged febrile seizure. 11 (12%, 6-18) of children with first ever febrile convulsive status epilepticus had acute bacterial meningitis. Conservative estimation of 1-year recurrence of convulsive status epilepticus was 16% (10-24%). Case fatality was 3% (2-7%). Interpretation Convulsive status epilepticus in childhood is more common, has a different range of causes, and a lower risk of death than that in adults. These paediatric data will help inform management of convulsive status epilepticus and appropriate allocation of resources to reduce the effects of this disorder in childhood.	UCL, Inst Child Hlth, Neurosci Unit, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; UCL, Inst Child Hlth, Radiol & Phys Unit, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London	Chin, RFM (corresponding author), Wolfson Ctr Magnet Technol, Mecklenburgh Sq, London WC1N 2AP, England.	r.chin@ich.ucl.ac.uk	peckham, catherine s/I-6300-2013; Scott, Rod/C-5363-2008	Chin, Richard/0000-0002-7256-3027	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AICARDI J, 1970, EPILEPSIA, V11, P187, DOI 10.1111/j.1528-1157.1970.tb03880.x; [Anonymous], 1993, EPILEPSIA, V34, P592; Cascino GD, 1998, EPILEPSIA, V39, P829, DOI 10.1111/j.1528-1157.1998.tb01176.x; Chang JW, 2001, ACTA NEUROCHIR, V143, P297, DOI 10.1007/s007010170110; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Chin RFM, 2004, EUR J NEUROL, V11, P800, DOI 10.1111/j.1468-1331.2004.00943.x; Chin RFM, 2005, ARCH DIS CHILD, V90, P66, DOI 10.1136/adc.2003.038844; Chin RFM, 2004, J NEUROL NEUROSUR PS, V75, P1584, DOI 10.1136/jnnp.2003.032797; Coeytaux A, 2000, NEUROLOGY, V55, P693, DOI 10.1212/WNL.55.5.693; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Drislane FW, 2000, EPILEPSY BEHAV, V1, P301, DOI 10.1006/ebeh.2000.0100; Garzon E, 2003, SEIZURE-EUR J EPILEP, V12, P337, DOI 10.1016/S1059-1311(02)00324-2; Hesdorffer DC, 1998, NEUROLOGY, V50, P735, DOI 10.1212/WNL.50.3.735; Holmes GL, 1997, EPILEPSIA, V38, P12, DOI 10.1111/j.1528-1157.1997.tb01074.x; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; LEPPIK IE, 1985, CLIN THER, V7, P272; Leung Alexander K C, 2005, J Natl Med Assoc, V97, P1708; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; NELSON KB, 1978, PEDIATRICS, V61, P720; Offringa M, 2001, BRIT MED J, V323, P1111, DOI 10.1136/bmj.323.7321.1111; ROSENBLOOM AL, 1994, PEDIATR ANN, V23, P284, DOI 10.3928/0090-4481-19940601-06; Simondon F, 1999, INT J EPIDEMIOL, V28, P113, DOI 10.1093/ije/28.1.113; Treiman DM, 1996, BAILLIERE CLIN NEUR, V5, P821; TREVATHAN E, 2002, EPILEPSIA S, V43, P75; *UK OFF NAT STAT, 2004, CENS 2001 STAND TABL; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070; YAGER JY, 1988, CAN J NEUROL SCI, V15, P402, DOI 10.1017/S0317167100028134	30	374	385	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2006	368	9531					222	229		10.1016/S0140-6736(06)69043-0	http://dx.doi.org/10.1016/S0140-6736(06)69043-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844492				2022-12-01	WOS:000239095000034
J	Nomura, K; DebRoy, S; Lee, YH; Pumplin, N; Jones, J; He, SY				Nomura, Kinya; DebRoy, Sruti; Lee, Yong Hoon; Pumplin, Nathan; Jones, Jonathan; He, Sheng Yang			A bacterial virulence protein suppresses host innate immunity to cause plant disease	SCIENCE			English	Article							III SECRETION SYSTEM; EFFECTOR PROTEINS; CELL-WALL; ARABIDOPSIS; RESISTANCE; PATHOGENS; DEFENSE; MECHANISM; PATHWAY; RIN4	Plants have evolved a powerful immune system to defend against infection by most microbial organisms. However, successful pathogens, such as Pseudomonas syringae, have developed countermeasures and inject virulence proteins into the host plant cell to suppress immunity and cause devastating diseases. Despite intensive research efforts, the molecular targets of bacterial virulence proteins that are important for plant disease development have remained obscure. Here, we show that a conserved P. syringae virulence protein, HopM1, targets an immunity-associated protein, AtMIN7, in Arabidopsis thaliana. HopM1 mediates the destruction of AtMIN7 via the host proteasome. Our results illustrate a strategy by which a bacterial pathogen exploits the host proteasome to subvert host immunity and causes infection in plants.	Michigan State Univ, Dept Plant Biol, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Michigan State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	He, SY (corresponding author), Michigan State Univ, Dept Plant Biol, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	hes@msu.edu	Pumplin, Nathan/F-5539-2016; Lee, Yong Hoon/S-8079-2016; Jones, Jonathan DG/J-5129-2012	Pumplin, Nathan/0000-0003-4492-5358; Lee, Yong Hoon/0000-0001-9921-3871; Jones, Jonathan DG/0000-0002-4953-261X; He, Sheng Yang/0000-0003-1308-498X				Abramovitch RB, 2004, CURR OPIN PLANT BIOL, V7, P356, DOI 10.1016/j.pbi.2004.05.002; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Badel JL, 2003, MOL MICROBIOL, V49, P1239, DOI 10.1046/j.1365-2958.2003.03647.x; BESTWICK CS, 1995, PLANT PHYSIOL, V108, P503, DOI 10.1104/pp.108.2.503; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Knodler LA, 2005, MOL BIOL CELL, V16, P4108, DOI 10.1091/mbc.E05-04-0367; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; SANDERFOOT AA, 2002, ARABIDOPSIS BOOK; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996	26	368	380	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					220	223		10.1126/science.1129523	http://dx.doi.org/10.1126/science.1129523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840699				2022-12-01	WOS:000239008000043
J	Galletto, R; Amitani, I; Baskin, RJ; Kowalczykowski, SC				Galletto, Roberto; Amitani, Ichiro; Baskin, Ronald J.; Kowalczykowski, Stephen C.			Direct observation of individual RecA filaments assembling on single DNA molecules	NATURE			English	Article							STRAND-EXCHANGE PROTEINS; ESCHERICHIA-COLI; DUPLEX DNA; ATP HYDROLYSIS; BINDING; RECOMBINATION; POLYMERIZATION; RECBCD; TRANSLOCATION; BIOCHEMISTRY	Escherichia coli RecA is essential for the repair of DNA double-strand breaks by homologous recombination(1). Repair requires the formation of a RecA nucleoprotein filament. Previous studies have indicated a mechanism of filament assembly whereby slow nucleation of RecA protein on DNA is followed by rapid growth(2-7). However, many aspects of this process remain unclear, including the rates of nucleation and growth and the involvement of ATP hydrolysis, largely because visualization at the single-filament level is lacking. Here we report the direct observation of filament assembly on individual double-stranded DNA molecules using fluorescently modified RecA. The nucleoprotein filaments saturate the DNA and extend it 1.6-fold. At early time points, discrete RecA clusters are seen, permitting analysis of single-filament growth from individual nuclei. Formation of nascent RecA filaments is independent of ATP hydrolysis but is dependent on the type of nucleotide cofactor and the RecA concentration, suggesting that nucleation involves binding of 4 - 5 ATP - RecA monomers to DNA. Individual RecA filaments grow at rates of 3 - 10 nm s(-1). Growth is bidirectional and, in contrast to nucleation, independent of nucleotide cofactor, suggesting addition of 2 - 7 monomers s(-1). These results are in accord with extensive genetic and biochemical studies, and indicate that assembly in vivo is controlled at the nucleation step. We anticipate that our approach and conclusions can be extended to the related eukaryotic counterpart, Rad51 (ref. 8), and to regulation by assembly mediators(9-11).	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Galletto, Roberto/0000-0001-6435-122X				Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; CHOW SA, 1988, J BIOL CHEM, V263, P3335; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Fulconis R, 2004, BIOPHYS J, V87, P2552, DOI 10.1529/biophysj.104.043059; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; KOWALCZYKOWSKI S, 1977, J MOL BIOL, V115, P201, DOI 10.1016/0022-2836(77)90097-3; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.bi.63.070194.005015; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.biophys.20.1.539; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MENETSKI JP, 1988, BIOCHEMISTRY-US, V27, P1205, DOI 10.1021/bi00404a021; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; PUGH BF, 1987, J BIOL CHEM, V262, P1326; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Sattin BD, 2004, BIOPHYS J, V87, P3430, DOI 10.1529/biophysj.104.045567; SHANER SL, 1987, J BIOL CHEM, V262, P9211; SHANER SL, 1987, J BIOL CHEM, V262, P9220; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; van der Heijden T, 2005, NUCLEIC ACIDS RES, V33, P2099, DOI 10.1093/nar/gki512; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zaitsev EN, 1998, NUCLEIC ACIDS RES, V26, P650, DOI 10.1093/nar/26.2.650; Zaitsev EN, 2000, GENE DEV, V14, P740	30	188	189	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					875	878		10.1038/nature05197	http://dx.doi.org/10.1038/nature05197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	16988658				2022-12-01	WOS:000241362700056
J	Gelfand, JM; Neimann, AL; Shin, DB; Wang, XM; Margolis, DJ; Troxel, AB				Gelfand, Joel M.; Neimann, Andrea L.; Shin, Daniel B.; Wang, Xingmei; Margolis, David J.; Troxel, Andrea B.			Risk of myocardial infarction in patients with psoriasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; CONSENSUS CONFERENCE; POPULATION; SMOKING; DISEASE; EPIDEMIOLOGY; PREVALENCE; SEVERITY; LIFE	Context Psoriasis is the most common T-helper cell type 1 (T(H)1) immunological disease. Evidence has linked T(H)1 diseases to myocardial infarction (MI). Psoriasis has been associated with cardiovascular diseases, but has only been investigated in hospital-based studies that did not control for major cardiovascular risk factors. Objective To determine if within a population-based cohort psoriasis is an independent risk factor for MI when controlling for major cardiovascular risk factors. Design, Setting, and Patients A prospective, population-based cohort study in the United Kingdom of patients with psoriasis aged 20 to 90 years, comparing outcomes among patients with and without a diagnosis of psoriasis. Data were collected by general practitioners as part of the patient's medical record and stored in the General Practice Research Database between 1987 and 2002, with a mean follow-up of 5.4 years. Adjustments were made for hypertension, diabetes, history of myocardial infarction, hyperlipidemia, age, sex, smoking, and body mass index. Patients with psoriasis were classified as severe if they ever received a systemic therapy. Up to 5 controls without psoriasis were randomly selected from the same practices and start dates as the patients with psoriasis. A total of 556 995 control patients and patients with mild (n = 127 139) and severe psoriasis (n = 3837) were identified. Main Outcome Measure Incident MI. Results There were 11 194 MIs (2.0%) within the control population and 2319 (1.8%) and 112 (2.9%) MIs within the mild and severe psoriasis groups, respectively. The incidences per 1000 person-years for control patients and patients with mild and severe psoriasis were 3.58 (95% confidence interval [CI], 3.52-3.65), 4.04 (95% CI, 3.88-4.21), and 5.13 (95% CI, 4.22-6.17), respectively. Patients with psoriasis had an increased adjusted relative risk (RR) for MI that varied by age. For example, for a 30-year-old patient with mild or severe psoriasis, the adjusted RR of having an MI is 1.29 (95% CI, 1.14-1.46) and 3.10 (95% CI, 1.98-4.86), respectively. For a 60-year-old patient with mild or severe psoriasis, the adjusted RR of having an MI is 1.08 (95% CI, 1.03-1.13) and 1.36 (95% CI, 1.13-1.64), respectively. Conclusions Psoriasis may confer an independent risk of MI. The RR was greatest in young patients with severe psoriasis.	Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Gelfand, JM (corresponding author), Univ Penn, Dept Dermatol, 3600 Spruce St,2 Maloney Bldg, Philadelphia, PA 19104 USA.	joel.gelfand@uphs.upenn.edu		Gelfand, Joel/0000-0003-3480-2661; Troxel, Andrea/0000-0002-1393-3075	NIAMS NIH HHS [K23AR051125-01, K23 AR051125] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR051125] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chodorowska G, 2004, J EUR ACAD DERMATOL, V18, P180, DOI 10.1111/j.1468-3083.2004.00863.x; ENA P, 1985, ACTA CARDIOL, V40, P199; Ford ES, 2000, J CLIN EPIDEMIOL, V53, P95, DOI 10.1016/S0895-4356(99)00143-2; Fortes C, 2005, ARCH DERMATOL, V141, P1580, DOI 10.1001/archderm.141.12.1580; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Gelfand JM, 2004, J AM ACAD DERMATOL, V51, P704, DOI 10.1016/j.jaad.2004.04.014; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Gelfand JM, 2003, ARCH DERMATOL, V139, P1425, DOI 10.1001/archderm.139.11.1425; Gelfand JM, 2005, PHARMACOEPIDEMIOL S, V14, pS23; Gelfand JM, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P337; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Herron MD, 2005, ARCH DERMATOL, V141, P1527, DOI 10.1001/archderm.141.12.1527; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1996, PHARMACOTHERAPY, V16, P321; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Kural BV, 2003, CLIN CHIM ACTA, V332, P23, DOI 10.1016/S0009-8981(03)00082-2; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Lebwohl M, 1998, J AM ACAD DERMATOL, V39, P464, DOI 10.1016/S0190-9622(98)70325-1; Lebwohl M, 2001, J AM ACAD DERMATOL, V45, P544, DOI 10.1067/mjd.2001.116347; Lewis JD, 2004, PHARMACOEPIDEM DR S, V13, P437, DOI 10.1002/pds.902; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; MCDONALD CJ, 1973, JAMA-J AM MED ASSOC, V224, P629; MCDONALD CJ, 1973, NEW ENGL J MED, V288, P912; McGowan JW, 2005, ARCH DERMATOL, V141, P1601, DOI 10.1001/archderm.141.12.1601; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; Prodanowich S, 2005, J AM ACAD DERMATOL, V52, P262, DOI 10.1016/j.jaad.2004.06.017; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rocha-Pereira P, 2004, BRIT J DERMATOL, V150, P917, DOI 10.1111/j.1365-2133.2004.05984.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Shbeeb M, 2000, J RHEUMATOL, V27, P1247; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Warrington KJ, 2005, ARTHRITIS RES THER, V7, pR984, DOI 10.1186/ar1775	40	1328	1364	2	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1735	1741		10.1001/jama.296.14.1735	http://dx.doi.org/10.1001/jama.296.14.1735			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032986	Bronze			2022-12-01	WOS:000241103400021
J	Artandi, SE				Artandi, Steven E.			Focus on research: Telomeres, telomerase, and human disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.								0	59	68	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1195	1197		10.1056/NEJMp068187	http://dx.doi.org/10.1056/NEJMp068187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990382				2022-12-01	WOS:000240598500003
J	Sackoff, JE; Hanna, DB; Pfeiffer, MR; Torian, LV				Sackoff, Judith E.; Hanna, David B.; Pfeiffer, Melissa R.; Torian, Lucia V.			Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; INJECTING DRUG-USERS; MORTALITY-RATES; HEPATOCELLULAR-CARCINOMA; MULTIPLE IMPUTATION; DISEASE PROGRESSION; TRENDS; HIV/AIDS; ASSOCIATION	Background: Monitoring the full spectrum of causes of death among persons with AIDS is increasingly important as survival improves because of highly active antiretroviral therapy. Objective: To describe recent trends in deaths due to HIV-related and non-HIV-related causes among persons with AIDS, identify factors associated with these deaths, and identify leading causes of non-HIV-related deaths. Design: Population-based cohort analysis. Setting: New York City. Patients: All adults (age >= 13 years) living with AIDS between 1999 and 2004 who were reported to the New York City HIV/AIDS Reporting System and Vital Statistics Registry through 2004 (n 68669). Measurements: Underlying cause of death on the death certificate Results: Between 1999 and 2004, the percentage of deaths due to non-HIV-related causes increased by 32.8% (from 19.8% to 26.3%; P = 0.015). The age-adjusted mortality rate decreased by 49.6 deaths per 10 000 persons with AIDS (P < 0.001) annually for HIV-related causes but only by 7.5 deaths per 10 000 persons with AIDS (P = 0.004) annually for non-HIV-related causes. Of deaths due to non-HIV-related causes, 76% could be attributed to substance abuse, cardiovascular disease, or a non-AIDS-defining type of cancer. Compared with men who have sex with men, injection drug users had a statistically significantly increased risk for death due to HIV-related causes (hazard ratio, 1.59 [95% CI, 1.49 to 1.70]) and non-HIV-related causes (hazard ratio, 2.54 [CI, 2.24 to 2.87]). Limitations: Compared with autopsy and chart review, death certificates may lack specificity in the underlying cause of death or detailed clinical and treatment-related information. Conclusions: Non-HIV-related causes of death account for one fourth of all deaths of persons with AIDS. Cardiovascular disease, non-AIDS-defining cancer, and substance abuse account for most non-HIV-related deaths. Reducing deaths from these causes requires a shift in the health care model for persons with AIDS from a primary focus on managing HIV infection to providing care that addresses all aspects of physical and mental health.	New York City Dept Hlth & Mental Hyg, HIV Epidemiol Program, Bur HIV AIDS Prevent & Control, New York, NY USA	New York City Department of Health & Mental Hygiene	Sackoff, JE (corresponding author), New York City Dept Hlth & Mental Hyg, HIV Epidemiol Program, Bur HIV AIDS Prevent & Control, New York, NY USA.	jsackoff@health.nyc.gov			PHS HHS [U62/CCU223595] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aberg JA, 2004, CLIN INFECT DIS, V39, P609, DOI 10.1086/423390; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2000, MMWR-MORBID MORTAL W, V51, P642; Arday D. R., 1993, Tobacco Control, V2, P156, DOI 10.1136/tc.2.2.156; Arias Elizabeth, 2003, Natl Vital Stat Rep, V52, P1; Bedimo R, 2004, CLIN INFECT DIS, V39, P1380, DOI 10.1086/424883; Bernicker EH, 1996, AM J MED SCI, V311, P215, DOI 10.1097/00000441-199605000-00004; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Bonnet F, 2002, HIV Med, V3, P195, DOI 10.1046/j.1468-1293.2002.00117.x; Casau NC, 2005, CLIN INFECT DIS, V41, P855, DOI 10.1086/432797; *CDCP, 2005, TRENDS ANN AG ADJ RA; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Engels EA, 2002, JAIDS, V31, P536, DOI 10.1097/00126334-200212150-00012; Frieden TR, 2005, AM J PUBLIC HEALTH, V95, P1016, DOI 10.2105/AJPH.2004.058164; GREENBERG AE, 1993, JAMA-J AM MED ASSOC, V269, P2995, DOI 10.1001/jama.269.23.2995; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; JONES JL, 1999, CDC MORB MORTAL WKLY, V48, P1; Klinkenberg WD, 2004, AIDS CARE, V16, pS22, DOI 10.1080/09540120412331315303; Krentz HB, 2005, HIV MED, V6, P99, DOI 10.1111/j.1468-1293.2005.00271.x; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lee LM, 2003, PUBLIC HEALTH REP, V118, P400, DOI 10.1093/phr/118.5.400; Lethbridge-Cejku M, 2004, VITAL HLTH STAT, V10, P1; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Louie JK, 2002, J INFECT DIS, V186, P1023, DOI 10.1086/343862; Miller N, 2005, LANCET, V365, P1849, DOI 10.1016/S0140-6736(05)66615-9; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Molenberghs G, 2002, STAT MED, V21, P1387, DOI 10.1002/sim.1118; National Center for Health Statistics, 1999, VIT STAT US MORT 199; Niaura R, 1999, ANN BEHAV MED, V21, pS116; *NY CIT DEP HLTH M, 2004, TAK CAR NY POL HEALT; *NY CIT DEP HLTH M, 2005, HIV EP PROGR 1 QUART; *NY CIT DEP HLTH M, 2004, SUMM VIT STAT 2003 C; *NY STAT DEP HLTH, 2005, SCREEN ONG ASS SUBST; *NY STAT DEP HLTH, 2005, SMOK CESS HIV INF PA; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prins M, 2000, AIDS, V14, P1829, DOI 10.1097/00002030-200008180-00019; Prins M, 1997, AIDS, V11, P1747, DOI 10.1097/00002030-199714000-00012; Puoti M, 2004, AIDS, V18, P2285, DOI 10.1097/00002030-200411190-00009; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; SELIK R, 2004, 11 C RETR OPP INF SA; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Selik RM, 2003, JAIDS-J ACQ IMM DEF, V32, P62, DOI 10.1097/00126334-200301010-00009; Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Smith DK, 2003, J URBAN HEALTH, V80, P676, DOI 10.1093/jurban/jtg074; U.S. Census Bureau, 2000, US CENS; Vandentorren S, 2001, EUR J EPIDEMIOL, V17, P7, DOI 10.1023/A:1010972410865; WEBER R, 2005, 12 C RETR OPP INF BO; WHO, 2019, INT STAT CLASS DIS R, V10th; 2004, MMWR MORB MORTAL WKL, V53, P866	53	348	356	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					397	406		10.7326/0003-4819-145-6-200609190-00003	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087OU	16983127				2022-12-01	WOS:000240752500001
J	Zhong, CB; Liljenquist, K				Zhong, Chen-Bo; Liljenquist, Katie			Washing away your sins: Threatened morality and physical cleansing	SCIENCE			English	Article								Physical cleansing has been a focal element in religious ceremonies for thousands of years. The prevalence of this practice suggests a psychological association between bodily purity and moral purity. In three studies, we explored what we call the "Macbeth effect'' - that is, a threat to one's moral purity induces the need to cleanse oneself. This effect revealed itself through an increased mental accessibility of cleansing-related concepts, a greater desire for cleansing products, and a greater likelihood of taking antiseptic wipes. Furthermore, we showed that physical cleansing alleviates the upsetting consequences of unethical behavior and reduces threats to one's moral self-image. Daily hygiene routines such as washing hands, as simple and benign as they might seem, can deliver a powerful antidote to threatened morality, enabling people to truly wash away their sins.	Univ Toronto, Joseph L Rotman Sch Management, Dept Org Behav & HR Management, Toronto, ON M5S 3E6, Canada; Northwestern Univ, JL Kellogg Grad Sch Management, Dept Management & Org, Evanston, IL 60208 USA	University of Toronto; Northwestern University	Zhong, CB (corresponding author), Univ Toronto, Joseph L Rotman Sch Management, Dept Org Behav & HR Management, Toronto, ON M5S 3E6, Canada.	chenbo.zhong@rotman.utoronto.ca						*BIBLE, ACTS, V22; Fuller CJ., 1992, CAMPHOR FLAME POPULA; Haidt J., 2004, HDB EXPT EXISTENTIAL, P322; Imada S., 1997, PSYCHOL DEV SOC, V9, P107, DOI [DOI 10.1177/097133369700900105, 10.1177/097133369700900105]; Lakoff G., 1987, WOMEN FIRE DANGEROUS, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; SHAKESPEARE W, 1998, MACBETH; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Wicklund RA, 1981, BASIC APPL SOC PSYCH, V2, P89, DOI 10.1207/s15324834basp0202_2	10	651	687	13	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1451	1452		10.1126/science.1130726	http://dx.doi.org/10.1126/science.1130726			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960010				2022-12-01	WOS:000240348700047
J	Dunkelberg, S				Dunkelberg, Sandra			A patient's journey: Our special girl	BRITISH MEDICAL JOURNAL			English	Article									Univ Hamburg Hosp, Inst Gen Practice, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Dunkelberg, S (corresponding author), Bergkoppelweg 2, D-22335 Hamburg, Germany.	dunkelbe@uke.uni-haruburg.de							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 26	2006	333	7565					430	431		10.1136/bmj.38937.455949.55	http://dx.doi.org/10.1136/bmj.38937.455949.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081AO	16931841	Green Published			2022-12-01	WOS:000240289800022
J	Tashiro, A; Sandler, VM; Toni, N; Zhao, CM; Gage, FH				Tashiro, Ayumu; Sandler, Vladislav M.; Toni, Nicolas; Zhao, Chunmei; Gage, Fred H.			NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus	NATURE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; NEUROGENESIS; DEATH; MICE; MEMORY; BRAIN; DIFFERENTIATION; APOPTOSIS	New neurons are continuously integrated into existing neural circuits in adult dentate gyrus of the mammalian brain(1-4). Accumulating evidence indicates that these new neurons are involved in learning and memory(5-8). A substantial fraction of newly born neurons die before they mature(9,10) and the survival of new neurons is regulated in an experience-dependent manner(5,6,11), raising the possibility that the selective survival or death of new neurons has a direct role in a process of learning and memory such as information storage - through the information-specific construction of new circuits. However, a critical assumption of this hypothesis is that the survival or death decision of new neurons is information-specific. Because neurons receive their information primarily through their input synaptic activity, we investigated whether the survival of new neurons is regulated by input activity in a cell-specific manner. Here we developed a retrovirus-mediated, single-cell gene knockout technique in mice and showed that the survival of new neurons is competitively regulated by their own NMDA-type glutamate receptor during a short, critical period soon after neuronal birth. This finding indicates that the survival of new neurons and the resulting formation of new circuits are regulated in an input-dependent, cell-specific manner. Therefore, the circuits formed by new neurons may represent information associated with input activity within a short time window in the critical period. This information-specific addition of new circuits through selective survival or death of new neurons may be a unique attribute of new neurons that enables them to play a critical role in learning and memory.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Toni, Nicolas/M-2057-2014; Tashiro, Ayumu/Z-2900-2019; Tashiro, Ayumu/A-2675-2008	Toni, Nicolas/0000-0001-5585-268X; Tashiro, Ayumu/0000-0001-7967-7409; Tashiro, Ayumu/0000-0001-7967-7409				Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; NARUSE I, 1995, PROG NEUROBIOL, V47, P135, DOI 10.1016/0301-0082(95)00024-P; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	30	463	486	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					929	933		10.1038/nature05028	http://dx.doi.org/10.1038/nature05028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16906136				2022-12-01	WOS:000239960500040
J	Murgia, C; Pritchard, JK; Kim, SY; Fassati, A; Weiss, RA				Murgia, Claudio; Pritchard, Jonathan K.; Kim, Su Yeon; Fassati, Ariberto; Weiss, Robin A.			Clonal origin and evolution of a transmissible cancer	CELL			English	Article							VENEREAL TUMOR-CELLS; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; DOMESTIC DOG; GENETIC INSTABILITY; SARCOMA; PROGRESSION; KARYOTYPE; INFERENCE; INSERTION	The transmissible agent causing canine transmissible venereal tumor (CTVT) is thought to be the tumor cell itself. To test this hypothesis, we analyzed genetic markers including major histocompatibility (MHC) genes, microsatellites, and mitochondrial DNA (mtDNA) in naturally occurring tumors and matched blood samples. In each case, the tumor is genetically distinct from its host. Moreover, tumors collected from 40 dogs in 5 continents are derived from a single neoplastic clone that has diverged into two subclades. Phylogenetic analyses indicate that CTVT most likely originated from a wolf or an East Asian breed of dog between 200 and 2500 years ago. Although CTVT is highly aneuploid, it has a remarkably stable genotype. During progressive growth, CTVT down-modulates MHC antigen expression. Our findings have implications for understanding genome instability in cancer, natural transplantation of allografts, and the capacity of a somatic cell to evolve into a transmissible parasite.	UCL, MRC, Ctr Med Mol Virol, Div Infect & Immun, London W1T 4JF, England; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of London; University College London; University of Chicago; University of Chicago	Weiss, RA (corresponding author), UCL, MRC, Ctr Med Mol Virol, Div Infect & Immun, 46 Cleveland St, London W1T 4JF, England.	r.weiss@ucl.ac.uk	Pepper, John W/O-1662-2013	Pepper, John W/0000-0001-9888-0437; Fassati, Ariberto/0000-0003-1934-5327	MRC [G8712499] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER; Medical Research Council [G8712499] Funding Source: Medline; NHGRI NIH HHS [R01 HG002772-03, R01 HG002772] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome Trust)		Affolter VK, 2002, VET PATHOL, V39, P74, DOI 10.1354/vp.39-1-74; [Anonymous], 2003, PAUP 4 0 PHYLOGENETI; BANFIELD WG, 1965, SCIENCE, V148, P1239, DOI 10.1126/science.148.3674.1239; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Battistacci M., 1974, Nuova Veterinaria, V50, P226; Brooks MB, 2003, MAMM GENOME, V14, P788, DOI 10.1007/s00335-003-2290-z; Brumer Y, 2006, J THEOR BIOL, V241, P216, DOI 10.1016/j.jtbi.2005.11.018; BUSS LW, 1982, P NATL ACAD SCI-BIOL, V79, P5337, DOI 10.1073/pnas.79.17.5337; Chu RM, 2001, ANTICANCER RES, V21, P4017; COHEN D, 1985, ADV CANCER RES, V43, P75, DOI 10.1016/S0065-230X(08)60943-4; COHEN D, 1984, JNCI-J NATL CANCER I, V72, P395; COOPER HL, 1964, J NATL CANCER I, V33, P691; Das U, 2000, VET RES COMMUN, V24, P545, DOI 10.1023/A:1006491918910; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Falush D, 2003, GENETICS, V164, P1567; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Greaves M, 2002, LANCET ONCOL, V3, P244, DOI 10.1016/S1470-2045(02)00716-7; Harmelin A, 2001, AM J VET RES, V62, P907, DOI 10.2460/ajvr.2001.62.907; HOLMES JM, 1981, RES VET SCI, V30, P248, DOI 10.1016/S0034-5288(18)32592-X; Hsiao YW, 2004, J IMMUNOL, V172, P1508, DOI 10.4049/jimmunol.172.3.1508; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; KATZIR N, 1987, ONCOGENE, V1, P445; KATZIR N, 1985, P NATL ACAD SCI USA, V82, P1054, DOI 10.1073/pnas.82.4.1054; Kauffman HM, 2002, TRANSPLANTATION, V74, P358, DOI 10.1097/00007890-200208150-00011; Kennedy LJ, 2002, TISSUE ANTIGENS, V60, P43, DOI 10.1034/j.1399-0039.2002.600106.x; Kennedy LJ, 2002, TISSUE ANTIGENS, V59, P194, DOI 10.1034/j.1399-0039.2002.590303.x; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Liao KW, 2003, J VET DIAGN INVEST, V15, P399, DOI 10.1177/104063870301500501; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LOMBARD C, 1967, B CANCER, V54, P357; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Marchal T, 1997, VET IMMUNOL IMMUNOP, V57, P1, DOI 10.1016/S0165-2427(96)05757-1; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; MURRAY M, 1969, RES VET SCI, V10, P565; Nowinsky M., 1876, ZENTRALBL MED WISS, V14, P790; OSHIMURA M, 1973, J NATL CANCER I, V51, P1197, DOI 10.1093/jnci/51.4.1197; OWEN D, 2006, TASMANIAN DEVIL UNIQ; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pritchard JK, 2000, GENETICS, V155, P945; Raptis S, 2006, EXP SUPPL, V96, P303; Rinkevich B, 2004, IMMUNOL REV, V198, P25, DOI 10.1111/j.0105-2896.2004.0114.x; Rosenberg N, 2004, MOL ECOL, V4, P127; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Seddon JM, 2002, IMMUNOGENETICS, V54, P490, DOI 10.1007/s00251-002-0489-x; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; WEBER W. T., 1965, J NAT CANCER INST, V35, P537	52	274	288	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2006	126	3					477	487		10.1016/j.cell.2006.05.051	http://dx.doi.org/10.1016/j.cell.2006.05.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901782	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000239883400009
J	Lu, C; Michaud, CM; Khan, K; Murray, CJL				Lu, Chunling; Michaud, Catherine M.; Khan, Kashif; Murray, Christopher J. L.			Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation	LANCET			English	Article							GROWTH; POLICIES; HEALTH	Background The Global Fund to Fight AIDS, Tuberculosis and Malaria was launched in 2002 to attract and rapidly disburse money to fight these diseases. However, some commentators believe that poor countries cannot effectively use such resources to increase delivery of their health programmes-referred to as a lack of absorptive capacity. We aimed to investigate the major determinants of grant implementation in developing countries. Methods With information available publicly on the Global Fund's website, we did random-effects analysis to investigate the effect of grant characteristics, types of primary recipient and local fund agent, and country attributes on disbursements that were made between 2003 and 2005 (phase one of Global Fund payments). To check the robustness of findings, regression results from alternative estimation methods and model specifications were also tested. Findings Grant characteristics-such as size of commitment, lag time between signature and first disbursement, and funding round-had significant effects on grant implementation. Enhanced political stability was associated with high use of grants. Low-income countries, and those with less-developed health systems for a given level of income, were more likely to have a higher rate of grant implementation than nations with higher incomes or more-developed health systems. Interpretation The higher rate of grant implementation seen in countries with low income and low health-spending lends support to proponents of major increases in health assistance for the poorest countries and argues that focusing resources on low-income nations, particularly those with political stability, will not create difficulties of absorptive capacity. Our analysis was restricted to grant implementation, which is one part of the issue of absorptive capacity In the future, assessment of the effect of Global Fund grants on intervention coverage will be vital.	Harvard Initiat Global Hlth, Cambridge, MA 02138 USA	Harvard University	Michaud, CM (corresponding author), Harvard Initiat Global Hlth, 104 Mt Auburn St, Cambridge, MA 02138 USA.	cmichaud@hsph.harvard.edu						[Anonymous], 2002, LANCET, V359, P367; BEZANSON KA, REPLENISHING GLOBAL; Brugha R, 2005, TROP MED INT HEALTH, V10, P623, DOI 10.1111/j.1365-3156.2005.01437.x; Brugha R, 2004, LANCET, V364, P95, DOI 10.1016/S0140-6736(04)16595-1; Burnside C, 2000, AM ECON REV, V90, P847, DOI 10.1257/aer.90.4.847; Caines K, 2004, ASSESSING IMPACT GLO; Collier P, 2002, EUR ECON REV, V46, P1475, DOI 10.1016/S0014-2921(01)00187-8; Devarajan S., 2001, Aid and reform in Africa: lessons from ten case studies; DOLALR D, 1999, WORLD BANK POLICY RE, V2070; DOLLAR D, 2004, 3299 WORLD BANK; Easterly W, 2004, AM ECON REV, V94, P774, DOI 10.1257/0002828041464560; *GLOB FUND, 2005, MON EV TOOLK HIV AID; Hansen H, 2001, J DEV ECON, V64, P547, DOI 10.1016/S0304-3878(00)00150-4; Heller P., 2002, WORLD ECON, V3, P131; *INT FIN FAC IMM, NEW INT FIN FAC IMM; KAUFMANN D, 2004, GOVERNANCE MATTERS, V4; MICHAUD C, 2003, 2 CONS COMM MACR HLT; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Nossal GJ, 2003, IMMUNOL CELL BIOL, V81, P20, DOI 10.1046/j.0818-9641.2002.01139.x; RADELET S, 2003, CHALLENGING FOREIGN; Radelet S., 2004, GLOBAL FUND FIGHT AI; RADELET S, 2004, 39 DTR GLOB DEV; RADELT S, 2005, GLOBAL FUND FIGHT AI; Ramsay S, 2002, LANCET, V359, P1581, DOI 10.1016/S0140-6736(02)08531-8; Sachs JD, 2004, B WORLD HEALTH ORGAN, V82, P947; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; *US DEP STAT, ACT TOD FDN TOM; *WORLD BANK, 2004, INT MON FUND AID EFF; *WORLD BANK, 2005, HLTH FIN REV C DRAFT	29	43	43	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2006	368	9534					483	488		10.1016/S0140-6736(06)69156-3	http://dx.doi.org/10.1016/S0140-6736(06)69156-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890835				2022-12-01	WOS:000239569000031
J	Demoly, P; Bousquet, J				Demoly, Pascal; Bousquet, Jean			The relation between asthma and allergic rhinitis	LANCET			English	Editorial Material							DIAGNOSIS; INFLAMMATION; THERAPY; NASAL; CARE		Univ Hosp Montpellier, Hop Arnaud de Villeneuve, INSERM, U454, F-34295 Montpellier 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Demoly, P (corresponding author), Univ Hosp Montpellier, Hop Arnaud de Villeneuve, INSERM, U454, F-34295 Montpellier 5, France.	demoly@montp.inserm.fr	Demoly, Pascal/Y-9938-2019	Demoly, Pascal/0000-0001-7827-7964				Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Braunstahl GJ, 2000, AM J RESP CRIT CARE, V161, P2051, DOI 10.1164/ajrccm.161.6.9906121; Celedon JC, 2001, AM J RESP CRIT CARE, V163, P1108, DOI 10.1164/ajrccm.163.5.2005086; Chanez P, 1999, AM J RESP CRIT CARE, V159, P588, DOI 10.1164/ajrccm.159.2.9801022; Corren J, 2004, J ALLERGY CLIN IMMUN, V113, P415, DOI 10.1016/j.jaci.2003.11.034; Dahl R, 2005, ALLERGY, V60, P875, DOI 10.1111/j.1398-9995.2005.00819.x; Demoly P, 2006, ALLERGY, V61, P699, DOI 10.1111/j.1398-9995.2006.01112.x; Demoly P, 2005, ALLERGY, V60, P1089, DOI 10.1111/j.1398-9995.2005.00843.x; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391, DOI 10.1164/ajrccm.162.4.9912033; Malo JL, 1997, EUR RESPIR J, V10, P1513, DOI 10.1183/09031936.97.10071513; Philip G, 2004, CURR MED RES OPIN, V20, P1549, DOI 10.1185/030079904X3348; Price D, 2005, CLIN EXP ALLERGY, V35, P282, DOI 10.1111/j.1365-2222.2005.02182.x; TARAMARCAZ P, 2003, COCHRANE DB SYST REV, V4; ten Brinke A, 2002, J ALLERGY CLIN IMMUN, V109, P621, DOI 10.1067/mai.2002.122458; Vignola AM, 2004, ALLERGY, V59, P709, DOI 10.1111/j.1398-9995.2004.00550.x	15	36	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2006	368	9537					711	713		10.1016/S0140-6736(06)69263-5	http://dx.doi.org/10.1016/S0140-6736(06)69263-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080ID	16935669				2022-12-01	WOS:000240240200007
J	Suh, BC; Inoue, T; Meyer, T; Hille, B				Suh, Byung-Chang; Inoue, Takanari; Meyer, Tobias; Hille, Bertil			Rapid chemically induced changes of Ptdlns(4,5)P-2 gate KCNQ ion channels	SCIENCE			English	Article							PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; LIVING CELLS; KINASE; ACTIVATION; 3-KINASE; INHIBITION; PATHWAYS	To resolve the controversy about messengers regulating KCNQ ion channels during phospholipase C - mediated suppression of current, we designed translocatable enzymes that quickly alter the phosphoinositide composition of the plasma membrane after application of a chemical cue. The KCNQ current falls rapidly to zero when phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5) P-2 or PI(4,5) P-2] is depleted without changing Ca2+, diacylglycerol, or inositol 1,4,5-trisphosphate. Current rises by 30% when PI(4,5) P-2 is overproduced and does not change when phosphatidylinositol 3,4,5-trisphosphate is raised. Hence, the depletion of PI(4,5) P-2 suffices to suppress current fully, and other second messengers are not needed. Our approach is ideally suited to study biological signaling networks involving membrane phosphoinositides.	Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; Stanford Univ, Dept Mol Pharmacol, Clark Ctr, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Hille, B (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	hille@u.washington.edu		Meyer, Tobias/0000-0003-4339-3804	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063702, R01GM030179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS008174, R01NS008174] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR017803, AR17803] Funding Source: Medline; NIGMS NIH HHS [GM63702, R01 GM030179-24A1, R01 GM030179, R01 GM030179-25, R01 GM063702] Funding Source: Medline; NIMH NIH HHS [MH64801, R01 MH064801] Funding Source: Medline; NINDS NIH HHS [R01 NS008174, R37 NS008174, NS08174] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; Lerche H, 2005, CURR PHARM DESIGN, V11, P2737, DOI 10.2174/1381612054546815; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005	25	389	389	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1454	1457		10.1126/science.1131163	http://dx.doi.org/10.1126/science.1131163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	16990515	Green Accepted			2022-12-01	WOS:000242406100042
J	Stoltenberg, J				Stoltenberg, Jens			Our children: the key to our common future	LANCET			English	Editorial Material												Tore.Godal@smk.dep.no						Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Bloom DE, 1998, BROOKINGS PAP ECO AC, P207, DOI 10.2307/2534695; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; GANDHI MK, 1972, TO MY COUNTRYMEN; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1	8	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1042	1044		10.1016/S0140-6736(06)69332-X	http://dx.doi.org/10.1016/S0140-6736(06)69332-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997647				2022-12-01	WOS:000240873000005
J	Bono, F; Ebert, J; Lorentzen, E; Conti, E				Bono, Fulvia; Ebert, Judith; Lorentzen, Esben; Conti, Elena			The crystal structure of the exon junction complex reveals how it maintains a stable grip on mRNA	CELL			English	Article							NONSENSE-MEDIATED DECAY; MAMMALIAN-CELLS; MAGO NASHI; MOLECULAR INSIGHTS; GENE-EXPRESSION; PROTEIN; DROSOPHILA; TRANSLATION; CORE; Y14	The exon junction complex (EJC) plays a major role in posttranscriptionall regulation of mRNA in metazoa. The EJC is deposited onto mRNA during splicing and is transported to the cytoplasm where it influences translation, surveillance, and localization of the spliced mRNA. The complex is formed by the association of four proteins (eIF4AIII, Barentsz [Btz], Mago, and Y14), mRNA, and ATP. The 2.2 angstrom resolution structure of the EJC reveals how it stably locks onto mRNA. The DEAD-box protein eIF4AIII encloses an ATP molecule and provides the binding sites for six ribonucleotides. Btz wraps around eIF4AIII and stacks against the 5' nucleotide. An intertwined network of interactions anchors Mago-Y14 and Btz at the interface between the two domains of eIF4AIII, effectively stabilizing the ATP bound state. Comparison with the structure of the eIF4aIII-Btz: subcomplex that we have also determined reveals that large conformational changes are required upon EJC assembly and disassembly.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Conti, E (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	conti@embl.de	Lorentzen, Esben/AAX-8077-2020	Lorentzen, Esben/0000-0001-6493-7220; Conti, Elena/0000-0003-1254-5588				Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hall KB, 2002, CURR OPIN STRUC BIOL, V12, P283, DOI 10.1016/S0959-440X(02)00323-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li QY, 1999, MOL CELL BIOL, V19, P7336; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Macchi P, 2003, J NEUROSCI, V23, P5778; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Mohr SE, 2001, GENE DEV, V15, P2886; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Radaev S, 2006, ACTA CRYSTALLOGR D, V62, P605, DOI 10.1107/S0907444906011735; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100	51	300	310	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 25	2006	126	4					713	725		10.1016/j.cell.2006.08.006	http://dx.doi.org/10.1016/j.cell.2006.08.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923391	Bronze, Green Accepted			2022-12-01	WOS:000240276700020
J	Adams, KF; Schatzkin, A; Harris, TB; Kipnis, V; Mouw, T; Ballard-Barbash, R; Hollenbeck, A; Leitzmann, MF				Adams, Kenneth F.; Schatzkin, Arthur; Harris, Tamara B.; Kipnis, Victor; Mouw, Traci; Ballard-Barbash, Rachel; Hollenbeck, Albert; Leitzmann, Michael F.			Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; FOLLOW-UP; WEIGHT; MEN; UNDERWEIGHT; ADULTS; GUIDELINES; ACCURACY; CANCER; TRENDS	Background: Obesity, defined by a body-mass index (BMI) (the weight in kilograms divided by the square of the height in meters) of 30.0 or more, is associated with an increased risk of death, but the relation between overweight (a BMI of 25.0 to 29.9) and the risk of death has been questioned. Methods: We prospectively examined BMI in relation to the risk of death from any cause in 527,265 U.S. men and women in the National Institutes of Health-AARP cohort who were 50 to 71 years old at enrollment in 1995-1996. BMI was calculated from self-reported weight and height. Relative risks and 95 percent confidence intervals were adjusted for age, race or ethnic group, level of education, smoking status, physical activity, and alcohol intake. We also conducted alternative analyses to address potential biases related to preexisting chronic disease and smoking status. Results: During a maximum follow-up of 10 years through 2005, 61,317 participants (42,173 men and 19,144 women) died. Initial analyses showed an increased risk of death for the highest and lowest categories of BMI among both men and women, in all racial or ethnic groups, and at all ages. When the analysis was restricted to healthy people who had never smoked, the risk of death was associated with both overweight and obesity among men and women. In analyses of BMI during midlife (age of 50 years) among those who had never smoked, the associations became stronger, with the risk of death increasing by 20 to 40 percent among overweight persons and by two to at least three times among obese persons; the risk of death among underweight persons was attenuated. Conclusions: Excess body weight during midlife, including overweight, is associated with an increased risk of death.	NCI, Nutr Epidemiol Branch, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; NCI, Biometry Res Grp, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Prevent, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); American Association of Retired Persons (AARP)	Adams, KF (corresponding author), Nutr Epidemiol Branch, 6120 Execut Blvd,Suite 320, Rockville, MD 20852 USA.	adamske@mail.nih.gov	Hollenbeck, Albert/AAG-9461-2020		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2004, AM J EPIDEMIOL, V160, P331, DOI 10.1093/aje/kwh222; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hauser TH, 2001, J CLIN EPIDEMIOL, V54, P1267, DOI 10.1016/S0895-4356(01)00421-8; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Leveille SG, 2005, AM J PUBLIC HEALTH, V95, P1607, DOI 10.2105/AJPH.2004.060418; Lindsted KD, 1998, INT J OBESITY, V22, P544, DOI 10.1038/sj.ijo.0800623; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; Michaud D., 2005, J REGISTRY MANAGE, V32, P70; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; ROTHMAN KJ, 1972, J R STAT SOC B, V34, P187; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Singh PN, 1999, AM J EPIDEMIOL, V150, P1152, DOI 10.1093/oxfordjournals.aje.a009942; Society of Actuaries, 1959, BUILD BLOOD PRESS ST; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Visscher TLS, 2000, AM J EPIDEMIOL, V151, P660, DOI 10.1093/oxfordjournals.aje.a010260; Willett WC, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; WILLETT WC, 1998, MONOGRAPHS EPIDEMIOL, V30, P514; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P190, DOI 10.1001/jama.295.2.190; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824	37	1531	1584	4	121	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2006	355	8					763	778		10.1056/NEJMoa055643	http://dx.doi.org/10.1056/NEJMoa055643			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076KA	16926275				2022-12-01	WOS:000239955200005
J	Chang, DC; Grant, GB; O'Donnell, K; Wannemuehler, KA; Noble-Wang, J; Rao, CY; Jacobson, LM; Crowell, CS; Sneed, RS; Lewis, FMT; Schaffzin, JK; Kainer, MA; Genese, CA; Alfonso, EC; Jones, DB; Srinivasan, A; Fridkin, SK; Park, BJ				Chang, Douglas C.; Grant, Gavin B.; O'Donnell, Kerry; Wannemuehler, Kathleen A.; Noble-Wang, Judith; Rao, Carol Y.; Jacobson, Lara M.; Crowell, Claudia S.; Sneed, Rodlescia S.; Lewis, Felicia M. T.; Schaffzin, Joshua K.; Kainer, Marion A.; Genese, Carol A.; Alfonso, Eduardo C.; Jones, Dan B.; Srinivasan, Arjun; Fridkin, Scott K.; Park, Benjamin J.		Fusarium Keratitis Investigation T	Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ULCERATIVE KERATITIS; MICROBIAL KERATITIS; FUNGAL KERATITIS; DAILY-WEAR; RISK; SPECTRUM; MEMBERS; COMPLEX; TRENDS	Context Fusarium keratitis is a serious corneal infection, most commonly associated with corneal injury. Beginning in March 2006, the Centers for Disease Control and Prevention received multiple reports of Fusarium keratitis among contact lens wearers. Objective To define the specific activities, contact lens hygiene practices, or products associated with this outbreak. Design, Setting, and Participants Epidemiological investigation of Fusarium keratitis occurring in the United States. A confirmed case was defined as keratitis with illness onset after June 1, 2005, with no history of recent ocular trauma and a corneal culture growing Fusarium species. Data were obtained by patient and ophthalmologist interviews for case patients and neighborhood-matched controls by trained personnel. Available Fusarium isolates from patients' clinical and environmental specimens were genotyped by multilocus sequence typing. Environmental sampling for Fusarium was conducted at a contact lens solution manufacturing plant. Main Outcome Measures Keratitis infection with Fusarium species. Results As of June 30, 2006, we identified 164 confirmed case patients in 33 states and 1 US territory. Median age was 41 years (range, 12-83 years). Corneal transplantation was required or planned in 55 (34%). One hundred fifty-four (94%) of the confirmed case patients wore soft contact lenses. Forty-five case patients and 78 controls were included in the case-control study. Case patients were significantly more likely than controls to report using a specific contact lens solution, ReNu with MoistureLoc (69% vs 15%; odds ratio, 13.3; 95% confidence interval, 3.1-119.5). The prevalence of reported use of ReNu MultiPlus solution was similar between case patients and controls (18% vs 20%; odds ratio, 0.7; 95% confidence interval, 0.2-2.8). Fusarium was not recovered from the factory, warehouse, solution filtrate, or unopened solution bottles; production of implicated lots was not clustered in time. Among 39 isolates tested, at least 10 different Fusarium species were identified, comprising 19 unique multilocus genotypes. Conclusions The findings from this investigation indicate that this outbreak of Fusarium keratitis was associated with use of ReNu with MoistureLoc contact lens solution. Contact lens users should not use ReNu with MoistureLoc.	Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Biostat Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol & Lab Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis & Epidem Intelligence Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Elect Program, Atlanta, GA USA; Ctr Dis Control & Prevent, Career Dev Div, Off Workforce & Career Dev, Atlanta, GA USA; ARS, Microbial Genom Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA; Miami Dade Cty Hlth Dept, Miami, FL USA; Philadelphia Dept Hlth, Philadelphia, PA USA; New York State Dept Hlth, Albany, NY USA; Tennessee Dept Hlth, Nashville, TN USA; New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA; Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA); State University of New York (SUNY) System; Tennessee Department Health; New Jersey Department of Health & Senior Services; Bascom Palmer Eye Institute; University of Miami; Baylor College of Medicine	Chang, DC (corresponding author), 1600 Clifton Rd,MS C-09, Atlanta, GA 30333 USA.	DChang@cdc.gov	Sneed, PhD, MPH, Rodlescia/ABG-8963-2021; Schaffzin, Joshua K/AAZ-9243-2021	Schaffzin, Joshua K/0000-0002-1190-1854; Kainer, Marion/0000-0001-7678-8744; Rao, Carol/0000-0001-7187-2189; Wannemuehler, Kathleen/0000-0001-9535-6277; Sneed, Rodlescia/0000-0001-7732-6197; Grant, Gavin/0000-0002-3271-5735				ALFONSO E, 1986, AM J OPHTHALMOL, V101, P429, DOI 10.1016/0002-9394(86)90641-0; Alfonso EC, 2006, AM J OPHTHALMOL, V142, P154, DOI 10.1016/j.ajo.2006.04.025; Alfonso EC, 2006, ARCH OPHTHALMOL-CHIC, V124, P941, DOI 10.1001/archopht.124.7.ecs60039; Anaissie EJ, 2001, CLIN INFECT DIS, V33, P1871, DOI 10.1086/324501; ASBELL P, 1982, ARCH OPHTHALMOL-CHIC, V100, P77, DOI 10.1001/archopht.1982.01030030079005; Bernal MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P1051, DOI 10.1001/archopht.124.7.ecr60006; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P400; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; *CONT LENS COUNC, STAT CONT LENS WEAR; Dart J, 1999, LANCET, V354, P174, DOI 10.1016/S0140-6736(99)90104-6; DART JKG, 1991, LANCET, V338, P650, DOI 10.1016/0140-6736(91)91231-I; de Hoog GS, 2020, ATLAS CLIN FUNGI ULT, V4th; Driebe William T Jr, 2003, Ophthalmol Clin North Am, V16, P485, DOI 10.1016/S0896-1549(03)00052-X; Foulks GN, 2006, AM J OPHTHALMOL, V141, P369, DOI 10.1016/j.ajo.2005.08.047; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Khor WB, 2006, JAMA-J AM MED ASSOC, V295, P2867, DOI 10.1001/jama.295.24.2867; KOIDOUTSILIGIANNI A, 1989, AM J OPHTHALMOL, V108, P64, DOI 10.1016/S0002-9394(14)73262-3; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; Mah-Sadorra JH, 2005, CORNEA, V24, P51, DOI 10.1097/01.ico.0000138839.29823.57; McLaughlin-Borlace L, 1998, J APPL MICROBIOL, V84, P827; *MIN HLTH SING, PUBL AL INCR INC CON; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; Nilsson Sven Erik G., 1994, CLAO Journal, V20, P225; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; POGGIO EC, 1989, NEW ENGL J MED, V321, P779, DOI 10.1056/NEJM198909213211202; Rattanatam T, 2001, CORNEA, V20, P290, DOI 10.1097/00003226-200104000-00010; Reeb V, 2004, MOL PHYLOGENET EVOL, V32, P1036, DOI 10.1016/j.ympev.2004.04.012; ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005; SCHEIN OD, 1994, ARCH OPHTHALMOL-CHIC, V112, P186, DOI 10.1001/archopht.1994.01090140062024; SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201; SCHEIN OD, 1989, CORNEA, V8, P281; Schein OD, 2005, OPHTHALMOLOGY, V112, P2172, DOI 10.1016/j.ophtha.2005.09.014; SCHEIN OD, 1990, CORNEA, V9, pS55; SIMMONS RB, 1986, J CLIN MICROBIOL, V24, P21, DOI 10.1128/JCM.24.1.21-25.1986; SWOFFORD DL, 2001, PAUP PHYLOGENIETIC A; THOMPSON TTT, 2006, TYLERS Q SOFT CONTEC, V23; TSANG T, 2006, COMMUNICABLE DI 0205; *US FDA, 2006, FDA PUBL HLTH NOT FU; *US PHARM NAT FORM, 2003, STER TEST, pCH71; WILSON LA, 1991, ARCH OPHTHALMOL-CHIC, V109, P1155, DOI 10.1001/archopht.1991.01080080115043; Wong TY, 1997, INT OPHTHALMOL, V21, P127, DOI 10.1023/A:1026462631716; Zhang N, 2006, J CLIN MICROBIOL, V44, P2186, DOI 10.1128/JCM.00120-06	42	409	422	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2006	296	8					953	963		10.1001/jama.296.8.953	http://dx.doi.org/10.1001/jama.296.8.953			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076AL	16926355	Bronze			2022-12-01	WOS:000239929300025
J	Horsley, V; O'Carroll, D; Tooze, R; Ohinata, Y; Saitou, M; Obukhanych, T; Nussenzweig, M; Tarakhovsky, A; Fuchs, E				Horsley, Valerie; O'Carroll, Donal; Tooze, Reuben; Ohinata, Yasuhide; Saitou, Mitinori; Obukhanych, Tetyana; Nussenzweig, Michel; Tarakhovsky, Alexander; Fuchs, Elaine			Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland	CELL			English	Article							EPIDERMAL STEM-CELLS; HAIR FOLLICLE BULGE; C-MYC; MOUSE SKIN; IN-VITRO; DIFFERENTIATION; REPRESSION; EXPRESSION; LINEAGE; MECHANISMS	Epidermal lineage commitment occurs when multipotent stem cells are specified to three lineages: the epidermis, the hair follicle, and the sebaceous gland (SG). How and when a lineage becomes specified remains unknown. Here, we report the existence of a population of unipotent progenitor cells that reside in the SG and express the transcriptional repressor Blimp1. Using cell-culture studies and genetic lineage tracing, we demonstrate that Blimp1-expressing cells are upstream from other cells of the SG lineage. Blimp1 appears to govern cellular input into the gland since its loss leads to elevated c-myc expression, augmented cell proliferation, and SG hyperplasia. Finally, BrdU labeling experiments demonstrate that the SG defects associated with loss of Blimp1 lead to enhanced bulge stem cell activity, suggesting that when normal SG homeostasis is perturbed, multipotent stem cells in the bulge can be mobilized to correct this imbalance.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Lymphocyte Signaling, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA; Univ Leeds, Leeds Inst Mol Med, Div Expt Haematol, Leeds LS9 7TF, W Yorkshire, England; RIKEN, Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol,Chuo Ku, Kobe, Hyogo 6500047, Japan	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Leeds; RIKEN	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Nussenzweig, Michel/AAE-7292-2019	O'Carroll, Donal/0000-0002-8626-2217; Tooze, Reuben/0000-0003-2915-7119	Medical Research Council [G108/500] Funding Source: Medline; NIAMS NIH HHS [R01 AR031737, R01 AR031737-24, R01-AR050452, R01 AR050452] Funding Source: Medline; MRC [G108/500] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR031737] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allen M, 2003, AM J PATHOL, V163, P2173, DOI 10.1016/S0002-9440(10)63574-2; Alonso LC, 2003, HORM RES, V60, P1, DOI 10.1159/000070821; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bull JJ, 2005, BRIT J DERMATOL, V152, P1125, DOI 10.1111/j.1365-2133.2005.06458.x; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; HUANG S, 1994, CELL, V78, P9, DOI 10.1016/0092-8674(94)90565-7; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Lee SC, 2003, MOL IMMUNOL, V39, P923, DOI 10.1016/S0161-5890(03)00029-4; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P93, DOI 10.1387/ijdb.15272374; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Panteleyev AA, 2000, ARCH DERMATOL RES, V292, P573, DOI 10.1007/s004030000182; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosenfield RL, 2002, IN VITRO CELL DEV-AN, V38, P54, DOI 10.1290/1071-2690(2002)038<0054:SECDRC>2.0.CO;2; Rosenfield RL, 1998, DERMATOLOGY, V196, P43, DOI 10.1159/000017864; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEWART ME, 1992, SEMIN DERMATOL, V11, P100; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298	42	329	335	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 11	2006	126	3					597	609		10.1016/j.cell.2006.06.048	http://dx.doi.org/10.1016/j.cell.2006.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901790	Green Accepted, Bronze			2022-12-01	WOS:000239883400018
J	Miller, JD; Scott, EC; Okamoto, S				Miller, Jon D.; Scott, Eugenie C.; Okamoto, Shinji			Public acceptance of evolution	SCIENCE			English	Editorial Material							SCIENCE		Michigan State Univ, E Lansing, MI 48824 USA; Natl Ctr Sci Educ, Oakland, CA 94609 USA; Kobe Univ, Rokkaido, Hyogo, Japan	Michigan State University; Kobe University	Miller, JD (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	jdmiller@msu.edu		Scott, Eugenie Carol/0000-0003-3795-8207				Barr Stephen M., 2005, 1 THINGS, V156, P9; Blalock H., 1960, SOCIAL STAT; Hayduk L.A., 1987, STRUCTURAL EQUATION; Joreskog, 1993, NEW FEATURE LISREL 8; Miller J.D., 2001, BIOMEDICAL COMMUNICA; Miller J. D, 2001, FREE CHOICE SCI ED W, P93; Miller J.D., 1997, PUBLIC PERCEPTIONS S; Miller JD, 2001, SCI COMMUN, V22, P256, DOI 10.1177/1075547001022003003; Paterson FRA, 1999, AM BIOL TEACH, V61, P358; Pollak SD, 2004, DEVELOPMENTAL SCI, V7, P10, DOI 10.1111/j.1467-7687.2004.00317.x; Scott E. C., 2004, EVOLUTION VS CREATIO; 2004, NEW YORK TIMES  1118	12	385	398	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2006	313	5788					765	766		10.1126/science.1126746	http://dx.doi.org/10.1126/science.1126746			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072KC	16902112				2022-12-01	WOS:000239671300030
J	Gilks, CF; Crowley, S; Ekpini, R; Gove, S; Perriens, J; Souteyrand, Y; Sutherland, D; Vitoria, M; Guerma, T; De Cock, K				Gilks, Charles F.; Crowley, Siobhan; Ekpini, Rene; Gove, Sandy; Perriens, Jos; Souteyrand, Yves; Sutherland, Don; Vitoria, Marco; Guerma, Teguest; De Cock, Kevin			The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings	LANCET			English	Article							THERAPY	WHO has proposed a public-health approach to antiretroviral therapy (ART) to enable scaling-up access to treatment for HIV-positive people in developing countries, recognising that the western model of specialist physician management and advanced laboratory monitoring is not feasible in resource-poor settings. In this approach, standardised simplified treatment protocols and decentralised service delivery enable treatment to be delivered to large numbers of HIV-positive adults and children through the public and private sector. Simplified tools and approaches to clinical decision-making, centred on the "four Ss"-when to: start drug treatment; substitute for toxicity; switch after treatment failure; and stop-enable lower level health-care workers to deliver care. Simple limited formularies have driven large-scale production of fixed-dose combinations for first-line treatment for adults and lowered prices, but to ensure access to ART in the poorest countries, the care and drugs should be given free at point of service delivery. Population-based surveillance for acquired and transmitted resistance is needed to address concerns that switching regimens on the basis of clinical criteria for failure alone could lead to widespread emergence of drug-resistant virus strains. The integrated management of adult or childhood illness (IMAI/IMCI) facilitates decentralised implementation that is integrated within existing health systems. Simplified operational guidelines, tools, and training materials enable clinical teams in primary-care and second-level facilities to deliver HIV prevention, HIV care, and ART, and to use a standardised patient-tracking system.	WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	World Health Organization	Gilks, CF (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	gilksc@who.int	Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123				Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; BECK EJ, IN PRESS AIDS; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Gallant JE, 2005, J INFECT DIS, V192, P1921, DOI 10.1086/498069; Gazzard B, 2005, HIV MED, V6, P1, DOI 10.1111/j.1468-1293.2005.0311b.x; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Libamba E, 2006, B WORLD HEALTH ORGAN, V84, P320; Mundy C, 2000, T ROY SOC TROP MED H, V94, P583, DOI 10.1016/S0035-9203(00)90098-1; RAMACHANDRAN G, 2006, J ACQ IMMUN DEF SYND, V41, P1; *US DHHS, 2006, GUID US ANT AG HIV 1; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2006, GUID COTR PROPH HIV; *WHO, 2004, ANT DRUGS TREAT PREG; *WHO, 2003, PUBL HLTH APPR ART O; *WHO, 2006, REC DIAGN HIV INF IN; WHO, HIV DRUG RES; *WHO, IMAI IMCI TOOLK CAN; *WHO, 2003, TREAT 3 MILL 2005 MA; WHO, 2005, PRACT CHARG US FEES; *WHO, 2005, PAT MON GUID HIV CAR; *WHO, 2006, WHO UNAIDS PROGR GLO; WHO, 2006, WORLD HLTH REPORT 20; World Health Organization, 2006, ANT THER HIV INF INF; World Health Organization, 2004, GUID ETH EQ ACC HIV; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2002, SCAL ANT THER RES LT; World Health Organization, 2006, ANT THER HIV INF AD; World health organization (WHO), 2006, REV WHO CLIN STAG IM	30	493	507	2	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2006	368	9534					505	510		10.1016/S0140-6736(06)69158-7	http://dx.doi.org/10.1016/S0140-6736(06)69158-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890837				2022-12-01	WOS:000239569000033
J	Lomvardas, S; Barnea, G; Pisapia, DJ; Mendelsohn, M; Kirkland, J; Axel, R				Lomvardas, Stavros; Barnea, Gilad; Pisapia, David J.; Mendelsohn, Monica; Kirkland, Jennifer; Axel, Richard			Interchromosornal interactions and olfactory receptor choice	CELL			English	Article							ODORANT RECEPTORS; GENE-EXPRESSION; DROSOPHILA; MOUSE; CHROMOSOME; NEURONS; TISSUE; TRANS; MAP	The expression of a single odorant receptor (OR) gene from a large gene family in individual sensory neurons is an essential feature of the organization and function of the olfactory system. We have used chromosome conformation capture to demonstrate the specific association of an enhancer element, H, on chromosome 14 with multiple OR gene promoters on different chromosomes. DNA and RNA fluorescence in situ hybridization (FISH) experiments allow us to visualize the colocalization of the H enhancer with the single OR allele, that is transcribed in a sensory neuron. In transgenic mice bearing additional H elements, sensory neurons that express OR pseudogenes also express a second functional receptor. These data suggest a model of receptor choice in which a single trans-acting enhancer element may allow the stochastic activation of only one OR allele in an olfactory sensory neuron.	Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076; Lomvardas, Stavros/0000-0002-7668-3026	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NCI NIH HHS [5P01 CA023767] Funding Source: Medline; NIDCD NIH HHS [5R01 DC004209-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; GELBART WM, 1982, P NATL ACAD SCI-BIOL, V79, P2636, DOI 10.1073/pnas.79.8.2636; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Kravchenko E, 2005, MOL CELL BIOL, V25, P9283, DOI 10.1128/MCB.25.21.9283-9291.2005; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; MacDonald JL, 2005, DEV BIOL, V288, P461, DOI 10.1016/j.ydbio.2005.09.048; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Qasba P, 1998, J NEUROSCI, V18, P227; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; VANDERPLOEG LHT, 1991, NEW BIOL, V3, P324; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zimmerman JE, 2000, GENETICS, V154, P237	36	451	469	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					403	413		10.1016/j.cell.2006.06.035	http://dx.doi.org/10.1016/j.cell.2006.06.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873069	Green Submitted, Bronze			2022-12-01	WOS:000239552600024
J	Attaran, A; Barnes, KI; Bate, R; Binka, F; d'Alessandro, U; Fanello, CI; Garrett, L; Mutabingwa, TK; Roberts, D; Sibley, CH; Talisuna, A; Van Geertruyden, JP; Watkins, WM				Attaran, Amir; Barnes, Karen I.; Bate, Roger; Binka, Fred; d'Alessandro, Umberto; Fanello, Caterina I.; Garrett, Laurie; Mutabingwa, Theonest K.; Roberts, Donald; Sibley, Carol Hopkins; Talisuna, Ambrose; Van Geertruyden, Jean-Pierre; Watkins, William M.			The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; GLOBAL FUND; CHLOROQUINE; RESISTANCE; INDIA		Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; Univ Cape Town, ZA-7925 Cape Town, South Africa; Amer Enterprise Inst Publ Policy Res, Washington, DC USA; Univ Ghana, Dept Epidemiol, Accra, Ghana; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; London Sch Hyg & Trop Med, London WC1, England; Council Foreign Relat, New York, NY USA; E African Network Monitoring Antimalarial Treatme, Muheza, Tanzania; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Univ Washington, Seattle, WA 98195 USA; Univ Oxford, Oxford, England	University of Ottawa; University of Ottawa; University of Cape Town; American Enterprise Institute for Public Policy Research; University of Ghana; Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; Uniformed Services University of the Health Sciences - USA; University of Washington; University of Washington Seattle; University of Oxford	Attaran, A (corresponding author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca	Van geertruyden, Jean-Pierre/K-6425-2014; Van geertruyden, Jean-Pierre/S-3254-2019; Fanello, Caterina/AAT-9679-2021; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Fanello, Caterina/0000-0003-1932-9562; D'Alessandro, Umberto/0000-0001-6341-5009				ADEYI S, 2005, COMMUNICATION   0110; Akhavan D, 1999, SOC SCI MED, V49, P1385, DOI 10.1016/S0277-9536(99)00214-2; Attaran A, 2004, NATURE, V430, P932, DOI 10.1038/430932a; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; ATTARAN A, 2005, E COMMUNICATION 0431; ATTARAN A, 2005, E COMMUNICATION 0603; ATTARAN A, 2005, E COMMUNICATION 0430; ATTARAN A, 2004, E COMMUNICATION 0525; Bell C, 2004, MACROECONOMICS HIV A; Butler D, 2004, NATURE, V429, P588, DOI 10.1038/429588a; *DIR NAT VECT BORN, 2002, IND EP SIT REP 1997; Einhorn J, 2001, FOREIGN AFF, V80, P22, DOI 10.2307/20050248; *IND NAT ANT PROGR, 2002, MAL DRUG POL; Kshirsagar NA, 2000, AM J TROP MED HYG, V62, P402, DOI 10.4269/ajtmh.2000.62.402; MALLABY S, 2004, WORLDS BANKER STORY; MCCARTHY FD, MALARIA GROWTH; *NAT ANT PROGR, 2003, STAT ENH MAL CONTR P; *ROLL BACK MAL MON, 2005, BRAZ COUNTR PROF; *SECR VIG SAUD, BRAZ REG CAS MAL 196; Singh N, 2004, VECTOR-BORNE ZOONOT, V4, P239, DOI 10.1089/1530366042162506; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI 10.1172/JCI200421682; *WHO, POS WHOS ROLL BACK M; *WHO, 2003, ASS MON ANT DRUG EFF; World Bank, 2005, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-6226-6; *WORLD BANK, 2005, ROLL BACK MAL WORLD; *WORLD BANK, 2002, WORLD BANK POL DISCL; *WORLD BANK, 2005, PRESS BRIEF WORLD BA; *WORLD BANK, 2004, WORLD BANK DRAFT DEC; *WORLD BANK, 2002, PUBL HLTH; *WORLD BANK, 2001, PARTN FIGHT MAL HUG; *WORLD BANK, CONTR AW DAT SEARCH; *WORLD BANK OP EV, 2005, COMM RES IMPR EFF HI; Yamey G, 2001, BMJ-BRIT MED J, V322, P1191, DOI 10.1136/bmj.322.7296.1191; 2002, ACHIEVING IMPACT ROL	36	16	17	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					247	252		10.1016/S0140-6736(06)68545-0	http://dx.doi.org/10.1016/S0140-6736(06)68545-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064MY	16844495				2022-12-01	WOS:000239095000037
J	Bensaad, K; Tsuruta, A; Selak, MA; Vidal, MNC; Nakano, K; Bartrons, R; Gottlieb, E; Vousden, KH				Bensaad, Karim; Tsuruta, Atsushi; Selak, Mary A.; Calvo Vidal, M. Nieves; Nakano, Katsunori; Bartrons, Ramon; Gottlieb, Eyal; Vousden, Karen H.			TIGAR, a p53-inducible regulator of glycolysis and apoptosis	CELL			English	Article							PENTOSE-PHOSPHATE PATHWAY; OXIDATIVE STRESS; GLUCOSE-METABOLISM; CANCER-CELLS; P53; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; ACTIVATION; GENE; FRUCTOSE-2,6-BISPHOSPHATASE; ARREST	The, p53 tumor-suppressor protein prevents cancer development through various mechanisms, including the induction of cell-cycle arrest, apoptosis, and the maintenance of genome stability. We have identified a p53-inducible gene named TIGAR (TP53-induced glycolysis and apoptosis regulator). TIGAR expression lowered fructose-2,6-bisphosphate levels in cells, resulting in an inhibition of glycolysis and an overall decrease in intracellular reactive oxygen species (ROS) levels. These functions of TIGAR correlated with an ability to protect cells from ROS-associated apoptosis, and consequently, knockdown of endogenous TIGAR expression sensitized cells to p53-induced death. Expression of TIGAR may therefore modulate the apoptotic response to p53, allowing survival in the face of mild or transient stress signals that may be reversed or repaired. The decrease of intracellular ROS levels in response to TIGAR may also play a role in the ability of p53 to protect from the accumulation of genomic damage.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, Unitat Bioquim & Biol Mol, Lhospitalet De Llobregat 08907, Spain	Beatson Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Vousden, KH (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010	Gottlieb, Eyal/0000-0002-9770-0956; Bartrons, Ramon/0000-0001-9349-5847				BAZAN JF, 1989, P NATL ACAD SCI USA, V86, P9642, DOI 10.1073/pnas.86.24.9642; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chen K, 2003, J BIOL CHEM, V278, P39527, DOI 10.1074/jbc.M304423200; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Fico A, 2004, CELL DEATH DIFFER, V11, P823, DOI 10.1038/sj.cdd.4401420; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Hsiao CH, 2006, EXP HEMATOL, V34, P264, DOI 10.1016/j.exphem.2005.12.009; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Le Goffe C, 2002, BIOCHEM J, V364, P349, DOI 10.1042/BJ20011856; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liang Y, 1997, DIABETOLOGIA, V40, P1018, DOI 10.1007/s001250050783; LIN K, 1992, J BIOL CHEM, V267, P6556; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; NISSLER K, 1995, J CANCER RES CLIN, V121, P739, DOI 10.1007/BF01213320; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Ozer N, 2001, INT J BIOCHEM CELL B, V33, P221, DOI 10.1016/S1357-2725(01)00011-5; Perez JX, 2000, AM J PHYSIOL-CELL PH, V279, pC1359, DOI 10.1152/ajpcell.2000.279.5.C1359; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WALDMAN T, 1995, CANCER RES, V55, P5187; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zhang YM, 2003, MOL MICROBIOL, V48, P1317, DOI 10.1046/j.1365-2958.2003.03486.x	43	1392	1458	11	161	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					107	120		10.1016/j.cell.2006.05.036	http://dx.doi.org/10.1016/j.cell.2006.05.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839880	Bronze			2022-12-01	WOS:000239224800020
J	Llano, M; Saenz, DT; Meehan, A; Wongthida, P; Peretz, M; Walker, WH; Teo, WL; Poeschla, EM				Llano, Manuel; Saenz, Dyana T.; Meehan, Anne; Wongthida, Phonphimon; Peretz, Mary; Walker, William H.; Teo, Wulin; Poeschla, Eric M.			An essential role for LEDGF/p75 in HIV integration	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-CELLS; IDENTIFICATION; REVEALS; BINDING; DOMAIN; REPLICATION; INFECTION; PROTEINS	Chromosomal integration enables human immunodeficiency virus (HIV) to establish a permanent reservoir that can be therapeutically suppressed but not eradicated. Participation of cellular proteins in this obligate replication step is poorly understood. We used intensified RNA interference and dominant-negative protein approaches to show that the cellular transcriptional coactivator lens epithelium - derived growth factor (LEDGF)/p75 (p75) is an essential HIV integration cofactor. The mechanism requires both linkages of a molecular tether that p75 forms between integrase and chromatin. Fractionally minute levels of endogenous p75 are sufficient to enable integration, showing that cellular factors that engage HIV after entry may elude identification in less intensive knockdowns. Perturbing the p75-integrase interaction may have therapeutic potential.	Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Poeschla, EM (corresponding author), Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA.	emp@mayo.edu		Teo, Wulin/0000-0001-7815-7014				Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Zielske SP, 2006, J VIROL, V80, P7275, DOI 10.1128/JVI.02470-05	15	399	425	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					461	464		10.1126/science.1132319	http://dx.doi.org/10.1126/science.1132319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	16959972				2022-12-01	WOS:000241382500041
J	Hallas, J; Dall, M; Andries, A; Andersen, BS; Aalykke, C; Hansen, JM; Andersen, M; Lassen, AT				Hallas, Jesper; Dall, Michael; Andries, Alin; Andersen, Birthe Sogaard; Aalykke, Claus; Moller Hansen, Jane; Andersen, Morten; Touborg Lassen, Annmarie			Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ORAL ANTIPLATELET THERAPY; ASPIRIN; CLOPIDOGREL; PREVENTION; PRETREATMENT; WARFARIN; STROKE; NUMBER	Objectives To assess the risk of serious upper gastrointestinal bleeding associated with the newer antithrombotic agents used alone or in combination with other antithrombotic drugs; to describe the trends in use of antithrombotic drugs in the background population. Design Population based case-control study. Setting Funen County, Denmark (population 470000). Subjects 1443 cases of serious upper gastrointestinal bleeding identified during 2000-4; 57 720 age and sex matched controls. Main outcome measure Exposure to low dose aspirin, clopidogrel, dipyridamole, vitamin K antagonists, and combined antithrombotic treatment. Results Adjusted odds ratios associating drug use with upper gastrointestinal bleeding were 1.8 (95% confidence interval 1.5 to 2.1) for low dose aspirin, 1.1 (0.6 to 2.1) for clopidogrel, 1.9 (1.3 to 2.8) for dipyridamole, and 1.8 (1.3 to 2.4) for vitamin K antagonists. Corresponding figures for combined use were 7.4 (3.5 to 15) for clopidogrel and aspirin, 5.3 (2.9 to 9.5) for vitamin K antagonists and aspirin, and 2.3 (1.7 to 3.3) for dipyridamole and aspirin. Other combinations were used too infrequently to allow estimation. The number of treatment years needed to produce one excess case varied from 124 for the clopidogrel-aspirin combination to 8800 for clopidogrel alone. During the study period, exposure to combined antithrombotic regimens increased by 425% in the background population. Conclusion Antithrombotic treatment is becoming increasingly aggressive. Combined antithrombotic treatment confers particular risk and is associated with high incidence of gastrointestinal bleeding.	Univ So Denmark, IST, Dept Clin Pharmacol, DK-5000 Odense, Denmark; Univ So Denmark, Res Unit Gen Practice, Odense, Denmark; Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Cardiol, Odense, Denmark; Odense Univ Hosp, Dept Infect Med, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Hallas, J (corresponding author), Univ So Denmark, IST, Dept Clin Pharmacol, DK-5000 Odense, Denmark.	jhallas@health.sdu.dk	Andersen, Morten/H-3555-2011; Lassen, Annmarie/AAA-5816-2019	Andersen, Morten/0000-0001-7029-2860; Hallas, Jesper/0000-0002-8097-8708				Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bjerre LM, 2000, BRIT MED J, V320, P503, DOI 10.1136/bmj.320.7233.503; Buresly K, 2005, ARCH INTERN MED, V165, P784, DOI 10.1001/archinte.165.7.784; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; COLLET JP, 2000, PHARMACOEPIDEM DR S, P765; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Fork FT, 2000, SCAND J GASTROENTERO, V35, P464; Gaist D, 1997, DAN MED BULL, V44, P445; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; LANAS A, 2006, GUT             0510; Massel D, 2001, J AM COLL CARDIOL, V37, P569, DOI 10.1016/S0735-1097(00)01135-9; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mehta SR, 2001, LANCET, V358, P527; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Rothman KJ, 2002, EPIDEMIOLOGY INTRO, P78; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; WHO Collaborating Centre for Drug Statistics Methodology, 2006, ATC IND DDDS GUID AT; Yusuf S, 2001, NEW ENGL J MED, V345, P494	24	292	318	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2006	333	7571					726	728A		10.1136/bmj.38947.697558.AE	http://dx.doi.org/10.1136/bmj.38947.697558.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	094OK	16984924	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000241248600018
J	Jacinto, E; Facchinetti, V; Liu, D; Soto, N; Wei, SN; Jung, SY; Huang, QJ; Qin, J; Su, B				Jacinto, Estela; Facchinetti, Valeria; Liu, Dou; Soto, Nelyn; Wei, Shiniu; Jung, Sung Yun; Huang, Qiaojia; Qin, Jun; Su, Bing			SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity	CELL			English	Article							PROTEIN-KINASE-B; FOXO TRANSCRIPTION FACTORS; CELL-GROWTH; TUBEROUS SCLEROSIS; BINDING PARTNER; SIGNAL RELAY; TOR; ACTIVATION; TSC2; SURVIVAL	Mammalian target of rapamycin (mTOR) controls cell growth and proliferation via the raptor-mTOR (TORC1) and rictor-mTOR (TORC2) protein complexes. Recent biochemical studies suggested that TORC2 is the elusive PDK2 for Akt/PKB Ser473 phosphorylation in the hydrophobic motif. Phosphorylation at Ser473, along with Thr308 of its activation loop, is deemed necessary for Akt function, although the regulatory mechanisms and physiological importance of each phosphorylation site remain to be fully understood. Here, we report that SIN1/MIP1 is an essential TORC2/PDK2 subunit. Genetic ablation of sin 1 abolished Akt-Ser473 phosphorylation and disrupted rictor-mTOR interaction but maintained Thr308 phosphorylation. Surprisingly, defective Ser473 phosphorylation affected only a subset of Akt targets in vivo, including FoxO1/3a, while other Akt targets, TSC2 and GSK3, and the TORC1 effectors, S6K and 4E-BP1, were unaffected. Our findings reveal that the SIN1-rictor-mTOR function in Akt-Ser473 phosphorylation is required for TORC2 function in cell survival but is dispensable for TORC1 function.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Baylor College of Medicine; Baylor College of Medicine	Jacinto, E (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	jqin@bcm.tmc.edu; bsu@mdanderson.org		Jacinto, Estela/0000-0001-7118-1759; Jung, Sung Yun/0000-0003-1521-7977	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline; NHLBI NIH HHS [HL070225] Funding Source: Medline; NIAID NIH HHS [AI063348] Funding Source: Medline; NIDDK NIH HHS [DK62434] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Cheng JK, 2005, J BIOL CHEM, V280, P13477, DOI 10.1074/jbc.M414258200; COLICELLI J, 1991, P NATL ACAD SCI USA, V88, P2913, DOI 10.1073/pnas.88.7.2913; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Dufner A, 1999, MOL CELL BIOL, V19, P4525; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schroder W, 2005, CELL SIGNAL, V17, P761, DOI 10.1016/j.cellsig.2004.10.015; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	69	1096	1138	3	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					125	137		10.1016/j.cell.2006.08.033	http://dx.doi.org/10.1016/j.cell.2006.08.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	16962653	Bronze			2022-12-01	WOS:000241445800019
J	Mathiason, CK; Powers, JG; Dahmes, SJ; Osborn, DA; Miller, KV; Warren, RJ; Mason, GL; Hays, SA; Hayes-Klug, J; Seelig, DM; Wild, MA; Wolfe, LL; Spraker, TR; Miller, MW; Sigurdson, CJ; Telling, GC; Hoover, EA				Mathiason, Candace K.; Powers, Jenny G.; Dahmes, Sallie J.; Osborn, David A.; Miller, Karl V.; Warren, Robert J.; Mason, Gary L.; Hays, Sheila A.; Hayes-Klug, Jeanette; Seelig, Davis M.; Wild, Margaret A.; Wolfe, Lisa L.; Spraker, Terry R.; Miller, Michael W.; Sigurdson, Christina J.; Telling, Glenn C.; Hoover, Edward A.			Infectious prions in the saliva and blood of deer with chronic wasting disease	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE VIRUS-INFECTION; ROCKY-MOUNTAIN ELK; WHITE-TAILED DEER; SPONGIFORM ENCEPHALOPATHY; MULE DEER; TRANSMISSION; TRANSFUSION; PROTEIN; SHEEP	A critical concern in the transmission of prion diseases, including chronic wasting disease (CWD) of cervids, is the potential presence of prions in body fluids. To address this issue directly, we exposed cohorts of CWD-naive deer to saliva, blood, or urine and feces from CWD-positive deer. We found infectious prions capable of transmitting CWD in saliva ( by the oral route) and in blood ( by transfusion). The results help to explain the facile transmission of CWD among cervids and prompt caution concerning contact with body fluids in prion infections.	Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; Colorado State Univ, Coll Vet Med & Biol Sci, Vet Diagnost Lab, Ft Collins, CO 80523 USA; Natl Pk Serv, Biol Resource Management Div, Ft Collins, CO 80525 USA; Wildlife Artist Supply Co, Monroe, GA 30655 USA; Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30609 USA; Colorado Div Wildlife, Wildlife Res Ctr, Ft Collins, CO 80526 USA; Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA	Colorado State University; Colorado State University; United States Department of the Interior; University System of Georgia; University of Georgia; University of Kentucky	Hoover, EA (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	edward.hoover@colostate.edu	Mathiason, Candace/H-9769-2017; Mathiason, Candace K/E-7843-2017; Telling, Glenn C/G-1217-2019	Mathiason, Candace/0000-0002-5920-4556; Mathiason, Candace K/0000-0002-5920-4556; Telling, Glenn C/0000-0002-6294-1805	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-25491] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; CLARKE MC, 1967, VET REC, V80, P504, DOI 10.1136/vr.80.16.504; DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; PERROTT MP, 2005, MOL MECH TRANSM SPON; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	25	364	372	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					133	136		10.1126/science.1132661	http://dx.doi.org/10.1126/science.1132661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023660				2022-12-01	WOS:000241031200053
J	Tsong, AE; Tuch, BB; Li, H; Johnson, AD				Tsong, Annie E.; Tuch, Brian B.; Li, Hao; Johnson, Alexander D.			Evolution of alternative transcriptional circuits with identical logic	NATURE			English	Article							MATING-TYPE GENES; MADS-BOX PROTEIN; CANDIDA-ALBICANS; NEUROSPORA-CRASSA; HOX PROTEIN; DNA-BINDING; YEAST; MCM1; GENOME; DIFFERENTIATION	Evolution of gene regulation is an important contributor to the variety of life. Here, we analyse the evolution of a combinatorial transcriptional circuit composed of sequence-specific DNA-binding proteins that are conserved among all eukaryotes. This circuit regulates mating in the ascomycete yeast lineage. We first identify a group of mating genes that was transcriptionally regulated by an activator in a fungal ancestor, but is now transcriptionally regulated by a repressor in modern bakers' yeast. Despite this change in regulatory mechanism, the logical output of the overall circuit remains the same. By examining the regulation of mating in modern yeasts that are related to different extents, we deduce specific, sequential changes in both cis- and trans-regulatory elements that constitute the transition from positive to negative regulation. These changes indicate specific mechanisms by which fitness barriers were traversed during the transition.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ajohnson@cgl.ucsf.edu						Acton TB, 1997, MOL CELL BIOL, V17, P1881, DOI 10.1128/MCB.17.4.1881; Acton TB, 2000, MOL CELL BIOL, V20, P1, DOI 10.1128/MCB.20.1.1-11.2000; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Belloch C, 2000, INT J SYST EVOL MICR, V50, P405, DOI 10.1099/00207713-50-1-405; BENDER A, 1986, CELL, V47, P929, DOI 10.1016/0092-8674(86)90808-1; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Broach J.R., 1992, MOL CELLULAR BIOL SA, P583; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Calderone R., 2012, CANDIDA CANDIDIASIS, V2; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Carroll S.B., 2001, DNA DIVERSITY; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Darwin C.R., 1877, DIFFERENT FORMS FLOW; Davidson EH, 2001, GENOMIC REGULATORY S; DEBUCHY R, 1993, MOL GEN GENET, V241, P667, DOI 10.1007/BF00279909; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; JACOBSON MP, 2006, PROTEIN LOCAL OPTIMI; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; Kjaerulff S, 1997, EMBO J, V16, P4021, DOI 10.1093/emboj/16.13.4021; Kurischko C, 1999, MOL GEN GENET, V262, P180, DOI 10.1007/s004380051073; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Mead J, 1996, MOL CELL BIOL, V16, P2135; PHILLEY ML, 1994, GENETICS, V137, P715; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; TURGEON BG, 1993, MOL GEN GENET, V238, P270; van Beest M, 2000, J BIOL CHEM, V275, P27266; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099	47	212	221	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					415	420		10.1038/nature05099	http://dx.doi.org/10.1038/nature05099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006507				2022-12-01	WOS:000240798800037
J	Yarchoan, R				Yarchoan, Robert			Key role for a viral lytic gene in Kaposi's sarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yarchoan, R (corresponding author), NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Bethesda, MD 20892 USA.							Bais C, 1998, NATURE, V392, P210, DOI 10.1038/32472; Grisotto MG, 2006, J CLIN INVEST, V116, P1264, DOI 10.1172/JCI26666; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Sodhi A, 2004, FASEB J, V18, P422, DOI 10.1096/fj.03-1035hyp	5	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1383	1385		10.1056/NEJMcibr063911	http://dx.doi.org/10.1056/NEJMcibr063911			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005960				2022-12-01	WOS:000240793600018
J	Yahr, TL				Yahr, Timothy L.			A critical new pathway for toxin secretion?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PSEUDOMONAS-AERUGINOSA		Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa	Yahr, TL (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.			Yahr, Timothy/0000-0001-9054-8704				Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103	4	17	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1171	1172		10.1056/NEJMcibr063931	http://dx.doi.org/10.1056/NEJMcibr063931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971725				2022-12-01	WOS:000240462800014
J	Gray, N; Henningfeld, J				Gray, Nigel; Henningfeld, Jack			Dissent over harm reduction for tobacco	LANCET			English	Editorial Material							DISEASE		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; Pinney Associates Inc, Bethesda, MD 20814 USA	Johns Hopkins University	Henningfeld, J (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	jhenning@pinneyassociates.com						BORLAND R, 1991, AUST J PUBLIC HEALTH, V15, P130; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; FIORE MC, 2000, CLIN PRACTICE; Gray NJ, 2004, NICOTINE TOB RES, V6, P759, DOI 10.1080/1462220042000274248; Henningfield JE, 2002, AM J PREV MED, V23, P226, DOI 10.1016/S0749-3797(02)00502-0; Hughes JR, 2005, TOB CONTROL, V14, P49, DOI 10.1136/tc.2004.008367; *STUD GROUP TOB PR, 2004, GUID PRINC DEV TOB P; Weinstein N., 2001, PUBLIC UNDERSTANDING	8	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					899	901		10.1016/S0140-6736(06)69349-5	http://dx.doi.org/10.1016/S0140-6736(06)69349-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962864				2022-12-01	WOS:000240502300008
J	Bausch, DG; Nichol, ST; Muyembe-Tamfum, JJ; Borchert, M; Rollin, PE; Sleurs, H; Campbell, P; Tshioko, FK; Roth, C; Colebunders, R; Pirard, P; Mardel, S; Olinda, LA; Zeller, H; Tshomba, A; Kulidri, A; Libande, ML; Mulangu, S; Formenty, P; Grein, T; Leirs, H; Braack, L; Ksiazek, T; Zaki, S; Bowen, MD; Smit, SB; Leman, PA; Burt, FJ; Kemp, A; Swanepoel, R				Bausch, Daniel G.; Nichol, Stuart T.; Muyembe-Tamfum, Jean Jacques; Borchert, Matthias; Rollin, Pierre E.; Sleurs, Hilde; Campbell, Patricia; Tshioko, Florimund K.; Roth, Catherine; Colebunders, Robert; Pirard, Patricia; Mardel, Simon; Olinda, Loku A.; Zeller, Herve; Tshomba, Antoine; Kulidri, Amayo; Libande, Modeste L.; Mulangu, Sabue; Formenty, Pierre; Grein, Thomas; Leirs, Herwig; Braack, Leo; Ksiazek, Tom; Zaki, Sherif; Bowen, Michael D.; Smit, Sheilagh B.; Leman, Patricia A.; Burt, Felicity J.; Kemp, Alan; Swanepoel, Robert		Int Sci Tech Comm Marbug	Marburg hemorrhagic fever associated with multiple genetic lineages of virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EBOLA-VIRUS; OUTBREAK; CONGO; DISEASE; KIKWIT; REEMERGENCE; DECLINE; GABON	Background: An outbreak of Marburg hemorrhagic fever was first observed in a gold-mining village in northeastern Democratic Republic of the Congo in October 1998. Methods: We investigated the outbreak of Marburg hemorrhagic fever most intensively in May and October 1999. Sporadic cases and short chains of human-to-human transmission continued to occur until September 2000. Suspected cases were identified on the basis of a case definition; cases were confirmed by the detection of virus antigen and nucleic acid in blood, cell culture, antibody responses, and immunohistochemical analysis. Results: A total of 154 cases (48 laboratory-confirmed and 106 suspected) were identified (case fatality rate, 83 percent); 52 percent of cases were in young male miners. Only 27 percent of these men reported having had contact with other affected persons, whereas 67 percent of patients who were not miners reported such contact (P < 0.001). Most of the affected miners (94 percent) worked in an underground mine. Cessation of the outbreak coincided with flooding of the mine. Epidemiologic evidence of multiple introductions of infection into the population was substantiated by the detection of at least nine genetically distinct lineages of virus in circulation during the outbreak. Conclusions: Marburg hemorrhagic fever can have a very high case fatality rate. Since multiple genetic variants of virus were identified, ongoing introduction of virus into the population helped perpetuate this outbreak. The findings imply that reservoir hosts of Marburg virus inhabit caves, mines, or similar habitats.	Ctr Dis Control & Prevent, Atlanta, GA USA; Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA; Minist Hlth, Kinshasa, DEM REP CONGO; Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; Inst Trop Med, B-2000 Antwerp, Belgium; Med Sans Frontieres, Brussels, Belgium; Med Sans Frontieres, Amsterdam, Netherlands; World Hlth Org, Kinshasa, DEM REP CONGO; World Hlth Org, Geneva, Switzerland; Minist Hlth, Kisangani, DEM REP CONGO; Inst Pasteur, Paris, France; Kilo Moto Hosp, Off Mines Or, Watsa, DEM REP CONGO; Minist Hlth, Watsa, DEM REP CONGO; Danish Pest Infestat Lab, Lyngby, Denmark; S African Natl Pk Board, Pretoria, South Africa; Natl Inst Communicable Dis, Johannesburg, South Africa	Centers for Disease Control & Prevention - USA; Tulane University; Institute Nacional de Recherche Biomedical; Institute of Tropical Medicine (ITM); Doctors Without Borders; Doctors Without Borders; World Health Organization; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Aarhus University; National Institute for Communicable Diseases (NICD)	Swanepoel, R (corresponding author), Natl Inst Communicable Dis, Private Bag X4, ZA-2131 Johannesburg, South Africa.	bobs@nicd.ac.za	Burt, Felicity/AAB-6993-2020; Braack, Leo/AAW-3025-2020; Leirs, Herwig/B-8197-2008	Burt, Felicity/0000-0002-7238-7799; Braack, Leo/0000-0002-5286-5052; Leirs, Herwig/0000-0002-7612-5024; Rollin, Pierre/0000-0002-4608-2641; Antoine, Tshomba/0000-0003-2440-8468; /0000-0002-2051-467X				[Anonymous], 1999, Wkly Epidemiol Rec, V74, P157; Bausch DG, 2004, EMERGING INFECTIONS 6, P35; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; Bertherat E, 1999, Med Trop (Mars), V59, P201; Biot M, 2000, TROP MED INT HEALTH, V5, P384, DOI 10.1046/j.1365-3156.2000.00564.x; Borchert M, 2006, EMERG INFECT DIS, V12, P433, DOI 10.3201/eid1203.050622; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73; Colebunders R, 2004, J INFECTION, V48, P347, DOI 10.1016/S0163-4453(03)00122-1; Egbring R, 1971, MARBURG VIRUS DIS, P42; Feldmann H, 1996, ARCH VIROL, P77; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Johnson ED, 1996, ARCH VIROL, P101; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Leroy EM, 2004, SCIENCE, V303, P628; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Martini G A, 1968, Ger Med Mon, V13, P457; Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281; Nikiforov V V, 1994, Zh Mikrobiol Epidemiol Immunobiol, P104; PATTYN S, 1977, LANCET, V1, P573; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Siegert R, 1968, Ger Med Mon, V13, P1; SMITH DH, 1982, LANCET, V1, P816; STILLE W, 1971, P10; TODOROVITCH K, 1971, P19; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; 2005, MMWR MORB MORTAL WKL, V54, P308; 1999, WKLY EPIDEMIOL REC, V74, P145; 1978, W WHO, V56, P247	41	159	165	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					909	919		10.1056/NEJMoa051465	http://dx.doi.org/10.1056/NEJMoa051465			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943403	Green Accepted			2022-12-01	WOS:000240113100008
J	Gibson, MC; Patel, AB; Nagpal, R; Perrimon, N				Gibson, Matthew C.; Patel, Ankit B.; Nagpal, Radhika; Perrimon, Norbert			The emergence of geometric order in proliferating metazoan epithelia	NATURE			English	Article							PATTERNED CELL-PROLIFERATION; DROSOPHILA-MELANOGASTER; WING DISK; DIVISION; POLARITY; PROTEIN; GROWTH; SHAPE; SIZE	The predominantly hexagonal cell pattern of simple epithelia was noted in the earliest microscopic analyses of animal tissues(1), a topology commonly thought to reflect cell sorting into optimally packed honeycomb arrays(2). Here we use a discrete Markov model validated by time-lapse microscopy and clonal analysis to demonstrate that the distribution of polygonal cell types in epithelia is not a result of cell packing, but rather a direct mathematical consequence of cell proliferation. On the basis of in vivo analysis of mitotic cell junction dynamics in Drosophila imaginal discs, we mathematically predict the convergence of epithelial topology to a fixed equilibrium distribution of cellular polygons. This distribution is empirically confirmed in tissue samples from vertebrate, arthropod and cnidarian organisms, suggesting that a similar proliferation-dependent cell pattern underlies pattern formation and morphogenesis throughout the metazoa.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University	Gibson, MC (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	mgx@stowers-institute.org; rad@eecs.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X; Gibson, Matthew/0000-0001-5588-8842				ABBOTT LA, 1981, J THEOR BIOL, V90, P495, DOI 10.1016/0022-5193(81)90302-7; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; COWAN R, 1988, J THEOR BIOL, V131, P33, DOI 10.1016/S0022-5193(88)80118-8; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Graustein W. C., 1931, ANN MATH, V32, P149; Halanych KM, 2001, AM ZOOL, V41, P629, DOI 10.1668/0003-1569(2001)041[0629:ABROMP]2.0.CO;2; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Lewis FT, 1926, ANAT REC, V33, P331, DOI 10.1002/ar.1090330502; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Resino J, 2002, P NATL ACAD SCI USA, V99, P7502, DOI 10.1073/pnas.072208199; Schwann, 1847, MICROSCOPICAL RES AC; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; TAYLOR HM, 1998, INTRO STOCHASTIC MOD; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Thompson D.W., 1945, GROWTH FORM; WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979; Zallen JA, 2004, J PHYS-CONDENS MAT, V16, pS5073, DOI 10.1088/0953-8984/16/44/005	26	292	295	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1038	1041		10.1038/nature05014	http://dx.doi.org/10.1038/nature05014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16900102				2022-12-01	WOS:000240142000049
J	Patolsky, F; Timko, BP; Yu, GH; Fang, Y; Greytak, AB; Zheng, GF; Lieber, CM				Patolsky, Fernando; Timko, Brian P.; Yu, Guihua; Fang, Ying; Greytak, Andrew B.; Zheng, Gengfeng; Lieber, Charles M.			Detection, stimulation, and inhibition of neuronal signals with high-density nanowire transistor arrays	SCIENCE			English	Article							ELECTRICAL DETECTION; PYRAMIDAL NEURONS; NETWORKS; PROPAGATION; RECORDINGS; DENDRITES; CELL	We report electrical properties of hybrid structures consisting of arrays of nanowire field-effect transistors integrated with the individual axons and dendrites of live mammalian neurons, where each nanoscale junction can be used for spatially resolved, highly sensitive detection, stimulation, and/or inhibition of neuronal signal propagation. Arrays of nanowire-neuron junctions enable simultaneous measurement of the rate, amplitude, and shape of signals propagating along individual axons and dendrites. The configuration of nanowire-axon junctions in arrays, as both inputs and outputs, makes possible controlled studies of partial to complete inhibition of signal propagation by both local electrical and chemical stimuli. In addition, nanowire-axon junction arrays were integrated and tested at a level of at least 50 "artificial synapses'' per neuron.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Zheng, Gengfeng/G-7023-2011; Timko, Brian/AAH-8466-2019; Chu, Yung-Ming/C-6318-2009; patolsky, Fernando/AAD-1188-2021	Zheng, Gengfeng/0000-0002-1803-6955; Timko, Brian/0000-0002-7958-8980; patolsky, Fernando/0000-0002-1382-5357; Greytak, Andrew/0000-0001-8978-6457				Antic S, 1999, J NEUROPHYSIOL, V82, P1615, DOI 10.1152/jn.1999.82.3.1615; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Fromherz P, 2002, CHEMPHYSCHEM, V3, P276, DOI 10.1002/1439-7641(20020315)3:3<276::AID-CPHC276>3.0.CO;2-A; Gulledge AT, 2003, J NEUROSCI, V23, P11363; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang Y, 2004, PURE APPL CHEM, V76, P2051, DOI 10.1351/pac200476122051; James CD, 2000, IEEE T BIO-MED ENG, V47, P17, DOI 10.1109/10.817614; James CD, 2004, IEEE T BIO-MED ENG, V51, P1640, DOI 10.1109/TBME.2004.827252; Jimbo Y, 2003, IEEE T BIO-MED ENG, V50, P241, DOI 10.1109/TBME.2002.805470; Jin S, 2004, NANO LETT, V4, P915, DOI 10.1021/nl049659j; Kawaguchi H, 1998, EXP BRAIN RES, V122, P378, DOI 10.1007/s002210050526; Lambacher A, 2004, APPL PHYS A-MATER, V79, P1607, DOI 10.1007/s00339-004-2991-5; Larkum ME, 2002, J NEUROSCI, V22, P6991; LARRY R, 2003, FUNDAMENTAL NEUROSCI, P115; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Martin AR, 2001, NEURON BRAIN CELLULA; Merz M, 2005, ADV FUNCT MATER, V15, P739, DOI 10.1002/adfm.200400316; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Offenhausser A, 1997, BIOSENS BIOELECTRON, V12, P819, DOI 10.1016/S0956-5663(97)00047-X; Oviedo H, 2005, J NEUROSCI, V25, P4985, DOI 10.1523/JNEUROSCI.0562-05.2005; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101; Patolsky F, 2006, ANAL CHEM, V78, P4260, DOI 10.1021/ac069419j; RIJKHOFF NJM, 1994, IEEE T BIO-MED ENG, V41, P413, DOI 10.1109/10.293215; Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Sze S. M., 1981, PHYS SEMICONDUCTOR D, P431; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Voelker M, 2005, SMALL, V1, P206, DOI 10.1002/smll.200400077; Vuckovic A, 2005, MED BIOL ENG COMPUT, V43, P365, DOI 10.1007/BF02345814; Windhorst U, 1999, MODERN TECHNIQUES NE; Wyart C, 2002, J NEUROSCI METH, V117, P123, DOI 10.1016/S0165-0270(02)00077-8; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; Zheng GF, 2004, ADV MATER, V16, P1890, DOI 10.1002/adma.200400472	38	703	746	5	341	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1100	1104		10.1126/science.1128640	http://dx.doi.org/10.1126/science.1128640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931757				2022-12-01	WOS:000239998200040
J	Xu, FJ; Sternberg, MR; Kottiri, BJ; McQuillan, GM; Lee, FK; Nahmias, AJ; Berman, SM; Markowitz, LE				Xu, Fujie; Sternberg, Maya R.; Kottiri, Benny J.; McQuillan, Geraldine M.; Lee, Francis K.; Nahmias, Andre J.; Berman, Stuart M.; Markowitz, Lauri E.			Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENITAL HERPES; CHANGING EPIDEMIOLOGY; RISK FACTOR; INFECTION; TRANSMISSION; ACQUISITION; GLYCOPROTEIN; MEN; PREVALENCE; ANTIBODIES	Context Herpes simplex virus type 1 (HSV-1) and type 2 are common infections worldwide. Herpes simplex virus type 2 (HSV-2) is the cause of most genital herpes and is almost always sexually transmitted. In contrast, HSV-1 is usually transmitted during childhood via nonsexual contacts. Preexisting HSV-1 antibodies can alleviate clinical manifestations of subsequently acquired HSV-2. Furthermore, HSV-1 has become an important cause of genital herpes in some developed countries. Objective To examine trends in HSV-1 and HSV-2 seroprevalence in the United States in 1999-2004 compared with 1988-1994. Design, Settings, and Participants Cross-sectional, nationally representative surveys (US National Health and Nutrition Examination Surveys [ NHANES]), were used to compare national seroprevalence estimates from 1999-2004 with those from 19881994, and changes in HSV-1 and HSV-2 seroprevalence since 1976-1980 were reviewed. Persons aged 14 to 49 years were included in these analyses. Main Outcome Measures Seroprevalence of HSV-1 and HSV-2 antibodies based on results from type-specific immunodot assays; diagnosis of genital herpes. Results The overall age-adjusted HSV-2 seroprevalence was 17.0% (95% confidence interval [CI], 15.8%-18.3%) in 1999-2004 and 21.0% (95% CI, 19.1%-23.1%) in 1988-1994, a relative decrease of 19.0% between the 2 surveys (95% CI, -28.6% to -9.5%; P < .001). Decreases in HSV-2 seroprevalence were especially concentrated in persons aged 14 to 19 years between 1988 and 2004. In adolescents aged 17 to 19 years and young adults, the decreases in HSV-2 seroprevalence were significant even after adjusting for changes in sexual behaviors. Among those infected with HSV-2, the percentage who reported having been diagnosed with genital herpes was statistically different (14.3% in 1999-2004 and 9.9% in 1988-1994; P =.02). Seroprevalence of HSV-1 decreased from 62.0% (95% CI, 59.6%-64.6%) in 1988-1994 to 57.7% (95% CI, 55.9%-59.5%) in 1999-2004, a relative decrease of 6.9% between the 2 surveys (95% CI, -11.6% to -2.3%; P =. 006). Among persons infected with HSV-1 but not with HSV-2, a higher percentage reported having been diagnosed with genital herpes in 1999-2004 compared with 1988-1994 (1.8% vs 0.4%, respectively; P < .001). Conclusions These data show declines in HSV-2 seroprevalence, suggesting that the trajectory of increasing HSV-2 seroprevalence in the United States has been reversed. Seroprevalence of HSV-1 decreased but the incidence of genital herpes caused by HSV-1 may be increasing.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Emory University	Xu, FJ (corresponding author), Ctr Dis Control & Prevent, Mailstop E-02,160 Clifton Rd, Atlanta, GA 30333 USA.	fax1@cdc.gov						ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Celum CL, 2005, J INFECT DIS, V191, pS107, DOI 10.1086/425272; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P856; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COREY L, 1999, SEXUALLY TRANSMITTED, P285; Cowan FM, 2001, INT J EPIDEMIOL, V30, P588, DOI 10.1093/ije/30.3.588; ELANDTJOHNSON RC, 1980, SURVIVAL MODELS DATA, P69; Engelberg R, 2003, SEX TRANSM DIS, V30, P174, DOI 10.1097/00007435-200302000-00015; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Halpern-Felsher BL, 2005, PEDIATRICS, V115, P845, DOI 10.1542/peds.2004-2108; Hashido M, 1999, MICROBIOL IMMUNOL, V43, P177, DOI 10.1111/j.1348-0421.1999.tb02390.x; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; Kimberlin DW, 2004, NEW ENGL J MED, V350, P1970, DOI 10.1056/NEJMcp023065; Korn E, 1999, ANAL HLTH SURVEYS; Lafferty WE, 2000, J INFECT DIS, V181, P1454, DOI 10.1086/315395; LAFFERTY WE, 1987, NEW ENGL J MED, V316, P1444, DOI 10.1056/NEJM198706043162304; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; LEE FK, 1986, J VIROL METHODS, V14, P111, DOI 10.1016/0166-0934(86)90041-8; LEE FK, 1985, J CLIN MICROBIOL, V22, P641, DOI 10.1128/JCM.22.4.641-644.1985; Lowhagen GB, 2000, SEX TRANSM INFECT, V76, P179, DOI 10.1136/sti.76.3.179; McClelland RS, 2002, AIDS, V16, P2425, DOI 10.1097/00002030-200212060-00007; MODADJER L, 1996, NATL HLTH NUTR EXAMI, V3; Mosher WD, 2005, ADV DATA, P10; NAHMIAS AJ, 1990, SCAND J INFECT DIS, P19; Nahmias AJ, 2006, HERPES SIMPLEX VIRUS, P55; National Center for Health Statistics/Centers for Disease Control and Prevention, 2004, NHANES AN GUID; Nilsen A, 2000, ACTA OBSTET GYN SCAN, V79, P693, DOI 10.1034/j.1600-0412.2000.079008693.x; Pebody RG, 2004, SEX TRANSM INFECT, V80, P185, DOI 10.1136/sti.2003.005850; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Ribes JA, 2001, J CLIN MICROBIOL, V39, P3321, DOI 10.1128/JCM.39.9.3321-3325.2001; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Santelli JS, 2004, J ADOLESCENT HEALTH, V35, P80, DOI 10.1016/j.jadohealth.2004.05.001; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Schillinger JA, 2004, SEX TRANSM DIS, V31, P753, DOI 10.1097/01.olq.0000145852.43262.c3; SCHMIDLEY D, 2001, PROFILE FOREIGN BORN; Scoular A, 2002, BRIT MED J, V324, P1366, DOI 10.1136/bmj.324.7350.1366; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stanberry L.R., 1997, VIRAL INFECT HUMANS, P419; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Tran T, 2004, SEX TRANSM INFECT, V80, P277, DOI 10.1136/sti.2004.009753; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Vyse AJ, 2000, SEX TRANSM INFECT, V76, P183, DOI 10.1136/sti.76.3.183; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; 1994, VITAL HLTH STAT, V1, P20	54	656	688	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2006	296	8					964	973		10.1001/jama.296.8.964	http://dx.doi.org/10.1001/jama.296.8.964			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	076AL	16926356	Bronze			2022-12-01	WOS:000239929300026
J	Arjamaa, O				Arjamaa, Olli			Gene silencing in wet age-related macular degeneration	LANCET			English	Editorial Material							RNA INTERFERENCE		Univ Turku, Dept Biol, Turku 20014, Finland	University of Turku	Arjamaa, O (corresponding author), Univ Turku, Dept Biol, Turku 20014, Finland.	olli.arjamaa@utu.fi						*ACQ PHARM, 2006, ACQ PHARM REP POS IN; Campochiaro PA, 2006, GENE THER, V13, P559, DOI 10.1038/sj.gt.3302653; Caplen NJ, 2004, GENE THER, V11, P1241, DOI 10.1038/sj.gt.3302324; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Mukesh BN, 2004, OPHTHALMOLOGY, V111, P1176, DOI 10.1016/j.ophtha.2003.08.042; Stevenson M, 2004, NEW ENGL J MED, V351, P1772, DOI 10.1056/NEJMra045004	7	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2006	368	9536					630	631		10.1016/S0140-6736(06)69226-X	http://dx.doi.org/10.1016/S0140-6736(06)69226-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074YT	16920453				2022-12-01	WOS:000239849200010
J	Bayer, R; Fairchild, AL				Bayer, Ronald; Fairchild, Amy L.			Changing the paradigm for HIV testing - The end of exceptionalism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				BAYER R, 1991, NEW ENGL J MED, V324, P1500, DOI 10.1056/NEJM199105233242111; HENN M, 2006, CITY HLTH INFORM, V25, P9; STOTO MA, 1999, REDUCING ODDS PREVEN; American Medical Association, 2001, MMWR Recomm Rep, V50, P1; 2001, MMWR RECOMM REP, V50, P63	5	122	126	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2006	355	7					647	649		10.1056/NEJMp068153	http://dx.doi.org/10.1056/NEJMp068153			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074AN	16914699	Bronze, Green Published			2022-12-01	WOS:000239784500002
J	Bernardi, R; Guernah, I; Jin, D; Grisendi, S; Alimonti, A; Teruya-Feldstein, J; Cordon-Cardo, C; Simon, MC; Rafii, S; Pandolfi, PP				Bernardi, Rosa; Guernah, Ilhem; Jin, David; Grisendi, Silvia; Alimonti, Andrea; Teruya-Feldstein, Julie; Cordon-Cardo, Carlos; Simon, M. Celeste; Rafii, Shahin; Pandolfi, Pier Paolo			PML inhibits HIF-1 alpha translation and neoangiogenesis through repression of mTOR	NATURE			English	Article							MAMMALIAN TARGET; TUMOR ANGIOGENESIS; SUPPRESSOR PML; RAR-ALPHA; RAPAMYCIN; PROTEIN; HYPOXIA; GROWTH; CANCER; EXPRESSION	Loss of the promyelocytic leukaemia (PML) tumour suppressor has been observed in several human cancers. The tumour-suppressive function of PML has been attributed to its ability to induce growth arrest, cellular senescence and apoptosis. Here we identify PML as a critical inhibitor of neoangiogenesis ( the formation of new blood vessels) in vivo, in both ischaemic and neoplastic conditions, through the control of protein translation. We demonstrate that in hypoxic conditions PML acts as a negative regulator of the synthesis rate of hypoxia-inducible factor 1 alpha (HIF-1 alpha) by repressing mammalian target of rapamycin ( mTOR). PML physically interacts with mTOR and negatively regulates its association with the small GTPase Rheb by favouring mTOR nuclear accumulation. Notably, Pml(-/-) cells and tumours display higher sensitivity both in vitro and in vivo to growth inhibition by rapamycin, and lack of PML inversely correlates with phosphorylation of ribosomal protein S6 and tumour angiogenesis in mouse and human tumours. Thus, our findings identify PML as a novel suppressor of mTOR and neoangiogenesis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Weill Cornell Med Coll, Howard Hughes Med Inst, Dept Med Genet, Div Hematol Oncol, New York, NY 10021 USA; Univ Penn, Ctr Canc, Howard Hughes Med Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Canc, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Simon, Celeste/AAG-3941-2021; bernardi, rosa/B-1650-2013	bernardi, rosa/0000-0002-3607-6336; Alimonti, Andrea/0000-0002-9362-2313				Amano K, 2004, J MOL CELL CARDIOL, V36, P469, DOI 10.1016/j.yjmcc.2004.01.006; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Brahimi-Horn C, 2005, CRIT REV ONCOL HEMAT, V53, P115, DOI 10.1016/j.critrevonc.2004.09.003; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gambacorta M, 1996, AM J PATHOL, V149, P2023; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kaelin WG, 2002, GENE DEV, V16, P1441, DOI 10.1101/gad.1003602; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; KOKEN MHM, 1995, ONCOGENE, V10, P1315; LAVAU C, 1995, ONCOGENE, V11, P871; Liao F, 2002, CANCER RES, V62, P2567; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Marti Hugo H., 1999, Thrombosis and Haemostasis, V82, P44; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; Park IH, 2002, J BIOL CHEM, V277, P31423, DOI 10.1074/jbc.M204080200; Rabbany SY, 2003, TRENDS MOL MED, V9, P109, DOI 10.1016/S1471-4914(03)00021-2; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Takahashi Y, 2004, ONCOGENE, V23, P2819, DOI 10.1038/sj.onc.1207533; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Zhang P, 2000, INT J CANCER, V85, P599, DOI 10.1002/(SICI)1097-0215(20000301)85:5<599::AID-IJC1>3.0.CO;2-#; Zhu J, 2001, ONCOGENE, V20, P7257, DOI 10.1038/sj.onc.1204852	47	310	325	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2006	442	7104					779	785		10.1038/nature05029	http://dx.doi.org/10.1038/nature05029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16915281				2022-12-01	WOS:000239792700038
J	Bunnell, R; Mermin, J; De Cock, KM				Bunnell, Rebecca; Mermin, Jonathan; De Cock, Kevin M.			HIV prevention for a threatened continent - Implementing positive prevention in Africa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEXUALLY-TRANSMITTED-DISEASES; ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; TRANSMISSION; INTERVENTIONS; RISK; BEHAVIOR; WOMEN		Ctr Dis Control & Prevent Uganda, Global AIDS Program, Natl Ctr HIV STD & TB Prevent, Entebbe, Uganda; World Hlth Org, Dept HIV AIDS, Geneva, Switzerland	World Health Organization	Bunnell, R (corresponding author), Uganda Virus Res Inst, POB 49, Entebbe, Uganda.	rrb7@cdc.gov	Mermin, Jonathan/J-9847-2012					ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Gichangi P, 2000, INT J STD AIDS, V11, P257, DOI 10.1258/0956462001915660; Gordon CM, 2005, AIDS EDUC PREV, V17, P6, DOI 10.1521/aeap.17.2.6.58697; Heyns AD, 2006, JAMA-J AM MED ASSOC, V295, P519, DOI 10.1001/jama.295.5.519; KORENROMP EL, 1995, J INFECT DIS S1, V191, pS168; Leonard L, 2000, AIDS EDUC PREV, V12, P21; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Mermin J, 2005, TROP MED INT HEALTH, V10, P961, DOI 10.1111/j.1365-3156.2005.01488.x; NAKAYIWA S, 2006, AIDS BEHAV      0520; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; *TACAIDS NBS ORC M, 2005, TANZ HIV AIDS IND SU; *UNAIDS, AIDS EP UPD DEC 2005; *UNAIDS, INT HIV PREV UNAIDS; *US DEP HHS, ACH HIV FREE GEN REC; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	24	108	108	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2006	296	7					855	858		10.1001/jama.296.7.855	http://dx.doi.org/10.1001/jama.296.7.855			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073SR	16905790	Green Published			2022-12-01	WOS:000239763400025
J	Porta, M				Porta, Miquel			Persistent organic pollutants and the burden of diabetes	LANCET			English	Editorial Material									Univ Autonoma Barcelona, Inst Municipal Invest Med, E-08003 Barcelona, Spain; Univ N Carolina, Chapel Hill, NC USA	Autonomous University of Barcelona; University of North Carolina; University of North Carolina Chapel Hill	Porta, M (corresponding author), Univ Autonoma Barcelona, Inst Municipal Invest Med, E-08003 Barcelona, Spain.	mporta@imim.es	Porta, Miquel/B-5787-2008; Porta, Miquel/AAD-5371-2020	Porta, Miquel/0000-0003-1684-7428; Porta, Miquel/0000-0003-1684-7428				Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Longnecker MP, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454649; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; NHANES III, 2005, 3 CDCP DEP HLTH HUM; Porta M, 2002, OCCUP ENVIRON MED, V59, P651, DOI 10.1136/oem.59.10.651; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Rewers M, 2004, LANCET, V364, P1645, DOI 10.1016/S0140-6736(04)17368-6; Schafer KS, 2002, J EPIDEMIOL COMMUN H, V56, P813, DOI 10.1136/jech.56.11.813; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5	12	76	80	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2006	368	9535					558	559		10.1016/S0140-6736(06)69174-5	http://dx.doi.org/10.1016/S0140-6736(06)69174-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074OF	16905002				2022-12-01	WOS:000239821000006
J	Gross, O; Gewies, A; Finger, K; Schafer, M; Sparwasser, T; Peschel, C; Forster, I; Ruland, J				Gross, Olaf; Gewies, Andreas; Finger, Katrin; Schaefer, Martin; Sparwasser, Tim; Peschel, Christian; Forster, Irmgard; Ruland, Juergen			Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity	NATURE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR-2; BETA-GLUCANS; MYD88-DEFICIENT MICE; T-CELL; ACTIVATION; CARMA1; RECOGNITION; MALT1; INDUCTION	Fungal infections are increasing worldwide due to the marked rise in immunodeficiencies including AIDS; however, immune responses to fungi are poorly understood. Dectin- 1 is the major mammalian pattern recognition receptor for the fungal component zymosan. Dectin- 1 represents the prototype of innate non- Toll- like receptors ( TLRs) containing immunoreceptor tyrosine- based activation motifs ( ITAMs) related to those of adaptive antigen receptors. Here we identify Card9 as a key transducer of Dectin- 1 signalling. Although being dispensable for TLR/ MyD88- induced responses, Card9 controls Dectin- 1- mediated myeloid cell activation, cytokine production and innate anti- fungal immunity. Card9 couples to Bcl10 and regulates Bcl10 - Malt1- mediated NF- kappa B activation induced by zymosan. Yet, Card9 is dispensable for antigen receptor signalling that uses Carma1 as a link to Bcl10 - Malt1. Thus, our results define a novel innate immune pathway and indicate that evolutionarily distinct ITAM receptors in innate and adaptive immune cells use diverse adaptor proteins to engage selectively the conserved Bcl10 - Malt1 module.	Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, Ismaninger Str 22, D-81675 Munich, Germany.	jruland@lrz.tum.de	Förster, Irmgard/P-8545-2016; Sparwasser, Tim D/AAA-4306-2022; Ruland, Jürgen/Q-6680-2018; Gross, Olaf/E-4570-2010; Sparwasser, Tim/AAF-7085-2019	Förster, Irmgard/0000-0002-7644-5642; Ruland, Jürgen/0000-0002-8381-3597; Gross, Olaf/0000-0001-8660-3619; Sparwasser, Tim/0000-0001-5645-902X; Gewies, Andreas/0000-0002-7606-6482				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Eliopoulos AG, 2006, J BIOL CHEM, V281, P1371, DOI 10.1074/jbc.M506790200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Villamon E, 2004, MICROBES INFECT, V6, P1, DOI 10.1016/j.micinf.2003.09.020	30	639	674	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2006	442	7103					651	656		10.1038/nature04926	http://dx.doi.org/10.1038/nature04926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16862125				2022-12-01	WOS:000239630200037
J	Lie, RK; Emanuel, EJ; Grady, C				Lie, Reidar K.; Emanuel, Ezekiel J.; Grady, Christine			Circumcision and HIV prevention research: an ethical analysis	LANCET			English	Article									NIH, Ctr Clin, Dept Clin Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Lie, RK (corresponding author), NIH, Ctr Clin, Dept Clin Bioeth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	riie@cc.nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 2001, IMP VOL COUNS TEST G; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Belsky L, 2004, BRIT MED J, V328, P1494, DOI 10.1136/bmj.328.7454.1494; Cleaton-Jones P, 2005, PLOS MED, V2, P1073, DOI 10.1371/journal.pmed.0020287; Macklin R, 2004, DOUBLE STANDARDS MED; National Institute of Allergy and Infectious Diseases (NIAID), 2001, WORKSH SUMM SCI EV C; Siegfried N, 2005, PLOS MED, V2, P1071, DOI 10.1371/journal.pmed.0020393; Slack C, 2005, SOC SCI MED, V60, P1197, DOI 10.1016/j.socscimed.2004.06.049; UNAIDS and WHO, 2000, ETH CONS HIV PREV VA; *VOL HIV 1 COUNS T, LANCET, V356, P103; Winstock AR, 2000, EUR J CLIN MICROBIOL, V19, P823, DOI 10.1007/s100960000377; 2005, PLOS MED, V2, P293	12	17	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2006	368	9534					522	525		10.1016/S0140-6736(06)69160-5	http://dx.doi.org/10.1016/S0140-6736(06)69160-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890839				2022-12-01	WOS:000239569000035
J	De Martino, B; Kumaran, D; Seymour, B; Dolan, RJ				De Martino, Benedetto; Kumaran, Dharshan; Seymour, Ben; Dolan, Raymond J.			Frames, biases, and rational decision-making in the human brain	SCIENCE			English	Article							ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; CHOICE; RISK; PSYCHOLOGY; DAMAGE	Human choices are remarkably susceptible to the manner in which options are presented. This so-called "framing effect" represents a striking violation of standard economic accounts of human rationality, although its underlying neurobiology is not understood. We found that the framing effect was specifically associated with amygdala activity, suggesting a key role for an emotional system in mediating decision biases. Moreover, across individuals, orbital and medial prefrontal cortex activity predicted a reduced susceptibility to the framing effect. This finding highlights the importance of incorporating emotional processes within models of human choice and suggests how the brain may modulate the effect of these biasing influences to approximate rationality.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1 3AR, England	University of London; University College London	De Martino, B (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1 3AR, England.	b.martino@fil.ion.ucl.ac.uk	Holman, B.J./E-8868-2010	De Martino, Benedetto/0000-0002-3555-2732; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adolphs R, 2006, BRAIN RES, V1079, P25, DOI 10.1016/j.brainres.2005.12.127; AMARAL D G, 1992, P1; [Anonymous], 2000, CHOICES VALUES FRAME; ARROW KJ, 1982, ECON INQ, V20, P1, DOI 10.1111/j.1465-7295.1982.tb01138.x; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; GABAIX X, 2003, PSYCHOL EC DECISIONS, V1, P169; Gilovich T., 2002, HEURISTICS BIASES PS, V16th edn, DOI DOI 10.1017/CBO9780511808098; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; LeDoux J.E., 1996, EMOTIONAL BRAIN; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Slovic P., 2002, HEURISTICS BIASES PS, P397, DOI DOI 10.1017/CBO9780511808098.025; Stanovich K. E., 2002, HEURISTICS BIASES PS, P421, DOI DOI 10.1017/CBO9780511808098.026; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	30	868	875	17	332	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					684	687		10.1126/science.1128356	http://dx.doi.org/10.1126/science.1128356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072IQ	16888142	Green Accepted, Green Submitted			2022-12-01	WOS:000239667500048
J	Bugreev, DV; Mazina, OM; Mazin, AV				Bugreev, Dmitry V.; Mazina, Olga M.; Mazin, Alexander V.			Rad54 protein promotes branch migration of Holliday junctions	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; MAMMALIAN-CELLS; RUVB PROTEINS; DNA; CHROMATIN; ATPASE; YEAST; CONVERSION	Homologous recombination has a crucial function in the repair of DNA double-strand breaks and in faithful chromosome segregation(1-3). The mechanism of homologous recombination involves the search for homology and invasion of the ends of a broken DNA molecule into homologous duplex DNA to form a cross-stranded structure, a Holliday junction (HJ)(4-7). A HJ is able to undergo branch migration along DNA, generating increasing or decreasing lengths of heteroduplex. In both prokaryotes and eukaryotes, the physical evidence for HJs, the key intermediate in homologous recombination, was provided by electron microscopy(8). In bacteria there are specialized enzymes that promote branch migration of HJs(7). However, in eukaryotes the identity of homologous recombination branch-migration protein(s) has remained elusive. Here we show that Rad54, a Swi2/Snf2 protein(9), binds HJ-like structures with high specificity and promotes their bidirectional branch migration in an ATPase-dependent manner. The activity seemed to be conserved in human and yeast Rad54 orthologues. In vitro, Rad54 has been shown to stimulate DNA pairing of Rad51, a key homologous recombination protein(10-12). However, genetic data indicate that Rad54 protein might also act at later stages of homologous recombination, after Rad51 (ref. 13). Novel DNA branch-migration activity is fully consistent with this late homologous recombination function of Rad54 protein.	Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia	Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu						Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; DRESSLER D, 1982, ANNU REV BIOCHEM, V51, P727, DOI 10.1146/annurev.bi.51.070182.003455; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kim PM, 2002, NUCLEIC ACIDS RES, V30, P2727, DOI 10.1093/nar/gkf413; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Shinohara M, 1997, GENETICS, V147, P1545; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUSLOVA N G, 1970, Genetika, V6, P158; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037	30	141	144	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					590	593		10.1038/nature04889	http://dx.doi.org/10.1038/nature04889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16862129				2022-12-01	WOS:000239455900049
J	Thornton, A; McAuliffe, K				Thornton, Alex; McAuliffe, Katherine			Teaching in wild meerkats	SCIENCE			English	Article							SURICATA-SURICATTA; ANIMALS	Despite the obvious benefits of directed mechanisms that facilitate the efficient transfer of skills, there is little critical evidence for teaching in nonhuman animals. Using observational and experimental data, we show that wild meerkats (Suricata suricatta) teach pups prey-handling skills by providing them with opportunities to interact with live prey. In response to changing pup begging calls, helpers alter their prey-provisioning methods as pups grow older, thus accelerating learning without the use of complex cognition. The lack of evidence for teaching in species other than humans may reflect problems in producing unequivocal support for the occurrence of teaching, rather than the absence of teaching.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Thornton, A (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	jant2@cam.ac.uk		Thornton, Alex/0000-0002-1607-2047				BOESCH C, 1991, ANIM BEHAV, V41, P530, DOI 10.1016/S0003-3472(05)80857-7; Boyd R., 1985, CULTURE EVOLUTIONARY; Caro, 1994, CHEETAHS SERENGETI G; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Cheney D.L., 1990, MONKEYS SEE WORLD IN; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Doolan SP, 1996, J ZOOL, V239, P697, DOI 10.1111/j.1469-7998.1996.tb05472.x; EWER RF, 1969, NATURE, V222, P698, DOI 10.1038/222698a0; Fragaszy D.M., 2003, BIOL TRADITIONS MODE; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Galef BG, 2005, ANIM BEHAV, V70, P91, DOI 10.1016/j.anbehav.2004.12.004; Heyes CM., 1996, SOCIAL LEARNING ANIM; Leeming J, 2003, SCORPIONS SO AFRICA; MAESTRIPIERI D, 1995, HUM NATURE-INT BIOS, V6, P361, DOI 10.1007/BF02734206; Manser MB, 2000, BEHAV ECOL SOCIOBIOL, V48, P429, DOI 10.1007/s002650000248; Pearson A, 1989, TEACHER THEORY PRACT; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; White SM, 2001, THESIS U CAMBRIDGE C	19	221	223	3	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					227	229		10.1126/science.1128727	http://dx.doi.org/10.1126/science.1128727			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840701				2022-12-01	WOS:000239008000045
J	Nguyen, H; Rendl, M; Fuchs, E				Nguyen, Hoang; Rendl, Michael; Fuchs, Elaine			Tcf3 governs stem cell features and represses cell fate determination in skin	CELL			English	Article							BETA-CATENIN; WNT/BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; TRANSIENT ACTIVATION; HAIR-FOLLICLES; PPAR; EXPRESSION; GAMMA; CANCER; MORPHOGENESIS	Many stem cells (SCs) respond to Wnt signaling, but whether beta-catenin's DNA binding partners, the Tcfs, play a role in SCs in the absence of Writs, is unknown. In adult skin, quiescent multipotent progenitors express Tcf3 and commit to a hair cell fate in response to Wnt signaling. We find that embryonic skin progenitors also express Tcf3. Using an inducible system in mice, we show that upon Tcf3 reactivation, committed epidermal cells induce genes associated with an undifferentiated, Wnt-inhibited state and Tcf3 promotes a transcriptional program shared by embryonic and postnatal SCs. Further, Tcf3-repressed genes include transcriptional regulators of the epidermal, sebaceous gland and hair follicle differentiation programs, and correspondingly, all three terminal differentiation pathways are suppressed when Tcf3 is induced postnatally. These data suggest that in the absence of Writ signals, Tcf3 may function in skin SCs to maintain an undifferentiated state and, through Wnt signaling, directs these cells along the hair lineage.	Rockefeller Univ, Dept Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Nguyen, H (corresponding author), Rockefeller Univ, Dept Mammalian Cell Biol & Dev, Howard Hughes Med Inst, 1230 York Ave,Box 300, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Rendl, Michael/0000-0001-6326-620X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR31737] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Di-Poi N, 2004, LIPIDS, V39, P1093, DOI 10.1007/s11745-004-1335-y; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Knott A, 2002, BIOTECHNIQUES, V32, P796, DOI 10.2144/02324st06; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI 10.1074/jbc.M407050200; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Michalik L, 2002, INT J DEV BIOL, V46, P105; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shetty P, 2005, DEV BIOL, V285, P584, DOI 10.1016/j.ydbio.2005.07.008; SIERRA J, 2000, GENE DEV, V20, P586; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	49	222	238	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					171	183		10.1016/j.cell.2006.07.036	http://dx.doi.org/10.1016/j.cell.2006.07.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018284	Bronze			2022-12-01	WOS:000241445800022
J	Champion, PAD; Stanley, SA; Champion, MM; Brown, EJ; Cox, JS				Champion, Patricia A. DiGiuseppe; Stanley, Sarah A.; Champion, Matthew M.; Brown, Eric J.; Cox, Jeffery S.			C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis	SCIENCE			English	Article							PROTEIN SECRETION; BOVIS BCG; ESAT-6; COMPLEX; PATHOGENESIS; MEMBRANES; ANTIGENS; SYSTEM; CFP-10	Mycobacterium tuberculosis uses the ESX-1/Snm system [ early secreted antigen 6 kilodaltons (ESAT-6) system 1/secretion in mycobacteria] to deliver virulence factors into host macrophages during infection. Despite its essential role in virulence, the mechanism of ESX-1 secretion is unclear. We found that the unstructured C terminus of the CFP-10 substrate was recognized by Rv3871, a cytosolic component of the ESX-1 system that itself interacts with the membrane protein Rv3870. Point mutations in the signal that abolished binding of CFP-10 to Rv3871 prevented secretion of the CFP-10 ( culture filtrate protein, 10 kilodaltons)/ESAT-6 virulence factor complex. Attachment of the signal to yeast ubiquitin was sufficient for secretion from M. tuberculosis cells, demonstrating that this ESX-1 signal is portable.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA; Appl Biosyst Inc, Foster City, CA 94404 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thermo Fisher Scientific; Applied Biosystems	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St,Campus Box 2200, San Francisco, CA 94143 USA.	Jeffery.Cox@ucsf.edu	Champion, Patricia A/AAD-8244-2019	Champion, Matthew M./0000-0001-5927-5277; Champion, Patricia/0000-0002-6733-596X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302] Funding Source: NIH RePORTER; NIAID NIH HHS [AI51667, AI63302] Funding Source: Medline; PHS HHS [A105155] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Emr S D, 1982, Prog Clin Biol Res, V91, P3; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Martz E, 2002, TRENDS BIOCHEM SCI, V27, P107, DOI 10.1016/S0968-0004(01)02008-4; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P935, DOI 10.1002/(SICI)1522-2683(20000301)21:5<935::AID-ELPS935>3.3.CO;2-G; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	25	155	179	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1632	1636		10.1126/science.1131167	http://dx.doi.org/10.1126/science.1131167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973880				2022-12-01	WOS:000240498900044
J	Singh, SB; Davis, AS; Taylor, GA; Deretic, V				Singh, Sudha B.; Davis, Alexander S.; Taylor, Gregory A.; Deretic, Vojo			Human IRGM induces autophagy to eliminate intracellular mycobacteria	SCIENCE			English	Article							3-KINASE COMPLEX; IMMUNE CONTROL; P47 GTPASES; TUBERCULOSIS; INDUCTION; MECHANISM; INFECTION; BECLIN-1; DEFENSE; INNATE	Immunity-related p47 guanosine triphosphatases (IRG) play a role in defense against intracellular pathogens. We found that the murine Irgm1 (LRG-47) guanosine triphosphatase induced autophagy and generated large autolysosomal organelles as a mechanism for the elimination of intracellular Mycobacterium tuberculosis. We also identified a function for a human IRG protein in the control of intracellular pathogens and report that the human Irgm1 ortholog, IRGM, plays a role in autophagy and in the reduction of intracellular bacillary load.	Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Duke Univ, Dept Med, Durham, NC 27710 USA; Duke Univ, Dept Microbiol & Mol Genet, Durham, NC 27710 USA; Duke Univ, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Ctr Study Aging, Durham, NC 27710 USA; Dept Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27710 USA	University of New Mexico; University of New Mexico; Duke University; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center	Deretic, V (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu		Deretic, Vojo/0000-0002-3624-5208	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042999, R01AI045148, T32AI007538, R01AI057831] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007538, AI42999, AI57831, AI45148, R01 AI057831] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Deretic V., 2006, AUTOPHAGY IMMUNITY I; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Seglen P O, 1990, Semin Cell Biol, V1, P441; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	23	691	717	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1438	1441		10.1126/science.1129577	http://dx.doi.org/10.1126/science.1129577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16888103				2022-12-01	WOS:000240348700043
J	Prokhorenko, VI; Nagy, AM; Waschuk, SA; Brown, LS; Birge, RR; Miller, RJD				Prokhorenko, Valentyn I.; Nagy, Andrea M.; Waschuk, Stephen A.; Brown, Leonid S.; Birge, Robert R.; Miller, R. J. Dwayne			Coherent control of retinal isomerization in bacteriorhodopsin	SCIENCE			English	Article							FEMTOSECOND PRIMARY EVENT; QUANTUM YIELD; MOLECULAR-DYNAMICS; PHOTOISOMERIZATION; ABSORPTION; EXCITATION; SPECTROSCOPY; PHOTOCYCLE; CHROMOPHORE; MODEL	Optical control of the primary step of photoisomerization of the retinal molecule in bacteriorhodopsin from the all-trans to the 13-cis state was demonstrated under weak field conditions (where only 1 of 300 retinal molecules absorbs a photon during the excitation cycle) that are relevant to understanding biological processes. By modulating the phases and amplitudes of the spectral components in the photoexcitation pulse, we showed that the absolute quantity of 13-cis retinal formed upon excitation can be enhanced or suppressed by +/-20% of the yield observed using a short transform-limited pulse having the same actinic energy. The shaped pulses were shown to be phase-sensitive at intensities too low to access different higher electronic states, and so these pulses apparently steer the isomerization through constructive and destructive interference effects, a mechanism supported by observed signatures of vibrational coherence. These results show that the wave properties of matter can be observed and even manipulated in a system as large and complex as a protein.	Univ Toronto, Inst Opt Sci, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Toronto, Inst Opt Sci, Dept Phys, Toronto, ON M5S 3H6, Canada; Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; Univ Connecticut, Dept Chem, Storrs, CT USA	University of Toronto; University of Toronto; University of Guelph; University of Connecticut	Miller, RJD (corresponding author), Univ Toronto, Inst Opt Sci, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	dmiller@lphys.chem.utoronto.ca	Brown, Leonid/X-7445-2019; Brown, Leonid/A-1050-2008	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317	NIGMS NIH HHS [R01 GM034548, R01 GM034548-17] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034548] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALASHOV SP, 1991, PHOTOCHEM PHOTOBIOL, V54, P955, DOI 10.1111/j.1751-1097.1991.tb02116.x; Blum K., 2022, P SOC BRAIN MAPP THE; DIOUMAEV AK, 1989, J PHOTOCH PHOTOBIO B, V3, P397, DOI 10.1016/1011-1344(89)80044-2; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Flores SC, 2004, J PHYS CHEM B, V108, P6745, DOI 10.1021/jp0370526; FRAGNITO HL, 1989, CHEM PHYS LETT, V160, P101, DOI 10.1016/0009-2614(89)87564-5; Gai F, 1998, SCIENCE, V279, P1886, DOI 10.1126/science.279.5358.1886; Gelman D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2136155; Gonzalez-Luque R, 2000, P NATL ACAD SCI USA, V97, P9379, DOI 10.1073/pnas.97.17.9379; Hasson KC, 1996, P NATL ACAD SCI USA, V93, P15124, DOI 10.1073/pnas.93.26.15124; Hauer J, 2006, CHEM PHYS LETT, V421, P523, DOI 10.1016/j.cplett.2006.01.115; Hayashi S, 2003, BIOPHYS J, V85, P1440, DOI 10.1016/S0006-3495(03)74576-7; Herbst J, 2002, SCIENCE, V297, P822, DOI 10.1126/science.1072144; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Hoki K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168305; Hou BX, 2003, CHEM PHYS LETT, V381, P549, DOI 10.1016/j.cplett.2003.10.038; Kamalov VF, 1996, J PHYS CHEM-US, V100, P2762, DOI 10.1021/jp952971k; Kennis JTM, 2002, J PHYS CHEM B, V106, P6067, DOI 10.1021/jp014681b; Kobayashi T, 2001, NATURE, V414, P531, DOI 10.1038/35107042; Logunov SL, 1997, J PHYS CHEM B, V101, P6629, DOI 10.1021/jp970955c; Morita R, 2001, OPT COMMUN, V197, P73, DOI 10.1016/S0030-4018(01)01409-2; MYERS AB, 1983, J CHEM PHYS, V79, P603, DOI 10.1063/1.445807; Oesterhelt D, 1974, Methods Enzymol, V31, P667; Ohtsuki Y, 2003, CHEM PHYS LETT, V369, P525, DOI 10.1016/S0009-2614(02)02030-4; PAYE J, 1992, IEEE J QUANTUM ELECT, V28, P2262, DOI 10.1109/3.159533; POLLAND HJ, 1986, BIOPHYS J, V49, P651, DOI 10.1016/S0006-3495(86)83692-X; POLLARD WT, 1990, J CHEM PHYS, V92, P4012, DOI 10.1063/1.457815; Prokhorenko VI, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1886750; SCHNEIDER G, 1989, CHEM PHYS, V131, P17, DOI 10.1016/0301-0104(89)87078-8; Shapiro M, 2003, REP PROG PHYS, V66, P859, DOI 10.1088/0034-4885/66/6/201; SHI SH, 1990, J CHEM PHYS, V92, P364, DOI 10.1063/1.458438; TITTOR J, 1990, FEBS LETT, V263, P269, DOI 10.1016/0014-5793(90)81390-A; Vogt G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.068305; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; XIE A, 1990, BIOPHYS J, V58, P1127, DOI 10.1016/S0006-3495(90)82455-3; Ye T, 1999, J PHYS CHEM B, V103, P5122, DOI 10.1021/jp9846227	36	308	322	2	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1257	1261		10.1126/science.1130747	http://dx.doi.org/10.1126/science.1130747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946063				2022-12-01	WOS:000240313500032
J	Engler, AJ; Sen, S; Sweeney, HL; Discher, DE				Engler, Adam J.; Sen, Shamik; Sweeney, H. Lee; Discher, Dennis E.			Matrix elasticity directs stem cell lineage specification	CELL			English	Article							MARROW STROMAL CELLS; IN-VITRO; OSTEOBLAST DIFFERENTIATION; FOCAL ADHESIONS; TISSUE; EXPRESSION; STIFFNESS; FIBROBLASTS; GROWTH; CONTRACTILITY	Microenvironments appear important in stem cell lineage specification but can be difficult to adequately characterize or control with soft tissues. Naive mesenchymal stem cells (MSCs) are shown hereto specify lineage and commit to phenotypes with extreme sensitivity to tissue-level elasticity. Soft matrices that mimic brain are neurogenic, stiffer matrices that mimic muscle are myogenic, and comparatively rigid matrices that mimic collagenous bone prove osteogenic. During the initial week in culture, reprogramming of these lineages is possible with addition of soluble induction factors, but after several weeks in culture, the cells commit to the lineage specified by matrix elasticity, consistent with the elasticity-insensitive commitment of differentiated cell types. Inhibition of nonmuscle myosin II blocks all elasticity-directed lineage specification-without strongly perturbing many other aspects of cell function and shape. The results have significant implications for understanding physical effects of the in vivo microenvironment and also for therapeutic uses of stem cells.	Univ Penn, Muscle Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; Univ Penn, Phys Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Discher, DE (corresponding author), Univ Penn, Muscle Inst, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Engler, Adam/AAF-4016-2019; Sweeney, H Lee/F-1862-2010	Engler, Adam/0000-0003-1642-5380; discher, dennis/0000-0001-6163-2229; Sen, Shamik/0000-0002-8639-8659				Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Andrades JA, 2001, INT J DEV BIOL, V45, P689; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Dhawan J, 2004, J CELL SCI, V117, P3735, DOI 10.1242/jcs.01197; Dinsmore J, 1996, CELL TRANSPLANT, V5, P131, DOI 10.1016/0963-6897(95)02040-3; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617; Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.3.CO;2-6; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lee Michael S, 2004, Rev Cardiovasc Med, V5, P82; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; NAKAGAWA S, 1989, EXP CELL RES, V182, P572, DOI 10.1016/0014-4827(89)90260-7; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raisz LG, 1999, CLIN CHEM, V45, P1353; Rattner A, 2000, CALCIFIED TISSUE INT, V66, P35, DOI 10.1007/s002230050007; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921; RUTISHAUSER U, 1984, NATURE, V310, P549, DOI 10.1038/310549a0; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Weitzer G, 1995, DEV BIOL, V172, P422, DOI 10.1006/dbio.1995.8070; Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010	60	9618	9908	79	2178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2006	126	4					677	689		10.1016/j.cell.2006.06.044	http://dx.doi.org/10.1016/j.cell.2006.06.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923388	Bronze			2022-12-01	WOS:000240276700017
J	Spechko, PL				Spechko, Phyllis L.			Knowing Ron	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		SPECHKO PL, 1985, JAMA-J AM MED ASSOC, V253, P985, DOI 10.1001/jama.1985.03350310067026	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2006	296	7					738	738		10.1001/jama.296.7.738	http://dx.doi.org/10.1001/jama.296.7.738			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073SR	16905774				2022-12-01	WOS:000239763400001
J	Muheim, R; Phillips, JB; Akesson, S				Muheim, Rachel; Phillips, John B.; Akesson, Susanne			Polarized light cues underlie compass calibration in migratory songbirds	SCIENCE			English	Article							MAGNETIC COMPASS; SKYLIGHT POLARIZATION; CONFLICT EXPERIMENTS; CELESTIAL CUES; SUN COMPASS; EUROPEAN ROBINS; SYLVIA-BORIN; ORIENTATION; BIRDS; PATTERNS	Migratory songbirds use the geomagnetic field, stars, the Sun, and polarized light patterns to determine their migratory direction. To prevent navigational errors, it is necessary to calibrate all of these compass systems to a common reference. We show that migratory Savannah sparrows use polarized light cues from the region of sky near the horizon to recalibrate the magnetic compass at both sunrise and sunset. We suggest that skylight polarization patterns are used to derive an absolute (i.e., geographic) directional system that provides the primary calibration reference for all of the compasses of migratory songbirds.	Lund Univ, Dept Anim Ecol, SE-22362 Lund, Sweden; Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Lund University; Virginia Polytechnic Institute & State University	Muheim, R (corresponding author), Lund Univ, Dept Anim Ecol, Ecol Bldg, SE-22362 Lund, Sweden.	rmuheim@vt.edu	Muheim, Rachel/D-3521-2009; Akesson, Susanne/F-3175-2015	Muheim, Rachel/0000-0002-2079-6443; Akesson, Susanne/0000-0001-9039-2180				ABLE KP, 1990, ANIM BEHAV, V39, P905, DOI 10.1016/S0003-3472(05)80955-8; ABLE KP, 1993, NATURE, V364, P523, DOI 10.1038/364523a0; ABLE KP, 1995, NATURE, V375, P230, DOI 10.1038/375230a0; ABLE KP, 1982, NATURE, V299, P550, DOI 10.1038/299550a0; ABLE KP, 1993, TRENDS ECOL EVOL, V8, P367, DOI 10.1016/0169-5347(93)90221-A; AKESSON S, 1994, ANIM BEHAV, V48, P1379, DOI 10.1006/anbe.1994.1374; Alerstam T, 2001, SCIENCE, V291, P300, DOI 10.1126/science.291.5502.300; ALERSTAM T, 2005, P RINO 5 C ROYAL I N, P1; BATSCHELET E., 1981, CIRCULAR STAT BIOL M; BEASON RC, 1987, J ORNITHOL, V128, P317, DOI 10.1007/BF01640301; BINGMAN VP, 1987, AUK, V104, P523, DOI 10.2307/4087555; BINGMAN VP, 1988, ETHOLOGY, V77, P1; BINGMAN VP, 1983, BEHAVIOUR, V87, P43, DOI 10.1163/156853983X00110; BRINES ML, 1982, J EXP BIOL, V96, P69; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; EMLEN ST, 1970, SCIENCE, V170, P1198, DOI 10.1126/science.170.3963.1198; GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; HELBIG AJ, 1989, ETHOLOGY, V82, P307; HorvuYth G., 2004, POLARIZED LIGHT ANIM; Kramer G., 1949, ORNITHOLOGIE ALS BIO, P269; MOORE FR, 1987, BIOL REV, V62, P65, DOI 10.1111/j.1469-185X.1987.tb00626.x; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; PHILLIPS JB, 1988, J THEOR BIOL, V131, P55, DOI 10.1016/S0022-5193(88)80120-6; PHILLIPS JB, 1992, BEHAV ECOL SOCIOBIOL, V31, P189; PRINZ K, 1992, ANIM BEHAV, V44, P539, DOI 10.1016/0003-3472(92)90063-F; Sandberg R, 2000, ANIM BEHAV, V60, P453, DOI 10.1006/anbe.2000.1582; Sauer F., 1957, Z TIERPSYCHOL, V14, P20, DOI [10.1111/j.1439-0310.1957.tb00525.x, DOI 10.1111/J.1439-0310.1957.TB00525.X]; Weindler P, 1996, NATURE, V383, P158, DOI 10.1038/383158a0; Weindler P, 1998, BEHAV ECOL SOCIOBIOL, V42, P289, DOI 10.1007/s002650050441; Weindler P., 1999, P 22 INT ORN C BIRDL, P979; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 1999, J AVIAN BIOL, V30, P56, DOI 10.2307/3677243; Wiltschko R, 2001, ANIM BEHAV, V62, P245, DOI 10.1006/anbe.2001.1751; Wiltschko W, 1998, J COMP PHYSIOL A, V182, P521, DOI 10.1007/s003590050199; Wiltschko W, 1998, J AVIAN BIOL, V29, P606, DOI 10.2307/3677181; WILTSCHKO W, 1987, ETHOLOGY, V74, P285; WILTSCHKO W, 1976, J COMP PHYSIOL, V109, P91, DOI 10.1007/BF00663437	37	183	200	6	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2006	313	5788					837	839		10.1126/science.1129709	http://dx.doi.org/10.1126/science.1129709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16902138				2022-12-01	WOS:000239671300060
J	Narita, M; Narita, M; Krizhanovsky, V; Nunez, S; Chicas, A; Hearn, SA; Myers, MP; Lowe, SW				Narita, Masashi; Narita, Masako; Krizhanovsky, Vale; Nunez, Sabrina; Chicas, Agustin; Hearn, Stephen A.; Myers, Michael P.; Lowe, Scott W.			A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation	CELL			English	Article							ARCHITECTURAL TRANSCRIPTION FACTOR; HISTONE H3; GENE; CHROMATIN; GROWTH; CELLS; P53; METHYLATION; SUPPRESSION; ONSET	Cellular senescence is a stable state of proliferative arrest that provides a barrier to malignant transformation and contributes to the antitumor activity of certain chemotherapies. Senescent cells can accumulate senescence-associated heterochromatic foci (SAHFs), which may provide a chromatin buffer that prevents activation of proliferation-associated genes by mitogenic transcription factors. Surprisingly, we show that the High-Mobility Group A (HMGA) proteins, which can promote tumorigenesis, accumulate on the chromatin of senescent fibroblasts and are essential structural components of SAHFs. HMGA proteins cooperate with the p16 INK4a tumor suppressor to promote SAHF formation and proliferative arrest and stabilize senescence by contributing to the repression of proliferation-associated genes. These antiproliferative activities are canceled by coexpression of the HDM2 and CDK4 oncogenes, which are often coamplified with HMGA2 in human cancers. Our results identify a component of the senescence machinery that contributes to heterochromatin formation and imply that HMGA proteins also act in tumor suppressor networks.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	; Krizhanovsky, Valery/D-1336-2010	Narita, Masako/0000-0002-9774-4908; Krizhanovsky, Valery/0000-0002-3977-5482; Narita, Masashi/0000-0001-7764-577X; Hearn, Stephen/0000-0002-2489-2424	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016379, R56AG016379] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIA NIH HHS [AG16379] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Berner JM, 1997, ONCOGENE, V14, P2935, DOI 10.1038/sj.onc.1201135; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Dillon N, 2004, BIOL CELL, V96, P631, DOI 10.1016/j.biolcel.2004.06.003; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Harrer M, 2004, J CELL SCI, V117, P3459, DOI 10.1242/jcs.01160; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hoyos JM, 2004, CANCER RES, V64, P5728, DOI 10.1158/0008-5472.CAN-04-1410; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Roninson IB, 2003, CANCER RES, V63, P2705; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	40	443	456	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2006	126	3					503	514		10.1016/j.cell.2006.05.052	http://dx.doi.org/10.1016/j.cell.2006.05.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	075KI	16901784	Bronze			2022-12-01	WOS:000239883400011
J	Cowgill, KD; Ndiritu, M; Nyiro, J; Slack, MPE; Chiphatsi, S; Ismail, A; Kamau, T; Mwangi, I; English, M; Newton, CRJC; Feikin, DR; Scott, JAG				Cowgill, Karen D.; Ndiritu, Moses; Nyiro, Joyce; Slack, Mary P. E.; Chiphatsi, Salome; Ismail, Amina; Kamau, Tatu; Mwangi, Isaiah; English, Mike; Newton, Charles R. J. C.; Feikin, Daniel R.; Scott, J. Anthony G.			Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE BACTERIAL-MENINGITIS; INVASIVE DISEASE; RANDOMIZED-TRIAL; UNITED-STATES; CHILDREN; INFANTS; POLYSACCHARIDE; EFFICACY; AFRICA; GAMBIA	Context Haemophilus influenzae type b (Hib) conjugate vaccine is not perceived as a public health priority in Africa because data on Hib disease burden and vaccine effectiveness are scarce. Hib immunization was introduced in Kenyan infants in 2001. Objective To define invasive Hib disease incidence and Hib vaccine program effectiveness in Kenya. Design, Setting, and Patients Culture-based surveillance for invasive Hib disease at Kilifi District Hospital from 2000 through 2005 was linked to demographic surveillance of 38 000 children younger than 5 years in Kilifi District, Kenya. Human immunodeficiency virus (HIV) infection and Hib vaccination status were determined for children with Hib disease admitted 2002-2005. Interventions Introduction of conjugate Hib vaccine within the routine childhood immunization program at ages 6, 10, and 14 weeks beginning November 2001. Main Outcome Measures Incidence of culture-proven Hib invasive disease before and after vaccine introduction and vaccine program effectiveness. Results Prior to vaccine introduction, the median age of children with Hib was 8 months; case fatality was 23%. Among children younger than 5 years, the annual incidence of invasive Hib disease 1 year before and 1 and 3 years after vaccine introduction was 66, 47, and 7.6 per 100 000, respectively. For children younger than 2 years, incidence was 119, 82, and 16 per 100 000, respectively. In 2004-2005, vaccine effectiveness was 88% (95% confidence interval, 73%-96%) among children younger than 5 years and 87% (95% confidence interval, 66%-96%) among children younger than 2 years. Of 53 children with Hib admitted during 2002-2005, 29 (55%) were age-ineligible to have received vaccine, 12 (23%) had not been vaccinated despite being eligible, and 12 (23%) had received 2 or more doses of vaccine (2 were HIV positive). Conclusions In Kenya, introduction of Hib vaccine into the routine childhood immunization program reduced Hib disease incidence among children younger than 5 years to 12% of its baseline level. This impact was not observed until the third year after vaccine introduction.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Div Appl Publ Hlth Training,Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Resp Dis Branch, Natl Ctr Infect Dis, Atlanta, GA USA; Kilifi Dist Hosp, Wellcome Trust Kenya Med Res Inst, Kilifi, Kenya; Kilifi Dist Hosp, Dist Publ Hlth Off, Kilifi, Kenya; Hlth Protect Agcy Ctr Infect, Resp & Systemic Infect Lab, Haemophilus Reference Unit, WHO Collaborating Ctr Haemophilus Influenzae, London, England; Minist Hlth, Kenya Expanded Programme Immunizat, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Univ London, Inst Child Hlth, London WC1N 1EH, England	University of Oxford; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Health Protection Agency; University of Oxford; University of London; University College London	Scott, JAG (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	ascott@ikilifi.net	Newton, Charles/V-7872-2019; Newton, Charles RJC/B-7578-2014	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Cowgill, Karen/0000-0002-4188-3757	Wellcome Trust [050563, 081835, 061089] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Adegbola RA, 1999, LANCET, V354, P1091, DOI 10.1016/S0140-6736(99)03010-X; BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2004, PEDIATRICS, V114, pE713, DOI 10.1542/peds.2004-0007; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; BIJLMER HA, 1990, J INFECT DIS, V161, P1210, DOI 10.1093/infdis/161.6.1210; Bisgard KM, 1998, EMERG INFECT DIS, V4, P229, DOI 10.3201/eid0402.980210; BLACK SB, 1991, PEDIATR INFECT DIS J, V10, P97, DOI 10.1097/00006454-199102000-00004; Campagne G, 1998, AM J TROP MED HYG, V59, P837, DOI 10.4269/ajtmh.1998.59.837; *CBS MOH ORC MACR, 2005, KEN DEM HLTH SURV 20; ESKOLA J, 1987, NEW ENGL J MED, V317, P717, DOI 10.1056/NEJM198709173171201; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994; HUSSEY G, 1994, ANN TROP PAEDIATR, V14, P97, DOI 10.1080/02724936.1994.11747700; Lagos R, 1996, PEDIATR INFECT DIS J, V15, P216, DOI 10.1097/00006454-199603000-00008; Lagos R, 1998, LANCET, V351, P1472, DOI 10.1016/S0140-6736(97)07456-4; Madhi SA, 2005, VACCINE, V23, P5517, DOI 10.1016/j.vaccine.2005.07.038; Moulton LH, 2000, INT J EPIDEMIOL, V29, P753, DOI 10.1093/ije/29.4.753; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1999, EPIDEMIOL REV, V21, P43, DOI 10.1093/oxfordjournals.epirev.a017987; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; NEWELL C, 1988, METHODS MODELS DEMOG, P180; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; PELTOLA H, 1992, LANCET, V340, P592, DOI 10.1016/0140-6736(92)92117-X; SANTOSHAM M, 1991, NEW ENGL J MED, V324, P1767, DOI 10.1056/NEJM199106203242503; SNOW RW, 1994, INT J EPIDEMIOL, V23, P1013, DOI 10.1093/ije/23.5.1013; Sow SO, 2005, PEDIATR INFECT DIS J, V24, P533, DOI 10.1097/01.inf.0000164768.28135.0d; URWIN G, 1994, BRIT MED J, V309, P1412, DOI 10.1136/bmj.309.6966.1412; *US BUR CENS POP D, INT DAT BAS	31	136	136	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2006	296	6					671	678		10.1001/jama.296.6.671	http://dx.doi.org/10.1001/jama.296.6.671			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	071LN	16896110	Green Accepted, Bronze			2022-12-01	WOS:000239603800029
J	Gayle, HD				Gayle, Helene D.			AIDS anniversaries in 2006 mark the time to deliver	LANCET			English	Editorial Material									Int AIDS Soc, CH-1216 Cointrin, Switzerland		Gayle, HD (corresponding author), Int AIDS Soc, CH-1216 Cointrin, Switzerland.	Hgayle@care.org						*CDC, 1981, MMWR-MORBID MORTAL W, V30, P250; G GLEN, 2005, GLEN COMM AFR CLIM C; Gayle HD, 2003, NEW ENGL J MED, V348, P1802, DOI 10.1056/NEJMsb030352; *GLOB FUND FIGHT A, HOW FUND WORKS; *GLOB HIV PREV WOR, 2002, GLOB MOB HIV PREV BL; Global HIV Prevention Working Group, 2004, HIV PREV ER EXP TREA; *INT AIDS SOC, FUT DIR PROJ MAX IMP; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; *UNAIDS WHO, 2006, PROGR GLOB ACC HIV A; *UNAIDS WHO, 2005, AIDS EP UPD SPEC REP; United Nations General Assembly, 2001, DECL COMM HIV AIDS	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2006	368	9534					425	427		10.1016/S0140-6736(06)69127-7	http://dx.doi.org/10.1016/S0140-6736(06)69127-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890809				2022-12-01	WOS:000239569000004
J	Leopold, DA; Bondar, IV; Giese, MA				Leopold, David A.; Bondar, Igor V.; Giese, Martin A.			Norm-based face encoding by single neurons in the monkey inferotemporal cortex	NATURE			English	Article							TEMPORAL CORTEX; DISTINCTIVENESS; RESPONSES; IDENTIFICATION; SELECTIVITY; CARICATURES; IDENTITY	The rich and immediate perception of a familiar face, including its identity, expression and even intent, is one of the most impressive shared faculties of human and non-human primate brains. Many visually responsive neurons in the inferotemporal cortex of macaque monkeys respond selectively to faces(1-4), sometimes to only one or a few individuals(5-7), while showing little sensitivity to scale and other details of the retinal image(8,9). Here we show that face-responsive neurons in the macaque monkey anterior inferotemporal cortex are tuned to a fundamental dimension of face perception. Using a norm-based caricaturization framework previously developed for human psychophysics(10-12), we varied the identity information present in photo-realistic human faces(13), and found that neurons of the anterior inferotemporal cortex were most often tuned around the average, identity-ambiguous face. These observations are consistent with face-selective responses in this area being shaped by a figural comparison, reflecting structural differences between an incoming face and an internal reference or norm. As such, these findings link the tuning of neurons in the inferotemporal cortex to psychological models of face identity perception.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Clin Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Lab Act Representat & Learning, D-72072 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Leopold, DA (corresponding author), NIMH, Unit Cognit Neurophysiol & Imaging, Neuropsychol Lab, NIH, 49 Convent Dr,Bldg 49,MSC 4400, Bethesda, MD 20892 USA.	leopoldd@mail.nih.gov	Bondar, Igor V/M-6416-2014	Bondar, Igor V/0000-0003-1307-5266; Leopold, David/0000-0002-1345-6360	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002838, ZIAMH002898, Z01MH002898, ZIAMH002838] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; GROSS CG, 1994, CEREB CORTEX, V4, P455, DOI 10.1093/cercor/4.5.455; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Kayaert G, 2005, EUR J NEUROSCI, V22, P212, DOI 10.1111/j.1460-9568.2005.04202.x; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Lee K, 2000, PSYCHOL SCI, V11, P379, DOI 10.1111/1467-9280.00274; Leopold D.A., 2005, FITTING MIND WORLD A, P189, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0008; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Lewis MB, 1998, Q J EXP PSYCHOL-A, V51, P321, DOI 10.1080/713755758; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MAURO R, 1992, MEM COGNITION, V20, P433, DOI 10.3758/BF03210927; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Persson J, 2002, NEUROREPORT, V13, P2181, DOI 10.1097/00001756-200212030-00004; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; Rhodes G., 2005, FITTING MIND WORLD A, P213, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0009; ROLLS ET, 1986, EXP BRAIN RES, V65, P38; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TOVEE MJ, 1994, J NEUROPHYSIOL, V72, P1049, DOI 10.1152/jn.1994.72.3.1049; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VALENTINE T, 1986, PERCEPTION, V15, P525, DOI 10.1068/p150525; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966	26	270	270	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					572	575		10.1038/nature04951	http://dx.doi.org/10.1038/nature04951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16862123				2022-12-01	WOS:000239455900045
J	Stafford, N				Stafford, Ned			Gas for the greenhouse	NATURE			English	News Item																			0	0	0	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					499	499		10.1038/442499a	http://dx.doi.org/10.1038/442499a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16885956	Bronze			2022-12-01	WOS:000239455900013
J	McClellan, JM; Susser, E; King, MC				McClellan, Jack M.; Susser, Ezra; King, Mary-Claire			Maternal famine, de novo mutations, and schizophrenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HUMAN GENOME; FOLIC-ACID; PRENATAL FAMINE; DISEASE; RISK; POLYMORPHISM; FOLATE		Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; Columbia University; New York State Psychiatry Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McClellan, JM (corresponding author), Univ Washington, Dept Psychiat, Box 356560, Seattle, WA 98195 USA.	drjack@u.washington.edu		King, Mary-Claire/0000-0001-9426-1743				Beetstra S, 2005, MUTAT RES-FUND MOL M, V578, P317, DOI 10.1016/j.mrfmmm.2005.05.012; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Goldstein DB, 2003, COLD SPRING HARB SYM, V68, P395, DOI 10.1101/sqb.2003.68.395; HOEK H, 1999, PRENATAL EXPOSURES S; KING MC, 2006, PSYCHIAT EPIDEMIOLOG; Lewis SJ, 2005, AM J MED GENET B, V135B, P2, DOI 10.1002/ajmg.b.30170; Lucock M, 2004, BMJ-BRIT MED J, V328, P211, DOI 10.1136/bmj.328.7433.211; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; McKay JA, 2004, BIOCHEM SOC T, V32, P1006, DOI 10.1042/BST0321006; Murray R. M., 2002, EPIDEMIOLOGY SCHIZOP; Nimgaonkar VL, 1998, ACTA PSYCHIAT SCAND, V98, P348, DOI 10.1111/j.1600-0447.1998.tb10097.x; Picker JD, 2005, HARVARD REV PSYCHIAT, V13, P197, DOI 10.1080/10673220500243372; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Smil V, 1999, BMJ-BRIT MED J, V319, P1619, DOI 10.1136/bmj.319.7225.1619; Spiegelstein O, 2004, NEUROCHEM RES, V29, P1105, DOI 10.1023/B:NERE.0000023597.37698.13; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Stein Z., 1975, FAMINE HUM DEV DUTCH; Susser E, 1998, AM J EPIDEMIOL, V147, P213; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25	25	52	52	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2006	296	5					582	584		10.1001/jama.296.5.582	http://dx.doi.org/10.1001/jama.296.5.582			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069YW	16882967				2022-12-01	WOS:000239486900025
J	Arnlov, J; Pencina, MJ; Amin, S; Nam, BH; Benjamin, EJ; Murabito, JM; Wang, TJ; Knapp, PE; D'Agostino, RB; Bhasin, S; Vasan, RS				Arnlov, Johan; Pencina, Michael J.; Amin, Shreyasee; Nam, Byung-Ho; Benjamin, Emelia J.; Murabito, Joanne M.; Wang, Thomas J.; Knapp, Philip E.; D'Agostino, Ralph B., Sr.; Bhasin, Shalendar; Vasan, Ramachandran S.			Endogenous sex hormones and cardiovascular disease incidence in men	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; ALPHA GENE VARIATION; MIDDLE-AGED MEN; DEHYDROEPIANDROSTERONE-SULFATE; MYOCARDIAL-INFARCTION; RISK-FACTORS; ELDERLY MEN; FREE TESTOSTERONE; ESTROGEN	Background: Data suggest that endogenous sex hormones (testosterone, dehydroepiandrosterone sulfate [DHEA-S], and estradiol) influence cardiovascular disease (CVD) risk factors and vascular function. Yet, prospective studies relating sex hormones to CVD incidence in men have yielded inconsistent results. Objective: To examine the association of circulating sex hormone levels and CVD risk in men. Design: Prospective cohort study. Setting: Community-based study in Framingham, Massachusetts. Participants: 2084 middle-aged white men without CVD at baseline. Measurements: The authors used multivariable Cox regression to relate baseline levels of testosterone, DHEA-S, and estradiol to the incidence of CVD (coronary, cerebrovascular, or peripheral vascular disease or heart failure) during 10 years of follow-up. Results: During follow-up, 386 men (18.5%) experienced a first CVD event. After adjustment for baseline standard CVD risk factors, higher estradiol level was associated with lower risk for CVD (hazard ratio per SD increment in log estradiol, 0.90 [95% Cl, 0.82 to 0.99]; P = 0.035). The authors observed effect modification by age: Higher estradiol levels were associated with lower CVD risk in older (median age > 56 years) men (hazard ratio per SD increment, 0.86 [Cl, 0.78 to 0.96]; P = 0.005) but not in younger (median age <= 56 years) men (hazard ratio per SD increment, 1.11 [Cl, 0.89 to 1.38]; P = 0.36). The association of higher estradiol level with lower CVD incidence remained robust in time-dependent Cox models (updating standard CVD risk factors during follow-up). Serum testosterone and DHEA-S levels were not statistically significantly associated with incident CVD. Limitations: Sex hormone levels were measured only at baseline, and the findings may not be generalizable to women and nonwhite people. Conclusions: In the community-based sample, a higher serum estradiol level was associated with lower risk for CVD events in older men. The findings are consistent with the hypothesis that endogenous estrogen has vasculoprotective influences in men.	Boston Univ, Sch Med, Framingham Heart Study, Massachusetts Gen Hosp, Framingham, MA 01702 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Mayo Clin, Coll Med, Rochester, MN USA; Uppsala Univ, Uppsala, Sweden; NHLBI, Framingham Heart Study, NIH, Bethesda, MD 20892 USA	Boston University; Framingham Heart Study; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mayo Clinic; Uppsala University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, Massachusetts Gen Hosp, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	Ramachandran, Vasan/Y-2527-2019; Ärnlöv, Johan/AAF-2746-2019; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Ärnlöv, Johan/0000-0002-6933-4637; Murabito, Joanne/0000-0002-0192-7516; Pencina, Michael/0000-0001-5798-8855; Benjamin, Emelia/0000-0003-4076-2336; Knapp, Philip/0000-0002-5290-6125	NHLBI NIH HHS [2K24 HL04334, K23 HL074077, N01-HC-25195] Funding Source: Medline; NINDS NIH HHS [6R01-NS 17950] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL074077, K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abate N, 2002, J CLIN ENDOCR METAB, V87, P4522, DOI 10.1210/jc.2002-020567; Amin S, 2000, ANN INTERN MED, V133, P951, DOI 10.7326/0003-4819-133-12-200012190-00010; Baker L, 2003, J SURG RES, V115, P325, DOI 10.1016/S0022-4804(03)00215-4; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Berr C, 1996, P NATL ACAD SCI USA, V93, P13410, DOI 10.1073/pnas.93.23.13410; CAULEY JA, 1987, AM J CARDIOL, V60, P771, DOI 10.1016/0002-9149(87)91021-6; CHANG IM, 1982, J CHRON DIS, V35, P669, DOI 10.1016/0021-9681(82)90019-4; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CONTOREGGI CS, 1990, J ANDROL, V11, P460; Cox DR., 1984, ANAL SURVIVAL DATA; Cupples LA, 1987, FRAMINGHAM STUDY EPI; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Feldman HA, 2001, AM J EPIDEMIOL, V153, P79, DOI 10.1093/aje/153.1.79; Giri S, 1998, ATHEROSCLEROSIS, V137, P359, DOI 10.1016/S0021-9150(98)00022-7; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gyllenborg J, 2001, METABOLISM, V50, P882, DOI 10.1053/meta.2001.24916; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; HAUTANEN A, 1994, ATHEROSCLEROSIS, V105, P191, DOI 10.1016/0021-9150(94)90049-3; Hougaku H, 2006, AM J PHYSIOL-ENDOC M, V290, pE234, DOI 10.1152/ajpendo.00059.2005; Jilma B, 1996, J CLIN ENDOCR METAB, V81, P2350, DOI 10.1210/jc.81.6.2350; Kajinami K, 2004, CORONARY ARTERY DIS, V15, P199; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kiechl S, 2000, ARTERIOSCL THROM VAS, V20, P1094, DOI 10.1161/01.ATV.20.4.1094; Komesaroff PA, 2001, HYPERTENSION, V38, P1011, DOI 10.1161/hy1101.095006; LACROIX AZ, 1992, CIRCULATION, V86, P1529, DOI 10.1161/01.CIR.86.5.1529; Lee TM, 2000, J MOL CELL CARDIOL, V32, P1147, DOI 10.1006/jmcc.2000.1167; Liu PY, 2005, J CLIN ENDOCR METAB, V90, P1041, DOI 10.1210/jc.2004-1211; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MITCHELL LE, 1994, CIRCULATION, V89, P89, DOI 10.1161/01.CIR.89.1.89; Muller M, 2004, CIRCULATION, V109, P2074, DOI 10.1161/01.CIR.0000125854.51637.06; Muller M, 2003, J CLIN ENDOCR METAB, V88, P5076, DOI 10.1210/jc.2003-030611; NEWCOMER LM, 1994, AM J EPIDEMIOL, V140, P870, DOI 10.1093/oxfordjournals.aje.a117175; Ohshige A, 1996, ARTERY, V22, P115; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Phillips GB, 2005, J CLIN ENDOCR METAB, V90, P2708, DOI 10.1210/jc.2004-2011; Phillips GB, 2003, METABOLISM, V52, P784, DOI 10.1016/S0026-0495(03)00072-6; PHILLIPS GB, 1988, J CLIN EPIDEMIOL, V41, P1151, DOI 10.1016/0895-4356(88)90018-2; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; Shearman AM, 2006, CIRC RES, V98, P590, DOI 10.1161/01.RES.0000210578.62102.a6; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Shono N, 1996, J Atheroscler Thromb, V3, P45; Sudhir K, 1999, J CLIN ENDOCR METAB, V84, P3411, DOI 10.1210/jc.84.10.3411; Sudhir K, 1997, CIRCULATION, V96, P3774; The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652, DOI DOI 10.1001/JAMA.1973.03230060030009; Tilvis RS, 1999, AGING CLIN EXP RES, V11, P30, DOI 10.1007/BF03399633; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Trivedi DP, 2001, J CLIN ENDOCR METAB, V86, P4171, DOI 10.1210/jc.86.9.4171; Tukey J.W, 1977, EXPLORATORY DATA ANA, P43; VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; *VET ADM COOP UR R, 1967, SURG GYNECOL OBSTET, V124, P1011; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; YARNELL JWG, 1993, ARTERIOSCLER THROMB, V13, P517, DOI 10.1161/01.ATV.13.4.517	60	168	173	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2006	145	3					176	184		10.7326/0003-4819-145-3-200608010-00005	http://dx.doi.org/10.7326/0003-4819-145-3-200608010-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070MN	16880459				2022-12-01	WOS:000239526800003
J	Kurth, T; Gaziano, JM; Cook, NR; Logroscino, G; Diener, HC; Buring, JE				Kurth, Tobias; Gaziano, J. Michael; Cook, Nancy R.; Logroscino, Giancarlo; Diener, Hans-Christoph; Buring, Julie E.			Migraine and risk of cardiovascular disease in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; VASCULAR EVENTS; STROKE; PREVALENCE; HEADACHE; ANGINA; ASSOCIATIONS; TOLERABILITY	Context Migraine with aura has been associated with an adverse cardiovascular risk profile and prothrombotic factors that, along with migraine-specific physiology, may increase the risk of vascular events. Although migraine with aura has been associated with increased risk of ischemic stroke, an association with cardiovascular disease (CVD) and, specifically, coronary events remains unclear. Objective To evaluate the association between migraine with and without aura and subsequent risk of overall and specific CVD. Design, Setting, and Participants Prospective cohort study of 27 840 US women aged 45 years or older who were participating in the Women's Health Study, were free of CVD and angina at study entry (1992-1995), and who had information on self-reported migraine and aura status, and lipid measurements. This report is based on follow-up data through March 31, 2004. Main Outcome Measures The primary outcome measure was the combined end point of major CVD (first instance of nonfatal ischemic stroke, nonfatal myocardial infarction, or death due to ischemic CVD); other measures were first ischemic stroke, myocardial infarction, coronary revascularization, angina, and death due to ischemic CVD. Results At baseline, 5125 women (18.4%) reported any history of migraine; of the 3610 with active migraine (migraine in the prior year), 1434 (39.7%) indicated aura symptoms. During a mean of 10 years of follow-up, 580 major CVD events occurred. Compared with women with no migraine history, women who reported active migraine with aura had multivariable-adjusted hazard ratios of 2.15 (95% confidence interval [CI], 1.58-2.92; P<.001) for major CVD, 1.91 (95% CI, 1.17-3.10; P=.01) for ischemic stroke, 2.08 (95% CI, 1.30-3.31; P=.002) for myocardial infarction, 1.74 (95% CI, 1.23-2.46; P=.002) for coronary revascularization, 1.71 (95% CI, 1.16-2.53; P=.007) for angina, and 2.33 (95% CI, 1.21-4.51; P=.01) for ischemic CVD death. After adjusting for age, there were 18 additional major CVD events attributable to migraine with aura per 10 000 women per year. Women who reported active migraine without aura did not have increased risk of any vascular events or angina. Conclusions In this large, prospective cohort of women, active migraine with aura was associated with increased risk of major CVD, myocardial infarction, ischemic stroke, and death due to ischemic CVD, as well as with coronary revascularization and angina. Active migraine without aura was not associated with increased risk of any CVD event.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Boston VA Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Univ Duisburg Essen, Dept Neurol, Essen, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; University of Duisburg Essen	Kurth, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	tkurth@rics.bwh.harvard.edu	Diener, Hans-Christoph/AAF-7275-2019; LOGROSCINO, GIANCARLO/K-5148-2016; Kurth, Tobias/A-9243-2012	LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Kurth, Tobias/0000-0001-7169-2620	NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Bednarczyk EM, 1998, NEUROLOGY, V50, P1736, DOI 10.1212/WNL.50.6.1736; Bensenor IM, 2001, CEPHALALGIA, V21, P175, DOI 10.1046/j.0333-1024.2001.00194.x; Cook NR, 2002, HEADACHE, V42, P715, DOI 10.1046/j.1526-4610.2002.02173.x; Dodick DW, 2004, HEADACHE, V44, pS20, DOI 10.1111/j.1526-4610.2004.04105.x; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; FERRARI MD, 1989, NEUROLOGY, V39, P1239, DOI 10.1212/WNL.39.9.1239; GALLAI V, 1994, ACTA NEUROL SCAND, V89, P47; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Hargreaves RJ, 1999, CAN J NEUROL SCI, V26, pS12, DOI 10.1017/S0317167100000147; Hering-Hanit R, 2001, CEPHALALGIA, V21, P137, DOI 10.1046/j.1468-2982.2001.00181.x; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Lafitte C, 1996, HEADACHE, V36, P332, DOI 10.1046/j.1526-4610.1996.3605332.x; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lea RA, 2005, MOL BRAIN RES, V136, P112, DOI 10.1016/j.molbrainres.2005.01.006; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Martin VT, 2005, AM J MED, V118, p36S, DOI 10.1016/j.amjmed.2005.01.018; Mitchell P, 1998, AUST NZ J MED, V28, P627, DOI 10.1111/j.1445-5994.1998.tb00659.x; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rosamond W, 2004, HEADACHE, V44, pS5, DOI 10.1111/j.1526-4610.2004.04103.x; Rose KM, 2004, NEUROLOGY, V63, P2233, DOI 10.1212/01.WNL.0000147289.50605.DC; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Soriani S, 1998, HEADACHE, V38, P779, DOI 10.1046/j.1526-4610.1998.3810779.x; Stang PE, 2005, NEUROLOGY, V64, P1573, DOI 10.1212/01.WNL.0000158326.31368.04; Sternfeld B, 1995, NEUROLOGY, V45, P2135, DOI 10.1212/WNL.45.12.2135; Tietjen GE, 2001, NEUROLOGY, V57, P334, DOI 10.1212/WNL.57.2.334; Uyarel H, 2005, ACTA CARDIOL, V60, P221, DOI 10.2143/AC.60.2.2005036; Vahedi K, 2004, ARCH NEUROL-CHICAGO, V61, P1237, DOI 10.1001/archneur.61.8.1237; Velentgas P, 2004, HEADACHE, V44, P642, DOI 10.1111/j.1526-4610.2004.04122.x; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; WATERS WE, 1983, BRIT MED J, V287, P1442, DOI 10.1136/bmj.287.6403.1442	41	398	405	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					283	291		10.1001/jama.296.3.283	http://dx.doi.org/10.1001/jama.296.3.283			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849661	Bronze			2022-12-01	WOS:000239089900020
J	Runyon, JB; Mescher, MC; De Moraes, CM				Runyon, Justin B.; Mescher, Mark C.; De Moraes, Consuelo M.			Volatile chemical cues guide host location and host selection by parasitic plants	SCIENCE			English	Article							INTERPLANT COMMUNICATION; CUSCUTA-CAMPESTRIS; INSECT HERBIVORE; TALKING TREES; SIGNALS; DAMAGE; COMMUNITIES; RESISTANCE; SAGEBRUSH; RESPONSES	The importance of plant volatiles in mediating interactions between plant species is much debated. Here, we demonstrate that the parasitic plant Cuscuta pentagona ( dodder) uses volatile cues for host location. Cuscuta pentagona seedlings exhibit directed growth toward nearby tomato plants ( Lycopersicon esculentum) and toward extracted tomato-plant volatiles presented in the absence of other cues. Impatiens ( Impatiens wallerana) and wheat plants ( Triticum aestivum) also elicit directed growth. Moreover, seedlings can distinguish tomato and wheat volatiles and preferentially grow toward the former. Several individual compounds from tomato and wheat elicit directed growth by C. pentagona, whereas one compound from wheat is repellent. These findings provide compelling evidence that volatiles mediate important ecological interactions among plant species.	Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	De Moraes, CM (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	czd10@psu.edu		Runyon, Justin B./0000-0002-0271-0511				Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bardgett RD, 2006, NATURE, V439, P969, DOI 10.1038/nature04197; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; D'Alessandro M, 2006, ANALYST, V131, P24, DOI 10.1039/b507589k; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; De Moraes CM, 2004, P NATL ACAD SCI USA, V101, P8993, DOI 10.1073/pnas.0403248101; Dicke M, 2003, TRENDS PLANT SCI, V8, P403, DOI 10.1016/S1360-1385(03)00183-3; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Esmon CA, 2005, INT J DEV BIOL, V49, P665, DOI 10.1387/ijdb.052028ce; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; KABAN R, 1997, INDUCED RESPONSES HE; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R, 2003, OIKOS, V100, P325, DOI 10.1034/j.1600-0706.2003.12075.x; KELLY CK, 1990, ECOLOGY, V71, P1916, DOI 10.2307/1937599; KELLY CK, 1992, P NATL ACAD SCI USA, V89, P12194, DOI 10.1073/pnas.89.24.12194; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Koch AM, 2004, NEW PHYTOL, V162, P147, DOI 10.1046/j.1469-8137.2004.00999.x; Metcalf RL, 1992, PLANT KAIROMONES INS; Nadler-Hassar T, 2003, WEED RES, V43, P341, DOI 10.1046/j.1365-3180.2003.00350.x; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; Pennings SC, 2002, OECOLOGIA, V131, P479, DOI 10.1007/s00442-002-0923-7; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; RHOADES DF, 1983, ACS SYM SER, V208, P55; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Yoder JI, 2001, CURR OPIN PLANT BIOL, V4, P359, DOI 10.1016/S1369-5266(00)00185-0	32	243	263	13	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1964	1967		10.1126/science.1131371	http://dx.doi.org/10.1126/science.1131371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008532				2022-12-01	WOS:000240832200052
J	Schneider, H; Downey, J; Smith, A; Zinselmeyer, BH; Rush, C; Brewer, JM; Wei, B; Hogg, N; Garside, P; Rudd, CE				Schneider, Helga; Downey, Jos; Smith, Andrew; Zinselmeyer, Bernd H.; Rush, Catherine; Brewer, James M.; Bin Wei; Hogg, Nancy; Garside, Paul; Rudd, Christopher E.			Reversal of the TCR stop signal by CTLA-4	SCIENCE			English	Article							LYMPHOCYTE-ASSOCIATED ANTIGEN-4; REGULATORY T-CELLS; IN-VIVO; DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; TOLERANCE; INDUCTION; NODES; CD28; ACTIVATION	The coreceptor cytotoxic T lymphocyte - associated antigen 4 (CTLA-4) is pivotal in regulating the threshold of signals during T cell activation, although the underlying mechanism is still not fully understood. Using in vitro migration assays and in vivo two-photon laser scanning microscopy, we showed that CTLA-4 increases T cell motility and overrides the T cell receptor (TCR)- induced stop signal required for stable conjugate formation between T cells and antigen-presenting cells. This event led to reduced contact periods between T cells and antigen-presenting cells that in turn decreased cytokine production and proliferation. These results suggest a fundamentally different model of reverse stop signaling, by which CTLA-4 modulates the threshold for T cell activation and protects against autoimmunity.	Univ Cambridge, Dept Pathol, Div Immunol, Cell Signalling Sect, Cambridge CB2 1QP, England; Univ London Imperial Coll Sci Technol & Med, Div Invest Sci, Dept Immunol, Mol Immunol Sect, London W12 0NN, England; Canc Res UK London Res Inst, London WC2A 3PX, England; Univ Glasgow, Western Infirm, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland; Univ Strathclyde, Ctr Biophoton, Glasgow G4 0NR, Lanark, Scotland	University of Cambridge; Imperial College London; Cancer Research UK; University of Glasgow; University of Strathclyde	Rudd, CE (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	cer51@cam.ac.uk	Garside, Paul/A-4227-2009; Brewer, James/A-7186-2010; Rush, Catherine M/L-4308-2013; Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021; Zinselmeyer, Bernd/X-4802-2018	Brewer, James/0000-0001-7933-0915; Rush, Catherine M/0000-0002-3044-9488; Rudd, Christopher E/0000-0001-5295-9019; Zinselmeyer, Bernd/0000-0003-4172-6767; Smith, Andrew/0000-0002-4691-5973	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fehervari Z, 2004, J CLIN INVEST, V114, P1209, DOI 10.1172/JCI200434495; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; RICHARDSON B, 1994, ARTHRITIS RHEUM, V37, P1363, DOI 10.1002/art.1780370915; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; RUDD CE, 2002, SCI STKE, pPE18; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 2002, J IMMUNOL, V169, P3475, DOI 10.4049/jimmunol.169.7.3475; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yung Raymond L., 2003, Biol Proced Online, V5, P211, DOI 10.1251/bpo64; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	34	457	477	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1972	1975		10.1126/science.1131078	http://dx.doi.org/10.1126/science.1131078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	16931720				2022-12-01	WOS:000240832200054
J	Bousquet, P; Ciais, P; Miller, JB; Dlugokencky, EJ; Hauglustaine, DA; Prigent, C; Van der Werf, GR; Peylin, P; Brunke, EG; Carouge, C; Langenfelds, RL; Lathiere, J; Papa, F; Ramonet, M; Schmidt, M; Steele, LP; Tyler, SC; White, J				Bousquet, P.; Ciais, P.; Miller, J. B.; Dlugokencky, E. J.; Hauglustaine, D. A.; Prigent, C.; Van der Werf, G. R.; Peylin, P.; Brunke, E. -G.; Carouge, C.; Langenfelds, R. L.; Lathiere, J.; Papa, F.; Ramonet, M.; Schmidt, M.; Steele, L. P.; Tyler, S. C.; White, J.			Contribution of anthropogenic and natural sources to atmospheric methane variability	NATURE			English	Article							INTERANNUAL GROWTH-RATE; ISOTOPIC COMPOSITION; CH4; EMISSIONS; TRANSPORT; AIR; CO2; INVERSION; PINATUBO; PERIOD	Methane is an important greenhouse gas, and its atmospheric concentration has nearly tripled since pre-industrial times(1). The growth rate of atmospheric methane is determined by the balance between surface emissions and photochemical destruction by the hydroxyl radical, the major atmospheric oxidant. Remarkably, this growth rate has decreased(2) markedly since the early 1990s, and the level of methane has remained relatively constant since 1999, leading to a downward revision of its projected influence on global temperatures. Large fluctuations in the growth rate of atmospheric methane are also observed from one year to the next(2), but their causes remain uncertain(2-13). Here we quantify the processes that controlled variations in methane emissions between 1984 and 2003 using an inversion model of atmospheric transport and chemistry. Our results indicate that wetland emissions dominated the inter-annual variability of methane sources, whereas fire emissions played a smaller role, except during the 1997 - 1998 El Nino event. These top-down estimates of changes in wetland and fire emissions are in good agreement with independent estimates based on remote sensing information and biogeochemical models. On longer timescales, our results show that the decrease in atmospheric methane growth during the 1990s was caused by a decline in anthropogenic emissions. Since 1999, however, they indicate that anthropogenic emissions of methane have risen again. The effect of this increase on the growth rate of atmospheric methane has been masked by a coincident decrease in wetland emissions, but atmospheric methane levels may increase in the near future if wetland emissions return to their mean 1990s levels.	UVSQ, CNRS, CEA, IPSL,LSCE, F-91191 Gif Sur Yvette, France; Univ Versailles, F-78035 Versailles, France; NOAA, Earth Syst Res Lab, Global Monitoring Div, Boulder, CO 80305 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Observ Paris, LERMA, F-75014 Paris, France; Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; LBI, F-78026 Versailles, France; S African Weather Serv, ZA-7599 Stellenbosch, South Africa; CSIRO, Mordialloc, Vic 3195, Australia; Columbia Univ, NASA, GISS, New York, NY 10025 USA; Univ Calif Irvine, Earth Syst Sci Dept, Irvine, CA 92697 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Vrije Universiteit Amsterdam; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Columbia University; National Aeronautics & Space Administration (NASA); University of California System; University of California Irvine; University of Colorado System; University of Colorado Boulder	Bousquet, P (corresponding author), UVSQ, CNRS, CEA, IPSL,LSCE, F-91191 Gif Sur Yvette, France.	philippe.bousquet@cea.fr	Prigent, Catherine/ABF-7175-2020; Schmidt, Martina/Q-6627-2017; Steele, Paul/B-3185-2009; Ciais, Philippe M/A-6840-2011; Langenfelds, Raymond L/B-5381-2012; Hauglustaine, Didier/A-4154-2012; Miller, John B./AAE-7714-2019; Papa, Fabrice/D-3695-2009; Carouge, Claire/A-4755-2012; Dlugokencky, Edward/AAN-8746-2020; White, James W.C./A-7845-2009; van der Werf, Guido/M-8260-2016; LATHIERE, Juliette/GPG-3400-2022	Schmidt, Martina/0000-0002-4648-769X; Steele, Paul/0000-0002-8234-3730; Ciais, Philippe M/0000-0001-8560-4943; Langenfelds, Raymond L/0000-0003-4890-2049; Hauglustaine, Didier/0000-0002-4826-5118; Miller, John B./0000-0001-8630-1610; Papa, Fabrice/0000-0001-6305-6253; Carouge, Claire/0000-0002-0313-8385; Dlugokencky, Edward/0000-0003-0612-6985; White, James W.C./0000-0001-6041-4684; van der Werf, Guido/0000-0001-9042-8630; Peylin, Philippe/0000-0001-9335-6994; Bousquet, Philippe/0000-0002-4444-2703				Bergamaschi P, 2005, ATMOS CHEM PHYS, V5, P2431, DOI 10.5194/acp-5-2431-2005; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Bousquet P, 2005, ATMOS CHEM PHYS, V5, P2635, DOI 10.5194/acp-5-2635-2005; Butler TM, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006071; Chen YH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006058; Dentener F, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002916; DLUGOKENCKY EJ, 1994, GEOPHYS RES LETT, V21, P507, DOI 10.1029/94GL00606; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Dlugokencky EJ, 1996, GEOPHYS RES LETT, V23, P2761, DOI 10.1029/96GL02638; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; *GLOBALVIEW CH4, 2005, COOP ATM DAT INT PRO; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Hansen J, 1996, GEOPHYS RES LETT, V23, P1665, DOI 10.1029/96GL01040; Hauglustaine DA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003957; Hein R, 1997, GLOBAL BIOGEOCHEM CY, V11, P43, DOI 10.1029/96GB03043; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Houghton J. T., 2001, CLIMATE CHANGE 2001; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Langenfelds RL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001466; Manning MR, 2005, NATURE, V436, P1001, DOI 10.1038/nature03900; Miller JB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000630; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Prigent C, 2001, GEOPHYS RES LETT, V28, P4631, DOI 10.1029/2001GL013263; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Simmonds PG, 2005, ATMOS ENVIRON, V39, P2513, DOI 10.1016/j.atmosenv.2005.02.018; Tyler SC, 1999, J GEOPHYS RES-ATMOS, V104, P13895, DOI 10.1029/1999JD900029; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180; Warwick NJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015282	33	641	682	14	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					439	443		10.1038/nature05132	http://dx.doi.org/10.1038/nature05132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006511				2022-12-01	WOS:000240798800042
J	Rodriguez, B; Sethi, AK; Cheruvu, VK; Mackay, W; Bosch, RJ; Kitahata, M; Boswell, SL; Mathews, WC; Bangsberg, DR; Martin, J; Whalen, CC; Sieg, S; Yadavalli, S; Deeks, SG; Lederman, MM				Rodriguez, Benigno; Sethi, Ajay K.; Cheruvu, Vinay K.; Mackay, Wilma; Bosch, Ronald J.; Kitahata, Mari; Boswell, Stephen L.; Mathews, W. Christopher; Bangsberg, David R.; Martin, Jeffrey; Whalen, Christopher C.; Sieg, Scott; Yadavalli, Suhrida; Deeks, Steven G.; Lederman, Michael M.			Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; TYPE-1 RNA; VIRAL LOAD; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; PROGNOSTIC VALUE; CONTROLLED-TRIAL; SAN-FRANCISCO; TENOFOVIR DF	Context Plasma human immunodeficiency virus (HIV) RNA level predicts HIV disease progression, but the extent to which it explains the variability in rate of CD4 cell depletion is poorly characterized. Objective To estimate the proportion of variability in rate of CD4 cell loss predicted by presenting plasma HIV RNA levels in untreated HIV-infected persons. Design Repeated-measures analyses of 2 multicenter cohorts, comprising observations beginning on May 12, 1984, and ending on August 26, 2004. Analyses were conducted between August 2004 and March 2006. Setting Two cohorts of HIV-infected persons: patients followed up at 4 US teaching medical institutions or participating in either the Research in Access to Care for the Homeless Cohort (REACH) or the San Francisco Men's Health Study (SFMHS) cohorts and participants in the Multicenter AIDS Cohort Study (MACS) cohort. Participants Antiretroviral treatment-naive, chronically HIV-infected persons (n = 1289 and n = 1512 for each of the 2 cohorts) untreated during the observation period (>= 6 months) and with at least 1 HIV RNA level and 2 CD4 cell counts available. Approximately 35% were nonwhite, and 35% had risk factors other than male-to-male sexual contact. Main Outcome Measures The extent to which presenting plasma HIV RNA level could explain the rate of model-derived yearly CD4 cell loss, as estimated by the coefficient of determination (R-2). Results In both cohorts, higher presenting HIV RNA levels were associated with greater subsequent CD4 cell decline. In the study cohort, median model-estimated CD4 cell decrease among participants with HIV RNA levels of 500 or less, 501 to 2000, 2001 to 10 000, 10 001 to 40 000, and more than 40 000 copies/mL were 20, 39, 48, 56, and 78 cells/mu L, respectively. Despite this trend across broad categories of HIV RNA levels, only a small proportion of CD4 cell loss variability (4%-6%) could be explained by presenting plasma HIV RNA level. Analyses using multiple HIV RNA measurements or restricting to participants with high HIV RNA levels improved this correlation minimally (R-2, 0.09), and measurement error was estimated to attenuate these associations only marginally (deattenuated R-2 in the 2 cohorts, 0.05 and 0.08, respectively). Conclusions Presenting HIV RNA level predicts the rate of CD4 cell decline only minimally in untreated persons. Other factors, as yet undefined, likely drive CD4 cell losses in HIV infection. These findings have implications for treatment decisions in HIV infection and for understanding the pathogenesis of progressive immune deficiency.	Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Modern Epidemiol Infect Dis, Cleveland, OH 44106 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Univ Washington, Dept Med, Seattle, WA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; Univ Calif San Francisco, Dept Med & Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Case Western Reserve University; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rodriguez, B (corresponding author), 2061 Cornell Rd,Off 401B, Cleveland, OH 44106 USA.	rodriguez.benigno@clevelandactu.org	Sieg, Scott/AAV-2429-2021; Mathews, William C/E-4451-2010; Rodriguez, Benigno/C-3365-2009	Mathews, William C/0000-0002-2352-0725; Rodriguez, Benigno/0000-0001-9736-7957	FOGARTY INTERNATIONAL CENTER [D43TW000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI051219, P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000011] Funding Source: Medline; NIAID NIH HHS [AI36219, P30 AI027757, R01 AI051219] Funding Source: Medline; NIMH NIH HHS [MH54907, R01 MH054907] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Arduino JM, 2001, AIDS RES HUM RETROV, V17, P1099, DOI 10.1089/088922201316912709; *BHIVA EX COMM, 2005, BRIT HIV ASS BHIVA G, P28; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; Brambilla D, 1999, AIDS, V13, P2269, DOI 10.1097/00002030-199911120-00009; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; *DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1, P4; *DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Erice A, 2000, J CLIN MICROBIOL, V38, P2837, DOI 10.1128/JCM.38.8.2837-2845.2000; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fuller WayneA., 2009, MEASUREMENT ERROR MO, V305; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gange SJ, 2001, AIDS RES HUM RETROV, V17, P1223, DOI 10.1089/088922201750461276; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; MCCLURE HM, 1989, VET IMMUNOL IMMUNOP, V21, P13, DOI 10.1016/0165-2427(89)90126-8; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Muchinsky PM, 1996, EDUC PSYCHOL MEAS, V56, P63, DOI 10.1177/0013164496056001004; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Rey-Cuille MA, 1998, J VIROL, V72, P3872; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Selliah N, 2003, IMMUNOL RES, V27, P247, DOI 10.1385/IR:27:2-3:247; Sieg SF, 2005, J INFECT DIS, V192, P62, DOI 10.1086/430620; VENET A, 1991, AIDS, V5, P283, DOI 10.1097/00002030-199103000-00006; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321	48	219	230	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1498	1506		10.1001/jama.296.12.1498	http://dx.doi.org/10.1001/jama.296.12.1498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003398	Bronze			2022-12-01	WOS:000240770000026
J	Stainton, M				Stainton, Mary			Raising a woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												stainton@uic.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1445	1446		10.1001/jama.296.12.1445	http://dx.doi.org/10.1001/jama.296.12.1445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003384				2022-12-01	WOS:000240770000001
J	Li, L; Ye, KQ				Li, Ling; Ye, Keqiong			Crystal structure of an H/ACA box ribonucleoprotein particle	NATURE			English	Article							SMALL NUCLEOLAR RNAS; RIBOSOMAL-RNA; PSEUDOURIDINE SYNTHASE; DYSKERATOSIS-CONGENITA; SNORNAS; COMPLEX; PROTEIN; TELOMERASE; NHP2P; CBF5P	H/ACA ribonucleoprotein particles (RNPs) are a family of RNA pseudouridine synthases that specify modification sites through guide RNAs. They also participate in eukaryotic ribosomal RNA processing and are a component of vertebrate telomerases. Here we report the crystal structure, at 2.3 angstrom resolution, of an entire archaeal H/ACA RNP consisting of proteins Cbf5, Nop10, Gar1 and L7ae, and a single-hairpin H/ACA RNA, revealing a modular organization of the complex. The RNA upper stem is bound to a composite surface formed by L7ae, Nop10 and Cbf5, and the RNA lower stem and ACA signature motif are bound to the PUA domain of Cbf5, thereby positioning middle guide sequences so that they are primed to pair with substrate RNA. Furthermore, Gar1 may regulate substrate loading and release. The structure rationalizes the consensus structure of H/ACA RNAs, suggests a functional role of each protein, and provides a framework for understanding the mechanism of RNA-guided pseudouridylation, as well as various cellular functions of H/ACA RNP.	Natl Inst Biol Sci, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing	Ye, KQ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn						Atzorn V, 2004, MOL CELL BIOL, V24, P1769, DOI 10.1128/MCB.24.4.1769-1778.2004; Baker DL, 2005, GENE DEV, V19, P1238, DOI 10.1101/gad.1309605; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; Charpentier B, 2005, NUCLEIC ACIDS RES, V33, P3133, DOI 10.1093/nar/gki630; DeLano WL., 2002, PYMOL USERS MANUAL D; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Ganot P, 1997, GENE DEV, V11, P941, DOI 10.1101/gad.11.7.941; GIRARD JP, 1994, J BIOL CHEM, V269, P18499; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; Hamma T, 2005, NAT STRUCT MOL BIOL, V12, P1101, DOI 10.1038/nsmb1036; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Henras AK, 2004, RNA, V10, P1704, DOI 10.1261/rna.7770604; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Liang XH, 2005, RNA, V11, P619, DOI 10.1261/rna.7174805; Manival X, 2006, NUCLEIC ACIDS RES, V34, P826, DOI 10.1093/nar/gkj482; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; MORRISSEY JP, 1993, MOL CELL BIOL, V13, P2469, DOI 10.1128/MCB.13.4.2469; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Russell AG, 2004, RNA, V10, P1034, DOI 10.1261/rna.7300804; Torchet C, 2005, RNA, V11, P928, DOI 10.1261/rna.2100905; Wang C, 2004, EMBO J, V23, P1857, DOI 10.1038/sj.emboj.7600181; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761	34	164	171	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					302	307		10.1038/nature05151	http://dx.doi.org/10.1038/nature05151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16943774				2022-12-01	WOS:000240622000038
J	Christophorou, MA; Ringshausen, I; Finch, AJ; Swigart, LB; Evan, GI				Christophorou, M. A.; Ringshausen, I.; Finch, A. J.; Swigart, L. Brown; Evan, G. I.			The pathological response to DNA damage does not contribute to p53-mediated tumour suppression	NATURE			English	Article							CELL-CYCLE ARREST; IN-VIVO; P53; APOPTOSIS; MICE; P19(ARF); TUMORIGENESIS; P16(INK4A); ACTIVATION; TARGET	The p53 protein has a highly evolutionarily conserved role in metazoans as 'guardian of the genome', mediating cell-cycle arrest and apoptosis in response to genotoxic injury(1). In large, long-lived animals with substantial somatic regenerative capacity, such as vertebrates, p53 is an important tumour suppressor - an attribute thought to stem directly from its induction of death or arrest in mutant cells with damaged or unstable genomes. Chemotherapy and radiation exposure both induce widespread p53-dependent DNA damage. This triggers potentially lethal pathologies(2) that are generally deemed an unfortunate but unavoidable consequence of the role p53 has in tumour suppression. Here we show, using a mouse model in which p53 status can be reversibly switched in vivo between functional and inactive states(3), that the p53-mediated pathological response to whole-body irradiation, a prototypical genotoxic carcinogen, is irrelevant for suppression of radiation-induced lymphoma. In contrast, delaying the restoration of p53 function until the acute radiation response has subsided abrogates all of the radiation-induced pathology yet preserves much of the protection from lymphoma. Such protection is absolutely dependent on p19(ARF) - a tumour suppressor induced not by DNA damage, but by oncogenic disruption of the cell cycle.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Evan, GI (corresponding author), Univ Calif San Francisco, Canc Res Inst, Box 0128, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu	Ringshausen, Ingo/AAW-8762-2020	Christophorou, Maria/0000-0001-5455-7283; Ringshausen, Ingo/0000-0002-7247-311X; Finch, Andrew/0000-0002-8065-4623				Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Komarova EA, 1998, SEMIN CANCER BIOL, V8, P389, DOI 10.1006/scbi.1998.0101; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; LANE DP, 1992, NATURE, V358, P16; Liao MJ, 1999, MOL CELL BIOL, V19, P3095; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MAO L, 1995, CANCER RES, V55, P2995; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; QUELLE DE, 1995, CELL, V83, P993; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Soengas MS, 2000, NAT GENET, V26, P391, DOI 10.1038/82497; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	29	324	329	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					214	217		10.1038/nature05077	http://dx.doi.org/10.1038/nature05077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16957739				2022-12-01	WOS:000240467000047
J	Hobbs, JB; Peterson, DR; Moss, AJ; McNitt, S; Zareba, W; Goldenberg, I; Qi, M; Robinson, JL; Sauer, AJ; Ackerman, MJ; Benhorin, J; Kaufman, ES; Locati, EH; Napolitano, C; Priori, SG; Towbin, JA; Vincent, GM; Zhang, L				Hobbs, Jenny B.; Peterson, Derick R.; Moss, Arthur J.; McNitt, Scott; Zareba, Wojciech; Goldenberg, Ilan; Qi, Ming; Robinson, Jennifer L.; Sauer, Andrew J.; Ackerman, Michael J.; Benhorin, Jesaia; Kaufman, Elizabeth S.; Locati, Emanuela H.; Napolitano, Carlo; Priori, Silvia G.; Towbin, Jeffrey A.; Vincent, G. Michael; Zhang, Li			Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-COURSE; SEX-DIFFERENCES; INTERVAL; GENDER; AGE; EXPRESSION; FAMILIES; CYCLE	Context Analysis of predictors of cardiac events in hereditary long-QT syndrome (LQTS) has primarily considered syncope as the predominant end point. Risk factors specific for aborted cardiac arrest and sudden cardiac death have not been investigated. Objective To identify risk factors associated with aborted cardiac arrest and sudden cardiac death during adolescence in patients with clinically suspected LQTS. Design, Setting, and Participants The study involved 2772 participants from the International Long QT Syndrome Registry who were alive at age 10 years and were followed up during adolescence until age 20 years. The registry enrollment began in 1979 at 5 cardiology centers in the United States and Europe. Main Outcome Measures Aborted cardiac arrest or LQTS-related sudden cardiac death; follow-up ended on February 15, 2005. Results There were 81 patients who experienced aborted cardiac arrest and 45 who had sudden cardiac death; 9 of the 81 patients who had an aborted cardiac arrest event experienced subsequent sudden cardiac death. Significant independent predictors of aborted cardiac arrest or sudden cardiac death during adolescence included recent syncope, QTc interval, and sex. Compared with those with no syncopal events in the last 10 years, patients with 1 or 2 or more episodes of syncope 2 to 10 years ago (but none in the last 2 years) had an adjusted hazard ratio (HR) of 2.7; (95% confidence interval [CI], 1.3-5.7; P < .01) and an adjusted HR of 5.8 (95% CI, 3.6-9.4; P < .001), respectively, for life-threatening events; those with 1 syncopal episodes in the last 2 years had an adjusted HR of 11.7 (95% CI, 7.0-19.5; P < .001) and those with 2 or more syncopal episodes in the last 2 years had an adjusted HR of 18.1 (95% CI, 10.4-31.2; P < .001). Irrespective of events occurring more than 2 years ago, QTc of 530 ms or longer was associated with increased risk (adjusted HR, 2.3; 95% CI, 1.6-3.3; P < .001) compared with those having a shorter QTc. Males between the ages of 10 and 12 years had higher risk than females (HR, 4.0; 95% CI, 1.8-9.2; P = .001), but there was no significant risk difference between males and females between the ages of 13 and 20 years. Among individuals with syncope in the past 2 years, beta-blocker therapy was associated with a 64% reduced risk (HR, 0.36; 95% CI, 0.18-0.72; P < .01). Conclusions In LQTS, the timing and frequency of syncope, QTc prolongation, and sex were predictive of risk for aborted cardiac arrest and sudden cardiac death during adolescence. Among patients with recent syncope, beta-blocker treatment was associated with reduced risk.	Univ Rochester, Med Ctr, HeartRes Followup Program, Dept Med,Cardiol Unit, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; Mayo Clin Coll Med, Dept Med, Rochester, MN USA; Mayo Clin Coll Med, Dept Pediat, Rochester, MN USA; Mayo Clin Coll Med, Dept Mol Pharmacol, Rochester, MN USA; Bikur Cholim Hosp, Dept Cardiol, Jerusalem, Israel; Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA; Osped Niguarda Ca Granda, Cardiovasc Dept De Gasperis, Milan, Italy; Univ Pavia, Fdn S Maugeri, I-27100 Pavia, Italy; Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA	University of Rochester; University of Rochester; University of Rochester; Mayo Clinic; Mayo Clinic; Mayo Clinic; Case Western Reserve University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Baylor College of Medicine; Utah System of Higher Education; University of Utah	Moss, AJ (corresponding author), Univ Rochester, Med Ctr, HeartRes Followup Program, Dept Med,Cardiol Unit, 601 Elmwood Ave,Box 653, Rochester, NY 14642 USA.	heartajm@heart.rochester.edu	Towbin, Jeffrey A./J-5595-2019; napolitano, carlo/ABI-4608-2020; Sauer, Andrew/AAB-5953-2021; Peterson, Derick/W-5240-2019; Locati, Emanuela Teresina/AAW-3821-2020; Sauer, Andrew J./K-6612-2019; Priori, Silvia G/ABH-6894-2020; Priori, Silvia G G/A-6116-2014; Napolitano, Carlo/K-4760-2016	Towbin, Jeffrey A./0000-0002-6585-714X; napolitano, carlo/0000-0002-7643-4628; Peterson, Derick/0000-0001-8603-660X; Locati, Emanuela Teresina/0000-0002-4488-0455; Priori, Silvia G/0000-0001-6877-0288; Priori, Silvia G G/0000-0001-6877-0288; Napolitano, Carlo/0000-0002-7643-4628; Sauer, Andrew/0000-0002-9268-2795	NHLBI NIH HHS [HL-33843, HL-51618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033843, R01HL051618] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benhorin J, 2002, ANN NONINVAS ELECTRO, V7, P40; Bidoggia H, 2000, AM HEART J, V140, P678, DOI 10.1067/mhj.2000.109918; BOYLE MB, 1987, NATURE, V330, P373, DOI 10.1038/330373a0; Drici MD, 1996, CIRCULATION, V94, P1471, DOI 10.1161/01.CIR.94.6.1471; Kimbrough J, 2001, CIRCULATION, V104, P557, DOI 10.1161/hc3001.093501; Lehmann MH, 1997, J AM COLL CARDIOL, V29, P93, DOI 10.1016/S0735-1097(96)00454-8; Liu XK, 1998, J PHARMACOL EXP THER, V285, P672; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; MERRI M, 1989, CIRCULATION, V80, P1301, DOI 10.1161/01.CIR.80.5.1301; Moss AJ, 1999, DRUG SAFETY, V21, P5, DOI 10.2165/00002018-199921001-00002; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Priori SG, 2004, JAMA-J AM MED ASSOC, V292, P1341, DOI 10.1001/jama.292.11.1341; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Schwartz PJ, 2006, CIRCULATION, V113, P783, DOI 10.1161/CIRCULATIONAHA.105.592899; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; Schwartz PJ, 1997, CURR PROB CARDIOLOGY, V22, P302, DOI 10.1016/S0146-2806(97)80009-6; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; Zareba W, 2003, J AM COLL CARDIOL, V42, P103, DOI 10.1016/S0735-1097(03)00554-0; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404; Zareba W, 2003, J CARDIOVASC ELECTR, V14, P337, DOI 10.1046/j.1540-8167.2003.02545.x	23	198	199	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1249	1254		10.1001/jama.296.10.1249	http://dx.doi.org/10.1001/jama.296.10.1249			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968849	Bronze			2022-12-01	WOS:000240437500027
J	Raymond, SN; Mandell, AM; Sigurdsson, S				Raymond, Sean N.; Mandell, Avi M.; Sigurdsson, Steinn			Exotic Earths: Forming habitable worlds with giant planet migration	SCIENCE			English	Article							TERRESTRIAL PLANETS; ORBITAL MIGRATION; MASS; ACCRETION; GROWTH; PROTOPLANETS; EVOLUTION; SYSTEMS	Close-in giant planets (e.g., "hot Jupiters'') are thought to form far from their host stars and migrate inward, through the terrestrial planet zone, via torques with a massive gaseous disk. Here we simulate terrestrial planet growth during and after giant planet migration. Several-Earth-mass planets also form interior to the migrating jovian planet, analogous to recently discovered "hot Earths.'' Very-water-rich, Earth-mass planets form from surviving material outside the giant planet's orbit, often in the habitable zone and with low orbital eccentricities. More than a third of the known systems of giant planets may harbor Earth-like planets.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Raymond, SN (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.	raymond@lasp.colorado.edu; mandell@astro.psu.edu	Mandell, Avi M/F-9361-2012	Mandell, Avi M/0000-0002-8119-3355; Sigurdsson, Steinn/0000-0002-8187-1144; Raymond, Sean/0000-0001-8974-0758				Armitage PJ, 2003, ASTROPHYS J, V582, pL47, DOI 10.1086/346198; Bodenheimer P, 2000, ICARUS, V143, P2, DOI 10.1006/icar.1999.6246; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; Butler RP, 2006, ASTROPHYS J, V646, P505, DOI 10.1086/504701; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; CLAIRE M, IN PRESS GEOBIOLOGY; D'Angelo G, 2003, ASTROPHYS J, V586, P540, DOI 10.1086/367555; Edgar R, 2004, MON NOT R ASTRON SOC, V354, P769, DOI 10.1111/j.1365-2966.2004.08238.x; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fogg MJ, 2005, ASTRON ASTROPHYS, V441, P791, DOI 10.1051/0004-6361:20053453; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hillenbrand LA, 2004, ASTROPHYS J, V604, P741, DOI 10.1086/382021; KASTING JF, 1993, ICARUS, V101, P108, DOI 10.1006/icar.1993.1010; Kim JS, 2005, ASTROPHYS J, V632, P659, DOI 10.1086/432863; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Lecuyer C, 1998, CHEM GEOL, V145, P249, DOI 10.1016/S0009-2541(97)00146-0; LIN DNC, 1986, ASTROPHYS J, V309, P846, DOI 10.1086/164653; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lodders K., 1998, PLANETARY SCI COMPAN; Mandell AM, 2003, ASTROPHYS J, V599, pL111, DOI 10.1086/381245; McArthur BE, 2004, ASTROPHYS J, V614, pL81, DOI 10.1086/425561; QUINN TR, 1991, ASTRON J, V101, P2287, DOI 10.1086/115850; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Raymond SN, 2006, ASTROPHYS J, V643, pL131, DOI 10.1086/505596; Raymond SN, 2005, ICARUS, V177, P256, DOI 10.1016/j.icarus.2005.03.008; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Rivera EJ, 2005, ASTROPHYS J, V634, P625, DOI 10.1086/491669; SCHNEIDER J, EXTRASOLAR PLANETS E; Silverstone MD, 2006, ASTROPHYS J, V639, P1138, DOI 10.1086/499418; Tabachnik S, 2002, MON NOT R ASTRON SOC, V335, P151, DOI 10.1046/j.1365-8711.2002.05610.x; Tanaka H, 1999, ICARUS, V139, P350, DOI 10.1006/icar.1999.6107; Thommes EW, 2003, ICARUS, V161, P431, DOI 10.1016/S0019-1035(02)00043-X; WETHERILL GW, 1989, ICARUS, V77, P330, DOI 10.1016/0019-1035(89)90093-6; Williams DM, 1997, NATURE, V385, P234, DOI 10.1038/385234a0; Zhou JL, 2005, ASTROPHYS J, V631, pL85, DOI 10.1086/497094	35	148	151	4	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1413	1416		10.1126/science.1130461	http://dx.doi.org/10.1126/science.1130461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960000	Green Submitted			2022-12-01	WOS:000240348700035
J	Keightley, PD; Otto, SP				Keightley, Peter D.; Otto, Sarah P.			Interference among deleterious mutations favours sex and recombination in finite populations	NATURE			English	Article							EVOLUTIONARY ADVANTAGE; SELECTION; LINKAGE; MODEL	Sex and recombination are widespread, but explaining these phenomena has been one of the most difficult problems in evolutionary biology. Recombination is advantageous when different individuals in a population carry different advantageous alleles(1,2). By bringing together advantageous alleles onto the same chromosome, recombination speeds up the process of adaptation(1,3-5) and opposes the fixation of harmful mutations by means of Muller's ratchet(4,5). Nevertheless, adaptive substitutions favour sex and recombination only if the rate of adaptive mutation is high(1,6), and Muller's ratchet operates only in small or asexual populations(7). Here, by tracking the fate of modifier alleles that alter the frequency of sex and recombination, we show that background selection against deleterious mutant alleles provides a stochastic advantage to sex and recombination that increases with population size. The advantage arises because, with low levels of recombination, selection at other loci severely reduces the effective population size and genetic variance in fitness at a focal locus(8) (the Hill-Robertson effect), making a population less able to respond to selection and to rid itself of deleterious mutations. Sex and recombination reveal the hidden genetic variance in fitness by combining chromosomes of intermediate fitness to create chromosomes that are relatively free of (or are loaded with) deleterious mutations. This increase in genetic variance within finite populations improves the response to selection and generates a substantial advantage to sex and recombination that is fairly insensitive to the form of epistatic interactions between deleterious alleles. The mechanism supported by our results offers a robust and broadly applicable explanation for the evolutionary advantage of recombination and can explain the spread of costly sex.	Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of Edinburgh; University of British Columbia	Keightley, PD (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	keightley.nature2006@spambob.net	Otto, Sarah Perin/K-5625-2012	Otto, Sarah Perin/0000-0003-3042-0818				BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Barton NH, 2005, GENETICS, V169, P2353, DOI 10.1534/genetics.104.032821; Bell G., 1982, MASTERPIECE NATURE E; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Burger R, 1999, GENETICS, V153, P1055; CABALLERO A, 1994, GENETICS, V138, P883; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; FELSENSTEIN J, 1965, GENETICS, V52, P349; FELSENSTEIN J, 1974, GENETICS, V78, P737; FELSENSTEIN J, 1976, GENETICS, V83, P845; Fisher R.A., 1930, GENETICAL THEORY NAT; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Iles MM, 2003, GENETICS, V165, P2249; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; Lynch M, 1995, EVOLUTION, V49, P1067, DOI 10.1111/j.1558-5646.1995.tb04434.x; Martin G, 2006, GENETICS, V172, P593, DOI 10.1534/genetics.104.039982; Morgan T.H., 1913, HEREDITY SEX; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Palsson S, 2002, J HERED, V93, P22, DOI 10.1093/jhered/93.1.22; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Santiago E, 1998, GENETICS, V149, P2105	30	261	263	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					89	92		10.1038/nature05049	http://dx.doi.org/10.1038/nature05049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957730				2022-12-01	WOS:000240313900045
J	Laslo, P; Spooner, CJ; Warmflash, A; Lancki, DW; Lee, HJ; Sciammas, R; Gantner, BN; Dinner, AR; Singh, H				Laslo, Peter; Spooner, Chauncey J.; Warmflash, Aryeh; Lancki, David W.; Lee, Hyun-Jun; Sciammas, Roger; Gantner, Benjamin N.; Dinner, Aaron R.; Singh, Harinder			Multilineage transcriptional priming and determination of alternate hematopoietic cell fates	CELL			English	Article							COLONY-STIMULATING FACTOR; FACTOR-RECEPTOR PROMOTER; STEM-CELLS; REGULATORY NETWORKS; LINEAGE COMMITMENT; ESCHERICHIA-COLI; PU.1; DIFFERENTIATION; MACROPHAGE; GFI-1	Hematopoietic stem cells and their progenitors exhibit multilineage patterns of gene expression. Molecular mechanisms underlying the generation and refinement of these patterns during cell fate determination remain unexplored because of the absence of suitable experimental systems. Using PU.1(-/-) progenitors, we demonstrate that at subthreshold levels, this Ets transcription factor regulates a mixed pattern (macrophage/neutrophil) of gene expression within individual myeloid progenitors. Increased PU.1 levels refine the pattern and promote macrophage differentiation by modulating a novel regulatory circuit comprised of counter antagonistic repressors, Egr-1,2/Nab2 and Gfi-1. Egr-1 and Egr-2 function redundantly to activate macrophage genes and to repress the neutrophil program. These results are used to assemble and mathematically model a gene regulatory network that exhibits both graded and bistable behaviors and accounts for the onset and resolution of mixed lineage patterns during cell fate determination.	Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Dinner, AR (corresponding author), Univ Chicago, Howard Hughes Med Inst, 929 E 57th St,GCIS W522, Chicago, IL 60637 USA.	dinner@uchicago.edu; hsingh@uchicago.edu	Warmflash, Aryeh/Y-6763-2019	Warmflash, Aryeh/0000-0002-5679-2268	NIAID NIH HHS [T32 AI07090] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Duan Zhijun, 2003, Hematology, V8, P339, DOI 10.1080/10245330310001612116; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Grose R, 2002, DEV DYNAM, V223, P371, DOI 10.1002/dvdy.10064; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Svaren J, 1996, MOL CELL BIOL, V16, P3545; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	47	476	487	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 25	2006	126	4					755	766		10.1016/j.cell.2006.06.052	http://dx.doi.org/10.1016/j.cell.2006.06.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923394	Bronze			2022-12-01	WOS:000240276700023
J	Oyadomari, S; Yun, C; Fisher, EA; Kreglinger, N; Kreibich, G; Oyadomari, M; Harding, HP; Goodman, AG; Harant, H; Garrison, JL; Taunton, J; Katze, MG; Ron, D				Oyadomari, Seiichi; Yun, Chi; Fisher, Edward A.; Kreglinger, Nicola; Kreibich, Gert; Oyadomari, Miho; Harding, Heather P.; Goodman, Alan G.; Harant, Hanna; Garrison, Jennifer L.; Taunton, Jack; Katze, Michael G.; Ron, David			Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload	CELL			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; SECRETORY PROTEINS; CELLULAR INHIBITOR; QUALITY-CONTROL; APOPROTEIN-B; TRANSLOCATION; CHAPERONE; KINASE; PATHWAY; BIP	The ER's capacity to process proteins is limited, and stress caused by accumulation of unfolded and misfolded proteins (ER stress) contributes to human disease. ER stress elicits the unfolded protein response (UPR), whose components attenuate protein synthesis, increase folding capacity, and enhance misfolded protein degradation. Here, we report that P58(IPK)/DNAJC3, a UPIR-responsive gene previously implicated in translational control, encodes a cytosolic cochaperone that associates with the ER protein translocation channel Sec61. P58(IPK) recruits HSP70 chaperones to the cytosolic face of Sec61 and can be crosslinked to proteins entering the ER that are delayed at the translocon. Proteasonne-mediated cytosolic degradation of translocating proteins delayed at Sec61 is cochaperone dependent. In P58(IPK-/-) mice, cells with a high secretory burden are markedly compromised in their ability to cope with ER stress. Thus, P58(IPK) is a key mediator of cotranslocational ER protein degradation, and this process likely contributes to ER homeostasis in stressed cells.	NYU, Sch Med, Skiball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; Novartis Inst BioMed Res, A-1235 Vienna, Austria; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA	New York University; New York University; New York University; New York University; University of Washington; University of Washington Seattle; Novartis; University of California System; University of California San Francisco	Ron, D (corresponding author), NYU, Sch Med, Skiball Inst Biomol Med, New York, NY 10016 USA.	ron@saturn.med.nyu.edu	Fisher, Edward/ABE-7469-2020; Goodman, Alan/AAQ-1108-2020; Oyadomari, Seiichi/GZA-7157-2022; Oyadomari, Seiichi/GZA-7072-2022	Goodman, Alan/0000-0001-6394-332X; Harding, Heather P/0000-0002-7359-7974; Fisher, Edward/0000-0001-9802-143X; Ron, David/0000-0002-3014-5636	NHLBI NIH HHS [HL58541] Funding Source: Medline; NIDDK NIH HHS [DK47119] Funding Source: Medline; NIEHS NIH HHS [ES08681] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047119, R37DK047119, R29DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARBER GN, 1994, P NATL ACAD SCI USA, V91, P4278, DOI 10.1073/pnas.91.10.4278; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Melville MW, 1999, J BIOL CHEM, V274, P3797, DOI 10.1074/jbc.274.6.3797; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang JX, 1997, MOL BIOL CELL, V8, P1943, DOI 10.1091/mbc.8.10.1943	39	196	204	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2006	126	4					727	739		10.1016/j.cell.2006.06.051	http://dx.doi.org/10.1016/j.cell.2006.06.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	080VN	16923392	Bronze			2022-12-01	WOS:000240276700021
J	Pastalkova, E; Serrano, P; Pinkhasova, D; Wallace, E; Fenton, AA; Sacktor, TC				Pastalkova, Eva; Serrano, Peter; Pinkhasova, Deana; Wallace, Emma; Fenton, Andre Antonio; Sacktor, Todd Charlton			Storage of spatial information by the maintenance mechanism of LTP	SCIENCE			English	Article							LONG-TERM-POTENTIATION; KINASE-M-ZETA; SYNAPTIC-TRANSMISSION; PLACE AVOIDANCE; MESSENGER-RNA; MEMORY; HIPPOCAMPUS; RETRIEVAL; RECONSOLIDATION; CONSOLIDATION	Analogous to learning and memory storage, long-term potentiation (LTP) is divided into induction and maintenance phases. Testing the hypothesis that the mechanism of LTP maintenance stores information requires reversing this mechanism in vivo and finding out whether long-term stored information is lost. This was not previously possible. Recently however, persistent phosphorylation by the atypical protein kinase C isoform, protein kinase Mzeta (PKM zeta), has been found to maintain late LTP in hippocampal slices. Here we show that a cell-permeable PKM zeta inhibitor, injected in the rat hippocampus, both reverses LTP maintenance in vivo and produces persistent loss of 1-day-old spatial information. Thus, the mechanism maintaining LTP sustains spatial memory.	Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pharmacol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Fenton, AA (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	afenton@downstate.edu; tsacktor@downstate.edu		Fenton, Andre/0000-0002-5063-1156	NIMH NIH HHS [R01 MH53576, MH57068] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057068, R01MH053576, R37MH057068] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmed T, 2004, NEUROSCIENCE, V124, P857, DOI 10.1016/j.neuroscience.2004.01.005; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Cimadevilla JM, 2000, NEUROSCI LETT, V285, P53, DOI 10.1016/S0304-3940(00)01019-3; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Jezek K, 2002, PHYSIOL RES, V51, pS35; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moser MB, 1998, J NEUROSCI, V18, P7535; Muslimov IA, 2004, J BIOL CHEM, V279, P52613, DOI 10.1074/jbc.M409240200; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Paulsen O, 2002, NAT NEUROSCI, V5, P289, DOI 10.1038/nn0402-289; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005	27	622	659	3	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1141	1144		10.1126/science.1128657	http://dx.doi.org/10.1126/science.1128657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931766				2022-12-01	WOS:000239998200052
J	Rembold, M; Loosli, F; Adams, RJ; Wittbrodt, J				Rembold, Martina; Loosli, Felix; Adams, Richard J.; Wittbrodt, Joachim			Individual cell migration serves as the driving force for optic vesicle evagination	SCIENCE			English	Article							MEDAKA ORYZIAS-LATIPES; EYE MORPHOGENESIS; NEURAL PLATE; ZEBRAFISH EYE; AXON GUIDANCE; FATE MAP; XENOPUS; MICROSCOPY; CHOKH/RX3; MUTATION	The cellular mechanisms underlying organ formation are largely unknown. We visualized early vertebrate eye morphogenesis at single-cell resolution by in vivo imaging in medaka ( Oryzias latipes). Before optic vesicle evagination, retinal progenitor cells (RPCs) modulate their convergence in a fate-specific manner. Presumptive forebrain cells converge toward the midline, whereas medial RPCs remain stationary, predetermining the site of evagination. Subsequent optic vesicle evagination is driven by the active migration of individual RPCs. The analysis of mutants demonstrated that the retina-specific transcription factor rx3 determines the convergence and migration behaviors of RPCs. Hence, the migration of individual cells mediates essential steps of organ morphogenesis.	European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	European Molecular Biology Laboratory (EMBL); University of Cambridge	Wittbrodt, J (corresponding author), European Mol Biol Lab, Dev Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jochen.wittbrodt@embl.de	Wittbrodt, Joachim/D-4735-2014; Loosli, Felix/H-7415-2013	Wittbrodt, Joachim/0000-0001-8550-7377; Adams, Richard/0000-0003-0280-0901	MRC [G0400709] Funding Source: UKRI; Medical Research Council [G0400709] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andreazzoli M, 1999, DEVELOPMENT, V126, P2451; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Deschet K, 1999, MECH DEVELOP, V83, P179, DOI 10.1016/S0925-4773(99)00037-4; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Easter SS, 2002, RES PRO CEL, V40, P346; Elul T, 2000, DEV BIOL, V224, P3, DOI 10.1006/dbio.2000.9746; Ezin AM, 2003, DEV BIOL, V256, P100, DOI 10.1016/S0012-1606(02)00130-6; Hirose Y, 2004, DEVELOPMENT, V131, P2553, DOI 10.1242/dev.01140; IWAMATSU T, 1994, ZOOL SCI, V11, P825; Kennedy BN, 2004, DEV BIOL, V270, P336, DOI 10.1016/j.ydbio.2004.02.026; Li Z, 2000, DEV DYNAM, V218, P175, DOI 10.1002/(SICI)1097-0177(200005)218:1<175::AID-DVDY15>3.0.CO;2-K; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; Loosli F, 2001, DEVELOPMENT, V128, P4035; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; MORSE DE, 1984, INVEST OPHTH VIS SCI, V25, P899; Rojas-Munoz A, 2005, DEV BIOL, V288, P348, DOI 10.1016/j.ydbio.2005.08.046; SCHMITT EA, 1994, J COMP NEUROL, V344, P532, DOI 10.1002/cne.903440404; Spemann H, 1901, VERH ANAT GESELLSCH, V15, P61; SVOBODA KKH, 1987, DEVELOPMENT, V100, P185; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Winkler S, 2000, DEVELOPMENT, V127, P1911; WOO K, 1995, DEVELOPMENT, V121, P2595	25	127	129	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1130	1134		10.1126/science.1127144	http://dx.doi.org/10.1126/science.1127144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931763				2022-12-01	WOS:000239998200049
J	Schaefer, H; Whiticar, MJ; Brook, EJ; Petrenko, VV; Ferretti, DF; Severinghaus, JP				Schaefer, Hinrich; Whiticar, Michael J.; Brook, Edward J.; Petrenko, Vasilii V.; Ferretti, Dominic F.; Severinghaus, Jeffrey P.			Ice record of delta C-13 for atmospheric CH4 across the Younger Dryas-Preboreal transition	SCIENCE			English	Article							ISOTOPIC COMPOSITION; METHANE; DYNAMICS; INCREASE	We report atmospheric methane carbon isotope ratios (delta(CH4)-C-13) from the Western Greenland ice margin spanning the Younger Dryas - to - Preboreal (YD-PB) transition. Over the recorded similar to 800 years, delta(CH4)-C-13 was around - 46 per mil (parts per thousand); that is, similar to 1 parts per thousand higher than in the modern atmosphere and similar to 5.5 parts per thousand higher than would be expected from budgets without C-13-rich anthropogenic emissions. This requires higher natural C-13-rich emissions or stronger sink fractionation than conventionally assumed. Constant delta(CH4)-C-13 during the rise in methane concentration at the YD-PB transition is consistent with additional emissions from tropical wetlands, or aerobic plant CH4 production, or with a multisource scenario. A marine clathrate source is unlikely.	Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	University of Victoria; Oregon State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Colorado System; University of Colorado Boulder; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Schaefer, H (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 3055, Victoria, BC V8W 3P6, Canada.	schaefeh@geo.oregonstate.edu	Brook, Edward/AAB-7807-2021	Schaefer, Hinrich/0000-0002-1163-2818; Petrenko, Vasilii/0000-0002-0263-8759				Allan W, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005650; Archer D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000854; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Carcaillet C, 2002, CHEMOSPHERE, V49, P845, DOI 10.1016/S0045-6535(02)00385-5; CHAPPELLAZ JA, 1993, TELLUS B, V45, P228, DOI 10.1034/j.1600-0889.1993.t01-2-00002.x; CRAIG H, 1988, SCIENCE, V242, P1535, DOI 10.1126/science.242.4885.1535; Etiope G, 2004, ENVIRON GEOL, V46, P997, DOI 10.1007/s00254-004-1085-1; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Francois LM, 1998, GLOBAL PLANET CHANGE, V17, P37; Grant NJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001851; Hein R, 1997, GLOBAL BIOGEOCHEM CY, V11, P43, DOI 10.1029/96GB03043; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Kaplan JO, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002590; Kaplan JO, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013366; Kennett J. P., 2003, METHANE HYDRATES QUA; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Luyendyk B, 2005, MAR PETROL GEOL, V22, P591, DOI 10.1016/j.marpetgeo.2004.08.005; Miller JB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000630; Peteet D, 2000, P NATL ACAD SCI USA, V97, P1359, DOI 10.1073/pnas.97.4.1359; Petrenko VV, 2006, QUATERNARY SCI REV, V25, P865, DOI 10.1016/j.quascirev.2005.09.005; Quay PD, 1991, GLOBAL BIOGEOCHEM CY, V5, P25, DOI 10.1029/91GB00003; Rice AL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003042; Scholze M, 2003, HOLOCENE, V13, P327, DOI 10.1191/0959683603hl625rp; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Sowers T, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002408; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Tans PP, 1997, GLOBAL BIOGEOCHEM CY, V11, P77, DOI 10.1029/96GB03940; THOMPSON AM, 1993, TELLUS B, V45, P242, DOI 10.1034/j.1600-0889.1993.t01-2-00003.x; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Whiticar M. J., 1993, ATMOSPHERIC METHANE, P138, DOI DOI 10.1007/978-3-642-84605-2_8	30	60	62	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1109	1112		10.1126/science.1126562	http://dx.doi.org/10.1126/science.1126562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16931759				2022-12-01	WOS:000239998200043
J	Savill, NJ; St Rose, SG; Keeling, MJ; Woolhouse, MEJ				Savill, Nicholas J.; St Rose, Suzanne G.; Keeling, Matthew J.; Woolhouse, Mark E. J.			Silent spread of H5N1 in vaccinated poultry	NATURE			English	Article							AVIAN INFLUENZA; EPIDEMIOLOGY; NETHERLANDS		Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Edinburgh; University of Warwick; University of Warwick	Savill, NJ (corresponding author), Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Kings Bldg, Edinburgh EH9 3JT, Midlothian, Scotland.	nick.savill@ed.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765; Woolhouse, Mark/0000-0003-3765-8167				Butler D, 2005, NATURE, V434, P810, DOI 10.1038/4344810a; Elbers ARW, 2004, AVIAN DIS, V48, P691, DOI 10.1637/7149; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; *EUR COMM, 2006, VACC POULTR HIGH PAT; Garcia A, 1998, AVIAN DIS, V42, P248, DOI 10.2307/1592474; Marangon S, 2003, AVIAN DIS, V47, P1006, DOI 10.1637/0005-2086-47.s3.1006; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Woolhouse MEJ, 1997, VET J, V153, P41, DOI 10.1016/S1090-0233(97)80007-X	10	112	115	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 17	2006	442	7104					757	757		10.1038/442757a	http://dx.doi.org/10.1038/442757a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16915278	Bronze			2022-12-01	WOS:000239792700032
J	Stone, A; Jiang, SB				Stone, Alan; Jiang, Shibo			Microbicides: stopping HIV at the gate	LANCET			English	Editorial Material							FUSION		MEDSA, London NW3 7QN, England; New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; So Med Univ, Antiviral Res Ctr, Guangzhou, Peoples R China	New York Blood Center; Southern Medical University - China	Stone, A (corresponding author), MEDSA, London NW3 7QN, England.	alan.stoneX@virgin.net	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	Medical Research Council [MC_U122861322] Funding Source: Medline; NICHD NIH HHS [U19 HD048957-03, U19 HD048957, P01 HD041761] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD041761, U19HD048957] Funding Source: NIH RePORTER; MRC [MC_U122861322] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*ALL MICR DEV, MICR RES DEV DAT; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; D'Cruz OJ, 2006, J ANTIMICROB CHEMOTH, V57, P411, DOI 10.1093/jac/dki464; *GLOB CAMP MICR, 2006, RETH ETH ROADM CLIN; *JOINT UN PROGR HI, 2005, AIDS EP UPD DEC 2005; Liu SW, 2005, ANTIMICROB AGENTS CH, V49, P1830, DOI 10.1128/AAC.49.5.1830-1836.2005; Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326; MATTHEWS J, 2006, MICROBICIDE Q, V4, P7; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Rao S, 2005, P NATL ACAD SCI USA, V102, P11993, DOI 10.1073/pnas.0504881102; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; STONE A, 2003, MICROBICIDE Q, V1, P13; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; 2006, MICR 2006 C CAP TOWN	14	26	34	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2006	368	9534					431	433		10.1016/S0140-6736(06)69131-9	http://dx.doi.org/10.1016/S0140-6736(06)69131-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	071AL	16890813	Green Accepted			2022-12-01	WOS:000239569000008
J	Haerizadeh, F; Singh, MB; Bhalla, PL				Haerizadeh, Farzad; Singh, Mohan B.; Bhalla, Prem L.			Transcriptional repression distinguishes somatic from germ cell lineages in a plant	SCIENCE			English	Article							FLOWERING PLANTS; IDENTIFICATION; SPERM; ARABIDOPSIS; EXPRESSION; PROMOTER; FAMILY; GENES	In flowering plants, the male germline begins with an asymmetric division, after which one of the resulting cells, the generative cell, divides symmetrically to produce two sperm cells. We show here that the male germline is initiated by transcriptional control. We identify GRSF, germline-restrictive silencing factor, from the lily. GRSF is ubiquitous in nongerm cells and is absent from male germ cells. GRSF recognizes silencer sequences in promoters of genes specific to the germline, stably repressing these genes in cells that are not destined to become germ cells.	Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Australian Res Council,Fac land & Food Resources, Ctr Excellence Integrat Legume Res, Parkville, Vic 3010, Australia	University of Melbourne	Bhalla, PL (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Australian Res Council,Fac land & Food Resources, Ctr Excellence Integrat Legume Res, Parkville, Vic 3010, Australia.	premlb@unimelb.edu.au		Singh, Mohan/0000-0001-9427-8975; Bhalla, Prem/0000-0002-2910-0393				Boyle B, 2001, PLANT CELL, V13, P2525, DOI 10.1105/tpc.13.11.2525; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Buttinelli M, 1999, GENETICA, V106, P117, DOI 10.1023/A:1003745315540; COOK WB, 1992, NUCLEIC ACIDS RES, V20, P359, DOI 10.1093/nar/20.2.359; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Imin N, 2006, MOL CELL PROTEOMICS, V5, P274, DOI 10.1074/mcp.M500242-MCP200; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Okada T, 2005, PLANT CELL PHYSIOL, V46, P797, DOI 10.1093/pcp/pci075; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Shidlovskii YV, 2005, EMBO J, V24, P97, DOI 10.1038/sj.emboj.7600508; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; Singh M, 2003, FEBS LETT, V542, P47, DOI 10.1016/S0014-5793(03)00335-1; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Xu HL, 1999, PLANT MOL BIOL, V39, P607, DOI 10.1023/A:1006162120037; Xu HL, 1999, P NATL ACAD SCI USA, V96, P2554, DOI 10.1073/pnas.96.5.2554	19	36	38	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					496	499		10.1126/science.1125526	http://dx.doi.org/10.1126/science.1125526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873660				2022-12-01	WOS:000239308600054
J	Despriet, DDG; Klaver, CCW; Witteman, JCM; Bergen, AAB; Kardys, I; de Maat, MPM; Boekhoorn, SS; Vingerling, JR; Hofman, A; Oostra, BA; Uitterlinden, AG; Stijnen, T; van Duijn, CM; de Jong, PTVM				Despriet, Dominiek D. G.; Klaver, Caroline C. W.; Witteman, Jacqueline C. M.; Bergen, Arthur A. B.; Kardys, Isabella; de Maat, Moniek P. M.; Boekhoorn, Sharmila S.; Vingerling, Johannes R.; Hofman, Albert; Oostra, Ben A.; Uitterlinden, Andre G.; Stijnen, Theo; van Duijn, Cornelia M.; de Jong, Paulus T. V. M.			Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; GENOMEWIDE-SCAN; FAMILIAL AGGREGATION; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; CRP LEVELS; MACULOPATHY; POPULATION; GENE	Context The evidence that inflammation is an important pathway in age-related macular degeneration (AMD) is growing. Recent case-control studies demonstrated an association between the complement factor H (CFH) gene, a regulator of complement, and AMD. Objectives To assess the associations between the CFH gene and AMD in the general population and to investigate the modifying effect of smoking, serum inflammatory markers, and genetic variation of C-reactive protein (CRP). Design, Setting, and Participants Population-based, prospective cohort study of individuals aged 55 years or older (enrollment between March 20, 1990, and July 31, 1993, and 3 follow-up examinations that were performed between September 1, 1993, and December 31, 2004) in Rotterdam, the Netherlands. The CFH Y402H polymorphism was determined in a total of 5681 individuals. Information on smoking, erythrocyte sedimentation rate, CRP serum levels, and haplotypes of the CRP gene were assessed at baseline. Main Outcome Measures All severity stages of prevalent and incident AMD, graded according to the international classification and grading system for AMD. Results The frequency of CFH Y402H was 36.2% (4116/11 362 alleles). At baseline, there were 2062 persons (36.3%) with any type of AMD (prevalent cases), including 78 (1.4%) with late AMD (stage 4). During follow-up (mean, 8 years; median, 10 years), 1649 (35.5%) of 4642 participants progressed to a higher stage of AMD (incident cases), including 93 (5.6%) who developed late AMD. The odds ratio (OR) of AMD increased in an allele-dose manner with 2.00 (95% confidence interval [CI], 1.56-2.55) for stage 2 AMD, 4.58 (95% CI, 2.82-7.44) for stage 3 AMD, and 11.02 (95% CI, 6.82-11.81) for stage 4 (late, vision threatening) AMD for homozygous persons. Cumulative risks calculated by Kaplan-Meier analysis of late AMD by age 95 years were 48.3% for homozygotes, 42.6% for heterozygotes, and 21.9% for noncarriers. The population-attributable risk for CFH Y402H was 54.0%. Elevated erythrocyte sedimentation rates further increased the OR to 20.2 (95% CI, 9.5-43.0), elevated serum CRP levels to 27.7 (95% CI, 10.7-72.0), and smoking to 34.0 (95% CI, 13.0-88.6) for homozygotes compared with noncarriers without these determinants. The CRP haplotypes conferring high levels of CRP significantly increased the effect of CFH Y402H (P<.01). Conclusions The CFH Y402H polymorphism may account for a substantial proportion of AMD in individuals similar to those in the Rotterdam Study and may confer particular risk in the presence of environmental and genetic stimulators of the complement cascade.	Netherlands Inst Neurosci, Dept Mol & Clin Ophthalmogenet, NL-1105 BA Amsterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; Erasmus MC, Dept Hematol, Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Jong, PTVM (corresponding author), Netherlands Inst Neurosci, Dept Mol & Clin Ophthalmogenet, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.dejong@nin.knaw.nl	Klaver, Caroline C.W./A-2013-2016; Bergen, Arthur/J-3637-2013	Bergen, Arthur/0000-0002-6333-9576; Van Duijn, Cornelia/0000-0002-2374-9204; Klaver, Caroline/0000-0002-2355-5258				Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Giannakis E, 2001, INT IMMUNOPHARMACOL, V1, P433, DOI 10.1016/S1567-5769(00)00040-0; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Souied EH, 2005, MOL VIS, V11, P1135; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	35	262	285	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					301	309		10.1001/jama.296.3.301	http://dx.doi.org/10.1001/jama.296.3.301			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849663	Bronze			2022-12-01	WOS:000239089900022
J	Frezza, C; Cipolat, S; de Brito, OM; Micaroni, M; Beznoussenko, GV; Rudka, T; Bartoli, D; Polishuck, RS; Danial, NN; De Strooper, B; Scorrano, L				Frezza, Christian; Cipolat, Sara; de Brito, Olga Martins; Micaroni, Massimo; Beznoussenko, Galina V.; Rudka, Tomasz; Bartoli, Davide; Polishuck, Roman S.; Danial, Nika N.; De Strooper, Bart; Scorrano, Luca			OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion	CELL			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; PROTEIN; FISSION; MITOFUSIN-1; BAX; MORPHOLOGY; MEDIATOR; REQUIRES; GTPASE	Mitochondria amplify activation of caspases during apoptosis by releasing cytochrome c and other cofactors. This is accompanied by fragmentation of the organelle and remodeling of the cristae. Here we provide evidence that Optic Atrophy 1 (OPA1), a profusion dynamin-related protein of the inner mitochondrial membrane mutated in dominant optic atrophy, protects from apoptosis by preventing cytochrome c release independently from mitochondrial fusion. OPA1 does not interfere with activation of the mitochondrial "gatekeepers" BAX and BAK, but it controls the shape of mitochondrial cristae, keeping their junctions; tight during apoptosis. Tightness of cristae junctions correlates with oligomerization of two forms of OPA1, a soluble, intermembrane space and an integral inner membrane one. The proapoptotic BCL-2 family member BID, which widens cristae junctions, also disrupts OPA1 oligomers. Thus, OPA1 has genetically and molecularly distinct functions in mitochondrial fusion and in cristae remodeling during apoptosis.	Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy; Flanders Interuniv Inst Biotechnol, VIB4, Ctr Human Genet, Neuronal Cell Biol & Gene Transfer Lab, Louvain, Belgium; Katholieke Univ Leuven, Louvain, Belgium; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; KU Leuven; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.	luca.scorrano@unipd.it	Scorrano, Luca/K-3967-2019; de+Strooper, Bart/Z-1638-2019; Frezza, Christian/G-2174-2010; Scorrano, Luca/A-6652-2008; De Strooper, Bart/F-6507-2012	Scorrano, Luca/0000-0002-8515-8928; Frezza, Christian/0000-0002-3293-7397; Scorrano, Luca/0000-0002-8515-8928; De Strooper, Bart/0000-0001-5455-5819; Micaroni, Massimo/0000-0001-6405-0451	Telethon [TCP02016] Funding Source: Medline	Telethon(Fondazione Telethon)		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; NICHOLLS P, 1980, CAN J BIOCHEM CELL B, V58, P969, DOI 10.1139/o80-132; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	47	1128	1158	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					177	189		10.1016/j.cell.2006.06.025	http://dx.doi.org/10.1016/j.cell.2006.06.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839885	Bronze, Green Accepted			2022-12-01	WOS:000239224800025
J	Dresler, CM; Leon, ME; Straif, K; Baan, R; Secretan, B				Dresler, Carolyn M.; Leon, Maria E.; Straif, Kurt; Baan, Robert; Secretan, Beatrice			Reversal of risk upon quitting smoking	LANCET			English	Editorial Material							MALE BRITISH DOCTORS; LUNG-FUNCTION; CESSATION; MORTALITY; CANCER; HEALTH; DISEASE; WOMEN		Int Agcy Res Canc, F-69008 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Dresler, CM (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France.	dresler@iarc.fr		Lauby-Secretan, Beatrice/0000-0001-6559-3351				[Anonymous], 2004, HLTH CONS SMOK REP S; [Anonymous], 2004, IARC MON EV CARC RIS; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; BROWN CA, 1991, THORAX, V46, P112, DOI 10.1136/thx.46.2.112; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; GARFINKEL L, 1988, CANCER RES, V48, P6951; Hooi JD, 2001, AM J EPIDEMIOL, V153, P666, DOI 10.1093/aje/153.7.666; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Rajkumar T, 2006, INT J CANCER, V118, P1481; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044	14	38	41	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					348	349		10.1016/S0140-6736(06)69086-7	http://dx.doi.org/10.1016/S0140-6736(06)69086-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069JJ	16876647				2022-12-01	WOS:000239441900008
